#BEGIN_DRUGCARD DB01907

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
53-84-9

# ChEBI_ID:
15846

# Chemical_Formula:
C21H27N7O14P2

# Chemical_IUPAC_Name:
1-[(2S,3S,4R,5S)-5-({[(S)-({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl phosphonato)]oxy}methyl)-3,4-dihydroxyoxolan-2-yl]-3-carbamoyl-1$l^{5}-pyridin-1-ylium

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Nicotinamide-Adenine-Dinucleotide

# HET_ID:
NAD

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C21H27N7O14P2/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33/h1-4,7-8,10-11,13-16,20-21,29-32H,5-6H2,(H5-,22,23,24,25,33,34,35,36,37)/t10-,11+,13-,14+,15-,16+,20-,21+/m0/s1

# InChI_Key:
InChIKey=BAWFJGJZGIEFAR-DQQFMEOOSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C00003

# KEGG_Drug_ID:
D00002

# LIMS_Drug_ID:
1907

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
663.4251

# Molecular_Weight_Mono:
663.109121631

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1OG3
2BGL

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.2

# Predicted_LogS:
-2.5

# Predicted_Water_Solubility:
2.14e+00 g/l

# Primary_Accession_No:
DB01907

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
Not Available

# PubChem_Substance_ID:
Not Available

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
DB03527
EXPT02287

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
NC(=O)C1=CC=C[N+](=C1)[C@H]1O[C@@H](CO[P@]([O-])(=O)O[P@@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C2N=CN=C3N)[C@H](O)[C@@H]1O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:36 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_100_Cellular_Location:
Not Available

# Drug_Target_100_Chromosome_Location:
Not Available

# Drug_Target_100_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_100_Essentiality:
Non-Essential

# Drug_Target_100_GenAtlas_ID:
Not Available

# Drug_Target_100_GenBank_ID_Gene:
D10497

# Drug_Target_100_GenBank_ID_Protein:
912437

# Drug_Target_100_GeneCard_ID:
Not Available

# Drug_Target_100_Gene_Name:
hdhA

# Drug_Target_100_Gene_Sequence:
>768 bp
GTGTTTAATTCTGACAACCTGAGACTCGACGGAAAATGCGCCATCATCACAGGTGCGGGT
GCAGGTATTGGTAAAGAAATCGCCATTACATTCGCGACAGCTGGCGCATCTGTGGTGGTC
AGTGATATTAACGCCGACGCAGCTAACCATGTTGTAGACGAAATTCAACAACTGGGTGGT
CAGGCATTTGCCTGCCGTTGTGATATTACTTCCGAACAGGAACTCTCTGCACTGGCAGAC
TTTGCTATCAGTAAGCTGGGTAAAGTTGATATTCTGGTTAACAACGCCGGTGGCGGTGGA
CCTAAACCGTTTGATATGCCAATGGCGGATTTTCGCCGTGCTTATGAACTGAATGTGTTT
TCTTTTTTCCATCTGTCACAACTTGTTGCGCCAGAAATGGAAAAAAATGGCGGTGGCGTT
ATTCTGACCATCACTTCTATGGCGGCAGAAAATAAAAATATAAACATGACTTCCTATGCA
TCATCTAAAGCTGCGGCCAGTCATCTGGTCAGAAATATGGCGTTTGACCTGGGTGAAAAA
AATATTCGGGTAAATGGCATTGCGCCGGGGGCAATATTAACCGATGCCCTGAAATCCGTT
ATTACACCAGAAATTGAACAAAAAATGTTACAGCACACGCCGATCAGACGTCTGGGCCAA
CCGCAAGATATTGCTAACGCAGCGCTGTTCCTTTGCTCGCCTGCTGCGAGCTGGGTAAGC
GGACAAATTCTCACCGTCTCCGGTGGTGGGGTACAGGAGCTCAATTAA

# Drug_Target_100_General_Function:
Lipid transport and metabolism

# Drug_Target_100_General_References:
2007545	Yoshimoto T, Higashi H, Kanatani A, Lin XS, Nagai H, Oyama H, Kurazono K, Tsuru D: Cloning and sequencing of the 7 alpha-hydroxysteroid dehydrogenase gene from Escherichia coli HB101 and characterization of the expressed enzyme. J Bacteriol. 1991 Apr;173(7):2173-9.
8672472	Tanaka N, Nonaka T, Tanabe T, Yoshimoto T, Tsuru D, Mitsui Y: Crystal structures of the binary and ternary complexes of 7 alpha-hydroxysteroid dehydrogenase from Escherichia coli. Biochemistry. 1996 Jun 18;35(24):7715-30.
9097039	Aiba H, Baba T, Hayashi K, Inada T, Isono K, Itoh T, Kasai H, Kashimoto K, Kimura S, Kitakawa M, Kitagawa M, Makino K, Miki T, Mizobuchi K, Mori H, Mori T, Motomura K, Nakade S, Nakamura Y, Nashimoto H, Nishio Y, Oshima T, Saito N, Sampei G, Horiuchi T, et al.: A 570-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 28.0-40.1 min region on the linkage map. DNA Res. 1996 Dec 31;3(6):363-77.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_100_HGNC_ID:
Not Available

# Drug_Target_100_HPRD_ID:
Not Available

# Drug_Target_100_ID:
3671

# Drug_Target_100_Locus:
Not Available

# Drug_Target_100_Molecular_Weight:
26779

# Drug_Target_100_Name:
7-alpha-hydroxysteroid dehydrogenase

# Drug_Target_100_Number_of_Residues:
255

# Drug_Target_100_PDB_ID:
1FMC

# Drug_Target_100_Pathway:
Not Available

# Drug_Target_100_Pfam_Domain_Function:
PF00106	adh_short

# Drug_Target_100_Protein_Sequence:
>7-alpha-hydroxysteroid dehydrogenase
MFNSDNLRLDGKCAIITGAGAGIGKEIAITFATAGASVVVSDINADAANHVVDEIQQLGG
QAFACRCDITSEQELSALADFAISKLGKVDILVNNAGGGGPKPFDMPMADFRRAYELNVF
SFFHLSQLVAPEMEKNGGGVILTITSMAAENKNINMTSYASSKAAASHLVRNMAFDLGEK
NIRVNGIAPGAILTDALKSVITPEIEQKMLQHTPIRRLGQPQDIANAALFLCSPAASWVS
GQILTVSGGGVQELN

# Drug_Target_100_Reaction:
3alpha,7alpha,12alpha-trihydroxy-5beta-cholanate + NAD+ = 3alpha,12alpha-dihydroxy-7-oxo-5beta-cholanate + NADH + H+

# Drug_Target_100_Signals:
None

# Drug_Target_100_Specific_Function:
7-alpha-dehydroxylation of cholic acid, yielding deoxycholic acid and lithocholic acid, respectively. Highest affinity with taurochenodeoxycholic acid

# Drug_Target_100_SwissProt_ID:
P0AET8

# Drug_Target_100_SwissProt_Name:
HDHA_ECOLI

# Drug_Target_100_Synonyms:
7-alpha-HSDH
EC 1.1.1.159

# Drug_Target_100_Theoretical_pI:
5.04

# Drug_Target_100_Transmembrane_Regions:
None

# Drug_Target_101_Cellular_Location:
Cytoplasm

# Drug_Target_101_Chromosome_Location:
Not Available

# Drug_Target_101_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_101_Essentiality:
Non-Essential

# Drug_Target_101_GenAtlas_ID:
Not Available

# Drug_Target_101_GenBank_ID_Gene:
K01444

# Drug_Target_101_GenBank_ID_Protein:
460072

# Drug_Target_101_GeneCard_ID:
Not Available

# Drug_Target_101_Gene_Name:
leuB

# Drug_Target_101_Gene_Sequence:
>1038 bp
ATGAAGGTGGCCGTGCTCCCCGGGGACGGGATCGGCCCCGAGGTCACCGAGGCCGCCCTG
AAGGTCCTGAGGGCCCTGGACGAGGCCGAGGGCCTGGGCCTCGCCTACGAGGTCTTCCCC
TTCGGCGGGGCGGCCATAGACGCCTTCGGCGAGCCCTTCCCCGAGCCCACGCGAAAGGGC
GTGGAGGAGGCGGAGGCGGTGCTTCTGGGAAGCGTGGGGGGGCCCAAGTGGGACGGCCTT
CCCCGCAAGATCAGCCCGGAGACGGGGCTTCTTTCCTTAAGGAAAAGCCAGGACCTCTTC
GCCAACCTCCGCCCGGCCAAGGTCTTCCCTGGGCTGGAAAGGCTTTCCCCCCTGAAGGAG
GAGATCGCCCGGGGGGTGGACGTCCTCATCGTCCGGGAGCTCACCGGGGGGATCTACTTC
GGGGAGCCCCGGGGGATGTCCGAGGCCGAGGCCTGGAACACGGAGCGCTACAGCAAGCCC
GAGGTGGAGCGGGTGGCCCGGGTGGCCTTTGAGGCGGCGAGGAAGCGCAGGAAGCACGTG
GTGAGCGTGGACAAGGCGAACGTCCTCGAGGTGGGAGAGTTCTGGCGCAAGACCGTGGAG
GAGGTGGGGCGGGGCTACCCCGACGTCGCCCTGGAGCACCAGTATGTGGACGCCATGGCC
ATGCACCTGGTCCGCTCCCCTGCCCGCTTTGACGTGGTGGTCACGGGGAACATCTTCGGG
GACATCCTCTCGGACCTGGCGAGCGTCCTCCCGGGCTCTCTAGGCCTCCTCCCCTCCGCC
TCCTTGGGAAGGGGCACCCCGGTCTTTGAGCCCGTGCACGGCTCCGCCCCCGACATCGCC
GGCAAGGGGATCGCTAACCCCACGGCCGCCATCCTCTCCGCGGCCATGATGCTGGAGCAC
GCCTTCGGCCTGGTGGAGCTGGCGCGGAAGGTGGAAGACGCGGTGGCCAAGGCCCTCCTG
GAGACCCCGCCCCCGGACCTCGGAGGAAGCGCGGGCACGGAGGCCTTCACGGCCACGGTC
CTCCGCCACCTCGCCTAA

# Drug_Target_101_General_Function:
Energy production and conversion

# Drug_Target_101_General_References:
10810156	Nurachman Z, Akanuma S, Sato T, Oshima T, Tanaka N: Crystal structures of 3-isopropylmalate dehydrogenases with mutations at the C-terminus: crystallographic analyses of structure-stability relationships. Protein Eng. 2000 Apr;13(4):253-8.
1748999	Imada K, Sato M, Tanaka N, Katsube Y, Matsuura Y, Oshima T: Three-dimensional structure of a highly thermostable enzyme, 3-isopropylmalate dehydrogenase of Thermus thermophilus at 2.2 A resolution. J Mol Biol. 1991 Dec 5;222(3):725-38.
6321488	Kagawa Y, Nojima H, Nukiwa N, Ishizuka M, Nakajima T, Yasuhara T, Tanaka T, Oshima T: High guanine plus cytosine content in the third letter of codons of an extreme thermophile. DNA sequence of the isopropylmalate dehydrogenase of Thermus thermophilus. J Biol Chem. 1984 Mar 10;259(5):2956-60.
8119295	Kirino H, Aoki M, Aoshima M, Hayashi Y, Ohba M, Yamagishi A, Wakagi T, Oshima T: Hydrophobic interaction at the subunit interface contributes to the thermostability of 3-isopropylmalate dehydrogenase from an extreme thermophile, Thermus thermophilus. Eur J Biochem. 1994 Feb 15;220(1):275-81.

# Drug_Target_101_HGNC_ID:
Not Available

# Drug_Target_101_HPRD_ID:
Not Available

# Drug_Target_101_ID:
2350

# Drug_Target_101_Locus:
Not Available

# Drug_Target_101_Molecular_Weight:
36781

# Drug_Target_101_Name:
3-isopropylmalate dehydrogenase

# Drug_Target_101_Number_of_Residues:
345

# Drug_Target_101_PDB_ID:
1XAB

# Drug_Target_101_Pathway:
Not Available

# Drug_Target_101_Pfam_Domain_Function:
PF00180	Iso_dh

# Drug_Target_101_Protein_Sequence:
>3-isopropylmalate dehydrogenase
MKVAVLPGDGIGPEVTEAALKVLRALDEAEGLGLAYEVFPFGGAAIDAFGEPFPEPTRKG
VEEAEAVLLGSVGGPKWDGLPRKIRPETGLLSLRKSQDLFANLRPAKVFPGLERLSPLKE
EIARGVDVLIVRELTGGIYFGEPRGMSEAEAWNTERYSKPEVERVARVAFEAARKRRKHV
VSVDKANVLEVGEFWRKTVEEVGRGYPDVALEHQYVDAMAMHLVRSPARFDVVVTGNIFG
DILSDLASVLPGSLGLLPSASLGRGTPVFEPVHGSAPDIAGKGIANPTAAILSAAMMLEH
AFGLVELARKVEDAVAKALLETPPPDLGGSAGTEAFTATVLRHLA

# Drug_Target_101_Reaction:
(1) (1a) (2R,3S)-3-isopropylmalate + NAD+ = (2S)-2-isopropyl-3-oxosuccinate + NADH + H+

# Drug_Target_101_Signals:
None

# Drug_Target_101_Specific_Function:
Catalyzes the oxidation of 3-carboxy-2-hydroxy-4- methylpentanoate (3-isopropylmalate) to 3-carboxy-4-methyl-2- oxopentanoate. The product decarboxylates to 4-methyl-2 oxopentanoate

# Drug_Target_101_SwissProt_ID:
Q5SIY4

# Drug_Target_101_SwissProt_Name:
LEU3_THET8

# Drug_Target_101_Synonyms:
3-IPM-DH
Beta-IPM dehydrogenase
EC 1.1.1.85
IMDH

# Drug_Target_101_Theoretical_pI:
5.18

# Drug_Target_101_Transmembrane_Regions:
None

# Drug_Target_102_Cellular_Location:
Cytoplasm

# Drug_Target_102_Chromosome_Location:
Not Available

# Drug_Target_102_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_102_Essentiality:
Non-Essential

# Drug_Target_102_GenAtlas_ID:
ADH1C

# Drug_Target_102_GenBank_ID_Gene:
X04299

# Drug_Target_102_GenBank_ID_Protein:
28404

# Drug_Target_102_GeneCard_ID:
ADH1C

# Drug_Target_102_Gene_Name:
ADH1C

# Drug_Target_102_Gene_Sequence:
>1128 bp
ATGAGCACAGCAGGAAAAGTAATCAAATGCAAAGCAGCTGTGCTATGGGAGTTAAAGAAA
CCCTTTTCCATTGAGGAGGTAGAGGTTGCACCTCCTAAGGCTCATGAAGTTCGCATTAAG
ATGGTGGCTGCAGGAATCTGTCGTTCAGATGAGCATGTGGTTAGTGGCAACCTGGTGACC
CCCCTTCCTGTGATTTTAGGCCATGAGGCAGCCGGCATCGTGGAAAGTGTTGGAGAAGGG
GTGACTACAGTCAAACCAGGTGATAAAGTCATCCCGCTCTTTACTCCTCAGTGTGGAAAA
TGCAGAATTTGCAAAAACCCAGAAAGCAACTACTGCTTGAAAAATGATCTAGGCAATCCT
CGGGGGACCCTGCAGGATGGCACCAGGAGGTTCACCTGCAGCGGGAAGCCCATCCACCAC
TTCGTCGGCGTCAGCACCTTCTCCCAGTACACAGTGGTGGATGAGAATGCAGTAGCCAAA
ATTGATGCAGCCTCGCCCCTGGAGAAAGTCTGCCTCATTGGCTGTGGATTTTCGACTGGT
TATGGGTCTGCAGTCAAAGTTGCCAAGGTCACCCCAGGGTCTACCTGTGCTGTGTTTGGC
CTGGGAGGGGTCGGCCTATCTGTTGTTATGGGCTGTAAAGCAGCTGGAGCAGCCAGAATC
ATTGCTGTGGACATCAACAAGGACAAATTTGCAAAGGCTAAAGAGTTGGGTGCCACTGAA
TGCATCAACCCTCAAGACTACAAGAAACCCATTCAGGAAGTGCTAAAGGAAATGACTGAT
GGAGGTGTGGATTTTTCGTTTGAAGTCATCGGTCAGCTTGACACCATGATGGCTTCCCTG
TTATGTTGTCATGAGGCATGTGGCACAAGTGTCATTGTAGGGGTACCTCCTGATTCCCAG
AACCTCTCAATAAACCCTATGCTGCTACTGACTGGACGCACGTGGAAAGGAGCTATTTTT
GGAGGCTTTAAGAGTAAAGAATCTGTCCCCAAACTTGTGGCTGACTTTATGGCTAAGAAG
TTTTCACTGGATGCATTAATAACAAATGTTTTACCTTTTGAAAAAATAAATGAAGGATTT
GACCTGCTTCGCTCTGGAAAGAGTATCCGTACCGTCCTGACGTTTTGA

# Drug_Target_102_General_Function:
Energy production and conversion

# Drug_Target_102_General_References:
1524834	Yokoyama S, Matsuo Y, Rajasekharan S, Yokoyama R: Molecular structure of the human alcohol dehydrogenase 3 gene. Jpn J Genet. 1992 Apr;67(2):167-71.
2935875	Ikuta T, Szeto S, Yoshida A: Three human alcohol dehydrogenase subunits: cDNA structure and molecular and evolutionary divergence. Proc Natl Acad Sci U S A. 1986 Feb;83(3):634-8.
3758060	Hoog JO, Heden LO, Larsson K, Jornvall H, von Bahr-Lindstrom H: The gamma 1 and gamma 2 subunits of human liver alcohol dehydrogenase. cDNA structures, two amino acid replacements, and compatibility with changes in the enzymatic properties. Eur J Biochem. 1986 Sep 1;159(2):215-8.
6391921	Buhler R, Hempel J, Kaiser R, de Zalenski C, von Wartburg JP, Jornvall H: Human liver alcohol dehydrogenase. 2. The primary structure of the gamma 1 protein chain. Eur J Biochem. 1984 Dec 17;145(3):447-53.

# Drug_Target_102_HGNC_ID:
HGNC:251

# Drug_Target_102_HPRD_ID:
00066

# Drug_Target_102_ID:
517

# Drug_Target_102_Locus:
4q21-q23

# Drug_Target_102_Molecular_Weight:
39737

# Drug_Target_102_Name:
Alcohol dehydrogenase 1C

# Drug_Target_102_Number_of_Residues:
374

# Drug_Target_102_PDB_ID:
1HT0

# Drug_Target_102_Pathway:
Not Available

# Drug_Target_102_Pfam_Domain_Function:
PF00107	ADH_zinc_N
PF08240	ADH_N

# Drug_Target_102_Protein_Sequence:
>Alcohol dehydrogenase 1C
STAGKVIKCKAAVLWELKKPFSIEEVEVAPPKAHEVRIKMVAAGICRSDEHVVSGNLVTP
LPVILGHEAAGIVESVGEGVTTVKPGDKVIPLFTPQCGKCRICKNPESNYCLKNDLGNPR
GTLQDGTRRFTCSGKPIHHFVGVSTFSQYTVVDENAVAKIDAASPLEKVCLIGCGFSTGY
GSAVKVAKVTPGSTCAVFGLGGVGLSVVMGCKAAGAARIIAVDINKDKFAKAKELGATEC
INPQDYKKPIQEVLKEMTDGGVDFSFEVIGRLDTMMASLLCCHEACGTSVIVGVPPDSQN
LSINPMLLLTGRTWKGAIFGGFKSKESVPKLVADFMAKKFSLDALITNILPFEKINEGFD
LLRSGKSIRTVLTF

# Drug_Target_102_Reaction:
an alcohol + NAD+ = an aldehyde or ketone + NADH + H+

# Drug_Target_102_Signals:
None

# Drug_Target_102_Specific_Function:
Not Available

# Drug_Target_102_SwissProt_ID:
P00326

# Drug_Target_102_SwissProt_Name:
ADH1G_HUMAN

# Drug_Target_102_Synonyms:
Alcohol dehydrogenase gamma subunit
EC 1.1.1.1

# Drug_Target_102_Theoretical_pI:
8.38

# Drug_Target_102_Transmembrane_Regions:
None

# Drug_Target_103_Cellular_Location:
Not Available

# Drug_Target_103_Chromosome_Location:
Not Available

# Drug_Target_103_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_103_Essentiality:
Non-Essential

# Drug_Target_103_GenAtlas_ID:
Not Available

# Drug_Target_103_GenBank_ID_Gene:
M15328

# Drug_Target_103_GenBank_ID_Protein:
146974

# Drug_Target_103_GeneCard_ID:
Not Available

# Drug_Target_103_Gene_Name:
nadE

# Drug_Target_103_Gene_Sequence:
>825 bp
ATGACATTGCAACAACAAATAATAAAGGCGCTGGGCGAAAACCGCAGATTAATGCTGAAG
AGGAAATTCGTCGTAGTGTCGATTTCTGAAAGCTACCTGCAAACTTATCCGTTCATTAAA
TCACTGGTGCTCGGGATCAGCGGCGGTCAGGACTCCACGCTTGCCGGAAAGCTGTGCCAG
ATGGCGATTAATGAGCTGCGCCTGGAAACCGGCAACGAATCACTGCAATTTATTGCCGTA
CGCCTGCCCTATGGTGTTCAGGCCGACGAACAAGATTGCCAGGATGCCATTGCCTTTATT
CAACCGGATCGCGTATTAACCGTTAATATCAAGGGCGCGGTATTGGCCAGCGAACAGGCA
TTGCGGGAAGCAGGCATTGAACTGAGCGATTTTGTCCGTGGCAATGAAAAAGCGCGTGAG
CGGATGAAAGCACAATATAGCATTGCGGGTATGACCAGCGGTGTCGTGGTGGGCACCGAT
CATGCAGCAGAAGCCATTACCGGATTCTTCACTAAATATGGTGACGGCGGTACGGACATT
AATCCGCTGTATCGTCTCAACAAACGTCAGGGTAAACAGTTACTGGCGGCATTAGCTTGC
CCGGAACACCTTTATAAGAAAGCGCCAACGGCCGATCTGGAAGATGATCGCCCTTCTCTG
CCAGATGAAGTGGCACTCGGCGTGACCTATGACAATATCGACGACTATCTGGAAGGGAAA
AACGTACCTCAACAGGTCGCCAGAACAATAGAGAACTGGTATCTGAAAACCGAACATAAA
CGCCGTCCGCCAATTACCGTTTTCGATGATTTCTGGAAAAAGTAA

# Drug_Target_103_General_Function:
Coenzyme transport and metabolism

# Drug_Target_103_General_References:
1512214	Willison JC: An essential gene (efg) located at 38.1 minutes on the Escherichia coli chromosome. J Bacteriol. 1992 Sep;174(17):5765-6.
3025172	Allibert P, Willison JC, Vignais PM: Complementation of nitrogen-regulatory (ntr-like) mutations in Rhodobacter capsulatus by an Escherichia coli gene: cloning and sequencing of the gene and characterization of the gene product. J Bacteriol. 1987 Jan;169(1):260-71.
8195100	Willison JC, Tissot G: The Escherichia coli efg gene and the Rhodobacter capsulatus adgA gene code for NH3-dependent NAD synthetase. J Bacteriol. 1994 Jun;176(11):3400-2.
9097039	Aiba H, Baba T, Hayashi K, Inada T, Isono K, Itoh T, Kasai H, Kashimoto K, Kimura S, Kitakawa M, Kitagawa M, Makino K, Miki T, Mizobuchi K, Mori H, Mori T, Motomura K, Nakade S, Nakamura Y, Nashimoto H, Nishio Y, Oshima T, Saito N, Sampei G, Horiuchi T, et al.: A 570-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 28.0-40.1 min region on the linkage map. DNA Res. 1996 Dec 31;3(6):363-77.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9298646	Link AJ, Robison K, Church GM: Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12. Electrophoresis. 1997 Aug;18(8):1259-313.

# Drug_Target_103_HGNC_ID:
Not Available

# Drug_Target_103_HPRD_ID:
Not Available

# Drug_Target_103_ID:
2434

# Drug_Target_103_Locus:
Not Available

# Drug_Target_103_Molecular_Weight:
30637

# Drug_Target_103_Name:
NH(3)-dependent NAD(+) synthetase

# Drug_Target_103_Number_of_Residues:
275

# Drug_Target_103_PDB_ID:
1WXI

# Drug_Target_103_Pathway:
Not Available

# Drug_Target_103_Pfam_Domain_Function:
PF02540	NAD_synthase

# Drug_Target_103_Protein_Sequence:
>NH(3)-dependent NAD(+) synthetase
MTLQQQIIKALGAKPQINAEEEIRRSVDFLKSYLQTYPFIKSLVLGISGGQDSTLAGKLC
QMAINELRLETGNESLQFIAVRLPYGVQADEQDCQDAIAFIQPDRVLTVNIKGAVLASEQ
ALREAGIELSDFVRGNEKARERMKAQYSIAGMTSGVVVGTDHAAEAITGFFTKYGDGGTD
INPLYRLNKRQGKQLLAALACPEHLYKKAPTADLEDDRPSLPDEVALGVTYDNIDDYLEG
KNVPQQVARTIENWYLKTEHKRRPPITVFDDFWKK

# Drug_Target_103_Reaction:
ATP + deamido-NAD+ + NH3 = AMP + diphosphate + NAD+

# Drug_Target_103_Signals:
None

# Drug_Target_103_Specific_Function:
Catalyzes a key step in NAD biosynthesis, transforming deamido-NAD into NAD by a two-step reaction

# Drug_Target_103_SwissProt_ID:
P18843

# Drug_Target_103_SwissProt_Name:
NADE_ECOLI

# Drug_Target_103_Synonyms:
EC 6.3.1.5
NADS
Nicotinamide adenine dinucleotide synthetase
Nitrogen-regulatory protein

# Drug_Target_103_Theoretical_pI:
5.24

# Drug_Target_103_Transmembrane_Regions:
None

# Drug_Target_104_Cellular_Location:
Cytoplasm

# Drug_Target_104_Chromosome_Location:
Not Available

# Drug_Target_104_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_104_Essentiality:
Non-Essential

# Drug_Target_104_GenAtlas_ID:
Not Available

# Drug_Target_104_GenBank_ID_Gene:
X74302

# Drug_Target_104_GenBank_ID_Protein:
396281

# Drug_Target_104_GeneCard_ID:
Not Available

# Drug_Target_104_Gene_Name:
ldh

# Drug_Target_104_Gene_Sequence:
>960 bp
ATGAAAATAGGTATCGTAGGACTCGGAAGGGTTGGTTCCAGCACGGCTTTTGCACTCCTG
ATGAAAGGTTTTGCGAGGGAAATGGTTCTGATAGACGTCGATAAGAAAAGAGCAGAAGGA
GACGCTCTCGATCTCATTCACGGAACACCTTTCACGAGAAGAGCGAACATCTACGCTGGA
GACTATGCGGATCTGAAAGGATCAGATGTGGTGATCGTCGCTGCGGGAGTACCTCAGAAA
CCAGGAGAGACGAGGCTTCAGCTTCTTGGGAGAAATGCAAGAGTGATGAAAGAAATAGCG
CGAAACGTCTCCAAATACGCTCCTGATTCGATTGTCATCGTGGTCACGAATCCCGTCGAT
GTCCTCACGTATTTCTTCCTCAAAGAGTCCGGAATGGATCCCAGGAAGGTGTTCGGTTCC
GGAACGGTTCTCGACACAGCAAGGCTCAGAACTTTGATAGCGCAACACTGCGGCTTTTCT
CCAAGAAGTGTGCACGTGTACGTGATAGGAGAACATGGAGATTCAGAGGTTCCTGTGTGG
AGCGGTGCCATGATAGGAGGTATCCCCCTACAGAACATGTGTCAGATTTGTCAGAAGTGC
GATTCGAAGATACTGGAAAACTTCGCTGAAAAAACCAAAAGAGCCGCGTACGAGATCATA
GAGAGAAAGGGAGCCACCCATTACGCCATAGCTCTCGCCGTGGCCGACATAGTGGAGAGC
ATCTTCTTCGACGAAAAGAGAGTGCTTACGCTTTCCGTTTATCTCGAAGATTACCTCGGT
GTAAAAGATCTCTGTATCAGTGTTCCTGTTACCCTTGGAAAGCACGGAGTGGAAAGAATC
CTCGAACTGAACCTGAACGAAGAAGAACTGGAAGCCTTCAGAAAGTCAGCTTCCATATTG
AAAAACGCCATCAACGAAATAACGGCCGAAGAGAACAAGCACCAGAACACCAGCGGTTAA

# Drug_Target_104_General_Function:
Energy production and conversion

# Drug_Target_104_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.
2318202	Wrba A, Jaenicke R, Huber R, Stetter KO: Lactate dehydrogenase from the extreme thermophile Thermotoga maritima. Eur J Biochem. 1990 Feb 22;188(1):195-201.
8404889	Ostendorp R, Liebl W, Schurig H, Jaenicke R: The L-lactate dehydrogenase gene of the hyperthermophilic bacterium Thermotoga maritima cloned by complementation in Escherichia coli. Eur J Biochem. 1993 Sep 15;216(3):709-15.
9655830	Auerbach G, Ostendorp R, Prade L, Korndorfer I, Dams T, Huber R, Jaenicke R: Lactate dehydrogenase from the hyperthermophilic bacterium thermotoga maritima: the crystal structure at 2.1 A resolution reveals strategies for intrinsic protein stabilization. Structure. 1998 Jun 15;6(6):769-81.

# Drug_Target_104_HGNC_ID:
Not Available

# Drug_Target_104_HPRD_ID:
Not Available

# Drug_Target_104_ID:
2424

# Drug_Target_104_Locus:
Not Available

# Drug_Target_104_Molecular_Weight:
34995

# Drug_Target_104_Name:
L-lactate dehydrogenase

# Drug_Target_104_Number_of_Residues:
319

# Drug_Target_104_PDB_ID:
1A5Z

# Drug_Target_104_Pathway:
Not Available

# Drug_Target_104_Pfam_Domain_Function:
PF00056	Ldh_1_N
PF02866	Ldh_1_C

# Drug_Target_104_Protein_Sequence:
>L-lactate dehydrogenase
MKIGIVGLGRVGSSTAFALLMKGFAREMVLIDVDKKRAEGDALDLIHGTPFTRRANIYAG
DYADLKGSDVVIVAAGVPQKPGETRLQLLGRNARVMKEIARNVSKYAPDSIVIVVTNPVD
VLTYFFLKESGMDPRKVFGSGTVLDTARLRTLIAQHCGFSPRSVHVYVIGEHGDSEVPVW
SGAMIGGIPLQNMCQICQKCDSKILENFAEKTKRAAYEIIERKGATHYAIALAVADIVES
IFFDEKRVLTLSVYLEDYLGVKDLCISVPVTLGKHGVERILELNLNEEELEAFRKSASIL
KNAINEITAEENKHQNTSG

# Drug_Target_104_Reaction:
(S)-lactate + NAD+ = pyruvate + NADH + H+

# Drug_Target_104_Signals:
None

# Drug_Target_104_Specific_Function:
(S)-lactate + NAD(+) = pyruvate + NADH

# Drug_Target_104_SwissProt_ID:
P16115

# Drug_Target_104_SwissProt_Name:
LDH_THEMA

# Drug_Target_104_Synonyms:
EC 1.1.1.27
L-LDH

# Drug_Target_104_Theoretical_pI:
7.16

# Drug_Target_104_Transmembrane_Regions:
None

# Drug_Target_105_Cellular_Location:
Not Available

# Drug_Target_105_Chromosome_Location:
Not Available

# Drug_Target_105_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_105_Essentiality:
Non-Essential

# Drug_Target_105_GenAtlas_ID:
Not Available

# Drug_Target_105_GenBank_ID_Gene:
Not Available

# Drug_Target_105_GenBank_ID_Protein:
Not Available

# Drug_Target_105_GeneCard_ID:
Not Available

# Drug_Target_105_Gene_Name:
ISYNA1

# Drug_Target_105_Gene_Sequence:
Not Available

# Drug_Target_105_General_Function:
Not Available

# Drug_Target_105_General_References:
Not Available

# Drug_Target_105_HGNC_ID:
Not Available

# Drug_Target_105_HPRD_ID:
Not Available

# Drug_Target_105_ID:
7006

# Drug_Target_105_Locus:
Not Available

# Drug_Target_105_Molecular_Weight:
Not Available

# Drug_Target_105_Name:
Inositol-3-phosphate synthase 1

# Drug_Target_105_Number_of_Residues:
0

# Drug_Target_105_PDB_ID:
Not Available

# Drug_Target_105_Pathway:
Not Available

# Drug_Target_105_Pfam_Domain_Function:
Not Available

# Drug_Target_105_Protein_Sequence:
Not Available

# Drug_Target_105_Reaction:
Not Available

# Drug_Target_105_Signals:
Not Available

# Drug_Target_105_Specific_Function:
Not Available

# Drug_Target_105_SwissProt_ID:
Q9NPH2

# Drug_Target_105_SwissProt_Name:
INO1_HUMAN

# Drug_Target_105_Synonyms:
Not Available

# Drug_Target_105_Theoretical_pI:
Not Available

# Drug_Target_105_Transmembrane_Regions:
Not Available

# Drug_Target_106_Cellular_Location:
Cytoplasm

# Drug_Target_106_Chromosome_Location:
Not Available

# Drug_Target_106_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_106_Essentiality:
Non-Essential

# Drug_Target_106_GenAtlas_ID:
GAPDH

# Drug_Target_106_GenBank_ID_Gene:
X01677

# Drug_Target_106_GenBank_ID_Protein:
31645

# Drug_Target_106_GeneCard_ID:
GAPDH

# Drug_Target_106_Gene_Name:
GAPDH

# Drug_Target_106_Gene_Sequence:
>1008 bp
ATGGGGAAGGTGAAGGTCGGAGTCAACGGATTTGGTCGTATTGGGCGCCTGGTCACCAGG
GCTGCTTTTAACTCTGGTAAAGTGGATATTGTTGCCATCAATGACCCCTTCATTGACCTC
AACTACATGGTTTACATGTTCCAATATGATTCCACCCATGGCAAATTCCATGGCACCGTC
AAGGCTGAGAACGGGAAGCTTGTCATCAATGGAAATCCCATCACCATCTTCCAGGAGCGA
GATCCCTCCAAAATCAAGTGGGGCGATGCTGGCGCTGAGTACGTCGTGGAGTCCACTGGC
GTCTTCACCACCATGGAGAAGGCTGGGGCTCATTTGCAGGGGGGAGCCAAAAGGGTCATC
ATCTCTGCCCCCTCTGCTGATGCCCCCATGTTCGTCATGGGTGTGAACCATGAGAAGTAT
GACAACAGCCTCAAGATCATCAGCAATGCCTCCTGCACCACCAACTGCTTAGCACCCCTG
GCCAAGGTCATCCATGACAACTTTGGTATCGTGGAAGGACTCATGACCACAGTCCATGCC
ATCACTGCCACCCAGAAGACTGTGGATGGCCCCTCCGGGAAACTGTGGCGTGATGGCCGC
GGGGCTCTCCAGAACATCATCCCTGCCTCTACTGGCGCTGCCAAGGCTGTGGGCAAGGTC
ATCCCTGAGCTAGACGGGAAGCTCACTGGCATGGCCTTCCGTGTCCCCACTGCCAACGTG
TCAGTGGTGGACCTGACCTGCCGTCTAGAAAAACCTGCCAAATATGATGACATCAAGAAG
GTGGTGAAGCAGGCGTCGGAGGGCCCCCTCAAAGGCATCCTGGGCTACACTGAGCACCAG
GTGGTCTCCTCTGACTTCAACAGCGACACCCACTCCTCCACCTTTGACGCTGGGGCTGGC
ATTGCCCTCAACGACCACTTTGTCAAGCTCATTTCCTGGTATGACAACGAATTTGGCTAC
AGCAACAGGGTGGTGGACCTCATGGCCCACATGGCCTCCAAGGAGTAA

# Drug_Target_106_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_106_General_References:
10944468	Ye Z, Connor JR: cDNA cloning by amplification of circularized first strand cDNAs reveals non-IRE-regulated iron-responsive mRNAs. Biochem Biophys Res Commun. 2000 Aug 18;275(1):223-7.
1193541	Nowak K, Kuczek M, Ostropolska L, Malarska A, Wolny M, Baranowski T: The covalent structure of glyceraldehyde-phosphate dehydrogenase from human muscles. Isolation and amino acid sequences of peptides from tryptic digest. Hoppe Seylers Z Physiol Chem. 1975 Jul;356(7):1181-3.
12665801	Gevaert K, Goethals M, Martens L, Van Damme J, Staes A, Thomas GR, Vandekerckhove J: Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat Biotechnol. 2003 May;21(5):566-9. Epub 2003 Mar 31.
1924305	Meyer-Siegler K, Mauro DJ, Seal G, Wurzer J, deRiel JK, Sirover MA: A human nuclear uracil DNA glycosylase is the 37-kDa subunit of glyceraldehyde-3-phosphate dehydrogenase. Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8460-4.
2987855	Tso JY, Sun XH, Kao TH, Reece KS, Wu R: Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 1985 Apr 11;13(7):2485-502.
3027061	Allen RW, Trach KA, Hoch JA: Identification of the 37-kDa protein displaying a variable interaction with the erythroid cell membrane as glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem. 1987 Jan 15;262(2):649-53.
3170585	Ercolani L, Florence B, Denaro M, Alexander M: Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J Biol Chem. 1988 Oct 25;263(30):15335-41.
3664468	Tokunaga K, Nakamura Y, Sakata K, Fujimori K, Ohkubo M, Sawada K, Sakiyama S: Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res. 1987 Nov 1;47(21):5616-9.
6096136	Hanauer A, Mandel JL: The glyceraldehyde 3 phosphate dehydrogenase gene family: structure of a human cDNA and of an X chromosome linked pseudogene; amazing complexity of the gene family in mouse. EMBO J. 1984 Nov;3(11):2627-33.
6096821	Arcari P, Martinelli R, Salvatore F: The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species. Nucleic Acids Res. 1984 Dec 11;12(23):9179-89.
7030790	Nowak K, Wolny M, Banas T: The complete amino acid sequence of human muscle glyceraldehyde 3-phosphate dehydrogenase. FEBS Lett. 1981 Nov 16;134(2):143-6.
7498159	Kovalyov LI, Shishkin SS, Efimochkin AS, Kovalyova MA, Ershova ES, Egorov TA, Musalyamov AK: The major protein expression profile and two-dimensional protein database of human heart. Electrophoresis. 1995 Jul;16(7):1160-9.
957435	Mercer WD, Winn SI, Watson HC: Twinning in crystals of human skeletal muscle D-glyceraldehyde-3-phosphate dehydrogenase. J Mol Biol. 1976 Jun 14;104(1):277-83.

# Drug_Target_106_HGNC_ID:
HGNC:4141

# Drug_Target_106_HPRD_ID:
00713

# Drug_Target_106_ID:
599

# Drug_Target_106_Locus:
12p13

# Drug_Target_106_Molecular_Weight:
35922

# Drug_Target_106_Name:
Glyceraldehyde-3-phosphate dehydrogenase

# Drug_Target_106_Number_of_Residues:
334

# Drug_Target_106_PDB_ID:
1J0X

# Drug_Target_106_Pathway:
Not Available

# Drug_Target_106_Pfam_Domain_Function:
PF00044	Gp_dh_N
PF02800	Gp_dh_C

# Drug_Target_106_Protein_Sequence:
>Glyceraldehyde-3-phosphate dehydrogenase
GKVKVGVNGFGRIGRLVTRAAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVK
AENGKLVINGNPITIFQERDPSKIKWGDAGAEYVVESTGVFTTMEKAGAHLQGGAKRVII
SAPSADAPMFVMGVNHEKYDNSLKIISNASCTTNCLAPLAKVIHDNFGIVEGLMTTVHAI
TATQKTVDGPSGKLWRDGRGALQNIIPASTGAAKAVGKVIPELNGKLTGMAFRVPTANVS
VVDLTCRLEKPAKYDDIKKVVKQASEGPLKGILGYTEHQVVSSDFNSDTHSSTFDAGAGI
ALNDHFVKLISWYDNEFGYSNRVVDLMAHMASKE

# Drug_Target_106_Reaction:
D-glyceraldehyde 3-phosphate + phosphate + NAD+ = 3-phospho-D-glyceroyl phosphate + NADH + H+

# Drug_Target_106_Signals:
None

# Drug_Target_106_Specific_Function:
Not Available

# Drug_Target_106_SwissProt_ID:
P04406

# Drug_Target_106_SwissProt_Name:
G3P_HUMAN

# Drug_Target_106_Synonyms:
EC 1.2.1.12
GAPDH

# Drug_Target_106_Theoretical_pI:
8.73

# Drug_Target_106_Transmembrane_Regions:
None

# Drug_Target_107_Cellular_Location:
Cytoplasm

# Drug_Target_107_Chromosome_Location:
Not Available

# Drug_Target_107_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_107_Essentiality:
Non-Essential

# Drug_Target_107_GenAtlas_ID:
ADH1B

# Drug_Target_107_GenBank_ID_Gene:
M24317

# Drug_Target_107_GenBank_ID_Protein:
178098

# Drug_Target_107_GeneCard_ID:
ADH1B

# Drug_Target_107_Gene_Name:
ADH1B

# Drug_Target_107_Gene_Sequence:
>1128 bp
ATGAGCACAGCAGGAAAAGTAATCAAATGCAAAGCAGCTGTGCTATGGGAGGTAAAGAAA
CCCTTTTCCATTGAGGATGTGGAGGTTGCACCTCCTAAGGCTTATGAAGTTCGCATTAAG
ATGGTGGCTGTAGGAATCTGTCGCACAGATGACCACGTGGTTAGTGGCAACCTGGTGACC
CCCCTTCCTGTGATTTTAGGCCATGAGGCAGCCGGCATCGTGGAGAGTGTTGGAGAAGGG
GTGACTACAGTCAAACCAGGTGATAAAGTCATCCCGCTCTTTACTCCTCAGTGTGGAAAA
TGCAGAGTTTGTAAAAACCCGGAGAGCAACTACTGCTTGAAAAATGATCTAGGCAATCCT
CGGGGGACCCTGCAGGATGGCACCAGGAGGTTCACCTGCAGGGGGAAGCCCATTCACCAC
TTCCTTGGCACCAGCACCTTCTCCCAGTACACGGTGGTGGATGAGAATGCAGTGGCCAAA
ATTGATGCAGCCTCGCCCCTGGAGAAAGTCTGCCTCATTGGCTGTGGATTCTCGACTGGT
TATGGGTCTGCAGTTAACGTTGCCAAGGTCACCCCAGGCTCTACCTGTGCTGTGTTTGGC
CTGGGAGGGGTCGGCCTATCTGCTGTTATGGGCTGTAAAGCAGCTGGAGCAGCCAGAATC
ATTGCGGTGGACATCAACAAGGACAAAAAAGCAAAGGCCAAAGAGTTGGGTGCCACTGAA
TGCATCAACCCTCAAGACTACAAGAAACCCATCCAGGAAGTGCTAAAGGAAATGACTGAT
GGAGGTGTGGATTTTTCGTTTGAAGTCATCGGTCGGCTTGACACCATGATGGCTTCCCTG
TTATGTTGTCATGAGGCATGTGGCACAAGCGTCATCGTAGGGGTACCTCCTGCTTCCCAG
AACCTCTCAATAAACCCTATGCTGCTACTGACTGGACGCACCTGGAAGGGGGCTGTTTAT
GGTGGCTTTAAGAGTAAAGAAGGTATCCCAAAACTTGTGGCTGATTTTATGGCTAAGAAG
TTTTCACTGGATGCGTTAATAACCCATGTTTTACCTTTTGAAAAAATAAATGAAGGATTT
GACCTGCTTCACTCTGGGAAAAGTATCCGTACCGTCCTGACGTTTTGA

# Drug_Target_107_General_Function:
Energy production and conversion

# Drug_Target_107_General_References:
10733556	Borras E, Coutelle C, Rosell A, Fernandez-Muixi F, Broch M, Crosas B, Hjelmqvist L, Lorenzo A, Gutierrez C, Santos M, Szczepanek M, Heilig M, Quattrocchi P, Farres J, Vidal F, Richart C, Mach T, Bogdal J, Jornvall H, Seitz HK, Couzigou P, Pares X: Genetic polymorphism of alcohol dehydrogenase in europeans: the ADH2*2 allele decreases the risk for alcoholism and is associated with ADH3*1. Hepatology. 2000 Apr;31(4):984-9.
11274460	Niederhut MS, Gibbons BJ, Perez-Miller S, Hurley TD: Three-dimensional structures of the three human class I alcohol dehydrogenases. Protein Sci. 2001 Apr;10(4):697-706.
1896463	Hurley TD, Bosron WF, Hamilton JA, Amzel LM: Structure of human beta 1 beta 1 alcohol dehydrogenase: catalytic effects of non-active-site substitutions. Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):8149-53.
2547609	Matsuo Y, Yokoyama R, Yokoyama S: The genes for human alcohol dehydrogenases beta 1 and beta 2 differ by only one nucleotide. Eur J Biochem. 1989 Aug 1;183(2):317-20.
2679216	Carr LG, Xu Y, Ho WH, Edenberg HJ: Nucleotide sequence of the ADH2(3) gene encoding the human alcohol dehydrogenase beta 3 subunit. Alcohol Clin Exp Res. 1989 Aug;13(4):594-6.
2935533	Duester G, Smith M, Bilanchone V, Hatfield GW: Molecular analysis of the human class I alcohol dehydrogenase gene family and nucleotide sequence of the gene encoding the beta subunit. J Biol Chem. 1986 Feb 15;261(5):2027-33.
2935875	Ikuta T, Szeto S, Yoshida A: Three human alcohol dehydrogenase subunits: cDNA structure and molecular and evolutionary divergence. Proc Natl Acad Sci U S A. 1986 Feb;83(3):634-8.
3000832	Heden LO, Hoog JO, Larsson K, Lake M, Lagerholm E, Holmgren A, Vallee BL, Jornvall H, von Bahr-Lindstrom H: cDNA clones coding for the beta-subunit of human liver alcohol dehydrogenase have differently sized 3'-non-coding regions. FEBS Lett. 1986 Jan 6;194(2):327-32.
3397059	Xu YL, Carr LG, Bosron WF, Li TK, Edenberg HJ: Genotyping of human alcohol dehydrogenases at the ADH2 and ADH3 loci following DNA sequence amplification. Genomics. 1988 Apr;2(3):209-14.
3619918	Burnell JC, Carr LG, Dwulet FE, Edenberg HJ, Li TK, Bosron WF: The human beta 3 alcohol dehydrogenase subunit differs from beta 1 by a Cys for Arg-369 substitution which decreases NAD(H) binding. Biochem Biophys Res Commun. 1987 Aug 14;146(3):1127-33.
6374651	Jornvall H, Hempel J, Vallee BL, Bosron WF, Li TK: Human liver alcohol dehydrogenase: amino acid substitution in the beta 2 beta 2 Oriental isozyme explains functional properties, establishes an active site structure, and parallels mutational exchanges in the yeast enzyme. Proc Natl Acad Sci U S A. 1984 May;81(10):3024-8.
6391920	Hempel J, Buhler R, Kaiser R, Holmquist B, de Zalenski C, von Wartburg JP, Vallee B, Jornvall H: Human liver alcohol dehydrogenase. 1. The primary structure of the beta 1 beta 1 isoenzyme. Eur J Biochem. 1984 Dec 17;145(3):437-45.
8201622	Hurley TD, Bosron WF, Stone CL, Amzel LM: Structures of three human beta alcohol dehydrogenase variants. Correlations with their functional differences. J Mol Biol. 1994 Jun 10;239(3):415-29.
8663387	Davis GJ, Bosron WF, Stone CL, Owusu-Dekyi K, Hurley TD: X-ray structure of human beta3beta3 alcohol dehydrogenase. The contribution of ionic interactions to coenzyme binding. J Biol Chem. 1996 Jul 19;271(29):17057-61.

# Drug_Target_107_HGNC_ID:
HGNC:250

# Drug_Target_107_HPRD_ID:
00065

# Drug_Target_107_ID:
444

# Drug_Target_107_Locus:
4q21-q23

# Drug_Target_107_Molecular_Weight:
39724

# Drug_Target_107_Name:
Alcohol dehydrogenase 1B

# Drug_Target_107_Number_of_Residues:
374

# Drug_Target_107_PDB_ID:
1HSZ

# Drug_Target_107_Pathway:
Not Available

# Drug_Target_107_Pfam_Domain_Function:
PF00107	ADH_zinc_N
PF08240	ADH_N

# Drug_Target_107_Protein_Sequence:
>Alcohol dehydrogenase 1B
STAGKVIKCKAAVLWEVKKPFSIEDVEVAPPKAYEVRIKMVAVGICRTDDHVVSGNLVTP
LPVILGHEAAGIVESVGEGVTTVKPGDKVIPLFTPQCGKCRVCKNPESNYCLKNDLGNPR
GTLQDGTRRFTCRGKPIHHFLGTSTFSQYTVVDENAVAKIDAASPLEKVCLIGCGFSTGY
GSAVNVAKVTPGSTCAVFGLGGVGLSAVMGCKAAGAARIIAVDINKDKFAKAKELGATEC
INPQDYKKPIQEVLKEMTDGGVDFSFEVIGRLDTMMASLLCCHEACGTSVIVGVPPASQN
LSINPMLLLTGRTWKGAVYGGFKSKEGIPKLVADFMAKKFSLDALITHVLPFEKINEGFD
LLHSGKSIRTVLTF

# Drug_Target_107_Reaction:
an alcohol + NAD+ = an aldehyde or ketone + NADH + H+

# Drug_Target_107_Signals:
None

# Drug_Target_107_Specific_Function:
Not Available

# Drug_Target_107_SwissProt_ID:
P00325

# Drug_Target_107_SwissProt_Name:
ADH1B_HUMAN

# Drug_Target_107_Synonyms:
Alcohol dehydrogenase beta subunit
EC 1.1.1.1

# Drug_Target_107_Theoretical_pI:
8.38

# Drug_Target_107_Transmembrane_Regions:
None

# Drug_Target_108_Cellular_Location:
Not Available

# Drug_Target_108_Chromosome_Location:
Not Available

# Drug_Target_108_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_108_Essentiality:
Non-Essential

# Drug_Target_108_GenAtlas_ID:
SORD

# Drug_Target_108_GenBank_ID_Gene:
U07361

# Drug_Target_108_GenBank_ID_Protein:
520450

# Drug_Target_108_GeneCard_ID:
SORD

# Drug_Target_108_Gene_Name:
SORD

# Drug_Target_108_Gene_Sequence:
>1074 bp
ATGGCGGCGGCGGCCAAGCCCAACAACCTTTCCCTGGTGGTGCACGGACCGGGGGACTTG
CGCCTGGAGAACTATCCTATCCCTGAACCAGGCCCAAATGAGGTCTTGCTGAGGATGCAT
TCTGTTGGAATCTGTGGCTCAGATGTCCACTACTGGGAGTATGGTCGAATTGGGAATTTT
ATTGTGAAAAAGCCCATGGTGCTGGGACATGAAGCTTCGGGAACAGTCGAAAAAGTGGGA
TCATCGGTAAAGCACCTAAAACCAGGTGATCGTGTTGCCATCGAGCCTGGTGCTCCCCGA
GAAAATGATGAATTCTGCAAGATGGGCCGATACAATCTGTCACCTTCCATCTTCTTCTGT
GCCACGCCCCCCGATGACGGGAACCTCTGCCGGTTCTATAAGCACAATGCAGCCTTTTGT
TACAAGCTTCCTGACAATGTCACCTTTGAGGAAGGCGCCCTGATCGAGCCACTTTCTGTG
GGGATCCATGCCTGCAGGAGAGGCGGAGTTACCCTGGGACACAAGGTCCTTGTGTGTGGA
GCTGGGCCAATCGGGATGGTCACTTTGCTCGTGGCCAAAGCAATGGGAGCAGCTCAAGTA
GTGGTGACTGATCTGTCTGCTACCCGATTGTCCAAAGCCAAGGAGATTGGGGCTGATTTA
GTCCTCCAGATCTCCAAGGAGAGCCCTCAGGAAATCGCCAGGAAAGTAGAAGGTCAGCTG
GGGTGCAAGCCGGAAGTCACCATCGAGTGCACGGGGGCAGAGGCCTCCATCCAGGCGGGC
ATCTACGCCACTCGCTCTGGTGGGACCCTCGTGCTTGTGGGGCTGGGCTCTGAGATGACC
ACCGTACCCCTACTGCATGCAGCCATCCGGGAGGTGGATATCAAGGGCGTGTTTCGATAC
TGCAACACGTGGCCAGTGGCGATTTCGATGCTTGCGTCCAAGTCTGTGAATGTAAAACCC
CTCGTCACCCATAGGTTTCCTCTGGAGAAAGCTCTGGAGGCCTTTGAAACATTTAAAAAG
GGATTGGGGTTGAAAATCATGCTCAAGTGTGACCCCAGTGACCAGAATCCCTGA

# Drug_Target_108_General_Function:
Amino acid transport and metabolism

# Drug_Target_108_General_References:
12665801	Gevaert K, Goethals M, Martens L, Van Damme J, Staes A, Thomas GR, Vandekerckhove J: Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat Biotechnol. 2003 May;21(5):566-9. Epub 2003 Mar 31.
2691249	Karlsson C, Maret W, Auld DS, Hoog JO, Jornvall H: Variability within mammalian sorbitol dehydrogenases. The primary structure of the human liver enzyme. Eur J Biochem. 1989 Dec 22;186(3):543-50.
7782086	Iwata T, Popescu NC, Zimonjic DB, Karlsson C, Hoog JO, Vaca G, Rodriguez IR, Carper D: Structural organization of the human sorbitol dehydrogenase gene (SORD). Genomics. 1995 Mar 1;26(1):55-62.
8088829	Lee FK, Cheung MC, Chung S: The human sorbitol dehydrogenase gene: cDNA cloning, sequence determination, and mapping by fluorescence in situ hybridization. Genomics. 1994 May 15;21(2):354-8.
9183016	Carr IM, Markham AF, Coletta PL: Identification and characterisation of a sequence related to human sorbitol dehydrogenase. Eur J Biochem. 1997 May 1;245(3):760-7.

# Drug_Target_108_HGNC_ID:
HGNC:11184

# Drug_Target_108_HPRD_ID:
01679

# Drug_Target_108_ID:
328

# Drug_Target_108_Locus:
15q15.3

# Drug_Target_108_Molecular_Weight:
38166

# Drug_Target_108_Name:
Sorbitol dehydrogenase

# Drug_Target_108_Number_of_Residues:
356

# Drug_Target_108_PDB_ID:
1PL8

# Drug_Target_108_Pathway:
Not Available

# Drug_Target_108_Pfam_Domain_Function:
PF00107	ADH_zinc_N
PF08240	ADH_N

# Drug_Target_108_Protein_Sequence:
>Sorbitol dehydrogenase
AAAAKPNNLSLVVHGPGDLRLENYPIPEPGPNEVLLRMHSVGICGSDVHYWEYGRIGNFI
VKKPMVLGHEASGTVEKVGSSVKHLKPGDRVAIEPGAPRENDEFCKMGRYNLSPSIFFCA
TPPDDGNLCRFYKHNAAFCYKLPDNVTFEEGALIEPLSVGIHACRRGGVTLGHKVLVCGA
GPIGMVTLLVAKAMGAAQVVVTDLSATRLSKAKEIGADLVLQISKESPQEIARKVEGLLG
CKPEVTIECTGAEASIQAGIYATRSGGTLVLVGLGSEMTTVPLLHAAIREVDIKGVFRYC
NTWPVAISMLASKSVNVKPLVTHRFPLEKALEAFETFKKGLGLKIMLKCDPSDQNP

# Drug_Target_108_Reaction:
L-iditol + NAD+ = L-sorbose + NADH + H+

# Drug_Target_108_Signals:
None

# Drug_Target_108_Specific_Function:
Not Available

# Drug_Target_108_SwissProt_ID:
Q00796

# Drug_Target_108_SwissProt_Name:
DHSO_HUMAN

# Drug_Target_108_Synonyms:
EC 1.1.1.14
L-iditol 2-dehydrogenase

# Drug_Target_108_Theoretical_pI:
8.06

# Drug_Target_108_Transmembrane_Regions:
None

# Drug_Target_109_Cellular_Location:
Not Available

# Drug_Target_109_Chromosome_Location:
Not Available

# Drug_Target_109_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_109_Essentiality:
Non-Essential

# Drug_Target_109_GenAtlas_ID:
Not Available

# Drug_Target_109_GenBank_ID_Gene:
BX842576

# Drug_Target_109_GenBank_ID_Protein:
1524230

# Drug_Target_109_GeneCard_ID:
Not Available

# Drug_Target_109_Gene_Name:
inhA

# Drug_Target_109_Gene_Sequence:
>810 bp
ATGACAGGACTGCTGGACGGCAAACGGATTCTGGTTAGCGGAATCATCACCGACTCGTCG
ATCGCGTTTCACATCGCACGGGTAGCCCAGGAGCAGGGCGCCCAGCTGGTGCTCACCGGG
TTCGACCGGCTGCGGCTGATTCAGCGCATCACCGACCGGCTGCCGGCAAAGGCCCCGCTG
CTCGAACTCGACGTGCAAAACGAGGAGCACCTGGCCAGCTTGGCCGGCCGGGTGACCGAG
GCGATCGGGGCGGGCAACAAGCTCGACGGGGTGGTGCATTCGATTGGGTTCATGCCGCAG
ACCGGGATGGGCATCAACCCGTTCTTCGACGCGCCCTACGCGGATGTGTCCAAGGGCATC
CACATCTCGGCGTATTCGTATGCTTCGATGGCCAAGGCGCTGCTGCCGATCATGAACCCC
GGAGGTTCCATCGTCGGCATGGACTTCGACCCGAGCCGGGCGATGCCGGCCTACAACTGG
ATGACGGTCGCCAAGAGCGCGTTGGAGTCGGTCAACAGGTTCGTGGCGCGCGAGGCCGGC
AAGTACGGTGTGCGTTCGAATCTCGTTGCCGCAGGCCCTATCCGGACGCTGGCGATGAGT
GCGATCGTCGGCGGTGCGCTCGGCGAGGAGGCCGGCGCCCAGATCCAGCTGCTCGAGGAG
GGCTGGGATCAGCGCGCTCCGATCGGCTGGAACATGAAGGATGCGACGCCGGTCGCCAAG
ACGGTGTGCGCGCTGCTGTCTGACTGGCTGCCGGCGACCACGGGTGACATCATCTACGCC
GACGGCGGCGCGCACACCCAATTGCTCTAG

# Drug_Target_109_General_Function:
Lipid transport and metabolism

# Drug_Target_109_General_References:
10336454	Rozwarski DA, Vilcheze C, Sugantino M, Bittman R, Sacchettini JC: Crystal structure of the Mycobacterium tuberculosis enoyl-ACP reductase, InhA, in complex with NAD+ and a C16 fatty acyl substrate. J Biol Chem. 1999 May 28;274(22):15582-9.
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
7886450	Dessen A, Quemard A, Blanchard JS, Jacobs WR Jr, Sacchettini JC: Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis. Science. 1995 Mar 17;267(5204):1638-41.
8284673	Banerjee A, Dubnau E, Quemard A, Balasubramanian V, Um KS, Wilson T, Collins D, de Lisle G, Jacobs WR Jr: inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science. 1994 Jan 14;263(5144):227-30.
9417034	Rozwarski DA, Grant GA, Barton DH, Jacobs WR Jr, Sacchettini JC: Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. Science. 1998 Jan 2;279(5347):98-102.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_109_HGNC_ID:
Not Available

# Drug_Target_109_HPRD_ID:
Not Available

# Drug_Target_109_ID:
368

# Drug_Target_109_Locus:
Not Available

# Drug_Target_109_Molecular_Weight:
28528

# Drug_Target_109_Name:
Enoyl-[acyl-carrier-protein] reductase [NADH]

# Drug_Target_109_Number_of_Residues:
269

# Drug_Target_109_PDB_ID:
1P45

# Drug_Target_109_Pathway:
Not Available

# Drug_Target_109_Pfam_Domain_Function:
Not Available

# Drug_Target_109_Protein_Sequence:
>Enoyl-[acyl-carrier-protein] reductase [NADH]
MTGLLDGKRILVSGIITDSSIAFHIARVAQEQGAQLVLTGFDRLRLIQRITDRLPAKAPL
LELDVQNEEHLASLAGRVTEAIGAGNKLDGVVHSIGFMPQTGMGINPFFDAPYADVSKGI
HISAYSYASMAKALLPIMNPGGSIVGMDFDPSRAMPAYNWMTVAKSALESVNRFVAREAG
KYGVRSNLVAAGPIRTLAMSAIVGGALGEEAGAQIQLLEEGWDQRAPIGWNMKDATPVAK
TVCALLSDWLPATTGDIIYADGGAHTQLL

# Drug_Target_109_Reaction:
acyl-[acyl-carrier-protein] + NAD+ = trans-2,3-dehydroacyl-[acyl-carrier-protein] + NADH + H+

# Drug_Target_109_Signals:
None

# Drug_Target_109_Specific_Function:
Involved in the resistance against the antituberculosis drugs isoniazid and ethionamide

# Drug_Target_109_SwissProt_ID:
P0A5Y6

# Drug_Target_109_SwissProt_Name:
INHA_MYCTU

# Drug_Target_109_Synonyms:
EC 1.3.1.9
NADH- dependent enoyl-ACP reductase

# Drug_Target_109_Theoretical_pI:
6.02

# Drug_Target_109_Transmembrane_Regions:
None

# Drug_Target_10_Cellular_Location:
Mitochondrion
mitochondrial matrix

# Drug_Target_10_Chromosome_Location:
Not Available

# Drug_Target_10_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_10_Essentiality:
Non-Essential

# Drug_Target_10_GenAtlas_ID:
ME3

# Drug_Target_10_GenBank_ID_Gene:
X79440

# Drug_Target_10_GenBank_ID_Protein:
535012

# Drug_Target_10_GeneCard_ID:
ME3

# Drug_Target_10_Gene_Name:
ME3

# Drug_Target_10_Gene_Sequence:
>1815 bp
ATGGGTGCCGCGCTGGGGACAGGCACGCGGCTGGCTCCCTGGCCGGGCCGGGCCTGCGGC
GCCCTCCCGCGCTGGACACCCACCGCGCCCGCCCAAGGCTGCCACTCCAAGCCTGGCCCG
GCGCGCCCTGTGCCCCTGAAGAAGCGCGGATACGATGTCACCAGGAACCCTCATCTCAAC
AAGGGGATGGCCTTTACCCTTGAAGAAAGGCTGCAGCTTGGAATCCACGGCCTAATCCCG
CCCTGCTTTCTGAGCCAGGACGTCCAGCTCCTCCGAATCATGAGATATTACGAGCGGCAG
CAGAGTGACCTGGACAAGTACATCATTCTCATGACACTCCAAGACCGGAACGAGAAGCTC
TTCTACCGAGTGCTGACTTCGGATGTGGAGAAGTTCATGCCAATCGTGTACACGCCTACC
GTGGGGCTGGCCTGTCAGCACTATGGCCTGACTTTCCGCAGGCCCCGTGGACTGTTCATC
ACCATTCATGACAAAGGTCATCTTGCAACAATGCTGAATTCTTGGCCAGAAGACAATATT
AAGGCCGTGGTGGTGACTGATGGGGAGCGCATCCTGGGCCTGGGAGACCTGGGCTGCTAC
GGCATGGGCATCCCTGTGGGCAAGCTGGCCCTGTACACGGCATGCGGAGGGGTGAACCCG
CAGCAGTGCCTCCCTGTGCTGCTGGACGTCGGCACCAACAATGAGGAGCTGCTCAGAGAC
CCTCTGTACATCGGCCTGAAACACCAGCGCGTGCACGGGAAGGCATACGATGACTTGCTG
GATGAGTTCATGCAGGCTGTGACAGACAAGTTTGGAATAAATTGCCTCATCCAATTTGAA
GACTTCGCCAATGCCAATGCCTTCCGCCTGCTCAACAAATACCGTAACAAGTACTGCATG
TTCAATGATGACATCCAAGGCACAGCCTCCGTTGCTGTGGCAGGGATCTTGGCTGCTCTG
CGAATCACCAACAACAAGCTTTCCAATCACGTGTTTGTTTTCCAAGGTGCAGGCGAGGCA
GCTATGGGCATTGCCCACCTCCTTGTCATGGCCCTAGAGAAAGAAGGTGTACCGAAGGCA
GAGGCCACAAGAAAGATCTGGATGGTGGACTCTAAAGGGCTCATTGTCAAGGGGAGGAGC
CACCTGAACCATGAAAAGGAGATGTTTGCCCAAGACCATCCTGAAGTCAACTCCCTGGAG
GAGGTGGTGAGGCTGGTGAAGCCCACAGCCATCATAGGTGTTGCTGCCATCGCAGGAGCC
TTCACGGAGCAGATTCTGAGGGACATGGCCTCCTTCCACGAGCGCCCTATCATCTTTGCC
CTGAGCAACCCCACCAGCAAGGCCGAGTGCACGGCTGAGAAGTGCTACCGGGTCACCGAG
GGCCGAGGGATTTTTGCCAGTGGAAGTCCTTTTAAGAGTGTGACTCTGGAAGATGGCAAG
ACCTTCATTCCTGGGCAGGGAAACAATGCTTACGTGTTCCCCGGGGTGGCACTGGGAGTC
ATCGCCGGCGGGATCCGGCACATCCCAGATGAGATCTTCCTCCTGACAGCAGAGCAAATT
GCCCAGGAAGTCTCTGAGCAGCATCTGTCCCAGGGGAGACTCTATCCACCACTCAGCACC
ATCCGAGACGTGTCTTTGAGAATTGCCATCAAAGTTCTCGACTACGCGTACAAACACAAC
CTGGCTTCCTACTACCCAGAGCCTAAGGACAAGGAGGCTTTTGTAAGATCCCTGGTCTAC
ACTCCAGACTATGACTCCTTTACACTGGACAGCTACACTTGGCCCAAGGAAGCCATGAAT
GTTCAGACGGTCTGA

# Drug_Target_10_General_Function:
Energy production and conversion

# Drug_Target_10_General_References:
7818469	Loeber G, Maurer-Fogy I, Schwendenwein R: Purification, cDNA cloning and heterologous expression of the human mitochondrial NADP(+)-dependent malic enzyme. Biochem J. 1994 Dec 15;304 ( Pt 3):687-92.

# Drug_Target_10_HGNC_ID:
HGNC:6985

# Drug_Target_10_HPRD_ID:
06862

# Drug_Target_10_ID:
363

# Drug_Target_10_Locus:
11cen-q22.3

# Drug_Target_10_Molecular_Weight:
67055

# Drug_Target_10_Name:
NADP-dependent malic enzyme, mitochondrial

# Drug_Target_10_Number_of_Residues:
604

# Drug_Target_10_PDB_ID:
Not Available

# Drug_Target_10_Pathway:
Not Available

# Drug_Target_10_Pfam_Domain_Function:
PF00390	malic
PF03949	Malic_M

# Drug_Target_10_Protein_Sequence:
>NADP-dependent malic enzyme, mitochondrial precursor
MGAALGTGTRLAPWPGRACGALPRWTPTAPAQGCHSKPGPARPVPLKKRGYDVTRNPHLN
KGMAFTLEERLQLGIHGLIPPCFLSQDVQLLRIMRYYERQQSDLDKYIILMTLQDRNEKL
FYRVLTSDVEKFMPIVYTPTVGLACQHYGLTFRRPRGLFITIHDKGHLATMLNSWPEDNI
KAVVVTDGERILGLGDLGCYGMGIPVGKLALYTACGGVNPQQCLPVLLDVGTNNEELLRD
PLYIGLKHQRVHGKAYDDLLDEFMQAVTDKFGINCLIQFEDFANANAFRLLNKYRNKYCM
FNDDIQGTASVAVAGILAALRITNNKLSNHVFVFQGAGEAAMGIAHLLVMALEKEGVPKA
EATRKIWMVDSKGLIVKGRSHLNHEKEMFAQDHPEVNSLEEVVRLVKPTAIIGVAAIAGA
FTEQILRDMASFHERPIIFALSNPTSKAECTAEKCYRVTEGRGIFASGSPFKSVTLEDGK
TFIPGQGNNAYVFPGVALGVIAGGIRHIPDEIFLLTAEQIAQEVSEQHLSQGRLYPPLST
IRDVSLRIAIKVLDYAYKHNLASYYPEPKDKEAFVRSLVYTPDYDSFTLDSYTWPKEAMN
VQTV

# Drug_Target_10_Reaction:
(S)-malate + NADP+ = pyruvate + CO2 + NADPH

# Drug_Target_10_Signals:
None

# Drug_Target_10_Specific_Function:
Not Available

# Drug_Target_10_SwissProt_ID:
Q16798

# Drug_Target_10_SwissProt_Name:
MAON_HUMAN

# Drug_Target_10_Synonyms:
EC 1.1.1.40
Malic enzyme 3
NADP-ME
NADP-dependent malic enzyme, mitochondrial precursor

# Drug_Target_10_Theoretical_pI:
7.92

# Drug_Target_10_Transmembrane_Regions:
None

# Drug_Target_110_Cellular_Location:
Mitochondrion
mitochondrial matrix

# Drug_Target_110_Chromosome_Location:
Not Available

# Drug_Target_110_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_110_Essentiality:
Non-Essential

# Drug_Target_110_GenAtlas_ID:
HADH

# Drug_Target_110_GenBank_ID_Gene:
X96752

# Drug_Target_110_GenBank_ID_Protein:
1483511

# Drug_Target_110_GeneCard_ID:
HADH

# Drug_Target_110_Gene_Name:
HADH

# Drug_Target_110_Gene_Sequence:
>945 bp
ATGGCCTTCGTCACCAGGCAGTTCATGCGTTCCGTGTCCTCCTCGTCCACCGCCTCGGCC
TCGGCCAAGAAGATAATCGTCAAGCACGTGACGGTCATCGGCGGCGGGCTGATGGGCGCC
GGCATTGCCCAGGTTGCTGCAGCAACTGGTCACACAGTAGTGTTGGTAGACCAGACAGAG
GACATCCTGGCAAAATCCAAAAAGGGAATTGAGGAAAGCCTTAGGAAAGTGGCAAAGAAG
AAGTTTGCAGAAAACCCTAAGGCCGGCGATGAATTTGTGGAGAAGACCCTGAGCACCATA
GCGACCAGCACGGATGCAGCCTCCGTTGTCCACAGCACAGACTTGGTGGTGGAAGCCATC
GTGGAGAATCTGAAGGTGAAAAACGAGCTCTTCAAAAGGCTGGACAAGTTTGCTGCTGAA
CATACAATCTTTGCCAGCAACACTTCCTCCTTGCATATTACAAGCATAGCTAATGCCACC
ACCAGACAAGACCGATTCGCTGGCCTCCATTTCTTCAACCCAGTGCCTGTCATGAAACTT
GTGGAGGTCATTAAAACACCAATGACCAGCCAGAAGACATTTGAATCTTTGGTAGACTTT
AGCAAAGCCCTAGGAAAGCATCCTGTTTCTTGCAAGGACACTCCTGGGTTTATTGTGAAC
CGCCTCCTGGTTCCATACCTCATGGAAGCAATCAGGCTGTATGAACGAGGTGACGCATCC
AAAGAAGACATTGACACTGCTATGAAATTAGGAGCCGGTTACCCCATGGGCCCATTTGAG
CTTCTAGATTATGTCGGACTGGATACTACGAAGTTCATCGTGGATGGGTGGCATGAAATG
GATGCAGAGAACCCATTACATCAGCCCAGCCCATCCTTAAATAAGCTGGTAGCAGAGAAC
AAGTTCGGCAAGAAGACTGGAGAAGGATTTTACAAATACAAGTGA

# Drug_Target_110_General_Function:
Lipid transport and metabolism

# Drug_Target_110_General_References:
10231530	Barycki JJ, O'Brien LK, Bratt JM, Zhang R, Sanishvili R, Strauss AW, Banaszak LJ: Biochemical characterization and crystal structure determination of human heart short chain L-3-hydroxyacyl-CoA dehydrogenase provide insights into catalytic mechanism. Biochemistry. 1999 May 4;38(18):5786-98.
10840044	Barycki JJ, O'Brien LK, Strauss AW, Banaszak LJ: Sequestration of the active site by interdomain shifting. Crystallographic and spectroscopic evidence for distinct conformations of L-3-hydroxyacyl-CoA dehydrogenase. J Biol Chem. 2000 Sep 1;275(35):27186-96.
8687463	Vredendaal PJ, van den Berg IE, Malingre HE, Stroobants AK, Olde Weghuis DE, Berger R: Human short-chain L-3-hydroxyacyl-CoA dehydrogenase: cloning and characterization of the coding sequence. Biochem Biophys Res Commun. 1996 Jun 25;223(3):718-23.

# Drug_Target_110_HGNC_ID:
HGNC:4799

# Drug_Target_110_HPRD_ID:
08372

# Drug_Target_110_ID:
419

# Drug_Target_110_Locus:
4q22-q26

# Drug_Target_110_Molecular_Weight:
34278

# Drug_Target_110_Name:
Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial

# Drug_Target_110_Number_of_Residues:
314

# Drug_Target_110_PDB_ID:
1F0Y

# Drug_Target_110_Pathway:
Not Available

# Drug_Target_110_Pfam_Domain_Function:
PF00725	3HCDH
PF02737	3HCDH_N

# Drug_Target_110_Protein_Sequence:
>Short chain 3-hydroxyacyl-CoA dehydrogenase, mitochondrial precursor
MAFVTRQFMRSVSSSSTASASAKKIIVKHVTVIGGGLMGAGIAQVAAATGHTVVLVDQTE
DILAKSKKGIEESLRKVAKKKFAENPKAGDEFVEKTLSTIATSTDAASVVHSTDLVVEAI
VENLKVKNELFKRLDKFAAEHTIFASNTSSLQITSIANATTRQDRFAGLHFFNPVPVMKL
VEVIKTPMTSQKTFESLVDFSKALGKHPVSCKDTPGFIVNRLLVPYLMEAIRLYERGDAS
KEDIDTAMKLGAGYPMGPFELLDYVGLDTTKFIVDGWHEMDAENPLHQPSPSLNKLVAEN
KFGKKTGEGFYKYK

# Drug_Target_110_Reaction:
(S)-3-hydroxyacyl-CoA + NAD+ = 3-oxoacyl-CoA + NADH + H+

# Drug_Target_110_Signals:
None

# Drug_Target_110_Specific_Function:
Plays an essential role in the mitochondrial beta- oxidation of short chain fatty acids. Exerts it highest activity toward 3-hydroxybutyryl-CoA

# Drug_Target_110_SwissProt_ID:
Q16836

# Drug_Target_110_SwissProt_Name:
HCDH_HUMAN

# Drug_Target_110_Synonyms:
EC 1.1.1.35
HCDH
Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial precursor
Medium and short chain L-3-hydroxyacyl-coenzyme A dehydrogenase
Short chain 3-hydroxyacyl-CoA dehydrogenase

# Drug_Target_110_Theoretical_pI:
9.41

# Drug_Target_110_Transmembrane_Regions:
None

# Drug_Target_111_Cellular_Location:
Not Available

# Drug_Target_111_Chromosome_Location:
Not Available

# Drug_Target_111_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_111_Essentiality:
Non-Essential

# Drug_Target_111_GenAtlas_ID:
Not Available

# Drug_Target_111_GenBank_ID_Gene:
M93720

# Drug_Target_111_GenBank_ID_Protein:
294165

# Drug_Target_111_GeneCard_ID:
Not Available

# Drug_Target_111_Gene_Name:
Not Available

# Drug_Target_111_Gene_Sequence:
>951 bp
ATGGCACCAAAAGCAAAAATCGTTTTAGTTGGCTCAGGTATGATTGGAGGAGTAATGGCT
ACCTTAATTGTTCAGAAAAATTTAGGAGATGTAGTTTTGTTCGATATTGTAAAGAACATG
CCACATGGAAAAGCTTTAGATACATCTCATACTAATGTTATGGCATATTCAAATTGCAAA
GTAAGTGGTTCAAACACTTATGACGATTTGGCTGGAGCAGATGTAGTAATAGTAACAGCT
GGATTTACCAAGGCCCCAGGAAAGAGTGACAAAGAATGGAATAGAGATGATTTATTACCA
TTAAACAACAAGATTATGATTGAAATTGGTGGTCATATTAAGAAGAATTGTCCAAATGCT
TTTATTATTGTTGTAACAAACCCAGTAGATGTTATGGTACAATTATTACATCAACATTCA
GGTGTTCCTAAAAACAAGATTATTGGTTTAGGTGGTGTATTAGATACATCAAGATTGAAG
TATTACATATCTCAGAAATTAAATGTATGCCCAAGAGATGTAAATGCACACATTGTAGGT
GCTCATGGAAATAAAATGGTTCTTTTAAAAAGATACATTACTGTAGGTGGTATCCCTTTA
CAAGAATTTATTAATAACAAGTTAATTTCTGATGCTGAATTAGAAGCTATATTTGATAGA
ACTGTTAATACTGCATTAGAAATTGTAAACTTACATGCATCACCATATGTTGCACCAGCT
GCTGCTATTATCGAAATGGCTGAATCCTACTTAAAAGATTTGAAAAAAGTATTAATTTGC
TCAACCTTGTTAGAAGGACAATATGGACACTCCGATATATTCGGTGGTACACCTGTTGTT
TTAGGTGCTAATGGTGTTGAACAAGTTATCGAATTACAATTAAATAGTGAGGAAAAAGCT
AAATTTGATGAAGCCATAGCTGAAACTAAGAGAATGAAGGCATTAGCTTAA

# Drug_Target_111_General_Function:
Energy production and conversion

# Drug_Target_111_General_References:
10187806	Read JA, Wilkinson KW, Tranter R, Sessions RB, Brady RL: Chloroquine binds in the cofactor binding site of Plasmodium falciparum lactate dehydrogenase. J Biol Chem. 1999 Apr 9;274(15):10213-8.
8515777	Bzik DJ, Fox BA, Gonyer K: Expression of Plasmodium falciparum lactate dehydrogenase in Escherichia coli. Mol Biochem Parasitol. 1993 May;59(1):155-66.
8901865	Dunn CR, Banfield MJ, Barker JJ, Higham CW, Moreton KM, Turgut-Balik D, Brady RL, Holbrook JJ: The structure of lactate dehydrogenase from Plasmodium falciparum reveals a new target for anti-malarial design. Nat Struct Biol. 1996 Nov;3(11):912-5.

# Drug_Target_111_HGNC_ID:
Not Available

# Drug_Target_111_HPRD_ID:
Not Available

# Drug_Target_111_ID:
2641

# Drug_Target_111_Locus:
Not Available

# Drug_Target_111_Molecular_Weight:
34108

# Drug_Target_111_Name:
L-lactate dehydrogenase

# Drug_Target_111_Number_of_Residues:
316

# Drug_Target_111_PDB_ID:
1T2D

# Drug_Target_111_Pathway:
Not Available

# Drug_Target_111_Pfam_Domain_Function:
PF00056	Ldh_1_N
PF02866	Ldh_1_C

# Drug_Target_111_Protein_Sequence:
>L-lactate dehydrogenase
MAPKAKIVLVGSGMIGGVMATLIVQKNLGDVVLFDIVKNMPHGKALDTSHTNVMAYSNCK
VSGSNTYDDLAGADVVIVTAGFTKAPGKSDKEWNRDDLLPLNNKIMIEIGGHIKKNCPNA
FIIVVTNPVDVMVQLLHQHSGVPKNKIIGLGGVLDTSRLKYYISQKLNVCPRDVNAHIVG
AHGNKMVLLKRYITVGGIPLQEFINNKLISDAELEAIFDRTVNTALEIVNLHASPYVAPA
AAIIEMAESYLKDLKKVLICSTLLEGQYGHSDIFGGTPVVLGANGVEQVIELQLNSEEKA
KFDEAIAETKRMKALA

# Drug_Target_111_Reaction:
(S)-lactate + NAD+ = pyruvate + NADH + H+

# Drug_Target_111_Signals:
None

# Drug_Target_111_Specific_Function:
(S)-lactate + NAD(+) = pyruvate + NADH

# Drug_Target_111_SwissProt_ID:
Q27743

# Drug_Target_111_SwissProt_Name:
LDH_PLAFD

# Drug_Target_111_Synonyms:
EC 1.1.1.27
LDH-P

# Drug_Target_111_Theoretical_pI:
7.63

# Drug_Target_111_Transmembrane_Regions:
None

# Drug_Target_112_Cellular_Location:
Not Available

# Drug_Target_112_Chromosome_Location:
Not Available

# Drug_Target_112_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_112_Essentiality:
Non-Essential

# Drug_Target_112_GenAtlas_ID:
DHPS

# Drug_Target_112_GenBank_ID_Gene:
L39068

# Drug_Target_112_GenBank_ID_Protein:
994715

# Drug_Target_112_GeneCard_ID:
DHPS

# Drug_Target_112_Gene_Name:
DHPS

# Drug_Target_112_Gene_Sequence:
>1110 bp
ATGGAAGGTTCCCTGGAACGGGAGGCGCCAGCGGGGGCGCTGGCCGCCGTGCTAAAGCAC
AGCTCGACGTTGCCGCCCGAAAGCACCCAGGTCCGGGGCTACGACTTCAACCGCGGTGTG
AATTACCGCGCACTGCTGGAGGCCTTCGGCACCACCGGCTTCCAAGCAACCAACTTCGGG
CGCGCTGTACAGCAAGTCAATGCCATGATCGAGAAGAAGCTGGAACCACTGTCACAGGAT
GAAGACCAGCACGCGGACCTGACCCAGAGCCGCCGCCCACTTACCAGCTGCACCATTTTC
CTGGGATATACATCCAACCTCATCAGTTCAGGCATCCGTGAGACCATTCGCTACCTTGTG
CAGCACAACATGGTGGACGTATTGGTGACCACAGCTGGCGGCGTGGAGGAAGACCTCATC
AAGTGCCTGGCGCCCACATACTTGGGCGAGTTTAGCCTCAGGGGGAAGGAGCTCCGGGAG
AACGGGATCAATAGGATCGGAAACCTGCTGGTGCCCAATGAGAATTACTGCAAGTTTGAG
GACTGGCTGATGCCCATTCTGGACCAGATGGTGATGGAGCAGAACACAGAGGGTGTAAAG
TGGACGCCTTCTAAGATGATCGCCCGGCTGGGCAAGGAGATCAACAACCCAGAGTCCGTG
TATTACTGGGCCCAGAAGAACCACATCCCTGTGTTTAGTCCCGCACTTACAGACGGCTCG
CTGGGCGACATGATCTTCTTCCATTCCTACAAGAACCCGGGCCTGGTCCTGGACATCGTT
GAGGACCTGAGGCTCATCAACACACAGGCCATCTTTGCCAAGTGCACTGGGATGATCATT
CTGGGCGGGGGCGTGGTCAAGCACCACATTGCCAATGCCAACCTCATGCGGAACGGGGCC
GACTACGCTGTTTACATCAACACAGCCCAGGAGTTTGATGGCTCTGACTCAGGTGCCCGA
CCAGACGAGGCTGTCTCCTGGGGCAAGATCCGGGTGGATGCACAGCCCGTCAAGGTCTAT
GCTGACGCCTCCCTGGTCTTCCCCCTGCTTGTGGCTGAAACCTTTGCCCAGAAGATGGAT
GCCTTCATGCATGAGAAGAACGAGGACTGA

# Drug_Target_112_General_Function:
Posttranslational modification, protein turnover, chaperones

# Drug_Target_112_General_References:
7673224	Joe YA, Wolff EC, Park MH: Cloning and expression of human deoxyhypusine synthase cDNA. Structure-function studies with the recombinant enzyme and mutant proteins. J Biol Chem. 1995 Sep 22;270(38):22386-92.
7750572	Klier H, Csonga R, Steinkasserer A, Wohl T, Lottspeich F, Eder J: Purification and characterization of human deoxyhypusine synthase from HeLa cells. FEBS Lett. 1995 May 8;364(2):207-10.
8549832	Bevec D, Kappel B, Jaksche H, Csonga R, Hauber J, Klier H, Steinkasserer A: Molecular characterization of a cDNA encoding functional human deoxyhypusine synthase and chromosomal mapping of the corresponding gene locus. FEBS Lett. 1996 Jan 8;378(2):195-8.
8615810	Yan YP, Tao Y, Chen KY: Molecular cloning and functional expression of human deoxyhypusine synthase cDNA based on expressed sequence tag information. Biochem J. 1996 Apr 15;315 ( Pt 2):429-34.
9110174	Yu W, Andersson B, Worley KC, Muzny DM, Ding Y, Liu W, Ricafrente JY, Wentland MA, Lennon G, Gibbs RA: Large-scale concatenation cDNA sequencing. Genome Res. 1997 Apr;7(4):353-8.
9493264	Liao DI, Wolff EC, Park MH, Davies DR: Crystal structure of the NAD complex of human deoxyhypusine synthase: an enzyme with a ball-and-chain mechanism for blocking the active site. Structure. 1998 Jan 15;6(1):23-32.
9666110	Mantuano E, Trettel F, Olsen AS, Lennon G, Frontali M, Jodice C: Localization and genomic structure of human deoxyhypusine synthase gene on chromosome 19p13.2-distal 19p13.1. Gene. 1998 Jul 17;215(1):153-7.

# Drug_Target_112_HGNC_ID:
HGNC:2869

# Drug_Target_112_HPRD_ID:
02969

# Drug_Target_112_ID:
2018

# Drug_Target_112_Locus:
19p13.2-p13.1

# Drug_Target_112_Molecular_Weight:
40971

# Drug_Target_112_Name:
Deoxyhypusine synthase

# Drug_Target_112_Number_of_Residues:
369

# Drug_Target_112_PDB_ID:
1RQD

# Drug_Target_112_Pathway:
Not Available

# Drug_Target_112_Pfam_Domain_Function:
PF01916	DS

# Drug_Target_112_Protein_Sequence:
>Deoxyhypusine synthase
MEGSLEREAPAGALAAVLKHSSTLPPESTQVRGYDFNRGVNYRALLEAFGTTGFQATNFG
RAVQQVNAMIEKKLEPLSQDEDQHADLTQSRRPLTSCTIFLGYTSNLISSGIRETIRYLV
QHNMVDVLVTTAGGVEEDLIKCLAPTYLGEFSLRGKELRENGINRIGNLLVPNENYCKFE
DWLMPILDQMVMEQNTEGVKWTPSKMIARLGKEINNPESVYYWAQKNHIPVFSPALTDGS
LGDMIFFHSYKNPGLVLDIVEDLRLINTQAIFAKCTGMIILGGGVVKHHIANANLMRNGA
DYAVYINTAQEFDGSDSGARPDEAVSWGKIRVDAQPVKVYADASLVFPLLVAETFAQKMD
AFMHEKNED

# Drug_Target_112_Reaction:
(1) [eIF5A-precursor]-lysine + spermidine = [eIF5A-precursor]-deoxyhypusine + propane-1,3-diamine

# Drug_Target_112_Signals:
None

# Drug_Target_112_Specific_Function:
Catalyzes the NAD-dependent oxidative cleavage of spermidine and the subsequent transfer of the butylamine moiety of spermidine to the epsilon-amino group of a specific lysine residue of the eIF-5A precursor protein to form the intermediate deoxyhypusine residue

# Drug_Target_112_SwissProt_ID:
P49366

# Drug_Target_112_SwissProt_Name:
DHYS_HUMAN

# Drug_Target_112_Synonyms:
DHS
EC 2.5.1.46

# Drug_Target_112_Theoretical_pI:
5.02

# Drug_Target_112_Transmembrane_Regions:
None

# Drug_Target_113_Cellular_Location:
Not Available

# Drug_Target_113_Chromosome_Location:
Not Available

# Drug_Target_113_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_113_Essentiality:
Non-Essential

# Drug_Target_113_GenAtlas_ID:
IMPDH2

# Drug_Target_113_GenBank_ID_Gene:
J04208

# Drug_Target_113_GenBank_ID_Protein:
307066

# Drug_Target_113_GeneCard_ID:
IMPDH2

# Drug_Target_113_Gene_Name:
IMPDH2

# Drug_Target_113_Gene_Sequence:
>1545 bp
ATGGCCGACTACCTGATTAGTGGGGGCACGTCCTACGTGCCAGACGACGGACTCACAGCA
CAGCAGCTCTTCAACTGCGGAGACGGCCTCACCTACAATGACTTTCTCATTCTCCCTGGG
TACATCGACTTCACTGCAGACCAGGTGGACCTGACTTCTGCTCTGACCAAGAAAATCACT
CTTAAGACCCCACTGGTTTCCTCTCCCATGGACACAGTCACAGAGGCTGGGATGGCCATA
GCAATGGCGCTTACAGGCGGTATTGGCTTCATCCACCACAACTGTACACCTGAATTCCAG
GCCAATGAAGTTCGGAAAGTGAAGAAATATGAACAGGGATTCATCACAGACCCTGTGGTC
CTCAGCCCCAAGGATCGCGTGCGGGATGTTTTTGAGGCCAAGGCCCGGCATGGTTTCTGC
GGTATCCCAATCACAGACACAGGCCGGATGGGGAGCCGCTTGGTGGGCATCATCTCCTCC
AGGGACATTGATTTTCTCAAAGAGGAGGAACATGACTGTTTCTTGGAAGAGATAATGACA
AAGAGGGAAGACTTGGTGGTAGCCCCCCGCAGCATCACACTGAAGGAGGCAAATGAAATT
CTGCAGCGCAGCAAGAAGGGAAAGTTGCCCATTGTAAATGAAGATGATGAGCTTGTGGCC
ATCATTGCCCGGACAGACCTGAAGAAGAATCGGGACTACCCACTAGCCTCCAAAGATGCC
AAGAAACAGCTGCTGTGTGGGGCAGCCATTGGCACTCATGAGGATGACAAGTATAGGCTG
GACTTGCTCGCCCAGGCTGGTGTGGATGTAGTGGTTTTGGACTCTTCCCAGGGAAATTCC
ATCTTCCAGATCAATATGATCAAGTACATCAAAGACAAATACCCTAATCTCCAAGTCATT
GGAGGCAATGTGGTCACTGCTGCCCAGGCCAAGAACCTCATTGATGCAGGTGTGGATGCC
CTGCGGGTGGGCATGGGAAGTGGCTCCATCTGCATTACGCAGGAAGTGCTGGCCTGTGGG
CGGCCCCAAGCAACAGCAGTGTACAAGGTGTCAGAGTATGCACGGCGCTTTGGTGTTCCG
GTCATTGCTGATGGAGGAATCCAAAATGTGGGTCATATTGCGAAAGCCTTGGCCCTTGGG
GCCTCCACAGTCATGATGGGCTCTCTCCTGGCTGCCACCACTGAGGCCCCTGGTGAATAC
TTCTTTTCCGATGGGATCCGGCTAAAGAAATATCGCGGTATGGGTTCTCTCGATGCCATG
GACAAGCACCTCAGCAGCCAGAACAGATATTTCAGTGAAGCTGACAAAATCAAAGTGGCC
CAGGGAGTGTCTGGTGCTGTGCAGGACAAAGGGTCAATCCACAAATTTGTCCCTTACCTG
ATTGCTGGCATCCAACACTCATGCCAGGACATTGGTGCCAAGAGCTTGACCCAAGTCCGA
GCCATGATGTACTCTGGGGAGCTTAAGTTTGAGAAGAGAACGTCCTCAGCCCAGGTGGAA
GGTGGCGTCCATAGCCTCCATTCGTATGAGAAGCGGCTTTTCTGA

# Drug_Target_113_General_Function:
Nucleotide transport and metabolism

# Drug_Target_113_General_References:
10097070	Colby TD, Vanderveen K, Strickler MD, Markham GD, Goldstein BM: Crystal structure of human type II inosine monophosphate dehydrogenase: implications for ligand binding and drug design. Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3531-6.
1969416	Natsumeda Y, Ohno S, Kawasaki H, Konno Y, Weber G, Suzuki K: Two distinct cDNAs for human IMP dehydrogenase. J Biol Chem. 1990 Mar 25;265(9):5292-5.
2902093	Collart FR, Huberman E: Cloning and sequence analysis of the human and Chinese hamster inosine-5'-monophosphate dehydrogenase cDNAs. J Biol Chem. 1988 Oct 25;263(30):15769-72.
7763314	Hager PW, Collart FR, Huberman E, Mitchell BS: Recombinant human inosine monophosphate dehydrogenase type I and type II proteins. Purification and characterization of inhibitor binding. Biochem Pharmacol. 1995 May 11;49(9):1323-9.
7896827	Zimmermann AG, Spychala J, Mitchell BS: Characterization of the human inosine-5'-monophosphate dehydrogenase type II gene. J Biol Chem. 1995 Mar 24;270(12):6808-14.
7999076	Glesne DA, Huberman E: Cloning and sequence of the human type II IMP dehydrogenase gene. Biochem Biophys Res Commun. 1994 Nov 30;205(1):537-44.
8098009	Glesne D, Collart F, Varkony T, Drabkin H, Huberman E: Chromosomal localization and structure of the human type II IMP dehydrogenase gene (IMPDH2). Genomics. 1993 Apr;16(1):274-7.

# Drug_Target_113_HGNC_ID:
HGNC:6053

# Drug_Target_113_HPRD_ID:
00895

# Drug_Target_113_ID:
796

# Drug_Target_113_Locus:
3p21.2

# Drug_Target_113_Molecular_Weight:
55806

# Drug_Target_113_Name:
Inosine-5'-monophosphate dehydrogenase 2

# Drug_Target_113_Number_of_Residues:
514

# Drug_Target_113_PDB_ID:
1NFB

# Drug_Target_113_Pathway:
Not Available

# Drug_Target_113_Pfam_Domain_Function:
PF00478	IMPDH
PF00571	CBS

# Drug_Target_113_Protein_Sequence:
>Inosine-5'-monophosphate dehydrogenase 2
MADYLISGGTSYVPDDGLTAQQLFNCGDGLTYNDFLILPGYIDFTADQVDLTSALTKKIT
LKTPLVSSPMDTVTEAGMAIAMALTGGIGFIHHNCTPEFQANEVRKVKKYEQGFITDPVV
LSPKDRVRDVFEAKARHGFCGIPITDTGRMGSRLVGIISSRDIDFLKEEEHDCFLEEIMT
KREDLVVAPAGITLKEANEILQRSKKGKLPIVNEDDELVAIIARTDLKKNRDYPLASKDA
KKQLLCGAAIGTHEDDKYRLDLLAQAGVDVVVLDSSQGNSIFQINMIKYIKDKYPNLQVI
GGNVVTAAQAKNLIDAGVDALRVGMGSGSICITQEVLACGRPQATAVYKVSEYARRFGVP
VIADGGIQNVGHIAKALALGASTVMMGSLLAATTEAPGEYFFSDGIRLKKYRGMGSLDAM
DKHLSSQNRYFSEADKIKVAQGVSGAVQDKGSIHKFVPYLIAGIQHSCQDIGAKSLTQVR
AMMYSGELKFEKRTSSAQVEGGVHSLHSYEKRLF

# Drug_Target_113_Reaction:
inosine 5'-phosphate + NAD+ + H2O = xanthosine 5'-phosphate + NADH + H+

# Drug_Target_113_Signals:
None

# Drug_Target_113_Specific_Function:
Rate limiting enzyme in the de novo synthesis of guanine nucleotides and therefore is involved in the regulation of cell growth. It may also have a role in the development of malignancy and the growth progression of some tumors

# Drug_Target_113_SwissProt_ID:
P12268

# Drug_Target_113_SwissProt_Name:
IMDH2_HUMAN

# Drug_Target_113_Synonyms:
EC 1.1.1.205
IMP dehydrogenase 2
IMPD 2
IMPDH-II

# Drug_Target_113_Theoretical_pI:
6.90

# Drug_Target_113_Transmembrane_Regions:
None

# Drug_Target_114_Cellular_Location:
Not Available

# Drug_Target_114_Chromosome_Location:
Not Available

# Drug_Target_114_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_114_Essentiality:
Non-Essential

# Drug_Target_114_GenAtlas_ID:
Not Available

# Drug_Target_114_GenBank_ID_Gene:
BA000033

# Drug_Target_114_GenBank_ID_Protein:
21205025

# Drug_Target_114_GeneCard_ID:
Not Available

# Drug_Target_114_Gene_Name:
nos

# Drug_Target_114_Gene_Sequence:
>1077 bp
ATGTTATTTAAAGAGGCTCAAGCTTTCATAGAAAACATGTATAAAGAGTGTCATTATGAA
ACGCAAATTATCAATAAACGTTTACATGACATTGAACTAGAAATAAAAGAAACTGGGACA
TATACACATACAGAAGAAGAACTTATTTATGGTGCTAAAATGGCTTGGCGTAATTCAAAT
CGTTGCATTGGTCGTTTATTTTGGGATTCGTTAAATGTCATTGATGCAAGAGATGTTACT
GACGAAGCATCGTTCTTATCATCAATTACTTATCATATTACACAGGCTACAAATGAAGGT
AAATTAAAGCCGTATATTACTATATATGCTCCAAAGGATGGACCTAAAATTTTCAACAAT
CAATTAATTCGCTATGCTGGCTATGACAATTGTGGTGATCCTGCTGAAAAAGAAGTTACA
CGCTTAGCAAATCACTTAGGTTGGAAAGGAAAAGGTACTAATTTTGACGTGTTACCACTG
ATTTACCAATTACCTAATGAGTCAGTTAAATTTTACGAATATCCTACTTCATTAATTAAA
GAAGTACCTATTGAACATAATCATTATCCAAAATTAAGAAAATTGAACTTAAAATGGTAT
GCAGTCCCTATCATTTCCAATATGGACTTAAAAATCGGTGGCATTGTATATCCAACTGCA
CCCTTTAACGGTTGGTATATGGTAACTGAAATTGGCGTACGTAACTTTATTGATGATTAC
CGTTACAATTTACTAGAAAAAGTTGCAGATGCGTTTGAATTTGATACACTTAAAAATAAT
TCATTTAATAAAGATCGAGCACTTGTTGAATTGAACTATGCTGTGTATCATTCCTTTAAA
AAAGAAGGCGTATCAATTGTCGATCATTTGACCGCTGCAAAGCAATTCGAACTATTCGAA
CGTAATGAAGCACAACAAGGTCGTCAAGTTACCGGAAAATGGTCTTGGCTAGCGCCGCCA
TTATCTCCAACATTGACGTCAAATTATCATCATGGATATGACAATACAGTAAAAGATCCA
AACTTTTTCTATAAAAAGAAAGAATCAAATGCTAACCAGTGCCCTTTCCATCATTAA

# Drug_Target_114_General_Function:
Involved in nitric-oxide synthase activity

# Drug_Target_114_General_References:
12044378	Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K, Oguchi A, Nagai Y, Iwama N, Asano K, Naimi T, Kuroda H, Cui L, Yamamoto K, Hiramatsu K: Genome and virulence determinants of high virulence community-acquired MRSA. Lancet. 2002 May 25;359(9320):1819-27.

# Drug_Target_114_HGNC_ID:
Not Available

# Drug_Target_114_HPRD_ID:
Not Available

# Drug_Target_114_ID:
2701

# Drug_Target_114_Locus:
Not Available

# Drug_Target_114_Molecular_Weight:
41711

# Drug_Target_114_Name:
Nitric oxide synthase oxygenase

# Drug_Target_114_Number_of_Residues:
358

# Drug_Target_114_PDB_ID:
1MJT

# Drug_Target_114_Pathway:
Not Available

# Drug_Target_114_Pfam_Domain_Function:
PF02898	NO_synthase

# Drug_Target_114_Protein_Sequence:
>Nitric oxide synthase oxygenase
MLFKEAQAFIENMYKECHYETQIINKRLHDIELEIKETGTYTHTEEELIYGAKMAWRNSN
RCIGRLFWDSLNVIDARDVTDEASFLSSITYHITQATNEGKLKPYITIYAPKDGPKIFNN
QLIRYAGYDNCGDPAEKEVTRLANHLGWKGKGTNFDVLPLIYQLPNESVKFYEYPTSLIK
EVPIEHNHYPKLRKLNLKWYAVPIISNMDLKIGGIVYPTAPFNGWYMVTEIGVRNFIDDY
RYNLLEKVADAFEFDTLKNNSFNKDRALVELNYAVYHSFKKEGVSIVDHLTAAKQFELFE
RNEAQQGRQVTGKWSWLAPPLSPTLTSNYHHGYDNTVKDPNFFYKKKESNANQCPFHH

# Drug_Target_114_Reaction:
Not Available

# Drug_Target_114_Signals:
None

# Drug_Target_114_Specific_Function:
Catalyzes the production of nitric oxide

# Drug_Target_114_SwissProt_ID:
P0A094

# Drug_Target_114_SwissProt_Name:
NOSO_STAAW

# Drug_Target_114_Synonyms:
EC 1.-.-.-
NOSoxy-like protein
SANOS

# Drug_Target_114_Theoretical_pI:
7.00

# Drug_Target_114_Transmembrane_Regions:
None

# Drug_Target_115_Cellular_Location:
Not Available

# Drug_Target_115_Chromosome_Location:
Not Available

# Drug_Target_115_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_115_Essentiality:
Non-Essential

# Drug_Target_115_GenAtlas_ID:
GALE

# Drug_Target_115_GenBank_ID_Gene:
L41668

# Drug_Target_115_GenBank_ID_Protein:
1119217

# Drug_Target_115_GeneCard_ID:
GALE

# Drug_Target_115_Gene_Name:
GALE

# Drug_Target_115_Gene_Sequence:
>1047 bp
ATGGCAGAGAAGGTGCTGGTAACAGGTGGGGCTGGCTACATTGGCAGCCACACGGTGCTG
GAGCTGCTGGAGGCTGGCTACTTGCCTGTGGTCATCGATAACTTCCATAATGCCTTCCGT
GGAGGGGGCTCCCTGCCTGAGAGCCTGCGGCGGGTCCAGGAGCTGACAGGCCGCTCTGTG
GAGTTTGAGGAGATGGACATTTTGGACCAGGGAGCCCTACAGCGTCTCTTCAAAAAGTAC
AGCTTTATGGCGGTCATCCACTTTGCGGGGCTCAAGGCCGTGGGCGAGTCGGTGCAGAAG
CCTCTGGATTATTACAGAGTTAACCTGACCGGGACCATCCAGCTTCTGGAGATCATGAAG
GCCCACGGGGTGAAGAACCTGGTGTTCAGCAGCTCAGCCACTGTGTACGGGAACCCCCAG
TACCTGCCCCTTGATGAGGCCCACCCCACGGGTGGTTGTACCAACCCTTACGGCAAGTCC
AAGTTCTTCATCGAGGAAATGATCCGGGACCTGTGCCAGGCAGACAAGACTTGGAACGTA
GTGCTGCTGCGCTATTTCAACCCCACAGGTGCCCATGCCTCTGGCTGCATTGGTGAGGAT
CCCCAGGGCATACCCAACAACCTCATGCCTTATGTCTCCCAGGTGGCGATCGGGCGACGG
GAGGCCCTGAATGTCTTTGGCAATGACTATGACACAGAGGATGGCACAGGTGTCCGGGAT
TACATCCATGTCGTGGATCTGGCCAAGGGCCACATTGCAGCCTTAAGGAAGCTGAAAGAA
CAGTGTGGCTGCCGGATCTACAACCTGGGCACGGGCACAGGCTATTCAGTGCTGCAGATG
GTCCAGGCTATGGAGAAGGCCTCTGGGAAGAAGATCCCGTACAAGGTGGTGGCACGGCGG
GAAGGTGATGTGGCAGCCTGTTACGCCAACCCCAGCCTGGCCCAAGAGGAGCTGGGGTGG
ACAGCAGCCTTAGGGCTGGACAGGATGTGTGAGGATCTCTGGCGCTGGCAGAAGCAGAAT
CCTTCAGGCTTTGGCACGCAAGCCTGA

# Drug_Target_115_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_115_General_References:
10801319	Thoden JB, Wohlers TM, Fridovich-Keil JL, Holden HM: Crystallographic evidence for Tyr 157 functioning as the active site base in human UDP-galactose 4-epimerase. Biochemistry. 2000 May 16;39(19):5691-701.
11279193	Thoden JB, Wohlers TM, Fridovich-Keil JL, Holden HM: Molecular basis for severe epimerase deficiency galactosemia. X-ray structure of the human V94m-substituted UDP-galactose 4-epimerase. J Biol Chem. 2001 Jun 8;276(23):20617-23. Epub 2001 Mar 7.
8593531	Daude N, Gallaher TK, Zeschnigk M, Starzinski-Powitz A, Petry KG, Haworth IS, Reichardt JK: Molecular cloning, characterization, and mapping of a full-length cDNA encoding human UDP-galactose 4'-epimerase. Biochem Mol Med. 1995 Oct;56(1):1-7.
9326324	Quimby BB, Alano A, Almashanu S, DeSandro AM, Cowan TM, Fridovich-Keil JL: Characterization of two mutations associated with epimerase-deficiency galactosemia, by use of a yeast expression system for human UDP-galactose-4-epimerase. Am J Hum Genet. 1997 Sep;61(3):590-8.
9538513	Maceratesi P, Daude N, Dallapiccola B, Novelli G, Allen R, Okano Y, Reichardt J: Human UDP-galactose 4' epimerase (GALE) gene and identification of five missense mutations in patients with epimerase-deficiency galactosemia. Mol Genet Metab. 1998 Jan;63(1):26-30.
9973283	Wohlers TM, Christacos NC, Harreman MT, Fridovich-Keil JL: Identification and characterization of a mutation, in the human UDP-galactose-4-epimerase gene, associated with generalized epimerase-deficiency galactosemia. Am J Hum Genet. 1999 Feb;64(2):462-70.

# Drug_Target_115_HGNC_ID:
HGNC:4116

# Drug_Target_115_HPRD_ID:
06092

# Drug_Target_115_ID:
2762

# Drug_Target_115_Locus:
1p36-p35

# Drug_Target_115_Molecular_Weight:
38282

# Drug_Target_115_Name:
UDP-glucose 4-epimerase

# Drug_Target_115_Number_of_Residues:
348

# Drug_Target_115_PDB_ID:
1EK6

# Drug_Target_115_Pathway:
Not Available

# Drug_Target_115_Pfam_Domain_Function:
PF01370	Epimerase

# Drug_Target_115_Protein_Sequence:
>UDP-glucose 4-epimerase
MAEKVLVTGGAGYIGSHTVLELLEAGYLPVVIDNFHNAFRGGGSLPESLRRVQELTGRSV
EFEEMDILDQGALQRLFKKYSFMAVIHFAGLKAVGESVQKPLDYYRVNLTGTIQLLEIMK
AHGVKNLVFSSSATVYGNPQYLPLDEAHPTGGCTNPYGKSKFFIEEMIRDLCQADKTWNA
VLLRYFNPTGAHASGCIGEDPQGIPNNLMPYVSQVAIGRREALNVFGNDYDTEDGTGVRD
YIHVVDLAKGHIAALRKLKEQCGCRIYNLGTGTGYSVLQMVQAMEKASGKKIPYKVVARR
EGDVAACYANPSLAQEELGWTAALGLDRMCEDLWRWQKQNPSGFGTQA

# Drug_Target_115_Reaction:
UDP-glucose = UDP-galactose

# Drug_Target_115_Signals:
None

# Drug_Target_115_Specific_Function:
Catalyzes two distinct but analogous reactions:the epimerization of UDP-glucose to UDP-galactose and the epimerization of UDP-N-acetylglucosamine to UDP-N- acetylgalactosamine

# Drug_Target_115_SwissProt_ID:
Q14376

# Drug_Target_115_SwissProt_Name:
GALE_HUMAN

# Drug_Target_115_Synonyms:
EC 5.1.3.2
Galactowaldenase
UDP-galactose 4-epimerase

# Drug_Target_115_Theoretical_pI:
6.71

# Drug_Target_115_Transmembrane_Regions:
None

# Drug_Target_116_Cellular_Location:
Cytoplasm

# Drug_Target_116_Chromosome_Location:
Not Available

# Drug_Target_116_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_116_Essentiality:
Non-Essential

# Drug_Target_116_GenAtlas_ID:
Not Available

# Drug_Target_116_GenBank_ID_Gene:
M13141

# Drug_Target_116_GenBank_ID_Protein:
146248

# Drug_Target_116_GeneCard_ID:
Not Available

# Drug_Target_116_Gene_Name:
gor

# Drug_Target_116_Gene_Sequence:
>1353 bp
ATGACTAAACACTATGATTACATCGCCATCGGCGGCGGCAGCGGCGGTATCGCCTCCATC
AACCGCGCGGCTATGTACGGCCAGAAATGTGCGCTGATTGAAGCCAAAGAGCTGGGCGGC
ACCTGCGTAAATGTTGGCTGTGTGCCGAAAAAAGTGATGTGGCACGCGGCGCAAATCCGT
GAAGCGATCCATATGTACGGCCCGGATTATGGTTTTGATACCACTATCAATAAATTCAAC
TGGGAAACGTTGATCGCCAGCCGTACCGCCTATATCGACCGTATTCATACTTCCTATGAA
AACGTGCTCGGTAAAAATAACGTTGATGTAATCAAAGGCTTTGCCCGCTTCGTTGATGCC
AAAACGCTGGAGGTAAACGGCGAAACCATCACGGCCGATCATATTCTGATCGCCACAGGC
GGTCGTCCGAGCCACCCGGATATTCCGGGCGTGGAATACGGTATTGATTCTGATGGCTTC
TTCGCCCTTCCTGCTTTGCCAGAGCGCGTGGCGGTTGTTGGCGCGGGTTACATCGCCGTT
GAGCTGGCGGGCGTGATTAACGGCCTCGGCGCGAAAACGCATCTGTTTGTGCGTAAACAT
GCGCCGCTGCGCAGCTTCGACCCGATGATTTCCGAAACGCTGGTCGAAGTGATGAACGCC
GAAGGCCCGCAGCTGCACACCAACGCCATCCCGAAAGCGGTAGTGAAAAATACCGATGGT
AGCCTGACGCTGGAGCTGGAAGATGGTCGCAGTGAAACGGTGGATTGCCTGATTTGGGCG
ATTGGTCGCGAGCCTGCCAATGACAACATCAACCTGGAAGCCGCTGGCGTTAAAACTAAC
GAAAAAGGCTATATCGTCGTCGATAAATATCAAAACACCAATATTGAAGGTATTTACGCG
GTGGGCGATAACACGGGTGCAGTGGAGCTGACACCGGTGGCAGTTGCAGCGGGTCGCCGT
CTCTCTGAACGCCTGTTTAATAACAAGCCGGATGAGCATCTGGATTACAGCAACATTCCG
ACCGTGGTCTTCAGCCATCCGCCGATTGGTACTGTTGGTTTAACGGAACCGCAGGCGCGC
GAGCAGTATGGCGACGATCAGGTGAAAGTGTATAAATCCTCTTTCACCGCGATGTATACC
GCCGTCACCACTCACCGCCAGCCGTGCCGCATGAAGCTGGTGTGCGTTGGATCGGAAGAG
AAGATTGTCGGTATTCACGGCATTGGCTTTGGTATGGACGAAATGTTGCAGGGCTTCGCG
GTGGCGCTGAAGATGGGGGCAACCAAAAAAGACTTCGACAATACCGTCGCCATTCACCCA
ACGGCGGCAGAAGAGTTCGTGACAATGCGTTAA

# Drug_Target_116_General_Function:
RNA processing and modification

# Drug_Target_116_General_References:
2006135	Ermler U, Schulz GE: The three-dimensional structure of glutathione reductase from Escherichia coli at 3.0 A resolution. Proteins. 1991;9(3):174-9.
3521741	Greer S, Perham RN: Glutathione reductase from Escherichia coli: cloning and sequence analysis of the gene and relationship to other flavoprotein disulfide oxidoreductases. Biochemistry. 1986 May 6;25(9):2736-42.
8041620	Sofia HJ, Burland V, Daniels DL, Plunkett G 3rd, Blattner FR: Analysis of the Escherichia coli genome. V. DNA sequence of the region from 76.0 to 81.5 minutes. Nucleic Acids Res. 1994 Jul 11;22(13):2576-86.
8061609	Mittl PR, Schulz GE: Structure of glutathione reductase from Escherichia coli at 1.86 A resolution: comparison with the enzyme from human erythrocytes. Protein Sci. 1994 May;3(5):799-809.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_116_HGNC_ID:
Not Available

# Drug_Target_116_HPRD_ID:
Not Available

# Drug_Target_116_ID:
327

# Drug_Target_116_Locus:
Not Available

# Drug_Target_116_Molecular_Weight:
48773

# Drug_Target_116_Name:
Glutathione reductase

# Drug_Target_116_Number_of_Residues:
450

# Drug_Target_116_PDB_ID:
1GET

# Drug_Target_116_Pathway:
Not Available

# Drug_Target_116_Pfam_Domain_Function:
PF00070	Pyr_redox
PF02852	Pyr_redox_dim
PF07992	Pyr_redox_2

# Drug_Target_116_Protein_Sequence:
>Glutathione reductase
MTKHYDYIAIGGGSGGIASINRAAMYGQKCALIEAKELGGTCVNVGCVPKKVMWHAAQIR
EAIHMYGPDYGFDTTINKFNWETLIASRTAYIDRIHTSYENVLGKNNVDVIKGFARFVDA
KTLEVNGETITADHILIATGGRPSHPDIPGVEYGIDSDGFFALPALPERVAVVGAGYIAV
ELAGVINGLGAKTHLFVRKHAPLRSFDPMISETLVEVMNAEGPQLHTNAIPKAVVKNTDG
SLTLELEDGRSETVDCLIWAIGREPANDNINLEAAGVKTNEKGYIVVDKYQNTNIEGIYA
VGDNTGAVELTPVAVAAGRRLSERLFNNKPDEHLDYSNIPTVVFSHPPIGTVGLTEPQAR
EQYGDDQVKVYKSSFTAMYTAVTTHRQPCRMKLVCVGSEEKIVGIHGIGFGMDEMLQGFA
VALKMGATKKDFDNTVAIHPTAAEEFVTMR

# Drug_Target_116_Reaction:
2 glutathione + NADP+ = glutathione disulfide + NADPH + H+

# Drug_Target_116_Signals:
None

# Drug_Target_116_Specific_Function:
Maintains high levels of reduced glutathione in the cytosol

# Drug_Target_116_SwissProt_ID:
P06715

# Drug_Target_116_SwissProt_Name:
GSHR_ECOLI

# Drug_Target_116_Synonyms:
EC 1.8.1.7
GR
GRase

# Drug_Target_116_Theoretical_pI:
5.88

# Drug_Target_116_Transmembrane_Regions:
None

# Drug_Target_117_Cellular_Location:
Cytoplasm

# Drug_Target_117_Chromosome_Location:
Not Available

# Drug_Target_117_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_117_Essentiality:
Non-Essential

# Drug_Target_117_GenAtlas_ID:
ADH5

# Drug_Target_117_GenBank_ID_Gene:
M30471

# Drug_Target_117_GenBank_ID_Protein:
178134

# Drug_Target_117_GeneCard_ID:
ADH5

# Drug_Target_117_Gene_Name:
ADH5

# Drug_Target_117_Gene_Sequence:
>1125 bp
ATGGCGAACGAGGTTATCAAGTGCAAGGCTGCAGTTGCTTGGGAGGCTGGAAAGCCTCTC
TCCATAGAGGAGATAGAGGTGGCACCCCCAAAGGCTCATGAAGTTCGAATCAAGATCATT
GCCACTGCGGTTTGCCACACCGATGCCTATACCCTGAGTGGAGCTGATCCTGAGGGTTGT
TTTCCAGTGATCTTGGGACATGAAGGTGCTGGAATTGTGGAAAGTGTTGGTGAGGGAGTT
ACTAAGCTGAAGGCGGGTGACACTGTCATCCCACTTTACATCCCACAGTGTGGAGAATGC
AAATTTTGTCTAAATCCTAAAACTAACCTTTGCCAGAAGATAAGAGTCACTCAAGGGAAA
GGATTAATGCCAGATGGTACCAGCAGATTTACTTGCAAAGGAAAGACAATTTTGCATTAC
ATGGGAACCAGCACATTTTCTGAATACACAGTTGTGGCTGATATCTCTGTTGCTAAAATA
GATCCTTTAGCACCTTTGGATAAAGTCTGCCTTCTAGGTTGTGGCATTTCAACCGGTTAT
GGTGCTGCTGTGAACACTGCCAAGTTGGAGCCTGGCTCTGTTTGTGCCGTCTTTGGTCTG
GGAGGAGTCGGATTGGCAGTTATCATGGGCTGTAAAGTGGCTGGTGCTTCCCGGATCATT
GGTGTGGACATCAATAAAGATAAATTTGCAAGGGCCAAAGAGTTTGGAGCCACTGAATGT
ATTAACCCTCAGGATTTTAGTAAACCCATCCAGGAAGTGCTCATTGAGATGACCGATGGA
GGAGTGGACTATTCCTTTGAATGTATTGGTAATGTGAAGGTCATGAGAGCAGCACTTGAG
GCATGTCACAAGGGCTGGGGCGTCAGCGTCGTGGTTGGAGTAGCTGCTTCAGGTGAAGAA
ATTGCCACTCGTCCATTCCAGCTGGTAACAGGTCGCACATGGAAAGGCACTGCCTTTGGA
GGATGGAAGAGTGTAGAAAGTGTCCCAAAGTTGGTGTCTGAATATATGTCCAAAAAGATA
AAAGTTGATGAATTTGTGACTCACAATCTGTCTTTTGATGAAATCAACAAAGCCTTTGAA
CTGATGCATTCTGGAAAGAGCATTCGAACTGTTGTAAAGATTTAA

# Drug_Target_117_General_Function:
Energy production and conversion

# Drug_Target_117_General_References:
1446828	Hur MW, Edenberg HJ: Cloning and characterization of the ADH5 gene encoding human alcohol dehydrogenase 5, formaldehyde dehydrogenase. Gene. 1992 Nov 16;121(2):305-11.
2679557	Giri PR, Krug JF, Kozak C, Moretti T, O'Brien SJ, Seuanez HN, Goldman D: Cloning and comparative mapping of a human class III (chi) alcohol dehydrogenase cDNA. Biochem Biophys Res Commun. 1989 Oct 16;164(1):453-60.
2818582	Sharma CP, Fox EA, Holmquist B, Jornvall H, Vallee BL: cDNA sequence of human class III alcohol dehydrogenase. Biochem Biophys Res Commun. 1989 Oct 31;164(2):631-7.
3365377	Kaiser R, Holmquist B, Hempel J, Vallee BL, Jornvall H: Class III human liver alcohol dehydrogenase: a novel structural type equidistantly related to the class I and class II enzymes. Biochemistry. 1988 Feb 23;27(4):1132-40.
8460164	Engeland K, Hoog JO, Holmquist B, Estonius M, Jornvall H, Vallee BL: Mutation of Arg-115 of human class III alcohol dehydrogenase: a binding site required for formaldehyde dehydrogenase activity and fatty acid activation. Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2491-4.
8494891	Holmquist B, Moulis JM, Engeland K, Vallee BL: Role of arginine 115 in fatty acid activation and formaldehyde dehydrogenase activity of human class III alcohol dehydrogenase. Biochemistry. 1993 May 18;32(19):5139-44.
9018047	Yang ZN, Bosron WF, Hurley TD: Structure of human chi chi alcohol dehydrogenase: a glutathione-dependent formaldehyde dehydrogenase. J Mol Biol. 1997 Jan 24;265(3):330-43.

# Drug_Target_117_HGNC_ID:
HGNC:253

# Drug_Target_117_HPRD_ID:
00064

# Drug_Target_117_ID:
12

# Drug_Target_117_Locus:
4q21-q25

# Drug_Target_117_Molecular_Weight:
39593

# Drug_Target_117_Name:
Alcohol dehydrogenase class 3

# Drug_Target_117_Number_of_Residues:
373

# Drug_Target_117_PDB_ID:
1MC5

# Drug_Target_117_Pathway:
Not Available

# Drug_Target_117_Pfam_Domain_Function:
PF00107	ADH_zinc_N
PF08240	ADH_N

# Drug_Target_117_Protein_Sequence:
>Alcohol dehydrogenase class 3 chi chain
ANEVIKCKAAVAWEAGKPLSIEEIEVAPPKAHEVRIKIIATAVCHTDAYTLSGADPEGCF
PVILGHEGAGIVESVGEGVTKLKAGDTVIPLYIPQCGECKFCLNPKTNLCQKIRVTQGKG
LMPDGTSRFTCKGKTILHYMGTSTFSEYTVVADISVAKIDPLAPLDKVCLLGCGISTGYG
AAVNTAKLEPGSVCAVFGLGGVGLAVIMGCKVAGASRIIGVDINKDKFARAKEFGATECI
NPQDFSKPIQEVLIEMTDGGVDYSFECIGNVKVMRAALEACHKGWGVSVVVGVAASGEEI
ATRPFQLVTGRTWKGTAFGGWKSVESVPKLVSEYMSKKIKVDEFVTHNLSFDEINKAFEL
MHSGKSIRTVVKI

# Drug_Target_117_Reaction:
an alcohol + NAD+ = an aldehyde or ketone + NADH + H+

# Drug_Target_117_Signals:
None

# Drug_Target_117_Specific_Function:
Class-III ADH is remarkably ineffective in oxidizing ethanol, but it readily catalyzes the oxidation of long-chain primary alcohols and the oxidation of S-(hydroxymethyl) glutathione

# Drug_Target_117_SwissProt_ID:
P11766

# Drug_Target_117_SwissProt_Name:
ADHX_HUMAN

# Drug_Target_117_Synonyms:
Alcohol dehydrogenase class III
Alcohol dehydrogenase class chi chain
EC 1.1.1.1
EC 1.1.1.284
FDH
Glutathione- dependent formaldehyde dehydrogenase
S- (hydroxymethyl)glutathione dehydrogenase

# Drug_Target_117_Theoretical_pI:
7.54

# Drug_Target_117_Transmembrane_Regions:
None

# Drug_Target_118_Cellular_Location:
Mitochondrion. Cytoplasm

# Drug_Target_118_Chromosome_Location:
Not Available

# Drug_Target_118_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_118_Essentiality:
Non-Essential

# Drug_Target_118_GenAtlas_ID:
GSR

# Drug_Target_118_GenBank_ID_Gene:
X15722

# Drug_Target_118_GenBank_ID_Protein:
31825

# Drug_Target_118_GeneCard_ID:
GSR

# Drug_Target_118_Gene_Name:
GSR

# Drug_Target_118_Gene_Sequence:
>1569 bp
ATGGCCCTGCTGCCCCGAGCCCTGAGCGCCGGCGCGGGACCGAGCTGGCGGCGGGCGGCG
CGCGCCTTCCGAGGCTTCCTGCTGCTTCTGCCCGAGCCCGCGGCCCTCACGCGCGCCCTC
TCCCGTGCCATGGCCTGCAGGCAGGAGCCGCAGCCGCAGGGCCCGCCGCCCGCTGCTGGC
GCCGTGGCCTCCTATGACTACCTGGTGATCGGGGGCGGCTCGGGCGGGCTGGCCAGCGCG
CGCAGGGCGGCCGAGCTGGGTGCCAGGGCCGCCGTGGTGGAGAGCCACAAGCTGGGTGGC
ACTTGCGTGAATGTTGGATGTGTACCCAAAAAGGTAATGTGGAACACAGCTGTCCACTCT
GAATTCATGCATGATCATGCTGATTATGGCTTTCCAAGTTGTGAGGGTAAATTCAATTGG
CGTGTTATTAAGGAAAAGCGGGATGCCTATGTGAGCCGCCTGAATGCCATCTATCAAAAC
AATCTCACCAAGTCCCATATAGAAATCATCCGTGGCCATGCAGCCTTCACGAGTGATCCC
AAGCCCACAATAGAGGTCAGTGGGAAAAAGTACACCGCCCCACACATCCTGATCGCCACA
GGTGGTATGCCCTCCACCCCTCATGAGAGCCAGATCCCCGGTGCCAGCTTAGGAATAACC
AGCGATGGATTTTTTCAGCTGGAAGAATTGCCCGGCCGCAGCGTCATTGTTGGTGCAGGT
TACATTGCTGTGGAGATGGCAGGGATCCTGTCAGCCCTGGGTTCTAAGACATCACTGATG
ATACGGCATGATAAGGTACTTAGAAGTTTTGATTCAATGATCAGCACCAACTGCACGGAG
GAGCTGGAGAACGCTGGCGTGGAGGTGCTGAAGTTCTCCCAGGTCAAGGAGGTTAAAAAG
ACTTTGTCGGGCTTGGAAGTCAGCATGGTTACTGCAGTTCCCGGTAGGCTACCAGTCATG
ACCATGATTCCAGATGTTGACTGCCTGCTCTGGGCCATTGGGCGGGTCCCGAATACCAAG
GACCTGAGTTTAAACAAACTGGGGATTCAAACCGATGACAAGGGTCATATCATCGTAGAC
GAATTCCAGAATACCAACGTCAAAGGCATCTATGCAGTTGGGGATGTATGTGGAAAAGCT
CTTCTTACTCCAGTTGCAATAGCTGCTGGCCGAAAACTTGCCCATCGACTTTTTGAATAT
AAGGAAGATTCCAAATTAGATTATAACAACATCCCAACTGTGGTCTTCAGCCACCCCCCT
ATTGGGACAGTGGGACTCACGGAAGATGAAGCCATTCATAAATATGGAATAGAAAATGTG
AAGACCTATTCAACGAGCTTTACCCCGATGTATCACGCAGTTACCAAAAGGAAAACAAAA
TGTGTGATGAAAATGGTCTGTGCTAACAAGGAAGAAAAGGTGGTTGGGATCCATATGCAG
GGACTTGGGTGTGATGAAATGCTGCAGGGTTTTGCTGTTGCAGTGAAGATGGGAGCAACG
AAGGCAGACTTTGACAACACAGTCGCCATTCACCCTACCTCTTCAGAAGAGCTGGTCACA
CTTCGTTGA

# Drug_Target_118_General_Function:
RNA processing and modification

# Drug_Target_118_General_References:
10708558	Kelner MJ, Montoya MA: Structural organization of the human glutathione reductase gene: determination of correct cDNA sequence and identification of a mitochondrial leader sequence. Biochem Biophys Res Commun. 2000 Mar 16;269(2):366-8.
2185014	Tutic M, Lu XA, Schirmer RH, Werner D: Cloning and sequencing of mammalian glutathione reductase cDNA. Eur J Biochem. 1990 Mar 30;188(3):523-8.
3656429	Karplus PA, Schulz GE: Refined structure of glutathione reductase at 1.54 A resolution. J Mol Biol. 1987 Jun 5;195(3):701-29.
7060551	Krauth-Siegel RL, Blatterspiel R, Saleh M, Schiltz E, Schirmer RH, Untucht-Grau R: Glutathione reductase from human erythrocytes. The sequences of the NADPH domain and of the interface domain. Eur J Biochem. 1982 Jan;121(2):259-67.
7334521	Thieme R, Pai EF, Schirmer RH, Schulz GE: Three-dimensional structure of glutathione reductase at 2 A resolution. J Mol Biol. 1981 Nov 15;152(4):763-82.
8626496	Savvides SN, Karplus PA: Kinetics and crystallographic analysis of human glutathione reductase in complex with a xanthene inhibitor. J Biol Chem. 1996 Apr 5;271(14):8101-7.
9174360	Stoll VS, Simpson SJ, Krauth-Siegel RL, Walsh CT, Pai EF: Glutathione reductase turned into trypanothione reductase: structural analysis of an engineered change in substrate specificity. Biochemistry. 1997 May 27;36(21):6437-47.
923580	Krohne-Ehrich G, Schirmer RH, Untucht-Grau R: Glutathione reductase from human erythrocytes. Isolation of the enzyme and sequence analysis of the redox-active peptide. Eur J Biochem. 1977 Oct 17;80(1):65-71.
9546215	Becker K, Savvides SN, Keese M, Schirmer RH, Karplus PA: Enzyme inactivation through sulfhydryl oxidation by physiologic NO-carriers. Nat Struct Biol. 1998 Apr;5(4):267-71.

# Drug_Target_118_HGNC_ID:
HGNC:4623

# Drug_Target_118_HPRD_ID:
00704

# Drug_Target_118_ID:
714

# Drug_Target_118_Locus:
8p21.1

# Drug_Target_118_Molecular_Weight:
56258

# Drug_Target_118_Name:
Glutathione reductase, mitochondrial

# Drug_Target_118_Number_of_Residues:
522

# Drug_Target_118_PDB_ID:
1BWC

# Drug_Target_118_Pathway:
Not Available

# Drug_Target_118_Pfam_Domain_Function:
PF00070	Pyr_redox
PF02852	Pyr_redox_dim
PF07992	Pyr_redox_2

# Drug_Target_118_Protein_Sequence:
>Glutathione reductase, mitochondrial precursor
MALLPRALSAGAGPSWRRAARAFRGFLLLLPEPAALTRALSRAMACRQEPQPQGPPPAAG
AVASYDYLVIGGGSGGLASARRAAELGARAAVVESHKLGGTCVNVGCVPKKVMWNTAVHS
EFMHDHADYGFPSCEGKFNWRVIKEKRDAYVSRLNAIYQNNLTKSHIEIIRGHAAFTSDP
KPTIEVSGKKYTAPHILIATGGMPSTPHESQIPGASLGITSDGFFQLEELPGRSVIVGAG
YIAVEMAGILSALGSKTSLMIRHDKVLRSFDSMISTNCTEELENAGVEVLKFSQVKEVKK
TLSGLEVSMVTAVPGRLPVMTMIPDVDCLLWAIGRVPNTKDLSLNKLGIQTDDKGHIIVD
EFQNTNVKGIYAVGDVCGKALLTPVAIAAGRKLAHRLFEYKEDSKLDYNNIPTVVFSHPP
IGTVGLTEDEAIHKYGIENVKTYSTSFTPMYHAVTKRKTKCVMKMVCANKEEKVVGIHMQ
GLGCDEMLQGFAVAVKMGATKADFDNTVAIHPTSSEELVTLR

# Drug_Target_118_Reaction:
2 glutathione + NADP+ = glutathione disulfide + NADPH + H+

# Drug_Target_118_Signals:
None

# Drug_Target_118_Specific_Function:
Maintains high levels of reduced glutathione in the cytosol

# Drug_Target_118_SwissProt_ID:
P00390

# Drug_Target_118_SwissProt_Name:
GSHR_HUMAN

# Drug_Target_118_Synonyms:
EC 1.8.1.7
GR
GRase
Glutathione reductase, mitochondrial precursor

# Drug_Target_118_Theoretical_pI:
8.66

# Drug_Target_118_Transmembrane_Regions:
None

# Drug_Target_119_Cellular_Location:
Not Available

# Drug_Target_119_Chromosome_Location:
Not Available

# Drug_Target_119_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_119_Essentiality:
Non-Essential

# Drug_Target_119_GenAtlas_ID:
Not Available

# Drug_Target_119_GenBank_ID_Gene:
J02799

# Drug_Target_119_GenBank_ID_Protein:
146432

# Drug_Target_119_GeneCard_ID:
Not Available

# Drug_Target_119_Gene_Name:
icd

# Drug_Target_119_Gene_Sequence:
>1251 bp
ATGGAAAGTAAAGTAGTTGTTCCGGCACAAGGCAAGAAGATCACCCTGCAAAACGGCAAA
CTCAACGTTCCTGAAAATCCGATTATCCCTTACATTGAAGGTGATGGAATCGGTGTAGAT
GTAACCCCAGCCATGCTGAAAGTGGTCGACGCTGCAGTCGAGAAAGCCTATAAAGGCGAG
CGTAAAATCTCCTGGATGGAAATTTACACCGGTGAAAAATCCACACAGGTTTATGGTCAG
GACGTCTGGCTGCCTGCTGAAACTCTTGATCTGATTCGTGAATATCGCGTTGCCATTAAA
GGTCCGCTGACCACTCCGGTTGGTGGCGGTATTCGCTCTCTGAACGTTGCCCTGCGCCAG
GAACTGGATCTCTACATCTGCCTGCGTCCGGTACGTTACTATCAGGGCACTCCAAGCCCG
GTTAAACACCCTGAACTGACCGATATGGTTATCTTCCGTGAAAACTCGGAAGACATTTAT
GCGGGTATCGAATGGAAAGCAGACTCTGCCGACGCCGAGAAAGTGATTAAATTCCTGCGT
GAAGAGATGGGGGTGAAGAAAATTCGCTTCCCGGAACATTGTGGTATCGGTATTAAGCCG
TGTTCGGAAGAAGGCACCAAACGTCTGGTTCGTGCAGCGATCGAATACGCAATTGCTAAC
GATCGTGACTCTGTGACTCTGGTGCACAAAGGCAACATCATGAAGTTCACCGAAGGAGCG
TTTAAAGACTGGGGCTACCAGCTGGCGCGTGAAGAGTTTGGCGGTGAACTGATCGACGGT
GGCCCGTGGCTGAAAGTTAAAAACCCGAACACTGGCAAAGAGATCGTCATTAAAGACGTG
ATTGCTGATGCATTCCTGCAACAGATCCTGCTGCGTCCGGCTGAATATGATGTTATCGCC
TGTATGAACCTGAACGGTGACTACATTTCTGACGCCCTGGCAGCGCAGGTTGGCGGTATC
GGTATCGCCCCTGGTGCAAACATCGGTGACGAATGCGCCCTGTTTGAAGCCACCCACGGT
ACTGCGCCGAAATATGCCGGTCAGGACAAAGTAAATCCTGGCTCTATTATTCTCTCCGCT
GAGATGATGCTGCGCCACATGGGTTGGACCGAAGCGGCTGACTTAATTGTTAAAGGTATG
GAAGGCGCAATCAACGCGAAAACCGTAACCTATGACTTCGAGCGTCTGATGGATGGCGCT
AAACTGCTGAAATGTTCAGAGTTTGGTGACGCGATCATCGAAAACATGTAA

# Drug_Target_119_General_Function:
Energy production and conversion

# Drug_Target_119_General_References:
10623532	Cherbavaz DB, Lee ME, Stroud RM, Koshland DE Jr: Active site water molecules revealed in the 2.1 A resolution structure of a site-directed mutant of isocitrate dehydrogenase. J Mol Biol. 2000 Jan 21;295(3):377-85.
2204109	Hurley JH, Dean AM, Sohl JL, Koshland DE Jr, Stroud RM: Regulation of an enzyme by phosphorylation at the active site. Science. 1990 Aug 31;249(4972):1012-6.
2682654	Hurley JH, Thorsness PE, Ramalingam V, Helmers NH, Koshland DE Jr, Stroud RM: Structure of a bacterial enzyme regulated by phosphorylation, isocitrate dehydrogenase. Proc Natl Acad Sci U S A. 1989 Nov;86(22):8635-9.
3112144	Thorsness PE, Koshland DE Jr: Inactivation of isocitrate dehydrogenase by phosphorylation is mediated by the negative charge of the phosphate. J Biol Chem. 1987 Aug 5;262(22):10422-5.
8905232	Oshima T, Aiba H, Baba T, Fujita K, Hayashi K, Honjo A, Ikemoto K, Inada T, Itoh T, Kajihara M, Kanai K, Kashimoto K, Kimura S, Kitagawa M, Makino K, Masuda S, Miki T, Mizobuchi K, Mori H, Motomura K, Nakamura Y, Nashimoto H, Nishio Y, Saito N, Horiuchi T, et al.: A 718-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 12.7-28.0 min region on the linkage map. DNA Res. 1996 Jun 30;3(3):137-55.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9298646	Link AJ, Robison K, Church GM: Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12. Electrophoresis. 1997 Aug;18(8):1259-313.
9352899	Wang FS, Whittam TS, Selander RK: Evolutionary genetics of the isocitrate dehydrogenase gene (icd) in Escherichia coli and Salmonella enterica. J Bacteriol. 1997 Nov;179(21):6551-9.

# Drug_Target_119_HGNC_ID:
Not Available

# Drug_Target_119_HPRD_ID:
Not Available

# Drug_Target_119_ID:
2302

# Drug_Target_119_Locus:
Not Available

# Drug_Target_119_Molecular_Weight:
45757

# Drug_Target_119_Name:
Isocitrate dehydrogenase [NADP]

# Drug_Target_119_Number_of_Residues:
416

# Drug_Target_119_PDB_ID:
1PB3

# Drug_Target_119_Pathway:
Not Available

# Drug_Target_119_Pfam_Domain_Function:
PF00180	Iso_dh

# Drug_Target_119_Protein_Sequence:
>Isocitrate dehydrogenase [NADP]
MESKVVVPAQGKKITLQNGKLNVPENPIIPYIEGDGIGVDVTPAMLKVVDAAVEKAYKGE
RKISWMEIYTGEKSTQVYGQDVWLPAETLDLIREYRVAIKGPLTTPVGGGIRSLNVALRQ
ELDLYICLRPVRYYQGTPSPVKHPELTDMVIFRENSEDIYAGIEWKADSADAEKVIKFLR
EEMGVKKIRFPEHCGIGIKPCSEEGTKRLVRAAIEYAIANDRDSVTLVHKGNIMKFTEGA
FKDWGYQLAREEFGGELIDGGPWLKVKNPNTGKEIVIKDVIADAFLQQILLRPAEYDVIA
CMNLNGDYISDALAAQVGGIGIAPGANIGDECALFEATHGTAPKYAGQDKVNPGSIILSA
EMMLRHMGWTEAADLIVKGMEGAINAKTVTYDFERLMDGAKLLKCSEFGDAIIENM

# Drug_Target_119_Reaction:
(1) isocitrate + NADP+ = 2-oxoglutarate + CO2 + NADPH

# Drug_Target_119_Signals:
None

# Drug_Target_119_Specific_Function:
Isocitrate + NADP(+) = 2-oxoglutarate + CO(2) + NADPH

# Drug_Target_119_SwissProt_ID:
P08200

# Drug_Target_119_SwissProt_Name:
IDH_ECOLI

# Drug_Target_119_Synonyms:
EC 1.1.1.42
IDH
IDP
NADP(+)-specific ICDH
Oxalosuccinate decarboxylase

# Drug_Target_119_Theoretical_pI:
4.90

# Drug_Target_119_Transmembrane_Regions:
None

# Drug_Target_11_Cellular_Location:
Cytoplasm. Melanosome. Note=Identified by mass spectrometry in melanosome fractions from stage I to

# Drug_Target_11_Chromosome_Location:
Not Available

# Drug_Target_11_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_11_Essentiality:
Non-Essential

# Drug_Target_11_GenAtlas_ID:
AHCY

# Drug_Target_11_GenBank_ID_Gene:
M61831

# Drug_Target_11_GenBank_ID_Protein:
178277

# Drug_Target_11_GeneCard_ID:
AHCY

# Drug_Target_11_Gene_Name:
AHCY

# Drug_Target_11_Gene_Sequence:
>1299 bp
ATGTCTGACAAACTGCCCTACAAAGTCGCCGACATCGGCCTGGCTGCCTGGGGACGCAAG
GCCCTGGACATTGCTGAGAACGAGATGCCGGGCCTGATGCGTATGCGGGAGCGGTACTCG
GCCTCCAAGCCACTGAAGGGCGCCCGCATCGCTGGCTGCCTGCACATGACCGTGGAGACG
GCCGTCCTCATTGAGACCCTCGTCACCCTGGGTGCTGAGGTGCAGTGGTCCAGCTGCAAC
ATCTTCTCCACCCAGAACCATGCGGCGGCTGCCATTGCCAAGGCTGGCATTCCGGTGTAT
GCCTGGAAGGGCGAAACGGACGAGGAGTACCTGTGGTGCATTGAGCAGACCCTGTACTTC
AAGGACGGGCCCCTCAACATGATTCTGGACGACGGGGGCGACCTCACCAACCTCATCCAC
ACCAAGTACCCGCAGCTTCTGCCAGGCATCCGAGGCATCTCTGAGGAGACCACGACTGGG
GTCCACAACCTCTACAAGATGATGGCCAATGGGATCCTCAAGGTGCCTGCCATCAATGTC
AATGACTCCGTCACCAAGAGCAAGTTTGACAACCTCTATGGCTGCCGGGAGTCCCTCATA
GATGGCATCAAGCGGGCCACAGATGTGATGATTGCCGGCAAGGTAGCGGTGGTAGCAGGC
TATGGTGATGTGGGCAAGGGCTGTGCCCAGGCCCTGCGGGGTTTCGGAGCCCGCGTCATC
ATCACCGAGATTGACCCCATCAACGCACTGCAGGCTGCCATGGAGGGCTATGAGGTGACC
ACCATGGATGAGGCCTGTCAGGAGGGCAACATCTTTGTCACCACCACAGGCTGTATTGAC
ATCATCCTTGGCCGGCACTTTGAGCAGATGAAGGATGATGCCATTGTGTGTAACATTGGA
CACTTTGACGTGGAGATCGATGTCAAGTGGCTCAACGAGAACGCCGTGGAGAAGGTGAAC
ATCAAGCCGCAGGTGGACCGGTATCGGTTGAAGAATGGGCGCCGCATCATCCTGCTGGCC
GAGGGTCGGCTGGTCAACCTGGGTTGTGCCATGGGCCACCCCAGCTTCGTGATGAGTAAC
TCCTTCACCAACCAGGTGATGGCGCAGATCGAGCTGTGGACCCATCCAGACAAGTACCCC
GTTGGGGTTCATTTCCTGCCCAAGAAGCTGGATGAGGCAGTGGCTGAAGCCCACCTGGGC
AAGCTGAATGTGAAGTTGACCAAGCTAACTGAGAAGCAAGCCCAGTACCTGGGCATGTCC
TGTGATGGCCCCTTCAAGCCGGATCACTACCGCTACTGA

# Drug_Target_11_General_Function:
Coenzyme transport and metabolism

# Drug_Target_11_General_References:
11780052	Deloukas P, Matthews LH, Ashurst J, Burton J, Gilbert JG, Jones M, Stavrides G, Almeida JP, Babbage AK, Bagguley CL, Bailey J, Barlow KF, Bates KN, Beard LM, Beare DM, Beasley OP, Bird CP, Blakey SE, Bridgeman AM, Brown AJ, Buck D, Burrill W, Butler AP, Carder C, Carter NP, Chapman JC, Clamp M, Clark G, Clark LN, Clark SY, Clee CM, Clegg S, Cobley VE, Collier RE, Connor R, Corby NR, Coulson A, Coville GJ, Deadman R, Dhami P, Dunn M, Ellington AG, Frankland JA, Fraser A, French L, Garner P, Grafham DV, Griffiths C, Griffiths MN, Gwilliam R, Hall RE, Hammond S, Harley JL, Heath PD, Ho S, Holden JL, Howden PJ, Huckle E, Hunt AR, Hunt SE, Jekosch K, Johnson CM, Johnson D, Kay MP, Kimberley AM, King A, Knights A, Laird GK, Lawlor S, Lehvaslaiho MH, Leversha M, Lloyd C, Lloyd DM, Lovell JD, Marsh VL, Martin SL, McConnachie LJ, McLay K, McMurray AA, Milne S, Mistry D, Moore MJ, Mullikin JC, Nickerson T, Oliver K, Parker A, Patel R, Pearce TA, Peck AI, Phillimore BJ, Prathalingam SR, Plumb RW, Ramsay H, Rice CM, Ross MT, Scott CE, Sehra HK, Shownkeen R, Sims S, Skuce CD, Smith ML, Soderlund C, Steward CA, Sulston JE, Swann M, Sycamore N, Taylor R, Tee L, Thomas DW, Thorpe A, Tracey A, Tromans AC, Vaudin M, Wall M, Wallis JM, Whitehead SL, Whittaker P, Willey DL, Williams L, Williams SA, Wilming L, Wray PW, Hubbard T, Durbin RM, Bentley DR, Beck S, Rogers J: The DNA sequence and comparative analysis of human chromosome 20. Nature. 2001 Dec 20-27;414(6866):865-71.
2596825	Coulter-Karis DE, Hershfield MS: Sequence of full length cDNA for human S-adenosylhomocysteine hydrolase. Ann Hum Genet. 1989 May;53(Pt 2):169-75.
9586999	Turner MA, Yuan CS, Borchardt RT, Hershfield MS, Smith GD, Howell PL: Structure determination of selenomethionyl S-adenosylhomocysteine hydrolase using data at a single wavelength. Nat Struct Biol. 1998 May;5(5):369-76.

# Drug_Target_11_HGNC_ID:
HGNC:343

# Drug_Target_11_HPRD_ID:
01621

# Drug_Target_11_ID:
3070

# Drug_Target_11_Locus:
20cen-q13.1

# Drug_Target_11_Molecular_Weight:
47717

# Drug_Target_11_Name:
Adenosylhomocysteinase

# Drug_Target_11_Number_of_Residues:
432

# Drug_Target_11_PDB_ID:
1LI4

# Drug_Target_11_Pathway:
Azathioprine Pathway	SMP00427
Mercaptopurine Pathway	SMP00428
Thioguanine Pathway	SMP00430

# Drug_Target_11_Pfam_Domain_Function:
PF00670	AdoHcyase_NAD
PF05221	AdoHcyase

# Drug_Target_11_Protein_Sequence:
>Adenosylhomocysteinase
MSDKLPYKVADIGLAAWGRKALDIAENEMPGLMRMRERYSASKPLKGARIAGCLHMTVET
AVLIETLVTLGAEVQWSSCNIFSTQDHAAAAIAKAGIPVYAWKGETDEEYLWCIEQTLYF
KDGPLNMILDDGGDLTNLIHTKYPQLLPGIRGISEETTTGVHNLYKMMANGILKVPAINV
NDSVTKSKFDNLYGCRESLIDGIKRATDVMIAGKVAVVAGYGDVGKGCAQALRGFGARVI
ITEIDPINALQAAMEGYEVTTMDEACQEGNIFVTTTGCIDIILGRHFEQMKDDAIVCNIG
HFDVEIDVKWLNENAVEKVNIKPQVDRYRLKNGRRIILLAEGRLVNLGCAMGHPSFVMSN
SFTNQVMAQIELWTHPDKYPVGVHFLPKKLDEAVAEAHLGKLNVKLTKLTEKQAQYLGMS
CDGPFKPDHYRY

# Drug_Target_11_Reaction:
S-adenosyl-L-homocysteine + H2O = L-homocysteine + adenosine

# Drug_Target_11_Signals:
None

# Drug_Target_11_Specific_Function:
Adenosylhomocysteine is a competitive inhibitor of S- adenosyl-L-methionine-dependent methyl transferase reactions; therefore adenosylhomocysteinase may play a key role in the control of methylations via regulation of the intracellular concentration of adenosylhomocysteine

# Drug_Target_11_SwissProt_ID:
P23526

# Drug_Target_11_SwissProt_Name:
SAHH_HUMAN

# Drug_Target_11_Synonyms:
AdoHcyase
EC 3.3.1.1
S-adenosyl-L-homocysteine hydrolase

# Drug_Target_11_Theoretical_pI:
6.29

# Drug_Target_11_Transmembrane_Regions:
None

# Drug_Target_120_Cellular_Location:
Not Available

# Drug_Target_120_Chromosome_Location:
Not Available

# Drug_Target_120_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_120_Essentiality:
Non-Essential

# Drug_Target_120_GenAtlas_ID:
Not Available

# Drug_Target_120_GenBank_ID_Gene:
X89038

# Drug_Target_120_GenBank_ID_Protein:
1491644

# Drug_Target_120_GeneCard_ID:
Not Available

# Drug_Target_120_Gene_Name:
mdh

# Drug_Target_120_Gene_Sequence:
>930 bp
ATGCGCAAGAAGATTAGTATTATCGGGGCAGGATTTGTCGGTTCGACGACAGCTCACTGG
CTGGCCGCTAAAGAATTAGGTGACATTGTTCTGCTTGATATTGTCGAGGGTGTGCCTCAA
GGCAAGGCTCTCGATCTCTACGAGGCATCACCAATTGAAGGGTTTGATGTTCGGGTGACC
GGCACGAACAACTACGCCGATACTGCCAACTCGGATGTCATCGTTGTTACGTCAGGTGCT
CCGCGCAAGCCGGGCATGAGCCGTGAGGATTTGATCAAGGTCAACGCCGACATCACCCGT
GCCTGTATCAGTCAGGCTGCCCCGCTCTCGCCGAATGCCGTGATTATCATGGTCAATAAT
CCTCTGGATGCGATGACCTATCTGGCGGCGGAGGTTAGTGGCTTCCCCAAAGAGCGTGTC
ATTGGTCAGGCCGGCGTCCTCGATGCGGCCCGCTATCGCACCTTCATTGCCATGGAGGCG
GGTGTTTCGGTTGAAGATGTTCAGGCGATGCTGATGGGTGGTCACGGCGATGAGATGGTA
CCGCTGCCCCGGTTTTCAACCATTAGCGGTATTCCGGTGAGCGAGTTCATTGCGCCTGAT
CGTCTGGCTCAGATTGTTGAGCGCACCCGGAAGGGTGGTGGCGAGATTGTGAATCTGCTG
AAGACCGGCAGTGCGTATTATGCTCCCGCCGCCGCCACAGCGCAGATGGTCGAAGCGGTG
CTCAAAGACAAGAAGCGGGTCATGCCGGTGGCAGCCTACCTGACCGGTCAGTACGGCCTG
AATGATATTTACTTTGGTGTACCGGTGATCCTCGGTGCCGGTGGAGTAGAGAAAATTCTC
GAATTGCCGCTCAACGAAGAGGAGATGGCACTGCTGAACGCATCGGCGAAAGCGGTACGT
GCCACCCTCGACACGCTGAAGTCTCTCTAA

# Drug_Target_120_General_Function:
Energy production and conversion

# Drug_Target_120_General_References:
3133356	Rolstad AK, Howland E, Sirevag R: Malate dehydrogenase from the thermophilic green bacterium Chloroflexus aurantiacus: purification, molecular weight, amino acid composition, and partial amino acid sequence. J Bacteriol. 1988 Jul;170(7):2947-53.
8661927	Synstad B, Emmerhoff O, Sirevag R: Malate dehydrogenase from the green gliding bacterium Chloroflexus aurantiacus is phylogenetically related to lactic dehydrogenases. Arch Microbiol. 1996 May;165(5):346-53.

# Drug_Target_120_HGNC_ID:
Not Available

# Drug_Target_120_HPRD_ID:
Not Available

# Drug_Target_120_ID:
2329

# Drug_Target_120_Locus:
Not Available

# Drug_Target_120_Molecular_Weight:
32717

# Drug_Target_120_Name:
Malate dehydrogenase

# Drug_Target_120_Number_of_Residues:
309

# Drug_Target_120_PDB_ID:
1UXG

# Drug_Target_120_Pathway:
Not Available

# Drug_Target_120_Pfam_Domain_Function:
PF00056	Ldh_1_N
PF02866	Ldh_1_C

# Drug_Target_120_Protein_Sequence:
>Malate dehydrogenase
MRKKISIIGAGFVGSTTAHWLAAKELGDIVLLDIVEGVPQGKALDLYEASPIEGFDVRVT
GTNNYADTANSDVIVVTSGAPRKPGMSREDLIKVNADITRACISQAAPLSPNAVIIMVNN
PLDAMTYLAAEVSGFPKERVIGQAGVLDAARYRTFIAMEAGVSVEDVQAMLMGGHGDEMV
PLPRFSTISGIPVSEFIAPDRLAQIVERTRKGGGEIVNLLKTGSAYYAPAAATAQMVEAV
LKDKKRVMPVAAYLTGQYGLNDIYFGVPVILGAGGVEKILELPLNEEEMALLNASAKAVR
ATLDTLKSL

# Drug_Target_120_Reaction:
(S)-malate + NAD+ = oxaloacetate + NADH + H+

# Drug_Target_120_Signals:
None

# Drug_Target_120_Specific_Function:
Catalyzes the reversible oxidation of malate to oxaloacetate

# Drug_Target_120_SwissProt_ID:
P80040

# Drug_Target_120_SwissProt_Name:
MDH_CHLAA

# Drug_Target_120_Synonyms:
EC 1.1.1.37

# Drug_Target_120_Theoretical_pI:
4.91

# Drug_Target_120_Transmembrane_Regions:
None

# Drug_Target_121_Cellular_Location:
Peroxisome

# Drug_Target_121_Chromosome_Location:
Not Available

# Drug_Target_121_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_121_Essentiality:
Non-Essential

# Drug_Target_121_GenAtlas_ID:
HSD17B4

# Drug_Target_121_GenBank_ID_Gene:
X87176

# Drug_Target_121_GenBank_ID_Protein:
1050517

# Drug_Target_121_GeneCard_ID:
HSD17B4

# Drug_Target_121_Gene_Name:
HSD17B4

# Drug_Target_121_Gene_Sequence:
>2211 bp
ATGGGCTCACCGCTGAGGTTCGACGGGCGGGTGGTACTGGTCACCGGCGCGGGGGCAGGA
TTGGGCCGAGCCTATGCCCTGGCTTTTGCAGAAAGAGGAGCGTTAGTTGTTGTGAATGAT
TTGGGAGGGGACTTCAAAGGAGTTGGTAAAGGCTCCTTAGCTGCTGATAAGGTTGTTGAA
GAAATAAGAAGGAGAGGTGGAAAAGCAGTGGCCAACTATGATTCAGTGGAAGAAGGAGAG
AAGGTTGTGAAGACAGCCCTGGATGCTTTTGGAAGAATAGATGTTGTGGTCAACAATGCT
GGAATTCTGAGGGATCGTTCCTTTGCTAGGATAAGTGATGAAGACTGGGATATAATCCAC
AGAGTTCATTTGCGGGGTTCATTCCAAGTGACACGGGCAGCATGGGAACACATGAAGAAA
CAGAAGTATGGAAGGATTATTATGACTTCATCAGCTTCAGGAATATATGGCAACTTTGGC
CAGGCCAATTATAGTGCTGCAAAGTTGGGTCTTCTGGGCCTTGCAAATTCTCTTGCAATT
GAAGGCAGGAAAAGCAACATTCATTGTAACACCATTGCTCCTAATGCGGGATCACGGATG
ACTCAGACAGTTATGCCTGAAGATCTTGTGGAAGCCCTGAAGCCAGAGTATGTGGCACCT
CTTGTCCTTTGGCTTTGTCACGAGAGTTGTGAGGAGAATGGTGGCTTGTTTGAGGTTGGA
GCAGGATGGATTGGAAAATTACGCTGGGAGCGGACTCTTGGAGCTATTGTAAGACAAAAG
AATCACCCAATGACTCCTGAGGCAGTCAAGGCTAACTGGAAGAAGATCTGTGACTTTGAG
AATGCCAGCAAGCCTCAGAGTATCCAAGAATCAACTGGCAGTATAATTGAAGTTCTGAGT
AAAATAGATTCAGAAGGAGGAGTTTCAGCAAATCATACTAGTCGTGCAACGTCTACAGCA
ACATCAGGATTTGCTGGAGCTATTGGCCAGAAACTCCCTCCATTTTCTTATGCTTATACG
GAACTGGAAGCTATTATGTATGCCCTTGGAGTGGGAGCGTCAATCAAGGATCCAAAAGAT
TTGAAATTTATTTATGAAGGAAGTTCTGATTTCTCCTGTTTGCCCACCTTCGGAGTTATC
ATAGGTCAGAAATCTATGATGGGTGGAGGATTAGCAGAAATTCCTGGACTTTCAATCAAC
TTTGCAAAGGTTCTTCATGGAGAGCAGTACTTAGAGTTATATAAACCACTTCCCAGAGCA
GGAAAATTAAAATGTGAAGCAGTTGTTGCTGATGTCCTAGATAAAGGATCCGGTGTAGTG
ATTATTATGGATGTCTATTCTTATTCTGAGAAGGAACTTATATGCCACAATCAGTTCTCT
CTCTTTCTTGTTGGCTCTGGAGGCTTTGGTGGAAAACGGACATCAGACAAAGTCAAGGTA
GCTGTAGCCATACCTAATAGACCTCCTGATGCTGTACTTACAGATACCACCTCTCTTAAT
CAGGCTGCTTTGTACCGCCTCAGTGGAGACTGGAATCCCTTACACATTGATCCTAACTTT
GCTAGTCTAGCAGGTTTTGACAAGCCCATATTACATGGATTATGTACATTTGGATTTTCT
GCCAGGCGTGTGTTACAGCAGTTTGCAGATAATGATGTGTCAAGATTCAAGGCAATTAAG
GCTCGTTTTGCAAAACCAGTATATCCAGGACAAACTCTACAAACTGAGATGTGGAAGGAA
GGAAACAGAATTCATTTTCAAACCAAGGTCCAAGAAACTGGAGACATTGTCATTTCAAAT
GCATATGTGGATCTTGCACCAACATCTGGTACTTCAGCTAAGACACCCTCTGAGGGCGGG
AAGCTTCAGAGTACCTTTGTATTTGAGGAAATAGGACGCCGCCTAAAGGATATTGGGCCT
GAGGTGGTGAAGAAAGTAAATGCTGTATTTGAGTGGCATATAACCAAAGGCGGAAATATT
GGGGCTAAGTGGACTATTGACCTGAAAAGTGGTTCTGGAAAAGTGTACCAAGGCCCTGCA
AAAGGTGCTGCTGATACAACAATCATACTTTCAGATGAAGATTTCATGGAGGTGGTCCTG
GGCAAGCTTGACCCTCAGAAGGCATTCTTTAGTGGCAGGCTGAAGGCCAGAGGGAACATC
ATGCTGAGCCAGAAACTTCAGATGATTCTTAAAGACTACGCCAAGCTCTGA

# Drug_Target_121_General_Function:
Lipid transport and metabolism

# Drug_Target_121_General_References:
11700068	Haapalainen AM, van Aalten DM, Merilainen G, Jalonen JE, Pirila P, Wierenga RK, Hiltunen JK, Glumoff T: Crystal structure of the liganded SCP-2-like domain of human peroxisomal multifunctional enzyme type 2 at 1.75 A resolution. J Mol Biol. 2001 Nov 9;313(5):1127-38.
7487879	Adamski J, Normand T, Leenders F, Monte D, Begue A, Stehelin D, Jungblut PW, de Launoit Y: Molecular cloning of a novel widely expressed human 80 kDa 17 beta-hydroxysteroid dehydrogenase IV. Biochem J. 1995 Oct 15;311 ( Pt 2):437-43.
8902629	Jiang LL, Kobayashi A, Matsuura H, Fukushima H, Hashimoto T: Purification and properties of human D-3-hydroxyacyl-CoA dehydratase: medium-chain enoyl-CoA hydratase is D-3-hydroxyacyl-CoA dehydratase. J Biochem (Tokyo). 1996 Sep;120(3):624-32.
9089413	Jiang LL, Miyazawa S, Souri M, Hashimoto T: Structure of D-3-hydroxyacyl-CoA dehydratase/D-3-hydroxyacyl-CoA dehydrogenase bifunctional protein. J Biochem (Tokyo). 1997 Feb;121(2):364-9.
9880674	Leenders F, Dolez V, Begue A, Moller G, Gloeckner JC, de Launoit Y, Adamski J: Structure of the gene for the human 17beta-hydroxysteroid dehydrogenase type IV. Mamm Genome. 1998 Dec;9(12):1036-41.

# Drug_Target_121_HGNC_ID:
HGNC:5213

# Drug_Target_121_HPRD_ID:
03514

# Drug_Target_121_ID:
454

# Drug_Target_121_Locus:
5q21

# Drug_Target_121_Molecular_Weight:
79556

# Drug_Target_121_Name:
Peroxisomal multifunctional enzyme type 2

# Drug_Target_121_Number_of_Residues:
735

# Drug_Target_121_PDB_ID:
1ZBQ

# Drug_Target_121_Pathway:
Not Available

# Drug_Target_121_Pfam_Domain_Function:
PF00106	adh_short
PF01575	MaoC_dehydratas
PF02036	SCP2

# Drug_Target_121_Protein_Sequence:
>Peroxisomal multifunctional enzyme type 2
GSPLRFDGRVVLVTGAGAGLGRAYALAFAERGALVVVNDLGGDFKGVGKGSLAADKVVEE
IRRRGGKAVANYDSVEEGEKVVKTALDAFGRIDVVVNNAGILRDRSFARISDEDWDIIHR
VHLRGSFQVTRAAWEHMKKQKYGRIIMTSSASGIYGNFGQANYSAAKLGLLGLANSLAIE
GRKSNIHCNTIAPNAGSRMTQTVMPEDLVEALKPEYVAPLVLWLCHESCEENGGLFEVGA
GWIGKLRWERTLGAIVRQKNHPMTPEAVKANWKKICDFENASKPQSIQESTGSIIEVLSK
IDSEGGVSANHTSRATSTATSGFAGAIGQKLPPFSYAYTELEAIMYALGVGASIKDPKDL
KFIYEGSSDFSCLPTFGVIIGQKSMMGGGLAEIPGLSINFAKVLHGEQYLELYKPLPRAG
KLKCEAVVADVLDKGSGVVIIMDVYSYSEKELICHNQFSLFLVGSGGFGGKRTSDKVKVA
VAIPNRPPDAVLTDTTSLNQAALYRLSGDWNPLHIDPNFASLAGFDKPILHGLCTFGFSA
RRVLQQFADNDVSRFKAIKARFAKPVYPGQTLQTEMWKEGNRIHFQTKVQETGDIVISNA
YVDLAPTSGTSAKTPSEGGKLQSTFVFEEIGRRLKDIGPEVVKKVNAVFEWHITKGGNIG
AKWTIDLKSGSGKVYQGPAKGAADTTIILSDEDFMEVVLGKLDPQKAFFSGRLKARGNIM
LSQKLQMILKDYAKL

# Drug_Target_121_Reaction:
(S)-3-hydroxyacyl-CoA + NAD+ = 3-oxoacyl-CoA + NADH + H+

# Drug_Target_121_Signals:
None

# Drug_Target_121_Specific_Function:
Bifunctional enzyme acting on the peroxisomal beta- oxidation pathway for fatty acids. Catalyzes the formation of 3- ketoacyl-CoA intermediates from both straight-chain and 2-methyl- branched-chain fatty acids

# Drug_Target_121_SwissProt_ID:
P51659

# Drug_Target_121_SwissProt_Name:
DHB4_HUMAN

# Drug_Target_121_Synonyms:
17-beta-HSD 4
17-beta-hydroxysteroid dehydrogenase 4
3- hydroxyacyl-CoA dehydrogenase
3-alpha,7- alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase
D-3-hydroxyacyl-CoA dehydratase
D-bifunctional protein
DBP
EC 1.1.1.35
EC 4.2.1.107
MFE-2

# Drug_Target_121_Theoretical_pI:
9.21

# Drug_Target_121_Transmembrane_Regions:
None

# Drug_Target_122_Cellular_Location:
Cytoplasm

# Drug_Target_122_Chromosome_Location:
Not Available

# Drug_Target_122_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_122_Essentiality:
Non-Essential

# Drug_Target_122_GenAtlas_ID:
Not Available

# Drug_Target_122_GenBank_ID_Gene:
AE015451

# Drug_Target_122_GenBank_ID_Protein:
24986811

# Drug_Target_122_GeneCard_ID:
Not Available

# Drug_Target_122_Gene_Name:
hutU

# Drug_Target_122_Gene_Sequence:
>1674 bp
TCAGCCGGTGATCATCGGCAGGTCCAGGCCCTGCTCCTTGGCGCAGTCGATGGCGATGTC
ATAACCGGCATCGGCGTGACGCATGACGCCAGTCCCTGGGTCGTTGGTCAGTACCCGGGC
GATGCGCTCGGCGGCCTCATCGGTACCGTCGCAGACGATGACCATGCCCGAGTGCTGCGA
GAAGCCCATGCCCACGCCACCGCCATGGTGCAGCGATACCCAGGTGGCGCCGCCTGCGGT
GTTCAGCAGGGCGTTGAGCAGCGGCCAGTCGGAAACAGCGTCCGAACCATCACGCATGGC
CTCGGTTTCGCGGTTCGGGCTGGATACCGAGCCGGAGTCGAGGTGGTCACGGCCGATCAC
CACCGGTGCCGACAGCTCGCCGCTGCGGACCATTTCGTTGAAAGCCAGGCCCAGCTTGGC
GCGAAGGCCCAGCCCCACCCAGCAGATACGTGCCGGCAGGCCCTGGAAGCTGATGCGCTC
GCGGGCCATGTCCAGCCAGCGGTGCAGGTGGGCGTCGTCGGGGATCAGTTCCTTGACCTT
GGCGTCGGTCTTGTAGATGTCCTCGGCTTCACCGGACAGCGCCGCCCAGCGGAACGGGCC
GACGCCGCGGCAGAACAGTGGGCGGATGTAGGCCGGGACGAAGCCTGGGAAGTCGAAGGC
ATTGGCCACGCCCTCCTCCTTGGCCATCTGGCGGATGTTGTTGCCGTAATCGAAGGTCGG
GATGCCCTGCTTCTGGAAGTCCAGCATGGCCTGCACGTGCACGGCCATCGACTGCTTGGC
GGCCTTGACCACTGCAGCCGGTTCGGTCTGCGCACGATCGCGGTACTGTTCCCAGGTCCA
GCCGGCTGGCAGGTAGCCGTTCAGTGGGTCGTGGGCGCTGGTCTGGTCGGTGACCATGTC
CGGGCGGACGCCACGTTTGACCAGCTCTGGGAGGATTTCGGCGGCGTTGCCGTGCAGGGC
GATGGAGATGGCCTTGCCTTCGGCGGTGTACTTGGCGATGCGTGCGAGGGCGTCGTCGAG
GTCAGTGGCCTGCTCGTCGACGTAGCGGGTTTCCAGGCGGAAGTCGATACGGCTCTGCTG
GCATTCGATGTTCAGCGAGCAAGCCCCAGCCAGGGTCGCGGCCAGTGGCTGGGCGCCGCC
CATGCCGCCCAGGCCAGCGGTGAGTACCCACTTGCCTTTCAGGCTGCCGCCGTAGTGCTG
GCGACCGGCTTCGACGAAGGTTTCATAGGTGCCCTGGACGATGCCCTGGCTGCCGATGTA
GATCCAGCTGCCGGCGGTCATCTGGCCATACATCGCCAGGCCCTTGGCGTCCAGTTCGTT
GAAGTGTTCCCAGTTGGCCCAGTGTGGCACCAGGTTGGAGTTGGCAATCAGCACGCGCGG
TGCGTTGCTGTGGGTCTTGAACACACCGACCGGCTTGCCCGACTGCACCAGCAGGGTTTC
GTCGTCTTCCAGGCGGGTCAGGGTTTCGACGATCTTGTCGTAGCAGGCCCAGTTGCGCGC
GGCGCGGCCGATACCGCCGTATACCACCAGCTCTTTCGGGTTTTCCGCGACCTGTGGATC
GAGGTTGTTCATCAGCATGCGCAGTGGCGCTTCGGTCAGCCAGCTTTTGGCGGTCAGCTT
GTTGCCACGTGGGGCACGGATTTCAACGTCACGGTATTTGTTGTTGTCGGTCAC

# Drug_Target_122_General_Function:
Amino acid transport and metabolism

# Drug_Target_122_General_References:
12534463	Nelson KE, Weinel C, Paulsen IT, Dodson RJ, Hilbert H, Martins dos Santos VA, Fouts DE, Gill SR, Pop M, Holmes M, Brinkac L, Beanan M, DeBoy RT, Daugherty S, Kolonay J, Madupu R, Nelson W, White O, Peterson J, Khouri H, Hance I, Chris Lee P, Holtzapple E, Scanlan D, Tran K, Moazzez A, Utterback T, Rizzo M, Lee K, Kosack D, Moestl D, Wedler H, Lauber J, Stjepandic D, Hoheisel J, Straetz M, Heim S, Kiewitz C, Eisen JA, Timmis KN, Dusterhoft A, Tummler B, Fraser CM: Complete genome sequence and comparative analysis of the metabolically versatile Pseudomonas putida KT2440. Environ Microbiol. 2002 Dec;4(12):799-808.

# Drug_Target_122_HGNC_ID:
Not Available

# Drug_Target_122_HPRD_ID:
Not Available

# Drug_Target_122_ID:
2591

# Drug_Target_122_Locus:
Not Available

# Drug_Target_122_Molecular_Weight:
60718

# Drug_Target_122_Name:
Urocanate hydratase

# Drug_Target_122_Number_of_Residues:
557

# Drug_Target_122_PDB_ID:
1UWL

# Drug_Target_122_Pathway:
Not Available

# Drug_Target_122_Pfam_Domain_Function:
PF01175	Urocanase

# Drug_Target_122_Protein_Sequence:
>Urocanate hydratase
MTDNNKYRDVEIRAPRGNKLTAKSWLTEAPLRMLMNNLDPQVAENPKELVVYGGIGRAAR
NWACYDKIVETLTRLEDDETLLVQSGKPVGVFKTHSNAPRVLIANSNLVPHWANWEHFNE
LDAKGLAMYGQMTAGSWIYIGSQGIVQGTYETFVEAGRQHYGGSLKGKWVLTAGLGGMGG
AQPLAATLAGACSLNIECQQSRIDFRLETRYVDEQATDLDDALARIAKYTAEGKAISIAL
HGNAAEILPELVKRGVRPDMVTDQTSAHDPLNGYLPAGWTWEQYRDRAQTEPAAVVKAAK
QSMAVHVQAMLDFQKQGIPTFDYGNNIRQMAKEEGVANAFDFPGFVPAYIRPLFCRGVGP
FRWAALSGEAEDIYKTDAKVKELIPDDAHLHRWLDMARERISFQGLPARICWVGLGLRAK
LGLAFNEMVRSGELSAPVVIGRDHLDSGSVSSPNRETEAMRDGSDAVSDWPLLNALLNTA
GGATWVSLHHGGGVGMGFSQHSGMVIVCDGTDEAAERIARVLTNDPGTGVMRHADAGYDI
AIDCAKEQGLDLPMITG

# Drug_Target_122_Reaction:
3-(5-oxo-4,5-dihydro-3H-imidazol-4-yl)propanoate = urocanate + H2O

# Drug_Target_122_Signals:
None

# Drug_Target_122_Specific_Function:
3-(5-oxo-4,5-dihydro-3H-imidazol-4- yl)propanoate = urocanate + H(2)O

# Drug_Target_122_SwissProt_ID:
Q88CZ6

# Drug_Target_122_SwissProt_Name:
HUTU_PSEPK

# Drug_Target_122_Synonyms:
EC 4.2.1.49
Imidazolonepropionate hydrolase
Urocanase

# Drug_Target_122_Theoretical_pI:
5.76

# Drug_Target_122_Transmembrane_Regions:
None

# Drug_Target_123_Cellular_Location:
Cytoplasm

# Drug_Target_123_Chromosome_Location:
Not Available

# Drug_Target_123_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_123_Essentiality:
Non-Essential

# Drug_Target_123_GenAtlas_ID:
HSD17B1

# Drug_Target_123_GenBank_ID_Gene:
X13440

# Drug_Target_123_GenBank_ID_Protein:
23365

# Drug_Target_123_GeneCard_ID:
HSD17B1

# Drug_Target_123_Gene_Name:
HSD17B1

# Drug_Target_123_Gene_Sequence:
>987 bp
ATGGCCCGCACCGTGGTGCTCATCACCGGCTGTTCCTCGGGCATCGGCCTGCACTTGGCC
GTACGTCTGGCTTCAGATCCATCCCAGAGCTTCAAAGTGTATGCCACGTTGAGGGACCTG
AAAACACAGGGCCGGCTGTGGGAGGCGGCCCGGGCCCTGGCATGCCCTCCGGGATCCCTG
GAGACGTTGCAGCTGGACGTAAGGGACTCAAAATCCGTGGCCGCTGCCCGGGAACGCGTG
ACTGAGGGCCGCGTGGACGTGCTGGTGTGTAACGCAGGCCTGGGCCTGCTGGGGCCGCTG
GAGGCGCTGGGGGAGGACGCCGTGGCCTCTGTGCTGGACGTGAATGTAGTAGGGACTGTG
CGGATGCTGCAGGCCTTCCTGCCAGACATGAAGAGGCGCGGTTCGGGACGCGTGTTGGTG
ACCGGGAGCGTGGGAGGATTGATGGGGCTGCCTTTCAATGACGTTTATTGCGCCAGCAAG
TTCGCGCTCGAAGGCTTATGCGAGAGTCTGGCGGTTCTGCTGCTGCCCTTTGGGGTCCAC
TTGAGCCTGATCGAGTGCGGCCCAGTGCACACCGCCTTCATGGAGAAGGTGTTGGGCAGC
CCAGAGGAGGTGCTGGACCGCACGGACATCCACACCTTCCACCGCTTCTACCAATACCTC
GCCCACAGCAAGCAAGTCTTTCGCGAGGCGGCGCAGAACCCTGAGGAGGTGGCGGAGGTC
TTCCTCACCGCTTTGCGCGCCCCGAAGCCGACCCTGCGCTACTTCACCACCGAGCGCTTC
CTGCCCCTGCTGCGGATGCGCCTGGACGACCCCAGCGGCTCCAACTACGTCACCGCCATG
CACCGGGAAGTGTTCGGCGACGTTCCGGCAAAGGCCGAGGCTGGGGCCGAGGCTGGGGGC
GGGGCCGGGCCTGGGGCAGAGGACGAGGCCGGGCGCAGTGCGGTGGGGGACCCTGAGCTC
GGCGATCCTCCGGCCGCCCCGCAGTAA

# Drug_Target_123_General_Function:
Lipid transport and metabolism

# Drug_Target_123_General_References:
10625652	Han Q, Campbell RL, Gangloff A, Huang YW, Lin SX: Dehydroepiandrosterone and dihydrotestosterone recognition by human estrogenic 17beta-hydroxysteroid dehydrogenase. C-18/c-19 steroid discrimination and enzyme-induced strain. J Biol Chem. 2000 Jan 14;275(2):1105-11.
1327779	Peltoketo H, Isomaa V, Vihko R: Genomic organization and DNA sequences of human 17 beta-hydroxysteroid dehydrogenase genes and flanking regions. Localization of multiple Alu sequences and putative cis-acting elements. Eur J Biochem. 1992 Oct 1;209(1):459-66.
2197970	Luu-The V, Labrie C, Zhao HF, Couet J, Lachance Y, Simard J, Cote J, Leblanc G, Lagace L, Berube D, et al.: Purification, cloning, complementary DNA structure, and predicted amino acid sequence of human estradiol 17 beta-dehydrogenase. Ann N Y Acad Sci. 1990;595:40-52.
2330005	Luu-The V, Labrie C, Simard J, Lachance Y, Zhao HF, Couet J, Leblanc G, Labrie F: Structure of two in tandem human 17 beta-hydroxysteroid dehydrogenase genes. Mol Endocrinol. 1990 Feb;4(2):268-75.
2547159	Baker ME: Human placental 17 beta-hydroxysteroid dehydrogenase is homologous to NodG protein of Rhizobium meliloti. Mol Endocrinol. 1989 May;3(5):881-4.
2779584	Luu The V, Labrie C, Zhao HF, Couet J, Lachance Y, Simard J, Leblanc G, Cote J, Berube D, Gagne R, et al.: Characterization of cDNAs for human estradiol 17 beta-dehydrogenase and assignment of the gene to chromosome 17: evidence of two mRNA species with distinct 5'-termini in human placenta. Mol Endocrinol. 1989 Aug;3(8):1301-9.
2846351	Peltoketo H, Isomaa V, Maentausta O, Vihko R: Complete amino acid sequence of human placental 17 beta-hydroxysteroid dehydrogenase deduced from cDNA. FEBS Lett. 1988 Oct 24;239(1):73-7.
3955020	Galdes A, Auld DS, Vallee BL: Elucidation of the chemical nature of the steady-state intermediates in the mechanism of carboxypeptidase A. Biochemistry. 1986 Feb 11;25(3):646-51.
4719204	Nicolas JC, Harris JI: Human placental 17 -oestradiol dehydrogenase. Sequence of a tryptic peptide containing an essential cysteine. FEBS Lett. 1973 Jan 15;29(2):173-6.
5045524	Burns DJ, Engel LL, Bethune JL: Amino acid composition and subunit structure. Human placental 17 -estradiol dehydrogenase. Biochemistry. 1972 Jul 4;11(14):2699-703.
6578212	Murdock GL, Chin CC, Offord RE, Bradshaw RA, Warren JC: Human placental estradiol 17 beta-dehydrogenase. Identification of a single histidine residue affinity-labeled by both 3-bromoacetoxyestrone and 12 beta-bromoacetoxy-4-estrene-3,17-dione. J Biol Chem. 1983 Oct 10;258(19):11460-4.
7663947	Ghosh D, Pletnev VZ, Zhu DW, Wawrzak Z, Duax WL, Pangborn W, Labrie F, Lin SX: Structure of human estrogenic 17 beta-hydroxysteroid dehydrogenase at 2.20 A resolution. Structure. 1995 May 15;3(5):503-13.
8389226	Normand T, Narod S, Labrie F, Simard J: Detection of polymorphisms in the estradiol 17 beta-hydroxysteroid dehydrogenase II gene at the EDH17B2 locus on 17q11-q21. Hum Mol Genet. 1993 Apr;2(4):479-83.
8805577	Breton R, Housset D, Mazza C, Fontecilla-Camps JC: The structure of a complex of human 17beta-hydroxysteroid dehydrogenase with estradiol and NADP+ identifies two principal targets for the design of inhibitors. Structure. 1996 Aug 15;4(8):905-15.
9525918	Mazza C, Breton R, Housset D, Fontecilla-Camps JC: Unusual charge stabilization of NADP+ in 17beta-hydroxysteroid dehydrogenase. J Biol Chem. 1998 Apr 3;273(14):8145-52.

# Drug_Target_123_HGNC_ID:
HGNC:5210

# Drug_Target_123_HPRD_ID:
00185

# Drug_Target_123_ID:
217

# Drug_Target_123_Locus:
17q11-q21

# Drug_Target_123_Molecular_Weight:
34849

# Drug_Target_123_Name:
Estradiol 17-beta-dehydrogenase 1

# Drug_Target_123_Number_of_Residues:
327

# Drug_Target_123_PDB_ID:
1QYX

# Drug_Target_123_Pathway:
Not Available

# Drug_Target_123_Pfam_Domain_Function:
PF00106	adh_short

# Drug_Target_123_Protein_Sequence:
>Estradiol 17-beta-dehydrogenase 1
ARTVVLITGCSSGIGLHLAVRLASDPSQSFKVYATLRDLKTQGRLWEAARALACPPGSLE
TLQLDVRDSKSVAAARERVTEGRVDVLVCNAGLGLLGPLEALGEDAVASVLDVNVVGTVR
MLQAFLPDMKRRGSGRVLVTGSVGGLMGLPFNDVYCASKFALEGLCESLAVLLLPFGVHL
SLIECGPVHTAFMEKVLGSPEEVLDRTDIHTFHRFYQYLAHSKQVFREAAQNPEEVAEVF
LTALRAPKPTLRYFTTERFLPLLRMRLDDPSGSNYVTAMHREVFGDVPAKAEAGAEAGGG
AGPGAEDEAGRSAVGDPELGDPPAAPQ

# Drug_Target_123_Reaction:
estradiol-17beta + NAD(P)+ = estrone + NAD(P)H + H+

# Drug_Target_123_Signals:
None

# Drug_Target_123_Specific_Function:
Favors the reduction of estrogens and androgens. Also has 20-alpha-HSD activity. Uses preferentially NADH

# Drug_Target_123_SwissProt_ID:
P14061

# Drug_Target_123_SwissProt_Name:
DHB1_HUMAN

# Drug_Target_123_Synonyms:
17-beta- hydroxysteroid dehydrogenase type 1
17-beta-HSD 1
20 alpha-hydroxysteroid dehydrogenase
20-alpha-HSD
E2DH
EC 1.1.1.62
Placental 17- beta-hydroxysteroid dehydrogenase

# Drug_Target_123_Theoretical_pI:
5.42

# Drug_Target_123_Transmembrane_Regions:
None

# Drug_Target_124_Cellular_Location:
Mitochondrion
mitochondrial matrix

# Drug_Target_124_Chromosome_Location:
Not Available

# Drug_Target_124_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_124_Essentiality:
Non-Essential

# Drug_Target_124_GenAtlas_ID:
ME2

# Drug_Target_124_GenBank_ID_Gene:
M55905

# Drug_Target_124_GenBank_ID_Protein:
187300

# Drug_Target_124_GeneCard_ID:
ME2

# Drug_Target_124_Gene_Name:
ME2

# Drug_Target_124_Gene_Sequence:
>1755 bp
ATGTTGTCCCGGTTAAGAGTAGTTTCCACCACTTGTACTTTGGCATGTCGACATTTGCAC
ATAAAAGAAAAAGGCAAGCCACTTATGCTGAACCCAAGAACAAACAAGGGAATGGCATTT
ACTTTACAAGAACGACAAATGCTTGGTCTTCAAGGACTTCTACCTCCCAAAATAGAGACA
CAAGATATTCAAGCCTTACGATTTCATAGAAACTTGAAGAAAATGACTAGCCCTTTGGAA
AAATATATCTACATAATGGGAATACAAGAAAGAAATGAGAAATTGTTTTATAGAATACTG
CAAGATGACATTGAGAGTTTAATGCCAATTGTATATACACCGACGGTTGGTCTTGCCTGC
TCCCAGTATGGACACATCTTTAGAAGACCTAAGGGATTATTTATTTCGATCTCAGACAGA
GGTCATGTTAGATCAATTGTGGATAACTGGCCAGAAAATCATGTTAAGGCTGTTGTAGTG
ACTGATGGAGAGAGAATTCTGGGTCTTGGAGATCTGGGTGTCTATGGAATGGGAATTCCA
GTAGGAAAACTTTGTTTGTATACAGCTTGTGCAGGAATACGGCCTGATAGATGCCTGCCA
GTGTGTATTGATGTGGGAACTGATAATATCGCACTCTTAAAAGACCCATTTTACATGGGC
TTGTACCAGAAACGAGATCGCACACAACAGTATGATGACCTGATTGATGAGTTTATGAAA
GCTATTACTGACAGATATGGCCGGAACACACTCATTCAGTTCGAAGACTTTGGAAATCAT
AATGCATTCAGGTTCTTGAGAAAGTACCGAGAAAAATATTGTACTTTCAATGATGATATT
CAAGGGACAGCTGCAGTAGCTCTAGCAGGTCTTCTTGCAGCACAAAAAGTTATTAGTAAA
CCAATCTCCGAACACAAAATCTTATTCCTTGGAGCAGGAGAGGCTGCTCTTGGAATTGCA
AATCTTATAGTTATGTCTATGGTAGAAAATGGCCTGTCAGAACAAGAGGCACAAAAGAAA
ATCTGGATGTTTGACAAGTATGGTTTATTAGTTAAGGGACGGAAAGCAAAAATAGATAGT
TATCAGGAACCATTTACTCACTCAGCCCCAGAGAGCATACCTGATACTTTTGAAGATGCA
GTGAATATACTGAAGCCTTCAACTATTATTGGAGTTGCAGGTGCTGGCCGTCTTTTCACT
CCTGATGTAATCAGAGCCATGGCCTCTATCAATGAAAGGCCTGTAATATTTGCATTAAGT
AATCCTACAGCACAGGCAGAGTGCACGGCTGAAGAAGCATATACACTTACAGAGGGCAGG
TGTTTGTTTGCCAGTGGCAGTCCATTTGGGCCAGTGAAACTTACAGATGGGCGAGTCTTT
ACACCAGGTCAAGGAAACAATGTTTATATTTTTCCAGGTGTGGCTTTAGCTGTTATTCTC
TGTAACACCCGGCATATTAGTGACAGTGTTTTCCTAGAAGCTGCAAAGGCCCTGACAAGC
CAATTGACAGATGAAGAGCTAGCCCAAGGGAGACTTTACCCACCGCTTGCTAATATTCAG
GAAGTTTCTATTAACATTGCTATTAAAGTTACAGAATACCTATATGCTAATAAAATGGCT
TTCCGATACCCAGAACCTGAAGACAAGGCCAAATATGTTAAAGAAAGAACATGGCGGAGT
GAATATGATTCCCTGCTGCCAGATGTGTATGAATGGCCAGAATCTGCATCAAGCCCTCCT
GTGATAACAGAATAG

# Drug_Target_124_General_Function:
Energy production and conversion

# Drug_Target_124_General_References:
11401430	Yanaihara N, Kohno T, Takakura S, Takei K, Otsuka A, Sunaga N, Takahashi M, Yamazaki M, Tashiro H, Fukuzumi Y, Fujimori Y, Hagiwara K, Tanaka T, Yokota J: Physical and transcriptional map of a 311-kb segment of chromosome 18q21, a candidate lung tumor suppressor locus. Genomics. 2001 Mar 1;72(2):169-79.
12121650	Yang Z, Lanks CW, Tong L: Molecular mechanism for the regulation of human mitochondrial NAD(P)+-dependent malic enzyme by ATP and fumarate. Structure. 2002 Jul;10(7):951-60.
12665801	Gevaert K, Goethals M, Martens L, Van Damme J, Staes A, Thomas GR, Vandekerckhove J: Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat Biotechnol. 2003 May;21(5):566-9. Epub 2003 Mar 31.
12962632	Tao X, Yang Z, Tong L: Crystal structures of substrate complexes of malic enzyme and insights into the catalytic mechanism. Structure. 2003 Sep;11(9):1141-50.
1993674	Loeber G, Infante AA, Maurer-Fogy I, Krystek E, Dworkin MB: Human NAD(+)-dependent mitochondrial malic enzyme. cDNA cloning, primary structure, and expression in Escherichia coli. J Biol Chem. 1991 Feb 15;266(5):3016-21.

# Drug_Target_124_HGNC_ID:
HGNC:6984

# Drug_Target_124_HPRD_ID:
01103

# Drug_Target_124_ID:
166

# Drug_Target_124_Locus:
6p25-p24|18q21

# Drug_Target_124_Molecular_Weight:
65444

# Drug_Target_124_Name:
NAD-dependent malic enzyme, mitochondrial

# Drug_Target_124_Number_of_Residues:
584

# Drug_Target_124_PDB_ID:
1QR6

# Drug_Target_124_Pathway:
Not Available

# Drug_Target_124_Pfam_Domain_Function:
PF00390	malic
PF03949	Malic_M

# Drug_Target_124_Protein_Sequence:
>NAD-dependent malic enzyme, mitochondrial precursor
MLSRLRVVSTTCTLACRHLHIKEKGKPLMLNPRTNKGMAFTLQERQMLGLQGLLPPKIET
QDIQALRFHRNLKKMTSPLEKYIYIMGIQERNEKLFYRILQDDIESLMPIVYTPTVGLAC
SQYGHIFRRPKGLFISISDRGHVRSIVDNWPENHVKAVVVTDGERILGLGDLGVYGMGIP
VGKLCLYTACAGIRPDRCLPVCIDVGTDNIALLKDPFYMGLYQKRDRTQQYDDLIDEFMK
AITDRYGRNTLIQFEDFGNHNAFRFLRKYREKYCTFNDDIQGTAAVALAGLLAAQKVISK
PISEHKILFLGAGEAALGIANLIVMSMVENGLSEQEAQKKIWMFDKYGLLVKGRKAKIDS
YQEPFTHSAPESIPDTFEDAVNILKPSTIIGVAGAGRLFTPDVIRAMASINERPVIFALS
NPTAQAECTAEEAYTLTEGRCLFASGSPFGPVKLTDGRVFTPGQGNNVYIFPGVALAVIL
CNTRHISDSVFLEAAKALTSQLTDEELAQGRLYPPLANIQEVSINIAIKVTEYLYANKMA
FRYPEPEDKAKYVKERTWRSEYDSLLPDVYEWPESASSPPVITE

# Drug_Target_124_Reaction:
(S)-malate + NAD+ = pyruvate + CO2 + NADH

# Drug_Target_124_Signals:
None

# Drug_Target_124_Specific_Function:
Not Available

# Drug_Target_124_SwissProt_ID:
P23368

# Drug_Target_124_SwissProt_Name:
MAOM_HUMAN

# Drug_Target_124_Synonyms:
EC 1.1.1.38
Malic enzyme 2
NAD-ME
NAD-dependent malic enzyme, mitochondrial precursor

# Drug_Target_124_Theoretical_pI:
7.67

# Drug_Target_124_Transmembrane_Regions:
None

# Drug_Target_125_Cellular_Location:
Not Available

# Drug_Target_125_Chromosome_Location:
Not Available

# Drug_Target_125_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_125_Essentiality:
Non-Essential

# Drug_Target_125_GenAtlas_ID:
Not Available

# Drug_Target_125_GenBank_ID_Gene:
M64446

# Drug_Target_125_GenBank_ID_Protein:
149631

# Drug_Target_125_GeneCard_ID:
Not Available

# Drug_Target_125_Gene_Name:
zwf

# Drug_Target_125_Gene_Sequence:
>1461 bp
ATGGTTTCAGAAATCAAGACGTTAGTAACTTTCTTTGGTGGCACTGGTGACTTGGCCAAG
CGTAAGCTTTACCCATCAGTTTTCAATCTTTATAAAAAAGGCTACTTGCAAAAGCATTTT
GCCATTGTTGGAACGGCCCGTCAAGCCCTCAATGATGACGAATTCAAACAATTGGTTCGT
GATTCAATTAAAGATTTCACTGACGATCAAGCACAAGCTGAGGCGTTCATCGAACATTTC
TCATACCGTGCACACGACGTAACAGATGCTGCTTCATACGCTGTTTTAAAAGAGGCGATT
GAAGAAGCTGCCGACAAATTTGATATCGATGGCAACCGCATTTTCTATATGTCAGTTGCG
CCACGTTTCTTTGGTACAATTGCCAAATATCTTAAGTCAGAAGGCCTACTAGCTGACACT
GGTTACAACCGTTTGATGATTGAAAAGCCTTTCGGTACATCATATGACACAGCTGCCGAA
CTCCAAAATGACTTGGAAAACGCATTTGATGATAACCAACTATTCCGTATTGACCACTAC
CTTGGTAAGGAAATGGTTCAAAACATTGCTGCCCTTCGCTTTGGTAACCCAATTTTCGAT
GCTGCTTGGAACAAGGATTACATCAAGAACGTTCAAGTAACATTGTCAGAAGTCTTGGGT
GTCGAAGAACGTGCCGGCTACTATGACACAGCCGGTGCATTGCTTGACATGATTCAAAAC
CACACCATGCAAATTGTTGGTTGGTTAGCCATGGAAAAACCAGAATCATTCACTGACAAA
GACATTCGTGCCGCTAAAAACGCAGCCTTTAATGCTTTGAAGATCTATGATGAAGCAGAA
GTTAACAAATACTTTGTTCGTGCACAATATGGTGCCGGTGATTCAGCTGACTTCAAGCCA
TACCTTGAAGAATTAGACGTACCTGCTGATTCTAAAAACAATACCTTCATCGCCGGCGAA
TTGCAATTTGATTTGCCACGTTGGGAGGGTGTCCCATTCTATGTCCGTTCAGGTAAGCGC
TTAGCTGCTAAACAGACACGGGTTGATATCGTCTTTAAGGCTGGCACGTTTAACTTTGGT
TCAGAACAAGAAGCACAAGAAGCTGTCTTGTCAATTATCATTGATCCAAAGGGTGCTATC
GAATTGAAGTTGAACGCCAAGTCAGTTGAAGATGCTTTCAACACACGTACAATTGACTTA
GGTTGGACTGTATCTGACGAAGATAAGAAGAACACGCCAGAACCATACGAACGTATGATT
CACGACACTATGAATGGTGATGGCTCTAACTTCGCTGACTGGAATGGCGTTTCAATCGCT
TGGAAGTTCGTTGATGCTATTTCAGCCGTTTATACCGCAGATAAAGCACCACTTGAAACT
TACAAGTCGGGCTCAATGGGTCCTGAAGCATCCGATAAATTATTGGCTGCCAATGGTGAT
GCTTGGGTGTTTAAAGGTTAA

# Drug_Target_125_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_125_General_References:
11106478	Cosgrove MS, Gover S, Naylor CE, Vandeputte-Rutten L, Adams MJ, Levy HR: An examination of the role of asp-177 in the His-Asp catalytic dyad of Leuconostoc mesenteroides glucose 6-phosphate dehydrogenase: X-ray structure and pH dependence of kinetic parameters of the D177N mutant enzyme. Biochemistry. 2000 Dec 12;39(49):15002-11.
11106479	Vought V, Ciccone T, Davino MH, Fairbairn L, Lin Y, Cosgrove MS, Adams MJ, Levy HR: Delineation of the roles of amino acids involved in the catalytic functions of Leuconostoc mesenteroides glucose 6-phosphate dehydrogenase. Biochemistry. 2000 Dec 12;39(49):15012-21.
1304341	Lee WT, Levy HR: Lysine-21 of Leuconostoc mesenteroides glucose 6-phosphate dehydrogenase participates in substrate binding through charge-charge interaction. Protein Sci. 1992 Mar;1(3):329-34.
2071589	Lee WT, Flynn TG, Lyons C, Levy HR: Cloning of the gene and amino acid sequence for glucose 6-phosphate dehydrogenase from Leuconostoc mesenteroides. J Biol Chem. 1991 Jul 15;266(20):13028-34.
3100332	Bhadbhade MM, Adams MJ, Flynn TG, Levy HR: Sequence identity between a lysine-containing peptide from Leuconostoc mesenteroides glucose-6-phosphate dehydrogenase and an active site peptide from human erythrocyte glucose-6-phosphate dehydrogenase. FEBS Lett. 1987 Jan 26;211(2):243-6.
7881907	Rowland P, Basak AK, Gover S, Levy HR, Adams MJ: The three-dimensional structure of glucose 6-phosphate dehydrogenase from Leuconostoc mesenteroides refined at 2.0 A resolution. Structure. 1994 Nov 15;2(11):1073-87.
9485426	Cosgrove MS, Naylor C, Paludan S, Adams MJ, Levy HR: On the mechanism of the reaction catalyzed by glucose 6-phosphate dehydrogenase. Biochemistry. 1998 Mar 3;37(9):2759-67.

# Drug_Target_125_HGNC_ID:
Not Available

# Drug_Target_125_HPRD_ID:
Not Available

# Drug_Target_125_ID:
2630

# Drug_Target_125_Locus:
Not Available

# Drug_Target_125_Molecular_Weight:
54441

# Drug_Target_125_Name:
Glucose-6-phosphate 1-dehydrogenase

# Drug_Target_125_Number_of_Residues:
486

# Drug_Target_125_PDB_ID:
1H94

# Drug_Target_125_Pathway:
Not Available

# Drug_Target_125_Pfam_Domain_Function:
PF00479	G6PD_N
PF02781	G6PD_C

# Drug_Target_125_Protein_Sequence:
>Glucose-6-phosphate 1-dehydrogenase
MVSEIKTLVTFFGGTGDLAKRKLYPSVFNLYKKGYLQKHFAIVGTARQALNDDEFKQLVR
DSIKDFTDDQAQAEAFIEHFSYRAHDVTDAASYAVLKEAIEEAADKFDIDGNRIFYMSVA
PRFFGTIAKYLKSEGLLADTGYNRLMIEKPFGTSYDTAAELQNDLENAFDDNQLFRIDHY
LGKEMVQNIAALRFGNPIFDAAWNKDYIKNVQVTLSEVLGVEERAGYYDTAGALLDMIQN
HTMQIVGWLAMEKPESFTDKDIRAAKNAAFNALKIYDEAEVNKYFVRAQYGAGDSADFKP
YLEELDVPADSKNNTFIAGELQFDLPRWEGVPFYVRSGKRLAAKQTRVDIVFKAGTFNFG
SEQEAQEAVLSIIIDPKGAIELKLNAKSVEDAFNTRTIDLGWTVSDEDKKNTPEPYERMI
HDTMNGDGSNFADWNGVSIAWKFVDAISAVYTADKAPLETYKSGSMGPEASDKLLAANGD
AWVFKG

# Drug_Target_125_Reaction:
D-glucose 6-phosphate + NADP+ = D-glucono-1,5-lactone 6-phosphate + NADPH + H+

# Drug_Target_125_Signals:
None

# Drug_Target_125_Specific_Function:
D-glucose 6-phosphate + NADP(+) = D-glucono- 1,5-lactone 6-phosphate + NADPH

# Drug_Target_125_SwissProt_ID:
P11411

# Drug_Target_125_SwissProt_Name:
G6PD_LEUME

# Drug_Target_125_Synonyms:
EC 1.1.1.49
G6PD

# Drug_Target_125_Theoretical_pI:
4.57

# Drug_Target_125_Transmembrane_Regions:
None

# Drug_Target_126_Cellular_Location:
Mitochondrion
mitochondrial matrix

# Drug_Target_126_Chromosome_Location:
Not Available

# Drug_Target_126_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_126_Essentiality:
Non-Essential

# Drug_Target_126_GenAtlas_ID:
ALDH2

# Drug_Target_126_GenBank_ID_Gene:
X05409

# Drug_Target_126_GenBank_ID_Protein:
28606

# Drug_Target_126_GeneCard_ID:
ALDH2

# Drug_Target_126_Gene_Name:
ALDH2

# Drug_Target_126_Gene_Sequence:
>1551 bp
ATGTTGCGCGCTGCCGCCGCTCGGGCCCCGCCTGGCCGCCGCCTCTTGTCAGCCGCCGCC
ACCCAGGCCGTGCCTGCCCCCAACCAGCAGCCCGAGGTCTTCTGCAACCAGATTTTCATA
AACAATGAATGGCACGATGCCGTCAGCAGGAAAACATTCCCCACCGTCAATCCGTCCACT
GGAGAGGTCATCTGTCAGGTAGCTGAAGGGGACAAGGAAGATGTGGACAAGGCACGTGAA
GGCCGCCCGGGCGCCTTCCAGCTGGGCTCACCTTGGCGCCGCATGGACGCATCACACAGC
GGCCGGCTGCTGAACCGCCTGGCCGATCTGATCGAGCGGGACCGGACCTACCTGGCGGCC
TTGGAGACCCTGGACAATGGCAAGCCCTATGTCATCTCCTACCTGGTGGATTTGGACATG
GTCCTCAAATGTCTCCGGTATTATGCCGGCTGGGCTGATAAGTACCACGGGAAAACCATC
CCCATTGACGGAGACTTCTTCAGCTACACACGCCATGAACCTGTGGGGGTGTGCGGGCAG
ATCATTCCGTGGAATTTCCCGCTCCTGATGCAAGCATGGAAGCTGGGCCCAGCCTTGGCA
ACTGGAAACGTGGTTGTGATGAAGGTAGCTGAGCAGACACCCCTCACCGCCCTCTATGTG
GCCAACCTGATCAAGGAGGCTGGCTTTCCCCCTGGTGTGGTCAACATTGTGCCTGGATTT
GGCCCCACGGCTGGGGCCGCCATTGCCTCCCATGAGGATGTGGACAAAGTGGCATTCACA
GGCTCCACTGAGATTGGCCGCGTAATCCAGGTTGCTGCTGGGAGCAGCAACCTCAAGAGA
GTGACCTTGGAGCTGGGGGGGAAGAGCCCCAACATCATCATGTCAGATGCCGATATGGAT
TGGGCCGTGGAACAGGCCCACTTCGCCCTGTTCTTCAACCAGGGCCAGTGCTGCTGTGCC
GGCTCCCGGACCTTCGTGCAGGAGGACATCTATGATGAGTTTGTGGTGCGGAGCGTTGCC
CGGGCCAAGTCTCGGGTGGTCGGGAACCCCTTTGATAGCAAGACCGAGCAGGGGCCGCAG
GTGGATGAAACTCAGTTTAAGAAGATCCTCGGCTACATCAACACGGGGAAGCAAGAGGGG
GCGAAGCTGCTGTGTGGTGGGGGCATTGCTGCTGACCGTGGTTACTTCATCCAGCCCACT
GTGTTTGGAGATGTGCAGGATGGCATGACCATCGCCAAGGAGGAGATCTTCGGGCCAGTG
ATGCAGATCCTGAAGTTCAAGACCATAGAGGAGGTTGTTGGGAGAGCCAACAATTCCACG
TACGGGCTGGCCGCAGCTGTCTTCACAAAGGATTTGGACAAGGCCAATTACCTGTCCCAG
GCCCTCCAGGCGGGCACTGTGTGGGTCAACTGCTATGATGTGTTTGGAGCCCAGTCACCC
TTTGGTGGCTACAAGATGTCGGGGAGTGGCCGGGAGTTGGGCGAGTACGGGCTGCAGGCA
TACACTGAAGTGAAAACTGTCACAGTCAAAGTGCCTCAGAAGAACTCATAA

# Drug_Target_126_General_Function:
Energy production and conversion

# Drug_Target_126_General_References:
10631996	Ni L, Zhou J, Hurley TD, Weiner H: Human liver mitochondrial aldehyde dehydrogenase: three-dimensional structure and the restoration of solubility and activity of chimeric forms. Protein Sci. 1999 Dec;8(12):2784-90.
2838413	Hsu LC, Bendel RE, Yoshida A: Genomic structure of the human mitochondrial aldehyde dehydrogenase gene. Genomics. 1988 Jan;2(1):57-65.
2987944	Hsu LC, Tani K, Fujiyoshi T, Kurachi K, Yoshida A: Cloning of cDNAs for human aldehyde dehydrogenases 1 and 2. Proc Natl Acad Sci U S A. 1985 Jun;82(11):3771-5.
3562250	Braun T, Bober E, Singh S, Agarwal DP, Goedde HW: Isolation and sequence analysis of a full length cDNA clone coding for human mitochondrial aldehyde dehydrogenase. Nucleic Acids Res. 1987 Apr 10;15(7):3179.
3582651	Braun T, Bober E, Singh S, Agarwal DP, Goedde HW: Evidence for a signal peptide at the amino-terminal end of human mitochondrial aldehyde dehydrogenase. FEBS Lett. 1987 May 11;215(2):233-6.
3610592	Agarwal DP, Goedde HW: Human aldehyde dehydrogenase isozymes and alcohol sensitivity. Isozymes Curr Top Biol Med Res. 1987;16:21-48.
3653404	Hempel J, Hoog JO, Jornvall H: Mitochondrial aldehyde dehydrogenase. Homology of putative targeting sequence to that of carbamyl phosphate synthetase I revealed by correlation of cDNA and protein data. FEBS Lett. 1987 Sep 28;222(1):95-8.
4015823	Yoshida A, Ikawa M, Hsu LC, Tani K: Molecular abnormality and cDNA cloning of human aldehyde dehydrogenases. Alcohol. 1985 Jan-Feb;2(1):103-6.
4065146	Hempel J, Kaiser R, Jornvall H: Mitochondrial aldehyde dehydrogenase from human liver. Primary structure, differences in relation to the cytosolic enzyme, and functional correlations. Eur J Biochem. 1985 Nov 15;153(1):13-28.
6582480	Yoshida A, Huang IY, Ikawa M: Molecular abnormality of an inactive aldehyde dehydrogenase variant commonly found in Orientals. Proc Natl Acad Sci U S A. 1984 Jan;81(1):258-61.
8561277	Novoradovsky A, Tsai SJ, Goldfarb L, Peterson R, Long JC, Goldman D: Mitochondrial aldehyde dehydrogenase polymorphism in Asian and American Indian populations: detection of new ALDH2 alleles. Alcohol Clin Exp Res. 1995 Oct;19(5):1105-10.

# Drug_Target_126_HGNC_ID:
HGNC:404

# Drug_Target_126_HPRD_ID:
00003

# Drug_Target_126_ID:
147

# Drug_Target_126_Locus:
12q24.2

# Drug_Target_126_Molecular_Weight:
56382

# Drug_Target_126_Name:
Aldehyde dehydrogenase, mitochondrial

# Drug_Target_126_Number_of_Residues:
517

# Drug_Target_126_PDB_ID:
1OF7

# Drug_Target_126_Pathway:
Not Available

# Drug_Target_126_Pfam_Domain_Function:
PF00171	Aldedh

# Drug_Target_126_Protein_Sequence:
>Aldehyde dehydrogenase, mitochondrial precursor
MLRAAARFGPRLGRRLLSAAATQAVPAPNQQPEVFCNQIFINNEWHDAVSRKTFPTVNPS
TGEVICQVAEGDKEDVDKAVKAARAAFQLGSPWRRMDASHRGRLLNRLADLIERDRTYLA
ALETLDNGKPYVISYLVDLDMVLKCLRYYAGWADKYHGKTIPIDGDFFSYTRHEPVGVCG
QIIPWNFPLLMQAWKLGPALATGNVVVMKVAEQTPLTALYVANLIKEAGFPPGVVNIVPG
FGPTAGAAIASHEDVDKVAFTGSTEIGRVIQVAAGSSNLKRVTLELGGKSPNIIMSDADM
DWAVEQAHFALFFNQGQCCCAGSRTFVQEDIYDEFVERSVARAKSRVVGNPFDSKTEQGP
QVDETQFKKILGYINTGKQEGAKLLCGGGIAADRGYFIQPTVFGDVQDGMTIAKEEIFGP
VMQILKFKTIEEVVGRANNSTYGLAAAVFTKDLDKANYLSQALQAGTVWVNCYDVFGAQS
PFGGYKMSGSGRELGEYGLQAYTEVKTVTVKVPQKNS

# Drug_Target_126_Reaction:
an aldehyde + NAD+ + H2O = an acid + NADH + H+

# Drug_Target_126_Signals:
None

# Drug_Target_126_Specific_Function:
Not Available

# Drug_Target_126_SwissProt_ID:
P05091

# Drug_Target_126_SwissProt_Name:
ALDH2_HUMAN

# Drug_Target_126_Synonyms:
ALDH class 2
ALDH-E2
ALDHI
Aldehyde dehydrogenase, mitochondrial precursor
EC 1.2.1.3

# Drug_Target_126_Theoretical_pI:
7.05

# Drug_Target_126_Transmembrane_Regions:
None

# Drug_Target_127_Cellular_Location:
Glycosome

# Drug_Target_127_Chromosome_Location:
Not Available

# Drug_Target_127_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_127_Essentiality:
Non-Essential

# Drug_Target_127_GenAtlas_ID:
Not Available

# Drug_Target_127_GenBank_ID_Gene:
X52898

# Drug_Target_127_GenBank_ID_Protein:
10609

# Drug_Target_127_GeneCard_ID:
Not Available

# Drug_Target_127_Gene_Name:
Not Available

# Drug_Target_127_Gene_Sequence:
>1080 bp
ATGCCCATCAAGGTCGGTATCAACGGCTTTGGCCGCATCGGACGCATGGTCTTTCAGGCC
TTGTGTGAGGACGGCCTTCTCGGGACGGAGATTGACGTCGTGGCGGTGGTCGATATGAAC
ACGGATGCCGAGTACTTTGCGTACCAGATGCGTTACGACACCGTGCATGGCAAGTTCAAG
TACGAGGTGACGACGACGAAGAGCAGCCCCTCCGTTGCGAAGGACGACACGCTTGTGGTG
AATGGCCACCGTATCCTGTGCGTGAAGGCGCAGCGGAACCCGGCGGATCTCCCATGGGGC
AAGCTTGGTGTGGAGTACGTAATTGAATCAACGGGCCTGTTCACCGCCAAGGCGGCGGCG
GAGGGCCACCTGCGCGGCGGTGCACGGAAGGTCGTCATCAGCGCTCCCGCCTCTGGTGGC
GCCAAGACACTTGTGATGGGCGTGAACCATCACGAGTACAACCCCAGTGAGCACCACGTT
GTGTCTAACGCGTCATGCACGACCAATTGCCTTGCGCCCATTGTGCACGTCCTGGTGAAG
GAGGGATTCGGCGTGCAGACCGGCCTCATGACGACGATCCACTCGTACACAGCAACGCAG
AAGACGGTGGACGGTGTGTCGGTGAAGGACTGGCGTGGCGGTCGTGCGGCTGCTGTCAAC
ATCATTCCGAGCACGACTGGTGCGGCGAAGGCGGTGGGCATGGTGATTCCGAGCACCCAG
GGCAAGCTGACGGGCATGTCTTTTCGTGTCCCCACCCCGGACGTGTCCGTGGTGGATCTC
ACCTTCACTGCGGCGCGCGACACCAGCATACAGGAGATCGACGCCGCCCTGAAGCGCGCG
TCTAAGACTTACATGAAAGGAATTCTCGGCTACACGGACGAGGAGCTTGTGAGTGCAGAC
TTCATTAATGACAACCGCAGCTCCATTTACGACTCCAAGGCAACGCTGCAGAACAACCTG
CCGAAGGAGCGCCGCTTCTTCAAGATTGTGTCGTGGTACGACAACGAGTGGGGATACTCC
CACCGCGTGGTGGACCTTGTACGCCACATGGCCTCGAAGGATCGTTCGGCAAGGTTGTAG

# Drug_Target_127_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_127_General_References:
2167831	Kendall G, Wilderspin AF, Ashall F, Miles MA, Kelly JM: Trypanosoma cruzi glycosomal glyceraldehyde-3-phosphate dehydrogenase does not conform to the 'hotspot' topogenic signal model. EMBO J. 1990 Sep;9(9):2751-8.

# Drug_Target_127_HGNC_ID:
Not Available

# Drug_Target_127_HPRD_ID:
Not Available

# Drug_Target_127_ID:
2799

# Drug_Target_127_Locus:
Not Available

# Drug_Target_127_Molecular_Weight:
39061

# Drug_Target_127_Name:
Glyceraldehyde-3-phosphate dehydrogenase, glycosomal

# Drug_Target_127_Number_of_Residues:
359

# Drug_Target_127_PDB_ID:
1QXS

# Drug_Target_127_Pathway:
Not Available

# Drug_Target_127_Pfam_Domain_Function:
PF00044	Gp_dh_N
PF02800	Gp_dh_C

# Drug_Target_127_Protein_Sequence:
>Glyceraldehyde-3-phosphate dehydrogenase, glycosomal
MPIKVGINGFGRIGRMVFQALCEDGLLGTEIDVVAVVDMNTDAEYFAYQMRYDTVHGKFK
YEVTTTKSSPSVAKDDTLVVNGHRILCVKAQRNPADLPWGKLGVEYVIESTGLFTAKAAA
EGHLRGGARKVVISAPASGGAKTLVMGVNHHEYNPSEHHVVSNASCTTNCLAPIVHVLVK
EGFGVQTGLMTTIHSYTATQKTVDGVSVKDWRGGRAAAVNIIPSTTGAAKAVGMVIPSTQ
GKLTGMSFRVPTPDVSVVDLTFTAARDTSIQEIDAALKRASKTYMKGILGYTDEELVSAD
FINDNRSSIYDSKATLQNNLPKERRFFKIVSWYDNEWGYSHRVVDLVRHMASKDRSARL

# Drug_Target_127_Reaction:
D-glyceraldehyde 3-phosphate + phosphate + NAD+ = 3-phospho-D-glyceroyl phosphate + NADH + H+

# Drug_Target_127_Signals:
None

# Drug_Target_127_Specific_Function:
D-glyceraldehyde 3-phosphate + phosphate + NAD(+) = 3-phospho-D-glyceroyl phosphate + NADH

# Drug_Target_127_SwissProt_ID:
P22513

# Drug_Target_127_SwissProt_Name:
G3PG_TRYCR

# Drug_Target_127_Synonyms:
EC 1.2.1.12
GAPDH

# Drug_Target_127_Theoretical_pI:
9.01

# Drug_Target_127_Transmembrane_Regions:
None

# Drug_Target_128_Cellular_Location:
Cytoplasm

# Drug_Target_128_Chromosome_Location:
Not Available

# Drug_Target_128_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_128_Essentiality:
Non-Essential

# Drug_Target_128_GenAtlas_ID:
ADH7

# Drug_Target_128_GenBank_ID_Gene:
L33179

# Drug_Target_128_GenBank_ID_Protein:
516618

# Drug_Target_128_GeneCard_ID:
ADH7

# Drug_Target_128_Gene_Name:
ADH7

# Drug_Target_128_Gene_Sequence:
>1125 bp
ATGGGCACTGCTGGAAAAGTTATTAAGTGCAAAGCAGCTGTGCTTTGGGAGCAGAAGCAA
CCCTTCTCCATTGAGGAAATAGAAGTTGCCCCACCAAAGACTAAAGAAGTTCGCATTAAG
ATTTTGGCCACAGGAATCTGTCGCACAGATGACCATGTGATAAAAGGAACAATGGTGTCC
AAGTTTCCAGTGATTGTGGGACATGAGGCAACTGGGATTGTAGAGAGCATTGGAGAAGGA
GTGACTACAGTGAAACCAGGTGACAAAGTCATCCCTCTCTTTCTGCCACAATGTAGAGAA
TGCAATGCTTGTCGCAACCCAGATGGCAACCTTTGCATTAGGAGCGATATTACTGGTCGT
GGAGTACTGGCTGATGGCACCACCAGATTTACATGCAAGGGCAAACCAGTCCACCACTTC
ATGAACACCAGTACATTTACCGAGTACACAGTGGTGGATGAATCTTCTGTTGCTAAGATT
GATGATGCAGCTCCTCCTGAGAAAGTCTGTTTAATTGGCTGTGGGTTTTCCACTGGATAT
GGCGCTGCTGTTAAAACTGGCAAGGTCAAACCTGGTTCCACTTGCGTCGTCTTTGGCCTG
GGAGGAGTTGGCCTGTCAGTCATCATGGGCTGTAAGTCAGCTGGTGCATCTAGGATCATT
GGGATTGACCTCAACAAAGACAAATTTGAGAAGGCCATGGCTGTAGGTGCCACTGAGTGT
ATCAGTCCCAAGGACTCTACCAAACCCATCAGTGAGGTGCTGTCAGAAATGACAGGCAAC
AACGTGGGATACACCTTTGAAGTTATTGGGCATCTTGAAACCATGATTGATGCCCTGGCA
TCCTGCCACATGAACTATGGGACCAGCGTGGTTGTAGGAGTTCCTCCATCAGCCAAGATG
CTCACCTATGACCCGATGTTGCTCTTCACTGGACGCACATGGAAGGGATGTGTCTTTGGA
GGTTTGAAAAGCAGAGATGATGTCCCAAAACTAGTGACTGAGTTCCTGGCAAAGAAATTT
GACCTGGACCAGTTGATAACTCATGTTTTACCATTTAAAAAAATCAGTGAAGGATTTGAG
CTGCTCAATTCAGGACAAAGCATTCGAACGGTCCTGACGTTTTGA

# Drug_Target_128_General_Function:
Energy production and conversion

# Drug_Target_128_General_References:
1592118	Pares X, Cederlund E, Moreno A, Saubi N, Hoog JO, Jornvall H: Class IV alcohol dehydrogenase (the gastric enzyme). Structural analysis of human sigma sigma-ADH reveals class IV to be variable and confirms the presence of a fifth mammalian alcohol dehydrogenase class. FEBS Lett. 1992 May 25;303(1):69-72.
7771649	Cheung B, Anderson JK, Holmes RS, Beacham IR: Human stomach class IV alcohol dehydrogenase: molecular genetic analysis. Alcohol Clin Exp Res. 1995 Feb;19(1):185-6.
7876099	Kedishvili NY, Bosron WF, Stone CL, Hurley TD, Peggs CF, Thomasson HR, Popov KM, Carr LG, Edenberg HJ, Li TK: Expression and kinetic characterization of recombinant human stomach alcohol dehydrogenase. Active-site amino acid sequence explains substrate specificity compared with liver isozymes. J Biol Chem. 1995 Feb 24;270(8):3625-30.
7876191	Zgombic-Knight M, Foglio MH, Duester G: Genomic structure and expression of the ADH7 gene encoding human class IV alcohol dehydrogenase, the form most efficient for retinol metabolism in vitro. J Biol Chem. 1995 Mar 3;270(9):4305-11.
7925371	Farres J, Moreno A, Crosas B, Peralba JM, Allali-Hassani A, Hjelmqvist L, Jornvall H, Pares X: Alcohol dehydrogenase of class IV (sigma sigma-ADH) from human stomach. cDNA sequence and structure/function relationships. Eur J Biochem. 1994 Sep 1;224(2):549-57.
8082805	Yokoyama S, Matsuo Y, Ramsbotham R, Yokoyama R: Molecular characterization of a class IV human alcohol dehydrogenase gene (ADH7). FEBS Lett. 1994 Sep 12;351(3):411-5.
8195208	Satre MA, Zgombic-Knight M, Duester G: The complete structure of human class IV alcohol dehydrogenase (retinol dehydrogenase) determined from the ADH7 gene. J Biol Chem. 1994 Jun 3;269(22):15606-12.
9228021	Xie P, Parsons SH, Speckhard DC, Bosron WF, Hurley TD: X-ray structure of human class IV sigmasigma alcohol dehydrogenase. Structural basis for substrate specificity. J Biol Chem. 1997 Jul 25;272(30):18558-63.

# Drug_Target_128_HGNC_ID:
HGNC:256

# Drug_Target_128_HPRD_ID:
02515

# Drug_Target_128_ID:
579

# Drug_Target_128_Locus:
4q23-q24

# Drug_Target_128_Molecular_Weight:
40006

# Drug_Target_128_Name:
Alcohol dehydrogenase class 4 mu/sigma chain

# Drug_Target_128_Number_of_Residues:
374

# Drug_Target_128_PDB_ID:
1D1S

# Drug_Target_128_Pathway:
Not Available

# Drug_Target_128_Pfam_Domain_Function:
PF00107	ADH_zinc_N
PF08240	ADH_N

# Drug_Target_128_Protein_Sequence:
>Alcohol dehydrogenase class 4 mu/sigma chain
MGTAGKVIKCKAAVLWEQKQPFSIEEIEVAPPKTKEVRIKILATGICRTDDHVIKGTMVS
KFPVIVGHEATGIVESIGEGVTTVKPGDKVIPLFLPQCRECNACRNPDGNLCIRSDITGR
GVLADGTTRFTCKGKPVHHFMNTSTFTEYTVVDESSVAKIDDAAPPEKVCLIGCGFSTGY
GAAVKTGKVKPGSTCVVFGLGGVGLSVIMGCKSAGASRIIGIDLNKDKFEKAMAVGATEC
ISPKDSTKPISEVLSEMTGNNVGYTFEVIGHLETMIDALASCHMNYGTSVVVGVPPSAKM
LTYDPMLLFTGRTWKGCVFGGLKSRDDVPKLVTEFLAKKFDLDQLITHVLPFKKISEGFE
LLNSGQSIRTVLTF

# Drug_Target_128_Reaction:
an alcohol + NAD+ = an aldehyde or ketone + NADH + H+

# Drug_Target_128_Signals:
None

# Drug_Target_128_Specific_Function:
Could function in retinol oxidation for the synthesis of retinoic acid, a hormone important for cellular differentiation. Medium-chain (octanol) and aromatic (m-nitrobenzaldehyde) compounds are the best substrates. Ethanol is not a good substrate but at the high ethanol concentrations reached in the digestive tract, it plays a role in the ethanol oxidation and contributes to the first pass ethanol metabolism

# Drug_Target_128_SwissProt_ID:
P40394

# Drug_Target_128_SwissProt_Name:
ADH7_HUMAN

# Drug_Target_128_Synonyms:
Alcohol dehydrogenase class IV mu/sigma chain
EC 1.1.1.1
Gastric alcohol dehydrogenase
Retinol dehydrogenase

# Drug_Target_128_Theoretical_pI:
8.08

# Drug_Target_128_Transmembrane_Regions:
None

# Drug_Target_129_Cellular_Location:
Cytoplasmic

# Drug_Target_129_Chromosome_Location:
Not Available

# Drug_Target_129_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_129_Essentiality:
Non-Essential

# Drug_Target_129_GenAtlas_ID:
Not Available

# Drug_Target_129_GenBank_ID_Gene:
D50543

# Drug_Target_129_GenBank_ID_Protein:
1486241

# Drug_Target_129_GeneCard_ID:
Not Available

# Drug_Target_129_Gene_Name:
glvA

# Drug_Target_129_Gene_Sequence:
>1350 bp
ATGAAGAAAAAATCATTCTCAATCGTAATAGCGGGCGGAGGGAGCACTTTCACTCCAGGG
ATCGTACTCATGCTCTTGGACCATTTGGAGGAGTTTCCGATCAGAAAGCTGAAGCTGTAT
GATAATGATAAGGAGAGACAGGATCGAATTGCAGGCGCCTGTGACGTTTTTATCAGAGAA
AAAGCGCCGGATATTGAATTTGCAGCGACGACTGACCCGGAAGAAGCTTTTACAGATGTC
GATTTTGTTATGGCGCACATCAGAGTAGGGAAATACGCGATGCGCGCGCTTGATGAGCAA
ATTCCGTTAAAGTACGGAGTTGTCGGCCAGGAGACGTGCGGGCCGGGCGGGATCGCATAC
GGTATGCGTTCGATCGGCGGTGTGCTTGAAATATTAGATTACATGGAAAAATACTCGCCT
GATGCGTGGATGCTCAATTATTCCAATCCGGCGGCAATTGTGGCTGAAGCTACGAGACGC
CTTAGACCGAATTCTAAAATTCTCAATATCTGTGATATGCCGGTTGGGATCGAAGACCGG
ATGGCGCAAATTCTTGGCTTATCCTCAAGAAAAGAAATGAAGGTCCGCTATTACGGATTG
AATCATTTCGGCTGGTGGACATCGATTCAGGATCAAGAGGGCAACGATTTAATGCCGAAG
CTGAAGGAACATGTATCCCAATACGGTTATATTCCGAAAACAGAGGCTGAAGCTGTGGAG
GCAAGCTGGAATGACACGTTCGCCAAAGCGCGTGACGTGCAGGCTGCAGATCCTGACACA
CTGCCGAATACGTATTTGCAATATTATTTGTTCCCAGATGATATGGTGAAAAAATCAAAT
CCGAATCATACGCGGGCGAATGAAGTCATGGAAGGGCGCGAAGCTTTTATTTTCAGCCAA
TGTGACATGATCACACGTGAACAGTCCTCGGAAAACAGCGAAATTAAAATCGATGACCAC
GCATCGTATATCGTTGATCTTGCCCGGGCGATTGCCTACAACACAGGTGAAAGAATGCTG
TTGATTGTTGAAAATAACGGTGCAATTGCGAACTTTGACCCGACTGCGATGGTTGAGGTG
CCATGCATCGTCGGCTCAAATGGACCTGAACCGATTACCGTTGGCACCATTCCGCAATTC
CAGAAAGGGCTCATGGAGCAGCAGGTATCCGTTGAGAAGCTGACTGTTGAAGCGTGGGCA
GAGAAATCGTTCCAAAAGCTGTGGCAGGCGCTGATCCTGTCAAAAACAGTGCCGAACGCG
CGTGTGGCAAGACTCATTCTTGAGGATTTAGTGGAGGCCAACAAAGACTTCTGGCCTGAG
CTTGATCAAAGCCCAACCCGCATATCATAA

# Drug_Target_129_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_129_General_References:
10329789	Varrot A, Yamamoto H, Sekiguchi J, Thompson J, Davies GJ: Crystallization and preliminary X-ray analysis of the 6-phospho-alpha-glucosidase from Bacillus subtilis. Acta Crystallogr D Biol Crystallogr. 1999 Jun;55(Pt 6):1212-4.
11489864	Yamamoto H, Serizawa M, Thompson J, Sekiguchi J: Regulation of the glv operon in Bacillus subtilis: YfiA (GlvR) is a positive regulator of the operon that is repressed through CcpA and cre. J Bacteriol. 2001 Sep;183(17):5110-21.
8704981	Yamamoto H, Uchiyama S, Fajar AN, Ogasawara N, Sekiguchi J: Determination of a 12 kb nucleotide sequence around the 76 degrees region of the Bacillus subtilis chromosome. Microbiology. 1996 Jun;142 ( Pt 6):1417-21.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.
9765262	Thompson J, Pikis A, Ruvinov SB, Henrissat B, Yamamoto H, Sekiguchi J: The gene glvA of Bacillus subtilis 168 encodes a metal-requiring, NAD(H)-dependent 6-phospho-alpha-glucosidase. Assignment to family 4 of the glycosylhydrolase superfamily. J Biol Chem. 1998 Oct 16;273(42):27347-56.

# Drug_Target_129_HGNC_ID:
Not Available

# Drug_Target_129_HPRD_ID:
Not Available

# Drug_Target_129_ID:
2393

# Drug_Target_129_Locus:
Not Available

# Drug_Target_129_Molecular_Weight:
50514

# Drug_Target_129_Name:
Maltose-6'-phosphate glucosidase

# Drug_Target_129_Number_of_Residues:
449

# Drug_Target_129_PDB_ID:
1U8X

# Drug_Target_129_Pathway:
Not Available

# Drug_Target_129_Pfam_Domain_Function:
PF02056	Glyco_hydro_4

# Drug_Target_129_Protein_Sequence:
>Maltose-6'-phosphate glucosidase
MKKKSFSIVIAGGGSTFTPGIVLMLLDHLEEFPIRKLKLYDNDKERQDRIAGACDVFIRE
KAPDIEFAATTDPEEAFTDVDFVMAHIRVGKYAMRALDEQIPLKYGVVGQETCGPGGIAY
GMRSIGGVLEILDYMEKYSPDAWMLNYSNPAAIVAEATRRLRPNSKILNICDMPVGIEDR
MAQILGLSSRKEMKVRYYGLNHFGWWTSIQDQEGNDLMPKLKEHVSQYGYIPKTEAEAVE
ASWNDTFAKARDVQAADPDTLPNTYLQYYLFPDDMVKKSNPNHTRANEVMEGREAFIFSQ
CDMITREQSSENSEIKIDDHASYIVDLARAIAYNTGERMLLIVENNGAIANFDPTAMVEV
PCIVGSNGPEPITVGTIPQFQKGLMEQQVSVEKLTVEAWAEKSFQKLWQALILSKTVPNA
RVARLILEDLVEANKDFWPELDQSPTRIS

# Drug_Target_129_Reaction:
maltose 6'-phosphate + H2O = D-glucose + D-glucose 6-phosphate

# Drug_Target_129_Signals:
None

# Drug_Target_129_Specific_Function:
Hydrolyzes maltose-6'P and trehalose-6'P. Is involved in the catabolism of alpha-glycosides accumulated via a phosphoenolpyruvate-dependent maltose phosphotransferase system (PEP-PTS)

# Drug_Target_129_SwissProt_ID:
P54716

# Drug_Target_129_SwissProt_Name:
GLVA_BACSU

# Drug_Target_129_Synonyms:
6-phospho-alpha-D- glucosidase
6-phosphoryl-O-alpha-D- glucopyranosyl:phosphoglucohydrolase
EC 3.2.1.122

# Drug_Target_129_Theoretical_pI:
4.67

# Drug_Target_129_Transmembrane_Regions:
None

# Drug_Target_12_Cellular_Location:
Not Available

# Drug_Target_12_Chromosome_Location:
Not Available

# Drug_Target_12_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_12_Essentiality:
Non-Essential

# Drug_Target_12_GenAtlas_ID:
Not Available

# Drug_Target_12_GenBank_ID_Gene:
X56793

# Drug_Target_12_GenBank_ID_Protein:
581654

# Drug_Target_12_GeneCard_ID:
Not Available

# Drug_Target_12_Gene_Name:
rfbB

# Drug_Target_12_Gene_Sequence:
>1086 bp
GTGAAGATACTTATTACTGGCGGGGCAGGTTTTATTGGATCAGCTGTTGTCCGCCATATT
ATTAAGAATACACAGGACACTGTAGTTAATATTGATAAATTAACCTACGCCGGTAATCTT
GAATCCCTTTCTGATATTTCTGAAAGTAATCGCTACAATTTTGAACACGCGGATATTTGT
GATTCCGCTGAAATAACGCGTATTTTTGAGCAGTACCAGCCGGACGCGGTGATGCATTTG
GCTGCGGAAAGTCATGTGGACCGTTCGATTACCGGGCCAGCAGCATTTATTGAAACCAAT
ATCGTCGGCACCTATGCACTTCTTGAAGTTGCGCGTAAATACTGGTCTGCCCTTGGCGAA
GATAAAAAAAATAATTTTCGTTTTCATCATATTTCCACTGATGAAGTTTACGGCGATTTA
CCGCATCCTGATGAAGTTGAAAACAGCGTTACGCTGCCGTTATTTACTGAAACGACGGCA
TATGCGCCAAGTAGCCCCTATTCTGCGTCAAAAGCATCCAGCGATCATTTAGTCCGTGCC
TGGCGGCGTACCTATGGTCTACCAACGATCGTTACCAATTGTTCTAATAACTATGGCCCT
TATCACTTCCCTGAAAAACTGATTCCGTTGGTCATTTTGAACGCACTGGAAGGAAAGCCT
TTGCCAATTTATGGCAAAGGGGATCAGATTCGCGATTGGCTATATGTAGAAGATCATGCT
CGCGCGCTTCATATGGTAGTGACTGAAGGCAAGGCAGGGGAGACTTATAACATTGGTGGA
CACAATGAGAAGAAAAATCTCGATGTGGTATTTACCATCTGTGATCTGCTGGATGAGATT
GTACCCAAAGCGACTTCTTATCGTGAACAAATCACTTATGTCGCGGATCGTCCGGGCCAT
GATCGTCGTTATGCCATTGATGCAGGTAAAATTAGCCGCGAATTAGGCTGGAAACCGCTG
GAGACCTTTGAAAGCGGTATTCGTAAAACAGTGGAATGGTACCTTGCAAATACTCAATGG
GTAAACAATGTTAAAAGTGGGGCGTATCAGAGTTGGATAGAACAGAACTATGAAGGACGC
CAGTAA

# Drug_Target_12_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_12_General_References:
11677609	McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, Porwollik S, Ali J, Dante M, Du F, Hou S, Layman D, Leonard S, Nguyen C, Scott K, Holmes A, Grewal N, Mulvaney E, Ryan E, Sun H, Florea L, Miller W, Stoneking T, Nhan M, Waterston R, Wilson RK: Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature. 2001 Oct 25;413(6858):852-6.
11796113	Allard ST, Beis K, Giraud MF, Hegeman AD, Gross JW, Wilmouth RC, Whitfield C, Graninger M, Messner P, Allen AG, Maskell DJ, Naismith JH: Toward a structural understanding of the dehydratase mechanism. Structure. 2002 Jan;10(1):81-92.
1710759	Jiang XM, Neal B, Santiago F, Lee SJ, Romana LK, Reeves PR: Structure and sequence of the rfb (O antigen) gene cluster of Salmonella serovar typhimurium (strain LT2). Mol Microbiol. 1991 Mar;5(3):695-713.

# Drug_Target_12_HGNC_ID:
Not Available

# Drug_Target_12_HPRD_ID:
Not Available

# Drug_Target_12_ID:
3177

# Drug_Target_12_Locus:
Not Available

# Drug_Target_12_Molecular_Weight:
40719

# Drug_Target_12_Name:
dTDP-glucose 4,6-dehydratase

# Drug_Target_12_Number_of_Residues:
361

# Drug_Target_12_PDB_ID:
1KEW

# Drug_Target_12_Pathway:
Not Available

# Drug_Target_12_Pfam_Domain_Function:
PF01370	Epimerase

# Drug_Target_12_Protein_Sequence:
>dTDP-glucose 4,6-dehydratase
MKILITGGAGFIGSAVVRHIIKNTQDTVVNIDKLTYAGNLESLSDISESNRYNFEHADIC
DSAEITRIFEQYQPDAVMHLAAESHVDRSITGPAAFIETNIVGTYALLEVARKYWSALGE
DKKNNFRFHHISTDEVYGDLPHPDEVENSVTLPLFTETTAYAPSSPYSASKASSDHLVRA
WRRTYGLPTIVTNCSNNYGPYHFPEKLIPLVILNALEGKPLPIYGKGDQIRDWLYVEDHA
RALHMVVTEGKAGETYNIGGHNEKKNLDVVFTICDLLDEIVPKATSYREQITYVADRPGH
DRRYAIDAGKISRELGWKPLETFESGIRKTVEWYLANTQWVNNVKSGAYQSWIEQNYEGR
Q

# Drug_Target_12_Reaction:
dTDP-glucose = dTDP-4-dehydro-6-deoxy-D-glucose + H2O

# Drug_Target_12_Signals:
None

# Drug_Target_12_Specific_Function:
dTDP-glucose = dTDP-4-dehydro-6-deoxy-D- glucose + H(2)O

# Drug_Target_12_SwissProt_ID:
P26391

# Drug_Target_12_SwissProt_Name:
RMLB_SALTY

# Drug_Target_12_Synonyms:
EC 4.2.1.46

# Drug_Target_12_Theoretical_pI:
5.74

# Drug_Target_12_Transmembrane_Regions:
None

# Drug_Target_130_Cellular_Location:
Not Available

# Drug_Target_130_Chromosome_Location:
Not Available

# Drug_Target_130_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_130_Essentiality:
Non-Essential

# Drug_Target_130_GenAtlas_ID:
Not Available

# Drug_Target_130_GenBank_ID_Gene:
V01536

# Drug_Target_130_GenBank_ID_Protein:
579179

# Drug_Target_130_GeneCard_ID:
Not Available

# Drug_Target_130_Gene_Name:
Not Available

# Drug_Target_130_Gene_Sequence:
>1683 bp
GTGAGCAGAAAACTGTTTGCGTCAATCTTAATAGGGGCGCTACTGGGGATAGGGGCCCCA
CCTTCAGCCCATGCAGGCGCTGATGATGTTGTTGATTCTTCTAAATCTTTTGTGATGGAA
AACTTTTCTTCGTACCACGGGACTAAACCTGGTTATGTAGATTCCATTCAAAAAGGTATA
CAAAAGCCAAAATCTGGTACACAAGGAAATTATGACGATGATTGGAAAGGGTTTTATAGT
ACCGACAATAAATACGACGCTGCGGGATACTCTGTAGATAATGAAAACCCGCTCTCTGGA
AAAGCTGGAGGCGTGGTCAAAGTGACGTATCCAGGACTGACGAAGGTTCTCGCACTAAAA
GTGGATAATGCCGAAACTATTAAGAAAGAGTTAGGTTTAAGTCTCACTGAACCGTTGATG
GAGCAAGTCGGAACGGAAGAGTTTATCAAAAGGTTCGGTGATGGTGCTTCGCGTGTAGTG
CTCAGCCTTCCCTTCGCTGAGGGGAGTTCTAGCGTTGAATATATTAATAACTGGGAACAG
GCGAAAGCGTTAAGCGTAGAACTTGAGATTAATTTTGAAACCCGTGGAAAACGTGGCCAA
GATGCGATGTATGAGTATATGGCTCAAGCCTGTGCAGGAAATCGTGTCAGGCGATCAGTA
GGTAGCTCATTGTCATGCATAAATCTTGATTGGGATGTCATAAGGGATAAAACTAAGACA
AAGATAGAGTCTTTGAAAGAGCATGGCCCTATCAAAAATAAAATGAGCGAAAGTCCCAAT
AAAACAGTATCTGAGGAAAAAGCTAAACAATACCTAGAAGAATTTCATCAAACGGCATTA
GAGCATCCTGAATTGTCAGAACTTAAAACCGTTACTGGGACCAATCCTGTATTCGCTGGG
GCTAACTATGCGGCGTGGGCAGTAAACGTTGCGCAAGTTATCGATAGCGAAACAGCTGAT
AATTTGGAAAAGACAACTGCTGCTCTTTCGATACTTCCTGGTATCGGTAGCGTAATGGGC
ATTGCAGACGGTGCCGTTCACCACAATACAGAAGAGATAGTGGCACAATCAATAGCTTTA
TCGTCTTTAATGGTTGCTCAAGCTATTCCATTGGTAGGAGAGCTAGTTGATATTGGTTTC
GCTGCATATAATTTTGTAGAGAGTATTATCAATTTATTTCAAGTAGTTCATAATTCGTAT
AATCGTCCCGCGTATTCTCCGGGGCATAAAACGCAACCATTTCTTCATGACGGGTATGCT
GTCAGTTGGAACACTGTTGAAGATTCGATAATCCGAACTGGTTTTCAAGGGGAGAGTGGG
CACGACATAAAAATTACTGCTGAAAATACCCCGCTTCCAATCGCGGGTGTCCTACTACCG
ACTATTCCTGGAAAGCTGGACGTTAATAAGTCCAAGACTCATATTTCCGTAAATGGTCGG
AAAATAAGGATGCGTTGCAGAGCTATAGACGGTGATGTAACTTTTTGTCGCCCTAAATCT
CCTGTTTATGTTGGTAATGGTGTGCATGCGAATCTTCACGTGGCATTTCACAGAAGCAGC
TCGGAGAAAATTCATTCTAATGAAATTTCGTCGGATTCCATAGGCGTTCTTGGGTACCAG
AAAACAGTAGATCACACCAAGGTTAATTCTAAGCTATCGCTATTTTTTGAAATCAAAAGC
TGA

# Drug_Target_130_General_Function:
Involved in NAD+-diphthamide ADP-ribosyltransferase activity

# Drug_Target_130_General_References:
6314249	Ratti G, Rappuoli R, Giannini G: The complete nucleotide sequence of the gene coding for diphtheria toxin in the corynephage omega (tox+) genome. Nucleic Acids Res. 1983 Oct 11;11(19):6589-95.

# Drug_Target_130_HGNC_ID:
Not Available

# Drug_Target_130_HPRD_ID:
Not Available

# Drug_Target_130_ID:
2507

# Drug_Target_130_Locus:
Not Available

# Drug_Target_130_Molecular_Weight:
60815

# Drug_Target_130_Name:
Diphtheria toxin

# Drug_Target_130_Number_of_Residues:
560

# Drug_Target_130_PDB_ID:
1F0L

# Drug_Target_130_Pathway:
Not Available

# Drug_Target_130_Pfam_Domain_Function:
PF01324	Diphtheria_R
PF02763	Diphtheria_C
PF02764	Diphtheria_T

# Drug_Target_130_Protein_Sequence:
>Diphtheria toxin precursor
MSRKLFASILIGALLGIGAPPSAHAGADDVVDSSKSFVMENFSSYHGTKPGYVDSIQKGI
QKPKSGTQGNYDDDWKGFYSTDNKYDAAGYSVDNENPLSGKAGGVVKVTYPGLTKVLALK
VDNAETIKKELGLSLTEPLMEQVGTEEFIKRFGDGASRVVLSLPFAEGSSSVEYINNWEQ
AKALSVELEINFETRGKRGQDAMYEYMAQACAGNRVRRSVGSSLSCINLDWDVIRDKTKT
KIESLKEHGPIKNKMSESPNKTVSEEKAKQYLEEFHQTALEHPELSELKTVTGTNPVFAG
ANYAAWAVNVAQVIDSETADNLEKTTAALSILPGIGSVMGIADGAVHHNTEEIVAQSIAL
SSLMVAQAIPLVGELVDIGFAAYNFVESIINLFQVVHNSYNRPAYSPGHKTQPFLHDGYA
VSWNTVEDSIIRTGFQGESGHDIKITAENTPLPIAGVLLPTIPGKLDVNKSKTHISVNGR
KIRMRCRAIDGDVTFCRPKSPVYVGNGVHANLHVAFHRSSSEKIHSNEISSDSIGVLGYQ
KTVDHTKVNSKLSLFFEIKS

# Drug_Target_130_Reaction:
NAD+ + peptide diphthamide = nicotinamide + peptide N-(ADP-D-ribosyl)diphthamide

# Drug_Target_130_Signals:
1-25

# Drug_Target_130_Specific_Function:
Diphtheria toxin, produced by a phage infecting corynebacterium diphtheriae, is a proenzyme that, after activation, catalyzes the covalent attachment of the ADP ribose moiety of NAD to elongation factor 2. Fragment A is responsible for enzymatic ADP-ribosylation of elongation factor 2, while fragment B is responsible for binding of toxin to cell receptors and entry of fragment A

# Drug_Target_130_SwissProt_ID:
P00587

# Drug_Target_130_SwissProt_Name:
DTX_COROM

# Drug_Target_130_Synonyms:
DT
Diphtheria toxin precursor
EC 2.4.2.36
NAD(+)--diphthamide ADP- ribosyltransferase

# Drug_Target_130_Theoretical_pI:
6.56

# Drug_Target_130_Transmembrane_Regions:
None

# Drug_Target_131_Cellular_Location:
GPI-anchor
Sarcoplasmic reticulum
lipid-anchor
sarcoplasmic reticulum membrane

# Drug_Target_131_Chromosome_Location:
Not Available

# Drug_Target_131_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_131_Essentiality:
Non-Essential

# Drug_Target_131_GenAtlas_ID:
ART1

# Drug_Target_131_GenBank_ID_Gene:
S74683

# Drug_Target_131_GenBank_ID_Protein:
807100

# Drug_Target_131_GeneCard_ID:
ART1

# Drug_Target_131_Gene_Name:
ART1

# Drug_Target_131_Gene_Sequence:
>984 bp
ATGCAGATGCCTGCTATGATGTCTCTGCTTCTTGTGTCTGTGGGCCTCATGGAAGCACTT
CAGGCCCAGAGCCACCCCATCACACGACGAGACCTCTTCTCTCAAGAGATTCAGCTGGAC
ATGGCCCTGGCCTCCTTTGATGACCAGTACGCTGGCTGTGCTGCTGCCATGACAGCTGCT
CTCCCGGATCTCAACCACACGGAGTTCCAGGCCAACCAGGTGTATGCAGACAGCTGGACA
CTGGCAAGCAGCCAATGGCAGGAGCGTCAGGCCAGGTGGCCAGAGTGGAGTCTCAGCCCC
ACCCGTCCATCCCCGCCACCCCTGGGCTTCCGCGATGAGCATGGGGTGGCCCTCCTGGCC
TACACAGCCAACAGCCCCCTGCACAAGGAGTTCAATGCAGCCGTGCGTGAGGCGGGCCGC
TCCCGGGCCCACTACCTCCACCACTTCTCCTTCAAGACACTCCATTTCCTGCTGACTGAG
GCCCTGCAGCTCCTGGGCAGCGGCCAGCGTCCACCCCGGTGCCACCAGGTGTTCCGAGGT
GTGCACGGCCTGCGCTTCCGGCCAGCAGGGCCCCGGGCCACCGTGAGGCTGGGGGGCTTT
GCTTCTGCCTCCCTGAAGCATGTTGCAGCCCAGCAGTTTGGTGAGGACACCTTCTTCGGC
ATCTGGACCTGCCTTGGGGCCCCTATCAAGGGCTACTCCTTCTTCCCTGGAGAGGAAGAG
GTGCTGATCCCCCCCTTTGAGACCTTCCAAGTGATCAATGCCAGCAGACCGGCCCAGGGC
CCCGCCCGCATCTACCTCCGAGCCCTGGGCAAGCACAGCACCTACAACTGCGAGTACATC
AAAGACAAGAAGTGCAAGTCTGGGCCTTGCCATCTGGATAATTCAGCCATGGGTCAGAGC
CCCCTCTCTGCAGTCTGGTCTTTGCTGCTGCTGCTCTGGTTCCTCGTGGTGAGGGCCTTT
CCAGATGGTCCAGGCCTCCTTTGA

# Drug_Target_131_General_Function:
Involved in NAD(P)+-protein-arginine ADP-ribosyltransferase activity

# Drug_Target_131_General_References:
7947688	Okazaki IJ, Zolkiewska A, Nightingale MS, Moss J: Immunological and structural conservation of mammalian skeletal muscle glycosylphosphatidylinositol-linked ADP-ribosyltransferases. Biochemistry. 1994 Nov 1;33(43):12828-36.

# Drug_Target_131_HGNC_ID:
HGNC:723

# Drug_Target_131_HPRD_ID:
03377

# Drug_Target_131_ID:
1199

# Drug_Target_131_Locus:
11p15

# Drug_Target_131_Molecular_Weight:
36319

# Drug_Target_131_Name:
GPI-linked NAD(P)(+)--arginine ADP-ribosyltransferase 1

# Drug_Target_131_Number_of_Residues:
327

# Drug_Target_131_PDB_ID:
Not Available

# Drug_Target_131_Pathway:
Not Available

# Drug_Target_131_Pfam_Domain_Function:
PF01129	ART

# Drug_Target_131_Protein_Sequence:
>GPI-linked NAD(P)(+)--arginine ADP-ribosyltransferase 1 precursor
MQMPAMMSLLLVSVGLMEALQAQSHPITRRDLFSQEIQLDMALASFDDQYAGCAAAMTAA
LPDLNHTEFQANQVYADSWTLASSQWQERQARWPEWSLSPTRPSPPPLGFRDEHGVALLA
YTANSPLHKEFNAAVREAGRSRAHYLHHFSFKTLHFLLTEALQLLGSGQRPPRCHQVFRG
VHGLRFRPAGPRATVRLGGFASASLKHVAAQQFGEDTFFGIWTCLGAPIKGYSFFPGEEE
VLIPPFETFQVINASRPAQGPARIYLRALGKHSTYNCEYIKDKKCKSGPCHLDNSAMGQS
PLSAVWSLLLLLWFLVVRAFPDGPGLL

# Drug_Target_131_Reaction:
(1) NAD+ + protein L-arginine = nicotinamide + Nomega-(ADP-D-ribosyl)-protein-L-arginine

# Drug_Target_131_Signals:
1-22

# Drug_Target_131_Specific_Function:
NAD(P)(+) + protein-L-arginine = nicotinamide + omega-N-(ADP-D-ribosyl)-protein-L-arginine

# Drug_Target_131_SwissProt_ID:
P52961

# Drug_Target_131_SwissProt_Name:
NAR1_HUMAN

# Drug_Target_131_Synonyms:
CD296 antigen
EC 2.4.2.31
GPI-linked NAD(P)(+)--arginine ADP-ribosyltransferase 1 precursor
Mono(ADP-ribosyl)transferase

# Drug_Target_131_Theoretical_pI:
8.38

# Drug_Target_131_Transmembrane_Regions:
None

# Drug_Target_132_Cellular_Location:
Cytoplasmic

# Drug_Target_132_Chromosome_Location:
Not Available

# Drug_Target_132_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_132_Essentiality:
Non-Essential

# Drug_Target_132_GenAtlas_ID:
Not Available

# Drug_Target_132_GenBank_ID_Gene:
AE000512

# Drug_Target_132_GenBank_ID_Protein:
4981838

# Drug_Target_132_GeneCard_ID:
Not Available

# Drug_Target_132_Gene_Name:
bglT

# Drug_Target_132_Gene_Sequence:
>1248 bp
ATGAGAATTGCGGTGATAGGTGGGGGAAGCAGCTACACCCCGGAGCTGGTGAAGGGACTT
CTCGACATTTCCGAGGATGTTCGCATCGACGAGGTGATCTTCTACGACATCGACGAAGAA
AAGCAGAAAATCGTCGTTGATTTCGTGAAGAGACTCGTCAAAGACAGGTTCAAGGTGCTC
ATAAGCGACACCTTCGAGGGTGCTGTCGTGGACGCGAAGTACGTGATCTTTCAGTTCAGA
CCCGGCGGACTCAAAGGTAGAGAAAACGACGAAGGCATTCCGCTGAAGTACGGTCTCATA
GGTCAAGAGACAACGGGGGTTGGGGGATTTTCAGCGGCTTTGAGGGCGTTTCCCATAGTA
GAAGAGTACGTTGATACCGTGAGAAAAACATCGAACGCGACCATCGTAAACTTCACCAAC
CCATCCGGCCACATTACGGAGTTCGTGAGAAACTACCTCGAATACGAAAAATTCATAGGT
CTCTGCAACGTTCCCATAAACTTCATCCGGGAGATCGCAGAGATGTTCTCAGCAAGGCTC
GAAGACGTGTTCCTGAAGTACTACGGCCTCAACCATCTGAGCTTCATAGAGAAGGTCTTC
GTAAAAGGTGAAGACGTGACGGAAAAGGTTTTCGAGAACCTGAAGCTGAAGCTCTCCAAC
ATACCAGACGAGGATTTCCCGACGTGGTTCTACGACTCGGTGAGACTCATTGTGAATCCT
TACCTGAGGTACTACCTGATGGAGAAGAAGATGTTCAAAAAGATCTCCACACACGAGCTC
AGAGCAAGGGAAGTGATGAAGATAGAGAAAGAACTCTTCGAGAAGTACAGAACCGCTGTC
GAGATACCGGAGGAACTCACAAAACGCGGTGGCAGCATGTATTCCACAGCGGCAGCTCAC
CTGATAAGAGACCTCGAAACCGACGAAGGAAAGATACACATCGTGAACACGAGAAACAAC
GGCTCGATCGAGAACCTCCCGGATGATTACGTTCTGGAGATCCCGTGTTATGTGAGATCC
GGCAGGGTTCACACGCTCTCGCAGGGAAAAGGAGATCACTTTGCTCTTTCTTTCATCCAC
GCGGTGAAGATGTACGAGCGACTCACAATAGAAGCGTATCTGAAGAGATCGAAAAAACTC
GCTCTAAAGGCTTTGCTTTCCCATCCTCTCGGACCCGATGTGGAGGACGCAAAAGACCTT
CTCGAAGAGATACTGGAGGCGAACAGAGAATACGTGAAACTGGGGTGA

# Drug_Target_132_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_132_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.

# Drug_Target_132_HGNC_ID:
Not Available

# Drug_Target_132_HPRD_ID:
Not Available

# Drug_Target_132_ID:
2538

# Drug_Target_132_Locus:
Not Available

# Drug_Target_132_Molecular_Weight:
47627

# Drug_Target_132_Name:
6-phospho-beta-glucosidase bglT

# Drug_Target_132_Number_of_Residues:
415

# Drug_Target_132_PDB_ID:
1UP7

# Drug_Target_132_Pathway:
Not Available

# Drug_Target_132_Pfam_Domain_Function:
PF02056	Glyco_hydro_4

# Drug_Target_132_Protein_Sequence:
>6-phospho-beta-glucosidase bglT
MRIAVIGGGSSYTPELVKGLLDISEDVRIDEVIFYDIDEEKQKIVVDFVKRLVKDRFKVL
ISDTFEGAVVDAKYVIFQFRPGGLKGRENDEGIPLKYGLIGQETTGVGGFSAALRAFPIV
EEYVDTVRKTSNATIVNFTNPSGHITEFVRNYLEYEKFIGLCNVPINFIREIAEMFSARL
EDVFLKYYGLNHLSFIEKVFVKGEDVTEKVFENLKLKLSNIPDEDFPTWFYDSVRLIVNP
YLRYYLMEKKMFKKISTHELRAREVMKIEKELFEKYRTAVEIPEELTKRGGSMYSTAAAH
LIRDLETDEGKIHIVNTRNNGSIENLPDDYVLEIPCYVRSGRVHTLSQGKGDHFALSFIH
AVKMYERLTIEAYLKRSKKLALKALLSHPLGPDVEDAKDLLEEILEANREYVKLG

# Drug_Target_132_Reaction:
6-phospho-beta-D-glucosyl-(1,4)-D-glucose + H2O = D-glucose + D-glucose 6-phosphate

# Drug_Target_132_Signals:
None

# Drug_Target_132_Specific_Function:
Hydrolyzes cellobiose 6'-phosphate into glucose 6- phosphate (Glc6P) and glucose

# Drug_Target_132_SwissProt_ID:
Q9X108

# Drug_Target_132_SwissProt_Name:
BGLT_THEMA

# Drug_Target_132_Synonyms:
EC 3.2.1.86

# Drug_Target_132_Theoretical_pI:
5.92

# Drug_Target_132_Transmembrane_Regions:
None

# Drug_Target_133_Cellular_Location:
Periplasm

# Drug_Target_133_Chromosome_Location:
Not Available

# Drug_Target_133_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_133_Essentiality:
Non-Essential

# Drug_Target_133_GenAtlas_ID:
Not Available

# Drug_Target_133_GenBank_ID_Gene:
M97379

# Drug_Target_133_GenBank_ID_Protein:
155588

# Drug_Target_133_GeneCard_ID:
Not Available

# Drug_Target_133_Gene_Name:
gfo

# Drug_Target_133_Gene_Sequence:
>1320 bp
ATGACGAACAAAATCTCGTCTTCAGATAATCTTTCCAATGCTGTTTCAGCAACGGATGAC
AACGCTTCCCGTACGCCAAATCTGAACCGTCGCGCTCTCGTTGGTGGTGGTGTTGGACTG
GCCGCACGTGGCGCCTTAGCCAGTGGTCTTCAGGCAGCGACGCTTCCTGCTGGTGCCAGC
CTGGTTCCGACCACGCCTGCAGGTCGCCCGATGCCTTACGCGATCCGCCCGATGCCGGAA
GATCGTCGTTTCGGTTATGCTATCGTCGGTCTGGGTAAATATGCCCTTAACCAGATTTTA
CCGGGTTTTGCCGGATGCCAGCATTCCCGCATGAAGCTTTGGTCAGCGGTAACCGAAAAA
GCTAAAATCGTTGCCGCTGAATATGGCGTCGATCCCCGTAAAATTTATGATTACAGCAAC
TTCGACAAGATCGCTAAAGATCCAAAAATCGACGCTGTTTACATCATTTTGCCAAACTCT
TTGCATGCTGAATTTGCTATCCGTTCTTTCAAAGCCGGCAAGCATGTTATGTGTGAAAAG
CCGATGGCAACCTCTGTTGCTGATTGTCAGCGGATGATCGATGCAGCCAAGGCTGCTAAT
AAAAAGCTGATGATCGGTTACCGTTGCCACTATGATCCAATGAACCGTGCAGCGGTAAAA
TTGATCCGTGAAAACCAGTTGGGTAAACTGGGCATGGTTACCACCGACAACTCAGACGTT
ATGGATCAGAACGACCTGCACAGCAGTGGCGTCTGCGTCGTGAACTCCGGTGGCGGTTCT
TTGATGGATATCGGTATTTATGGCTTGAACGGTACCCGTTACTTGCTGGGTGAAGAACCG
ATCGAAGTCCGTGCTTACACCTACAGCGATCCGAATGATGAACGTTTCGTTGAAGTCGAA
GATCGTATTATTTGGCAGATGCGCTTCAGAAGCGGTGCTCTGTCTCATGGTGCATCTTCT
TATTCGACCACGACGACTTCACGTTTCTCGGTGCAGGGCGACAAAGCTGTTCTGTTGATG
GATCCGGCTACCGGATATTATCAGAATTTGATTTCTGTCCAGACCCCAGGCCATGCTAAC
CAGTCGATGATGCCACAGTTCATCATGCCAGCGAACAACCAGTTCTCTGCACAGTTGGAT
CATCTGGCTGAAGCCGTCATCAATAACAAACCAGTTCGTAGCCCGGGTGAAGAAGGTATG
CAGGATGTGCGCCTGATTCAGGCCATTTATGAAGCAGCTCGTACCGGTCGCGCCGTCAAC
ACGGATTGGGGTTATGTGCGTCAGGTGGTTATTGATTCTGACTTAACCTATTTGGGTTAA

# Drug_Target_133_General_Function:
Involved in oxidoreductase activity

# Drug_Target_133_General_References:
1537789	Kanagasundaram V, Scopes RK: Cloning, sequence analysis, and expression of the structural gene encoding glucose-fructose oxidoreductase from Zymomonas mobilis. J Bacteriol. 1992 Mar;174(5):1439-47.
8472911	Loos H, Sahm H, Sprenger GA: Glucose-fructose oxidoreductase, a periplasmic enzyme of Zymomonas mobilis, is active in its precursor form. FEMS Microbiol Lett. 1993 Mar 1;107(2-3):293-8.
8994968	Kingston RL, Scopes RK, Baker EN: The structure of glucose-fructose oxidoreductase from Zymomonas mobilis: an osmoprotective periplasmic enzyme containing non-dissociable NADP. Structure. 1996 Dec 15;4(12):1413-28.

# Drug_Target_133_HGNC_ID:
Not Available

# Drug_Target_133_HPRD_ID:
Not Available

# Drug_Target_133_ID:
2826

# Drug_Target_133_Locus:
Not Available

# Drug_Target_133_Molecular_Weight:
47190

# Drug_Target_133_Name:
Glucose--fructose oxidoreductase

# Drug_Target_133_Number_of_Residues:
433

# Drug_Target_133_PDB_ID:
1H6A

# Drug_Target_133_Pathway:
Not Available

# Drug_Target_133_Pfam_Domain_Function:
PF01408	GFO_IDH_MocA
PF02894	GFO_IDH_MocA_C

# Drug_Target_133_Protein_Sequence:
>Glucose--fructose oxidoreductase precursor
MTNKISSSDNLSNAVSATDDNASRTPNLTRRALVGGGVGLAAAGALASGLQAATLPAGAS
QVPTTPAGRPMPYAIRPMPEDRRFGYAIVGLGKYALNQILPGFAGCQHSRIEALVSGNAE
KAKIVAAEYGVDPRKIYDYSNFDKIAKDPKIDAVYIILPNSLHAEFAIRAFKAGKHVMCE
KPMATSVADCQRMIDAAKAANKKLMIGYRCHYDPMNRAAVKLIRENQLGKLGMVTTDNSD
VMDQNDPAQQWRLRRELAGGGSLMDIGIYGLNGTRYLLGEEPIEVRAYTYSDPNDERFVE
VEDRIIWQMRFRSGALSHGASSYSTTTTSRFSVQGDKAVLLMDPATGYYQNLISVQTPGH
ANQSMMPQFIMPANNQFSAQLDHLAEAVINNKPVRSPGEEGMQDVRLIQAIYEAARTGRP
VNTDWGYVRQGGY

# Drug_Target_133_Reaction:
D-glucose + D-fructose = D-gluconolactone + D-glucitol

# Drug_Target_133_Signals:
1-52

# Drug_Target_133_Specific_Function:
D-glucose + D-fructose = D-gluconolactone + D- glucitol

# Drug_Target_133_SwissProt_ID:
Q07982

# Drug_Target_133_SwissProt_Name:
GFO_ZYMMO

# Drug_Target_133_Synonyms:
EC 1.1.99.28
GFOR
Glucose--fructose oxidoreductase precursor

# Drug_Target_133_Theoretical_pI:
8.73

# Drug_Target_133_Transmembrane_Regions:
None

# Drug_Target_134_Cellular_Location:
Cytoplasm

# Drug_Target_134_Chromosome_Location:
Not Available

# Drug_Target_134_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_134_Essentiality:
Non-Essential

# Drug_Target_134_GenAtlas_ID:
ADH1A

# Drug_Target_134_GenBank_ID_Gene:
M12271

# Drug_Target_134_GenBank_ID_Protein:
178092

# Drug_Target_134_GeneCard_ID:
ADH1A

# Drug_Target_134_Gene_Name:
ADH1A

# Drug_Target_134_Gene_Sequence:
>1128 bp
ATGAGCACAGCAGGAAAAGTAATCAAATGCAAAGCAGCTGTGCTATGGGAGTTAAAGAAA
CCCTTTTCCATTGAGGAGGTGGAGGTTGCACCTCCTAAGGCCCATGAAGTTCGTATTAAG
ATGGTGGCTGTAGGAATCTGTGGCACAGATGACCACGTGGTTAGTGGTACCATGGTGACC
CCACTTCCTGTGATTTTAGGCCATGAGGCAGCCGGCATCGTGGAGAGTGTTGGAGAAGGG
GTGACTACAGTCAAACCAGGTGATAAAGTCATCCCACTCGCTATTCCTCAGTGTGGAAAA
TGCAGAATTTGTAAAAACCCGGAGAGCAACTACTGCTTGAAAAACGATGTAAGCAATCCT
CAGGGGACCCTGCAGGATGGCACCAGCAGGTTCACCTGCAGGAGGAAGCCCATCCACCAC
TTCCTTGGCATCAGCACCTTCTCACAGTACACAGTGGTGGATGAAAATGCAGTAGCCAAA
ATTGATGCAGCCTCGCCTCTAGAGAAAGTCTGTCTCATTGGCTGTGGATTTTCAACTGGT
TATGGGTCTGCAGTCAATGTTGCCAAGGTCACCCCAGGCTCTACCTGTGCTGTGTTTGGC
CTGGGAGGGGTCGGCCTATCTGCTATTATGGGCTGTAAAGCAGCTGGGGCAGCCAGAATC
ATTGCGGTGGACATCAACAAGGACAAATTTGCAAAGGCCAAAGAGTTGGGGGCCACTGAA
TGCATCAACCCTCAAGACTACAAGAAACCCATCCAGGAGGTGCTAAAGGAAATGACTGAT
GGAGGTGTGGATTTTTCATTTGAAGTCATCGGTCGGCTTGACACCATGATGGCTTCCCTG
TTATGTTGTCATGAGGCATGTGGCACAAGTGTCATCGTAGGGGTACCTCCTGATTCCCAA
AACCTCTCAATGAACCCTATGCTGCTACTGACTGGACGTACCTGGAAGGGAGCTATTCTT
GGTGGCTTTAAAAGTAAAGAATGTGTCCCAAAACTTGTGGCTGATTTTATGGCTAAGAAG
TTTTCATTGGATGCATTAATAACCCATGTTTTACCTTTTGAAAAAATAAATGAAGGATTT
GACCTGCTTCACTCTGGGAAAAGTATCCGTACCATTCTGATGTTTTGA

# Drug_Target_134_General_Function:
Energy production and conversion

# Drug_Target_134_General_References:
2347582	Yasunami M, Kikuchi I, Sarapata D, Yoshida A: The human class I alcohol dehydrogenase gene cluster: three genes are tandemly organized in an 80-kb-long segment of the genome. Genomics. 1990 Jun;7(2):152-8.
2920825	Matsuo Y, Yokoyama S: Molecular structure of the human alcohol dehydrogenase 1 gene. FEBS Lett. 1989 Jan 16;243(1):57-60.
2935875	Ikuta T, Szeto S, Yoshida A: Three human alcohol dehydrogenase subunits: cDNA structure and molecular and evolutionary divergence. Proc Natl Acad Sci U S A. 1986 Feb;83(3):634-8.
3013304	von Bahr-Lindstrom H, Hoog JO, Heden LO, Kaiser R, Fleetwood L, Larsson K, Lake M, Holmquist B, Holmgren A, Hempel J, et al.: cDNA and protein structure for the alpha subunit of human liver alcohol dehydrogenase. Biochemistry. 1986 May 6;25(9):2465-70.

# Drug_Target_134_HGNC_ID:
HGNC:249

# Drug_Target_134_HPRD_ID:
00063

# Drug_Target_134_ID:
251

# Drug_Target_134_Locus:
4q21-q23

# Drug_Target_134_Molecular_Weight:
39728

# Drug_Target_134_Name:
Alcohol dehydrogenase 1A

# Drug_Target_134_Number_of_Residues:
374

# Drug_Target_134_PDB_ID:
1HSO

# Drug_Target_134_Pathway:
Cyclophosphamide Pathway	SMP00447
Disulfiram Pathway	SMP00429

# Drug_Target_134_Pfam_Domain_Function:
PF00107	ADH_zinc_N
PF08240	ADH_N

# Drug_Target_134_Protein_Sequence:
>Alcohol dehydrogenase 1A
STAGKVIKCKAAVLWELKKPFSIEEVEVAPPKAHEVRIKMVAVGICGTDDHVVSGTMVTP
LPVILGHEAAGIVESVGEGVTTVKPGDKVIPLAIPQCGKCRICKNPESNYCLKNDVSNPQ
GTLQDGTSRFTCRRKPIHHFLGISTFSQYTVVDENAVAKIDAASPLEKVCLIGCGFSTGY
GSAVNVAKVTPGSTCAVFGLGGVGLSAIMGCKAAGAARIIAVDINKDKFAKAKELGATEC
INPQDYKKPIQEVLKEMTDGGVDFSFEVIGRLDTMMASLLCCHEACGTSVIVGVPPDSQN
LSMNPMLLLTGRTWKGAILGGFKSKECVPKLVADFMAKKFSLDALITHVLPFEKINEGFD
LLHSGKSIRTILMF

# Drug_Target_134_Reaction:
an alcohol + NAD+ = an aldehyde or ketone + NADH + H+

# Drug_Target_134_Signals:
None

# Drug_Target_134_Specific_Function:
Not Available

# Drug_Target_134_SwissProt_ID:
P07327

# Drug_Target_134_SwissProt_Name:
ADH1A_HUMAN

# Drug_Target_134_Synonyms:
Alcohol dehydrogenase alpha subunit
EC 1.1.1.1

# Drug_Target_134_Theoretical_pI:
8.02

# Drug_Target_134_Transmembrane_Regions:
None

# Drug_Target_135_Cellular_Location:
Not Available

# Drug_Target_135_Chromosome_Location:
Not Available

# Drug_Target_135_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_135_Essentiality:
Non-Essential

# Drug_Target_135_GenAtlas_ID:
QDPR

# Drug_Target_135_GenBank_ID_Gene:
X04882

# Drug_Target_135_GenBank_ID_Protein:
30819

# Drug_Target_135_GeneCard_ID:
QDPR

# Drug_Target_135_Gene_Name:
QDPR

# Drug_Target_135_Gene_Sequence:
>735 bp
ATGGCGGCGGCGGCGGCTGCAGGCGAGGCGCGCCGGGTGCTGGTGTACGGCGGCAGGGGC
GCTCTGGGTTCTCGATGCGTGCAGGCTTTTCGGGCCCGCAACTGGTGGGTTGCCAGCGTT
GATGTGGTGGAGAATGAAGAGGCCAGCGCTACGATCATTGTTAAAATGACAGACTCGTTC
ACTGAGCAGGCTGACCAGGTGACTGCTGAGGTTGGAAAGCTCTTGGGTGAAGAGAAGGTG
GATGCAATTCTTTGCGTTGCTGGAGGATGGGCCGGGGGCAATGCCAAATCCAAGTCTCTC
TTTAAGAACTGTGACCTGATGTGGAAGCAGAGCATATGGACATCGACCATCTCCAGCCAT
CTGGCTACCAAGCATCTCAAGGAAGGAGGCCTCCTGACCTTGGCTGGCGCAAAGGCTGCC
CTGGATGGGACTCCTGGTATGATCGGGTACGGCATGGCCAAGGGTGCTGTTCACCAGCTC
TGCCAGAGCCTGGCTGGGAAGAACAGCGGCATGCCGCCCGGGGCAGCCGCCATCGCTGTG
CTCCCGGTTACCCTGGATACCCCGATGAACAGGAAATCAATGCCTGAGGCTGACTTCAGC
TCCTGGACACCCTTAGAATTCCTAGTTGAAACTTTCCATGACTGGATCACAGGGAAAAAC
CGACCGAGCTCAGGAAGCCTAATCCAGGTGGTAACCACAGAAGGAAGGACGGAACTCACC
CCAGCATATTTTTAG

# Drug_Target_135_General_Function:
Lipid transport and metabolism

# Drug_Target_135_General_References:
10408783	Smooker PM, Gough TJ, Cotton RG, Alliaudi C, de Sanctis L, Dianzani I: A series of mutations in the dihydropteridine reductase gene resulting in either abnormal RNA splicing or DHPR protein defects. Mutations in brief no. 244. Online. Hum Mutat. 1999;13(6):503-4.
11153907	Romstad A, Kalkanoglu HS, Coskun T, Demirkol M, Tokatli A, Dursun A, Baykal T, Ozalp I, Guldberg P, Guttler F: Molecular analysis of 16 Turkish families with DHPR deficiency using denaturing gradient gel electrophoresis (DGGE). Hum Genet. 2000 Dec;107(6):546-53.
2116088	Howells DW, Forrest SM, Dahl HH, Cotton RG: Insertion of an extra codon for threonine is a cause of dihydropteridine reductase deficiency. Am J Hum Genet. 1990 Aug;47(2):279-85.
3031582	Dahl HH, Hutchison W, McAdam W, Wake S, Morgan FJ, Cotton RG: Human dihydropteridine reductase: characterisation of a cDNA clone and its use in analysis of patients with dihydropteridine reductase deficiency. Nucleic Acids Res. 1987 Mar 11;15(5):1921-32.
3033643	Lockyer J, Cook RG, Milstien S, Kaufman S, Woo SL, Ledley FD: Structure and expression of human dihydropteridine reductase. Proc Natl Acad Sci U S A. 1987 May;84(10):3329-33.
7627180	Smooker PM, Cotton RG: Molecular basis of dihydropteridine reductase deficiency. Hum Mutat. 1995;5(4):279-84.
8262916	Su Y, Varughese KI, Xuong NH, Bray TL, Roche DJ, Whiteley JM: The crystallographic structure of a human dihydropteridine reductase NADH binary complex expressed in Escherichia coli by a cDNA constructed from its rat homologue. J Biol Chem. 1993 Dec 25;268(36):26836-41.
8326489	Dianzani I, Howells DW, Ponzone A, Saleeba JA, Smooker PM, Cotton RG: Two new mutations in the dihydropteridine reductase gene in patients with tetrahydrobiopterin deficiency. J Med Genet. 1993 Jun;30(6):465-9.
9744478	Dianzani I, de Sanctis L, Smooker PM, Gough TJ, Alliaudi C, Brusco A, Spada M, Blau N, Dobos M, Zhang HP, Yang N, Ponzone A, Armarego WL, Cotton RG: Dihydropteridine reductase deficiency: physical structure of the QDPR gene, identification of two new mutations and genotype-phenotype correlations. Hum Mutat. 1998;12(4):267-73.

# Drug_Target_135_HGNC_ID:
HGNC:9752

# Drug_Target_135_HPRD_ID:
02025

# Drug_Target_135_ID:
597

# Drug_Target_135_Locus:
4p15.31

# Drug_Target_135_Molecular_Weight:
25804

# Drug_Target_135_Name:
Dihydropteridine reductase

# Drug_Target_135_Number_of_Residues:
244

# Drug_Target_135_PDB_ID:
1HDR

# Drug_Target_135_Pathway:
Not Available

# Drug_Target_135_Pfam_Domain_Function:
PF00106	adh_short

# Drug_Target_135_Protein_Sequence:
>Dihydropteridine reductase
MAAAAAAGEARRVLVYGGRGALGSRCVQAFRARNWWVASVDVVENEEASATIIVKMTDSF
TEQADQVTAEVGKLLGEEKVDAILCVAGGWAGGNAKSKSLFKNCDLMWKQSIWTSTISSH
LATKHLKEGGLLTLAGAKAALDGTPGMIGYGMAKGAVHQLCQSLAGKNSGMPPGAAAIAV
LPVTLDTPMNRKSMPEADFSSWTPLEFLVETFHDWITGKNRPSSGSLIQVVTTEGRTELT
PAYF

# Drug_Target_135_Reaction:
a 5,6,7,8-tetrahydropteridine + NAD(P)+ = a 6,7-dihydropteridine + NAD(P)H + H+

# Drug_Target_135_Signals:
None

# Drug_Target_135_Specific_Function:
The product of this enzyme, tetrahydrobiopterin (BH-4), is an essential cofactor for phenylalanine, tyrosine, and tryptophan hydroxylases

# Drug_Target_135_SwissProt_ID:
P09417

# Drug_Target_135_SwissProt_Name:
DHPR_HUMAN

# Drug_Target_135_Synonyms:
EC 1.5.1.34
HDHPR
Quinoid dihydropteridine reductase

# Drug_Target_135_Theoretical_pI:
7.45

# Drug_Target_135_Transmembrane_Regions:
None

# Drug_Target_136_Cellular_Location:
Not Available

# Drug_Target_136_Chromosome_Location:
Not Available

# Drug_Target_136_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_136_Essentiality:
Non-Essential

# Drug_Target_136_GenAtlas_ID:
Not Available

# Drug_Target_136_GenBank_ID_Gene:
Y00129

# Drug_Target_136_GenBank_ID_Protein:
41989

# Drug_Target_136_GeneCard_ID:
Not Available

# Drug_Target_136_Gene_Name:
mdh

# Drug_Target_136_Gene_Sequence:
>939 bp
ATGAAAGTCGCAGTCCTCGGCGCTGCTGGCGGTATTGGCCAGGCGCTTGCACTACTGTTA
AAAACCCAACTGCCTTCAGGTTCAGAACTCTCTCTGTATGATATCGCTCCTGTGACTCCC
GGTGTGGCTGTCGATCTGAGCCATATCCCTACTGCTGTGAAAATCAAAGGTTTTTCTGGT
GAAGATGCGACTCCGGCGCTGGAAGGCGCAGATGTCGTTCTTATCTCTGCAGGCGTACGG
CGTAAACCGGGTATGGATCGTTCCGACCTGTTTAACGTTAACGCCGGCATCGTGAAAAAC
CTGGTACAGCAAGTTGCGAAAACCTGCCCGAAAGCGTGCATTGGTATTATCACTAACCCG
GTTAACACCACAGTTGCAATTGCTGCTGAAGTGCTGAAAAAAGCCGGTGTTTATGACAAA
AACAAACTGTTGGGCGTTACCACGCTGGATATCATTCGTTCCAACACCTTTGTTGCGGAA
CTGAAAGGCAAACAGCCTGGCGAAGTTGAAGTGCCGGTTATTGGCGGTCACTCTGGTGTT
ACCATTCTGCCGCTGCTGTCACAGGTTCCTGGCGTTAGTTTTACCGAGCAGGAAGTCGCT
GATCTGACCAAACGCATCCAGAACGCGGGTACTGAAGTGGTTGAAGCGAAGGCCGGTGGC
GGGTCTGCAACCCTGTCTATGGGCCAGGCAGCTGCACGTTTTGGTCTGTCTCTGGTTCGT
GCACTGCAGGGCGAACAAGGCGTTGTCGAATGTGCCTACGTTGAAGGCGACGGTCAGTAC
GCCCGTTTCTTCTCTCAACCGCTGCTGCTGGGTAAAAACGGCGTGGAAGAGCGTAAATCT
ATCGGTACCCTGAGCGCATTTGAACAGAACGCGCTGGAAGGTATGCTGGATACGCTGAAG
AAAGATATCGCCCTGGGGCAAGAGTTCGTTAATAAGTAA

# Drug_Target_136_General_Function:
Energy production and conversion

# Drug_Target_136_General_References:
11214793	Pupo GM, Lan R, Reeves PR, Baverstock PR: Population genetics of Escherichia coli in a natural population of native Australian rats. Environ Microbiol. 2000 Dec;2(6):594-610.
1507230	Hall MD, Levitt DG, Banaszak LJ: Crystal structure of Escherichia coli malate dehydrogenase. A complex of the apoenzyme and citrate at 1.87 A resolution. J Mol Biol. 1992 Aug 5;226(3):867-82.
2993232	Sutherland P, McAlister-Henn L: Isolation and expression of the Escherichia coli gene encoding malate dehydrogenase. J Bacteriol. 1985 Sep;163(3):1074-9.
3299262	McAlister-Henn L, Blaber M, Bradshaw RA, Nisco SJ: Complete nucleotide sequence of the Escherichia coli gene encoding malate dehydrogenase. Nucleic Acids Res. 1987 Jun 25;15(12):4993.
3322223	Vogel RF, Entian KD, Mecke D: Cloning and sequence of the mdh structural gene of Escherichia coli coding for malate dehydrogenase. Arch Microbiol. 1987;149(1):36-42.
7028159	Fernley RT, Lentz SR, Bradshaw RA: Malate dehydrogenase: isolation from E. coli and comparison with the eukaryotic mitochondrial and cytoplasmic forms. Biosci Rep. 1981 Jun;1(6):497-507.
8108402	Boyd EF, Nelson K, Wang FS, Whittam TS, Selander RK: Molecular genetic basis of allelic polymorphism in malate dehydrogenase (mdh) in natural populations of Escherichia coli and Salmonella enterica. Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1280-4.
8506346	Henzel WJ, Billeci TM, Stults JT, Wong SC, Grimley C, Watanabe C: Identifying proteins from two-dimensional gels by molecular mass searching of peptide fragments in protein sequence databases. Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5011-5.
8670822	Nystrom T, Larsson C, Gustafsson L: Bacterial defense against aging: role of the Escherichia coli ArcA regulator in gene expression, readjusted energy flux and survival during stasis. EMBO J. 1996 Jul 1;15(13):3219-28.
9190829	Charnock C: Structural studies of malate dehydrogenases (MDHs): MDHs in Brevundimonas species are the first reported MDHs in Proteobacteria which resemble lactate dehydrogenases in primary structure. J Bacteriol. 1997 Jun;179(12):4066-70.
9199437	Pupo GM, Karaolis DK, Lan R, Reeves PR: Evolutionary relationships among pathogenic and nonpathogenic Escherichia coli strains inferred from multilocus enzyme electrophoresis and mdh sequence studies. Infect Immun. 1997 Jul;65(7):2685-92.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9298646	Link AJ, Robison K, Church GM: Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12. Electrophoresis. 1997 Aug;18(8):1259-313.
9600841	Wilkins MR, Gasteiger E, Tonella L, Ou K, Tyler M, Sanchez JC, Gooley AA, Walsh BJ, Bairoch A, Appel RD, Williams KL, Hochstrasser DF: Protein identification with N and C-terminal sequence tags in proteome projects. J Mol Biol. 1998 May 8;278(3):599-608.

# Drug_Target_136_HGNC_ID:
Not Available

# Drug_Target_136_HPRD_ID:
Not Available

# Drug_Target_136_ID:
63

# Drug_Target_136_Locus:
Not Available

# Drug_Target_136_Molecular_Weight:
32338

# Drug_Target_136_Name:
Malate dehydrogenase

# Drug_Target_136_Number_of_Residues:
312

# Drug_Target_136_PDB_ID:
2CMD

# Drug_Target_136_Pathway:
Not Available

# Drug_Target_136_Pfam_Domain_Function:
PF00056	Ldh_1_N
PF02866	Ldh_1_C

# Drug_Target_136_Protein_Sequence:
>Malate dehydrogenase
MKVAVLGAAGGIGQALALLLKTQLPSGSELSLYDIAPVTPGVAVDLSHIPTAVKIKGFSG
EDATPALEGADVVLISAGVARKPGMDRSDLFNVNAGIVKNLVQQVAKTCPKACIGIITNP
VNTTVAIAAEVLKKAGVYDKNKLFGVTTLDIIRSNTFVAELKGKQPGEVEVPVIGGHSGV
TILPLLSQVPGVSFTEQEVADLTKRIQNAGTEVVEAKAGGGSATLSMGQAAARFGLSLVR
ALQGEQGVVECAYVEGDGQYARFFSQPLLLGKNGVEERKSIGTLSAFEQNALEGMLDTLK
KDIALGEEFVNK

# Drug_Target_136_Reaction:
(S)-malate + NAD+ = oxaloacetate + NADH + H+

# Drug_Target_136_Signals:
None

# Drug_Target_136_Specific_Function:
Catalyzes the reversible oxidation of malate to oxaloacetate

# Drug_Target_136_SwissProt_ID:
P61889

# Drug_Target_136_SwissProt_Name:
MDH_ECOLI

# Drug_Target_136_Synonyms:
EC 1.1.1.37

# Drug_Target_136_Theoretical_pI:
5.46

# Drug_Target_136_Transmembrane_Regions:
None

# Drug_Target_137_Cellular_Location:
Not Available

# Drug_Target_137_Chromosome_Location:
Not Available

# Drug_Target_137_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_137_Essentiality:
Non-Essential

# Drug_Target_137_GenAtlas_ID:
HSD17B10

# Drug_Target_137_GenBank_ID_Gene:
U96132

# Drug_Target_137_GenBank_ID_Protein:
2558754

# Drug_Target_137_GeneCard_ID:
HSD17B10

# Drug_Target_137_Gene_Name:
HSD17B10

# Drug_Target_137_Gene_Sequence:
>786 bp
ATGGCAGCAGCGTGTCGGAGCGTGAAGGGCCTGGTGGCGGTAATAACCGGAGGAGCCTCG
GGCCTGGGCCTGGCCACGGCGGAGCGACTTGTGGGGCAGGGAGCCTCTGCTGTGCTTCTG
GACCTGCCCAACTCGGGTGGGGAGGCCCAAGCCAAGAAGTTAGGAAACAACTGCGTTTTC
GCCCCAGCCGACGTGACCTCTGAGAAGGATGTGCAAACAGCTCTGGCTCTAGCAAAAGGA
AAGTTTGGCCGTGTGGATGTAGCTGTCAACTGTGCAGGCATCGCGGTGGCTAGCAAGACG
TACAACTTAAAGAAGGGCCAGACCCATACCTTGGAAGACTTCCAGCGAGTTCTTGATGTG
AATCTCATGGGCACCTTCAATGTGATCCGCCTGGTGGCTGGTGAGATGGGCCAGAATGAA
CCAGACCAGGGAGGCCAACGTGGGGTCATCATCAACACTGCCAGTGTGGCTGCCTTCGAG
GGTCAGGTTGGACAAGCTGCATACTCTGCTTCCAAGGGGGGAATAGTGGGCATGACACTG
CCCATTGCTCGGGATCTGGCTCCCATAGGTATCCGGGTGATGACCATTGCCCCAGGTCTG
TTTGGCACCCCACTGCTGACCAGCCTCCCAGAGAAAGTGTGCAACTTCTTGGCCAGCCAA
GTGCCCTTCCCTAGCCGACTGGGTGACCCTGCTGAGTATGCTCACCTCGTACAGGCCATC
ATCGAGAACCCATTCCTCAATGGAGAGGTCATCCGGCTGGATGGGGCCATTCGTATGCAG
CCTTGA

# Drug_Target_137_General_Function:
Lipid transport and metabolism

# Drug_Target_137_General_References:
12696021	Ofman R, Ruiter JP, Feenstra M, Duran M, Poll-The BT, Zschocke J, Ensenauer R, Lehnert W, Sass JO, Sperl W, Wanders RJ: 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency is caused by mutations in the HADH2 gene. Am J Hum Genet. 2003 May;72(5):1300-7. Epub 2003 Apr 14.
9338779	Yan SD, Fu J, Soto C, Chen X, Zhu H, Al-Mohanna F, Collison K, Zhu A, Stern E, Saido T, Tohyama M, Ogawa S, Roher A, Stern D: An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease. Nature. 1997 Oct 16;389(6652):689-95.
9553139	He XY, Schulz H, Yang SY: A human brain L-3-hydroxyacyl-coenzyme A dehydrogenase is identical to an amyloid beta-peptide-binding protein involved in Alzheimer's disease. J Biol Chem. 1998 Apr 24;273(17):10741-6.
9671743	Miller AP, Willard HF: Chromosomal basis of X chromosome inactivation: identification of a multigene domain in Xp11.21-p11.22 that escapes X inactivation. Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8709-14.

# Drug_Target_137_HGNC_ID:
HGNC:4800

# Drug_Target_137_HPRD_ID:
02223

# Drug_Target_137_ID:
350

# Drug_Target_137_Locus:
Xp11.2

# Drug_Target_137_Molecular_Weight:
26792

# Drug_Target_137_Name:
3-hydroxyacyl-CoA dehydrogenase type-2

# Drug_Target_137_Number_of_Residues:
260

# Drug_Target_137_PDB_ID:
1SO8

# Drug_Target_137_Pathway:
Not Available

# Drug_Target_137_Pfam_Domain_Function:
PF00106	adh_short

# Drug_Target_137_Protein_Sequence:
>3-hydroxyacyl-CoA dehydrogenase type-2
AAACRSVKGLVAVITGGASGLGLATAERLVGQGASAVLLDLPNSGGEAQAKKLGNNCVFA
PADVTSEKDVQTALALAKGKFGRVDVAVNCAGIAVASKTYNLKKGQTHTLEDFQRVLDVN
LMGTFNVIRLVAGEMGQNEPDQGGQRGVIINTASVAAFEGQVGQAAYSASKGGIVGMTLP
IARDLAPIGIRVMTIAPGLFGTPLLTSLPEKVCNFLASQVPFPSRLGDPAEYAHLVQAII
ENPFLNGEVIRLDGAIRMQP

# Drug_Target_137_Reaction:
(S)-3-hydroxyacyl-CoA + NAD+ = 3-oxoacyl-CoA + NADH + H+

# Drug_Target_137_Signals:
None

# Drug_Target_137_Specific_Function:
Binds intracellular amyloid-beta. By interacting with amyloid-beta, it may contribute to the neuronal dysfunction associated with Alzheimer disease (AD)

# Drug_Target_137_SwissProt_ID:
Q99714

# Drug_Target_137_SwissProt_Name:
HCD2_HUMAN

# Drug_Target_137_Synonyms:
3-hydroxy-2-methylbutyryl- CoA dehydrogenase
3-hydroxyacyl- CoA dehydrogenase type II
EC 1.1.1.178
EC 1.1.1.35
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein
Short-chain type dehydrogenase/reductase XH98G2
Type II HADH

# Drug_Target_137_Theoretical_pI:
7.94

# Drug_Target_137_Transmembrane_Regions:
None

# Drug_Target_138_Cellular_Location:
Cytoplasm

# Drug_Target_138_Chromosome_Location:
Not Available

# Drug_Target_138_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_138_Essentiality:
Non-Essential

# Drug_Target_138_GenAtlas_ID:
LDHB

# Drug_Target_138_GenBank_ID_Gene:
X13794

# Drug_Target_138_GenBank_ID_Protein:
1200083

# Drug_Target_138_GeneCard_ID:
LDHB

# Drug_Target_138_Gene_Name:
LDHB

# Drug_Target_138_Gene_Sequence:
>1005 bp
ATGGCAACTCTTAAGGAAAAACTCATTGCACCAGTTGCGGAAGAAGAGGCAACAGTTCCA
AACAATAAGATCACTGTAGTGGGTGTTGGACAAGTTGGTATGGCGTGTGCTATCAGCATT
CTGGGAAAGTCTCTGGCTGATGAACTTGCTCTTGTGGATGTTTTGGAAGATAAGCTTAAA
GGAGAAATGATGGATCTGCAGCATGGGAGCTTATTTCTTCAGACACCTAAAATTGTGGCA
GATAAAGATTATTCTGTGACCGCCAATTCTAAGATTGTAGTGGTAACTGCAGGAGTCCGT
CAGCAAGAAGGGGAGAGTCGGCTCAATCTGGTGCAGAGAAATGTTAATGTCTTCAAATTC
ATTATTCCTCAGATCGTCAAGTACAGTCCTGATTGCATCATAATTGTGGTTTCCAACCCA
GTGGACATTCTTACGTATGTTACCTGGAAACTAAGTGGATTACCCAAACACCGCGTGATT
GGAAGTGGATGTAATCTGGATTCTGCTAGATTTCGCTACCTTATGGCTGAAAAACTTGGC
ATTCATCCCAGCAGCTGCCATGGATGGATTTTGGGGGAACATGGCGACTCAAGTGTGGCT
GTGTGGAGTGGTGTGAATGTGGCAGGTGTTTCTCTCCAGGAATTGAATCCAGAAATGGGA
ACTGACAATGATAGTGAAAATTGGAAGGAAGTGCATAAGATGGTGGTTGAAAGTGCCTAT
GAAGTCATCAAGCTAAAAGGATATACCAACTGGGCTATTGGATTAAGTGTGGCTGATCTT
ATTGAATCCATGTTGAAAAATCTATCCAGGATTCATCCCGTGTCAACAATGGTAAAGGGG
ATGTATGGCATTGAGAATGAAGTCTTCCTGAGCCTTCCATGTATCCTCAATGCCCGGGGA
TTAACCAGCGTTATCAACCAGAAGCTAAAGGATGATGAGGTTGCTCAGCTCAAGAAAAGT
GCAGATACCCTGTGGGACATCCAGAAGGACCTAAAAGACCTGTGA

# Drug_Target_138_General_Function:
Energy production and conversion

# Drug_Target_138_General_References:
10211631	Sudo K, Maekawa M, Houki N, Okuda T, Akizuki S, Magara T, Kawano K: A novel in-frame deletion mutation in a case of lactate dehydrogenase (LD) H subunit deficiency showing an atypical LD isoenzyme pattern in serum and erythrocytes. Clin Biochem. 1999 Mar;32(2):137-41.
10508479	Scanlan MJ, Gordan JD, Williamson B, Stockert E, Bander NH, Jongeneel V, Gure AO, Jager D, Jager E, Knuth A, Chen YT, Old LJ: Antigens recognized by autologous antibody in patients with renal-cell carcinoma. Int J Cancer. 1999 Nov 12;83(4):456-64.
11509017	Takatani T, Takaoka N, Tatsumi M, Kawamoto H, Okuno Y, Morita K, Masutani T, Murakawa K, Okamoto Y: A novel missense mutation in human lactate dehydrogenase B-subunit gene. Mol Genet Metab. 2001 Aug;73(4):344-8.
1587525	Sudo K, Maekawa M, Tomonaga A, Tsukada T, Nakayama T, Kitamura M, Li SS, Kanno T, Toriumi J: Molecular characterization of genetic mutations in human lactate dehydrogenase (LDH) B (H) variant. Hum Genet. 1992 May;89(2):158-62.
2334429	Sudo K, Maekawa M, Ikawa S, Machida K, Kitamura M, Li SS: A missense mutation found in human lactate dehydrogenase-B (H) variant gene. Biochem Biophys Res Commun. 1990 Apr 30;168(2):672-6.
2930497	Takeno T, Li SS: Structure of the human lactate dehydrogenase B gene. Biochem J. 1989 Feb 1;257(3):921-4.
3435492	Sakai I, Sharief FS, Pan YC, Li SS: The cDNA and protein sequences of human lactate dehydrogenase B. Biochem J. 1987 Dec 15;248(3):933-6.
8314553	Maekawa M, Sudo K, Kitajima M, Matsuura Y, Li SS, Kanno T: Analysis of a genetic mutation in an electrophoretic variant of the human lactate dehydrogenase-B(H) subunit. Hum Genet. 1993 Jun;91(5):423-6.
8462975	Maekawa M, Sudo K, Kitajima M, Matsuura Y, Li SS, Kanno T: Detection and characterization of new genetic mutations in individuals heterozygous for lactate dehydrogenase-B(H) deficiency using DNA conformation polymorphism analysis and silver staining. Hum Genet. 1993 Mar;91(2):163-8.
8611651	Shonnard GC, Hud NV, Mohrenweiser HW: Arginine to tryptophan substitution in the active site of a human lactate dehydrogenase variant--LDHB GUA1: postulated effects on subunit structure and catalysis. Biochim Biophys Acta. 1996 Jan 17;1315(1):9-14.
9929983	Hidaka K, Ueda N, Hirata I, Watanabe Y, Minatogawa Y, Iuchi I: First case of missense mutation (LDH-H:R171P) in exon 4 of the lactate dehydrogenase gene detected in a Japanese patient. J Hum Genet. 1999;44(1):69-72.

# Drug_Target_138_HGNC_ID:
HGNC:6541

# Drug_Target_138_HPRD_ID:
01026

# Drug_Target_138_ID:
77

# Drug_Target_138_Locus:
12p12.2-p12.1

# Drug_Target_138_Molecular_Weight:
36508

# Drug_Target_138_Name:
L-lactate dehydrogenase B chain

# Drug_Target_138_Number_of_Residues:
333

# Drug_Target_138_PDB_ID:
1I0Z

# Drug_Target_138_Pathway:
Not Available

# Drug_Target_138_Pfam_Domain_Function:
PF00056	Ldh_1_N
PF02866	Ldh_1_C

# Drug_Target_138_Protein_Sequence:
>L-lactate dehydrogenase B chain
ATLKEKLIAPVAEEEATVPNNKITVVGVGQVGMACAISILGKSLADELALVDVLEDKLKG
EMMDLQHGSLFLQTPKIVADKDYSVTANSKIVVVTAGVRQQEGESRLNLVQRNVNVFKFI
IPQIVKYSPDCIIIVVSNPVDILTYVTWKLSGLPKHRVIGSGCNLDSARFRYLMAEKLGI
HPSSCHGWILGEHGDSSVAVWSGVNVAGVSLQELNPEMGTDNDSENWKEVHKMVVESAYE
VIKLKGYTNWAIGLSVADLIESMLKNLSRIHPVSTMVKGMYGIENEVFLSLPCILNARGL
TSVINQKLKDDEVAQLKKSADTLWDIQKDLKDL

# Drug_Target_138_Reaction:
(S)-lactate + NAD+ = pyruvate + NADH + H+

# Drug_Target_138_Signals:
None

# Drug_Target_138_Specific_Function:
Not Available

# Drug_Target_138_SwissProt_ID:
P07195

# Drug_Target_138_SwissProt_Name:
LDHB_HUMAN

# Drug_Target_138_Synonyms:
EC 1.1.1.27
LDH heart subunit
LDH-B
LDH-H
Renal carcinoma antigen NY-REN-46

# Drug_Target_138_Theoretical_pI:
5.93

# Drug_Target_138_Transmembrane_Regions:
None

# Drug_Target_139_Cellular_Location:
Cytoplasm (Potential)

# Drug_Target_139_Chromosome_Location:
Not Available

# Drug_Target_139_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_139_Essentiality:
Non-Essential

# Drug_Target_139_GenAtlas_ID:
Not Available

# Drug_Target_139_GenBank_ID_Gene:
U00039

# Drug_Target_139_GenBank_ID_Protein:
466713

# Drug_Target_139_GeneCard_ID:
Not Available

# Drug_Target_139_Gene_Name:
dlgD

# Drug_Target_139_Gene_Sequence:
>999 bp
ATGAAAGTGACATTTGAGCAGTTAAAAGCAGCCTTTAATCGGGTCTTAATTTCACGCGGC
GTTGACAGCGAAACGGCTGACGCCTGTGCAGAGATGTTCGCCCGCACCACCGAATCCGGC
GTTTATTCTCACGGCGTTAATCGTTTCCCTCGTTTCATTCAACAACTGGAAAACGGCGAT
ATCATTCCTGATGCCCAACCCAAACGTATAACCAGCCTCGGCGCAATTGAACAGTGGGAC
GCCCAGCGTTCGATCGGTAACCTGACAGCGAAAAAGATGATGGATCGCGCCATTGAACTG
GCTGCCGATCACGGTATTGGTCTGGTGGCACTACGTAATGCCAACCACTGGATGCGCGGC
GGCAGNTACGGCTGGCAGGCGGCGGAAAAAGGCTATATTGGCATTTGCTGGACCAACTCC
ATCGCCGTAATGCCGCCGTGGGGCGCAAAAGAGTGTCGCATAGGCACTAACCCGCTGATC
GTCGCCATTCCTTCCACGCCGATCACCATGGTCGATATGTCGATGTCGATGTTCTCTTAC
GGCATGTTAGAAGTTAACCGTCTGGCAGGTCGTCAGCTCCCGGTCGATGGTGGCTTTGAT
GATGAGGGCAATTTGACCAAAGAACCTGGCGTTATCGAGAAGAATCGCCGCATTTTGCCG
ATGGGCTACTGGAAAGGTTCTGGCATGTCGATTGTGCTGGATATGATCGCTACTCTCCTT
TCCGACGGCGCATCCGTTGCCGAAGTCACCCAGGACAACAGCGACGAATACGGCATTTCA
CAAATTTTTATTGCCATTGAAGTGGACAAGCTTATCGACGGTCCCACCCGCGATGCCAAG
CTGCAACGCATCATGGATTACGTTACTAGTGCCGAGCGTGCTGACGAAAATCAGGCCATT
CGCTTACCCGGCCATGAATTTACTACCCTGCTGGCCGAAAACCGCCGTAACGGCATCACT
GTTGATGACAGCGTGTGGGCCAAAATCCAGGCGTTATGA

# Drug_Target_139_General_Function:
Energy production and conversion

# Drug_Target_139_General_References:
11741871	Yew WS, Gerlt JA: Utilization of L-ascorbate by Escherichia coli K-12: assignments of functions to products of the yjf-sga and yia-sgb operons. J Bacteriol. 2002 Jan;184(1):302-6.
8041620	Sofia HJ, Burland V, Daniels DL, Plunkett G 3rd, Blattner FR: Analysis of the Escherichia coli genome. V. DNA sequence of the region from 76.0 to 81.5 minutes. Nucleic Acids Res. 1994 Jul 11;22(13):2576-86.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9525947	Badia J, Ibanez E, Sabate M, Baldoma L, Aguilar J: A rare 920-kilobase chromosomal inversion mediated by IS1 transposition causes constitutive expression of the yiaK-S operon for carbohydrate utilization in Escherichia coli. J Biol Chem. 1998 Apr 3;273(14):8376-81.

# Drug_Target_139_HGNC_ID:
Not Available

# Drug_Target_139_HPRD_ID:
Not Available

# Drug_Target_139_ID:
2336

# Drug_Target_139_Locus:
Not Available

# Drug_Target_139_Molecular_Weight:
36573

# Drug_Target_139_Name:
2,3-diketo-L-gulonate reductase

# Drug_Target_139_Number_of_Residues:
332

# Drug_Target_139_PDB_ID:
1S20

# Drug_Target_139_Pathway:
Not Available

# Drug_Target_139_Pfam_Domain_Function:
PF02615	Ldh_2

# Drug_Target_139_Protein_Sequence:
>2,3-diketo-L-gulonate reductase
MKVTFEQLKAAFNRVLISRGVDSETADACAEMFARTTESGVYSHGVNRFPRFIQQLENGD
IIPDAQPKRITSLGAIEQWDAQRSIGNLTAKKMMDRAIELAADHGIGLVALRNANHWMRG
GSYGWQAAEKGYIGICWTNSIAVMPPWGAKECRIGTNPLIVAIPSTPITMVDMSMSMFSY
GMLEVNRLAGRQLPVDGGFDDEGNLTKEPGVIEKNRRILPMGYWKGSGMSIVLDMIATLL
SDGASVAEVTQDNSDEYGISQIFIAIEVDKLIDGPTRDAKLQRIMDYVTSAERADENQAI
RLPGHEFTTLLAENRRNGITVDDSVWAKIQAL

# Drug_Target_139_Reaction:
3-dehydro-L-gulonate + NAD(P)+ = (4R,5S)-4,5,6-trihydroxy-2,3-dioxohexanoate + NAD(P)H + H+

# Drug_Target_139_Signals:
None

# Drug_Target_139_Specific_Function:
Catalyzes the reduction of 2,3-diketo-L-gulonate in the presence of NADH, to form 3-keto-L-gulonate

# Drug_Target_139_SwissProt_ID:
P37672

# Drug_Target_139_SwissProt_Name:
DLGD_ECOLI

# Drug_Target_139_Synonyms:
2,3-DKG reductase
3- dehydro-L-gulonate 2-dehydrogenase
EC 1.1.1.130

# Drug_Target_139_Theoretical_pI:
4.97

# Drug_Target_139_Transmembrane_Regions:
None

# Drug_Target_13_Cellular_Location:
Not Available

# Drug_Target_13_Chromosome_Location:
Not Available

# Drug_Target_13_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_13_Essentiality:
Non-Essential

# Drug_Target_13_GenAtlas_ID:
Not Available

# Drug_Target_13_GenBank_ID_Gene:
BX842578

# Drug_Target_13_GenBank_ID_Protein:
3261591

# Drug_Target_13_GeneCard_ID:
Not Available

# Drug_Target_13_Gene_Name:
fabG3

# Drug_Target_13_Gene_Sequence:
>783 bp
ATGTCTGGACGGTTGATAGGAAAGGTCGCACTTGTCAGCGGCGGGGCGCGCGGTATGGGT
GCATCCCATGTGCGGGCGATGGTGGCCGAAGGCGCAAAGGTTGTGTTCGGCGACATCCTC
GACGAGGAGGGCAAGGCGGTGGCCGCCGAACTGGCCGATGCGGCCCGCTACGTCCATCTC
GACGTTACCCAACCCGCGCAATGGACGGCTGCGGTGGACACCGCGGTCACCGCATTCGGT
GGCCTGCACGTGCTGGTCAACAACGCCGGCATTCTCAACATCGGGACGATCGAGGACTAC
GCCCTCACCGAATGGCAGCGCATCCTCGATGTCAACCTGACCGGAGTCTTCCTGGGCATC
CGCGCTGTCGTCAAGCCAATGAAAGAGGCTGGTCGCGGCTCCATCATCAACATTTCGTCG
ATCGAGGGGCTGGCCGGCACGGTTGCTTGTCATGGCTATACCGCCACCAAGTTCGCCGTG
CGGGGGCTGACCAAGTCCACCGCTCTCGAGTTGGGGCCCAGCGGAATTCGAGTCAACTCG
ATTCACCCTGGGTTGGTCAAGACGCCGATGACTGACTGGGTCCCCGAAGACATCTTCCAG
ACCGCGCTGGGCCGCGCGGCCGAACCCGTGGAAGTGTCCAACCTCGTCGTCTACCTGGCC
AGCGATGAGTCGAGCTATTCCACCGGCGCGGAATTTGTGGTCGACGGCGGGACCGTAGCT
GGCCTGGCACACAACGACTTCGGTGCCGTCGAGGTGTCCTCGCAGCCGGAATGGGTGACG
TAA

# Drug_Target_13_General_Function:
Lipid transport and metabolism

# Drug_Target_13_General_References:
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_13_HGNC_ID:
Not Available

# Drug_Target_13_HPRD_ID:
Not Available

# Drug_Target_13_ID:
3059

# Drug_Target_13_Locus:
Not Available

# Drug_Target_13_Molecular_Weight:
27030

# Drug_Target_13_Name:
3-alpha-(or 20-beta)-hydroxysteroid dehydrogenase

# Drug_Target_13_Number_of_Residues:
260

# Drug_Target_13_PDB_ID:
1NFQ

# Drug_Target_13_Pathway:
Not Available

# Drug_Target_13_Pfam_Domain_Function:
PF00106	adh_short

# Drug_Target_13_Protein_Sequence:
>3-alpha-(or 20-beta)-hydroxysteroid dehydrogenase
MSGRLIGKVALVSGGARGMGASHVRAMVAEGAKVVFGDILDEEGKAVAAELADAARYVHL
DVTQPAQWTAAVDTAVTAFGGLHVLVNNAGILNIGTIEDYALTEWQRILDVNLTGVFLGI
RAVVKPMKEAGRGSIINISSIEGLAGTVACHGYTATKFAVRGLTKSTALELGPSGIRVNS
IHPGLVKTPMTDWVPEDIFQTALGRAAEPVEVSNLVVYLASDESSYSTGAEFVVDGGTVA
GLAHNDFGAVEVSSQPEWVT

# Drug_Target_13_Reaction:
androstan-3alpha,17beta-diol + NAD+ = 17beta-hydroxyandrostan-3-one + NADH + H+

# Drug_Target_13_Signals:
None

# Drug_Target_13_Specific_Function:
Androstan-3-alpha,17-beta-diol + NAD(+) = 17- beta-hydroxyandrostan-3-one + NADH

# Drug_Target_13_SwissProt_ID:
P69167

# Drug_Target_13_SwissProt_Name:
HSD_MYCTU

# Drug_Target_13_Synonyms:
EC 1.1.1.53

# Drug_Target_13_Theoretical_pI:
4.79

# Drug_Target_13_Transmembrane_Regions:
None

# Drug_Target_140_Cellular_Location:
Not Available

# Drug_Target_140_Chromosome_Location:
Not Available

# Drug_Target_140_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_140_Essentiality:
Non-Essential

# Drug_Target_140_GenAtlas_ID:
Not Available

# Drug_Target_140_GenBank_ID_Gene:
Not Available

# Drug_Target_140_GenBank_ID_Protein:
Not Available

# Drug_Target_140_GeneCard_ID:
Not Available

# Drug_Target_140_Gene_Name:
Not Available

# Drug_Target_140_Gene_Sequence:
Not Available

# Drug_Target_140_General_Function:
Lipid transport and metabolism

# Drug_Target_140_General_References:
1946424	Ghosh D, Weeks CM, Grochulski P, Duax WL, Erman M, Rimsay RL, Orr JC: Three-dimensional structure of holo 3 alpha,20 beta-hydroxysteroid dehydrogenase: a member of a short-chain dehydrogenase family. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10064-8.
2194840	Marekov L, Krook M, Jornvall H: Prokaryotic 20 beta-hydroxysteroid dehydrogenase is an enzyme of the 'short-chain, non-metalloenzyme' alcohol dehydrogenase type. FEBS Lett. 1990 Jun 18;266(1-2):51-4.

# Drug_Target_140_HGNC_ID:
Not Available

# Drug_Target_140_HPRD_ID:
Not Available

# Drug_Target_140_ID:
2831

# Drug_Target_140_Locus:
Not Available

# Drug_Target_140_Molecular_Weight:
26484

# Drug_Target_140_Name:
3-alpha-(or 20-beta)-hydroxysteroid dehydrogenase

# Drug_Target_140_Number_of_Residues:
255

# Drug_Target_140_PDB_ID:
2HSD

# Drug_Target_140_Pathway:
Not Available

# Drug_Target_140_Pfam_Domain_Function:
PF00106	adh_short

# Drug_Target_140_Protein_Sequence:
>3-alpha-(or 20-beta)-hydroxysteroid dehydrogenase
MNDLSGKTVIITGGARGLGAEAARQAVAAGARVVLADVLDEEGAATARELGDAARYQHLD
VTIEEDWQRVVAYAREEFGSVDGLVNNAGISTGMFLETESVERFRKVVDINLTGVFIGMK
TVIPAMKDAGGGSIVNISSAAGLMGLALTSSYGASKWGVRGLSKLAAVELGTDRIRVNSV
HPGMTYTPMTAETGIRQGEGNYPNTPMGRVGNEPGEIAGAVVKLLSDTSSYVTGAELAVD
GGWTTGPTVKYVMGQ

# Drug_Target_140_Reaction:
androstan-3alpha,17beta-diol + NAD+ = 17beta-hydroxyandrostan-3-one + NADH + H+

# Drug_Target_140_Signals:
None

# Drug_Target_140_Specific_Function:
Androstan-3-alpha,17-beta-diol + NAD(+) = 17- beta-hydroxyandrostan-3-one + NADH

# Drug_Target_140_SwissProt_ID:
P19992

# Drug_Target_140_SwissProt_Name:
HSD_STREX

# Drug_Target_140_Synonyms:
EC 1.1.1.53

# Drug_Target_140_Theoretical_pI:
4.71

# Drug_Target_140_Transmembrane_Regions:
None

# Drug_Target_141_Cellular_Location:
Cytoplasmic

# Drug_Target_141_Chromosome_Location:
Not Available

# Drug_Target_141_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_141_Essentiality:
Non-Essential

# Drug_Target_141_GenAtlas_ID:
SIRT5

# Drug_Target_141_GenBank_ID_Gene:
AF083110

# Drug_Target_141_GenBank_ID_Protein:
Not Available

# Drug_Target_141_GeneCard_ID:
Not Available

# Drug_Target_141_Gene_Name:
SIRT5

# Drug_Target_141_Gene_Sequence:
>933 bp
ATGCGACCTCTCCAGATTGTCCCAAGTCGATTGATTTCCCAGCTATATTGTGGCCTGAAG
CCTCCAGCGTCCACACGAAACCAGATTTGCCTGAAAATGGCTCGGCCAAGTTCAAGTATG
GCAGATTTTCGAAAGTTTTTTGCAAAAGCAAAGCACATAGTCATCATCTCAGGAGCTGGT
GTTAGTGCAGAAAGTGGTGTTCCGACCTTCAGAGGAGCTGGAGGTTATTGGAGAAAATGG
CAAGCCCAGGACCTGGCGACTCCCCTGGCCTTTGCCCACAACCCGTCCCGGGTGTGGGAG
TTCTACCACTACCGGCGGGAGGTCATGGGGAGCAAGGAGCCCAACGCCGGGCACCGCGCC
ATAGCCGAGTGTGAGACCCGGCTGGGCAAGCAGGGCCGGCGAGTCGTGGTCATCACCCAG
AACATCGATGAGCTGCACCGCAAGGCTGGCACCAAGAACCTTCTGGAGATCCATGGTAGC
TTATTTAAAACTCGATGTACCTCTTGTGGAGTTGTGGCTGAGAATTACAAGAGTCCAATT
TGTCCAGCTTTATCAGGAAAAGGTGCTCCAGAACCTGGAACTCAAGATGCCAGCATCCCA
GTTGAGAAACTTCCCCGGTGTGAAGAGGCAGGCTGCGGGGGCTTGCTGCGACCTCACGTC
GTGTGGTTTGGAGAAAACCTGGATCCTGCCATTCTGGAGGAGGTTGACAGAGAGCTCGCC
CACTGTGATTTATGTCTAGTGGTGGGCACTTCCTCTGTGGTGTACCCAGCAGCCATGTTT
GCCCCCCAGGTGGCTGCCAGGGGCGTGCCAGTGGCTGAATTTAACACGGAGACCACCCCA
GCTACGAACAGATTCAGGTTTCATTTCCAGGGACCCTGTGGAACGACTCTTCCTGAAGCC
CTTGCCTGTCATGAAAATGAAACTGTTTCTTAA

# Drug_Target_141_General_Function:
Involved in DNA binding

# Drug_Target_141_General_References:
10381378	Frye RA: Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem Biophys Res Commun. 1999 Jun 24;260(1):273-9.
14574404	Mungall AJ, Palmer SA, Sims SK, Edwards CA, Ashurst JL, Wilming L, Jones MC, Horton R, Hunt SE, Scott CE, Gilbert JG, Clamp ME, Bethel G, Milne S, Ainscough R, Almeida JP, Ambrose KD, Andrews TD, Ashwell RI, Babbage AK, Bagguley CL, Bailey J, Banerjee R, Barker DJ, Barlow KF, Bates K, Beare DM, Beasley H, Beasley O, Bird CP, Blakey S, Bray-Allen S, Brook J, Brown AJ, Brown JY, Burford DC, Burrill W, Burton J, Carder C, Carter NP, Chapman JC, Clark SY, Clark G, Clee CM, Clegg S, Cobley V, Collier RE, Collins JE, Colman LK, Corby NR, Coville GJ, Culley KM, Dhami P, Davies J, Dunn M, Earthrowl ME, Ellington AE, Evans KA, Faulkner L, Francis MD, Frankish A, Frankland J, French L, Garner P, Garnett J, Ghori MJ, Gilby LM, Gillson CJ, Glithero RJ, Grafham DV, Grant M, Gribble S, Griffiths C, Griffiths M, Hall R, Halls KS, Hammond S, Harley JL, Hart EA, Heath PD, Heathcott R, Holmes SJ, Howden PJ, Howe KL, Howell GR, Huckle E, Humphray SJ, Humphries MD, Hunt AR, Johnson CM, Joy AA, Kay M, Keenan SJ, Kimberley AM, King A, Laird GK, Langford C, Lawlor S, Leongamornlert DA, Leversha M, Lloyd CR, Lloyd DM, Loveland JE, Lovell J, Martin S, Mashreghi-Mohammadi M, Maslen GL, Matthews L, McCann OT, McLaren SJ, McLay K, McMurray A, Moore MJ, Mullikin JC, Niblett D, Nickerson T, Novik KL, Oliver K, Overton-Larty EK, Parker A, Patel R, Pearce AV, Peck AI, Phillimore B, Phillips S, Plumb RW, Porter KM, Ramsey Y, Ranby SA, Rice CM, Ross MT, Searle SM, Sehra HK, Sheridan E, Skuce CD, Smith S, Smith M, Spraggon L, Squares SL, Steward CA, Sycamore N, Tamlyn-Hall G, Tester J, Theaker AJ, Thomas DW, Thorpe A, Tracey A, Tromans A, Tubby B, Wall M, Wallis JM, West AP, White SS, Whitehead SL, Whittaker H, Wild A, Willey DJ, Wilmer TE, Wood JM, Wray PW, Wyatt JC, Young L, Younger RM, Bentley DR, Coulson A, Durbin R, Hubbard T, Sulston JE, Dunham I, Rogers J, Beck S: The DNA sequence and analysis of human chromosome 6. Nature. 2003 Oct 23;425(6960):805-11.

# Drug_Target_141_HGNC_ID:
HGNC:14933

# Drug_Target_141_HPRD_ID:
Not Available

# Drug_Target_141_ID:
5766

# Drug_Target_141_Locus:
6p23

# Drug_Target_141_Molecular_Weight:
33881

# Drug_Target_141_Name:
NAD-dependent deacetylase sirtuin-5

# Drug_Target_141_Number_of_Residues:
310

# Drug_Target_141_PDB_ID:
Not Available

# Drug_Target_141_Pathway:
Not Available

# Drug_Target_141_Pfam_Domain_Function:
PF02146	SIR2

# Drug_Target_141_Protein_Sequence:
>NAD-dependent deacetylase sirtuin-5
MRPLQIVPSRLISQLYCGLKPPASTRNQICLKMARPSSSMADFRKFFAKAKHIVIISGAG
VSAESGVPTFRGAGGYWRKWQAQDLATPLAFAHNPSRVWEFYHYRREVMGSKEPNAGHRA
IAECETRLGKQGRRVVVITQNIDELHRKAGTKNLLEIHGSLFKTRCTSCGVVAENYKSPI
CPALSGKGAPEPGTQDASIPVEKLPRCEEAGCGGLLRPHVVWFGENLDPAILEEVDRELA
HCDLCLVVGTSSVVYPAAMFAPQVAARGVPVAEFNTETTPATNRFRFHFQGPCGTTLPEA
LACHENETVS

# Drug_Target_141_Reaction:
Not Available

# Drug_Target_141_Signals:
None

# Drug_Target_141_Specific_Function:
Probable NAD-dependent deacetylase (By similarity)

# Drug_Target_141_SwissProt_ID:
Q9NXA8

# Drug_Target_141_SwissProt_Name:
SIRT5_HUMAN

# Drug_Target_141_Synonyms:
EC 3.5.1.-
SIR2-like protein 5

# Drug_Target_141_Theoretical_pI:
8.55

# Drug_Target_141_Transmembrane_Regions:
None

# Drug_Target_142_Cellular_Location:
Secreted protein

# Drug_Target_142_Chromosome_Location:
Not Available

# Drug_Target_142_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_142_Essentiality:
Non-Essential

# Drug_Target_142_GenAtlas_ID:
Not Available

# Drug_Target_142_GenBank_ID_Gene:
X59040

# Drug_Target_142_GenBank_ID_Protein:
505281

# Drug_Target_142_GeneCard_ID:
Not Available

# Drug_Target_142_Gene_Name:
C3

# Drug_Target_142_Gene_Sequence:
>756 bp
ATGAAAGGTTTAAGAAAATCAATTTTATGTTTAGTTTTGTCAGCAGGAGTAATAGCTCCA
GTAACATCTGGGATGATTCAAAGTCCTCAAAAATGTTATGCTTATTCCATTAATCAAAAG
GCTTATTCAAATACTTACCAGGAGTTTACTAATATTGATCAAGCAAAAGCTTGGGGTAAT
GCTCAGTATAAAAAGTATGGACTAAGCAAATCAGAAAAAGAAGCTATAGTATCATATACT
AAAAGCGCTAGTGAAATAAATGGAAAGCTAAGACAAAATAAGGGAGTTATCAATGGATTT
CCTTCAAATTTAATAAAACAAGTTGAACTTTTAGATAAATCTTTTAATAAAATGAAGACC
CCTGAAAATATTATGTTATTTAGAGGCGACGACCCTGCTTATTTAGGAACAGAATTTCAA
AACACTCTTCTTAATTCAAATGGTACAATTAATAAAACGGCTTTTGAAAAGGCTAAAGCT
AAGTTTTTAAATAAAGATAGACTTGAATATGGATATATTAGTACTTCATTAATGAATGTT
TCTCAATTTGCAGGAAGACCAATTATTACAAAATTTAAAGTAGCAAAAGGCTCAAAGGCA
GGATATATTGACCCTATTAGTGCTTTTGCAGGACAACTTGAAATGTTGCTTCCTAGACAT
AGTACTTATCATATAGACGATATGAGATTGTCTTCTGATGGTAAACAAATAATAATTACA
GCAACAATGATGGGCACAGCTATCAATCCTAAATAA

# Drug_Target_142_General_Function:
Involved in protein binding

# Drug_Target_142_General_References:
1910014	Popoff MR, Hauser D, Boquet P, Eklund MW, Gill DM: Characterization of the C3 gene of Clostridium botulinum types C and D and its expression in Escherichia coli. Infect Immun. 1991 Oct;59(10):3673-9.
1917836	Moriishi K, Syuto B, Yokosawa N, Oguma K, Saito M: Purification and characterization of ADP-ribosyltransferases (exoenzyme C3) of Clostridium botulinum type C and D strains. J Bacteriol. 1991 Oct;173(19):6025-9.
2108433	Popoff M, Boquet P, Gill DM, Eklund MW: DNA sequence of exoenzyme C3, an ADP-ribosyltransferase encoded by Clostridium botulinum C and D phages. Nucleic Acids Res. 1990 Mar 11;18(5):1291.

# Drug_Target_142_HGNC_ID:
Not Available

# Drug_Target_142_HPRD_ID:
Not Available

# Drug_Target_142_ID:
2683

# Drug_Target_142_Locus:
Not Available

# Drug_Target_142_Molecular_Weight:
27841

# Drug_Target_142_Name:
Mono-ADP-ribosyltransferase C3

# Drug_Target_142_Number_of_Residues:
251

# Drug_Target_142_PDB_ID:
2BOV

# Drug_Target_142_Pathway:
Not Available

# Drug_Target_142_Pfam_Domain_Function:
PF03496	Binary_toxA

# Drug_Target_142_Protein_Sequence:
>Mono-ADP-ribosyltransferase C3 precursor
MKGLRKSILCLVLSAGVIAPVTSGMIQSPQKCYAYSINQKAYSNTYQEFTNIDQAKAWGN
AQYKKYGLSKSEKEAIVSYTKSASEINGKLRQNKGVINGFPSNLIKQVELLDKSFNKMKT
PENIMLFRGDDPAYLGTEFQNTLLNSNGTINKTAFEKAKAKFLNKDRLEYGYISTSLMNV
SQFAGRPIITKFKVAKGSKAGYIDPISAFAGQLEMLLPRHSTYHIDDMRLSSDGKQIIIT
ATMMGTAINPK

# Drug_Target_142_Reaction:
Not Available

# Drug_Target_142_Signals:
1-40

# Drug_Target_142_Specific_Function:
ADP-ribosylates eukaryotic Rho and Rac proteins on an asparagine residue

# Drug_Target_142_SwissProt_ID:
P15879

# Drug_Target_142_SwissProt_Name:
ARC3_CBDP

# Drug_Target_142_Synonyms:
EC 2.4.2.-
Exoenzyme C3
Mono-ADP-ribosyltransferase C3 precursor

# Drug_Target_142_Theoretical_pI:
10.20

# Drug_Target_142_Transmembrane_Regions:
None

# Drug_Target_143_Cellular_Location:
Secreted (Potential)

# Drug_Target_143_Chromosome_Location:
1

# Drug_Target_143_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_143_Essentiality:
Non-Essential

# Drug_Target_143_GenAtlas_ID:
Not Available

# Drug_Target_143_GenBank_ID_Gene:
BC000663

# Drug_Target_143_GenBank_ID_Protein:
34809552

# Drug_Target_143_GeneCard_ID:
DHRS4L2

# Drug_Target_143_Gene_Name:
DHRS4L2

# Drug_Target_143_Gene_Sequence:
>693 bp
ATGGCCAGGCTGCTAGGCCTCTGTGCCTGGGCACGGAAGTCGGTGCGGTTGGCCAGCTCC
AGGATGACCCGCCGGGACCCGCTCACAAATAAGGTGGCCCTGGTAACGGCCTCCACCGAC
GGGATCGGCTTCGCCATCGCCCGGCGTTTGGCCCAGGACAGGGCCCACGTGGTCGTCAGC
AGCCGGAAGCAGCAGAATGTGGACCAGGCGGTGGCCACGCTGCAGGGGGAGGGGCTGAGC
GTGACGGGCACTGTGTGCCATGTGGGGAAGGCGGAGGACCGGGAGCGGCTGGTGGCCATG
GCTGTGAAGCTTCATGGAGGTATCGATATCCTAGTCTCCAATGCTGCTGTCAACCCTTTC
TTTGGAAGCCTAATGGATGTCACCGAGGAGGTGTGGGACAAGACTCTGGACATTAATGTG
AAGGCCCCAGCCCTGATGACAAAGGCAGTGGTGCCAGAAATGGAGAAACGAGGAGGCGGC
TCAGTGGTGATCGTGTCTTCCATAGCAGCCTTCAGTCCATCTCCTGGCTTCAGTCCTTAC
AATGTCAGTAAAACAGCCTTGCTGGGCCTCAACAATACCCTGGCCATAGAGCTGGCCCCA
AGGAACATTAGGGTGAACTGCCTGCACCTGGACTTATCAAGACTAGCTTCAGCAGGATGC
TCTGGATGGACAAGGAAAAAGAGGAAAGCATGA

# Drug_Target_143_General_Function:
Lipid transport and metabolism

# Drug_Target_143_General_References:
15489334	Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.
16204458	Hiller M, Huse K, Platzer M, Backofen R: Non-EST based prediction of exon skipping and intron retention events using Pfam information. Nucleic Acids Res. 2005 Oct 4;33(17):5611-21. Print 2005.

# Drug_Target_143_HGNC_ID:
GNC:19731

# Drug_Target_143_HPRD_ID:
Not Available

# Drug_Target_143_ID:
6698

# Drug_Target_143_Locus:
14q11.2

# Drug_Target_143_Molecular_Weight:
24585.3

# Drug_Target_143_Name:
Dehydrogenase/reductase SDR family member 4-like 2

# Drug_Target_143_Number_of_Residues:
230

# Drug_Target_143_PDB_ID:
Not Available

# Drug_Target_143_Pathway:
Not Available

# Drug_Target_143_Pfam_Domain_Function:
PF00106	adh_short

# Drug_Target_143_Protein_Sequence:
>Dehydrogenase/reductase SDR family member 4-like 2
MARLLGLCAWARKSVRLASSRMTRRDPLTNKVALVTASTDGIGFAIARRLAQDRAHVVVS
SRKQQNVDQAVATLQGEGLSVTGTVCHVGKAEDRERLVAMAVKLHGGIDILVSNAAVNPF
FGSLMDVTEEVWDKTLDINVKAPALMTKAVVPEMEKRGGGSVVIVSSIAAFSPSPGFSPY
NVSKTALLGLNNTLAIELAPRNIRVNCLHLDLSRLASAGCSGWTRKKRKA

# Drug_Target_143_Reaction:
Not Available

# Drug_Target_143_Signals:
1-20

# Drug_Target_143_Specific_Function:
Probable oxidoreductase (By similarity)

# Drug_Target_143_SwissProt_ID:
Q6PKH6

# Drug_Target_143_SwissProt_Name:
DR4L2_HUMAN

# Drug_Target_143_Synonyms:
Not Available

# Drug_Target_143_Theoretical_pI:
10.84

# Drug_Target_143_Transmembrane_Regions:
None

# Drug_Target_14_Cellular_Location:
Not Available

# Drug_Target_14_Chromosome_Location:
Not Available

# Drug_Target_14_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_14_Essentiality:
Non-Essential

# Drug_Target_14_GenAtlas_ID:
Not Available

# Drug_Target_14_GenBank_ID_Gene:
U00096

# Drug_Target_14_GenBank_ID_Protein:
1787715

# Drug_Target_14_GeneCard_ID:
Not Available

# Drug_Target_14_Gene_Name:
prr

# Drug_Target_14_Gene_Sequence:
>1425 bp
ATGCAACATAAGTTACTGATTAACGGAGAACTGGTTAGCGGCGAAGGGGAAAAACAGCCT
GTCTATAATCCGGCAACGGGGGACGTTTTACTGGAAATTGCCGAGGCATCCGCAGAGCAG
GTCGATGCTGCTGTGCGCGCGGCAGATGCAGCATTTGCCGAATGGGGGCAAACCACGCCG
AAAGTGCGTGCGGAATGTCTGCTGAAACTGGCTGATGTTATCGAAGAAAATGGTCAGGTT
TTTGCCGAACTGGAGTCCCGTAATTGTGGCAAACCGCTGCATAGTGCGTTCAATGATGAA
ATCCCGGCGATTGTCGATGTTTTTCGCTTTTTCGCGGGTGCGGCGCGCTGTCTGAATGGT
CTGGCGGCAGGTGAATATCTTGAAGGTCATACTTCGATGATCCGTCGCGATCCGTTGGGG
GTCGTGGCTTCTATCGCACCGTGGAATTATCCGCTGATGATGGCCGCGTGGAAACTTGCT
CCGGCGCTGGCGGCAGGGAACTGCGTAGTGCTTAAACCATCAGAAATTACCCCGCTGACC
GCGTTGAAGTTGGCAGAGCTGGCGAAAGATATCTTCCCGGCAGGCGTGATTAACATACTG
TTTGGCAGAGGCAAAACGGTGGGTGATCCGCTGACCGGTCATCCCAAAGTGCGGATGGTG
TCGCTGACGGGCTCTATCGCCACCGGCGAGCACATCATCAGCCATACCGCGTCGTCCATT
AAGCGTACTCATATGGAACTTGGTGGCAAAGCGCCAGTGATTGTTTTTGATGATGCGGAT
ATTGAAGCAGTGGTCGAAGGTGTACGTACATTTGGCTATTACAATGCTGGACAGGATTGT
ACTGCGGCTTGTCGGATCTACGCGCAAAAAGGCATTTACGATACGCTGGTGGAAAAACTG
GGTGCTGCGGTGGCAACGTTAAAATCTGGTGCGCCAGATGACGAGTCTACGGAGCTTGGA
CCTTTAAGCTCGCTGGCGCATCTCGAACGCGTCGGCAAGGCAGTAGAAGAGGCGAAAGCG
ACAGGGCACATCAAAGTGATCACTGGCGGTGAAAAGCGCAAGGGTAATGGCTATTACTAT
GCGCCGACGCTGCTGGCTGGCGCATTACAGGACGATGCCATCGTGCAAAAAGAGGTATTT
GGTCCAGTAGTGAGTGTTACGCCCTTCGACAACGAAGAACAGGTGGTGAACTGGGCGAAT
GACAGCCAGTACGGACTTGCATCTTCGGTATGGACGAAAGATGTGGGCAGGGCGCATCGC
GTCAGCGCACGGCTGCAATATGGTTGTACCTGGGTCAATACCCATTTCATGCTGGTAAGT
GAAATGCCGCACGGTGGGCAGAAACTTTCTGGTTACGGCAAGGATATGTCACTTTATGGG
CTGGAGGATTACACCGTCGTCCGCCACGTCATGGTTAAACATTAA

# Drug_Target_14_General_Function:
Energy production and conversion

# Drug_Target_14_General_References:
9097039	Aiba H, Baba T, Hayashi K, Inada T, Isono K, Itoh T, Kasai H, Kashimoto K, Kimura S, Kitakawa M, Kitagawa M, Makino K, Miki T, Mizobuchi K, Mori H, Mori T, Motomura K, Nakade S, Nakamura Y, Nashimoto H, Nishio Y, Oshima T, Saito N, Sampei G, Horiuchi T, et al.: A 570-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 28.0-40.1 min region on the linkage map. DNA Res. 1996 Dec 31;3(6):363-77.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_14_HGNC_ID:
Not Available

# Drug_Target_14_HPRD_ID:
Not Available

# Drug_Target_14_ID:
2881

# Drug_Target_14_Locus:
Not Available

# Drug_Target_14_Molecular_Weight:
50830

# Drug_Target_14_Name:
Gamma-aminobutyraldehyde dehydrogenase

# Drug_Target_14_Number_of_Residues:
474

# Drug_Target_14_PDB_ID:
1WND

# Drug_Target_14_Pathway:
Not Available

# Drug_Target_14_Pfam_Domain_Function:
PF00171	Aldedh

# Drug_Target_14_Protein_Sequence:
>Gamma-aminobutyraldehyde dehydrogenase
MQHKLLINGELVSGEGEKQPVYNPATGDVLLEIAEASAEQVDAAVRAADAAFAEWGQTTP
KVRAECLLKLADVIEENGQVFAELESRNCGKPLHSAFNDEIPAIVDVFRFFAGAARCLNG
LAAGEYLEGHTSMIRRDPLGVVASIAPWNYPLMMAAWKLAPALAAGNCVVLKPSEITPLT
ALKLAELAKDIFPAGVINILFGRGKTVGDPLTGHPKVRMVSLTGSIATGEHIISHTASSI
KRTHMELGGKAPVIVFDDADIEAVVEGVRTFGYYNAGQDCTAACRIYAQKGIYDTLVEKL
GAAVATLKSGAPDDESTELGPLSSLAHLERVGKAVEEAKATGHIKVITGGEKRKGNGYYY
APTLLAGALQDDAIVQKEVFGPVVSVTPFDNEEQVVNWANDSQYGLASSVWTKDVGRAHR
VSARLQYGCTWVNTHFMLVSEMPHGGQKLSGYGKDMSLYGLEDYTVVRHVMVKH

# Drug_Target_14_Reaction:
Not Available

# Drug_Target_14_Signals:
None

# Drug_Target_14_Specific_Function:
Catalyzes the oxidation of 1-pyrroline, which is spontaneously formed from 4-aminobutanal, leading to 4- aminobutanoate (GABA). Can also oxidize n-alkyl medium-chain aldehydes, but with a lower catalytic efficiency

# Drug_Target_14_SwissProt_ID:
P77674

# Drug_Target_14_SwissProt_Name:
ABDH_ECOLI

# Drug_Target_14_Synonyms:
1-pyrroline dehydrogenase
4-aminobutanal dehydrogenase
ABALDH
EC 1.5.1.35

# Drug_Target_14_Theoretical_pI:
5.89

# Drug_Target_14_Transmembrane_Regions:
None

# Drug_Target_15_Cellular_Location:
Not Available

# Drug_Target_15_Chromosome_Location:
Not Available

# Drug_Target_15_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_15_Essentiality:
Non-Essential

# Drug_Target_15_GenAtlas_ID:
Not Available

# Drug_Target_15_GenBank_ID_Gene:
X66723

# Drug_Target_15_GenBank_ID_Protein:
43997

# Drug_Target_15_GeneCard_ID:
Not Available

# Drug_Target_15_Gene_Name:
Not Available

# Drug_Target_15_Gene_Sequence:
>1014 bp
ATGACAAAGGTTTTTGCTTACGCTATTCGAAAAGACGAAGAACCATTCTTGAATGAATGG
AAGGAAGCTCACAAGGATATCGATGTTGATTACACTGATAAGCTTTTGACTCCTGAAACT
GCTAAGCTAGCTAAGGGTGCTGACGGTGTTGTTGTTTACCAACAATTAGACTACACTGCA
GATACTCTTCAAGCTTTAGCAGACGCTGGCGTAACTAAGATGTCATTACGTAACGTTGGT
GTTGACAACATTGATATGGACAAGGCTAAGGAATTAGGTTTCCAAATTACCAATGTTCCT
GTTTACTCACCAAACGCTATTGCTGAACATGCTGCTATTCAAGCTGCACGTGTATTACGT
CAAGACAAGCGCATGGACGAAAAGATGGCTAAACGTGACTTACGTTGGGCACCAACTATC
GGCCGTGAAGTTCGTGACCAAGTTGTCGGTGTTGTTGGTACCGGTCACATTGGTCAAGTA
TTTATGCGTATTATGGAAGGTTTCGGCGCAAAGGTTATTGCTTACGATATCTTCAAGAAC
CCAGAACTTGAAAAGAAGGGTTACTACGTTGACTCACTTGACGACTTGTACAAGCAAGCT
GATGTAATTTCACTTCACGTACCAGATGTTCCAGCTAACGTTCACATGATCAACGACAAG
TCAATCGCTGAAATGAAAGACGGCGTTGTAATTGTAAACTGCTCACGTGGTCGACTTGTT
GACACTGACGCTGTAATCCGTGGTTTGGACTCAGGCAAGATCTTCGGCTTCGTTATGGAT
ACTTACGAAGACGAAGTTGGTGTATTTAACAAGGATTGGGAAGGTAAAGAATTCCCAGAC
AAGCGTTTGGCAGACTTAATTGATCGTCCAAACGTATTGGTAACTCCACACACCGCCTTC
TACACTACTCACGCTGTACGTAACATGGTTGTTAAGGCATTCAACAACAACTTGAAGTTA
ATCAACGGCGAAAAGCCAGATTCTCCAGTTGCTTTGAACAAGAACAAGTTTTAA

# Drug_Target_15_General_Function:
Energy production and conversion

# Drug_Target_15_General_References:
1396685	Kochhar S, Hottinger H, Chuard N, Taylor PG, Atkinson T, Scawen MD, Nicholls DJ: Cloning and overexpression of Lactobacillus helveticus D-lactate dehydrogenase gene in Escherichia coli. Eur J Biochem. 1992 Sep 15;208(3):799-805.
7765104	Bhowmik T, Steele JL: Cloning, characterization and insertional inactivation of the Lactobacillus helveticus D(-) lactate dehydrogenase gene. Appl Microbiol Biotechnol. 1994 Jun;41(4):432-9.

# Drug_Target_15_HGNC_ID:
Not Available

# Drug_Target_15_HPRD_ID:
Not Available

# Drug_Target_15_ID:
3545

# Drug_Target_15_Locus:
Not Available

# Drug_Target_15_Molecular_Weight:
37780

# Drug_Target_15_Name:
D-lactate dehydrogenase

# Drug_Target_15_Number_of_Residues:
337

# Drug_Target_15_PDB_ID:
2DLD

# Drug_Target_15_Pathway:
Not Available

# Drug_Target_15_Pfam_Domain_Function:
PF00389	2-Hacid_dh
PF02826	2-Hacid_dh_C

# Drug_Target_15_Protein_Sequence:
>D-lactate dehydrogenase
MTKVFAYAIRKDEEPFLNEWKEAHKDIDVDYTDKLLTPETAKLAKGADGVVVYQQLDYTA
DTLQALADAGVTKMSLRNVGVDNIDMDKAKELGFQITNVPVYSPNAIAEHAAIQAARVLR
QDKRMDEKMAKRDLRWAPTIGREVRDQVVGVVGTGHIGQVFMRIMEGFGAKVIAYDIFKN
PELEKKGYYVDSLDDLYKQADVISLHVPDVPANVHMINDKSIAEMKDGVVIVNCSRGRLV
DTDAVIRGLDSGKIFGFVMDTYEDEVGVFNKDWEGKEFPDKRLADLIDRPNVLVTPHTAF
YTTHAVRNMVVKAFNNNLKLINGEKPDSPVALNKNKF

# Drug_Target_15_Reaction:
(R)-lactate + NAD+ = pyruvate + NADH + H+

# Drug_Target_15_Signals:
None

# Drug_Target_15_Specific_Function:
(R)-lactate + NAD(+) = pyruvate + NADH

# Drug_Target_15_SwissProt_ID:
P30901

# Drug_Target_15_SwissProt_Name:
LDHD_LACHE

# Drug_Target_15_Synonyms:
D-LDH
D-specific D-2- hydroxyacid dehydrogenase
EC 1.1.1.28

# Drug_Target_15_Theoretical_pI:
5.70

# Drug_Target_15_Transmembrane_Regions:
None

# Drug_Target_16_Cellular_Location:
Cytoplasm (Probable)

# Drug_Target_16_Chromosome_Location:
Not Available

# Drug_Target_16_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_16_Essentiality:
Non-Essential

# Drug_Target_16_GenAtlas_ID:
Not Available

# Drug_Target_16_GenBank_ID_Gene:
BX571856

# Drug_Target_16_GenBank_ID_Protein:
49241783

# Drug_Target_16_GeneCard_ID:
Not Available

# Drug_Target_16_Gene_Name:
aroB

# Drug_Target_16_Gene_Sequence:
>1065 bp
CTACTTAAAATATGTTTTTAATTGTTCACATGCATGTTGTAATGTTAGTTGATCAACATG
TTGTACAACGATATCTCCAAATTGTCTAATCAAGACCATTTGTACACCTTGCTTATCATT
CTTTTTATCACTTAGCATATATTGGTATAACGTTTCAAAATCCAAGTCAGTTATCATGTC
TAAAGGATAGCCAAGTTGTATTAAATATTGAATATAATGATTAATATCATGCTTAGAATC
AAATAAAGCATTCGCAACTATAAATTGATAGATAATGCCAACCATCACTGCATGACCATG
TGGTATTTTATGATAGTATTCAACAGCATGCCCAAATGTATGACCTAAATTTAAAAATTT
ACGTACACCTTGTTCTTTTTCATCTGCAACAACAATATCTAGCTTCGTTTCAATACCTTT
AGCAATATATTTATCCATACCTTTTAATGACTGTAATATCTCTCTATCTTTAAAGTGCTG
TTCGATATCTTGCGTCGCTGATTCACCATTCAATAACGCATGCTTATAAACTTCTGCATA
GCCACTTAATATTTGCTCAAATGGTAACGTCTTTAAAAAGTCTAAATCATAAATAACAGC
AGTTGGACGATAAAATGCACCGATAAGGTTTTTACCTTGCTTTGAGTTAATACCCACTTT
ACCGCCAACACTAGAATCATGCGCCAAAATCGTTGTGGGAACTTGTATAAAATGGACACC
TCTTAATAGTGTTGCTGCTACAAATCCTGCAAAATCTCCTGTCGCACCACCACCAACAGC
TATAATCGCTGTATTACGTGTTACATGATGAGACAAAATGTATTCTAATGTTTCTTGATA
TTGCTCAAATGTTTTCGTCTTTTCACCAGCTGGAATAATGACTTTATGCACATTTTCATA
TGATAAAATATCATTAAATTTATCAGCAAAATATTGATTTACATGCTCGTCAATTAATAT
AAAACTTTGATCAAACTGATCAATATACGTGCTAATATGGTCAATTGCACCATGTTCAAC
AAATATTGGATAATTGTTTGAAGGATAGGTTGTTTGTAATTTCAT

# Drug_Target_16_General_Function:
Amino acid transport and metabolism

# Drug_Target_16_General_References:
Not Available

# Drug_Target_16_HGNC_ID:
Not Available

# Drug_Target_16_HPRD_ID:
Not Available

# Drug_Target_16_ID:
3081

# Drug_Target_16_Locus:
Not Available

# Drug_Target_16_Molecular_Weight:
40285

# Drug_Target_16_Name:
3-dehydroquinate synthase

# Drug_Target_16_Number_of_Residues:
354

# Drug_Target_16_PDB_ID:
1XAL

# Drug_Target_16_Pathway:
Not Available

# Drug_Target_16_Pfam_Domain_Function:
PF01761	DHQ_synthase

# Drug_Target_16_Protein_Sequence:
>3-dehydroquinate synthase
MKLQTTYPSNNYPIFVEHGAIDHISTYIDQFDQSFILIDEHVNQYFADKFNDILSYENVH
KVIIPAGEKTKTFEQYQETLEYILSHHVTRNTAIIAVGGGATGDFAGFVAATLLRGVHFI
QVPTTILAHDSSVGGKVGINSKQGKNLIGAFYRPTAVIYDLDFLKTLPFEQILSGYAEVY
KHALLNGESATQDIEQHFKDREILQSLKGMDKYIAKGIETKLDIVVADEKEQGVRKFLNL
GHTFGHAVEYYHKIPHGHAVMVGIIYQFIVANALFDSKHDINHYIQYLIQLGYPLDMITD
LDFETLYQYMLSDKKNDKQGVQMVLIRQFGDIVVQHVDQLTLQHACEQLKTYFK

# Drug_Target_16_Reaction:
3-deoxy-arabino-heptulonate 7-phosphate = 3-dehydroquinate + phosphate

# Drug_Target_16_Signals:
None

# Drug_Target_16_Specific_Function:
3-deoxy-arabino-heptulonate 7-phosphate = 3- dehydroquinate + phosphate

# Drug_Target_16_SwissProt_ID:
Q6GGU4

# Drug_Target_16_SwissProt_Name:
AROB_STAAR

# Drug_Target_16_Synonyms:
EC 4.2.3.4

# Drug_Target_16_Theoretical_pI:
6.29

# Drug_Target_16_Transmembrane_Regions:
None

# Drug_Target_17_Cellular_Location:
Not Available

# Drug_Target_17_Chromosome_Location:
Not Available

# Drug_Target_17_Drug_References:
Not Available

# Drug_Target_17_Essentiality:
Non-Essential

# Drug_Target_17_GenAtlas_ID:
Not Available

# Drug_Target_17_GenBank_ID_Gene:
AE008363

# Drug_Target_17_GenBank_ID_Protein:
Not Available

# Drug_Target_17_GeneCard_ID:
Not Available

# Drug_Target_17_Gene_Name:
AGR_L_3209

# Drug_Target_17_Gene_Sequence:
>1077 bp
ATGGCGCACGGTAACGAAAAGGCCACTGTTCTGGCGAGGCTGGACGAGTTGGAGCGGTTC
TGCCGCGCCGTTTTTCTGGCCGTCGGCACCGATGAGGAAACGGCCGATGCGGCGACCCGC
GCCATGATGCACGGCACAAGGCTCGGCGTGGACAGCCATGGCGTGCGCCTGCTTGCCCAT
TATGTCACGGCCCTTGAAGGCGGGCGCCTCAATCGGCGGCCGCAGATCAGCCGCGTGTCC
GGTTTCGGTGCCGTGGAAACGATCGATGCCGATCATGCCCATGGCGCCCGCGCCACCTAT
GCGGCCATGGAGAATGCCATGGCGCTTGCGGAAAAATTCGGCATTGGCGCGGTGGCGATC
CGCAACTCCTCGCATTTCGGCCCGGCCGGCGCTTATGCGCTGGAAGCGGCCCGGCAGGGT
TATATCGGCCTTGCCTTCTGCAATTCGGACAGTTTCGTGCGTCTGCATGATGGTGCCATG
CGGTTTCACGGCACCAACCCGATTGCCGTCGGTGTGCCGGCAGCGGATGACATGCCCTGG
CTGCTGGATATGGCCACAAGCGCCGTGCCCTATAACCGTGTTCTGCTATACCGCAGCCTC
GGCCAGCAACTGCCGCAAGGCGTCGCCTCGGATGGCGACGGCGTCGATACGCGCGACCCC
AATGCCGTCGAGATGCTTGCCCCCGTTGGCGGTGAATTCGGTTTCAAGGGGGCGGCGCTG
GCGGGAGTGGTCGAGATTTTCAGCGCAGTTCTCACCGGCATGAGGCTCAGTTTCGATCTC
GCCCCCATGGGCGGGCCGGATTTTTCAACGCCGCGTGGGCTTGGAGCCTTCGTGCTGGCG
CTGAAGCCGGAGGCCTTCCTGGAGCGGGACGTGTTCGACGAGAGCATGAAACGTTATCTC
GAAGTGCTGCGCGGATCACCCGCCCGCGAAGATTGCAAGGTCATGGCGCCGGGCGACCGG
GAATGGGCGGTTGCGGCAAAACGGGAGAGGGAAGGCGCGCCGGTCGATCCCGTCACACGG
GCGGCCTTTTCGGAGCTTGCGGAAAAATTCTCGGTCAGCCCACCCACCTATCATTAA

# Drug_Target_17_General_Function:
Involved in oxidoreductase activity

# Drug_Target_17_General_References:
11743194	Goodner B, Hinkle G, Gattung S, Miller N, Blanchard M, Qurollo B, Goldman BS, Cao Y, Askenazi M, Halling C, Mullin L, Houmiel K, Gordon J, Vaudin M, Iartchouk O, Epp A, Liu F, Wollam C, Allinger M, Doughty D, Scott C, Lappas C, Markelz B, Flanagan C, Crowell C, Gurson J, Lomo C, Sear C, Strub G, Cielo C, Slater S: Genome sequence of the plant pathogen and biotechnology agent Agrobacterium tumefaciens C58. Science. 2001 Dec 14;294(5550):2323-8.

# Drug_Target_17_HGNC_ID:
Not Available

# Drug_Target_17_HPRD_ID:
Not Available

# Drug_Target_17_ID:
4418

# Drug_Target_17_Locus:
Not Available

# Drug_Target_17_Molecular_Weight:
38253

# Drug_Target_17_Name:
AGR_L_3209p

# Drug_Target_17_Number_of_Residues:
358

# Drug_Target_17_PDB_ID:
1Z2I

# Drug_Target_17_Pathway:
Not Available

# Drug_Target_17_Pfam_Domain_Function:
PF02615	Ldh_2

# Drug_Target_17_Protein_Sequence:
>AGR_L_3209p
MAHGNEKATVLARLDELERFCRAVFLAVGTDEETADAATRAMMHGTRLGVDSHGVRLLAH
YVTALEGGRLNRRPQISRVSGFGAVETIDADHAHGARATYAAMENAMALAEKFGIGAVAI
RNSSHFGPAGAYALEAARQGYIGLAFCNSDSFVRLHDGAMRFHGTNPIAVGVPAADDMPW
LLDMATSAVPYNRVLLYRSLGQQLPQGVASDGDGVDTRDPNAVEMLAPVGGEFGFKGAAL
AGVVEIFSAVLTGMRLSFDLAPMGGPDFSTPRGLGAFVLALKPEAFLERDVFDESMKRYL
EVLRGSPAREDCKVMAPGDREWAVAAKREREGAPVDPVTRAAFSELAEKFSVSPPTYH

# Drug_Target_17_Reaction:
Not Available

# Drug_Target_17_Signals:
None

# Drug_Target_17_Specific_Function:
Not Available

# Drug_Target_17_SwissProt_ID:
Q7CRW4

# Drug_Target_17_SwissProt_Name:
Q7CRW4_AGRT5

# Drug_Target_17_Synonyms:
Not Available

# Drug_Target_17_Theoretical_pI:
5.81

# Drug_Target_17_Transmembrane_Regions:
None

# Drug_Target_18_Cellular_Location:
Cytoplasm

# Drug_Target_18_Chromosome_Location:
Not Available

# Drug_Target_18_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_18_Essentiality:
Non-Essential

# Drug_Target_18_GenAtlas_ID:
Not Available

# Drug_Target_18_GenBank_ID_Gene:
M10611

# Drug_Target_18_GenBank_ID_Protein:
145710

# Drug_Target_18_GeneCard_ID:
Not Available

# Drug_Target_18_Gene_Name:
dapB

# Drug_Target_18_Gene_Sequence:
>822 bp
ATGCATGATGCAAACATCCGCGTTGCCATCGCGGGAGCCGGGGGGCGTATGGGCCGCCAG
TTGATTCAGGCGGCGCTGGCATTAGAGGGCGTGCAGTTGGGCGCTGCGCTGGAGCGTGAA
GGATCTTCTTTACTGGGCAGCGACGCCGGTGAGCTGGCCGGAGCCGGGAAAACAGGCGTT
ACCGTGCAAAGCAGCCTCGATGCGGTAAAAGATGATTTTGATGTGTTTATCGATTTTACC
CGTCCGGAAGGTACGCTGAACCATCTCGCTTTTTGTCGCCAGCATGGCAAAGGGATGGTG
ATCGGCACTACGGGGTTTGACGAAGCCGGTAAACAAGCAATTCGTGACGCCGCTGCCGAT
ATTGCGATTGTCTTTGCGGCCAATTTTAGCGTTGGCGTTAACGTCATGCTTAAGCTGCTG
GAGAAAGCAGCCAAAGTGATGGGTGACTACACCGATATCGAAATTATTGAAGCACATCAT
AGACATAAAGTTGATGCGCCGTCAGGCACCGCACTGGCAATGGGAGAGGCGATCGCCCAC
GCCCTTGATAAAGATCTGAAAGATTGCGCGGTCTACAGTCGTGAAGGCCACACCGGTGAA
CGTGTGCCTGGCACCATTGGTTTTGCCACCGTGCGTGCAGGTGACATCGTTGGTGAACAT
ACCGCGATGTTTGCCGATATTGGCGAGCGTCTGGAGATCACCCATAAGGCGTCCAGCCGT
ATGACATTTGCTAACGGCGCGGTAAGATCGGCTTTGTGGTTGAGTGGTAAGGAAAGCGGT
CTTTTTGATATGCGAGATGTACTTGATCTCAATAATTTGTAA

# Drug_Target_18_General_Function:
Amino acid transport and metabolism

# Drug_Target_18_General_References:
1630901	Yura T, Mori H, Nagai H, Nagata T, Ishihama A, Fujita N, Isono K, Mizobuchi K, Nakata A: Systematic sequencing of the Escherichia coli genome: analysis of the 0-2.4 min region. Nucleic Acids Res. 1992 Jul 11;20(13):3305-8.
6094578	Bouvier J, Richaud C, Richaud F, Patte JC, Stragier P: Nucleotide sequence and expression of the Escherichia coli dapB gene. J Biol Chem. 1984 Dec 10;259(23):14829-34.
6377309	Bouvier J, Patte JC, Stragier P: Multiple regulatory signals in the control region of the Escherichia coli carAB operon. Proc Natl Acad Sci U S A. 1984 Jul;81(13):4139-43.
7893645	Scapin G, Blanchard JS, Sacchettini JC: Three-dimensional structure of Escherichia coli dihydrodipicolinate reductase. Biochemistry. 1995 Mar 21;34(11):3502-12.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9398235	Scapin G, Reddy SG, Zheng R, Blanchard JS: Three-dimensional structure of Escherichia coli dihydrodipicolinate reductase in complex with NADH and the inhibitor 2,6-pyridinedicarboxylate. Biochemistry. 1997 Dec 9;36(49):15081-8.

# Drug_Target_18_HGNC_ID:
Not Available

# Drug_Target_18_HPRD_ID:
Not Available

# Drug_Target_18_ID:
3618

# Drug_Target_18_Locus:
Not Available

# Drug_Target_18_Molecular_Weight:
28757

# Drug_Target_18_Name:
Dihydrodipicolinate reductase

# Drug_Target_18_Number_of_Residues:
273

# Drug_Target_18_PDB_ID:
1DRW

# Drug_Target_18_Pathway:
Not Available

# Drug_Target_18_Pfam_Domain_Function:
PF01113	DapB_N
PF05173	DapB_C

# Drug_Target_18_Protein_Sequence:
>Dihydrodipicolinate reductase
MHDANIRVAIAGAGGRMGRQLIQAALALEGVQLGAALEREGSSLLGSDAGELAGAGKTGV
TVQSSLDAVKDDFDVFIDFTRPEGTLNHLAFCRQHGKGMVIGTTGFDEAGKQAIRDAAAD
IAIVFAANFSVGVNVMLKLLEKAAKVMGDYTDIEIIEAHHRHKVDAPSGTALAMGEAIAH
ALDKDLKDCAVYSREGHTGERVPGTIGFATVRAGDIVGEHTAMFADIGERLEITHKASSR
MTFANGAVRSALWLSGKESGLFDMRDVLDLNNL

# Drug_Target_18_Reaction:
(S)-2,3,4,5-tetrahydropyridine-2,6-dicarboxylate + NAD(P)+ = 2,3-dihydrodipicolinate + NAD(P)H + H+

# Drug_Target_18_Signals:
None

# Drug_Target_18_Specific_Function:
2,3,4,5-tetrahydrodipicolinate + NAD(P)(+) = 2,3-dihydrodipicolinate + NAD(P)H

# Drug_Target_18_SwissProt_ID:
P04036

# Drug_Target_18_SwissProt_Name:
DAPB_ECOLI

# Drug_Target_18_Synonyms:
DHPR
EC 1.3.1.26

# Drug_Target_18_Theoretical_pI:
5.55

# Drug_Target_18_Transmembrane_Regions:
None

# Drug_Target_19_Cellular_Location:
Mitochondrion
mitochondrial matrix

# Drug_Target_19_Chromosome_Location:
Not Available

# Drug_Target_19_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_19_Essentiality:
Non-Essential

# Drug_Target_19_GenAtlas_ID:
GLUD1

# Drug_Target_19_GenBank_ID_Gene:
X07674

# Drug_Target_19_GenBank_ID_Protein:
31707

# Drug_Target_19_GeneCard_ID:
GLUD1

# Drug_Target_19_Gene_Name:
GLUD1

# Drug_Target_19_Gene_Sequence:
>1677 bp
ATGTACCGCTACCTGGGCGAAGCGCTGTTGCTGTCCCGGGCCGGGCCCGCTGCCCTGGGC
TCGGCGTCCGCCGACTCGGCCGCGTTGCTGGGCTGGGCCCGGGGACAGCCCGCCGCCGCC
CCGCAGCCGGGGCTGGCATTGGCCGCCCGGCGCCACTACAGCGAGGCGGTGGCCGACCGC
GAGGACGACCCCAACTTCTTCAAGATGGTGGAGGGCTTCTTCGATCGCGGCGCCAGCATC
GTGGAGGACAAGCTGGTGGAGGACCTGAGGACCCGGGAGAGCGAGGAGCAGAAGCGGAAC
CGGGTGCGCGGCATCCTGCGGATCATCAAGCCCTGCAACCATGTGCTGAGTCTCTCCTTC
CCCATCCGGCGCGACGACGGCTCCTGGGAGGTCATCGAAGGCTACCGGGCCCAGCACAGC
CAGCACCGCACGCCCTGCAAGGGAGGTATCCGTTACAGCACTGATGTGAGTGTAGATGAA
GTAAAAGCTTTGGCTTCTCTGATGACATACAAGTGTGCAGTGGTTGATGTGCCGTTTGGG
GGTGCTAAAGCTGGTGTTAAGATCAATCCCAAGAACTATACTGATAATGAATTGGAAAAG
ATCACAAGGAGGTTCACCATGGAGCTAGCAAAAAAGGGCTTTATTGGTCCTGGCATTGAT
GTGCCTGCTCCAGACATGAGCACAGGTGAGCGGGAGATGTCCTGGATCGCTGATACCTAT
GCCAGCACCATAGGGCACTATGATATTAATGCACACGCCTGTGTTACTGGTAAACCCATC
AGCCAAGGGGGAATCCATGGACGCATCTCTGCTACTGGCCGTGGTGTCTTCCATGGGATT
GAAAATTTCATCAATGAAGCTTCTTACATGAGCATTTTAGGAATGACACCAGGGTTTGGA
GATAAAACATTTGTTGTTCAGGGATTTGGTAATGTGGGCCTACACTCTATGAGATATTTA
CATCGTTTTGGTGCTAAATGTATTGCTGTTGGTGAGTCTGATGGGAGTATATGGAATCCA
GATGGTATTGACCCAAAGGAACTGGAAGACTTCAAATTGCAACATGGGTCCATTCTGGGC
TTCCCCAAGGCAAAGCCCTATGAAGGAAGCATCTTGGAGGCCGACTGTGACATACTGATC
CCAGCTGCCAGTGAGAAGCAGTTGACCAAATCCAACGCACCCAGAGTCAAAGCCAAGATC
ATTGCTGAAGGTGCCAATGGGCCAACAACTCCAGAAGCTGACAAGATCTTCCTGGAGAGA
AACATTATGGTTATTCCAGATCTCTACTTGAATGCTGGAGGAGTGACAGTATCTTACTTT
GAGTGGCTGAAGAATCTAAATCATGTCAGCTATGGCCGTTTGACCTTCAAATATGAAAGG
GATTCTAACTACCACTTGCTCATGTCTGTTCAAGAGAGTTTAGAAAGAAAATTTGGAAAG
CATGGTGGAACTATTCCCATTGTACCCACGGCAGAGTTCCAAGACAGGATATCGGGTGCA
TCTGAGAAAGACATCGTGCACTCTGGCTTGGCATACACAATGGAGCGTTCTGCCAGGCAA
ATTATGCGCACAGCCATGAAGTATAACCTGGGATTGGACCTGAGAACAGCTGCCTATGTT
AATGCCATTGAGAAAGTCTTCAAAGTGTACAATGAAGCTGGTGTGACCTTCACATAG

# Drug_Target_19_General_Function:
Replication, recombination and repair

# Drug_Target_19_General_References:
10338089	Meissner T, Beinbrech B, Mayatepek E: Congenital hyperinsulinism: molecular basis of a heterogeneous disease. Hum Mutat. 1999;13(5):351-61.
10636977	Miki Y, Taki T, Ohura T, Kato H, Yanagisawa M, Hayashi Y: Novel missense mutations in the glutamate dehydrogenase gene in the congenital hyperinsulinism-hyperammonemia syndrome. J Pediatr. 2000 Jan;136(1):69-72.
11214910	Santer R, Kinner M, Passarge M, Superti-Furga A, Mayatepek E, Meissner T, Schneppenheim R, Schaub J: Novel missense mutations outside the allosteric domain of glutamate dehydrogenase are prevalent in European patients with the congenital hyperinsulinism-hyperammonemia syndrome. Hum Genet. 2001 Jan;108(1):66-71.
11254391	Smith TJ, Peterson PE, Schmidt T, Fang J, Stanley CA: Structures of bovine glutamate dehydrogenase complexes elucidate the mechanism of purine regulation. J Mol Biol. 2001 Mar 23;307(2):707-20.
11297618	MacMullen C, Fang J, Hsu BY, Kelly A, de Lonlay-Debeney P, Saudubray JM, Ganguly A, Smith TJ, Stanley CA: Hyperinsulinism/hyperammonemia syndrome in children with regulatory mutations in the inhibitory guanosine triphosphate-binding domain of glutamate dehydrogenase. J Clin Endocrinol Metab. 2001 Apr;86(4):1782-7.
11903050	Fang J, Hsu BY, MacMullen CM, Poncz M, Smith TJ, Stanley CA: Expression, purification and characterization of human glutamate dehydrogenase (GDH) allosteric regulatory mutations. Biochem J. 2002 Apr 1;363(Pt 1):81-7.
12054821	Smith TJ, Schmidt T, Fang J, Wu J, Siuzdak G, Stanley CA: The structure of apo human glutamate dehydrogenase details subunit communication and allostery. J Mol Biol. 2002 May 3;318(3):765-77.
12653548	Banerjee S, Schmidt T, Fang J, Stanley CA, Smith TJ: Structural studies on ADP activation of mammalian glutamate dehydrogenase and the evolution of regulation. Biochemistry. 2003 Apr 1;42(12):3446-56.
1286669	Hochstrasser DF, Frutiger S, Paquet N, Bairoch A, Ravier F, Pasquali C, Sanchez JC, Tissot JD, Bjellqvist B, Vargas R, et al.: Human liver protein map: a reference database established by microsequencing and gel comparison. Electrophoresis. 1992 Dec;13(12):992-1001.
3368458	Mavrothalassitis G, Tzimagiorgis G, Mitsialis A, Zannis V, Plaitakis A, Papamatheakis J, Moschonas N: Isolation and characterization of cDNA clones encoding human liver glutamate dehydrogenase: evidence for a small gene family. Proc Natl Acad Sci U S A. 1988 May;85(10):3494-8.
3377777	Amuro N, Yamaura M, Goto Y, Okazaki T: Molecular cloning and nucleotide sequence of the cDNA for human liver glutamate dehydrogenase precursor. Biochem Biophys Res Commun. 1988 May 16;152(3):1395-400.
3399399	Nakatani Y, Schneider M, Banner C, Freese E: Complete nucleotide sequence of human glutamate dehydrogenase cDNA. Nucleic Acids Res. 1988 Jul 11;16(13):6237.
3426581	Nakatani Y, Banner C, von Herrath M, Schneider ME, Smith HH, Freese E: Comparison of human brain and liver glutamate dehydrogenase cDNAS. Biochem Biophys Res Commun. 1987 Dec 16;149(2):405-10.
3585334	Banner C, Silverman S, Thomas JW, Lampel KA, Vitkovic L, Huie D, Wenthold RJ: Isolation of a human brain cDNA for glutamate dehydrogenase. J Neurochem. 1987 Jul;49(1):246-52.
429360	Julliard JH, Smith EL: Partial amino acid sequence of the glutamate dehydrogenase of human liver and a revision of the sequence of the bovine enzyme. J Biol Chem. 1979 May 10;254(9):3427-38.
8314555	Tzimagiorgis G, Leversha MA, Chroniary K, Goulielmos G, Sargent CA, Ferguson-Smith M, Moschonas NK: Structure and expression analysis of a member of the human glutamate dehydrogenase (GLUD) gene family mapped to chromosome 10p11.2. Hum Genet. 1993 Jun;91(5):433-8.
8486350	Michaelidis TM, Tzimagiorgis G, Moschonas NK, Papamatheakis J: The human glutamate dehydrogenase gene family: gene organization and structural characterization. Genomics. 1993 Apr;16(1):150-60.
9571255	Stanley CA, Lieu YK, Hsu BY, Burlina AB, Greenberg CR, Hopwood NJ, Perlman K, Rich BH, Zammarchi E, Poncz M: Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med. 1998 May 7;338(19):1352-7.

# Drug_Target_19_HGNC_ID:
HGNC:4335

# Drug_Target_19_HPRD_ID:
11748

# Drug_Target_19_ID:
201

# Drug_Target_19_Locus:
10q23.3

# Drug_Target_19_Molecular_Weight:
61399

# Drug_Target_19_Name:
Glutamate dehydrogenase 1, mitochondrial

# Drug_Target_19_Number_of_Residues:
558

# Drug_Target_19_PDB_ID:
1L1F

# Drug_Target_19_Pathway:
Not Available

# Drug_Target_19_Pfam_Domain_Function:
PF00208	ELFV_dehydrog
PF02812	ELFV_dehydrog_N

# Drug_Target_19_Protein_Sequence:
>Glutamate dehydrogenase 1, mitochondrial precursor
MYRYLGEALLLSRAGPAALGSASADSAALLGWARGQPAAAPQPGLALAARRHYSEAVADR
EDDPNFFKMVEGFFDRGASIVEDKLVEDLRTRESEEQKRNRVRGILRIIKPCNHVLSLSF
PIRRDDGSWEVIEGYRAQHSQHRTPCKGGIRYSTDVSVDEVKALASLMTYKCAVVDVPFG
GAKAGVKINPKNYTDNELEKITRRFTMELAKKGFIGPGIDVPAPDMSTGEREMSWIADTY
ASTIGHYDINAHACVTGKPISQGGIHGRISATGRGVFHGIENFINEASYMSILGMTPGFG
DKTFVVQGFGNVGLHSMRYLHRFGAKCIAVGESDGSIWNPDGIDPKELEDFKLQHGSILG
FPKAKPYEGSILEADCDILIPAASEKQLTKSNAPRVKAKIIAEGANGPTTPEADKIFLER
NIMVIPDLYLNAGGVTVSYFEWLKNLNHVSYGRLTFKYERDSNYHLLMSVQESLERKFGK
HGGTIPIVPTAEFQDRISGASEKDIVHSGLAYTMERSARQIMRTAMKYNLGLDLRTAAYV
NAIEKVFKVYNEAGVTFT

# Drug_Target_19_Reaction:
L-glutamate + H2O + NAD(P)+ = 2-oxoglutarate + NH3 + NAD(P)H + H+

# Drug_Target_19_Signals:
None

# Drug_Target_19_Specific_Function:
May be involved in learning and memory reactions by increasing the turnover of the excitatory neurotransmitter glutamate

# Drug_Target_19_SwissProt_ID:
P00367

# Drug_Target_19_SwissProt_Name:
DHE3_HUMAN

# Drug_Target_19_Synonyms:
EC 1.4.1.3
GDH
Glutamate dehydrogenase 1, mitochondrial precursor

# Drug_Target_19_Theoretical_pI:
7.91

# Drug_Target_19_Transmembrane_Regions:
None

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
X56793

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
rfbD

# Drug_Target_1_Gene_Sequence:
>900 bp
ATGAATATCTTACTTTTTGGTAAGACAGGGCAAGTAGGCTGGGAGTTGCAACGTTCTCTG
GCACCGGTAGGGAATCTGATTGCCCTGGATGTCCATTCAAAAGAGTTTTGCGGTGATTTT
AGTAATCCGAAAGGCGTTGCCGAAACCGTTCGTAAGCTTCGTCCCGATGTGATTGTTAAC
GCAGCAGCCCATACTGCAGTAGATAAAGCAGAGTCTGAACCAGAACTGGCGCAGTTACTT
AACGCCACCAGTGTGGAAGCCATCGCTAAAGCAGCCAACGAAACTGGCGCATGGGTAGTG
CATTATTCAACCGATTATGTATTTCCTGGTACCGGCGATATCCCATGGCAGGAAACGGAC
GCTACGTCGCCGCTGAATGTCTATGGCAAAACCAAACTGGCGGGAGAAAAGGCCCTGCAG
GATAACTGCCCTAAACACCTTATCTTCCGCACCAGTTGGGTTTATGCAGGTAAGGGCAAT
AATTTCGCAAAGACAATGCTTCGTCTGGCGAAAGAGCGTCAGACACTTTCAGTCATTAAC
GATCAGTACGGTGCGCCAACCGGTGCGGAATTACTGGCTGACTGTACGGCGCATGCGATC
CGTGTGGCGTTAAATAAACCAGAAGTCGCAGGTCTTTACCATCTGGTTGCCGGGGGAACC
ACAACCTGGCATGACTACGCGGCCTTAGTCTTTGACGAGGCGCGCAAAGCAGGGATAACG
CTTGCGCTGACTGAGCTTAATGCTGTGCCGACCAGCGCCTACCCGACGCCGGCGAGCAGA
CCAGGCAATTCGCGTCTCAATACTGAAAAGTTTCAGCGTAATTTTGACCTTATTCTGCCT
CAATGGGAATTAGGAGTTAAGCGTATGCTGACTGAAATGTTTACGACGACAACCATCTAA

# Drug_Target_1_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_1_General_References:
11677609	McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, Porwollik S, Ali J, Dante M, Du F, Hou S, Layman D, Leonard S, Nguyen C, Scott K, Holmes A, Grewal N, Mulvaney E, Ryan E, Sun H, Florea L, Miller W, Stoneking T, Nhan M, Waterston R, Wilson RK: Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature. 2001 Oct 25;413(6858):852-6.
1710759	Jiang XM, Neal B, Santiago F, Lee SJ, Romana LK, Reeves PR: Structure and sequence of the rfb (O antigen) gene cluster of Salmonella serovar typhimurium (strain LT2). Mol Microbiol. 1991 Mar;5(3):695-713.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3598

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
32554

# Drug_Target_1_Name:
dTDP-4-dehydrorhamnose reductase

# Drug_Target_1_Number_of_Residues:
299

# Drug_Target_1_PDB_ID:
1N2S

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF04321	RmlD_sub_bind

# Drug_Target_1_Protein_Sequence:
>dTDP-4-dehydrorhamnose reductase
MNILLFGKTGQVGWELQRSLAPVGNLIALDVHSKEFCGDFSNPKGVAETVRKLRPDVIVN
AAAHTAVDKAESEPELAQLLNATSVEAIAKAANETGAWVVHYSTDYVFPGTGDIPWQETD
ATSPLNVYGKTKLAGEKALQDNCPKHLIFRTSWVYAGKGNNFAKTMLRLAKERQTLSVIN
DQYGAPTGAELLADCTAHAIRVALNKPEVAGLYHLVAGGTTTWHDYAALVFDEARKAGIT
LALTELNAVPTSAYPTPASRPGNSRLNTEKFQRNFDLILPQWELGVKRMLTEMFTTTTI

# Drug_Target_1_Reaction:
dTDP-6-deoxy-L-mannose + NADP+ = dTDP-4-dehydro-6-deoxy-L-mannose + NADPH + H+

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
dTDP-6-deoxy-L-mannose + NADP(+) = dTDP-4- dehydro-6-deoxy-L-mannose + NADPH

# Drug_Target_1_SwissProt_ID:
P26392

# Drug_Target_1_SwissProt_Name:
RMLD_SALTY

# Drug_Target_1_Synonyms:
EC 1.1.1.133
dTDP-4-keto-L- rhamnose reductase
dTDP-6-deoxy-L-mannose dehydrogenase
dTDP-L- rhamnose synthetase

# Drug_Target_1_Theoretical_pI:
6.88

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_20_Cellular_Location:
Not Available

# Drug_Target_20_Chromosome_Location:
Not Available

# Drug_Target_20_Drug_References:
Not Available

# Drug_Target_20_Essentiality:
Non-Essential

# Drug_Target_20_GenAtlas_ID:
Not Available

# Drug_Target_20_GenBank_ID_Gene:
X80838

# Drug_Target_20_GenBank_ID_Protein:
Not Available

# Drug_Target_20_GeneCard_ID:
Not Available

# Drug_Target_20_Gene_Name:
mdh

# Drug_Target_20_Gene_Sequence:
>930 bp
ATGAAAATCACCGTTATTGGCGCAGGAAACGTTGGGGCAACCACGGCTTTCCGTCTTGCA
GAAAAACAGCTTGCAAGAGAGCTCGTGTTGCTCGATGTCGTCGAAGGCATACCTCAGGGA
AAAGCACTTGACATGTACGAAAGCGGCCCGGTCGGCCTGTTCGACACGAAGGTAACCGGC
TCAAACGACTATGCCGACACTGCAAATTCCGATATCGTCGTCATCACCGCCGGTCTGCCG
AGAAAACCAGGCATGACTCGCGAGGATCTGCTTTCGATGAATGCCGGTATCGTCAGGGAG
GTGACCGGACGGATCATGGAGCACTCGAAAAATCCGATCATCGTGGTGGTTTCCAACCCG
CTCGATATCATGACGCACGTGGCCTGGCAGAAAAGCGGATTACCGAAAGAGCGGGTCATC
GGCATGGCCGGTGTGCTTGACTCGGCGCGCTTCCGCTCCTTCATCGCCATGGAACTTGGC
GTTTCGATGCAGGATGTGACCGCATGCGTGCTCGGCGGCCACGGCGACGCAATGGTGCCG
GTAGTCAAATACACCACGGTGGCAGGCATTCCGGTTGCCGACCTCATTTCCGCAGAAAGG
ATCGCGGAGCTGGTCGAGCGCACCCGCACCGGCGGCGCAGAGATCGTCAACCACCTCAAG
CAGGGTTCGGCATTTTACTCTCCCGCAACATCGGTGGTCGAAATGGTAGAGTCGATCGTG
CTGGATCGCAAGCGCGTGCTGACCTGCGCTGTAAGCCTCGACGGGCAGTACGGCATCGAC
GGCACCTTCGTTGGCGTCCCGGTCAAGCTCGGCAAAAACGGCGTCGAGCACATCTACGAA
ATCAAGCTCGACCAGAGTGACCTCGACCTGTTGCAGAAATCGGCAAAGATCGTCGATGAA
AACTGCAAAATGCTCGATGCATCGCAGGGC

# Drug_Target_20_General_Function:
Involved in oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor

# Drug_Target_20_General_References:
12093901	Eisen JA, Nelson KE, Paulsen IT, Heidelberg JF, Wu M, Dodson RJ, Deboy R, Gwinn ML, Nelson WC, Haft DH, Hickey EK, Peterson JD, Durkin AS, Kolonay JL, Yang F, Holt I, Umayam LA, Mason T, Brenner M, Shea TP, Parksey D, Nierman WC, Feldblyum TV, Hansen CL, Craven MB, Radune D, Vamathevan J, Khouri H, White O, Gruber TM, Ketchum KA, Venter JC, Tettelin H, Bryant DA, Fraser CM: The complete genome sequence of Chlorobium tepidum TLS, a photosynthetic, anaerobic, green-sulfur bacterium. Proc Natl Acad Sci U S A. 2002 Jul 9;99(14):9509-14. Epub 2002 Jul 1.
1735722	Charnock C, Refseth UH, Sirevag R: Malate dehydrogenase from Chlorobium vibrioforme, Chlorobium tepidum, and Heliobacterium gestii: purification, characterization, and investigation of dinucleotide binding by dehydrogenases by use of empirical methods of protein sequence analysis. J Bacteriol. 1992 Feb;174(4):1307-13.
8955383	Naterstad K, Lauvrak V, Sirevag R: Malate dehydrogenase from the mesophile Chlorobium vibrioforme and from the mild thermophile Chlorobium tepidum: molecular cloning, construction of a hybrid, and expression in Escherichia coli. J Bacteriol. 1996 Dec;178(24):7047-52.

# Drug_Target_20_HGNC_ID:
Not Available

# Drug_Target_20_HPRD_ID:
Not Available

# Drug_Target_20_ID:
4420

# Drug_Target_20_Locus:
Not Available

# Drug_Target_20_Molecular_Weight:
33093

# Drug_Target_20_Name:
Malate dehydrogenase

# Drug_Target_20_Number_of_Residues:
310

# Drug_Target_20_PDB_ID:
1GV0

# Drug_Target_20_Pathway:
Not Available

# Drug_Target_20_Pfam_Domain_Function:
PF00056	Ldh_1_N
PF02866	Ldh_1_C

# Drug_Target_20_Protein_Sequence:
>Malate dehydrogenase
MKITVIGAGNVGATTAFRLAEKQLARELVLLDVVEGIPQGKALDMYESGPVGLFDTKVTG
SNDYADTANSDIVVITAGLPRKPGMTREDLLSMNAGIVREVTGRIMEHSKNPIIVVVSNP
LDIMTHVAWQKSGLPKERVIGMAGVLDSARFRSFIAMELGVSMQDVTACVLGGHGDAMVP
VVKYTTVAGIPVADLISAERIAELVERTRTGGAEIVNHLKQGSAFYAPATSVVEMVESIV
LDRKRVLTCAVSLDGQYGIDGTFVGVPVKLGKNGVEHIYEIKLDQSDLDLLQKSAKIVDE
NCKMLDASQG

# Drug_Target_20_Reaction:
Not Available

# Drug_Target_20_Signals:
None

# Drug_Target_20_Specific_Function:
Catalyzes the reversible oxidation of malate to oxaloacetate

# Drug_Target_20_SwissProt_ID:
P80039

# Drug_Target_20_SwissProt_Name:
MDH_CHLTE

# Drug_Target_20_Synonyms:
EC 1.1.1.37

# Drug_Target_20_Theoretical_pI:
5.21

# Drug_Target_20_Transmembrane_Regions:
None

# Drug_Target_21_Cellular_Location:
Cytoplasm

# Drug_Target_21_Chromosome_Location:
Not Available

# Drug_Target_21_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_21_Essentiality:
Non-Essential

# Drug_Target_21_GenAtlas_ID:
ALDH1A1

# Drug_Target_21_GenBank_ID_Gene:
M31994

# Drug_Target_21_GenBank_ID_Protein:
178372

# Drug_Target_21_GeneCard_ID:
ALDH1A1

# Drug_Target_21_Gene_Name:
ALDH1A1

# Drug_Target_21_Gene_Sequence:
>1506 bp
ATGTCATCCTCAGGCACGCCAGACTTACCTGTCCTACTCACCGATTTGAAGATTCAATAT
ACTAAGATCTTCATAAACAATGAATGGCATGATTCAGTGAGTGGCAAGAAATTTCCTGTC
TTTAATCCTGCAACTGAGGAGGAGCTCTGCCAGGTAGAAGAAGGAGATAAGGAGGATGTT
GACAAGGCAGTGAAGGCCGCAAGACAGGCTTTTCAGATTGGATCTCCGTGGCGTACTATG
GATGCTTCCGAGAGGGGGCGACTATTATACAAGTTGGCTGATTTAATCGAAAGAGATCGT
CTGCTGCTGGCGACAATGGAGTCAATGAATGGTGGAAAACTCTATTCCAATGCATATCTG
AATGATTTAGCAGGCTGCATCAAAACATTGCGCTACTGTGCAGGTTGGGCTGACAAGATC
CAGGGCCGTACAATACCAATTGATGGAAATTTTTTTACATATACAAGACATGAACCTATT
GGTGTATGTGGCCAAATCATTCCTTGGAATTTCCCGTTGGTTATGCTCATTTGGAAGATA
GGGCCTGCACTGAGCTGTGGAAACACAGTGGTTGTCAAACCAGCAGAGCAAACTCCTCTC
ACTGCTCTCCACGTGGCATCTTTAATAAAAGAGGCAGGGTTTCCTCCTGGAGTAGTGAAT
ATTGTTCCTGGTTATGGGCCTACAGCAGGGGCAGCCATTTCTTCTCACATGGATATAGAC
AAAGTAGCCTTCACAGGATCAACAGAGGTTGGCAAGTTGATCAAAGAAGCTGCCGGGAAA
AGCAATCTGAAGAGGGTGACCCTGGAGCTTGGAGGAAAGAGCCCTTGCATTGTGTTAGCT
GATGCCGACTTGGACAATGCTGTTGAATTTGCACACCATGGGGTATTCTACCACCAGGGC
CAGTGTTGTATAGCCGCATCCAGGATTTTTGTGGAAGAATCAATTTATGATGAGTTTGTT
CGAAGGAGTGTTGAGCGGGCTAAGAAGTATATCCTTGGAAATCCTCTGACCCCAGGAGTC
ACTCAAGGCCCTCAGATTGACAAGGAACAATATGATAAAATACTTGACCTCATTGAGAGT
GGGAAGAAAGAAGGGGCCAAACTGGAATGTGGAGGAGGCCCGTGGGGGAATAAAGGCTAC
TTTGTCCAGCCCACAGTGTTCTCTAATGTTACAGATGAGATGCGCATTGCCAAAGAGGAG
ATTTTTGGACCAGTGCAGCAAATCATGAAGTTTAAATCTTTAGATGACGTGATCAAAAGA
GCAAACAATACTTTCTATGGCTTATCAGCAGGAGTGTTTACCAAAGACATTGATAAAGCC
ATAACAATCTCCTCTGCTCTGCAGGCAGGAACAGTGTGGGTGAATTGCTATGGCGTGGTA
AGTGCCCAGTGCCCCTTTGGTGGATTCAAGATGTCTGGAAATGGAAGAGAACTGGGAGAG
TACGGTTTCCATGAATATACAGAGGTCAAAACAGTCACAGTGAAAATCTCTCAGAAGAAC
TCATAA

# Drug_Target_21_General_Function:
Energy production and conversion

# Drug_Target_21_General_References:
2591967	Hsu LC, Chang WC, Yoshida A: Genomic structure of the human cytosolic aldehyde dehydrogenase gene. Genomics. 1989 Nov;5(4):857-65.
2776714	Agarwal DP, Cohn P, Goedde HW, Hempel J: Aldehyde dehydrogenase from human erythrocytes: structural relationship to the liver cytosolic isozyme. Enzyme. 1989;42(1):47-52.
2987944	Hsu LC, Tani K, Fujiyoshi T, Kurachi K, Yoshida A: Cloning of cDNAs for human aldehyde dehydrogenases 1 and 2. Proc Natl Acad Sci U S A. 1985 Jun;82(11):3771-5.
3676276	Abriola DP, Fields R, Stein S, MacKerell AD Jr, Pietruszko R: Active site of human liver aldehyde dehydrogenase. Biochemistry. 1987 Sep 8;26(18):5679-84.
4015823	Yoshida A, Ikawa M, Hsu LC, Tani K: Molecular abnormality and cDNA cloning of human aldehyde dehydrogenases. Alcohol. 1985 Jan-Feb;2(1):103-6.
6723659	Hempel J, von Bahr-Lindstrom H, Jornvall H: Aldehyde dehydrogenase from human liver. Primary structure of the cytoplasmic isoenzyme. Eur J Biochem. 1984 May 15;141(1):21-35.
8214422	Zheng CF, Wang TT, Weiner H: Cloning and expression of the full-length cDNAS encoding human liver class 1 and class 2 aldehyde dehydrogenase. Alcohol Clin Exp Res. 1993 Aug;17(4):828-31.
8493914	Yoshida A, Hsu LC, Yanagawa Y: Biological role of human cytosolic aldehyde dehydrogenase 1: hormonal response, retinal oxidation and implication in testicular feminization. Adv Exp Med Biol. 1993;328:37-44.

# Drug_Target_21_HGNC_ID:
HGNC:402

# Drug_Target_21_HPRD_ID:
00001

# Drug_Target_21_ID:
611

# Drug_Target_21_Locus:
9q21.13

# Drug_Target_21_Molecular_Weight:
54731

# Drug_Target_21_Name:
Retinal dehydrogenase 1

# Drug_Target_21_Number_of_Residues:
500

# Drug_Target_21_PDB_ID:
1BXS

# Drug_Target_21_Pathway:
Cyclophosphamide Pathway	SMP00447
Ifosfamide Pathway	SMP00448

# Drug_Target_21_Pfam_Domain_Function:
PF00171	Aldedh

# Drug_Target_21_Protein_Sequence:
>Retinal dehydrogenase 1
SSSGTPDLPVLLTDLKIQYTKIFINNEWHDSVSGKKFPVFNPATEEELCQVEEGDKEDVD
KAVKAARQAFQIGSPWRTMDASERGRLLYKLADLIERDRLLLATMESMNGGKLYSNAYLN
DLAGCIKTLRYCAGWADKIQGRTIPIDGNFFTYTRHEPIGVCGQIIPWNFPLVMLIWKIG
PALSCGNTVVVKPAEQTPLTALHVASLIKEAGFPPGVVNIVPGYGPTAGAAISSHMDIDK
VAFTGSTEVGKLIKEAAGKSNLKRVTLELGGKSPCIVLADADLDNAVEFAHHGVFYHQGQ
CCIAASRIFVEESIYDEFVRRSVERAKKYILGNPLTPGVTQGPQIDKEQYDKILDLIESG
KKEGAKLECGGGPWGNKGYFVQPTVFSNVTDEMRIAKEEIFGPVQQIMKFKSLDDVIKRA
NNTFYGLSAGVFTKDIDKAITISSALQAGTVWVNCYGVVSAQCPFGGFKMSGNGRELGEY
GFHEYTEVKTVTVKISQKNS

# Drug_Target_21_Reaction:
retinal + NAD+ + H2O = retinoate + NADH + 2 H+

# Drug_Target_21_Signals:
None

# Drug_Target_21_Specific_Function:
Binds free retinal and cellular retinol-binding protein- bound retinal. Can convert/oxidize retinaldehyde to retinoic acid

# Drug_Target_21_SwissProt_ID:
P00352

# Drug_Target_21_SwissProt_Name:
AL1A1_HUMAN

# Drug_Target_21_Synonyms:
ALDH-E1
ALHDII
Aldehyde dehydrogenase family 1 member A1
Aldehyde dehydrogenase, cytosolic
EC 1.2.1.36
RALDH 1
RalDH1

# Drug_Target_21_Theoretical_pI:
6.71

# Drug_Target_21_Transmembrane_Regions:
None

# Drug_Target_22_Cellular_Location:
Cytoplasm

# Drug_Target_22_Chromosome_Location:
Not Available

# Drug_Target_22_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_22_Essentiality:
Non-Essential

# Drug_Target_22_GenAtlas_ID:
ADH4

# Drug_Target_22_GenBank_ID_Gene:
M15943

# Drug_Target_22_GenBank_ID_Protein:
178121

# Drug_Target_22_GeneCard_ID:
ADH4

# Drug_Target_22_Gene_Name:
ADH4

# Drug_Target_22_Gene_Sequence:
>1179 bp
ATGGGCACCAAGGGCAAAGTTATTAAATGCAAAGCAGCCATCGCCTGGGAAGCAGGCAAG
CCCCTTTGCATTGAAGAGGTTGAAGTAGCTCCCCCCAAGGCTCATGAAGTTCGCATTCAG
ATCATTGCTACCTCCCTGTGCCATACTGATGCCAGTGTTATCGATTCTAAATTTGAGGGC
CTAGCTTTCCCAGTGATCGTTGGCCATGAGGCTGCAGGTATTGTGGAAAGTATTGGGCCA
GGAGTGACCAACGTCAAACCAGGTGACAAAGTAATTCCACTTTATGCACCTCTATGTAGA
AAATGCAAGTTTTGTCTGAGTCCACTCACAAATTTGTGTGGGAAAATCAGTAATCTCAAA
AGTCCTGCTAGTGATCAACAACTAATGGAAGACAAAACCAGCAGGTTTACCTGCAAAGGA
AAACCAGTTTACCATTTCTTTGGAACCAGTACATTCTCTCAGTACACTGTGGTGTCAGAT
ATCAATCTTGCCAAAATAGATGATGATGCAAATTTAGAGAGAGTTTGTCTGCTTGGATGT
GGGTTTTCAACTGGCTATGGGGCTGCAATCAACAATGCCAAGGTCACCCCTGGTTCGACT
TGTGCTGTCTTTGGCCTAGGAGGTGTGGGTCTTTCTGCTGTAATGGGTTGTAAAGCAGCA
GGAGCTTCCAGAATCATAGGTATTGACATCAACAGTGAGAAGTTTGTGAAGGCTAAAGCC
CTGGGAGCCACTGACTGCCTCAATCCTAGAGACTTACATAAACCGATCCAGGAAGTTATC
ATTGAATTGACCAAGGGAGGTGTGGATTTTGCCCTTGACTGTGCAGGTGGATCTGAAACC
ATGAAAGCAGCCCTGGACTGTACAACCGCAGGCTGGGGATCATGTACTTTCATTGGAGTA
GCTGCTGGTAGCAAAGGATTGACTATTTTTCCAGAGGAGCTAATAATCGGCCGTACTATA
AATGGAACATTCTTTGGTGGTTGGAAAAGTGTAGATTCTATCCCAAAGCTGGTCACTGAC
TATAAGAATAAGAAATTCAATCTGGATGCATTGGTGACCCATACCCTGCCTTTTGACAAA
ATCAGTGAGGCATTTGACCTAATGAACCAAGGAAAAAGCGTCCGAACAATCCTCATCTTT
GGAAGATGCCAGGAGCAATTCAGAATACTATCTGATTGA

# Drug_Target_22_General_Function:
Energy production and conversion

# Drug_Target_22_General_References:
1889753	von Bahr-Lindstrom H, Jornvall H, Hoog JO: Cloning and characterization of the human ADH4 gene. Gene. 1991 Jul 22;103(2):269-74.
3036213	Hoog JO, von Bahr-Lindstrom H, Heden LO, Holmquist B, Larsson K, Hempel J, Vallee BL, Jornvall H: Structure of the class II enzyme of human liver alcohol dehydrogenase: combined cDNA and protein sequence determination of the pi subunit. Biochemistry. 1987 Apr 7;26(7):1926-32.

# Drug_Target_22_HGNC_ID:
HGNC:252

# Drug_Target_22_HPRD_ID:
00068

# Drug_Target_22_ID:
396

# Drug_Target_22_Locus:
4q21-q24|4q22

# Drug_Target_22_Molecular_Weight:
40091

# Drug_Target_22_Name:
Alcohol dehydrogenase 4

# Drug_Target_22_Number_of_Residues:
379

# Drug_Target_22_PDB_ID:
Not Available

# Drug_Target_22_Pathway:
Not Available

# Drug_Target_22_Pfam_Domain_Function:
PF00107	ADH_zinc_N
PF08240	ADH_N

# Drug_Target_22_Protein_Sequence:
>Alcohol dehydrogenase 4
GTKGKVIKCKAAIAWEAGKPLCIEEVEVAPPKAHEVRIQIIATSLCHTDATVIDSKFEGL
AFPVIVGHEAAGIVESIGPGVTNVKPGDKVIPLYAPLCRKCKFCLSPLTNLCGKISNLKS
PASDQQLMEDKTSRFTCKGKPVYHFFGTSTFSQYTVVSDINLAKIDDDANLERVCLLGCG
FSTGYGAAINNAKVTPGSTCAVFGLGGVGLSAVMGCKAAGASRIIGIDINSEKFVKAKAL
GATDCLNPRDLHKPIQEVIIELTKGGVDFALDCAGGSETMKAALDCTTAGWGSCTFIGVA
AGSKGLTVFPEELIIGRTINGTFFGGWKSVDSIPKLVTDYKNKKFNLDALVTHTLPFDKI
SEAFDLMNQGKSIRTILIF

# Drug_Target_22_Reaction:
an alcohol + NAD+ = an aldehyde or ketone + NADH + H+

# Drug_Target_22_Signals:
None

# Drug_Target_22_Specific_Function:
Not Available

# Drug_Target_22_SwissProt_ID:
P08319

# Drug_Target_22_SwissProt_Name:
ADH4_HUMAN

# Drug_Target_22_Synonyms:
Alcohol dehydrogenase class II pi chain
EC 1.1.1.1

# Drug_Target_22_Theoretical_pI:
8.01

# Drug_Target_22_Transmembrane_Regions:
None

# Drug_Target_23_Cellular_Location:
Cytoplasm

# Drug_Target_23_Chromosome_Location:
Not Available

# Drug_Target_23_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_23_Essentiality:
Non-Essential

# Drug_Target_23_GenAtlas_ID:
BLVRA

# Drug_Target_23_GenBank_ID_Gene:
X93086

# Drug_Target_23_GenBank_ID_Protein:
1246749

# Drug_Target_23_GeneCard_ID:
BLVRA

# Drug_Target_23_Gene_Name:
BLVRA

# Drug_Target_23_Gene_Sequence:
>891 bp
ATGAATGCAGAGCCCGAGAGGAAGTTTGGCGTGGTGGTGGTTGGTGTTGGCCGAGCCGGC
TCCGTGCGGATGAGGGACTTGCGGAATCCACACCCTTCCTCAGCGTTCCTGAACCTGATT
GGCTTCGTGTCGAGAAGGGAGCTCGGGAGCATTGATGGAGTCCAGCAGATTTCTTTGGAG
GATGCTCTTTCCAGCCAAGAGGTGGAGGTCGCCTATATCTGCAGTGAGAGCTCCAGCCAT
GAGGACTACATCAGGCAGTTCCTTAATGCTGGCAAGCACGTCCTTGTGGAATACCCCATG
ACACTGTCATTGGCGGCCGCTCAGGAACTGTGGGAGCTGGCTGAGCAGAAAGGAAAAGTC
TTGCACGAGGAGCATGTTGAACTCTTGATGGAGGAATTCGCTTTCCTGAAAAAAGAAGTG
GTGGGGAAAGACCTGCTGAAAGGGTCGCTCCTCTTCACATCTGACCCGTTGGAAGAAGAC
CGGTTTGGCTTCCCTGCATTCAGCGGCATCTCTCGACTGACCTGGCTGGTCTCCCTCTTT
GGGGAGCTTTCTCTTGTGTCTGCCACTTTGGAAGAGCGAAAGGAAGATCAGTATATGAAA
ATGACAGTGTGTCTGGAGACAGAGAAGAAAAGTCCACTGTCATGGATTGAAGAAAAAGGA
CCTGGTCTAAAACGAAACAGATATTTAAGCTTCCATTTCAAGTCTGGGTCCTTGGAGAAT
GTGCCAAATGTAGGAGTGAATAAGAACATATTTCTGAAAGATCAAAATATATTTGTCCAG
AAACTCTTGGGCCAGTTCTCTGAGAAGGAACTGGCTGCTGAAAAGAAACGCATCCTGCAC
TGCCTGGGGCTTGCAGAAGAAATCCAGAAATATTGCTGTTCAAGGAAGTAA

# Drug_Target_23_General_Function:
Involved in oxidoreductase activity

# Drug_Target_23_General_References:
12853948	Hillier LW, Fulton RS, Fulton LA, Graves TA, Pepin KH, Wagner-McPherson C, Layman D, Maas J, Jaeger S, Walker R, Wylie K, Sekhon M, Becker MC, O'Laughlin MD, Schaller ME, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Cordes M, Du H, Sun H, Edwards J, Bradshaw-Cordum H, Ali J, Andrews S, Isak A, Vanbrunt A, Nguyen C, Du F, Lamar B, Courtney L, Kalicki J, Ozersky P, Bielicki L, Scott K, Holmes A, Harkins R, Harris A, Strong CM, Hou S, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Leonard S, Rohlfing T, Rock SM, Tin-Wollam AM, Abbott A, Minx P, Maupin R, Strowmatt C, Latreille P, Miller N, Johnson D, Murray J, Woessner JP, Wendl MC, Yang SP, Schultz BR, Wallis JW, Spieth J, Bieri TA, Nelson JO, Berkowicz N, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Bedell JA, Mardis ER, Clifton SW, Chissoe SL, Marra MA, Raymond C, Haugen E, Gillett W, Zhou Y, James R, Phelps K, Iadanoto S, Bubb K, Simms E, Levy R, Clendenning J, Kaul R, Kent WJ, Furey TS, Baertsch RA, Brent MR, Keibler E, Flicek P, Bork P, Suyama M, Bailey JA, Portnoy ME, Torrents D, Chinwalla AT, Gish WR, Eddy SR, McPherson JD, Olson MV, Eichler EE, Green ED, Waterston RH, Wilson RK: The DNA sequence of human chromosome 7. Nature. 2003 Jul 10;424(6945):157-64.
7929092	Yamaguchi T, Komoda Y, Nakajima H: Biliverdin-IX alpha reductase and biliverdin-IX beta reductase from human liver. Purification and characterization. J Biol Chem. 1994 Sep 30;269(39):24343-8.
8424666	Maines MD, Trakshel GM: Purification and characterization of human biliverdin reductase. Arch Biochem Biophys. 1993 Jan;300(1):320-6.
8631357	Maines MD, Polevoda BV, Huang TJ, McCoubrey WK Jr: Human biliverdin IXalpha reductase is a zinc-metalloprotein. Characterization of purified and Escherichia coli expressed enzymes. Eur J Biochem. 1996 Jan 15;235(1-2):372-81.

# Drug_Target_23_HGNC_ID:
HGNC:1062

# Drug_Target_23_HPRD_ID:
11229

# Drug_Target_23_ID:
816

# Drug_Target_23_Locus:
7p14-cen

# Drug_Target_23_Molecular_Weight:
33429

# Drug_Target_23_Name:
Biliverdin reductase A

# Drug_Target_23_Number_of_Residues:
296

# Drug_Target_23_PDB_ID:
Not Available

# Drug_Target_23_Pathway:
Not Available

# Drug_Target_23_Pfam_Domain_Function:
PF01408	GFO_IDH_MocA

# Drug_Target_23_Protein_Sequence:
>Biliverdin reductase A precursor
MNAEPERKFGVVVVGVGRAGSVRMRDLRNPHPSSAFLNLIGFVSRRELGSIDGVQQISLE
DALSSQEVEVAYICSESSSHEDYIRQFLNAGKHVLVEYPMTLSLAAAQELWELAEQKGKV
LHEEHVELLMEEFAFLKKEVVGKDLLKGSLLFTAGPLEEERFGFPAFSGISRLTWLVSLF
GELSLVSATLEERKEDQYMKMTVCLETEKKSPLSWIEEKGPGLKRNRYLSFHFKSGSLEN
VPNVGVNKNIFLKDQNIFVQKLLGQFSEKELAAEKKRILHCLGLAEEIQKYCCSRK

# Drug_Target_23_Reaction:
bilirubin + NAD(P)+ = biliverdin + NAD(P)H + H+

# Drug_Target_23_Signals:
None

# Drug_Target_23_Specific_Function:
Reduces the gamma-methene bridge of the open tetrapyrrole, biliverdin IX alpha, to bilirubin with the concomitant oxidation of a NADH or NADPH cofactor

# Drug_Target_23_SwissProt_ID:
P53004

# Drug_Target_23_SwissProt_Name:
BIEA_HUMAN

# Drug_Target_23_Synonyms:
BVR A
Biliverdin reductase A precursor
Biliverdin-IX alpha- reductase
EC 1.3.1.24

# Drug_Target_23_Theoretical_pI:
6.41

# Drug_Target_23_Transmembrane_Regions:
None

# Drug_Target_24_Cellular_Location:
Nucleus (Probable)

# Drug_Target_24_Chromosome_Location:
Not Available

# Drug_Target_24_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_24_Essentiality:
Non-Essential

# Drug_Target_24_GenAtlas_ID:
NMNAT3

# Drug_Target_24_GenBank_ID_Gene:
AF345564

# Drug_Target_24_GenBank_ID_Protein:
14029540

# Drug_Target_24_GeneCard_ID:
NMNAT3

# Drug_Target_24_Gene_Name:
NMNAT3

# Drug_Target_24_Gene_Sequence:
>759 bp
ATGAAGAGCCGAATACCTGTGGTGCTCCTGGCCTGTGGCTCCTTTAACCCCATCACCAAC
ATGCACCTGCGCATGTTTGAGGTGGCCAGAGATCACCTACACCAAACAGGAATGTACCAG
GTCATCCAGGGTATCATCTCTCCTGTCAACGACACCTATGGGAAGAAAGACCTCGCAGCT
TCTCATCACCGAGTGGCCATGGCCCGGCTGGCCCTGCAGACATCCGACTGGATCCGGGTG
GACCCTTGGGAGAGTGAGCAGGCACAGTGGATGGAGACAGTGAAGGTGCTGAGGCATCAT
CACAGCAAACTGCTCAGATCTCCACCCCAGATGGAAGGCCCAGACCATGGCAAGGCACTC
TTCTCGACCCCTGCAGCTGTGCCTGAGCTGAAGCTTCTCTGTGGGGCAGACGTCTTGAAG
ACCTTCCAGACCCCCAACCTCTGGAAGGATGCGCACATCCAGGAAATAGTGGAGAAGTTT
GGCTTGGTGTGCGTGGGCCGAGTAAGTCACGACCCAAAAGGTTACATCGCAGAATCTCCC
ATCCTACGGATGCACCAGCACAACATTCACCTGGCCAAGGAGCCTGTGCAGAATGAGATC
AGTGCCACATACATCAGGCGAGCCTTGGGCCAAGGGCAGAGCGTAAAGTACCTGATTCCC
GATGCTGTCATCACGTACATCAAGGACCATGGCCTCTACACCAAGGGCAGTACCTGGAAA
GGCAAAAGCACCCAGAGCACTGAGGGCAAGACAAGCTAG

# Drug_Target_24_General_Function:
Coenzyme transport and metabolism

# Drug_Target_24_General_References:
Not Available

# Drug_Target_24_HGNC_ID:
HGNC:20989

# Drug_Target_24_HPRD_ID:
16370

# Drug_Target_24_ID:
3333

# Drug_Target_24_Locus:
3q23

# Drug_Target_24_Molecular_Weight:
28322

# Drug_Target_24_Name:
Nicotinamide mononucleotide adenylyltransferase 3

# Drug_Target_24_Number_of_Residues:
252

# Drug_Target_24_PDB_ID:
1NUU

# Drug_Target_24_Pathway:
Not Available

# Drug_Target_24_Pfam_Domain_Function:
PF01467	CTP_transf_2

# Drug_Target_24_Protein_Sequence:
>Nicotinamide mononucleotide adenylyltransferase 3
MKSRIPVVLLACGSFNPITNMHLRMFEVARDHLHQTGMYQVIQGIISPVNDTYGKKDLAA
SHHRVAMARLALQTSDWIRVDPWESEQAQWMETVKVLRHHHSKLLRSPPQMEGPDHGKAL
FSTPAAVPELKLLCGADVLKTFQTPNLWKDAHIQEIVEKFGLVCVGRVGHDPKGYIAESP
ILRMHQHNIHLAKEPVQNEISATYIRRALGQGQSVKYLIPDAVITYIKDHGLYTKGSTWK
GKSTQSTEGKTS

# Drug_Target_24_Reaction:
ATP + nicotinamide ribonucleotide = diphosphate + NAD+

# Drug_Target_24_Signals:
None

# Drug_Target_24_Specific_Function:
ATP + nicotinamide ribonucleotide = diphosphate + NAD(+)

# Drug_Target_24_SwissProt_ID:
Q96T66

# Drug_Target_24_SwissProt_Name:
NMNA3_HUMAN

# Drug_Target_24_Synonyms:
EC 2.7.7.1
NMN adenylyltransferase 3

# Drug_Target_24_Theoretical_pI:
9.69

# Drug_Target_24_Transmembrane_Regions:
None

# Drug_Target_25_Cellular_Location:
Not Available

# Drug_Target_25_Chromosome_Location:
Not Available

# Drug_Target_25_Drug_References:
Not Available

# Drug_Target_25_Essentiality:
Non-Essential

# Drug_Target_25_GenAtlas_ID:
Not Available

# Drug_Target_25_GenBank_ID_Gene:
AB042262

# Drug_Target_25_GenBank_ID_Protein:
Not Available

# Drug_Target_25_GeneCard_ID:
Not Available

# Drug_Target_25_Gene_Name:
lvr

# Drug_Target_25_Gene_Sequence:
>804 bp
ATGACCGCAACCAGCTCCCCCACGACCCGCTTCACCGACCGCGTCGTGCTCATCACCGGC
GGCGGCTCCGGCCTCGGCCGTGCGACCGCCGTCCGTCTCGCCGCCGAGGGCGCGAAGCTC
TCCCTCGTCGACGTCTCCTCCGAGGGACTCGAGGCCTCGAAGGCCGCCGTGCTCGAGACC
GCCCCCGACGCCGAGGTCCTCACCACCGTCGCCGACGTCTCGGACGAGGCCCAGGTCGAG
GCCTACGTCACCGCCACCACCGAGCGCTTCGGCCGCATCGACGGCTTCTTCAACAACGCC
GGCATCGAGGGCAAGCAGAACCCGACCGAGTCGTTCACCGCCGCCGAGTTCGACAAGGTC
GTCTCGATCAACCTGCGCGGCGTGTTCCTCGGCCTCGAGAAGGTCCTGAAGATCATGCGC
GAGCAGGGCTCCGGCATGGTCGTCAACACGGCGAGCGTCGGCGGCATCCGCGGCATCGGC
AACCAGTCCGGCTACGCCGCCGCCAAGCACGGGGTCGTCGGTCTCACCCGCAACTCCGCC
GTCGAGTACGGCCGCTACGGCATCCGCATCAACGCCATCGCCCCCGGCGCCATCTGGACG
CCGATGGTCGAGAACTCGATGAAGCAGCTCGACCCGGAGAACCCCCGCAAGGCCGCCGAG
GAGTTCATCCAGGTCAACCCCTCCAAGCGCTACGGCGAGGCGCCCGAGATCGCCGCGGTC
GTCGCCTTCCTGCTGTCCGACGACGCCTCGTACGTCAACGCCACGGTCGTCCCGATCGAC
GGCGGGCAGTCCGCCGCGTACTGA

# Drug_Target_25_General_Function:
Involved in oxidoreductase activity

# Drug_Target_25_General_References:
10508066	Wada M, Yoshizumi A, Nakamori S, Shimizu S: Purification and characterization of monovalent cation-activated levodione reductase from Corynebacterium aquaticum M-13. Appl Environ Microbiol. 1999 Oct;65(10):4399-403.
11388460	Yoshisumi A, Wada M, Takagi H, Shimizu S, Nakamori S: Cloning, sequence analysis, and expression in Escherichia coli of the gene encoding monovalent cation-activated levodione reductase from Corynebacterium aquaticum M-13. Biosci Biotechnol Biochem. 2001 Apr;65(4):830-6.

# Drug_Target_25_HGNC_ID:
Not Available

# Drug_Target_25_HPRD_ID:
Not Available

# Drug_Target_25_ID:
4423

# Drug_Target_25_Locus:
Not Available

# Drug_Target_25_Molecular_Weight:
27921

# Drug_Target_25_Name:
Levodione reductase

# Drug_Target_25_Number_of_Residues:
267

# Drug_Target_25_PDB_ID:
1IY8

# Drug_Target_25_Pathway:
Not Available

# Drug_Target_25_Pfam_Domain_Function:
PF00106	adh_short

# Drug_Target_25_Protein_Sequence:
>Levodione reductase
MTATSSPTTRFTDRVVLITGGGSGLGRATAVRLAAEGAKLSLVDVSSEGLEASKAAVLET
APDAEVLTTVADVSDEAQVEAYVTATTERFGRIDGFFNNAGIEGKQNPTESFTAAEFDKV
VSINLRGVFLGLEKVLKIMREQGSGMVVNTASVGGIRGIGNQSGYAAAKHGVVGLTRNSA
VEYGRYGIRINAIAPGAIWTPMVENSMKQLDPENPRKAAEEFIQVNPSKRYGEAPEIAAV
VAFLLSDDASYVNATVVPIDGGQSAAY

# Drug_Target_25_Reaction:
Not Available

# Drug_Target_25_Signals:
None

# Drug_Target_25_Specific_Function:
Catalyzes the regio- and stereoselective reversible NAD- dependent reduction of (6R)-2,2,6-trimethyl-1,4-cyclohexanedione (levodione) to (4R,6R)-4-hydroxy-2,2,6-trimethylcyclohexanone (actinol)

# Drug_Target_25_SwissProt_ID:
Q9LBG2

# Drug_Target_25_SwissProt_Name:
LVR_LEIAQ

# Drug_Target_25_Synonyms:
(6R)-2,2,6-trimethyl-1,4- cyclohexanedione reductase
EC 1.1.1.-

# Drug_Target_25_Theoretical_pI:
4.66

# Drug_Target_25_Transmembrane_Regions:
None

# Drug_Target_26_Cellular_Location:
Cell inner membrane
peripheral membrane protein

# Drug_Target_26_Chromosome_Location:
Not Available

# Drug_Target_26_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_26_Essentiality:
Non-Essential

# Drug_Target_26_GenAtlas_ID:
Not Available

# Drug_Target_26_GenBank_ID_Gene:
AE000511

# Drug_Target_26_GenBank_ID_Protein:
2313282

# Drug_Target_26_GeneCard_ID:
Not Available

# Drug_Target_26_Gene_Name:
fabI

# Drug_Target_26_Gene_Sequence:
>828 bp
ATGGGATTTTTAAAAGGTAAAAAAGGGCTTATTGTAGGGGTGGCGAACAATAAATCCATC
GCTTATGGGATCGCTCAATCTTGTTTCAATCAAGGGGCTACTTTGGCTTTCACTTATTTG
AATGAGAGTTTAGAAAAGCGCGTAAGGCCTATCGCGCAGGAATTGAATAGCCCCTATGTG
TATGAATTGGATGTGAGCAAAGAAGAGCATTTCAAGTCGCTATACAATAGCGTTAAAAAG
GATTTAGGCTCATTGGATTTTATTGTTCATAGCGTGGCCTTTGCCCCTAAAGAGGCTTTA
GAGGGGAGCTTGTTGGAAACTTCTAAAAGCGCGTTTAACACCGCTATGGAAATTTCTGTT
TATTCTTTAATAGAGCTGACAAACACCCTAAAACCTTTATTGAATAACGGAGCGTCTGTT
TTGACTCTAAGCTATTTGGGTAGCACCAAATACATGGCGCATTACAATGTGATGGGGTTG
GCTAAAGCGGCCCTAGAGAGTGCGGTGCGTTATTTAGCGGTGGATTTAGGCAAACACCAT
ATAAGAGTGAATGCCCTATCGGCCGGGCCTATTAGGACGCTCGCTTCTAGCGGGATCGCT
GATTTTAGAATGATTTTAAAATGGAATGAAATCAACGCCCCTTTAAGAAAAAATGTGAGT
TTAGAAGAAGTGGGCAATGCCGGGATGTATTTGCTCTCTAGTTTGTCTAGCGGGGTGAGT
GGGGAAGTGCATTTTGTGGATGCTGGCTATCATGTTATGGGCATGGGGGCTGTGGAAGAA
AAAGATAATAAAGCTACGCTACTGTGGGATTTGCATAAAGAACAATAA

# Drug_Target_26_General_Function:
Lipid transport and metabolism

# Drug_Target_26_General_References:
9252185	Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, Ketchum KA, Klenk HP, Gill S, Dougherty BA, Nelson K, Quackenbush J, Zhou L, Kirkness EF, Peterson S, Loftus B, Richardson D, Dodson R, Khalak HG, Glodek A, McKenney K, Fitzegerald LM, Lee N, Adams MD, Hickey EK, Berg DE, Gocayne JD, Utterback TR, Peterson JD, Kelley JM, Cotton MD, Weidman JM, Fujii C, Bowman C, Watthey L, Wallin E, Hayes WS, Borodovsky M, Karp PD, Smith HO, Fraser CM, Venter JC: The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature. 1997 Aug 7;388(6642):539-47.

# Drug_Target_26_HGNC_ID:
Not Available

# Drug_Target_26_HPRD_ID:
Not Available

# Drug_Target_26_ID:
3228

# Drug_Target_26_Locus:
Not Available

# Drug_Target_26_Molecular_Weight:
29982

# Drug_Target_26_Name:
Enoyl-[acyl-carrier-protein] reductase [NADH]

# Drug_Target_26_Number_of_Residues:
275

# Drug_Target_26_PDB_ID:
1JVF

# Drug_Target_26_Pathway:
Not Available

# Drug_Target_26_Pfam_Domain_Function:
Not Available

# Drug_Target_26_Protein_Sequence:
>Enoyl-[acyl-carrier-protein] reductase [NADH]
MGFLKGKKGLIVGVANNKSIAYGIAQSCFNQGATLAFTYLNESLEKRVRPIAQELNSPYV
YELDVSKEEHFKSLYNSVKKDLGSLDFIVHSVAFAPKEALEGSLLETSKSAFNTAMEISV
YSLIELTNTLKPLLNNGASVLTLSYLGSTKYMAHYNVMGLAKAALESAVRYLAVDLGKHH
IRVNALSAGPIRTLASSGIADFRMILKWNEINAPLRKNVSLEEVGNAGMYLLSSLSSGVS
GEVHFVDAGYHVMGMGAVEEKDNKATLLWDLHKEQ

# Drug_Target_26_Reaction:
acyl-[acyl-carrier-protein] + NAD+ = trans-2,3-dehydroacyl-[acyl-carrier-protein] + NADH + H+

# Drug_Target_26_Signals:
None

# Drug_Target_26_Specific_Function:
Acyl-[acyl-carrier-protein] + NAD(+) = trans- 2,3-dehydroacyl-[acyl-carrier-protein] + NADH

# Drug_Target_26_SwissProt_ID:
O24990

# Drug_Target_26_SwissProt_Name:
FABI_HELPY

# Drug_Target_26_Synonyms:
EC 1.3.1.9
NADH- dependent enoyl-ACP reductase

# Drug_Target_26_Theoretical_pI:
7.80

# Drug_Target_26_Transmembrane_Regions:
None

# Drug_Target_27_Cellular_Location:
Cytoplasmic

# Drug_Target_27_Chromosome_Location:
Not Available

# Drug_Target_27_Drug_References:
Not Available

# Drug_Target_27_Essentiality:
Non-Essential

# Drug_Target_27_GenAtlas_ID:
Not Available

# Drug_Target_27_GenBank_ID_Gene:
U07365

# Drug_Target_27_GenBank_ID_Protein:
Not Available

# Drug_Target_27_GeneCard_ID:
Not Available

# Drug_Target_27_Gene_Name:
PFE1050w

# Drug_Target_27_Gene_Sequence:
>1440 bp
ATGGTTGAAAATAAGAGCAAGGTCAAAGATATCAGTTTGGCCCCCTTTGGAAAAATGCAG
ATGGAAATTTCTGAAAATGAAATGCCGGGATTAATGAGAATAAGAGAAGAATACGGAAAA
GATCAACCATTAAAAAATGCTAAAATTACTGGTTGTTTACATATGACTGTTGAATGTGCT
TTATTAATTGAGACTTTACAAAAATTAGGAGCTCAGATTAGGTGGTGTTCATGTAATATT
TATTCAACAGCTGATTATGCTGCAGCAGCAGTAAGTACATTAGAAAATGTAACGGTTTTT
GCTTGGAAAAATGAAACTTTAGAAGAATACTGGTGGTGTGTTGAAAGTGCCCTTACGTGG
GGTGATGGAGATGATAATGGTCCAGATATGATTGTAGATGATGGGGGTGATGCAACCTTA
TTAGTTCATAAAGGTGTTGAGTATGAAAAATTATATGAAGAGAAAAATATATTACCTGAT
CCAGAAAAAGCAAAAAATGAAGAAGAACGATGTTTTCTAACTTTATTAAAAAATTCCATA
TTAAAAAATCCAAAGAAATGGACAAATATTGCAAAGAAAATTATAGGTGTATCTGAAGAA
ACTACTACAGGAGTATTAAGATTAAAAAAAATGGACAAACAAAATGAATTATTATTTACT
GCTATTAATGTAAATGATGCTGTCACTAAACAAAAATATGATAATGTGTATGGATGTAGA
CATTCCTATACTGACGGATTAATGAGAGCTACCGATTTTTTAATATCTGGAAAAATCGTT
GTCATATGTGGATATGGTGACGTAGGTAAAGGATGTGCTTCTTCTATGAAAGGTTTAGGT
GCAAGAGTATATATAACAGAAATTGATCCCATATGTGCTATACAAGCTGTAATGGAAGGA
TTTAATGTTGTTACTTTAGATGAAATTGTAGATAAAGGAGATTTTTTTATTACTTGTACA
GGTAATGTTGATGTTATTAAATTAGAACACTTACTTAAAATGAAAAATAATGCTGTTGTT
GGAAACATTGGTCATTTTGATGATGAAATACAAGTAAATGAACTTTTTAATTATAAAGGA
ATACATATAGAAAATGTAAAACCACAGGTTGATAGAATTACTTTACCTAATGGAAATAAA
ATTATTGTTTTAGCTAGAGGGAGATTATTAAATCTAGGATGTGCAACAGGACATCCAGCA
TTTGTTATGTCCTTTTCATTTTGTAATCAAACCTTTGCTCAATTAGATTTATGGCAAAAC
AAGGATACAAACAAATATGAAAATAAAGTTTATTTGTTACCTAAACATCTTGATGAAAAG
GTTGCTCTTTATCATTTGAAAAAATTGAACGCTTCCTTGACAGAATTGGATGACAATCAA
TGTCAATTTTTGGGAGTCAACAAAAGTGGTCCCTTTAAGAGTAACGAATACAGATATTAA

# Drug_Target_27_General_Function:
Involved in adenosylhomocysteinase activity

# Drug_Target_27_General_References:
12368867	Hall N, Pain A, Berriman M, Churcher C, Harris B, Harris D, Mungall K, Bowman S, Atkin R, Baker S, Barron A, Brooks K, Buckee CO, Burrows C, Cherevach I, Chillingworth C, Chillingworth T, Christodoulou Z, Clark L, Clark R, Corton C, Cronin A, Davies R, Davis P, Dear P, Dearden F, Doggett J, Feltwell T, Goble A, Goodhead I, Gwilliam R, Hamlin N, Hance Z, Harper D, Hauser H, Hornsby T, Holroyd S, Horrocks P, Humphray S, Jagels K, James KD, Johnson D, Kerhornou A, Knights A, Konfortov B, Kyes S, Larke N, Lawson D, Lennard N, Line A, Maddison M, McLean J, Mooney P, Moule S, Murphy L, Oliver K, Ormond D, Price C, Quail MA, Rabbinowitsch E, Rajandream MA, Rutter S, Rutherford KM, Sanders M, Simmonds M, Seeger K, Sharp S, Smith R, Squares R, Squares S, Stevens K, Taylor K, Tivey A, Unwin L, Whitehead S, Woodward J, Sulston JE, Craig A, Newbold C, Barrell BG: Sequence of Plasmodium falciparum chromosomes 1, 3-9 and 13. Nature. 2002 Oct 3;419(6906):527-31.
8206944	Creedon KA, Rathod PK, Wellems TE: Plasmodium falciparum S-adenosylhomocysteine hydrolase. cDNA identification, predicted protein sequence, and expression in Escherichia coli. J Biol Chem. 1994 Jun 10;269(23):16364-70.

# Drug_Target_27_HGNC_ID:
Not Available

# Drug_Target_27_HPRD_ID:
Not Available

# Drug_Target_27_ID:
4424

# Drug_Target_27_Locus:
Not Available

# Drug_Target_27_Molecular_Weight:
53840

# Drug_Target_27_Name:
Adenosylhomocysteinase

# Drug_Target_27_Number_of_Residues:
479

# Drug_Target_27_PDB_ID:
1V8B

# Drug_Target_27_Pathway:
Not Available

# Drug_Target_27_Pfam_Domain_Function:
PF00670	AdoHcyase_NAD
PF05221	AdoHcyase

# Drug_Target_27_Protein_Sequence:
>Adenosylhomocysteinase
MVENKSKVKDISLAPFGKMQMEISENEMPGLMRIREEYGKDQPLKNAKITGCLHMTVECA
LLIETLQKLGAQIRWCSCNIYSTADYAAAAVSTLENVTVFAWKNETLEEYWWCVESALTW
GDGDDNGPDMIVDDGGDATLLVHKGVEYEKLYEEKNILPDPEKAKNEEERCFLTLLKNSI
LKNPKKWTNIAKKIIGVSEETTTGVLRLKKMDKQNELLFTAINVNDAVTKQKYDNVYGCR
HSLPDGLMRATDFLISGKIVVICGYGDVGKGCASSMKGLGARVYITEIDPICAIQAVMEG
FNVVTLDEIVDKGDFFITCTGNVDVIKLEHLLKMKNNAVVGNIGHFDDEIQVNELFNYKG
IHIENVKPQVDRITLPNGNKIIVLARGRLLNLGCATGHPAFVMSFSFCNQTFAQLDLWQN
KDTNKYENKVYLLPKHLDEKVALYHLKKLNASLTELDDNQCQFLGVNKSGPFKSNEYRY

# Drug_Target_27_Reaction:
Not Available

# Drug_Target_27_Signals:
None

# Drug_Target_27_Specific_Function:
Adenosylhomocysteine is a competitive inhibitor of S- adenosyl-L-methionine-dependent methyl transferase reactions; therefore adenosylhomocysteinase may play a key role in the control of methylations via regulation of the intracellular concentration of adenosylhomocysteine (By similarity)

# Drug_Target_27_SwissProt_ID:
P50250

# Drug_Target_27_SwissProt_Name:
SAHH_PLAF7

# Drug_Target_27_Synonyms:
AdoHcyase
EC 3.3.1.1
PfSAHH
S-adenosyl-L-homocysteine hydrolase

# Drug_Target_27_Theoretical_pI:
5.71

# Drug_Target_27_Transmembrane_Regions:
None

# Drug_Target_28_Cellular_Location:
Cytoplasm

# Drug_Target_28_Chromosome_Location:
Not Available

# Drug_Target_28_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_28_Essentiality:
Non-Essential

# Drug_Target_28_GenAtlas_ID:
LDHA

# Drug_Target_28_GenBank_ID_Gene:
X02152

# Drug_Target_28_GenBank_ID_Protein:
34313

# Drug_Target_28_GeneCard_ID:
LDHA

# Drug_Target_28_Gene_Name:
LDHA

# Drug_Target_28_Gene_Sequence:
>999 bp
ATGGCAACTCTAAAGGATCAGCTGATTTATAATCTTCTAAAGGAAGAACAGACCCCCCAG
AATAAGATTACAGTTGTTGGGGTTGGTGCTGTTGGCATGGCCTGTGCCATCAGTATCTTA
ATGAAGGACTTGGCAGATGAACTTGCTCTTGTTGATGTCATCGAAGACAAATTGAAGGGA
GAGATGATGGATCTCCAACATGGCAGCCTTTTCCTTAGAACACCAAAGATTGTCTCTGGC
AAAGACTATAATGTAACTGCAAACTCCAAGCTGGTCATTATCACGGCTGGGGCACGTCAG
CAAGAGGGAGAAAGCCGTCTTAATTTGGTCCAGCGTAACGTGAACATATTTAAATTCATC
ATTCCTAATGTTGTAAAATACAGCCCGAACTGCAAGTTGCTTATTGTTTCAAATCCAGTG
GATATCTTGACCTACGTGGCTTGGAAGATAAGTGGTTTTCCCAAAAACCGTGTTATTGGA
AGTGGTTGCAATCTGGATTCAGCCCGATTCCGTTACCTGATGGGGGAAAGGCTGGGAGTT
CACCCATTAAGCTGTCATGGGTGGGTCCTTGGGGAACATGGAGATTCCAGTGTGCCTGTA
TGGAGTGGAATGAATGTTGCTGGTGTCTCTCTGAAGACTCTGCACCCAGATTTAGGGACT
GATAAAGATAAGGAACAGTGGAAAGAGGTTCACAAGCAGGTGGTTGAGAGTGCTTATGAG
GTGATCAAACTCAAAGGCTACACATCCTGGGCTATTGGACTCTCTGTAGCAGATTTGGCA
GAGAGTATAATGAAGAATCTTAGGCGGGTGCACCCAGTTTCCACCATGATTAAGGGTCTT
TACGGAATAAAGGATGATGTCTTCCTTAGTGTTCCTTGCATTTTGGGACAGAATGGAATC
TCAGACCTTGTGAAGGTGACTCTGACTTCTGAGGAAGAGGCCCGTTTGAAGAAGAGTGCA
GATACACTTTGGGGGATCCAAAAGGAGCTGCAATTTTAA

# Drug_Target_28_General_Function:
Energy production and conversion

# Drug_Target_28_General_References:
10508479	Scanlan MJ, Gordan JD, Williamson B, Stockert E, Bander NH, Jongeneel V, Gure AO, Jager D, Jager E, Knuth A, Chen YT, Old LJ: Antigens recognized by autologous antibody in patients with renal-cell carcinoma. Int J Cancer. 1999 Nov 12;83(4):456-64.
1445373	Sudo K, Maekawa M, Shioya M, Ikeda K, Takahashi N, Isogai Y, Li SS, Kanno T, Machida K, Toriumi J: Molecular analysis of genetic mutation in electrophoretic variant of human lactate dehydrogenase-A(M) subunit. Biochem Int. 1992 Sep;27(6):1051-7.
1959923	Maekawa M, Sudo K, Li SS, Kanno T: Genotypic analysis of families with lactate dehydrogenase A (M) deficiency by selective DNA amplification. Hum Genet. 1991 Nov;88(1):34-8.
3000353	Chung FZ, Tsujibo H, Bhattacharyya U, Sharief FS, LI SS: Genomic organization of human lactate dehydrogenase-A gene. Biochem J. 1985 Nov 1;231(3):537-41.
3838278	Tsujibo H, Tiano HF, Li SS: Nucleotide sequences of the cDNA and an intronless pseudogene for human lactate dehydrogenase-A isozyme. Eur J Biochem. 1985 Feb 15;147(1):9-15.
7908613	Maekawa M, Sudo K, Kobayashi A, Sugiyama E, Li SS, Kanno T: Fast-type electrophoretic variant of lactate dehydrogenase M(A) and comparison with other missense mutations in lactate dehydrogenase M(A) and H(B) genes. Clin Chem. 1994 Apr;40(4):665-8.

# Drug_Target_28_HGNC_ID:
HGNC:6535

# Drug_Target_28_HPRD_ID:
01025

# Drug_Target_28_ID:
473

# Drug_Target_28_Locus:
11p15.4

# Drug_Target_28_Molecular_Weight:
36558

# Drug_Target_28_Name:
L-lactate dehydrogenase A chain

# Drug_Target_28_Number_of_Residues:
331

# Drug_Target_28_PDB_ID:
1I10

# Drug_Target_28_Pathway:
Not Available

# Drug_Target_28_Pfam_Domain_Function:
PF00056	Ldh_1_N
PF02866	Ldh_1_C

# Drug_Target_28_Protein_Sequence:
>L-lactate dehydrogenase A chain
ATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGE
MMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFII
PNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVH
PLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEV
IKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGIS
DLVKVTLTSEEEARLKKSADTLWGIQKELQF

# Drug_Target_28_Reaction:
(S)-lactate + NAD+ = pyruvate + NADH + H+

# Drug_Target_28_Signals:
None

# Drug_Target_28_Specific_Function:
Not Available

# Drug_Target_28_SwissProt_ID:
P00338

# Drug_Target_28_SwissProt_Name:
LDHA_HUMAN

# Drug_Target_28_Synonyms:
EC 1.1.1.27
LDH muscle subunit
LDH-A
LDH-M
Proliferation-inducing gene 19 protein
Renal carcinoma antigen NY-REN-59

# Drug_Target_28_Theoretical_pI:
8.45

# Drug_Target_28_Transmembrane_Regions:
None

# Drug_Target_29_Cellular_Location:
Nucleus

# Drug_Target_29_Chromosome_Location:
Not Available

# Drug_Target_29_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_29_Essentiality:
Non-Essential

# Drug_Target_29_GenAtlas_ID:
NMNAT1

# Drug_Target_29_GenBank_ID_Gene:
AF314163

# Drug_Target_29_GenBank_ID_Protein:
11245478

# Drug_Target_29_GeneCard_ID:
NMNAT1

# Drug_Target_29_Gene_Name:
NMNAT1

# Drug_Target_29_Gene_Sequence:
>840 bp
ATGGAAAATTCCGAGAAGACTGAAGTGGTTCTCCTTGCTTGTGGTTCATTCAATCCCATC
ACCAACATGCACCTCAGGTTGTTTGAGCTGGCCAAGGACTACATGAATGGAACAGGAAGG
TACACAGTTGTCAAAGGCATCATCTCTCCTGTTGGTGATGCCTACAAGAAGAAAGGACTC
ATTCCTGCCTATCACCGGGTCATCATGGCAGAACTTGCTACCAAGAATTCTAAATGGGTG
GAAGTTGATACATGGGAAAGTCTTCAGAAGGAGTGGAAAGAGACTCTGAAGGTGCTAAGA
CACCATCAAGAGAAATTGGAGGCTAGTGACTGTGATCACCAGCAGAACTCACCTACTCTA
GAAAGGCCTGGAAGGAAGAGGAAGTGGACTGAAACACAAGATTCTAGTCAAAAGAAATCC
CTAGAGCCAAAAACAAAAGCTGTGCCAAAGGTCAAGCTGCTGTGTGGGGCAGATTTATTG
GAGTCCTTTGCTGTTCCCAATTTGTGGAAGAGTGAAGACATCACCCAAATCGTGGCCAAC
TATGGGCTCATATGTGTTACTCGGGCTGGAAATGATGCTCAGAAGTTTATCTATGAATCG
GATGTGCTGTGGAAACACCGGAGCAACATTCACGTGGTGAATGAATGGATCGCTAATGAC
ATCTCATCCACAAAAATCCGGAGAGCCCTCAGAAGGGGCCAGAGCATTCGCTACTTGGTA
CCAGATCTTGTCCAAGAATACATTGAAAAGCATAATTTGTACAGCTCTGAGAGTGAAGAC
AGGAATGCTGGGGTCATCCTGGCCCCTTTGCAGAGAAACACTGCAGAAGCTAAGACATAG

# Drug_Target_29_General_Function:
Coenzyme transport and metabolism

# Drug_Target_29_General_References:
11248244	Schweiger M, Hennig K, Lerner F, Niere M, Hirsch-Kauffmann M, Specht T, Weise C, Oei SL, Ziegler M: Characterization of recombinant human nicotinamide mononucleotide adenylyl transferase (NMNAT), a nuclear enzyme essential for NAD synthesis. FEBS Lett. 2001 Mar 9;492(1-2):95-100.
11751893	Garavaglia S, D'Angelo I, Emanuelli M, Carnevali F, Pierella F, Magni G, Rizzi M: Structure of human NMN adenylyltransferase. A key nuclear enzyme for NAD homeostasis. J Biol Chem. 2002 Mar 8;277(10):8524-30. Epub 2001 Dec 19.
11891043	Fernando FS, Conforti L, Tosi S, Smith AD, Coleman MP: Human homologue of a gene mutated in the slow Wallerian degeneration (C57BL/Wld(s)) mouse. Gene. 2002 Feb 6;284(1-2):23-9.

# Drug_Target_29_HGNC_ID:
HGNC:17877

# Drug_Target_29_HPRD_ID:
16369

# Drug_Target_29_ID:
3296

# Drug_Target_29_Locus:
1p32-p35

# Drug_Target_29_Molecular_Weight:
31933

# Drug_Target_29_Name:
Nicotinamide mononucleotide adenylyltransferase 1

# Drug_Target_29_Number_of_Residues:
279

# Drug_Target_29_PDB_ID:
1KQO

# Drug_Target_29_Pathway:
Not Available

# Drug_Target_29_Pfam_Domain_Function:
PF01467	CTP_transf_2

# Drug_Target_29_Protein_Sequence:
>Nicotinamide mononucleotide adenylyltransferase 1
MENSEKTEVVLLACGSFNPITNMHLRLFELAKDYMNGTGRYTVVKGIISPVGDAYKKKGL
IPAYHRVIMAELATKNSKWVEVDTWESLQKEWKETLKVLRHHQEKLEASDCDHQQNSPTL
ERPGRKRKWTETQDSSQKKSLEPKTKAVPKVKLLCGADLLESFAVPNLWKSEDITQIVAN
YGLICVTRAGNDAQKFIYESDVLWKHRSNIHVVNEWIANDISSTKIRRALRRGQSIRYLV
PDLVQEYIEKHNLYSSESEDRNAGVILAPLQRNTAEAKT

# Drug_Target_29_Reaction:
ATP + nicotinamide ribonucleotide = diphosphate + NAD+

# Drug_Target_29_Signals:
None

# Drug_Target_29_Specific_Function:
ATP + nicotinamide ribonucleotide = diphosphate + NAD(+)

# Drug_Target_29_SwissProt_ID:
Q9HAN9

# Drug_Target_29_SwissProt_Name:
NMNA1_HUMAN

# Drug_Target_29_Synonyms:
EC 2.7.7.1
NMN adenylyltransferase 1

# Drug_Target_29_Theoretical_pI:
9.24

# Drug_Target_29_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
X06226

# Drug_Target_2_GenBank_ID_Protein:
41523

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
galE

# Drug_Target_2_Gene_Sequence:
>1017 bp
ATGAGAGTTCTGGTTACCGGTGGTAGCGGTTACATTGGAAGTCATACCTGTGTGCAATTA
CTGCAAAACGGTCATGATGTCATCATTCTTGATAACCTCTGTAACAGTAAGCGCAGCGTA
CTGCCTGTTATCGAGCGTTTAGGCGGCAAACATCCAACGTTTGTTGAAGGCGATATTCGT
AACGAAGCGTTGATGACCGAGATCCTGCACGATCACGCTATCGACACCGTGATCCACTTC
GCCGGGCTGAAAGCCGTGGGCGAATCGGTACAAAAACCGCTGGAATATTACGACAACAAT
GTCAACGGCACTCTGCGCCTGATTAGCGCCATGCGCGCCGCTAACGTCAAAAACTTTATT
TTTAGCTCCTCCGCCACCGTTTATGGCGATCAGCCCAAAATTCCATACGTTGAAAGCTTC
CCGACCGGCACACCGCAAAGCCCTTACGGCAAAAGCAAGCTGATGGTGGAACAGATCCTC
ACCGATCTGCAAAAAGCCCAGCCGGACTGGAGCATTGCCCTGCTGCGCTACTTCAACCCG
GTTGGCGCGCATCCGTCGGGCGATATGGGCGAAGATCCGCAAGGCATTCCGAATAACCTG
ATGCCATACATCGCCCAGGTTGCTGTAGGCCGTCGCGACTCGCTGGCGATTTTTGGTAAC
GATTATCCGACCGAAGATGGTACTGGCGTACGCGATTACATCCACGTAATGGATCTGGCG
GACGGTCACGTCGTGGCGATGGAAAAACTGGCGAACAAGCCAGGCGTACACATCTACAAC
CTCGGCGCTGGCGTAGGCAACAGCGTGCTGGACGTGGTTAATGCCTTCAGCAAAGCCTGC
GGCAAACCGGTTAATTATCATTTTGCACCGCGTCGCGAGGGCGACCTTCCGGCCTACTGG
GCGGACGCCAGCAAAGCCGACCGTGAACTGAACTGGCGCGTAACGCGCACACTCGATGAA
ATGGCGCAGGACACCTGGCACTGGCAGTCACGCCATCCACAGGGATATCCCGATTAA

# Drug_Target_2_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_2_General_References:
1579570	Bauer AJ, Rayment I, Frey PA, Holden HM: The molecular structure of UDP-galactose 4-epimerase from Escherichia coli determined at 2.5 A resolution. Proteins. 1992 Apr;12(4):372-81.
2134186	Bernardi F, Bernardi A: Completed sequence of pKG1800, a vector for determination of transcription terminators. DNA Seq. 1990;1(2):147-50.
3022232	Lemaire HG, Muller-Hill B: Nucleotide sequences of the gal E gene and the gal T gene of E. coli. Nucleic Acids Res. 1986 Oct 10;14(19):7705-11.
6301942	Busby S, Dreyfus M: Segment-specific mutagenesis of the regulatory region in the Escherichia coli galactose operon: isolation of mutations reducing the initiation of transcription and translation. Gene. 1983 Jan-Feb;21(1-2):121-31.
8564363	Walkenhorst HM, Hemschemeier SK, Eichenlaub R: Molecular analysis of the molybdate uptake operon, modABCD, of Escherichia coli and modR, a regulatory gene. Microbiol Res. 1995 Nov;150(4):347-61.
8611559	Thoden JB, Frey PA, Holden HM: Crystal structures of the oxidized and reduced forms of UDP-galactose 4-epimerase isolated from Escherichia coli. Biochemistry. 1996 Feb 27;35(8):2557-66.
8905232	Oshima T, Aiba H, Baba T, Fujita K, Hayashi K, Honjo A, Ikemoto K, Inada T, Itoh T, Kajihara M, Kanai K, Kashimoto K, Kimura S, Kitagawa M, Makino K, Masuda S, Miki T, Mizobuchi K, Mori H, Motomura K, Nakamura Y, Nashimoto H, Nishio Y, Saito N, Horiuchi T, et al.: A 718-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 12.7-28.0 min region on the linkage map. DNA Res. 1996 Jun 30;3(3):137-55.
8931134	Thoden JB, Frey PA, Holden HM: High-resolution X-ray structure of UDP-galactose 4-epimerase complexed with UDP-phenol. Protein Sci. 1996 Nov;5(11):2149-61.
9174344	Thoden JB, Hegeman AD, Wesenberg G, Chapeau MC, Frey PA, Holden HM: Structural analysis of UDP-sugar binding to UDP-galactose 4-epimerase from Escherichia coli. Biochemistry. 1997 May 27;36(21):6294-304.
9271499	Thoden JB, Gulick AM, Holden HM: Molecular structures of the S124A, S124T, and S124V site-directed mutants of UDP-galactose 4-epimerase from Escherichia coli. Biochemistry. 1997 Sep 2;36(35):10685-95.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9708982	Thoden JB, Holden HM: Dramatic differences in the binding of UDP-galactose and UDP-glucose to UDP-galactose 4-epimerase from Escherichia coli. Biochemistry. 1998 Aug 18;37(33):11469-77.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
3461

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
37266

# Drug_Target_2_Name:
UDP-glucose 4-epimerase

# Drug_Target_2_Number_of_Residues:
338

# Drug_Target_2_PDB_ID:
2UDP

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF01370	Epimerase

# Drug_Target_2_Protein_Sequence:
>UDP-glucose 4-epimerase
MRVLVTGGSGYIGSHTCVQLLQNGHDVIILDNLCNSKRSVLPVIERLGGKHPTFVEGDIR
NEALMTEILHDHAIDTVIHFAGLKAVGESVQKPLEYYDNNVNGTLRLISAMRAANVKNFI
FSSSATVYGDQPKIPYVESFPTGTPQSPYGKSKLMVEQILTDLQKAQPDWSIALLRYFNP
VGAHPSGDMGEDPQGIPNNLMPYIAQVAVGRRDSLAIFGNDYPTEDGTGVRDYIHVMDLA
DGHVVAMEKLANKPGVHIYNLGAGVGNSVLDVVNAFSKACGKPVNYHFAPRREGDLPAYW
ADASKADRELNWRVTRTLDEMAQDTWHWQSRHPQGYPD

# Drug_Target_2_Reaction:
UDP-glucose = UDP-galactose

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
UDP-glucose = UDP-galactose

# Drug_Target_2_SwissProt_ID:
P09147

# Drug_Target_2_SwissProt_Name:
GALE_ECOLI

# Drug_Target_2_Synonyms:
EC 5.1.3.2
Galactowaldenase
UDP-galactose 4-epimerase

# Drug_Target_2_Theoretical_pI:
6.32

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_30_Cellular_Location:
Not Available

# Drug_Target_30_Chromosome_Location:
Not Available

# Drug_Target_30_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_30_Essentiality:
Non-Essential

# Drug_Target_30_GenAtlas_ID:
Not Available

# Drug_Target_30_GenBank_ID_Gene:
M24015

# Drug_Target_30_GenBank_ID_Protein:
151259

# Drug_Target_30_GeneCard_ID:
Not Available

# Drug_Target_30_Gene_Name:
mvaA

# Drug_Target_30_Gene_Sequence:
>1287 bp
ATGAGCCTCGATTCCCGCCTGCCCGCTTTCCGTAACCTGTCCCCTGCCGCGCGCCTGGAC
CACATCGGCCAGTTGCTCGGCCTGAGCCACGACGATGTCAGCCTGCTGGCCAACGCCGGT
GCCCTGCCGATGGACATCGCCAACGGCATGATCGAAAACGTCATCGGCACCTTCGAGCTG
CCCTATGCCGTGGCCAGCAACTTCCAGATCAATGGCCGTGATGTGCTGGTGCCGCTGGTG
GTGGAAGAGCCCTCGATCGTCGCCGCTGCTTCGTACATGGCCAAGCTGGCCCGTGCCAAC
GGCGGCTTCACCACCTCCAGCAGCGCCCCGCTGATGCATGCCCAGGTACAGATCGTCGGC
ATACAGGACCCGCTCAATGCACGCCTGAGCCTGCTGCGCCGCAAAGACGAAATCATTGAA
CTGGCCAACCGCAAGGACCAGTTGCTCAACAGCCTCGGCGGCGGCTGCCGCGACATCGAA
GTGCACACCTTCGCCGATACCCCGCGTGGCCCGATGCTGGTGGCGCACCTGATCGTCGAT
GTACGCGATGCCATGGGCGCCAACACCGTCAATACCATGGCCGAGGCCGTTGCGCCGCTG
ATGGAAGCCATCACCGGGGGCCAGGTACGCCTGCGCATTCTGTCCAACCTGGCCGACCTG
CGCCTGGCCAGGGCCCAGGTGCGGATTACTCCGCAGCAACTGGAAACGGCCGAATTCAGT
GGCGAGGCAGTGATCGAAGGCATCCTCGACGCCTACGCCTTCGCTGCGGTCGACCCTTAC
CGCGCGGCCACCCACAACAAGGGCATCATGAATGGCATCGACCCACTGATCGTCGCCACT
GGCAACGACTGGCGTGCAGTGGAAGCCGGCGCCCATGCGTATGCCTGCCGCAGTGGTCAC
TACGGCTCGCTGACCACCTGGGAAAAGGACAACAACGGCCATTTGGTCGGCACCCTGGAA
ATGCCGATGCCCGTAGGCCTGGTCGGCGGCGCCACCAAAACCCATCCGCTGGCGCAACTG
TCGCTGCGCATCCTCGGCGTGAAAACAGCCCAGGCGCTCGCTGAGATTGCCGTGGCCGTA
GGCCTGGCGCAAAACCTCGGGGCCATGCGCGCCCTGGCCACCGAAGGCATCCAGCGCGGC
CACATGGCCCTGCATGCGCGCAATATTGCCGTGGTGGCGGGCGCCCGAGGCGATGAGGTG
GACTGGGTTGCCCGGCAGTTGGTGGAATACCACGACGTGCGCGCCGACCGCGCCGTAGCA
CTGCTGAAACAAAAGCGCGGCCAATGA

# Drug_Target_30_General_Function:
Lipid transport and metabolism

# Drug_Target_30_General_References:
10377386	Tabernero L, Bochar DA, Rodwell VW, Stauffacher CV: Substrate-induced closure of the flap domain in the ternary complex structures provides insights into the mechanism of catalysis by 3-hydroxy-3-methylglutaryl-CoA reductase. Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7167-71.
1634543	Darnay BG, Wang Y, Rodwell VW: Identification of the catalytically important histidine of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem. 1992 Jul 25;267(21):15064-70.
2123872	Wang Y, Darnay BG, Rodwell VW: Identification of the principal catalytically important acidic residue of 3-hydroxy-3-methylglutaryl coenzyme A reductase. J Biol Chem. 1990 Dec 15;265(35):21634-41.
2477360	Wang YL, Beach MJ, Rodwell VW: (S)-3-hydroxy-3-methylglutaryl coenzyme A reductase, a product of the mva operon of Pseudomonas mevalonii, is regulated at the transcriptional level. J Bacteriol. 1989 Oct;171(10):5567-71.
2656635	Beach MJ, Rodwell VW: Cloning, sequencing, and overexpression of mvaA, which encodes Pseudomonas mevalonii 3-hydroxy-3-methylglutaryl coenzyme A reductase. J Bacteriol. 1989 Jun;171(6):2994-3001.

# Drug_Target_30_HGNC_ID:
Not Available

# Drug_Target_30_HPRD_ID:
Not Available

# Drug_Target_30_ID:
3387

# Drug_Target_30_Locus:
Not Available

# Drug_Target_30_Molecular_Weight:
45591

# Drug_Target_30_Name:
3-hydroxy-3-methylglutaryl-coenzyme A reductase

# Drug_Target_30_Number_of_Residues:
428

# Drug_Target_30_PDB_ID:
1T02

# Drug_Target_30_Pathway:
Not Available

# Drug_Target_30_Pfam_Domain_Function:
Not Available

# Drug_Target_30_Protein_Sequence:
>3-hydroxy-3-methylglutaryl-coenzyme A reductase
MSLDSRLPAFRNLSPAARLDHIGQLLGLSHDDVSLLANAGALPMDIANGMIENVIGTFEL
PYAVASNFQINGRDVLVPLVVEEPSIVAAASYMAKLARANGGFTTSSSAPLMHAQVQIVG
IQDPLNARLSLLRRKDEIIELANRKDQLLNSLGGGCRDIEVHTFADTPRGPMLVAHLIVD
VRDAMGANTVNTMAEAVAPLMEAITGGQVRLRILSNLADLRLARAQVRITPQQLETAEFS
GEAVIEGILDAYAFAAVDPYRAATHNKGIMNGIDPLIVATGNDWRAVEAGAHAYACRSGH
YGSLTTWEKDNNGHLVGTLEMPMPVGLVGGATKTHPLAQLSLRILGVKTAQALAEIAVAV
GLAQNLGAMRALATEGIQRGHMALHARNIAVVAGARGDEVDWVARQLVEYHDVRADRAVA
LLKQKRGQ

# Drug_Target_30_Reaction:
(R)-mevalonate + CoA + 2 NAD+ = 3-hydroxy-3-methylglutaryl-CoA + 2 NADH + 2 H+

# Drug_Target_30_Signals:
None

# Drug_Target_30_Specific_Function:
P.mevalonii can use mevalonate as sole carbon source. With this enzyme mevalonate is deacetylated to HMG-CoA

# Drug_Target_30_SwissProt_ID:
P13702

# Drug_Target_30_SwissProt_Name:
MVAA_PSEMV

# Drug_Target_30_Synonyms:
EC 1.1.1.88
HMG-CoA reductase

# Drug_Target_30_Theoretical_pI:
6.71

# Drug_Target_30_Transmembrane_Regions:
None

# Drug_Target_31_Cellular_Location:
Not Available

# Drug_Target_31_Chromosome_Location:
Not Available

# Drug_Target_31_Drug_References:
Not Available

# Drug_Target_31_Essentiality:
Non-Essential

# Drug_Target_31_GenAtlas_ID:
Not Available

# Drug_Target_31_GenBank_ID_Gene:
AE017222

# Drug_Target_31_GenBank_ID_Protein:
Not Available

# Drug_Target_31_GeneCard_ID:
Not Available

# Drug_Target_31_Gene_Name:
TT_P0035

# Drug_Target_31_Gene_Sequence:
>1035 bp
GTGAGGTGGCGGGCGGACTTCCTCTCGGCCTGGGCGGAGGCCCTCTTGCGAAAGGCGGGG
GCGGACGAACCCTCCGCCAAGGCGGTGGCCTGGGCCCTGGTGGAGGCGGACCTCAGGGGG
GTGGGAAGCCACGGGCTTCTGCGCCTTCCCGTTTACGTGCGCCGCCTCGAGGCGGGCCTG
GTGAACCCCAGCCCCACCCTGCCCCTGGAGGAACGGGGCCCCGTGGCCCTCCTGGACGGG
GAGCACGGCTTCGGACCCCGCGTGGCCCTAAAGGCCGTGGAGGCGGCCCAAAGCCTCGCA
AGGAGGCACGGCCTCGGGGCCGTGGGGGTCAGGCGGAGCACCCACTTCGGCATGGCGGGC
CTCTACGCGGAGAAGCTCGCCCAGGCAGGTTTCCTGGCCCTCGTCACCACCAACGCCGAG
CCCGACGTGGTGCCCTTCGGGGGGCGGGAGAAGGCCTTGGGCACCAACCCTCTGGCCTTC
GCCGCCCCGGCCCCTCAGGGGATCCTCGTGGCCGACCTCGCCACCTCGGAAAGCGCCATG
GGCAAGGTCTTCCTAGCCCGGGAGAAGGGGGAGAGGATCCCCCCAAGCTGGGGGGTGGAC
CGGGAGGGGAACCCCACGGACGACCCCCACCGGGTCTACGCCCTGAGGCCCCTCGGGGGG
CCCAAGGGGTACGCCCTGGCCCTTTTGGTGGAGGTGCTCTCGGGGGTGCTCACGGGGGCG
GGGGTGGCCCACGGCATCGGCCGCATGTACGACGAGTGGGACCGCCCCCAGGACGTGGGC
CACTTCCTCCTGGCCCTGGACCCGGGGCGCTTCGTGGGCAAAGAGGCCTTCCTGGAGCGG
ATGGGGGCCCTTTGGCAAGCCCTAAAGGCCACTCCCCCGGCGCCGGGGCACGAGGAGGTC
TTCCTCCCCGGGGAGTTGGAGGCCAGGAGGCGGGAGCGGGCCCTGGCGGAGGGGATGGCC
CTTCCGGAGCGGGTGGTGGCGGAGCTTAAGGCCTTGGGGGAGCGCTACGGCGTGCCTTGG
AGGGACGATGCTTGA

# Drug_Target_31_General_Function:
Involved in oxidoreductase activity

# Drug_Target_31_General_References:
Not Available

# Drug_Target_31_HGNC_ID:
Not Available

# Drug_Target_31_HPRD_ID:
Not Available

# Drug_Target_31_ID:
4414

# Drug_Target_31_Locus:
Not Available

# Drug_Target_31_Molecular_Weight:
36830

# Drug_Target_31_Name:
Dehydrogenase

# Drug_Target_31_Number_of_Residues:
344

# Drug_Target_31_PDB_ID:
1VBI

# Drug_Target_31_Pathway:
Not Available

# Drug_Target_31_Pfam_Domain_Function:
PF02615	Ldh_2

# Drug_Target_31_Protein_Sequence:
>Dehydrogenase
MRWRADFLSAWAEALLRKAGADEPSAKAVAWALVEADLRGVGSHGLLRLPVYVRRLEAGL
VNPSPTLPLEERGPVALLDGEHGFGPRVALKAVEAAQSLARRHGLGAVGVRRSTHFGMAG
LYAEKLAQAGFLALVTTNAEPDVVPFGGREKALGTNPLAFAAPAPQGILVADLATSESAM
GKVFLAREKGERIPPSWGVDREGNPTDDPHRVYALRPLGGPKGYALALLVEVLSGVLTGA
GVAHGIGRMYDEWDRPQDVGHFLLALDPGRFVGKEAFLERMGALWQALKATPPAPGHEEV
FLPGELEARRRERALAEGMALPERVVAELKALGERYGVPWRDDA

# Drug_Target_31_Reaction:
Not Available

# Drug_Target_31_Signals:
None

# Drug_Target_31_Specific_Function:
Not Available

# Drug_Target_31_SwissProt_ID:
Q746L8

# Drug_Target_31_SwissProt_Name:
Q746L8_THET2

# Drug_Target_31_Synonyms:
Not Available

# Drug_Target_31_Theoretical_pI:
6.98

# Drug_Target_31_Transmembrane_Regions:
None

# Drug_Target_32_Cellular_Location:
Cytoplasm

# Drug_Target_32_Chromosome_Location:
Not Available

# Drug_Target_32_Drug_References:
Not Available

# Drug_Target_32_Essentiality:
Non-Essential

# Drug_Target_32_GenAtlas_ID:
Not Available

# Drug_Target_32_GenBank_ID_Gene:
X72629

# Drug_Target_32_GenBank_ID_Protein:
Not Available

# Drug_Target_32_GeneCard_ID:
Not Available

# Drug_Target_32_Gene_Name:
gap

# Drug_Target_32_Gene_Sequence:
>996 bp
GCTCGAGTTGCTATCAACGGTTTCGGTCGTATCGGTAGACTAGTTTATAGGATAATTTAC
GAGAGGAAGAACCCCGACATCGAAGTAGTGGCTATTAACGATTTGACAGACACCAAGACC
CTTGCACACCTTCTGAAGTACGACTCCGTTCACAAGAAGTTCCCCGGTAAAGTCGAGTAC
ACCGAGAACTCTCTAATCGTCGATGGAAAAGAGATCAAGGTCTTCGCGGAACCCGATCCT
TCGAAACTGCCCTGGAAGGACCTCGGTGTTGACTTCGTGATCGAATCCACCGGTGTCTTC
AGAAACAGAGAAAAGGCAGAACTTCACCTGCAGGCTGGAGCGAAGAAAGTCATCATCACA
GCGCCCGCCAAGGGAGAAGACATCACCGTTGTTATCGGTTGTAACGAAGACCAGCTGAAA
CCCGAACACACCATCATTTCCTGTGCGTCCTGTACAACCAACTCCATTGCACCCATCGTG
AAGGTGCTCCATGAGAAGTTTGGAATCGTCAGCGGAATGCTCACGACTGTTCACTCTTAC
ACGAACGACCAGAGAGTTCTCGACCTGCCTCACAAAGATCTGAGAAGGGCAAGAGCAGCT
GCGGTGAACATCATTCCGACAACCACGGGTGCCGCAAAAGCAGTTGCGCTCGTTGTTCCT
GAAGTGAAGGGCAAACTCGATGGTATGGCTATCAGGGTACCTACTCCCGATGGATCCATC
ACCGATCTTACAGTTCTGGTCGAGAAAGAAACCACGGTCGAGGAAGTCAACGCTGTCATG
AAAGAAGCCACAGAGGGAAGACTCAAGGGAATCATCGGATACAACGATGAACCCATTGTG
AGCAGCGACATCATTGGAACGACGTTCTCCGGTATCTTCGATGCCACAATCACCAACGTT
ATCGGTGGAAAGCTCGTGAAGGTGGCTTCCTGGTACGATAATGAATACGGTTACTCCAAC
AGAGTTGTCGACACCCTGGAACTGCTGCTGAAAATG

# Drug_Target_32_General_Function:
Involved in glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity

# Drug_Target_32_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.
2401296	Schultes V, Deutzmann R, Jaenicke R: Complete amino-acid sequence of glyceraldehyde-3-phosphate dehydrogenase from the hyperthermophilic eubacterium Thermotoga maritima. Eur J Biochem. 1990 Aug 28;192(1):25-31.
7877172	Korndorfer I, Steipe B, Huber R, Tomschy A, Jaenicke R: The crystal structure of holo-glyceraldehyde-3-phosphate dehydrogenase from the hyperthermophilic bacterium Thermotoga maritima at 2.5 A resolution. J Mol Biol. 1995 Mar 3;246(4):511-21.
8508805	Tomschy A, Glockshuber R, Jaenicke R: Functional expression of D-glyceraldehyde-3-phosphate dehydrogenase from the hyperthermophilic eubacterium Thermotoga maritima in Escherichia coli. Authenticity and kinetic properties of the recombinant enzyme. Eur J Biochem. 1993 May 15;214(1):43-50.

# Drug_Target_32_HGNC_ID:
Not Available

# Drug_Target_32_HPRD_ID:
Not Available

# Drug_Target_32_ID:
4426

# Drug_Target_32_Locus:
Not Available

# Drug_Target_32_Molecular_Weight:
36425

# Drug_Target_32_Name:
Glyceraldehyde-3-phosphate dehydrogenase

# Drug_Target_32_Number_of_Residues:
333

# Drug_Target_32_PDB_ID:
1HDG

# Drug_Target_32_Pathway:
Not Available

# Drug_Target_32_Pfam_Domain_Function:
PF00044	Gp_dh_N
PF02800	Gp_dh_C

# Drug_Target_32_Protein_Sequence:
>Glyceraldehyde-3-phosphate dehydrogenase
MARVAINGFGRIGRLVYRIIYERKNPDIEVVAINDLTDTKTLAHLLKYDSVHKKFPGKVE
YTENSLIVDGKEIKVFAEPDPSKLPWKDLGVDFVIESTGVFRNREKAELHLQAGAKKVII
TAPAKGEDITVVIGCNEDQLKPEHTIISCASCTTNSIAPIVKVLHEKFGIVSGMLTTVHS
YTNDQRVLDLPHKDLRRARAAAVNIIPTTTGAAKAVALVVPEVKGKLDGMAIRVPTPDGS
ITDLTVLVEKETTVEEVNAVMKEATEGRLKGIIGYNDEPIVSSDIIGTTFSGIFDATITN
VIGGKLVKVASWYDNEYGYSNRVVDTLELLLKM

# Drug_Target_32_Reaction:
Not Available

# Drug_Target_32_Signals:
None

# Drug_Target_32_Specific_Function:
D-glyceraldehyde 3-phosphate + phosphate + NAD(+) = 3-phospho-D-glyceroyl phosphate + NADH

# Drug_Target_32_SwissProt_ID:
P17721

# Drug_Target_32_SwissProt_Name:
G3P_THEMA

# Drug_Target_32_Synonyms:
EC 1.2.1.12
GAPDH

# Drug_Target_32_Theoretical_pI:
6.64

# Drug_Target_32_Transmembrane_Regions:
None

# Drug_Target_33_Cellular_Location:
Not Available

# Drug_Target_33_Chromosome_Location:
Not Available

# Drug_Target_33_Drug_References:
Not Available

# Drug_Target_33_Essentiality:
Non-Essential

# Drug_Target_33_GenAtlas_ID:
Not Available

# Drug_Target_33_GenBank_ID_Gene:
AF079762

# Drug_Target_33_GenBank_ID_Protein:
Not Available

# Drug_Target_33_GeneCard_ID:
Not Available

# Drug_Target_33_Gene_Name:
desIV

# Drug_Target_33_Gene_Sequence:
>1014 bp
TCACGCGGACACCTCCACGGCGGTGGCGGGCAGCTGCGGGGCGGTCGCCTTGAGCGGCTC
CCACCAGCCGCGGTTCTCCCGGTACCAGCGGACGGTCCGCGCGAGGCCGTCCGCGAAGGA
GACCTGCGGGCGGTAGCCGAGCTCGCGCTCGATCTCGCCGCCGTCGAGGGAGTAGCGCAG
GTCGTGGCCCTTGCGGTCGGCGACCTTCCGGACCGAGGACCAGTCGGCGCCGAGCGAGTC
CAGGAGGATGCCGGTGAGTTCGCGGTTGGTCAGCTCCAGGCCGCCGCCGATGTGGTAGAT
CTCGCCGGCCCGGCCGCCCGCGAGGACGAGCGCGATGCCCCGGCAGTGGTCGTCGGTGTG
CACCCACTCGCGGACGTTCGCGCCGTCGCCGTACAGCGGGAGCGTCCCGCCGTCGAGGAG
GTTCGTCACGAAGAGGGGGATGAGCTTCTCGGGGTGCTGGTACGGCCCGTAGTTGTTGCA
GCAGCGGGTGATCCGTACGTCGAGGCCGTACGTCCGGTGGTAGGCGCGGGCAACGAGGTC
GGAGCCGGCCTTGGACGCCGCGTAGGGCGAGTTGGGCTCCAGCGGGCTGCTCTCGGTCCA
GGAGCCGGAGTCGATCGACCCGTACACCTCGTCGGTGGAGACGTGCACGACCCGGCCGAC
GCCGGCGTCGACGGCGCACTGGAGCAGCGTCTGCGTGCCCTGCACGTTGGTCTCGGTGAA
CACGGACGCGCCCGCGATGGAGCGGTCCACGTGGCTCTCGGCCGCGAAGTGGACGATGGC
GTCCACGCCGCGCAGTTCCCGGGCGAGGAGGCCGGCGTCGCGGATGTCGCCGTGGACGAA
GCGCAGTCGCGGGTCCGCGTCCACCGGGGCGAGGTTGGCGCGGTTGCCCGCGTAGGTGAG
GCTGTCCAGGACGATCACCTCATCGGCGGGCACGTCGGGGTACGCCCCGGCGAGGAGCTG
CCGCACGAAGTGCGAGCCGATGAAGCCCGCACCTCCGGTCACCAGAAGCCGCAC

# Drug_Target_33_General_Function:
Involved in dTDP-glucose 4,6-dehydratase activity

# Drug_Target_33_General_References:
9770448	Xue Y, Zhao L, Liu HW, Sherman DH: A gene cluster for macrolide antibiotic biosynthesis in Streptomyces venezuelae: architecture of metabolic diversity. Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12111-6.

# Drug_Target_33_HGNC_ID:
Not Available

# Drug_Target_33_HPRD_ID:
Not Available

# Drug_Target_33_ID:
4427

# Drug_Target_33_Locus:
Not Available

# Drug_Target_33_Molecular_Weight:
36457

# Drug_Target_33_Name:
TDP-glucose-4,6-dehydratase

# Drug_Target_33_Number_of_Residues:
337

# Drug_Target_33_PDB_ID:
1R66

# Drug_Target_33_Pathway:
Not Available

# Drug_Target_33_Pfam_Domain_Function:
PF01370	Epimerase

# Drug_Target_33_Protein_Sequence:
>TDP-glucose-4,6-dehydratase
MRLLVTGGAGFIGSHFVRQLLAGAYPDVPADEVIVLDSLTYAGNRANLAPVDADPRLRFV
HGDIRDAGLLARELRGVDAIVHFAAESHVDRSIAGASVFTETNVQGTQTLLQCAVDAGVG
RVVHVSTDEVYGSIDSGSWTESSPLEPNSPYAASKAGSDLVARAYHRTYGLDVRITRCCN
NYGPYQHPEKLIPLFVTNLLDGGTLPLYGDGANVREWVHTDDHCRGIALVLAGGRAGEIY
HIGGGLELTNRELTGILLDSLGADWSSVRKVADRKGHDLRYSLDGGEIERELGYRPQVSF
ADGLARTVRWYRENRGWWEPLKATAPQLPATAVEVSA

# Drug_Target_33_Reaction:
Not Available

# Drug_Target_33_Signals:
None

# Drug_Target_33_Specific_Function:
Not Available

# Drug_Target_33_SwissProt_ID:
Q9ZGH3

# Drug_Target_33_SwissProt_Name:
Q9ZGH3_9ACTO

# Drug_Target_33_Synonyms:
Not Available

# Drug_Target_33_Theoretical_pI:
5.76

# Drug_Target_33_Transmembrane_Regions:
None

# Drug_Target_34_Cellular_Location:
Cytoplasm (Probable)

# Drug_Target_34_Chromosome_Location:
Not Available

# Drug_Target_34_Drug_References:
Not Available

# Drug_Target_34_Essentiality:
Non-Essential

# Drug_Target_34_GenAtlas_ID:
Not Available

# Drug_Target_34_GenBank_ID_Gene:
AF061257

# Drug_Target_34_GenBank_ID_Protein:
Not Available

# Drug_Target_34_GeneCard_ID:
Not Available

# Drug_Target_34_Gene_Name:
rex

# Drug_Target_34_Gene_Sequence:
>636 bp
ATGAAGGTCCCCGAAGCGGCCATCAGCCGCCTGATCACCTACCTCCGCATCTTGGAGGAG
CTGGAGGCCCAGGGGGTTCACCGGACGAGCTCCGAGCAGCTTGGGGAGCTCGCCCAGGTC
ACGGCCTTCCAGGTGCGGAAGGACCTTTCCTACTTCGGCTCCTACGGGACGCGCGGGGTG
GGGTACACCGTCCCCGTCCTGAAGCGGGAGCTCCGCCACATCCTGGGGCTCAACCGCAAG
TGGGGCCTGTGCATCGTGGGCATGGGCCGGCTCGGGAGCGCCCTGGCCGACTACCCGGGG
TTCGGGGAGAGCTTTGAGCTTAGGGGCTTCTTTGACGTGGACCCGGAGAAGGTGGGCCGC
CCGGTGCGGGGCGGGGTCATTGAGCACGTGGACCTCCTGCCCCAGCGGGTTCCCGGCCGC
ATTGAGATCGCCCTCCTCACCGTGCCCCGGGAAGCGGCCCAGAAGGCGGCGGACCTGTTG
GTGGCGGCGGGGATCAAGGGGATCCTGAACTTCGCCCCGGTGGTCCTCGAGGTGCCCAAG
GAGGTGGCGGTGGAGAACGTGGACTTCTTGGCGGGGCTCACGCGGCTTTCTTTCGCTATC
CTGAACCCCAAGTGGCGGGAAGAGATGATGGGGTGA

# Drug_Target_34_General_Function:
Involved in transcription repressor activity

# Drug_Target_34_General_References:
10076001	Du X, Pene JJ: Identification, cloning and expression of p25, an AT-rich DNA-binding protein from the extreme thermophile, Thermus aquaticus YT-1. Nucleic Acids Res. 1999 Apr 1;27(7):1690-7.

# Drug_Target_34_HGNC_ID:
Not Available

# Drug_Target_34_HPRD_ID:
Not Available

# Drug_Target_34_ID:
4428

# Drug_Target_34_Locus:
Not Available

# Drug_Target_34_Molecular_Weight:
23222

# Drug_Target_34_Name:
Redox-sensing transcriptional repressor rex

# Drug_Target_34_Number_of_Residues:
211

# Drug_Target_34_PDB_ID:
1XCB

# Drug_Target_34_Pathway:
Not Available

# Drug_Target_34_Pfam_Domain_Function:
PF02629	CoA_binding
PF06971	Put_DNA-bind_N

# Drug_Target_34_Protein_Sequence:
>Redox-sensing transcriptional repressor rex
MKVPEAAISRLITYLRILEELEAQGVHRTSSEQLGELAQVTAFQVRKDLSYFGSYGTRGV
GYTVPVLKRELRHILGLNRKWGLCIVGMGRLGSALADYPGFGESFELRGFFDVDPEKVGR
PVRGGVIEHVDLLPQRVPGRIEIALLTVPREAAQKAADLLVAAGIKGILNFAPVVLEVPK
EVAVENVDFLAGLTRLSFAILNPKWREEMMG

# Drug_Target_34_Reaction:
Not Available

# Drug_Target_34_Signals:
None

# Drug_Target_34_Specific_Function:
Modulates transcription in response to changes in cellular NADH/NAD(+) redox state (By similarity)

# Drug_Target_34_SwissProt_ID:
Q9X2V5

# Drug_Target_34_SwissProt_Name:
REX_THEAQ

# Drug_Target_34_Synonyms:
Not Available

# Drug_Target_34_Theoretical_pI:
8.45

# Drug_Target_34_Transmembrane_Regions:
None

# Drug_Target_35_Cellular_Location:
Mitochondrion
mitochondrial matrix

# Drug_Target_35_Chromosome_Location:
Not Available

# Drug_Target_35_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_35_Essentiality:
Non-Essential

# Drug_Target_35_GenAtlas_ID:
GLUD2

# Drug_Target_35_GenBank_ID_Gene:
X66310

# Drug_Target_35_GenBank_ID_Protein:
31815

# Drug_Target_35_GeneCard_ID:
GLUD2

# Drug_Target_35_Gene_Name:
GLUD2

# Drug_Target_35_Gene_Sequence:
>1677 bp
ATGTACCGCTACCTGGCCAAAGCGCTGCTGCCGTCCCGGGCCGGGCCCGCTGCCCTGGGC
TCCGCGGCCAACCACTCGGCCGCGTTGCTGGGCCGGGGCCGCGGACAGCCCGCCGCCGCC
TCGCAGCCGGGGCTCGCATTGGCCGCCCGGCGCCACTACAGCGAGTTGGTGGCCGACCGC
GAGGACGACCCCAACTTCTTCAAGATGGTGGAGGGCTTCTTCGATCGCGGCGCCAGCATC
GTGGAGGACAAGTTGGTGAAGGACCTGAGGACCCAGGAAAGCGAGGAGCAGAAGCGGAAC
CGGGTGCGCGGCATCCTGCGGATCATCAAGCCCTGCAACCATGTGCTGAGTCTCTCCTTC
CCCATCCGGCGCGACGACGGCTCCTGGGAGGTCATCGAAGGCTACCGGGCCCAGCACAGC
CAGCACCGCACGCCCTGCAAGGGAGGTATCCGTTACAGCACTGATGTGAGTGTAGATGAA
GTAAAAGCTTTGGCTTCTCTGATGACATACAAGTGTGCAGTGGTTGATGTGCCGTTTGGG
GGTGCTAAAGCTGGTGTTAAGATCAATCCCAAGAACTATACCGAAAATGAATTGGAAAAG
ATCACAAGGAGGTTCACCATGGAGCTAGCAAAGAAGGGCTTTATTGGTCCTGGCGTTGAT
GTGCCTGCTCCAGACATGAACACAGGTGAGCGGGAGATGTCCTGGATTGCTGATACCTAT
GCCAGCACCATAGGGCACTATGATATTAATGCACACGCCTGTGTTACTGGTAAACCCATC
AGCCAAGGGGGAATCCATGGACGCATCTCTGCTACTGGCCGTGGTGTCTTCCATGGGATT
GAAAACTTCATCAATCAAGCTTCTTACATGAGCATTTTAGGAATGACACCAGGGTTTAGA
GATAAAACATTTGTTGTTCAGGGATTTGGTAATGTGGGCCTACACTCTATGAGATATTTA
CATCGTTTTGGTGCTAAATGTATTGCTGTTGGTGAGTCTGATGGGAGTATATGGAATCCA
GATGGTATTGACCCAAAGGAACTGGAAGACTTCAAATTGCAACATGGGTCCATTCTGGGC
TTCCCCAAGGCAAAGCCCTATGAAGGAAGCATCTTGGAGGTCGACTGTGACATACTGATC
CCAGCTGCCACTGAGAAGCAGTTGACCAAATCCAACGCACCCAGAGTCAAAGCCAAGATC
ATTGCTGAAGGTGCCAATGGGCCAACAACTCCAGAAGCTGATAAGATCTTCCTGGAGAGA
AACATTTTGGTTATTCCAGATCTCTACTTGAATGCTGGAGGAGTGACAGTATCTTACTTT
GAGTGGCTGAAGAATCTAAATCATGTCAGCTATGGCCGTTTGACCTTCAAATATGAAAGG
GATTCTAACTACCACTTGCTCCTGTCTGTTCAAGAGAGTTTAGAAAGAAAATTTGGAAAG
CATGGTGGAACTATTCCCATTGTACCCACGGCAGAGTTCCAAGACAGTATATCGGGTGCA
TCTGAGAAAGACATTGTGCACTCTGCCTTGGCATACACAATGGAGCGTTCTGCCAGGCAA
ATTATGCACACAGCCATGAAGTATAACCTGGGATTGGACCTGAGAACAGCTGCCTATGTC
AATGCCATTGAAAAAGTCTTCAAAGTGTACAGTGAAGCTGGTGTGACCTTCACATAG

# Drug_Target_35_General_Function:
Replication, recombination and repair

# Drug_Target_35_General_References:
8207021	Shashidharan P, Michaelidis TM, Robakis NK, Kresovali A, Papamatheakis J, Plaitakis A: Novel human glutamate dehydrogenase expressed in neural and testicular tissues and encoded by an X-linked intronless gene. J Biol Chem. 1994 Jun 17;269(24):16971-6.

# Drug_Target_35_HGNC_ID:
HGNC:4336

# Drug_Target_35_HPRD_ID:
02143

# Drug_Target_35_ID:
830

# Drug_Target_35_Locus:
Xq24-q25

# Drug_Target_35_Molecular_Weight:
61435

# Drug_Target_35_Name:
Glutamate dehydrogenase 2, mitochondrial

# Drug_Target_35_Number_of_Residues:
558

# Drug_Target_35_PDB_ID:
1L1F

# Drug_Target_35_Pathway:
Not Available

# Drug_Target_35_Pfam_Domain_Function:
PF00208	ELFV_dehydrog
PF02812	ELFV_dehydrog_N

# Drug_Target_35_Protein_Sequence:
>Glutamate dehydrogenase 2, mitochondrial precursor
MYRYLAKALLPSRAGPAALGSAANHSAALLGRGRGQPAAASQPGLALAARRHYSELVADR
EDDPNFFKMVEGFFDRGASIVEDKLVKDLRTQESEEQKRNRVRGILRIIKPCNHVLSLSF
PIRRDDGSWEVIEGYRAQHSQHRTPCKGGIRYSTDVSVDEVKALASLMTYKCAVVDVPFG
GAKAGVKINPKNYTENELEKITRRFTMELAKKGFIGPGVDVPAPDMNTGEREMSWIADTY
ASTIGHYDINAHACVTGKPISQGGIHGRISATGRGVFHGIENFINEASYMSILGMTPGFR
DKTFVVQGFGNVGLHSMRYLHRFGAKCIAVGESDGSIWNPDGIDPKELEDFKLQHGSILG
FPKAKPYEGSILEVDCDILIPAATEKQLTKSNAPRVKAKIIAEGANGPTTPEADKIFLER
NILVIPDLYLNAGGVTVSYFEWLKNLNHVSYGRLTFKYERDSNYHLLLSVQESLERKFGK
HGGTIPIVPTAEFQDSISGASEKDIVHSALAYTMERSARQIMHTAMKYNLGLDLRTAAYV
NAIEKVFKVYSEAGVTFT

# Drug_Target_35_Reaction:
L-glutamate + H2O + NAD(P)+ = 2-oxoglutarate + NH3 + NAD(P)H + H+

# Drug_Target_35_Signals:
None

# Drug_Target_35_Specific_Function:
Important for recycling the chief excitatory neurotransmitter, glutamate, during neurotransmission

# Drug_Target_35_SwissProt_ID:
P49448

# Drug_Target_35_SwissProt_Name:
DHE4_HUMAN

# Drug_Target_35_Synonyms:
EC 1.4.1.3
GDH
Glutamate dehydrogenase 2, mitochondrial precursor

# Drug_Target_35_Theoretical_pI:
8.67

# Drug_Target_35_Transmembrane_Regions:
None

# Drug_Target_36_Cellular_Location:
Mitochondrion

# Drug_Target_36_Chromosome_Location:
Not Available

# Drug_Target_36_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_36_Essentiality:
Non-Essential

# Drug_Target_36_GenAtlas_ID:
DECR1

# Drug_Target_36_GenBank_ID_Gene:
L26050

# Drug_Target_36_GenBank_ID_Protein:
Not Available

# Drug_Target_36_GeneCard_ID:
Not Available

# Drug_Target_36_Gene_Name:
DECR1

# Drug_Target_36_Gene_Sequence:
>1008 bp
ATGAAGCTACCGGCCAGGGTTTTCTTTACTCTGGGGTCCCGGCTGCCCTGTGGCCTCGCT
CCTCGGAGGTTTTTCAGTTATGGGACAAAAATATTATATCAAAACACTGAAGCTTTGCAA
TCTAAATTCTTTTCACCTCTTCAAAAAGCGATGCTACCACCTAATAGTTTTCAAGGAAAA
GTGGCATTCATTACTGGGGGAGGTACTGGCCTTGGTAAAGGAATGACAACTCTTCTGTCC
AGCCTAGGTGCTCAGTGCGTGATAGCCAGCCGGAAGATGGATGTTTTGAAAGCTACCGCA
GAACAAATTTCTTCTCAAACTGGAAATAAGGTTCATGCAATTCAGTGTGATGTGAGGGAT
CCTGATATGGTTCAAAACACTGTGTCAGAACTGATCAAAGTTGCAGGACATCCTAATATT
GTGATAAACAATGCAGCAGGGAATTTTATTTCTCCTACTGAAAGACTTTCTCCTAATGCT
TGGAAAACCATAACTGACATAGTTCTAAATGGCACAGCCTTCGTGACACTAGAAATTGGA
AAACAACTAATTAAAGCACAGAAAGGAGCAGCATTTCTTTCTATTACTACTATCTATGCT
GAGACTGGTTCAGGTTTTGTAGTACCAAGTGCTTCTGCCAAAGCAGGTGTGGAAGCCATG
AGCAAGTCTCTTGCAGCTGAATGGGGTAAATATGGAATGCGATTCAATGTGATTCAACCA
GGGCCTATAAAAACCAAAGGTGCCTTTAGCCGTCTGGACCCAACTGGAACATTTGAGAAA
GAAATGATTGGCAGAATTCCCTGTGGTCGCCTGGGGACTGTAGAAGAACTCGCAAATCTT
GCTGCTTTCCTTTGTAGTGATTATGCTTCTTGGATTAATGGAGCAGTCATTAAATTTGAC
GGTGGAGAGGAAGTACTTATTTCAGGGGAATTCAACGACCTGAGAAAGGTCACCAAGGAG
CAGTGGGACACCATAGAAGAACTCATCAGGAAGACAAAAGGTTCCTAA

# Drug_Target_36_General_Function:
Involved in oxidoreductase activity

# Drug_Target_36_General_References:
7818482	Koivuranta KT, Hakkola EH, Hiltunen JK: Isolation and characterization of cDNA for human 120 kDa mitochondrial 2,4-dienoyl-coenzyme A reductase. Biochem J. 1994 Dec 15;304 ( Pt 3):787-92.
9403065	Helander HM, Koivuranta KT, Horelli-Kuitunen N, Palvimo JJ, Palotie A, Hiltunen JK: Molecular cloning and characterization of the human mitochondrial 2,4-dienoyl-CoA reductase gene (DECR). Genomics. 1997 Nov 15;46(1):112-9.

# Drug_Target_36_HGNC_ID:
HGNC:2753

# Drug_Target_36_HPRD_ID:
Not Available

# Drug_Target_36_ID:
5325

# Drug_Target_36_Locus:
8q21.3

# Drug_Target_36_Molecular_Weight:
36068

# Drug_Target_36_Name:
2,4-dienoyl-CoA reductase, mitochondrial

# Drug_Target_36_Number_of_Residues:
335

# Drug_Target_36_PDB_ID:
1W6U

# Drug_Target_36_Pathway:
Not Available

# Drug_Target_36_Pfam_Domain_Function:
PF00106	adh_short

# Drug_Target_36_Protein_Sequence:
>2,4-dienoyl-CoA reductase, mitochondrial
MKLPARVFFTLGSRLPCGLAPRRFFSYGTKILYQNTEALQSKFFSPLQKAMLPPNSFQGK
VAFITGGGTGLGKGMTTLLSSLGAQCVIASRKMDVLKATAEQISSQTGNKVHAIQCDVRD
PDMVQNTVSELIKVAGHPNIVINNAAGNFISPTERLSPNAWKTITDIVLNGTAFVTLEIG
KQLIKAQKGAAFLSITTIYAETGSGFVVPSASAKAGVEAMSKSLAAEWGKYGMRFNVIQP
GPIKTKGAFSRLDPTGTFEKEMIGRIPCGRLGTVEELANLAAFLCSDYASWINGAVIKFD
GGEEVLISGEFNDLRKVTKEQWDTIEELIRKTKGS

# Drug_Target_36_Reaction:
Not Available

# Drug_Target_36_Signals:
None

# Drug_Target_36_Specific_Function:
Auxiliary enzyme of beta-oxidation. It participates in the metabolism of unsaturated fatty enoyl-CoA esters having double bonds in both even- and odd-numbered positions. Catalyzes the NADP-dependent reduction of 2,4-dienoyl-CoA to yield trans-3- enoyl-CoA

# Drug_Target_36_SwissProt_ID:
Q16698

# Drug_Target_36_SwissProt_Name:
DECR_HUMAN

# Drug_Target_36_Synonyms:
2,4- dienoyl-CoA reductase [NADPH]
2,4-dienoyl-CoA reductase, mitochondrial precursor
4-enoyl-CoA reductase [NADPH]
EC 1.3.1.34

# Drug_Target_36_Theoretical_pI:
9.84

# Drug_Target_36_Transmembrane_Regions:
None

# Drug_Target_37_Cellular_Location:
Mitochondrion
mitochondrial matrix

# Drug_Target_37_Chromosome_Location:
Not Available

# Drug_Target_37_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_37_Essentiality:
Non-Essential

# Drug_Target_37_GenAtlas_ID:
DLD

# Drug_Target_37_GenBank_ID_Gene:
J03490

# Drug_Target_37_GenBank_ID_Protein:
307137

# Drug_Target_37_GeneCard_ID:
DLD

# Drug_Target_37_Gene_Name:
DLD

# Drug_Target_37_Gene_Sequence:
>1530 bp
ATGCAGAGCTGGAGTCGTGTGTACTGCTCCTTGGCCAAGAGAGGCCATTTCAATCGAATA
TCTCATGGCCTACAGGGACTTTCTGCAGTGCCTCTGAGAACTTACGCAGATCAGCCGATT
GATGCTGATGTAACAGTTATAGGTTCTGGTCCTGGAGGATATGTTGCTGCTATTAAAGCT
GCCCAGTTAGGCTTCAAGACAGTCTGCATTGAGAAAAATGAAACACTTGGTGGAACATGC
TTGAATGTTGGTTGTATTCCTTCTAAGGCTTTATTGAACAACTCTCATTATTACCATATG
GCCCATGGAACAGATTTTGCATCTAGAGGAATTGAAATGTCCGAAGTTCGCTTGAATTTA
GACAAGATGATGGAGCAGAAGAGTACTGCAGTAAAAGCTTTAACAGGTGGAATTGCCCAC
TTATTCAAACAGAATAAGGTTGTTCATGTCAATGGATATGGAAAGATAACTGGCAAAAAT
CAAGTCACTGCTACGAAAGCTGATGGCGGCACTCAGGTTATTGATACAAAGAACATTCTT
ATAGCCACGGGTTCAGAAGTTACTCCTTTTCCTGGAATCACGATAGATGAAGATACAATA
GTGTCATCTACAGGTGCTTTATCTTTAAAAAAAGTTCCAGAAAAGATGGTTGTTATTGGT
GCAGGAGTAATAGGTGTAGAATTGGGTTCAGTTTGGCAAAGACTTGGTGCAGATGTGACA
GCAGTTGAATTTTTAGGTCATGTAGGTGGAGTTGGAATTGATATGGAGATATCTAAAAAC
TTTCAACGCATCCTTCAAAAACAGGGGTTTAAATTTAAATTGAATACAAAGGTTACTGGT
GCTACCAAGAAGTCAGATGGAAAAATTGATGTTTCTATTGAAGCTGCTTCTGGTGGTAAA
GCTGAAGTTATCACTTGTGATGTACTCTTGGTTTGCATTGGCCGACGACCCTTTACTAAG
AATTTGGGACTAGAAGAGCTGGGAATTGAACTAGATCCTAGAGGTAGAATTCCAGTCAAT
ACCAGATTTCAAACTAAAATTCCAAATATCTATGCCATTGGTGATGTAGTTGCTGGTCCA
ATGCTGGCTCACAAAGCAGAGGATGAAGGCATTATCTGTGTTGAAGGAATGGCTGGTGGT
GCTGTGCACATTGACTACAATTGTGTGCCATCAGTGATTTACACACACCCTGAAGTTGCT
TGGGTTGGCAAATCAGAAGAGCAGTTGAAAGAAGAGGGTATTGAGTACAAAGTTGGGAAA
TTCCCATTTGCTGCTAACAGCAGAGCTAAGACAAATGCTGACACAGATGGCATGGTGAAG
ATCCTTGGGCAGAAATCGACAGACAGAGTACTGGGAGCACATATTCTTGGACCAGGTGCT
GGAGAAATGGTAAATGAAGCTGCTCTTGCTTTGGAATATGGAGCATCCTGTGAAGATATA
GCTAGAGTCTGTCATGCACATCCGACCTTATCAGAAGCTTTTAGAGAAGCAAATCTTGCT
GCGTCATTTGGCAAATCAATCAACTTTTGA

# Drug_Target_37_General_Function:
Energy production and conversion

# Drug_Target_37_General_References:
1332063	Johanning GL, Morris JI, Madhusudhan KT, Samols D, Patel MS: Characterization of the transcriptional regulatory region of the human dihydrolipoamide dehydrogenase gene. Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10964-8.
3278312	Pons G, Raefsky-Estrin C, Carothers DJ, Pepin RA, Javed AA, Jesse BW, Ganapathi MK, Samols D, Patel MS: Cloning and cDNA sequence of the dihydrolipoamide dehydrogenase component human alpha-ketoacid dehydrogenase complexes. Proc Natl Acad Sci U S A. 1988 Mar;85(5):1422-6.
3693355	Otulakowski G, Robinson BH: Isolation and sequence determination of cDNA clones for porcine and human lipoamide dehydrogenase. Homology to other disulfide oxidoreductases. J Biol Chem. 1987 Dec 25;262(36):17313-8.
8406489	Feigenbaum AS, Robinson BH: The structure of the human dihydrolipoamide dehydrogenase gene (DLD) and its upstream elements. Genomics. 1993 Aug;17(2):376-81.
8506365	Liu TC, Kim H, Arizmendi C, Kitano A, Patel MS: Identification of two missense mutations in a dihydrolipoamide dehydrogenase-deficient patient. Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5186-90.
8968745	Hong YS, Kerr DS, Craigen WJ, Tan J, Pan Y, Lusk M, Patel MS: Identification of two mutations in a compound heterozygous child with dihydrolipoamide dehydrogenase deficiency. Hum Mol Genet. 1996 Dec;5(12):1925-30.
9934985	Shaag A, Saada A, Berger I, Mandel H, Joseph A, Feigenbaum A, Elpeleg ON: Molecular basis of lipoamide dehydrogenase deficiency in Ashkenazi Jews. Am J Med Genet. 1999 Jan 15;82(2):177-82.

# Drug_Target_37_HGNC_ID:
HGNC:2898

# Drug_Target_37_HPRD_ID:
02006

# Drug_Target_37_ID:
812

# Drug_Target_37_Locus:
7q31-q32

# Drug_Target_37_Molecular_Weight:
54151

# Drug_Target_37_Name:
Dihydrolipoyl dehydrogenase, mitochondrial

# Drug_Target_37_Number_of_Residues:
509

# Drug_Target_37_PDB_ID:
Not Available

# Drug_Target_37_Pathway:
Not Available

# Drug_Target_37_Pfam_Domain_Function:
PF00070	Pyr_redox
PF02852	Pyr_redox_dim
PF07992	Pyr_redox_2

# Drug_Target_37_Protein_Sequence:
>Dihydrolipoyl dehydrogenase, mitochondrial precursor
MQSWSRVYCSLAKRGHFNRISHGLQGLSAVPLRTYADQPIDADVTVIGSGPGGYVAAIKA
AQLGFKTVCIEKNETLGGTCLNVGCIPSKALLNNSHYYHMAHGTDFASRGIEMSEVRLNL
DKMMEQKSTAVKALTGGIAHLFKQNKVVHVNGYGKITGKNQVTATKADGGTQVIDTKNIL
IATGSEVTPFPGITIDEDTIVSSTGALSLKKVPEKMVVIGAGVIGVELGSVWQRLGADVT
AVEFLGHVGGVGIDMEISKNFQRILQKQGFKFKLNTKVTGATKKSDGKIDVSIEAASGGK
AEVITCDVLLVCIGRRPFTKNLGLEELGIELDPRGRIPVNTRFQTKIPNIYAIGDVVAGP
MLAHKAEDEGIICVEGMAGGAVHIDYNCVPSVIYTHPEVAWVGKSEEQLKEEGIEYKVGK
FPFAANSRAKTNADTDGMVKILGQKSTDRVLGAHILGPGAGEMVNEAALALEYGASCEDI
ARVCHAHPTLSEAFREANLAASFGKSINF

# Drug_Target_37_Reaction:
protein N6-(dihydrolipoyl)lysine + NAD+ = protein N6-(lipoyl)lysine + NADH + H+ ALL_REAC (other) R00209 R01698 R03815 R07618

# Drug_Target_37_Signals:
None

# Drug_Target_37_Specific_Function:
Lipoamide dehydrogenase is a component of the glycine cleavage system as well as of the alpha-ketoacid dehydrogenase complexes

# Drug_Target_37_SwissProt_ID:
P09622

# Drug_Target_37_SwissProt_Name:
DLDH_HUMAN

# Drug_Target_37_Synonyms:
Dihydrolipoamide dehydrogenase
Dihydrolipoyl dehydrogenase, mitochondrial precursor
EC 1.8.1.4
Glycine cleavage system L protein

# Drug_Target_37_Theoretical_pI:
7.76

# Drug_Target_37_Transmembrane_Regions:
None

# Drug_Target_38_Cellular_Location:
Not Available

# Drug_Target_38_Chromosome_Location:
Not Available

# Drug_Target_38_Drug_References:
Not Available

# Drug_Target_38_Essentiality:
Non-Essential

# Drug_Target_38_GenAtlas_ID:
Not Available

# Drug_Target_38_GenBank_ID_Gene:
AE000512

# Drug_Target_38_GenBank_ID_Protein:
Not Available

# Drug_Target_38_GeneCard_ID:
Not Available

# Drug_Target_38_Gene_Name:
nadX

# Drug_Target_38_Gene_Sequence:
>726 bp
ATGACTGTTCTGATCATCGGAATGGGAAATATTGGGAAAAAACTCGTAGAACTGGGAAAT
TTCGAGAAAATCTACGCTTACGACAGGATTTCAAAAGACATTCCGGGAGTCGTTCGCCTC
GATGAATTCCAGGTTCCTTCAGACGTCAGCACGGTTGTCGAATGCGCTTCTCCAGAAGCC
GTTAAAGAATACTCACTTCAGATCCTGAAAAACCCTGTGAACTACATCATAATCAGCACC
AGCGCTTTCGCGGACGAAGTTTTCAGGGAAAGGTTCTTCAGCGAATTGAAAAATTCACCA
GCCAGGGTCTTTTTCCCATCCGGTGCCATCGGCGGTCTCGATGTTCTCTCTTCCATCAAA
GATTTCGTCAAAAACGTCCGCATAGAAACAATAAAACCTCCAAAGAGTCTCGGCCTGGAT
TTGAAAGGTAAAACAGTCGTGTTCGAAGGAAGTGTTGAGGAAGCGTCAAAACTATTTCCA
AGAAACATCAACGTAGCGTCGACCATCGGCCTTATAGTGGGCTTTGAAAAGGTAAAGGTA
ACAATAGTGGCAGATCCCGCCATGGATCACAACATCCACATTGTAAGAATCTCCTCCGCT
ATCGGAAACTACGAATTCAAAATAGAGAATATTCCATCACCAGAAAACCCAAAAACAAGT
ATGCTAACAGTCTATTCGATTCTCAGAACCTTGAGAAATCTCGAATCAAAAATCATATTC
GGATGA

# Drug_Target_38_General_Function:
Involved in oxidoreductase activity

# Drug_Target_38_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.

# Drug_Target_38_HGNC_ID:
Not Available

# Drug_Target_38_HPRD_ID:
Not Available

# Drug_Target_38_ID:
4435

# Drug_Target_38_Locus:
Not Available

# Drug_Target_38_Molecular_Weight:
26640

# Drug_Target_38_Name:
L-aspartate dehydrogenase

# Drug_Target_38_Number_of_Residues:
241

# Drug_Target_38_PDB_ID:
1J5P

# Drug_Target_38_Pathway:
Not Available

# Drug_Target_38_Pfam_Domain_Function:
PF01958	DUF108
PF03447	NAD_binding_3

# Drug_Target_38_Protein_Sequence:
>L-aspartate dehydrogenase
MTVLIIGMGNIGKKLVELGNFEKIYAYDRISKDIPGVVRLDEFQVPSDVSTVVECASPEA
VKEYSLQILKNPVNYIIISTSAFADEVFRERFFSELKNSPARVFFPSGAIGGLDVLSSIK
DFVKNVRIETIKPPKSLGLDLKGKTVVFEGSVEEASKLFPRNINVASTIGLIVGFEKVKV
TIVADPAMDHNIHIVRISSAIGNYEFKIENIPSPENPKTSMLTVYSILRTLRNLESKIIF
G

# Drug_Target_38_Reaction:
Not Available

# Drug_Target_38_Signals:
None

# Drug_Target_38_Specific_Function:
Specifically catalyzes the NAD or NADP-dependent dehydrogenation of L-aspartate to iminoaspartate. Does not show aspartate oxidase activity. Is also able to catalyze the reverse reaction, i.e. the reductive amination of oxaloacetate

# Drug_Target_38_SwissProt_ID:
Q9X1X6

# Drug_Target_38_SwissProt_Name:
ASPD_THEMA

# Drug_Target_38_Synonyms:
EC 1.4.1.21

# Drug_Target_38_Theoretical_pI:
8.40

# Drug_Target_38_Transmembrane_Regions:
None

# Drug_Target_39_Cellular_Location:
Not Available

# Drug_Target_39_Chromosome_Location:
Not Available

# Drug_Target_39_Drug_References:
Not Available

# Drug_Target_39_Essentiality:
Non-Essential

# Drug_Target_39_GenAtlas_ID:
Not Available

# Drug_Target_39_GenBank_ID_Gene:
Not Available

# Drug_Target_39_GenBank_ID_Protein:
Not Available

# Drug_Target_39_GeneCard_ID:
Not Available

# Drug_Target_39_Gene_Name:
tthHB8IM

# Drug_Target_39_Gene_Sequence:
Not Available

# Drug_Target_39_General_Function:
Involved in glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity

# Drug_Target_39_General_References:
Not Available

# Drug_Target_39_HGNC_ID:
Not Available

# Drug_Target_39_HPRD_ID:
Not Available

# Drug_Target_39_ID:
4436

# Drug_Target_39_Locus:
Not Available

# Drug_Target_39_Molecular_Weight:
35894

# Drug_Target_39_Name:
Glyceraldehyde 3-phosphate dehydrogenase

# Drug_Target_39_Number_of_Residues:
331

# Drug_Target_39_PDB_ID:
1VC2

# Drug_Target_39_Pathway:
Not Available

# Drug_Target_39_Pfam_Domain_Function:
PF00044	Gp_dh_N
PF02800	Gp_dh_C

# Drug_Target_39_Protein_Sequence:
>Glyceraldehyde 3-phosphate dehydrogenase
MKVGINGFGRIGRQVFRILHERGVEVALINDLTDNKTLAHLLKYDSTYGRFPGAVGYDEE
NLYVDGKAIRATAIKDPREIPWKQAGVGVVVESTGVFTDGEKARAHLEAGAKKVIITAPA
KNEDITVVLGVNHEQYDPAKHHILSNASCTTNSLAPVMKVLEKAFGVEKALMTTVHSYTN
DQRLLDLPHKDLRRARAAALNIIPTTTGAAKATALVLPSLKGRFDGMALRVPTPTGSISD
ITALLKREVTAEEVNAALKAAAEGPLKGILAYTEDEIVLRDIVMDPHSSIVDGKLTKAIG
NLVKVFAWYDNEWGYANRVADLVELVLKKGV

# Drug_Target_39_Reaction:
Not Available

# Drug_Target_39_Signals:
None

# Drug_Target_39_Specific_Function:
Not Available

# Drug_Target_39_SwissProt_ID:
P84125

# Drug_Target_39_SwissProt_Name:
P84125_THETH

# Drug_Target_39_Synonyms:
EC 1.2.1.12

# Drug_Target_39_Theoretical_pI:
8.83

# Drug_Target_39_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Not Available

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
Y00337

# Drug_Target_3_GenBank_ID_Protein:
45268

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
algD

# Drug_Target_3_Gene_Sequence:
>1311 bp
ATGCGAATCAGCATCTTTGGTTTGGGCTATGTCGGTGCAGTATGTGCTGGCTGCCTGTCG
GCACGCGGTCATGAAGTCATTGGTGTGGATGTCTCCAGCACCAAGATCGACCTGATCAAC
CAGGGCAAGTCGCCCATCGTCGAACCGGGCCTGGAAGCGTTGTTGCAGCAAGGCCGGCAG
ACCGGACGGCTGTCGGGCACCACCGACTTCAAGAAGGCTGTGCTGGACTCCGACGTATCG
TTCATCTGCGTCGGCACGCCGAGCAAGAAGAACGGCGACCTGGACCTGGGCTACATCGAG
ACCGTCTGCCGCGAGATCGGCTTCGCCATCCGCGAGAAGTCCGAACGCCACACCGTGGTG
GTGCGCAGCACCGTACTGCCGGGCACCGTCAACAACGTGGTGATCCCGCTGATCGAGGAC
TGCTCGGGCAAGAAGGCCGGGGTCGACTTCGGCGTCGGCACCAACCCCGAATTCCTCCGC
GAGAGCACCGCGATCAAGGACTACGACTTCCCGCCGATGACCGTGATCGGCGAACTGGAC
AAGCAGACCGGCGACCTTCTCGAGGAAATCTACCGCGAGCTGGACGCGCCGATCATCCGC
AAGACCGTCGAGGTCGCCGAGATGATCAAGTACACCTGCAACGTCTGGCACGCCGCCAAG
GTCACCTTCGCCAACGAGATCGGCAACATCGCCAAGGCGGTCGGCGTCGACGGCCGCGAG
GTGATGGACGTGATCTGCCAGGACCACAAGCTCAACCTGTCGCGCTACTACATGCGTCCC
GGCTTCGCCTTCGGCGGCTCCTGCCTGCCCAAGGATGTACGCGCCCTCACCTATCGCGCC
AGCCAGCTGGACGTCGAGCACCCGATGCTCGGTTCGTTGATGCGCAGCAACTCCAACCAG
GTGCAGAAGGCCTTCGATCTCATCACCAGCCACGACACCCGCAAGGTCGGCCTGCTCGGC
CTGTCGTTCAAGGCCGGCACCGACGATTTGCGCGAAAGCCCGCTGGTGGAGCTGGCCGAG
ATGCTCATCGGCAAGGGCTACGAGTTCCGCATCTTCGACCGCAACGTCGAATACGCGCGT
GTCCACGGGGCCAACAAGGAATACATCGAGTCGAAGATCCCGCACGTCTCCTCGCTGCTG
GTCTCCGACCTCGACGAAGTGGTGGCGAGTTCCGATGTGCTGGTGCTGGGCAATGGCGAC
GAGCTGTTCGTCGACCTGGTGAACAAGACCCCGAGCGGCAAGAAGCTGGTCGACCTGGTG
GGCTTCATGCCGCACACCACCACTGCCCAGGCCGAGGGCATCTGCTGGTAG

# Drug_Target_3_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_3_General_References:
10984043	Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV: Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature. 2000 Aug 31;406(6799):959-64.
12135385	Naught LE, Gilbert S, Imhoff R, Snook C, Beamer L, Tipton P: Allosterism and cooperativity in Pseudomonas aeruginosa GDP-mannose dehydrogenase. Biochemistry. 2002 Jul 30;41(30):9637-45.
12705829	Snook CF, Tipton PA, Beamer LJ: Crystal structure of GDP-mannose dehydrogenase: a key enzyme of alginate biosynthesis in P. aeruginosa. Biochemistry. 2003 Apr 29;42(16):4658-68.
1370473	Roychoudhury S, Chakrabarty K, Ho YK, Chakrabarty AM: Characterization of guanosine diphospho-D-mannose dehydrogenase from Pseudomonas aeruginosa. Structural analysis by limited proteolysis. J Biol Chem. 1992 Jan 15;267(2):990-6.
2470755	Roychoudhury S, May TB, Gill JF, Singh SK, Feingold DS, Chakrabarty AM: Purification and characterization of guanosine diphospho-D-mannose dehydrogenase. A key enzyme in the biosynthesis of alginate by Pseudomonas aeruginosa. J Biol Chem. 1989 Jun 5;264(16):9380-5.
3108855	Deretic V, Gill JF, Chakrabarty AM: Pseudomonas aeruginosa infection in cystic fibrosis: nucleotide sequence and transcriptional regulation of the algD gene. Nucleic Acids Res. 1987 Jun 11;15(11):4567-81.
8294014	Maharaj R, May TB, Wang SK, Chakrabarty AM: Sequence of the alg8 and alg44 genes involved in the synthesis of alginate by Pseudomonas aeruginosa. Gene. 1993 Dec 22;136(1-2):267-9.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
3367

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
47600

# Drug_Target_3_Name:
GDP-mannose 6-dehydrogenase

# Drug_Target_3_Number_of_Residues:
436

# Drug_Target_3_PDB_ID:
1MV8

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF00984	UDPG_MGDP_dh
PF03720	UDPG_MGDP_dh_C
PF03721	UDPG_MGDP_dh_N

# Drug_Target_3_Protein_Sequence:
>GDP-mannose 6-dehydrogenase
MRISIFGLGYVGAVCAGCLSARGHEVIGVDVSSTKIDLINQGKSPIVEPGLEALLQQGRQ
TGRLSGTTDFKKAVLDSDVSFICVGTPSKKNGDLDLGYIETVCREIGFAIREKSERHTVV
VRSTVLPGTVNNVVIPLIEDCSGKKAGVDFGVGTNPEFLRESTAIKDYDFPPMTVIGELD
KQTGDLLEEIYRELDAPIIRKTVEVAEMIKYTCNVWHAAKVTFANEIGNIAKAVGVDGRE
VMDVICQDHKLNLSRYYMRPGFAFGGSCLPKDVRALTYRASQLDVEHPMLGSLMRSNSNQ
VQKAFDLITSHDTRKVGLLGLSFKAGTDDLRESPLVELAEMLIGKGYELRIFDRNVEYAR
VHGANKEYIESKIPHVSSLLVSDLDEVVASSDVLVLGNGDELFVDLVNKTPSGKKLVDLV
GFMPHTTTAQAEGICW

# Drug_Target_3_Reaction:
GDP-D-mannose + 2 NAD+ + H2O = GDP-D-mannuronate + 2 NADH + 2 H+

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Catalyzes the oxidation of guanosine diphospho-D-mannose (GDP-D-mannose) to GDP-D-mannuronic acid, a precursor for alginate polymerization. The alginate layer causes a mucoid phenotype and provides a protective barrier against host immune defenses and antibiotics

# Drug_Target_3_SwissProt_ID:
P11759

# Drug_Target_3_SwissProt_Name:
ALGD_PSEAE

# Drug_Target_3_Synonyms:
EC 1.1.1.132
GMD

# Drug_Target_3_Theoretical_pI:
5.35

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_40_Cellular_Location:
Cytoplasm (By similarity)

# Drug_Target_40_Chromosome_Location:
Not Available

# Drug_Target_40_Drug_References:
Not Available

# Drug_Target_40_Essentiality:
Non-Essential

# Drug_Target_40_GenAtlas_ID:
Not Available

# Drug_Target_40_GenBank_ID_Gene:
D90340

# Drug_Target_40_GenBank_ID_Protein:
Not Available

# Drug_Target_40_GeneCard_ID:
Not Available

# Drug_Target_40_Gene_Name:
ldh

# Drug_Target_40_Gene_Sequence:
>963 bp
TTGTCAAGCATGCCAAATCATCAAAAAGTTGTGTTAGTCGGCGACGGCGCTGTTGGTTCT
AGTTACGCTTTTGCCATGGCACAACAAGGAATTGCTGAAGAATTTGTAATTGTCGATGTT
GTTAAGGATCGGACAAAGGGTGACGCCCTTGATCTTGAAGACGCCCAAGCTTTCACCGCT
CCCAAGAAGATTTACTCCGGCGAATATTCTGATTGCAAGGACGCCGATTTAGTTGTGATT
ACCGCTGGTGCCCCACAAAAGCCTGGCGAATCACGTTTAGACTTAGTTAACAAGAACTTG
AACATTTTATCATCAATCGTAAAACCAGTGGTCGACTCCGGCTTCGACGGCATCTTCTTA
GTTGCTGCTAACCCAGTTGACATCCTGACTTACGCGACTTGGAAATTCTCTGGTTTCCCA
AAGGAACGCGTCATTGGTTCCGGGACTTCCTTAGATTCTTCACGTCTACGGGTTGCGTTA
GGCAAGCAATTCAATGTCGACCCTCGCTCCGTTGATGCTTACATCATGGGTGAACACGGT
GACTCTGAATTCGCTGCTTACTCAACTGCCACTATCGGGACTCGTCCTGTACGCGACGTT
GCTAAGGAACAAGGCGTTTCTGACGACGACTTAGCTAAGTTGGAAGATGGCGTTCGGAAC
AAAGCTTACGACATTATCAACTTAAAGGGTGCAACCTTCTACGGTATCGGGACTGCTTTA
ATGCGGATCTCAAAGGCCATCTTACGTGATGAAAATGCCGTCTTACCAGTTGGCGCCTAT
ATGGACGGCCAATATGGTTTGAATGACATCTACATCGGGACACCAGCAATCATCGGTGGG
ACTGGTTTGAAGCAAATCATCGAATCCCCACTTTCAGCTGATGAACTGAAGAAGATGCAA
GATTCTGCTGCTACTTTGAAAAAAGTGCTTAACGACGGTTTAGCAGAATTAGAAAACAAA
TAA

# Drug_Target_40_General_Function:
Involved in oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor

# Drug_Target_40_General_References:
1425707	Taguchi H, Ohta T: Unusual amino acid substitution in the anion-binding site of Lactobacillus plantarum non-allosteric L-lactate dehydrogenase. Eur J Biochem. 1992 Nov 1;209(3):993-8.
1840590	Taguchi H, Ohta T: D-lactate dehydrogenase is a member of the D-isomer-specific 2-hydroxyacid dehydrogenase family. Cloning, sequencing, and expression in Escherichia coli of the D-lactate dehydrogenase gene of Lactobacillus plantarum. J Biol Chem. 1991 Jul 5;266(19):12588-94.

# Drug_Target_40_HGNC_ID:
Not Available

# Drug_Target_40_HPRD_ID:
Not Available

# Drug_Target_40_ID:
4437

# Drug_Target_40_Locus:
Not Available

# Drug_Target_40_Molecular_Weight:
34220

# Drug_Target_40_Name:
L-lactate dehydrogenase

# Drug_Target_40_Number_of_Residues:
320

# Drug_Target_40_PDB_ID:
1EZ4

# Drug_Target_40_Pathway:
Not Available

# Drug_Target_40_Pfam_Domain_Function:
PF00056	Ldh_1_N
PF02866	Ldh_1_C

# Drug_Target_40_Protein_Sequence:
>L-lactate dehydrogenase
MSSMPNHQKVVLVGDGAVGSSYAFAMAQQGIAEEFVIVDVVKDRTKGDALDLEDAQAFTA
PKKIYSGEYSDCKDADLVVITAGAPQKPGESRLDLVNKNLNILSSIVKPVVDSGFDGIFL
VAANPVDILTYATWKFSGFPKERVIGSGTSLDSSRLRVALGKQFNVDPRSVDAYIMGEHG
DSEFAAYSTATIGTRPVRDVAKEQGVSDDDLAKLEDGVRNKAYDIINLKGATFYGIGTAL
MRISKAILRDENAVLPVGAYMDGQYGLNDIYIGTPAIIGGTGLKQIIESPLSADELKKMQ
DSAATLKKVLNDGLAELENK

# Drug_Target_40_Reaction:
Not Available

# Drug_Target_40_Signals:
None

# Drug_Target_40_Specific_Function:
(S)-lactate + NAD(+) = pyruvate + NADH

# Drug_Target_40_SwissProt_ID:
P56511

# Drug_Target_40_SwissProt_Name:
LDH_LACPE

# Drug_Target_40_Synonyms:
EC 1.1.1.27
L-LDH

# Drug_Target_40_Theoretical_pI:
4.63

# Drug_Target_40_Transmembrane_Regions:
None

# Drug_Target_41_Cellular_Location:
Not Available

# Drug_Target_41_Chromosome_Location:
Not Available

# Drug_Target_41_Drug_References:
Not Available

# Drug_Target_41_Essentiality:
Non-Essential

# Drug_Target_41_GenAtlas_ID:
Not Available

# Drug_Target_41_GenBank_ID_Gene:
J02598

# Drug_Target_41_GenBank_ID_Protein:
Not Available

# Drug_Target_41_GeneCard_ID:
Not Available

# Drug_Target_41_Gene_Name:
mdh

# Drug_Target_41_Gene_Sequence:
>984 bp
GTGAAGGCACCCGTACGCGTGGCGGTTACCGGAGCCGCGGGACAGATCGGCTACAGCCTC
CTCTTCCGCATCGCCGCGGGGGAGATGCTGGGCAAGGACCAGCCGGTGATCCTCCAGCTT
TTGGAGATCCCCCAGGCCATGAAGGCCCTGGAGGGCGTGGTCATGGAGCTGGAGGACTGC
GCTTTCCCCCTGCTTGCGGGCCTCGAGGCCACCGACGACCCCAAGGTGGCCTTCAAGGAC
GCCGACTACGCCCTCCTGGTGGGGGCGGCCCCCCGCAAGGCGGGGATGGAGCGCCGGGAC
CTTCTGCAGGTGAACGGCAAGATCTTCACCGAGCAGGGCCGGGCCCTGGCCGAGGTGGCC
AAGAAGGACGTCAAGGTGCTGGTGGTGGGCAACCCCGCCAACACCAACGCCCTCATCGCC
TACAAGAACGCCCCCGGCCTCAACCCCCGGAACTTCACCGCCATGACCCGGCTGGACCAC
AACCGGGCCAAGGCCCAGCTCGCCAAGAAGACCGGGACGGGCGTGGACCGCATCCGCCGC
ATGACGGTGTGGGGCAACCACTCCTCCACCATGTTCCCCGACCTCTTCCACGCCGAGGTG
GACGGCAGGCCCGCCCTGGAGCTCGTGGACATGGAGTGGTACGAGAAGGTCTTCATCCCC
ACCGTGGCCCAGCGGGGGGCGGCCATCATCCAGGCCCGGGGGGCCAGCAGCGCCGCCAGC
GCCGCGAACGCCGCCATAGAGCATATCCGCGACTGGGCCCTGGGCACCCCGGAGGGGGAC
TGGGTCTCCATGGCCGTCCCCTCCCAAGGGGAGTACGGCATCCCCGAAGGCATCGTCTAC
TCCTTCCCGGTGACAGCCAAGGACGGAGCGTACCGGGTCGTGGAAGGCCTGGAGATCAAC
GAGTTCGCCCGCAAGCGCATGGAGATCACGGCCCAGGAACTCCTGGACGAGATGGAGCAG
GTGAAGGCCCTGGGCCTCATCTGA

# Drug_Target_41_General_Function:
Involved in oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor

# Drug_Target_41_General_References:
2034208	Nishiyama M, Horinouchi S, Beppu T: Characterization of an operon encoding succinyl-CoA synthetase and malate dehydrogenase from Thermus flavus AT-62 and its expression in Escherichia coli. Mol Gen Genet. 1991 Apr;226(1-2):1-9.
2204576	Nicholls DJ, Sundaram TK, Atkinson T, Minton NP: Cloning and nucleotide sequences of the mdh and sucD genes from Thermus aquaticus B. FEMS Microbiol Lett. 1990 Jun 15;58(1):7-14.
3771528	Nishiyama M, Matsubara N, Yamamoto K, Iijima S, Uozumi T, Beppu T: Nucleotide sequence of the malate dehydrogenase gene of Thermus flavus and its mutation directing an increase in enzyme activity. J Biol Chem. 1986 Oct 25;261(30):14178-83.
8471603	Kelly CA, Nishiyama M, Ohnishi Y, Beppu T, Birktoft JJ: Determinants of protein thermostability observed in the 1.9-A crystal structure of malate dehydrogenase from the thermophilic bacterium Thermus flavus. Biochemistry. 1993 Apr 20;32(15):3913-22.

# Drug_Target_41_HGNC_ID:
Not Available

# Drug_Target_41_HPRD_ID:
Not Available

# Drug_Target_41_ID:
4438

# Drug_Target_41_Locus:
Not Available

# Drug_Target_41_Molecular_Weight:
35426

# Drug_Target_41_Name:
Malate dehydrogenase

# Drug_Target_41_Number_of_Residues:
327

# Drug_Target_41_PDB_ID:
1IZ9

# Drug_Target_41_Pathway:
Not Available

# Drug_Target_41_Pfam_Domain_Function:
PF00056	Ldh_1_N
PF02866	Ldh_1_C

# Drug_Target_41_Protein_Sequence:
>Malate dehydrogenase
MKAPVRVAVTGAAGQIGYSLLFRIAAGEMLGKDQPVILQLLEIPQAMKALEGVVMELEDC
AFPLLAGLEATDDPKVAFKDADYALLVGAAPRKAGMERRDLLQVNGKIFTEQGRALAEVA
KKDVKVLVVGNPANTNALIAYKNAPGLNPRNFTAMTRLDHNRAKAQLAKKTGTGVDRIRR
MTVWGNHSSTMFPDLFHAEVDGRPALELVDMEWYEKVFIPTVAQRGAAIIQARGASSAAS
AANAAIEHIRDWALGTPEGDWVSMAVPSQGEYGIPEGIVYSFPVTAKDGAYRVVEGLEIN
EFARKRMEITAQELLDEMEQVKALGLI

# Drug_Target_41_Reaction:
Not Available

# Drug_Target_41_Signals:
None

# Drug_Target_41_Specific_Function:
Catalyzes the reversible oxidation of malate to oxaloacetate

# Drug_Target_41_SwissProt_ID:
P10584

# Drug_Target_41_SwissProt_Name:
MDH_THETH

# Drug_Target_41_Synonyms:
EC 1.1.1.37

# Drug_Target_41_Theoretical_pI:
5.81

# Drug_Target_41_Transmembrane_Regions:
None

# Drug_Target_42_Cellular_Location:
Not Available

# Drug_Target_42_Chromosome_Location:
Not Available

# Drug_Target_42_Drug_References:
Not Available

# Drug_Target_42_Essentiality:
Non-Essential

# Drug_Target_42_GenAtlas_ID:
Not Available

# Drug_Target_42_GenBank_ID_Gene:
D16831

# Drug_Target_42_GenBank_ID_Protein:
Not Available

# Drug_Target_42_GeneCard_ID:
Not Available

# Drug_Target_42_Gene_Name:
bphA4

# Drug_Target_42_Gene_Sequence:
>1227 bp
ATGTCACAAGAAGCATTGAAAGCCCCCGTTGTAGTTCTCGGTGCAGGCTTGGCCTCCGTC
TCCTTTGTGGCCGAACTGCGCCAGGCGGGCTACCAGGGGCTGATCACCGTAGTCGGCGAT
GAGGCCGAGCGACCTTACGACCGCCCGCCCTTGTCTAAGGACTTCATGGCCCATGGCGAC
GCCGAGAAGATCCGCCTTGACTGCAAGCGCGCGCCTGAGGTCGAATGGCTGCTGGGCGTC
ACGGCGCAGTCGTTCGATCCGCAGGCACACACGGTGGCGCTGTCGGACGGGCGCACCCTT
CCCTATGGCACGCTGGTGCTGGCCACGGGTGCAGCGCCGCGCGCGCTACCGACCTTGCAG
GGCGCCACCATGCCGGTACATACGCTGCGCACGCTGGAAGATGCGCGGCGCATCCAGGCC
GGGCTGCGCCCGCAGTCGCGACTTTTGATCGTAGGCGGCGGTGTGATCGGGCTCGAACTC
GCCGCCACGGCGCGCACTGCTGGTGTCCACGTGAGCCTTGTCGAAACTCAGCCGCGCCTC
ATGAGCCGCGCTGCACCGGCCACGCTGGCCGACTTCGTCGCGCGCTACCACGCGGCGCAA
GGGGTCGATCTGCGCTTTGAGCGCAGCGTCACGGGCTCTGTCGATGGCGTGGTGCTGCTC
GACGATGGCACGCGCATCGCGGCCGACATGGTGGTTGTGGGCATAGGCGTGTTGGCCAAC
GACGCGCTTGCGCGCGCAGCCGGGCTGGCCTGCGACGACGGCATCTTCGTCGATGCCTAT
GGGCGTACCACCTGTCCCGACGTCTATGCTCTTGGCGACGTAACGCGCCAGCGCAACCCT
CTAAGCGGGCGTTTCGAGCGGATCGAAACCTGGTCGAACGCGCAGAACCAGGGCATCGCG
GTGGCGCGCCACTTGGTCGATCCAACCGCGCCTGGATATGCCGAGTTGCCGTGGTATTGG
TCCGACCAGGGTGCGCTGCGCATCCAGGTGGCGGGGCTTGCGAGCGGCGACGAGGAAATC
GTGCGTGGCGAAGTCTCACTCGACGCCCCCAAGTTCACGCTCATCGAGCTGCAAAAGGGC
CGCATTGTGGGCGCGACCTGCGTGAACAACGCGCGCGACTTCGCACCGCTGCGGCGCCTG
CTCGCGGTCGGCGCCAAGCCCGACCGCGCCGCGCTCGCCGACCCGGCCACCGACTTGCGC
AAGCTCGCTGCCGCCGTTGCCGCGTGA

# Drug_Target_42_General_Function:
Involved in oxidoreductase activity

# Drug_Target_42_General_References:
11090282	Senda T, Yamada T, Sakurai N, Kubota M, Nishizaki T, Masai E, Fukuda M, Mitsuidagger Y: Crystal structure of NADH-dependent ferredoxin reductase component in biphenyl dioxygenase. J Mol Biol. 2000 Dec 1;304(3):397-410.
8132464	Kikuchi Y, Nagata Y, Hinata M, Kimbara K, Fukuda M, Yano K, Takagi M: Identification of the bphA4 gene encoding ferredoxin reductase involved in biphenyl and polychlorinated biphenyl degradation in Pseudomonas sp. strain KKS102. J Bacteriol. 1994 Mar;176(6):1689-94.

# Drug_Target_42_HGNC_ID:
Not Available

# Drug_Target_42_HPRD_ID:
Not Available

# Drug_Target_42_ID:
4439

# Drug_Target_42_Locus:
Not Available

# Drug_Target_42_Molecular_Weight:
43174

# Drug_Target_42_Name:
Ferredoxin reductase

# Drug_Target_42_Number_of_Residues:
408

# Drug_Target_42_PDB_ID:
1F3P

# Drug_Target_42_Pathway:
Not Available

# Drug_Target_42_Pfam_Domain_Function:
PF00070	Pyr_redox
PF07992	Pyr_redox_2

# Drug_Target_42_Protein_Sequence:
>Ferredoxin reductase
MSQEALKAPVVVLGAGLASVSFVAELRQAGYQGLITVVGDEAERPYDRPPLSKDFMAHGD
AEKIRLDCKRAPEVEWLLGVTAQSFDPQAHTVALSDGRTLPYGTLVLATGAAPRALPTLQ
GATMPVHTLRTLEDARRIQAGLRPQSRLLIVGGGVIGLELAATARTAGVHVSLVETQPRL
MSRAAPATLADFVARYHAAQGVDLRFERSVTGSVDGVVLLDDGTRIAADMVVVGIGVLAN
DALARAAGLACDDGIFVDAYGRTTCPDVYALGDVTRQRNPLSGRFERIETWSNAQNQGIA
VARHLVDPTAPGYAELPWYWSDQGALRIQVAGLASGDEEIVRGEVSLDAPKFTLIELQKG
RIVGATCVNNARDFAPLRRLLAVGAKPDRAALADPATDLRKLAAAVAA

# Drug_Target_42_Reaction:
Not Available

# Drug_Target_42_Signals:
None

# Drug_Target_42_Specific_Function:
Not Available

# Drug_Target_42_SwissProt_ID:
Q52437

# Drug_Target_42_SwissProt_Name:
Q52437_PSES1

# Drug_Target_42_Synonyms:
Not Available

# Drug_Target_42_Theoretical_pI:
6.27

# Drug_Target_42_Transmembrane_Regions:
None

# Drug_Target_43_Cellular_Location:
Not Available

# Drug_Target_43_Chromosome_Location:
Not Available

# Drug_Target_43_Drug_References:
Not Available

# Drug_Target_43_Essentiality:
Non-Essential

# Drug_Target_43_GenAtlas_ID:
Not Available

# Drug_Target_43_GenBank_ID_Gene:
X62755

# Drug_Target_43_GenBank_ID_Protein:
Not Available

# Drug_Target_43_GeneCard_ID:
Not Available

# Drug_Target_43_Gene_Name:
npr

# Drug_Target_43_Gene_Sequence:
>1344 bp
ATGAAAGTTATTGTTTTAGGATCATCACATGGAGGTTATGAAGCGGTAGAGGAATTACTA
AATCTTCATCCTGATGCAGAAATTCAATGGTATGAGAAAGGTGATTTTATCTCATTCTTG
TCTTGTGGCATGCAGTTGTACCTAGAAGGAAAAGTGAAAGATGTTAATTCTGTTCGCTAT
ATGACTGGCGAAAAAATGGAGAGCCGTGGTGTAAATGTCTTTTCTAATACTGAAATTACA
GCGATTCAACCAAAAGAACATCAAGTGACAGTGAAAGATTTAGTGTCAGGTGAAGAACGT
GTTGAAAATTATGATAAATTAATCATCAGTCCCGGAGCTGTCCCATTTGAATTAGATATT
CCAGGTAAAGATTTGGATAATATTTACTTGATGCGTGGTCGTCAATGGGCCATTAAATTA
AAACAAAAAACAGTAGATCCAGAAGTCAATAATGTGGTTGTGATTGGTAGTGGTTATATT
GGGATTGAAGCTGCCGAAGCATTTGCAAAAGCCGGTAAAAAGGTTACCGTTATTGATATT
TTAGATCGTCCATTAGGGGTGTATCTAGATAAAGAATTTACAGATGTTTTAACAGAAGAG
ATGGAAGCCAATAACATTACCATTGCAACTGGTGAAACAGTTGAACGTTACGAAGGCGAC
GGTCGTGTGCAAAAAGTCGTTACAGATAAAAATGCGTACGATGCTGATTTGGTCGTTGTA
GCGGTTGGTGTCCGTCCAAACACTGCTTGGTTAAAAGGTACCTTAGAATTACATCCGAAT
GGCCTAATCAAGACGGATGAATACATGCGGACAAGTGAGCCAGATGTATTTGCAGTAGGG
GATGCTACGTTAATTAAATACAATCCTGCAGACACAGAAGTAAATATTGCCTTAGCAACG
AATGCTCGTAAACAAGGTCGCTTTGCTGTGAAAAACCTAGAGGAACCAGTTAAACCTTTC
CCTGGTGTTCAAGGATCTTCTGGCTTGGCCGTCTTTGATTATAAATTTGCTTCAACAGGG
ATTAACGAAGTCATGGCTCAAAAATTAGGAAAAGAAACAAAAGCGGTGACAGTAGTAGAA
GACTACTTGATGGACTTTAATCCAGACAAACAAAAAGCTTGGTTTAAATTAGTGTATGAT
CCTGAAACAACACAAATTTTAGGCGCTCAATTAATGTCAAAAGCAGATTTAACTGCAAAC
ATTAATGCTATTTCATTAGCGATTCAAGCCAAAATGACAATTGAAGACTTAGCCTATGCG
GATTTCTTCTTCCAACCAGCGTTTGACAAACCTTGGAATATTATTAATACAGCGGCTTTA
GAAGCGGTGAAACAAGAACGTTAA

# Drug_Target_43_General_Function:
Involved in oxidoreductase activity

# Drug_Target_43_General_References:
12663927	Paulsen IT, Banerjei L, Myers GS, Nelson KE, Seshadri R, Read TD, Fouts DE, Eisen JA, Gill SR, Heidelberg JF, Tettelin H, Dodson RJ, Umayam L, Brinkac L, Beanan M, Daugherty S, DeBoy RT, Durkin S, Kolonay J, Madupu R, Nelson W, Vamathevan J, Tran B, Upton J, Hansen T, Shetty J, Khouri H, Utterback T, Radune D, Ketchum KA, Dougherty BA, Fraser CM: Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus faecalis. Science. 2003 Mar 28;299(5615):2071-4.
1719212	Ross RP, Claiborne A: Cloning, sequence and overexpression of NADH peroxidase from Streptococcus faecalis 10C1. Structural relationship with the flavoprotein disulfide reductases. J Mol Biol. 1991 Oct 5;221(3):857-71.
1942054	Stehle T, Ahmed SA, Claiborne A, Schulz GE: Structure of NADH peroxidase from Streptococcus faecalis 10C1 refined at 2.16 A resolution. J Mol Biol. 1991 Oct 20;221(4):1325-44.
2501302	Poole LB, Claiborne A: The non-flavin redox center of the streptococcal NADH peroxidase. I. Thiol reactivity and redox behavior in the presence of urea. J Biol Chem. 1989 Jul 25;264(21):12322-9.
8425532	Stehle T, Claiborne A, Schulz GE: NADH binding site and catalysis of NADH peroxidase. Eur J Biochem. 1993 Jan 15;211(1-2):221-6.
8756456	Yeh JI, Claiborne A, Hol WG: Structure of the native cysteine-sulfenic acid redox center of enterococcal NADH peroxidase refined at 2.8 A resolution. Biochemistry. 1996 Aug 6;35(31):9951-7.
9214307	Crane EJ 3rd, Vervoort J, Claiborne A: 13C NMR analysis of the cysteine-sulfenic acid redox center of enterococcal NADH peroxidase. Biochemistry. 1997 Jul 15;36(28):8611-8.

# Drug_Target_43_HGNC_ID:
Not Available

# Drug_Target_43_HPRD_ID:
Not Available

# Drug_Target_43_ID:
4440

# Drug_Target_43_Locus:
Not Available

# Drug_Target_43_Molecular_Weight:
49566

# Drug_Target_43_Name:
NADH peroxidase

# Drug_Target_43_Number_of_Residues:
447

# Drug_Target_43_PDB_ID:
2NPX

# Drug_Target_43_Pathway:
Not Available

# Drug_Target_43_Pfam_Domain_Function:
PF00070	Pyr_redox
PF02852	Pyr_redox_dim
PF07992	Pyr_redox_2

# Drug_Target_43_Protein_Sequence:
>NADH peroxidase
MKVIVLGSSHGGYEAVEELLNLHPDAEIQWYEKGDFISFLSCGMQLYLEGKVKDVNSVRY
MTGEKMESRGVNVFSNTEITAIQPKEHQVTVKDLVSGEERVENYDKLIISPGAVPFELDI
PGKDLDNIYLMRGRQWAIKLKQKTVDPEVNNVVVIGSGYIGIEAAEAFAKAGKKVTVIDI
LDRPLGVYLDKEFTDVLTEEMEANNITIATGETVERYEGDGRVQKIVTDKNAYDADLVVV
AVGVRPNTAWLKGTLELHPNGLIKTDEYMRTSEPDVFAVGDATLIKYNPADTEVNIALAT
NARKQGRFAVKNLEEPVKPFPGVQGSSGLAVFDYKFASTGINEVMAQKLGKETKAVTVVE
DYLMDFNPDKQKAWFKLVYDPETTQILGAQLMSKADLTANINAISLAIQAKMTIEDLAYA
DFFFQPAFDKPWNIINTAALEAVKQER

# Drug_Target_43_Reaction:
Not Available

# Drug_Target_43_Signals:
None

# Drug_Target_43_Specific_Function:
Peroxidase whose active site is a redox-active cysteine- sulfenic acid

# Drug_Target_43_SwissProt_ID:
P37062

# Drug_Target_43_SwissProt_Name:
NAPE_ENTFA

# Drug_Target_43_Synonyms:
EC 1.11.1.1
NPXase
Npx

# Drug_Target_43_Theoretical_pI:
4.56

# Drug_Target_43_Transmembrane_Regions:
None

# Drug_Target_44_Cellular_Location:
Cytoplasm

# Drug_Target_44_Chromosome_Location:
Not Available

# Drug_Target_44_Drug_References:
Not Available

# Drug_Target_44_Essentiality:
Non-Essential

# Drug_Target_44_GenAtlas_ID:
Not Available

# Drug_Target_44_GenBank_ID_Gene:
M14788

# Drug_Target_44_GenBank_ID_Protein:
Not Available

# Drug_Target_44_GeneCard_ID:
Not Available

# Drug_Target_44_Gene_Name:
ldh

# Drug_Target_44_Gene_Sequence:
>954 bp
ATGAAAAACAACGGTGGAGCCCGAGTAGTGGTCATCGGCGCCGGGTTTGTCGGCGCCAGT
TATGTGTTTGCCTTAATGAATCAAGGGATTGCCGATGAGATCGTGCTCATCGATGCGAAT
GAAAGCAAGGCCATAGGCGATGCGATGGACTTCAACCATGGGAAAGTATTTGCGCCGAAG
CCGGTTGACATTTGGCACGGCGATTACGATGATTGCCGCGATGCCGATTTGGTTGTCATT
TGCGCCGGCGCCAACCAAAAACCGGGCGAGACGCGGCTTGATCTTGTGGACAAAAACATT
GCCATTTTCCGCTCGATCGTTGAGTCGGTCATGGCATCCGGATTTCAAGGACTGTTTCTC
GTCGCCACCAATCCGGTCGACATTTTAACGTACGCGACGTGGAAATTCAGCGGCCTGCCG
CATGAGCGGGTGATCGGTTCGGGGACGATTTTAGATACGGCGCGGTTCCGCTTTTTGTTG
GGCGAGTATTTCTCTGTCGCTCCGCAAAATGTTCATGCCTATATTATTGGGGAACACGGC
GACACTGAACTCCCGGTCTGGAGCCAGGCTTATATCGGCGTCATGCCGATCCGCAAGCTG
GTCGAGTCCAAAGGGGAAGAAGCGCAAAAAGATCTCGAGCGCATTTTTGTCAATGTGCGC
GATGCCGCCTACCAAATTATTGAGAAAAAAGGAGCGACGTACTACGGGATTGCGATGGGG
CTTGCCCGCGTGACGCGCGCCATTTTGCATAACGAAAACGCTATTTTGACCGTATCAGCC
TACCTCGATGGCCTATATGGGGAGCGCGACGTCTACATCGGAGTGCCGGCTGTCATTAAC
CGCAATGGCATCCGCGAGGTGATCGAAATTGAATTGAATGATGACGAAAAAAATCGATTC
CATCATAGCGCAGCTACATTAAAAAGCGTGCTAGCCCGTGCTTTTACGCGATGA

# Drug_Target_44_General_Function:
Involved in oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor

# Drug_Target_44_General_References:
1731077	Wigley DB, Gamblin SJ, Turkenburg JP, Dodson EJ, Piontek K, Muirhead H, Holbrook JJ: Structure of a ternary complex of an allosteric lactate dehydrogenase from Bacillus stearothermophilus at 2.5 A resolution. J Mol Biol. 1992 Jan 5;223(1):317-35.
3026926	Barstow DA, Clarke AR, Chia WN, Wigley D, Sharman AF, Holbrook JJ, Atkinson T, Minton NP: Cloning, expression and complete nucleotide sequence of the Bacillus stearothermophilus L-lactate dehydrogenase gene. Gene. 1986;46(1):47-55.
3675869	Zulli F, Weber H, Zuber H: Structure and function of L-lactate dehydrogenases from thermophilic and mesophilic bacteria, VI. Nucleotide sequences of lactate dehydrogenase genes from the thermophilic bacteria Bacillus stearothermophilus, B. caldolyticus and B. caldotenax. Biol Chem Hoppe Seyler. 1987 Sep;368(9):1167-77.
6352452	Wirz B, Suter F, Zuber H: Structure and function of L-lactate dehydrogenases from thermophilic and mesophilic bacteria. III) The primary structure of thermophilic lactate dehydrogenase from Bacillus stearothermophilus. Hydroxylamine-, o-iodosobenzoic acid- and tryptic-fragments. The complete amino-acid sequence. Hoppe Seylers Z Physiol Chem. 1983 Jul;364(7):893-909.
6618448	Tratschin JD, Wirz B, Frank G, Zuber H: Structure and function of L-lactate dehydrogenases from thermophilic and mesophilic bacteria. II) The primary structure of thermophilic lactate dehydrogenase from Bacillus stearothermophilus. Cyanogen bromide fragments and partial sequence. Hoppe Seylers Z Physiol Chem. 1983 Jul;364(7):879-92.

# Drug_Target_44_HGNC_ID:
Not Available

# Drug_Target_44_HPRD_ID:
Not Available

# Drug_Target_44_ID:
4442

# Drug_Target_44_Locus:
Not Available

# Drug_Target_44_Molecular_Weight:
34863

# Drug_Target_44_Name:
L-lactate dehydrogenase

# Drug_Target_44_Number_of_Residues:
317

# Drug_Target_44_PDB_ID:
2LDB

# Drug_Target_44_Pathway:
Not Available

# Drug_Target_44_Pfam_Domain_Function:
PF00056	Ldh_1_N
PF02866	Ldh_1_C

# Drug_Target_44_Protein_Sequence:
>L-lactate dehydrogenase
MKNNGGARVVVIGAGFVGASYVFALMNQGIADEIVLIDANESKAIGDAMDFNHGKVFAPK
PVDIWHGDYDDCRDADLVVICAGANQKPGETRLDLVDKNIAIFRSIVESVMASGFQGLFL
VATNPVDILTYATWKFSGLPHERVIGSGTILDTARFRFLLGEYFSVAPQNVHAYIIGEHG
DTELPVWSQAYIGVMPIRKLVESKGEEAQKDLERIFVNVRDAAYQIIEKKGATYYGIAMG
LARVTRAILHNENAILTVSAYLDGLYGERDVYIGVPAVINRNGIREVIEIELNDDEKNRF
HHSAATLKSVLARAFTR

# Drug_Target_44_Reaction:
Not Available

# Drug_Target_44_Signals:
None

# Drug_Target_44_Specific_Function:
(S)-lactate + NAD(+) = pyruvate + NADH

# Drug_Target_44_SwissProt_ID:
P00344

# Drug_Target_44_SwissProt_Name:
LDH_GEOSE

# Drug_Target_44_Synonyms:
EC 1.1.1.27
L-LDH

# Drug_Target_44_Theoretical_pI:
5.62

# Drug_Target_44_Transmembrane_Regions:
None

# Drug_Target_45_Cellular_Location:
Not Available

# Drug_Target_45_Chromosome_Location:
Not Available

# Drug_Target_45_Drug_References:
Not Available

# Drug_Target_45_Essentiality:
Non-Essential

# Drug_Target_45_GenAtlas_ID:
Not Available

# Drug_Target_45_GenBank_ID_Gene:
U00096

# Drug_Target_45_GenBank_ID_Protein:
Not Available

# Drug_Target_45_GeneCard_ID:
Not Available

# Drug_Target_45_Gene_Name:
ydiB

# Drug_Target_45_Gene_Sequence:
>867 bp
ATGGATGTTACCGCAAAATACGAATTGATTGGGTTGATGGCCTATCCTATCCGCCACAGT
TTATCGCCCGAAATGCAGAATAAAGCCTTAGAAAAAGCGGGATTGCCATTTACCTATATG
GCCTTCGAAGTGGATAACGATAGCTTTCCTGGAGCAATTGAAGGATTAAAAGCCCTCAAA
ATGCGCGGAACTGGTGTATCGATGCCGAACAAACAACTGGCGTGTGAATATGTTGATGAA
TTAACACCAGCTGCCAAACTGGTGGGGGCCATCAACACCATCGTTAATGATGATGGCTAT
CTGCGTGGCTATAACACCGACGGCACGGGCCATATTCGCGCCATTAAAGAGAGCGGTTTT
GATATCAAAGGCAAAACGATGGTGCTGTTAGGGGCCGGTGGTGCCTCAACGGCAATTGGC
GCGCAGGGGGCAATTGAAGGTTTAAAAGAAATTAAACTCTTTAACCGTCGGGATGAGTTC
TTCGATAAAGCCCTCGCCTTCGCGCAGCGGGTTAATGAAAACACCGATTGTGTCGTCACG
GTCACCGATCTCGCCGATCAGCAAGCCTTTGCTGAAGCCCTGGCTTCCGCCGACATTTTA
ACCAATGGCACAAAAGTGGGTATGAAACCCCTTGAGAATGAATCATTGGTTAATGATATC
AGTCTGTTACATCCGGGACTTCTGGTCACTGAATGCGTGTATAACCCGCATATGACGAAG
TTATTGCAGCAGGCGCAACAAGCTGGTTGCAAAACGATTGATGGATACGGCATGTTGTTG
TGGCAAGGGGCTGAACAGTTCACATTATGGACTGGCAAAGATTTCCCTCTGGAATATGTT
AAACAGGTCATGGGGTTCGGTGCCTGA

# Drug_Target_45_General_Function:
Involved in shikimate 5-dehydrogenase activity

# Drug_Target_45_General_References:
12624088	Benach J, Lee I, Edstrom W, Kuzin AP, Chiang Y, Acton TB, Montelione GT, Hunt JF: The 2.3-A crystal structure of the shikimate 5-dehydrogenase orthologue YdiB from Escherichia coli suggests a novel catalytic environment for an NAD-dependent dehydrogenase. J Biol Chem. 2003 May 23;278(21):19176-82. Epub 2003 Mar 6.
3541912	Duncan K, Chaudhuri S, Campbell MS, Coggins JR: The overexpression and complete amino acid sequence of Escherichia coli 3-dehydroquinase. Biochem J. 1986 Sep 1;238(2):475-83.
9097039	Aiba H, Baba T, Hayashi K, Inada T, Isono K, Itoh T, Kasai H, Kashimoto K, Kimura S, Kitakawa M, Kitagawa M, Makino K, Miki T, Mizobuchi K, Mori H, Mori T, Motomura K, Nakade S, Nakamura Y, Nashimoto H, Nishio Y, Oshima T, Saito N, Sampei G, Horiuchi T, et al.: A 570-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 28.0-40.1 min region on the linkage map. DNA Res. 1996 Dec 31;3(6):363-77.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_45_HGNC_ID:
Not Available

# Drug_Target_45_HPRD_ID:
Not Available

# Drug_Target_45_ID:
4443

# Drug_Target_45_Locus:
Not Available

# Drug_Target_45_Molecular_Weight:
31228

# Drug_Target_45_Name:
Quinate/shikimate dehydrogenase

# Drug_Target_45_Number_of_Residues:
288

# Drug_Target_45_PDB_ID:
1VI2

# Drug_Target_45_Pathway:
Not Available

# Drug_Target_45_Pfam_Domain_Function:
PF01488	Shikimate_DH
PF08501	Shikimate_dh_N

# Drug_Target_45_Protein_Sequence:
>Quinate/shikimate dehydrogenase
MDVTAKYELIGLMAYPIRHSLSPEMQNKALEKAGLPFTYMAFEVDNDSFPGAIEGLKALK
MRGTGVSMPNKQLACEYVDELTPAAKLVGAINTIVNDDGYLRGYNTDGTGHIRAIKESGF
DIKGKTMVLLGAGGASTAIGAQGAIEGLKEIKLFNRRDEFFDKALAFAQRVNENTDCVVT
VTDLADQQAFAEALASADILTNGTKVGMKPLENESLVNDISLLHPGLLVTECVYNPHMTK
LLQQAQQAGCKTIDGYGMLLWQGAEQFTLWTGKDFPLEYVKQVMGFGA

# Drug_Target_45_Reaction:
Not Available

# Drug_Target_45_Signals:
None

# Drug_Target_45_Specific_Function:
The physiological substrate is not known

# Drug_Target_45_SwissProt_ID:
P0A6D5

# Drug_Target_45_SwissProt_Name:
YDIB_ECOLI

# Drug_Target_45_Synonyms:
EC 1.1.1.282
NAD-dependent shikimate 5-dehydrogenase 2

# Drug_Target_45_Theoretical_pI:
4.79

# Drug_Target_45_Transmembrane_Regions:
None

# Drug_Target_46_Cellular_Location:
Cytoplasm

# Drug_Target_46_Chromosome_Location:
Not Available

# Drug_Target_46_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_46_Essentiality:
Non-Essential

# Drug_Target_46_GenAtlas_ID:
GAPDHS

# Drug_Target_46_GenBank_ID_Gene:
AJ005371

# Drug_Target_46_GenBank_ID_Protein:
3046742

# Drug_Target_46_GeneCard_ID:
GAPDHS

# Drug_Target_46_Gene_Name:
GAPDHS

# Drug_Target_46_Gene_Sequence:
>1227 bp
ATGTCGAAGCGCGACATCGTCCTCACCAATGTCACCGTTGTCCAGTTGCTGCGACAGCCG
TGCCCGGTGACCAGAGCACCGCCCCCACCTGAGCCTAAGGCTGAAGTAGAGCCCCAGCCA
CAACCAGAGCCCACACCAGTCAGGGAGGAAATAAAGCCACCACCGCCACCACTGCCTCCT
CACCCCGCTACTCCTCCTCCTAAGATGGTGTCTGTGGCCCGGGAGCTGACTGTGGGCATC
AATGGATTTGGACGCATCGGTCGCCTGGTCCTGCGCGCCTGCATGGAGAAGGGTGTTAAG
GTGGTGGCTGTGAATGATCCATTCATTGACCCGGAATACATGGTGTACATGTTTAAGTAT
GACTCCACCCACGGCCGATACAAGGGAAGTGTGGAATTCAGGAATGGACAACTGGTCGTG
GACAACCATGAGATCTCTGTCTACCAGTGCAAAGAGCCCAAACAGATCCCCTGGAGGGCT
GTCGGGAGCCCCTACGTGGTGGAGTCCACAGGCGTGTACCTCTCCATACAGGCAGCTTCG
GACCACATCTCTGCAGGTGCTCAACGTGTGGTCATCTCCGCGCCCTCACCGGATGCACCA
ATGTTCGTCATGGGTGTCAATGAAAATGACTATAACCCTGGCTCCATGAACATTGTGAGC
AACGCGTCCTGCACCACCAACTGTTTGGCTCCCCTCGCCAAAGTCATCCACGAGCGATTT
GGGATCGTGGAAGGGTTGATGACCACAGTCCATTCCTACACGGCCACCCAGAAGACAGTG
GACGGGCCATCAAGGAAGGCCTGGCGAGATGGGCGGGGTGCCCACCAGAACATCATCCCA
GCCTCCACTGGGGCTGCGAAAGCTGTGACCAAAGTCATCCCAGAGCTCAAAGGGAAGCTG
ACAGGGATGGCGTTCCGGGTACCAACCCCGGATGTGTCTGTCGTGGACCTGACCTGCCGC
CTCGCCCAGCCTGCCCCCTACTCAGCCATCAAGGAGGCTGTAAAAGCAGCAGCCAAGGGG
CCCATGGCTGGCATCCTTGCCTACACCGAGGATGAGGTCGTCTCTACGGACTTCCTCGGT
GATACCCACTCGTCCATCTTCGATGCTAAGGCCGGCATTGCGCTCAATGACAATTTCGTG
AAGCTCATTTCATGGTACGACAACGAATATGGCTACAGTCACCGGGTGGTCGACCTCCTC
CGCTACATGTTCAGCCGAGACAAGTGA

# Drug_Target_46_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_46_General_References:
10714828	Welch JE, Brown PL, O'Brien DA, Magyar PL, Bunch DO, Mori C, Eddy EM: Human glyceraldehyde 3-phosphate dehydrogenase-2 gene is expressed specifically in spermatogenic cells. J Androl. 2000 Mar-Apr;21(2):328-38.

# Drug_Target_46_HGNC_ID:
HGNC:24864

# Drug_Target_46_HPRD_ID:
13566

# Drug_Target_46_ID:
794

# Drug_Target_46_Locus:
19q13.1

# Drug_Target_46_Molecular_Weight:
44502

# Drug_Target_46_Name:
Glyceraldehyde-3-phosphate dehydrogenase, testis-specific

# Drug_Target_46_Number_of_Residues:
408

# Drug_Target_46_PDB_ID:
Not Available

# Drug_Target_46_Pathway:
Not Available

# Drug_Target_46_Pfam_Domain_Function:
PF00044	Gp_dh_N
PF02800	Gp_dh_C

# Drug_Target_46_Protein_Sequence:
>Glyceraldehyde-3-phosphate dehydrogenase, testis-specific
MSKRDIVLTNVTVVQLLRQPCPVTRAPPPPEPKAEVEPQPQPEPTPVREEIKPPPPPLPP
HPATPPPKMVSVARELTVGINGFGRIGRLVLRACMEKGVKVVAVNDPFIDPEYMVYMFKY
DSTHGRYKGSVEFRNGQLVVDNHEISVYQCKEPKQIPWRAVGSPYVVESTGVYLSIQAAS
DHISAGAQRVVISAPSPDAPMFVMGVNENDYNPGSMNIVSNASCTTNCLAPLAKVIHERF
GIVEGLMTTVHSYTATQKTVDGPSRKAWRDGRGAHQNIIPASTGAAKAVTKVIPELKGKL
TGMAFRVPTPDVSVVDLTCRLAQPAPYSAIKEAVKAAAKGPMAGILAYTEDEVVSTDFLG
DTHSSIFDAKAGIALNDNFVKLISWYDNEYGYSHRVVDLLRYMFSRDK

# Drug_Target_46_Reaction:
D-glyceraldehyde 3-phosphate + phosphate + NAD+ = 3-phospho-D-glyceroyl phosphate + NADH + H+

# Drug_Target_46_Signals:
None

# Drug_Target_46_Specific_Function:
May play an important role in regulating the switch between different pathways for energy production during spermiogenesis and in the spermatozoon. Required for sperm motility and male fertility

# Drug_Target_46_SwissProt_ID:
O14556

# Drug_Target_46_SwissProt_Name:
G3PT_HUMAN

# Drug_Target_46_Synonyms:
EC 1.2.1.12
GAPDH-2
Spermatogenic cell-specific glyceraldehyde 3-phosphate dehydrogenase 2
Spermatogenic glyceraldehyde-3-phosphate dehydrogenase

# Drug_Target_46_Theoretical_pI:
8.34

# Drug_Target_46_Transmembrane_Regions:
None

# Drug_Target_47_Cellular_Location:
Cytoplasm

# Drug_Target_47_Chromosome_Location:
Not Available

# Drug_Target_47_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_47_Essentiality:
Non-Essential

# Drug_Target_47_GenAtlas_ID:
ALDH3A1

# Drug_Target_47_GenBank_ID_Gene:
M74542

# Drug_Target_47_GenBank_ID_Protein:
178402

# Drug_Target_47_GeneCard_ID:
ALDH3A1

# Drug_Target_47_Gene_Name:
ALDH3A1

# Drug_Target_47_Gene_Sequence:
>1362 bp
ATGAGCAAGATCAGCGAGGCCGTGAAGCGCGCCCGCGCCGCCTTCAGCTCGGGCAGGACC
CGTCCGCTGCAGTTCCGATTCCAGCAGCTGGAGGCGCTGCAGCGCCTGATCCAGGAGCAG
GAGCAGGAGCTGGTGGGCGCGCTGGCCGCAGACCTGCACAAGAATGAATGGAACGCCTAC
TATGAGGAGGTGGTGTACGTCCTAGAGGAGATCGAGTACATGATCCAGAAGCTCCCTGAG
TGGGCCGCGGATGAGCCCGTGGAGAAGACGCCCCAGACTCAGCAGGACGAGCTCTACATC
CACTCGGAGCCACTGGGCGTGGTCCTCGTCATTGGCACCTGGAACTACCCCTTCAACCTC
ACCATCCAGCCCATGGTGGGCGCCATCGCTGCAGGGAACGCAGTGGTCCTCAAGCCCTCG
GAGCTGAGTGAGAACATGGCGAGCCTGCTGGCTACCATCATCCCCCAGTACCTGGACAAG
GATCTGTACCCAGTAATCAATGGGGGTGTCCCTGAGACCACGGAGCTGCTCAAGGAGAGG
TTCGACCATATCCTGTACACGGGCAGCACGGGGGTGGGGAAGATCATCATGACGGCTGCT
GCCAAGCACCTGACCCCTGTCACGCTGGAGCTGGGAGGGAAGAGTCCCTGCTACGTGGAC
AAGAACTGTGACCTGGACGTGGCCTGCCGACGCATCGCCTGGGGGAAATTCATGAACAGT
GGCCAGACCTGCGTGGCCCCAGACTACATCCTCTGTGACCCCTCGATCCAGAACCAAATT
GTGGAGAAGCTCAAGAAGTCACTGAAAGAGTTCTACGGGGAAGATGCTAAGAAATCCCGG
GACTATGGAAGAATCATTAGTGCCCGGCACTTCCAGAGGGTGATGGGCCTGATTGAGGGC
CAGAAGGTGGCTTATGGGGGCACCGGGGATGCCGCCACTCGCTACATAGCCCCCACCATC
CTCACGGACGTGGACCCCCAGTCCCCGGTGATGCAAGAGGAGATCTTCGGGCCTGTGCTG
CCCATCGTGTGCGTGCGCAGCCTGGAGGAGGCCATCCAGTTCATCAACCAGCGTGAGAAG
CCCCTGGCCCTCTACATGTTCTCCAGCAACGACAAGGTGATTAAGAAGATGATTGCAGAG
ACATCCAGTGGTGGGGTGGCGGCCAACGATGTCATCGTCCACATCACCTTGCACTCTCTG
CCCTTCGGGGGCGTGGGGAACAGCGGCATGGGATCCTACCATGGCAAGAAGAGCTTCGAG
ACTTTCTCTCACCGCCGCTCTTGCCTGGTGAGGCCTCTGATGAATGATGAAGGCCTGAAG
GTCAGATACCCCCCGAGCCCGGCCAAGATGACCCAGCACTGA

# Drug_Target_47_General_Function:
Energy production and conversion

# Drug_Target_47_General_References:
1737758	Hsu LC, Chang WC, Shibuya A, Yoshida A: Human stomach aldehyde dehydrogenase cDNA and genomic cloning, primary structure, and expression in Escherichia coli. J Biol Chem. 1992 Feb 15;267(5):3030-7.
2037078	Yin SJ, Vagelopoulos N, Wang SL, Jornvall H: Structural features of stomach aldehyde dehydrogenase distinguish dimeric aldehyde dehydrogenase as a 'variable' enzyme. 'Variable' and 'constant' enzymes within the alcohol and aldehyde dehydrogenase families. FEBS Lett. 1991 May 20;283(1):85-8.
8493892	Hsu LC, Yoshida A: Human stomach aldehyde dehydrogenase, ALDH3. Adv Exp Med Biol. 1993;328:141-52.
9250352	Tsukamoto N, Chang C, Yoshida A: Mutations associated with Sjogren-Larsson syndrome. Ann Hum Genet. 1997 May;61(Pt 3):235-42.

# Drug_Target_47_HGNC_ID:
HGNC:405

# Drug_Target_47_HPRD_ID:
00004

# Drug_Target_47_ID:
792

# Drug_Target_47_Locus:
17p11.2

# Drug_Target_47_Molecular_Weight:
50380

# Drug_Target_47_Name:
Aldehyde dehydrogenase, dimeric NADP-preferring

# Drug_Target_47_Number_of_Residues:
453

# Drug_Target_47_PDB_ID:
Not Available

# Drug_Target_47_Pathway:
Cyclophosphamide Pathway	SMP00447
Ifosfamide Pathway	SMP00448

# Drug_Target_47_Pfam_Domain_Function:
PF00171	Aldedh

# Drug_Target_47_Protein_Sequence:
>Aldehyde dehydrogenase, dimeric NADP-preferring
MSKISEAVKRARAAFSSGRTRPLQFRIQQLEALQRLIQEQEQELVGALAADLHKNEWNAY
YEEVVYVLEEIEYMIQKLPEWAADEPVEKTPQTQQDELYIHSEPLGVVLVIGTWNYPFNL
TIQPMVGAIAAGNAVVLKPSELSENMASLLATIIPQYLDKDLYPVINGGVPETTELLKER
FDHILYTGSTGVGKIIMTAAAKHLTPVTLELGGKSPCYVDKNCDLDVACRRIAWGKFMNS
GQTCVAPDYILCDPSIQNQIVEKLKKSLKEFYGEDAKKSRDYGRIISARHFQRVMGLIEG
QKVAYGGTGDAATRYIAPTILTDVDPQSPVMQEEIFGPVLPIVCVRSLEEAIQFINQREK
PLALYMFSSNDKVIKKMIAETSSGGVAANDVIVHITLHSLPFGGVGNSGMGSYHGKKSFE
TFSHRRSCLVRPLMNDEGLKVRYPPSPAKMTQH

# Drug_Target_47_Reaction:
an aldehyde + NAD(P)+ + H2O = an acid + NAD(P)H + H+

# Drug_Target_47_Signals:
None

# Drug_Target_47_Specific_Function:
ALDHs play a major role in the detoxification of alcohol-derived acetaldehyde. They are involved in the metabolism of corticosteroids, biogenic amines, neurotransmitters, and lipid peroxidation. This protein preferentially oxidizes aromatic aldehyde substrates. It may play a role in the oxidation of toxic aldehydes

# Drug_Target_47_SwissProt_ID:
P30838

# Drug_Target_47_SwissProt_Name:
AL3A1_HUMAN

# Drug_Target_47_Synonyms:
ALDH class 3
ALDHIII
EC 1.2.1.5

# Drug_Target_47_Theoretical_pI:
6.52

# Drug_Target_47_Transmembrane_Regions:
None

# Drug_Target_48_Cellular_Location:
Not Available

# Drug_Target_48_Chromosome_Location:
Not Available

# Drug_Target_48_Drug_References:
Not Available

# Drug_Target_48_Essentiality:
Non-Essential

# Drug_Target_48_GenAtlas_ID:
Not Available

# Drug_Target_48_GenBank_ID_Gene:
AF092031

# Drug_Target_48_GenBank_ID_Protein:
Not Available

# Drug_Target_48_GeneCard_ID:
Not Available

# Drug_Target_48_Gene_Name:
Not Available

# Drug_Target_48_Gene_Sequence:
>774 bp
ATGTCCATCATCGTGATAAGCGGCTGCGCCACCGGCATTGGTGCGGCTACGCGCAAGGTC
CTGGAGGCGGCCGGTCACCAGATCGTAGGCATCGATATACGCGATGCGGAAGTGATTGCC
GATCTCTCGACGGCCGAAGGTCGAAAGCAGGCGATTGCCGATGTACTGGCGAAGTGCAGC
AAGGGCATGGACGGCCTGGTGCTGTGCGCCGGCCTGGGACCGCAGACCAAGGTGCTTGGC
AATGTGGTTTCGGTCAATTATTTTGGCGCGACCGAGCTGATGGATGCCTTTTTGCCAGCG
CTGAAAAAAGGCCATCAGCCCGCAGCCGTCGTCATCTCGTCCGTGGCTTCCGCGCATCTG
GCTTTTGACAAGAACCCACTGGCGCTGGCACTGGAAGCCGGCGAGGAAGCCAAGGCCCGC
GCCATTGTCGAACATGCGGGAGAGCAGGGCGGAAATCTGGCCTATGCGGGCAGCAAGAAT
GCTTTGACGGTGGCTGTGCGCAAACGCGCCGCCGCCTGGGGCGAGGCTGGCGTGCGCCTG
AACACCATCGCCCCCGGTGCAACCGAGACTCCCTTGCTGCAGGCGGGCCTGCAGGACCCG
CGCTATGGCGAATCCATTGCCAAGTTCGTTCCTCCCATGGGCCGCCGTGCCGAGCCGTCC
GAGATGGCGTCGGTCATCGCCTTTTTGATGAGCCCGGCCGCAAGCTATGTGCATGGCGCG
CAGATCGTCATTGATGGCGGCATTGATGCGGTGATGCGCCCGACACAGTTCTGA

# Drug_Target_48_General_Function:
Involved in oxidoreductase activity

# Drug_Target_48_General_References:
10833462	Maser E, Mobus E, Xiong G: Functional expression, purification, and characterization of 3alpha-hydroxysteroid dehydrogenase/carbonyl reductase from Comamonas testosteroni. Biochem Biophys Res Commun. 2000 Jun 7;272(2):622-8.
11007791	Grimm C, Maser E, Mobus E, Klebe G, Reuter K, Ficner R: The crystal structure of 3alpha -hydroxysteroid dehydrogenase/carbonyl reductase from Comamonas testosteroni shows a novel oligomerization pattern within the short chain dehydrogenase/reductase family. J Biol Chem. 2000 Dec 29;275(52):41333-9.
11139589	Xiong G, Maser E: Regulation of the steroid-inducible 3alpha-hydroxysteroid dehydrogenase/carbonyl reductase gene in Comamonas testosteroni. J Biol Chem. 2001 Mar 30;276(13):9961-70. Epub 2001 Jan 3.
9812981	Mobus E, Maser E: Molecular cloning, overexpression, and characterization of steroid-inducible 3alpha-hydroxysteroid dehydrogenase/carbonyl reductase from Comamonas testosteroni. A novel member of the short-chain dehydrogenase/reductase superfamily. J Biol Chem. 1998 Nov 20;273(47):30888-96.

# Drug_Target_48_HGNC_ID:
Not Available

# Drug_Target_48_HPRD_ID:
Not Available

# Drug_Target_48_ID:
4446

# Drug_Target_48_Locus:
Not Available

# Drug_Target_48_Molecular_Weight:
26393

# Drug_Target_48_Name:
3alpha-hydroxysteroid dehydrogenase/carbonyl reductase

# Drug_Target_48_Number_of_Residues:
257

# Drug_Target_48_PDB_ID:
1FK8

# Drug_Target_48_Pathway:
Not Available

# Drug_Target_48_Pfam_Domain_Function:
Not Available

# Drug_Target_48_Protein_Sequence:
>3alpha-hydroxysteroid dehydrogenase/carbonyl reductase
MSIIVISGCATGIGAATRKVLEAAGHQIVGIDIRDAEVIADLSTAEGRKQAIADVLAKCS
KGMDGLVLCAGLGPQTKVLGNVVSVNYFGATELMDAFLPALKKGHQPAAVVISSVASAHL
AFDKNPLALALEAGEEAKARAIVEHAGEQGGNLAYAGSKNALTVAVRKRAAAWGEAGVRL
NTIAPGATETPLLQAGLQDPRYGESIAKFVPPMGRRAEPSEMASVIAFLMSPAASYVHGA
QIVIDGGIDAVMRPTQF

# Drug_Target_48_Reaction:
Not Available

# Drug_Target_48_Signals:
None

# Drug_Target_48_Specific_Function:
Not Available

# Drug_Target_48_SwissProt_ID:
Q9ZFY9

# Drug_Target_48_SwissProt_Name:
Q9ZFY9_COMTE

# Drug_Target_48_Synonyms:
Not Available

# Drug_Target_48_Theoretical_pI:
7.04

# Drug_Target_48_Transmembrane_Regions:
None

# Drug_Target_49_Cellular_Location:
Not Available

# Drug_Target_49_Chromosome_Location:
Not Available

# Drug_Target_49_Drug_References:
Not Available

# Drug_Target_49_Essentiality:
Non-Essential

# Drug_Target_49_GenAtlas_ID:
Not Available

# Drug_Target_49_GenBank_ID_Gene:
Y14084

# Drug_Target_49_GenBank_ID_Protein:
Not Available

# Drug_Target_49_GeneCard_ID:
Not Available

# Drug_Target_49_Gene_Name:
yhfP

# Drug_Target_49_Gene_Sequence:
>993 bp
ATGTCAACGTTATTTCAAGCCTTGCAGGCAGAAAAAAATGCCGATGATGTTTCAGTCCAT
GTGAAAACCATATCAACAGAGGATTTGCCGAAGGATGGTGTCCTGATTAAAGTTGCTTAT
TCCGGCATTAATTACAAAGATGGTCTGGCCGGAAAAGCAGGAGGCAATATCGTCAGAGAG
TATCCGCTTATTTTAGGCATTGATGCTGCGGGTACGGTCGTCTCTTCCAATGATCCGCGT
TTTGCGGAGGGGGATGAGGTGATCGCGACAAGCTATGAGCTCGGTGTCTCACGTGATGGC
GGATTAAGTGAATACGCTTCGGTGCCTGGTGACTGGCTGGTGCCTTTGCCACAGAATCTT
TCGTTAAAAGAAGCGATGGTGTACGGAACGGCGGGATTTACTGCGGCGTTATCAGTGCAT
CGGCTTGAACAGAACGGTCTGTCTCCGGAAAAAGGCAGCGTGCTAGTCACAGGAGCAACC
GGCGGTGTCGGCGGAATTGCGGTATCGATGCTGAACAAGCGGGGTTATGATGTGGTGGCA
AGTACCGGAAACCGGGAGGCGGCTGATTATTTGAAACAGCTTGGTGCAAGCGAAGTAATC
AGCAGGGAAGATGTCTATGACGGAACGCTTAAGGCGCTGTCCAAGCAGCAATGGCAGGGA
GCGGTTGATCCAGTCGGCGGAAAACAGCTTGCCTCGCTTTTAAGCAAAATTCAATACGGC
GGATCTGTCGCAGTGAGCGGCTTAACCGGCGGAGGAGAAGTTCCGGCAACCGTGTATCCT
TTTATTCTTCGCGGAGTAAGCCTGCTCGGAATCGATTCAGTATATTGTCCGATGGACGTC
AGAGCCGCTGTTTGGGAGCGCATGTCTTCTGATCTCAAGCCTGATCAGCTGCTGACCATC
GTGGACAGGGAAGTATCATTGGAAGAAACGCCGGGTGCGTTAAAAGATATTTTGCAAAAT
CGCATTCAAGGAAGAGTGATTGTGAAGCTTTAA

# Drug_Target_49_General_Function:
Involved in zinc ion binding

# Drug_Target_49_General_References:
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.

# Drug_Target_49_HGNC_ID:
Not Available

# Drug_Target_49_HPRD_ID:
Not Available

# Drug_Target_49_ID:
4447

# Drug_Target_49_Locus:
Not Available

# Drug_Target_49_Molecular_Weight:
34757

# Drug_Target_49_Name:
Hypothetical protein yhfP

# Drug_Target_49_Number_of_Residues:
330

# Drug_Target_49_PDB_ID:
1Y9E

# Drug_Target_49_Pathway:
Not Available

# Drug_Target_49_Pfam_Domain_Function:
PF00107	ADH_zinc_N
PF08240	ADH_N

# Drug_Target_49_Protein_Sequence:
>Hypothetical protein yhfP
MSTLFQALQAEKNADDVSVHVKTISTEDLPKDGVLIKVAYSGINYKDGLAGKAGGNIVRE
YPLILGIDAAGTVVSSNDPRFAEGDEVIATSYELGVSRDGGLSEYASVPGDWLVPLPQNL
SLKEAMVYGTAGFTAALSVHRLEQNGLSPEKGSVLVTGATGGVGGIAVSMLNKRGYDVVA
STGNREAADYLKQLGASEVISREDVYDGTLKALSKQQWQGAVDPVGGKQLASLLSKIQYG
GSVAVSGLTGGGEVPATVYPFILRGVSLLGIDSVYCPMDVRAAVWERMSSDLKPDQLLTI
VDREVSLEETPGALKDILQNRIQGRVIVKL

# Drug_Target_49_Reaction:
Not Available

# Drug_Target_49_Signals:
None

# Drug_Target_49_Specific_Function:
Not Available

# Drug_Target_49_SwissProt_ID:
O07615

# Drug_Target_49_SwissProt_Name:
YHFP_BACSU

# Drug_Target_49_Synonyms:
Not Available

# Drug_Target_49_Theoretical_pI:
4.66

# Drug_Target_49_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Cytoplasm

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
U66101

# Drug_Target_4_GenBank_ID_Protein:
1513224

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
dapB

# Drug_Target_4_Gene_Sequence:
>738 bp
ATGCGGGTAGGCGTCCTTGGAGCCAAAGGCAAGGTCGGAACGACAATGGTGCGGGCGGTG
GCCGCCGCCGACGACCTGACCCTATCCGCCGAGCTGGATGCCGGCGATCCGCTGAGCCTG
CTAACGGACGGTAACACCGAGGTCGTCATCGACTTCACCCACCCGGACGTGGTGATGGGC
AATCTGGAGTTCCTCATCGACAACGGAATTCACGCCGTGGTCGGTACCACGGGGTTCACC
GCCGAGCGGTTTCAACAAGTCGAATCGTGGCTCGTCGCAAAACCCAACACATCGGTGTTG
ATAGCGCCAAACTTCGCGATCGGAGCGGTGCTGTCCATGCATTTCGCCAAGCAGGCCGCA
CGGTTTTTCGACTCGGCCGAGGTCATTGAGCTGCATCATCCGCACAAGGCTGACGCGCCG
TCAGGCACGGCCGCGCGTACCGCGAAGCTGATCGCCGAGGCCCGAAAAGGCTTGCCGCCC
AATCCCGATGCCACCAGTACCAGCCTGCCGGGCGCGCGTGGTGCCGACGTCGACGGCATA
CCGGTGCACGCGGTGCGGCTGGCCGGACTGGTCGCCCACCAGGAAGTGCTGTTCGGGACC
GAGGGGGAGACTCTGACCATCCGCCACGATAGCCTCGATCGCACATCGTTTGTGCCCGGT
GTGCTGTTGGCGGTGCGCCGCATCGCCGAACGCCCTGGTCTCACCGTAGGTCTTGAGCCC
CTACTCGATCTGCACTGA

# Drug_Target_4_General_Function:
Amino acid transport and metabolism

# Drug_Target_4_General_References:
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
9098082	Pavelka MS Jr, Weisbrod TR, Jacobs WR Jr: Cloning of the dapB gene, encoding dihydrodipicolinate reductase, from Mycobacterium tuberculosis. J Bacteriol. 1997 Apr;179(8):2777-82.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
3615

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
25734

# Drug_Target_4_Name:
Dihydrodipicolinate reductase

# Drug_Target_4_Number_of_Residues:
245

# Drug_Target_4_PDB_ID:
1P9L

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF01113	DapB_N
PF05173	DapB_C

# Drug_Target_4_Protein_Sequence:
>Dihydrodipicolinate reductase
MRVGVLGAKGKVGATMVRAVAAADDLTLSAELDAGDPLSLLTDGNTEVVIDFTHPDVVMG
NLEFLIDNGIHAVVGTTGFTAERFQQVESWLVAKPNTSVLIAPNFAIGAVLSMHFAKQAA
RFFDSAEVIELHHPHKADAPSGTAARTAKLIAEARKGLPPNPDATSTSLPGARGADVDGI
PVHAVRLAGLVAHQEVLFGTEGETLTIRHDSLDRTSFVPGVLLAVRRIAERPGLTVGLEP
LLDLH

# Drug_Target_4_Reaction:
(S)-2,3,4,5-tetrahydropyridine-2,6-dicarboxylate + NAD(P)+ = 2,3-dihydrodipicolinate + NAD(P)H + H+

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
2,3,4,5-tetrahydrodipicolinate + NAD(P)(+) = 2,3-dihydrodipicolinate + NAD(P)H

# Drug_Target_4_SwissProt_ID:
P72024

# Drug_Target_4_SwissProt_Name:
DAPB_MYCTU

# Drug_Target_4_Synonyms:
DHPR
EC 1.3.1.26

# Drug_Target_4_Theoretical_pI:
5.75

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_50_Cellular_Location:
Not Available

# Drug_Target_50_Chromosome_Location:
Not Available

# Drug_Target_50_Drug_References:
Not Available

# Drug_Target_50_Essentiality:
Non-Essential

# Drug_Target_50_GenAtlas_ID:
Not Available

# Drug_Target_50_GenBank_ID_Gene:
M31425

# Drug_Target_50_GenBank_ID_Protein:
Not Available

# Drug_Target_50_GeneCard_ID:
Not Available

# Drug_Target_50_Gene_Name:
Not Available

# Drug_Target_50_Gene_Sequence:
>933 bp
ATGGCACGTAAGATTGGAATTATCGGCCTTGGAAACGTTGGGGCTGCAGTAGCGCACGGA
TTGATTGCACAAGGTGTAGCCGACGACTACGTCTTTATTGATGCAAACGAAGCAAAGGTG
AAGGCTGATCAAATTGATTTCCAAGACGCAATGGCGAACTTGGAAGCGCACGGTAACATT
GTGATTAACGATTGGGCAGCCTTGGCTGATGCTGATGTTGTGATTTCAACACTGGGGAAC
ATCAAGTTGCAACAAGACAACCCAACCGGTGACCGTTTTGCTGAGTTGAAGTTTACCAGC
AGCATGGTGCAATCAGTCGGCACAAACTTGAAGGAATCTGGTTTCCACGGCGTATTGGTC
GTGATTTCAAACCCGGTCGACGTGATTACGGCCTTGTTCCAACACGTGACTGGTTTCCCA
GCTCACAAGGTTATCGGAACCGGTACTTTGCTTGACACGGCGCGTATGCAACGTGCAGTT
GGTGAGGCGTTTGATTTGGATCCACGTTCTGTTTCAGGTTACAACTTGGGTGAGCACGGT
AACTCACAATTCGTAGCTTGGTCAACGGTGCGCGTGATGGGTCAACCAATCGTGACGTTG
GCTGATGCCGGCGATATTGACTTGGCGGCCATCGAAGAGGAAGCACGTAAGGGTGGCTTC
ACGGTCTTGAATGGTAAGGGCTACACGAGTTATGGTGTTGCAACGTCAGCAATCCGCATT
GCCAAGGCTGTTATGGCTGACGCGCATGCTGAATTGGTTGTCTCAAATCGTCGCGATGAC
ATGGGAATGTACTTGTCATACCCAGCGATTATTGGTCGCGATGGTGTCTTGGCAGAAACG
ACGCTTGATTTGACGACGGATGAGCAAGAAAAGCTTTTGCAATCACGTGACTACATCCAA
CAACGTTTCGACGAAATTGTGGATACACTCTAA

# Drug_Target_50_General_Function:
Involved in oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor

# Drug_Target_50_General_References:
2684788	Lerch HP, Frank R, Collins J: Cloning, sequencing and expression of the L-2-hydroxyisocaproate dehydrogenase-encoding gene of Lactobacillus confusus in Escherichia coli. Gene. 1989 Nov 30;83(2):263-70.
7643402	Niefind K, Hecht HJ, Schomburg D: Crystal structure of L-2-hydroxyisocaproate dehydrogenase from Lactobacillus confusus at 2.2 A resolution. An example of strong asymmetry between subunits. J Mol Biol. 1995 Aug 11;251(2):256-81.

# Drug_Target_50_HGNC_ID:
Not Available

# Drug_Target_50_HPRD_ID:
Not Available

# Drug_Target_50_ID:
4448

# Drug_Target_50_Locus:
Not Available

# Drug_Target_50_Molecular_Weight:
33181

# Drug_Target_50_Name:
L-2-hydroxyisocaproate dehydrogenase

# Drug_Target_50_Number_of_Residues:
310

# Drug_Target_50_PDB_ID:
1HYH

# Drug_Target_50_Pathway:
Not Available

# Drug_Target_50_Pfam_Domain_Function:
PF00056	Ldh_1_N
PF02866	Ldh_1_C

# Drug_Target_50_Protein_Sequence:
>L-2-hydroxyisocaproate dehydrogenase
MARKIGIIGLGNVGAAVAHGLIAQGVADDYVFIDANEAKVKADQIDFQDAMANLEAHGNI
VINDWAALADADVVISTLGNIKLQQDNPTGDRFAELKFTSSMVQSVGTNLKESGFHGVLV
VISNPVDVITALFQHVTGFPAHKVIGTGTLLDTARMQRAVGEAFDLDPRSVSGYNLGEHG
NSQFVAWSTVRVMGQPIVTLADAGDIDLAAIEEEARKGGFTVLNGKGYTSYGVATSAIRI
AKAVMADAHAELVVSNRRDDMGMYLSYPAIIGRDGVLAETTLDLTTDEQEKLLQSRDYIQ
QRFDEIVDTL

# Drug_Target_50_Reaction:
Not Available

# Drug_Target_50_Signals:
None

# Drug_Target_50_Specific_Function:
Catalyzes the NADP dependent reversible and stereospecific interconversion between 2-ketocarboxylic acids and L-2-hydroxy-carboxylic acids. 2-ketoacids with medium chain length (five to six C-atoms) are the best substrates

# Drug_Target_50_SwissProt_ID:
P14295

# Drug_Target_50_SwissProt_Name:
DHL2_LACCO

# Drug_Target_50_Synonyms:
EC 1.1.1.-
L-HicDH

# Drug_Target_50_Theoretical_pI:
4.47

# Drug_Target_50_Transmembrane_Regions:
None

# Drug_Target_51_Cellular_Location:
Not Available

# Drug_Target_51_Chromosome_Location:
Not Available

# Drug_Target_51_Drug_References:
Not Available

# Drug_Target_51_Essentiality:
Non-Essential

# Drug_Target_51_GenAtlas_ID:
Not Available

# Drug_Target_51_GenBank_ID_Gene:
AJ277173

# Drug_Target_51_GenBank_ID_Protein:
Not Available

# Drug_Target_51_GeneCard_ID:
Not Available

# Drug_Target_51_Gene_Name:
Not Available

# Drug_Target_51_Gene_Sequence:
>639 bp
GCCGAGACTAAAAATTTTACAGACTTAGTTGAAGCTACTAAATGGGGAAACTCATTAATA
AAGTCAGCCAAGTATTCTTCTAAAGATAAGATGGCTATTTATAATTATACAAAAAATAGT
TCACCCATAAATACTCCTCTAAGATCAGCAAATGGTGACGTGAACAAATTATCCGAAAAC
ATTCAAGAGCAGGTTAGACAATTAGACTCAACGATATCTAAATCTGTAACACCAGATTCA
GTCTATGTATACAGATTATTAAATTTAGACTACTTATCAAGTATAACTGGCTTTACGCGA
GAAGATTTACATATGTTACAACAAACTAACAATGGTCAATATAATGAAGCGCTTGTGTCA
AAACTAAATAATCTTATGAATAGTAGAATTTACAGAGAAAATGGCTACTCTAGTACACAA
CTAGTTAGTGGTGCAGCACTAGCAGGTAGGCCAATTGAATTAAAATTAGAATTACCTAAA
GGTACTAAAGCAGCATATATTGATTCTAAAGAGTTAACAGCATACCCAGGTCAACAAGAA
GTTCTTTTGCCTAGAGGGACAGAATATGCTGTAGGCAGTGTTAAACTTTCTGATAACAAA
AGAAAGATAATTATAACTGCTGTAGTTTTTAAAAAATAA

# Drug_Target_51_General_Function:
Not Available

# Drug_Target_51_General_References:
11124969	Wilde C, Chhatwal GS, Schmalzing G, Aktories K, Just I: A novel C3-like ADP-ribosyltransferase from Staphylococcus aureus modifying RhoE and Rnd3. J Biol Chem. 2001 Mar 23;276(12):9537-42. Epub 2000 Dec 21.

# Drug_Target_51_HGNC_ID:
Not Available

# Drug_Target_51_HPRD_ID:
Not Available

# Drug_Target_51_ID:
4449

# Drug_Target_51_Locus:
Not Available

# Drug_Target_51_Molecular_Weight:
23638

# Drug_Target_51_Name:
ADP-ribosyltransferase

# Drug_Target_51_Number_of_Residues:
212

# Drug_Target_51_PDB_ID:
1OJZ

# Drug_Target_51_Pathway:
Not Available

# Drug_Target_51_Pfam_Domain_Function:
PF03496	Binary_toxA

# Drug_Target_51_Protein_Sequence:
>ADP-ribosyltransferase
AETKNFTDLVEATKWGNSLIKSAKYSSKDKMAIYNYTKNSSPINTPLRSANGDVNKLSEN
IQEQVRQLDSTISKSVTPDSVYVYRLLNLDYLSSITGFTREDLHMLQQTNNGQYNEALVS
KLNNLMNSRIYRENGYSSTQLVSGAALAGRPIELKLELPKGTKAAYIDSKELTAYPGQQE
VLLPRGTEYAVGSVKLSDNKRKIIITAVVFKK

# Drug_Target_51_Reaction:
Not Available

# Drug_Target_51_Signals:
None

# Drug_Target_51_Specific_Function:
Not Available

# Drug_Target_51_SwissProt_ID:
Q9ADS9

# Drug_Target_51_SwissProt_Name:
Q9ADS9_STAAU

# Drug_Target_51_Synonyms:
Not Available

# Drug_Target_51_Theoretical_pI:
9.83

# Drug_Target_51_Transmembrane_Regions:
None

# Drug_Target_52_Cellular_Location:
Not Available

# Drug_Target_52_Chromosome_Location:
Not Available

# Drug_Target_52_Drug_References:
Not Available

# Drug_Target_52_Essentiality:
Non-Essential

# Drug_Target_52_GenAtlas_ID:
Not Available

# Drug_Target_52_GenBank_ID_Gene:
X73562

# Drug_Target_52_GenBank_ID_Protein:
Not Available

# Drug_Target_52_GeneCard_ID:
Not Available

# Drug_Target_52_Gene_Name:
Not Available

# Drug_Target_52_Gene_Sequence:
>1365 bp
ATGAAAAAAGTTAATAAATCTATATCTGTATTTCTAATATTATATTTAATTTTAACTAGT
TCATTTCCTAGTTATACTTATGCACAAGATTTACAAATAGCAAGCAATTATATTACAGAT
AGAGCTTTTATTGAAAGACCAGAAGATTTTCTTAAAGATAAAGAAAATGCTATTCAATGG
GAAAAAAAGGAGGCTGAAAGAGTAGAAAAAAACCTTGATACACTTGAAAAAGAAGCATTA
GAATTATATAAAAAAGATTCTGAACAAATAAGTAACTACTCTCAGACAAGACAGTATTTT
TACGACTATCAAATAGAATCAAATCCTAGAGAAAAAGAATACAAAAATCTTAGAAATGCC
ATATCAAAAAATAAGATAGATAAACCTATAAATGTTTATTATTTTGAGTCTCCAGAGAAA
TTTGCGTTTAATAAAGAAATAAGAACAGAAAATCAAAATGAAATTTCTTTAGAGAAATTT
AATGAGTTGAAAGAAACTATTCAAGATAAATTGTTTAAACAAGATGGATTTAAGGATGTT
TCTTTATATGAACCAGGTAATGGCGATGAAAAGCCTACACCACTACTTATACATTTGAAA
TTACCAAAAAATACTGGTATGTTACCATATATAAATTCTAATGATGTAAAAACATTAATA
GAACAAGACTATAGCATAAAGATAGACAAAATTGTTCGTATAGTAATAGAAGGAAAGCAA
TATATAAAAGCTGAAGCTTCTATTGTAAACAGTCTTGATTTTAAAGATGATGTAAGTAAA
GGTGATTTATGGGGAAAAGAAAATTATAGTGATTGGAGTAATAAATTAACTCCTAATGAA
CTTGCTGATGTAAATGACTATATGCGTGGAGGATATACCGCAATTAATAACTATTTAATA
TCAAATGGTCCTTTAAATAATCCTAATCCAGAACTAGACTCTAAAGTAAATAACATTGAA
AACGCATTAAAGCTCACACCTATTCCATCTAACTTAATTGTATATAGAAGGTCTGGTCCA
CAAGAATTTGGATTAACTCTCACATCTCCTGAATATGATTTTAATAAAATAGAAAATATA
GATGCTTTTAAAGAAAAATGGGAAGGAAAAGTAATAACATACCCAAACTTTATTAGTACT
AGTATTGGAAGTGTAAATATGAGTGCATTTGCTAAAAGAAAAATAATACTACGTATAAAC
ATACCAAAAGATTCTCCAGGAGCTTATTTATCAGCCATTCCAGGTTATGCAGGAGAATAT
GAAGTACTTTTAAATCATGGAAGTAAATTTAAAATCAATAAAGTTGATTCTTATAAAGAT
GGAACTGTAACAAAACTAATTTTGGATGCAACATTGATAAATTAA

# Drug_Target_52_General_Function:
Not Available

# Drug_Target_52_General_References:
8225592	Perelle S, Gibert M, Boquet P, Popoff MR: Characterization of Clostridium perfringens iota-toxin genes and expression in Escherichia coli. Infect Immun. 1993 Dec;61(12):5147-56.
8601443	van Damme J, Jung M, Hofmann F, Just I, Vandekerckhove J, Aktories K: Analysis of the catalytic site of the actin ADP-ribosylating Clostridium perfringens iota toxin. FEBS Lett. 1996 Feb 19;380(3):291-5.

# Drug_Target_52_HGNC_ID:
Not Available

# Drug_Target_52_HPRD_ID:
Not Available

# Drug_Target_52_ID:
4450

# Drug_Target_52_Locus:
Not Available

# Drug_Target_52_Molecular_Weight:
52318

# Drug_Target_52_Name:
Iota toxin component Ia

# Drug_Target_52_Number_of_Residues:
454

# Drug_Target_52_PDB_ID:
1GIR

# Drug_Target_52_Pathway:
Not Available

# Drug_Target_52_Pfam_Domain_Function:
PF03496	Binary_toxA

# Drug_Target_52_Protein_Sequence:
>Iota toxin component Ia
MKKVNKSISVFLILYLILTSSFPSYTYAQDLQIASNYITDRAFIERPEDFLKDKENAIQW
EKKEAERVEKNLDTLEKEALELYKKDSEQISNYSQTRQYFYDYQIESNPREKEYKNLRNA
ISKNKIDKPINVYYFESPEKFAFNKEIRTENQNEISLEKFNELKETIQDKLFKQDGFKDV
SLYEPGNGDEKPTPLLIHLKLPKNTGMLPYINSNDVKTLIEQDYSIKIDKIVRIVIEGKQ
YIKAEASIVNSLDFKDDVSKGDLWGKENYSDWSNKLTPNELADVNDYMRGGYTAINNYLI
SNGPLNNPNPELDSKVNNIENALKLTPIPSNLIVYRRSGPQEFGLTLTSPEYDFNKIENI
DAFKEKWEGKVITYPNFISTSIGSVNMSAFAKRKIILRINIPKDSPGAYLSAIPGYAGEY
EVLLNHGSKFKINKVDSYKDGTVTKLILDATLIN

# Drug_Target_52_Reaction:
Not Available

# Drug_Target_52_Signals:
1-41

# Drug_Target_52_Specific_Function:
Not Available

# Drug_Target_52_SwissProt_ID:
Q46220

# Drug_Target_52_SwissProt_Name:
Q46220_CLOPE

# Drug_Target_52_Synonyms:
Iota toxin component Ia precursor

# Drug_Target_52_Theoretical_pI:
5.34

# Drug_Target_52_Transmembrane_Regions:
None

# Drug_Target_53_Cellular_Location:
Not Available

# Drug_Target_53_Chromosome_Location:
Not Available

# Drug_Target_53_Drug_References:
Not Available

# Drug_Target_53_Essentiality:
Non-Essential

# Drug_Target_53_GenAtlas_ID:
Not Available

# Drug_Target_53_GenBank_ID_Gene:
AY245547

# Drug_Target_53_GenBank_ID_Protein:
Not Available

# Drug_Target_53_GeneCard_ID:
Not Available

# Drug_Target_53_Gene_Name:
vip2Ac

# Drug_Target_53_Gene_Sequence:
>1389 bp
ATGAAAAGAATGGAGGGAAAATTGTTTATGGTGTCCACAAAATTACAAGCAGTTACTAAA
GCTGTATTACTTAGTACAGTTTTATCTATATCTTTATTAAATAATGAAGTGATAAAAGCT
GAACAATTAAATATGAATTCTCAAAATAAATATACTAATTTTGAAAATCTAAAAATCACT
GACAAGGTAGAGGATTTTAAAGAAGATAAGGAAAAAGCGAAAGAATGGGGGAAAGAAAAA
GAAAAAGAGTGGAAACTAACTGCTACTGAAAAAGGAAAAATGAATAATTTTTTAGATAAT
AAAAATGATATAAAAACAAATTATAAAGAAATTACTTTTTCTATGGCAGGTTCATTTGAA
GATGAAATAAAAGATTTAAAAGAAATTGATAAGATCTTTGATAAAGCCAATCTCTCAAGT
CCTATTATCACCTATAAAAATGTGGAACCAGCAACAATTGGATTTAATAAATCTTTAACA
GAAGGTAATACAATTAATTCTGATGCAATGGCACAGTTTAAAGAACAATTTTTAGATAGG
GATATTAAGTTTGATAGTTATCTGGATACGCATTTAACTGTTCAACAAGTTTCCAGTAAA
GAAAGAGTTATTTTGAAGGTTAAGGTTCCGAGTGGAAAAGGTTCTACTACTCCAACAAAA
GCAGGTATCATTTTAAATAATAGTGAATACAAAATGCTTATTGATAATGGGTATATGGTC
CATGTAGATAAGGTGTCAAAAGTGGTAAAAAAAGGGGTGGAGTGCTTACAAGTTGAAGGG
ACTTTAAAAAAGAGTCTTGATTTTAAAAATGATATAAATGCTGGAGCGCATAGCTGGGGT
ATGAAGAATTATGAAGAGTGGGCTAAAGATTTAACCGATTTACAAAGGGAAGCTTTAGAT
GGGTATGCTAGGCAAGATTATAAAGAAATCAATAATTATTTACGAAATCAAGGCGGAAAT
GGAAATGAAAAACTAGATGCTCAAATAAAAAATATTTCTGATGCTTTAGGGAAGAAACCA
ATACCGGAAAATATTACTGTGTATAGATGGTGTGGCATGCCGGAATTTGGTTATCAAATT
AGTGATCCGTTACCTTCTTTAAAAGATTTTGAAGAACAATTTTTAAATACAATCAAAGAA
GACAAAGGATATATGAGTACAAGCTTATCGAGTGAACGTCTTGCAGCTTTTGGATCTAGA
AAAATTATATTACGATTACAAGTTCCGAAAGGAAGTACGGGTGCGTATTTAAGTGCCATA
GGTGGATTTGCAAATGAAAAAGAGATACTACTTGATAAAGATAGTAAATATCATATTGAT
AAAGTAACAGAGGTAATTATTAAAGGTGTTAAGCGATATGTAGTGGATGCAACATTATTA
ACAAATTAA

# Drug_Target_53_General_Function:
Not Available

# Drug_Target_53_General_References:
Not Available

# Drug_Target_53_HGNC_ID:
Not Available

# Drug_Target_53_HPRD_ID:
Not Available

# Drug_Target_53_ID:
4451

# Drug_Target_53_Locus:
Not Available

# Drug_Target_53_Molecular_Weight:
52374

# Drug_Target_53_Name:
Vip2Ac

# Drug_Target_53_Number_of_Residues:
462

# Drug_Target_53_PDB_ID:
1QS1

# Drug_Target_53_Pathway:
Not Available

# Drug_Target_53_Pfam_Domain_Function:
PF03496	Binary_toxA

# Drug_Target_53_Protein_Sequence:
>Vip2Ac
MKRMEGKLFMVSTKLQAVTKAVLLSTVLSISLLNNEVIKAEQLNMNSQNKYTNFENLKIT
DKVEDFKEDKEKAKEWGKEKEKEWKLTATEKGKMNNFLDNKNDIKTNYKEITFSMAGSFE
DEIKDLKEIDKIFDKANLSSPIITYKNVEPATIGFNKSLTEGNTINSDAMAQFKEQFLDR
DIKFDSYLDTHLTVQQVSSKERVILKVKVPSGKGSTTPTKAGIILNNSEYKMLIDNGYMV
HVDKVSKVVKKGVECLQVEGTLKKSLDFKNDINAGAHSWGMKNYEEWAKDLTDLQREALD
GYARQDYKEINNYLRNQGGNGNEKLDAQIKNISDALGKKPIPENITVYRWCGMPEFGYQI
SDPLPSLKDFEEQFLNTIKEDKGYMSTSLSSERLAAFGSRKIILRLQVPKGSTGAYLSAI
GGFANEKEILLDKDSKYHIDKVTEVIIKGVKRYVVDATLLTN

# Drug_Target_53_Reaction:
Not Available

# Drug_Target_53_Signals:
None

# Drug_Target_53_Specific_Function:
Not Available

# Drug_Target_53_SwissProt_ID:
Q844J9

# Drug_Target_53_SwissProt_Name:
Q844J9_BACTU

# Drug_Target_53_Synonyms:
Not Available

# Drug_Target_53_Theoretical_pI:
8.74

# Drug_Target_53_Transmembrane_Regions:
None

# Drug_Target_54_Cellular_Location:
Cytoplasm

# Drug_Target_54_Chromosome_Location:
Not Available

# Drug_Target_54_Drug_References:
Not Available

# Drug_Target_54_Essentiality:
Non-Essential

# Drug_Target_54_GenAtlas_ID:
Not Available

# Drug_Target_54_GenBank_ID_Gene:
M24493

# Drug_Target_54_GenBank_ID_Protein:
Not Available

# Drug_Target_54_GeneCard_ID:
Not Available

# Drug_Target_54_Gene_Name:
gap

# Drug_Target_54_Gene_Sequence:
>1008 bp
ATGGCAGTCAAAGTGGGAATCAACGGATTTGGCCGCATCGGACGCAACGTCTTCCGCGCG
GCATTGAAAAACCCGGACATTGAAGTGGTGGCGGTGAACGATTTAACCGATGCGAATACG
CTTGCTCATTTGTTGAAGTACGACTCTGTCCATGGCCGTTTGGATGCCGAAGTGTCGGTG
AACGGCAACAACTTGGTCGTCAACGGCAAAGAAATCATCGTCAAGGCGGAACGCGATCCG
GAGAACTTGGCGTGGGGCGAGATCGGCGTTGACATCGTCGTTGAGTCGACCGGCCGCTTC
ACGAAACGCGAAGACGCCGCCAAACATTTGGAAGCGGGTGCGAAAAAAGTGATCATTTCC
GCCCCGGCGAAAAACGAAGACATTACGATCGTCATGGGCGTCAACCAAGACAAATACGAT
CCGAAAGCCCATCATGTCATCTCGAACGCGTCGTGCACGACGAACTGCTTGGCGCCGTTT
GCCAAAGTGCTGCATGAACAATTCGGCATCGTCCGCGGCATGATGACGACCGTTCACTCG
TACACAAACGACCAACGAATTTTGGACTTGCCGCATAAAGATTTGCGCCGGGCTCGCGCC
GCGGCCGAATCGATCATTCCGACGACGACCGGGGCGGCGAAAGCGGTCGCGCTCGTTTTG
CCGGAATTGAAAGGAAAGTTGAACGGCATGGCGATGCGCGTGCCGACGCCGAACGTATCC
GTTGTCGACTTGGTGGCGGAATTGGAAAAAGAAGTGACGGTCGAAGAAGTGAATGCCGCG
TTGAAAGCAGCAGCTGAAGGCGAGCTGAAAGGCATTTTGGCCTACAGCGAAGAACCGCTC
GTGTCGCGCGACTACAACGGCAGCACCGTTTCGTCGACGATCGACGCGTTGTCGACAATG
GTCATTGATGGCAAAATGGTGAAAGTCGTTTCGTGGTATGACAACGAAACGGGCTATTCG
CACCGCGTCGTCGACTTAGCTGCCTACATCGCCTCGAAAGGGCTGTAA

# Drug_Target_54_General_Function:
Involved in glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity

# Drug_Target_54_General_References:
193030	Biesecker G, Harris JI, Thierry JC, Walker JE, Wonacott AJ: Sequence and structure of D-glyceraldehyde 3-phosphate dehydrogenase from Bacillus stearothermophilus. Nature. 1977 Mar 24;266(5600):328-33.
2227448	Tesfay HS, Amelunxen RE, Goldberg ID: Nucleotide sequences of genes encoding heat-stable and heat-labile glyceraldehyde-3-phosphate dehydrogenases; amino acid sequence and protein thermostability. Gene. 1990 Sep 28;94(1):144.
2656407	Branlant C, Oster T, Branlant G: Nucleotide sequence determination of the DNA region coding for Bacillus stearothermophilus glyceraldehyde-3-phosphate dehydrogenase and of the flanking DNA regions required for its expression in Escherichia coli. Gene. 1989 Jan 30;75(1):145-55.
2684782	Tesfay HS, Amelunxen RE, Goldberg ID: Nucleotide sequences of genes encoding heat-stable and heat-labile glyceraldehyde-3-phosphate dehydrogenases; amino acid sequence and protein thermostability. Gene. 1989 Oct 30;82(2):237-48.
3586018	Skarzynski T, Moody PC, Wonacott AJ: Structure of holo-glyceraldehyde-3-phosphate dehydrogenase from Bacillus stearothermophilus at 1.8 A resolution. J Mol Biol. 1987 Jan 5;193(1):171-87.
7408868	Walker JE, Carne AF, Runswick MJ, Bridgen J, Harris JI: D-glyceraldehyde-3-phosphate dehydrogenase. Complete amino-acid sequence of the enzyme from Bacillus stearothermophilus. Eur J Biochem. 1980 Jul;108(2):549-65.
9175858	Didierjean C, Rahuel-Clermont S, Vitoux B, Dideberg O, Branlant G, Aubry A: A crystallographic comparison between mutated glyceraldehyde-3-phosphate dehydrogenases from Bacillus stearothermophilus complexed with either NAD+ or NADP+. J Mol Biol. 1997 May 16;268(4):739-59.

# Drug_Target_54_HGNC_ID:
Not Available

# Drug_Target_54_HPRD_ID:
Not Available

# Drug_Target_54_ID:
4454

# Drug_Target_54_Locus:
Not Available

# Drug_Target_54_Molecular_Weight:
36076

# Drug_Target_54_Name:
Glyceraldehyde-3-phosphate dehydrogenase

# Drug_Target_54_Number_of_Residues:
335

# Drug_Target_54_PDB_ID:
2GD1

# Drug_Target_54_Pathway:
Not Available

# Drug_Target_54_Pfam_Domain_Function:
PF00044	Gp_dh_N
PF02800	Gp_dh_C

# Drug_Target_54_Protein_Sequence:
>Glyceraldehyde-3-phosphate dehydrogenase
MAVKVGINGFGRIGRNVFRAALKNPDIEVVAVNDLTDANTLAHLLKYDSVHGRLDAEVSV
NGNNLVVNGKEIIVKAERDPENLAWGEIGVDIVVESTGRFTKREDAAKHLEAGAKKVIIS
APAKNEDITIVMGVNQDKYDPKAHHVISNASCTTNCLAPFAKVLHEQFGIVRGMMTTVHS
YTNDQRILDLPHKDLRRARAAAESIIPTTTGAAKAVALVLPELKGKLNGMAMRVPTPNVS
VVDLVAELEKEVTVEEVNAALKAAAEGELKGILAYSEEPLVSRDYNGSTVSSTIDALSTM
VIDGKMVKVVSWYDNETGYSHRVVDLAAYIASKGL

# Drug_Target_54_Reaction:
Not Available

# Drug_Target_54_Signals:
None

# Drug_Target_54_Specific_Function:
D-glyceraldehyde 3-phosphate + phosphate + NAD(+) = 3-phospho-D-glyceroyl phosphate + NADH

# Drug_Target_54_SwissProt_ID:
P00362

# Drug_Target_54_SwissProt_Name:
G3P_GEOSE

# Drug_Target_54_Synonyms:
EC 1.2.1.12
GAPDH

# Drug_Target_54_Theoretical_pI:
6.43

# Drug_Target_54_Transmembrane_Regions:
None

# Drug_Target_55_Cellular_Location:
Not Available

# Drug_Target_55_Chromosome_Location:
Not Available

# Drug_Target_55_Drug_References:
Not Available

# Drug_Target_55_Essentiality:
Non-Essential

# Drug_Target_55_GenAtlas_ID:
Not Available

# Drug_Target_55_GenBank_ID_Gene:
M65289

# Drug_Target_55_GenBank_ID_Protein:
Not Available

# Drug_Target_55_GeneCard_ID:
Not Available

# Drug_Target_55_Gene_Name:
gldA

# Drug_Target_55_Gene_Sequence:
>1113 bp
ATGGCGGCAGAAAGAGTATTTATCAGCCCTGCAAAATATGTTCAAGGTAAAAATGTCATT
ACAAAAATCGCGAATTATCTTGAAGGAATTGGAAACAAGACAGTCGTGATAGCTGATGAA
ATAGTTTGGAAAATAGCTGGGCATACAATAGTAAACGAATTAAAAAAAGGAAATATTGCA
GCCGAAGAAGTAGTTTTTAGCGGAGAAGCTTCAAGAAACGAGGTAGAAAGAATCGCGAAT
ATTGCAAGAAAAGCAGAAGCTGCTATTGTAATCGGCGTTGGTGGAGGAAAAACGTTAGAT
ACCGCAAAAGCGGTAGCGGATGAATTAGATGCTTATATAGTGATTGTGCCGACAGCTGCT
TCAACTGATGCGCCAACTAGTGCTCTTTCTGTTATATATTCTGATGACGGCGTATTTGAA
AGCTACCGTTTTTATAAAAAGAATCCAGATCTTGTACTTGTCGATACGAAAATTATCGCC
AATGCTCCGCCACGTTTACTTGCCTCTGGAATCGCTGATGCACTTGCAACTTGGGTGGAA
GCACGCAGTGTTATAAAATCCGGAGGAAAAACGATGGCGGGCGGTATCCCTACAATTGCA
GCTGAAGCAATTGCAGAAAAATGTGAACAAACTTTATTCAAGTACGGGAAGCTTGCCTAT
GAATCAGTAAAAGCAAAAGTCGTCACCCCTGCGTTAGAAGCGGTCGTCGAAGCAAACACG
CTCCTTAGCGGACTAGGTTTTGAAAGCGGCGGTTTGGCAGCGGCTCATGCTATTCATAAC
GGATTTACCGCGTTAGAAGGCGAAATACATCATTTGACACACGGAGAGAAAGTGGCATTT
GGTACTCTTGTCCAGCTCGCTCTCGAAGAACATTCACAACAAGAAATTGAACGCTATATT
GAGCTTTATTTGAGCCTTGATTTGCCAGTCACGTTGGAGGACATTAAATTAAAAGATGCT
TCACGCGAAGATATACTAAAAGTCGCTAAAGCAGCAACCGCAGAAGGGGAAACAATCCAT
AATGCATTCAATGTGACAGCTGATGATGTAGCAGATGCGATTTTTGCTGCTGATCAATAT
GCGAAAGCATATAAAGAAAAACACCGCAAATAA

# Drug_Target_55_General_Function:
Involved in oxidoreductase activity

# Drug_Target_55_General_References:
1339360	Mallinder PR, Pritchard A, Moir A: Cloning and characterization of a gene from Bacillus stearothermophilus var. non-diastaticus encoding a glycerol dehydrogenase. Gene. 1992 Jan 2;110(1):9-16.

# Drug_Target_55_HGNC_ID:
Not Available

# Drug_Target_55_HPRD_ID:
Not Available

# Drug_Target_55_ID:
4455

# Drug_Target_55_Locus:
Not Available

# Drug_Target_55_Molecular_Weight:
39501

# Drug_Target_55_Name:
Glycerol dehydrogenase

# Drug_Target_55_Number_of_Residues:
370

# Drug_Target_55_PDB_ID:
1JQA

# Drug_Target_55_Pathway:
Not Available

# Drug_Target_55_Pfam_Domain_Function:
PF00465	Fe-ADH

# Drug_Target_55_Protein_Sequence:
>Glycerol dehydrogenase
MAAERVFISPAKYVQGKNVITKIANYLEGIGNKTVVIADEIVWKIAGHTIVNELKKGNIA
AEEVVFSGEASRNEVERIANIARKAEAAIVIGVGGGKTLDTAKAVADELDAYIVIVPTAA
STDAPTSALSVIYSDDGVFESYRFYKKNPDLVLVDTKIIANAPPRLLASGIADALATWVE
ARSVIKSGGKTMAGGIPTIAAEAIAEKCEQTLFKYGKLAYESVKAKVVTPALEAVVEANT
LLSGLGFESGGLAAAHAIHNGFTALEGEIHHLTHGEKVAFGTLVQLALEEHSQQEIERYI
ELYLSLDLPVTLEDIKLKDASREDILKVAKAATAEGETIHNAFNVTADDVADAIFAADQY
AKAYKEKHRK

# Drug_Target_55_Reaction:
Not Available

# Drug_Target_55_Signals:
None

# Drug_Target_55_Specific_Function:
Glycerol + NAD(+) = glycerone + NADH

# Drug_Target_55_SwissProt_ID:
P32816

# Drug_Target_55_SwissProt_Name:
GLDA_GEOSE

# Drug_Target_55_Synonyms:
EC 1.1.1.6
GLDH

# Drug_Target_55_Theoretical_pI:
5.19

# Drug_Target_55_Transmembrane_Regions:
None

# Drug_Target_56_Cellular_Location:
Cytoplasm

# Drug_Target_56_Chromosome_Location:
Not Available

# Drug_Target_56_Drug_References:
Not Available

# Drug_Target_56_Essentiality:
Non-Essential

# Drug_Target_56_GenAtlas_ID:
Not Available

# Drug_Target_56_GenBank_ID_Gene:
AB044336

# Drug_Target_56_GenBank_ID_Protein:
Not Available

# Drug_Target_56_GeneCard_ID:
Not Available

# Drug_Target_56_Gene_Name:
ppnK

# Drug_Target_56_Gene_Sequence:
>924 bp
GTGACCGCTCATCGCAGTGTTCTGCTGGTCGTCCACACCGGGCGCGACGAAGCCACCGAG
ACCGCACGGCGCGTAGAAAAAGTATTGGGCGACAATAAAATTGCGCTTCGCGTGCTCTCG
GCCGAAGCAGTCGACCGAGGGTCGTTGCATCTGGCTCCCGACGACATGCGGGCCATGGGC
GTCGAGATCGAGGTGGTTGACGCGGACCAGCACGCAGCCGACGGCTGCGAACTGGTGCTG
GTTTTGGGCGGCGATGGCACCTTTTTGCGGGCAGCCGAGCTGGCCCGCAACGCCAGCATT
CCGGTGTTGGGCGTCAATCTGGGCCGCATCGGCTTTTTGGCCGAGGCCGAGGCGGAGGCA
ATCGACGCGGTGCTCGAGCATGTTGTCGCACAGGATTACCGGGTGGAAGACCGCTTGACT
CTGGATGTCGTGGTGCGCCAGGGCGGGCGCATCGTCAACCGGGGTTGGGCGCTCAACGAA
GTCAGTCTGGAAAAGGGCCCGAGGCTCGGCGTGCTTGGGGTGGTCGTGGAAATTGACGGT
CGGCCGGTGTCGGCGTTTGGCTGCGACGGGGTGTTGGTGTCCACGCCGACCGGATCAACC
GCCTATGCATTCTCGGCGGGAGGCCCGGTGCTGTGGCCCGACCTCGAAGCGATCCTGGTG
GTCCCCAACAACGCTCACGCGCTGTTTGGCCGGCCGATGGTCACCAGCCCCGAAGCCACC
ATCGCCATCGAAATAGAGGCCGACGGGCATGACGCCTTGGTGTTCTGCGACGGTCGCCGC
GAAATGCTGATACCGGCCGGCAGCAGACTCGAGGTCACCCGCTGTGTCACGTCCGTCAAA
TGGGCACGGCTGGACAGTGCGCCATTCACCGACCGGCTGGTGCGCAAGTTCCGGTTGCCG
GTGACCGGTTGGCGCGGAAAGTAG

# Drug_Target_56_General_Function:
Involved in NAD+ kinase activity

# Drug_Target_56_General_References:
11006082	Kawai S, Mori S, Mukai T, Suzuki S, Yamada T, Hashimoto W, Murata K: Inorganic Polyphosphate/ATP-NAD kinase of Micrococcus flavus and Mycobacterium tuberculosis H37Rv. Biochem Biophys Res Commun. 2000 Sep 16;276(1):57-63.
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_56_HGNC_ID:
Not Available

# Drug_Target_56_HPRD_ID:
Not Available

# Drug_Target_56_ID:
4456

# Drug_Target_56_Locus:
Not Available

# Drug_Target_56_Molecular_Weight:
32904

# Drug_Target_56_Name:
Inorganic polyphosphate/ATP-NAD kinase

# Drug_Target_56_Number_of_Residues:
307

# Drug_Target_56_PDB_ID:
1U0T

# Drug_Target_56_Pathway:
Not Available

# Drug_Target_56_Pfam_Domain_Function:
PF01513	NAD_kinase

# Drug_Target_56_Protein_Sequence:
>Inorganic polyphosphate/ATP-NAD kinase
MTAHRSVLLVVHTGRDEATETARRVEKVLGDNKIALRVLSAEAVDRGSLHLAPDDMRAMG
VEIEVVDADQHAADGCELVLVLGGDGTFLRAAELARNASIPVLGVNLGRIGFLAEAEAEA
IDAVLEHVVAQDYRVEDRLTLDVVVRQGGRIVNRGWALNEVSLEKGPRLGVLGVVVEIDG
RPVSAFGCDGVLVSTPTGSTAYAFSAGGPVLWPDLEAILVVPNNAHALFGRPMVTSPEAT
IAIEIEADGHDALVFCDGRREMLIPAGSRLEVTRCVTSVKWARLDSAPFTDRLVRKFRLP
VTGWRGK

# Drug_Target_56_Reaction:
Not Available

# Drug_Target_56_Signals:
None

# Drug_Target_56_Specific_Function:
Catalyzes the phosphorylation of NAD to NADP. Utilizes ATP and other nucleoside triphosphates as well as inorganic polyphosphate as a source of phosphorus

# Drug_Target_56_SwissProt_ID:
P0A5S6

# Drug_Target_56_SwissProt_Name:
PPNK_MYCTU

# Drug_Target_56_Synonyms:
EC 2.7.1.23
Poly(P)/ATP NAD kinase

# Drug_Target_56_Theoretical_pI:
5.10

# Drug_Target_56_Transmembrane_Regions:
None

# Drug_Target_57_Cellular_Location:
Not Available

# Drug_Target_57_Chromosome_Location:
1

# Drug_Target_57_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_57_Essentiality:
Non-Essential

# Drug_Target_57_GenAtlas_ID:
Not Available

# Drug_Target_57_GenBank_ID_Gene:
J04794

# Drug_Target_57_GenBank_ID_Protein:
178481

# Drug_Target_57_GeneCard_ID:
AKR1A1

# Drug_Target_57_Gene_Name:
AKR1A1

# Drug_Target_57_Gene_Sequence:
>978 bp
ATGGCGGCTTCCTGTGTTCTACTGCACACTGGGCAGAAGATGCCTCTGATTGGTCTGGGT
ACCTGGAAGAGTGAGCCTGGTCAGGTAAAAGCAGCTGTTAAGTATGCCCTTAGCGTAGGC
TACCGCCACATTGATTGTGCTGCTATCTACGGCAATGAGCCTGAGATTGGGGAGGCCCTG
AAGGAGGACGTGGGACCAGGCAAGGCGGTGCCTCGGGAGGAGCTGTTTGTGACATCCAAG
CTGTGGAACACCAAGCACCACCCCGAGGATGTGGAGCCTGCCCTCCGGAAGACTCTGGCT
GACCTCCAGCTGGAGTATCTGGACCTGTACCTGATGCACTGGCCTTATGCCTTTGAGCGG
GGAGACAACCCCTTCCCCAAGAATGCTGATGGGACTATATGCTACGACTCCACCCACTAC
AAGGAGACTTGGAAGGCTCTGGAGGCACTGGTGGCTAAGGGGCTGGTGCAGGCGCTGGGC
CTGTCCAACTTCAACAGTCGGCAGATTGATGACATACTCAGTGTGGCCTCCGTGCGTCCA
GCTGTCTTGCAGGTGGAATGCCACCCATACTTGGCTCAAAATGAGCTAATTGCCCACTGC
CAAGCACGTGGCTTGGAGGTAACTGCTTATAGCCCTTTGGGCTCCTCTGATCGTGCATGG
CGTGATCCTGATGAGCCTGTCCTGCTGGAGGAACCAGTAGTCCTGGCATTGGCTGAAAAG
TATGGCCGATCTCCAGCTCAGATCTTGCTCAGGTGGCAGGTCCAGCGGAAAGTGATCTGC
ATCCCCAAAAGTATCACTCCTTCTCGAATCCTTCAGAACATCAAGGTGTTTGACTTCACC
TTTAGCCCAGAAGAGATGAAGCAGCTAAATGCCCTGAACAAAAATTGGAGATATATTGTG
CCTATGCTTACGGTGGATGGGAAGAGAGTCCCAAGGGATGCAGGGCATCCTCTGTACCCC
TTTAATGACCCGTACTGA

# Drug_Target_57_General_Function:
Involved in alcohol dehydrogenase (NADP+) activity

# Drug_Target_57_General_References:
10393438	Fujii J, Hamaoka R, Matsumoto A, Fujii T, Yamaguchi Y, Egashira M, Miyoshi O, Niikawa N, Taniguchi N: The structural organization of the human aldehyde reductase gene, AKR1A1, and mapping to chromosome 1p33-->p32. Cytogenet Cell Genet. 1999;84(3-4):230-2.
10486210	Barski OA, Gabbay KH, Bohren KM: Characterization of the human aldehyde reductase gene and promoter. Genomics. 1999 Sep 1;60(2):188-98.
14702039	Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21.
15489334	Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.
16710414	Gregory SG, Barlow KF, McLay KE, Kaul R, Swarbreck D, Dunham A, Scott CE, Howe KL, Woodfine K, Spencer CC, Jones MC, Gillson C, Searle S, Zhou Y, Kokocinski F, McDonald L, Evans R, Phillips K, Atkinson A, Cooper R, Jones C, Hall RE, Andrews TD, Lloyd C, Ainscough R, Almeida JP, Ambrose KD, Anderson F, Andrew RW, Ashwell RI, Aubin K, Babbage AK, Bagguley CL, Bailey J, Beasley H, Bethel G, Bird CP, Bray-Allen S, Brown JY, Brown AJ, Buckley D, Burton J, Bye J, Carder C, Chapman JC, Clark SY, Clarke G, Clee C, Cobley V, Collier RE, Corby N, Coville GJ, Davies J, Deadman R, Dunn M, Earthrowl M, Ellington AG, Errington H, Frankish A, Frankland J, French L, Garner P, Garnett J, Gay L, Ghori MR, Gibson R, Gilby LM, Gillett W, Glithero RJ, Grafham DV, Griffiths C, Griffiths-Jones S, Grocock R, Hammond S, Harrison ES, Hart E, Haugen E, Heath PD, Holmes S, Holt K, Howden PJ, Hunt AR, Hunt SE, Hunter G, Isherwood J, James R, Johnson C, Johnson D, Joy A, Kay M, Kershaw JK, Kibukawa M, Kimberley AM, King A, Knights AJ, Lad H, Laird G, Lawlor S, Leongamornlert DA, Lloyd DM, Loveland J, Lovell J, Lush MJ, Lyne R, Martin S, Mashreghi-Mohammadi M, Matthews L, Matthews NS, McLaren S, Milne S, Mistry S, Moore MJ, Nickerson T, O'Dell CN, Oliver K, Palmeiri A, Palmer SA, Parker A, Patel D, Pearce AV, Peck AI, Pelan S, Phelps K, Phillimore BJ, Plumb R, Rajan J, Raymond C, Rouse G, Saenphimmachak C, Sehra HK, Sheridan E, Shownkeen R, Sims S, Skuce CD, Smith M, Steward C, Subramanian S, Sycamore N, Tracey A, Tromans A, Van Helmond Z, Wall M, Wallis JM, White S, Whitehead SL, Wilkinson JE, Willey DL, Williams H, Wilming L, Wray PW, Wu Z, Coulson A, Vaudin M, Sulston JE, Durbin R, Hubbard T, Wooster R, Dunham I, Carter NP, McVean G, Ross MT, Harrow J, Olson MV, Beck S, Rogers J, Bentley DR, Banerjee R, Bryant SP, Burford DC, Burrill WD, Clegg SM, Dhami P, Dovey O, Faulkner LM, Gribble SM, Langford CF, Pandian RD, Porter KM, Prigmore E: The DNA sequence and biological annotation of human chromosome 1. Nature. 2006 May 18;441(7091):315-21.
2498333	Bohren KM, Bullock B, Wermuth B, Gabbay KH: The aldo-keto reductase superfamily. cDNAs and deduced amino acid sequences of human aldehyde and aldose reductases. J Biol Chem. 1989 Jun 5;264(16):9547-51.
3615425	Wermuth B, Omar A, Forster A, di Francesco C, Wolf M, von Wartburg JP, Bullock B, Gabbay KH: Primary structure of aldehyde reductase from human liver. Prog Clin Biol Res. 1987;232:297-307.

# Drug_Target_57_HGNC_ID:
GNC:380

# Drug_Target_57_HPRD_ID:
Not Available

# Drug_Target_57_ID:
6861

# Drug_Target_57_Locus:
1p33-p32

# Drug_Target_57_Molecular_Weight:
36572.7

# Drug_Target_57_Name:
Alcohol dehydrogenase [NADP+]

# Drug_Target_57_Number_of_Residues:
325

# Drug_Target_57_PDB_ID:
2ALR

# Drug_Target_57_Pathway:
Cyclophosphamide Pathway	SMP00447

# Drug_Target_57_Pfam_Domain_Function:
PF00248	Aldo_ket_red

# Drug_Target_57_Protein_Sequence:
>Alcohol dehydrogenase [NADP+]
MAASCVLLHTGQKMPLIGLGTWKSEPGQVKAAVKYALSVGYRHIDCAAIYGNEPEIGEAL
KEDVGPGKAVPREELFVTSKLWNTKHHPEDVEPALRKTLADLQLEYLDLYLMHWPYAFER
GDNPFPKNADGTICYDSTHYKETWKALEALVAKGLVQALGLSNFNSRQIDDILSVASVRP
AVLQVECHPYLAQNELIAHCQARGLEVTAYSPLGSSDRAWRDPDEPVLLEEPVVLALAEK
YGRSPAQILLRWQVQRKVICIPKSITPSRILQNIKVFDFTFSPEEMKQLNALNKNWRYIV
PMLTVDGKRVPRDAGHPLYPFNDPY

# Drug_Target_57_Reaction:
Not Available

# Drug_Target_57_Signals:
None

# Drug_Target_57_Specific_Function:
Catalyzes the NADPH-dependent reduction of a variety of aromatic and aliphatic aldehydes to their corresponding alcohols. Catalyzes the reduction of mevaldate to mevalonic acid and of glyceraldehyde to glycerol. Has broad substrate specificity. In vitro substrates include succinic semialdehyde, 4- nitrobenzaldehyde, 1,2-naphthoquinone, methylglyoxal, and D- glucuronic acid. Plays a role in the activation of procarcinogens, such as polycyclic aromatic hydrocarbon trans-dihydrodiols, and in the metabolism of various xenobiotics and drugs, including the anthracyclines doxorubicin (DOX) and daunorubicin (DAUN)

# Drug_Target_57_SwissProt_ID:
P14550

# Drug_Target_57_SwissProt_Name:
AK1A1_HUMAN

# Drug_Target_57_Synonyms:
Aldehyde reductase
Aldo-keto reductase family 1 member A1

# Drug_Target_57_Theoretical_pI:
6.79

# Drug_Target_57_Transmembrane_Regions:
None

# Drug_Target_58_Cellular_Location:
Not Available

# Drug_Target_58_Chromosome_Location:
Not Available

# Drug_Target_58_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_58_Essentiality:
Non-Essential

# Drug_Target_58_GenAtlas_ID:
Not Available

# Drug_Target_58_GenBank_ID_Gene:
L29397

# Drug_Target_58_GenBank_ID_Protein:
Not Available

# Drug_Target_58_GeneCard_ID:
Not Available

# Drug_Target_58_Gene_Name:
serA

# Drug_Target_58_Gene_Sequence:
Not Available

# Drug_Target_58_General_Function:
Coenzyme transport and metabolism

# Drug_Target_58_General_References:
1917830	Rex JH, Aronson BD, Somerville RL: The tdh and serA operons of Escherichia coli: mutational analysis of the regulatory elements of leucine-responsive genes. J Bacteriol. 1991 Oct;173(19):5944-53.
3017965	Tobey KL, Grant GA: The nucleotide sequence of the serA gene of Escherichia coli and the amino acid sequence of the encoded protein, D-3-phosphoglycerate dehydrogenase. J Biol Chem. 1986 Sep 15;261(26):12179-83.
7719856	Schuller DJ, Grant GA, Banaszak LJ: The allosteric ligand site in the Vmax-type cooperative enzyme phosphoglycerate dehydrogenase. Nat Struct Biol. 1995 Jan;2(1):69-76.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9298646	Link AJ, Robison K, Church GM: Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12. Electrophoresis. 1997 Aug;18(8):1259-313.

# Drug_Target_58_HGNC_ID:
Not Available

# Drug_Target_58_HPRD_ID:
Not Available

# Drug_Target_58_ID:
3726

# Drug_Target_58_Locus:
Not Available

# Drug_Target_58_Molecular_Weight:
44176

# Drug_Target_58_Name:
D-3-phosphoglycerate dehydrogenase

# Drug_Target_58_Number_of_Residues:
410

# Drug_Target_58_PDB_ID:
1PSD

# Drug_Target_58_Pathway:
Not Available

# Drug_Target_58_Pfam_Domain_Function:
PF00389	2-Hacid_dh
PF01842	ACT
PF02826	2-Hacid_dh_C

# Drug_Target_58_Protein_Sequence:
>D-3-phosphoglycerate dehydrogenase
MAKVSLEKDKIKFLLVEGVHQKALESLRAAGYTNIEFHKGALDDEQLKESIRDAHFIGLR
SRTHLTEDVINAAEKLVAIGCFCIGTNQVDLDAAAKRGIPVFNAPFSNTRSVAELVIGEL
LLLLRGVPEANAKAHRGVWNKLAAGSFEARGKKLGIIGYGHIGTQLGILAESLGMYVYFY
DIENKLPLGNATQVQHLSDLLNMSDVVSLHVPENPSTKNMMGAKEISLMKPGSLLINASR
GTVVDIPALCDALASKHLAGAAIDVFPTEPATNSDPFTSPLCEFDNVLLTPHIGGSTQEA
QENIGLEVAGKLIKYSDNGSTLSAVNFPEVSLPLHGGRRLMHIHENRPGVLTALNKIFAE
QGVNIAAQYLQTSAQMGYVVIDIEADEDVAEKALQAMKAIPGTIRARLLY

# Drug_Target_58_Reaction:
3-phosphoglycerate + NAD+ = 3-phosphohydroxypyruvate + NADH + H+

# Drug_Target_58_Signals:
None

# Drug_Target_58_Specific_Function:
3-phospho-D-glycerate + NAD(+) = 3- phosphonooxypyruvate + NADH

# Drug_Target_58_SwissProt_ID:
P0A9T0

# Drug_Target_58_SwissProt_Name:
SERA_ECOLI

# Drug_Target_58_Synonyms:
EC 1.1.1.95
PGDH

# Drug_Target_58_Theoretical_pI:
6.32

# Drug_Target_58_Transmembrane_Regions:
None

# Drug_Target_59_Cellular_Location:
Not Available

# Drug_Target_59_Chromosome_Location:
Not Available

# Drug_Target_59_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_59_Essentiality:
Non-Essential

# Drug_Target_59_GenAtlas_ID:
Not Available

# Drug_Target_59_GenBank_ID_Gene:
J01619

# Drug_Target_59_GenBank_ID_Protein:
Not Available

# Drug_Target_59_GeneCard_ID:
Not Available

# Drug_Target_59_Gene_Name:
gltA

# Drug_Target_59_Gene_Sequence:
Not Available

# Drug_Target_59_General_Function:
Energy production and conversion

# Drug_Target_59_General_References:
1939121	Donald LJ, Crane BR, Anderson DH, Duckworth HW: The role of cysteine 206 in allosteric inhibition of Escherichia coli citrate synthase. Studies by chemical modification, site-directed mutagenesis, and 19F NMR. J Biol Chem. 1991 Nov 5;266(31):20709-13.
3309132	Wilde RJ, Guest JR: Transcript analysis of the citrate synthase and succinate dehydrogenase genes of Escherichia coli K12. J Gen Microbiol. 1986 Dec;132(12):3239-51.
3514304	Ner SS, Bloxham DP, Handford PA, Akhtar M: The synthesis and use of oligodeoxynucleotides in plasmid DNA sequencing. Int J Biochem. 1986;18(3):257-62.
6343122	Hull EP, Spencer ME, Wood D, Guest JR: Nucleotide sequence of the promoter region of the citrate synthase gene (gltA) of Escherichia coli. FEBS Lett. 1983 Jun 13;156(2):366-70.
6380576	Bhayana V, Duckworth HW: Amino acid sequence of Escherichia coli citrate synthase. Biochemistry. 1984 Jun 19;23(13):2900-5.
6383359	Wood D, Darlison MG, Wilde RJ, Guest JR: Nucleotide sequence encoding the flavoprotein and hydrophobic subunits of the succinate dehydrogenase of Escherichia coli. Biochem J. 1984 Sep 1;222(2):519-34.
7730298	Helling RB: icdB mutants of Escherichia coli. J Bacteriol. 1995 May;177(9):2592-3.
8905232	Oshima T, Aiba H, Baba T, Fujita K, Hayashi K, Honjo A, Ikemoto K, Inada T, Itoh T, Kajihara M, Kanai K, Kashimoto K, Kimura S, Kitagawa M, Makino K, Masuda S, Miki T, Mizobuchi K, Mori H, Motomura K, Nakamura Y, Nashimoto H, Nishio Y, Saito N, Horiuchi T, et al.: A 718-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 12.7-28.0 min region on the linkage map. DNA Res. 1996 Jun 30;3(3):137-55.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_59_HGNC_ID:
Not Available

# Drug_Target_59_HPRD_ID:
Not Available

# Drug_Target_59_ID:
3729

# Drug_Target_59_Locus:
Not Available

# Drug_Target_59_Molecular_Weight:
48016

# Drug_Target_59_Name:
Citrate synthase

# Drug_Target_59_Number_of_Residues:
427

# Drug_Target_59_PDB_ID:
1K3P

# Drug_Target_59_Pathway:
Not Available

# Drug_Target_59_Pfam_Domain_Function:
PF00285	Citrate_synt

# Drug_Target_59_Protein_Sequence:
>Citrate synthase
MADTKAKLTLNGDTAVELDVLKGTLGQDVIDIRTLGSKGVFTFDPGFTSTASCESKITFI
DGDEGILLHRGFPIDQLATDSNYLEVCYILLNGEKPTQEQYDEFKTTVTRHTMIHEQITR
LFHAFRRDSHPMAVMCGITGALAAFYHDSLDVNNPRHREIAAFRLLSKMPTMAAMCYKYS
IGQPFVYPRNDLSYAGNFLNMMFSTPCEPYEVNPILERAMDRILILHADHEQNASTSTVR
TAGSSGANPFACIAAGIASLWGPAHGGANEAALKMLEEISSVKHIPEFVRRAKDKNDSFR
LMGFGHRVYKNYDPRATVMRETCHEVLKELGTKDDLLEVAMELENIALNDPYFIEKKLYP
NVDFYSGIILKAMGIPSSMFTVIFAMARTVGWIAHWSEMHSDGMKIARPRQLYTGYEKRD
FKSDIKR

# Drug_Target_59_Reaction:
acetyl-CoA + H2O + oxaloacetate = citrate + CoA

# Drug_Target_59_Signals:
None

# Drug_Target_59_Specific_Function:
Acetyl-CoA + H(2)O + oxaloacetate = citrate + CoA

# Drug_Target_59_SwissProt_ID:
P0ABH7

# Drug_Target_59_SwissProt_Name:
CISY_ECOLI

# Drug_Target_59_Synonyms:
EC 2.3.3.1

# Drug_Target_59_Theoretical_pI:
6.67

# Drug_Target_59_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Not Available

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
M15811

# Drug_Target_5_GenBank_ID_Protein:
143279

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
nadE

# Drug_Target_5_Gene_Sequence:
>819 bp
ATGAGCATGCAGGAAAAGATTATGCGTGAGTTACATGTGAAGCCCTCAATTGATCCAAAG
CAAGAAATTGAGGACCGAGTCAATTTTTTAAAACAATATGTAAAGAAAACCGGTGCTAAA
GGCTTTGTATTGGGAATCAGCGGGGGCCAGGATTCAACACTTGCGGGAAGACTCGCTCAG
CTTGCGGTGGAGAGCATTCGCGAGGAGGGCGGAGACGCTCAATTTATCGCGGTCCGTCTT
CCGCATGGCACACAGCAGGATGAAGACGATGCCCAGCTTGCTTTGAAGTTTATTAAGCCG
GATAAATCATGGAAGTTTGATATTAAATCGACAGTCAGCGCTTTTTCTGATCAGTATCAG
CAGGAAACAGGCGATCAGCTGACGGACTTTAATAAAGGAAACGTAAAAGCAAGAACAAGA
ATGATCGCGCAATACGCGATCGGCGGCCAGGAAGGTCTTCTTGTGTTAGGAACAGACCAT
GCTGCTGAAGCAGTGACTGGTTTCTTTACGAAGTACGGTGACGGCGGAGCAGACCTCCTG
CCGCTGACAGGCTTGACGAAGCGCCAGGGAAGAACCTTGCTGAAAGAGCTGGGTGCACCG
GAACGCTTATACTTAAAAGAACCGACTGCCGATCTGCTCGACGAAAAACCGCAGCAGTCG
GATGAAACAGAGCTTGGCATTTCCTACGACGAGATTGACGATTATCTCGAAGGAAAAGAA
GTATCAGCGAAAGTATCAGAAGCGCTGGAAAAACGCTACAGCATGACTGAACATAAACGC
CAGGTTCCGGCGTCTATGTTTGATGACTGGTGGAAATAA

# Drug_Target_5_General_Function:
Coenzyme transport and metabolism

# Drug_Target_5_General_References:
11375500	Devedjiev Y, Symersky J, Singh R, Jedrzejas M, Brouillette C, Brouillette W, Muccio D, Chattopadhyay D, DeLucas L: Stabilization of active-site loops in NH3-dependent NAD+ synthetase from Bacillus subtilis. Acta Crystallogr D Biol Crystallogr. 2001 Jun;57(Pt 6):806-12. Epub 2001 May 25.
12077433	Symersky J, Devedjiev Y, Moore K, Brouillette C, DeLucas L: NH3-dependent NAD+ synthetase from Bacillus subtilis at 1 A resolution. Acta Crystallogr D Biol Crystallogr. 2002 Jul;58(Pt 7):1138-46. Epub 2002 Jun 20.
1556067	Mitchell C, Morris PW, Vary JC: Identification of proteins phosphorylated by ATP during sporulation of Bacillus subtilis. J Bacteriol. 1992 Apr;174(8):2474-7.
2118513	Albertini AM, Galizzi A: The Bacillus subtilis outB gene is highly homologous to an Escherichia coli ntr-like gene. J Bacteriol. 1990 Sep;172(9):5482-5.
2435704	Albertini AM, Caramori T, Henner D, Ferrari E, Galizzi A: Nucleotide sequence of the outB locus of Bacillus subtilis and regulation of its expression. J Bacteriol. 1987 Apr;169(4):1480-4.
7890752	Nessi C, Albertini AM, Speranza ML, Galizzi A: The outB gene of Bacillus subtilis codes for NAD synthetase. J Biol Chem. 1995 Mar 17;270(11):6181-5.
8895556	Rizzi M, Nessi C, Mattevi A, Coda A, Bolognesi M, Galizzi A: Crystal structure of NH3-dependent NAD+ synthetase from Bacillus subtilis. EMBO J. 1996 Oct 1;15(19):5125-34.
8969502	Yamane K, Kumano M, Kurita K: The 25 degrees-36 degrees region of the Bacillus subtilis chromosome: determination of the sequence of a 146 kb segment and identification of 113 genes. Microbiology. 1996 Nov;142 ( Pt 11):3047-56.
9298659	Antelmann H, Bernhardt J, Schmid R, Mach H, Volker U, Hecker M: First steps from a two-dimensional protein index towards a response-regulation map for Bacillus subtilis. Electrophoresis. 1997 Aug;18(8):1451-63.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.
9753692	Rizzi M, Bolognesi M, Coda A: A novel deamido-NAD+-binding site revealed by the trapped NAD-adenylate intermediate in the NAD+ synthetase structure. Structure. 1998 Sep 15;6(9):1129-40.

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
2910

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
30396

# Drug_Target_5_Name:
NH(3)-dependent NAD(+) synthetase

# Drug_Target_5_Number_of_Residues:
272

# Drug_Target_5_PDB_ID:
1IH8

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF02540	NAD_synthase

# Drug_Target_5_Protein_Sequence:
>NH(3)-dependent NAD(+) synthetase
MSMQEKIMRELHVKPSIDPKQEIEDRVNFLKQYVKKTGAKGFVLGISGGQDSTLAGRLAQ
LAVESIREEGGDAQFIAVRLPHGTQQDEDDAQLALKFIKPDKSWKFDIKSTVSAFSDQYQ
QETGDQLTDFNKGNVKARTRMIAQYAIGGQEGLLVLGTDHAAEAVTGFFTKYGDGGADLL
PLTGLTKRQGRTLLKELGAPERLYLKEPTADLLDEKPQQSDETELGISYDEIDDYLEGKE
VSAKVSEALEKRYSMTEHKRQVPASMFDDWWK

# Drug_Target_5_Reaction:
ATP + deamido-NAD+ + NH3 = AMP + diphosphate + NAD+

# Drug_Target_5_Signals:
None

# Drug_Target_5_Specific_Function:
Catalyzes a key step in NAD biosynthesis, transforming deamido-NAD into NAD by a two-step reaction

# Drug_Target_5_SwissProt_ID:
P08164

# Drug_Target_5_SwissProt_Name:
NADE_BACSU

# Drug_Target_5_Synonyms:
EC 6.3.1.5
GSP38
General stress protein 38
Spore outgrowth factor B
Sporulation protein outB

# Drug_Target_5_Theoretical_pI:
4.83

# Drug_Target_5_Transmembrane_Regions:
None

# Drug_Target_60_Cellular_Location:
Cytoplasm

# Drug_Target_60_Chromosome_Location:
Not Available

# Drug_Target_60_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_60_Essentiality:
Non-Essential

# Drug_Target_60_GenAtlas_ID:
Not Available

# Drug_Target_60_GenBank_ID_Gene:
X02662

# Drug_Target_60_GenBank_ID_Protein:
Not Available

# Drug_Target_60_GeneCard_ID:
Not Available

# Drug_Target_60_Gene_Name:
gapA

# Drug_Target_60_Gene_Sequence:
Not Available

# Drug_Target_60_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_60_General_References:
1862091	Nelson K, Whittam TS, Selander RK: Nucleotide polymorphism and evolution in the glyceraldehyde-3-phosphate dehydrogenase gene (gapA) in natural populations of Salmonella and Escherichia coli. Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6667-71.
2124629	Doolittle RF, Feng DF, Anderson KL, Alberro MR: A naturally occurring horizontal gene transfer from a eukaryote to a prokaryote. J Mol Evol. 1990 Nov;31(5):383-8.
2990926	Branlant G, Branlant C: Nucleotide sequence of the Escherichia coli gap gene. Different evolutionary behavior of the NAD+-binding domain and of the catalytic domain of D-glyceraldehyde-3-phosphate dehydrogenase. Eur J Biochem. 1985 Jul 1;150(1):61-6.
7896119	Guttman DS, Dykhuizen DE: Detecting selective sweeps in naturally occurring Escherichia coli. Genetics. 1994 Dec;138(4):993-1003.
8636984	Duee E, Olivier-Deyris L, Fanchon E, Corbier C, Branlant G, Dideberg O: Comparison of the structures of wild-type and a N313T mutant of Escherichia coli glyceraldehyde 3-phosphate dehydrogenases: implication for NAD binding and cooperativity. J Mol Biol. 1996 Apr 12;257(4):814-38.
9097039	Aiba H, Baba T, Hayashi K, Inada T, Isono K, Itoh T, Kasai H, Kashimoto K, Kimura S, Kitakawa M, Kitagawa M, Makino K, Miki T, Mizobuchi K, Mori H, Mori T, Motomura K, Nakade S, Nakamura Y, Nashimoto H, Nishio Y, Oshima T, Saito N, Sampei G, Horiuchi T, et al.: A 570-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 28.0-40.1 min region on the linkage map. DNA Res. 1996 Dec 31;3(6):363-77.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9298646	Link AJ, Robison K, Church GM: Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12. Electrophoresis. 1997 Aug;18(8):1259-313.

# Drug_Target_60_HGNC_ID:
Not Available

# Drug_Target_60_HPRD_ID:
Not Available

# Drug_Target_60_ID:
3736

# Drug_Target_60_Locus:
Not Available

# Drug_Target_60_Molecular_Weight:
35533

# Drug_Target_60_Name:
Glyceraldehyde-3-phosphate dehydrogenase A

# Drug_Target_60_Number_of_Residues:
331

# Drug_Target_60_PDB_ID:
1S7C

# Drug_Target_60_Pathway:
Not Available

# Drug_Target_60_Pfam_Domain_Function:
PF00044	Gp_dh_N
PF02800	Gp_dh_C

# Drug_Target_60_Protein_Sequence:
>Glyceraldehyde-3-phosphate dehydrogenase A
MTIKVGINGFGRIGRIVFRAAQKRSDIEIVAINDLLDADYMAYMLKYDSTHGRFDGTVEV
KDGHLIVNGKKIRVTAERDPANLKWDEVGVDVVAEATGLFLTDETARKHITAGAKKVVMT
GPSKDNTPMFVKGANFDKYAGQDIVSNASCTTNCLAPLAKVINDNFGIIEGLMTTVHATT
ATQKTVDGPSHKDWRGGRGASQNIIPSSTGAAKAVGKVLPELNGKLTGMAFRVPTPNVSV
VDLTVRLEKAATYEQIKAAVKAAAEGEMKGVLGYTEDDVVSTDFNGEVCTSVFDAKAGIA
LNDNFVKLVSWYDNETGYSNKVLDLIAHISK

# Drug_Target_60_Reaction:
D-glyceraldehyde 3-phosphate + phosphate + NAD+ = 3-phospho-D-glyceroyl phosphate + NADH + H+

# Drug_Target_60_Signals:
None

# Drug_Target_60_Specific_Function:
D-glyceraldehyde 3-phosphate + phosphate + NAD(+) = 3-phospho-D-glyceroyl phosphate + NADH

# Drug_Target_60_SwissProt_ID:
P0A9B2

# Drug_Target_60_SwissProt_Name:
G3P1_ECOLI

# Drug_Target_60_Synonyms:
EC 1.2.1.12
GAPDH-A

# Drug_Target_60_Theoretical_pI:
7.13

# Drug_Target_60_Transmembrane_Regions:
None

# Drug_Target_61_Cellular_Location:
Cell inner membrane
multi-pass membrane protein

# Drug_Target_61_Chromosome_Location:
Not Available

# Drug_Target_61_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_61_Essentiality:
Non-Essential

# Drug_Target_61_GenAtlas_ID:
Not Available

# Drug_Target_61_GenBank_ID_Gene:
U01158

# Drug_Target_61_GenBank_ID_Protein:
Not Available

# Drug_Target_61_GeneCard_ID:
Not Available

# Drug_Target_61_Gene_Name:
pntAA

# Drug_Target_61_Gene_Sequence:
Not Available

# Drug_Target_61_General_Function:
Energy production and conversion

# Drug_Target_61_General_References:
10997900	Buckley PA, Baz Jackson J, Schneider T, White SA, Rice DW, Baker PJ: Protein-protein recognition, hydride transfer and proton pumping in the transhydrogenase complex. Structure. 2000 Aug 15;8(8):809-15.
11250201	Cotton NP, White SA, Peake SJ, McSweeney S, Jackson JB: The crystal structure of an asymmetric complex of the two nucleotide binding components of proton-translocating transhydrogenase. Structure. 2001 Feb 7;9(2):165-76.
7844118	Yamaguchi M, Hatefi Y: Energy-transducing nicotinamide nucleotide transhydrogenase: nucleotide sequences of the genes and predicted amino acid sequences of the subunits of the enzyme from Rhodospirillum rubrum. J Bioenerg Biomembr. 1994 Aug;26(4):435-45.

# Drug_Target_61_HGNC_ID:
Not Available

# Drug_Target_61_HPRD_ID:
Not Available

# Drug_Target_61_ID:
3735

# Drug_Target_61_Locus:
Not Available

# Drug_Target_61_Molecular_Weight:
40277

# Drug_Target_61_Name:
NAD(P) transhydrogenase subunit alpha part 1

# Drug_Target_61_Number_of_Residues:
384

# Drug_Target_61_PDB_ID:
1XLT

# Drug_Target_61_Pathway:
Not Available

# Drug_Target_61_Pfam_Domain_Function:
PF01262	AlaDh_PNT_C
PF05222	AlaDh_PNT_N

# Drug_Target_61_Protein_Sequence:
>NAD(P) transhydrogenase subunit alpha part 1
MKIAIPKERRPGEDRVAISPEVVKKLVGLGFEVIVEQGAGVGASITDDALTAAGATIAST
AAQALSQADVVWKVQRPMTAEEGTDEVALIKEGAVLMCHLGALTNRPVVEALTKRKITAY
AMELMPRISRAQSMDILSSQSNLAGYRAVIDGAYEFARAFPMMMTAAGTVPPARVLVFGV
GVAGLQAIATAKRLGAVVMATDVRAATKEQVESLGGKFITVDDEAMKTAETAGGYAKEMG
EEFRKKQAEAVLKELVKTDIAITTALIPGKPAPVLITEEMVTKMKPGSVIIDLAVEAGGN
CPLSEPGKIVVKHGVKIVGHTNVPSRVAADASPLFAKNLLNFLTPHVDKDTKTLVMKLED
ETVSGTCVTRDGAIVHPALTGQGA

# Drug_Target_61_Reaction:
NADPH + NAD+ = NADP+ + NADH

# Drug_Target_61_Signals:
None

# Drug_Target_61_Specific_Function:
The transhydrogenation between NADH and NADP is coupled to respiration and ATP hydrolysis and functions as a proton pump across the membrane

# Drug_Target_61_SwissProt_ID:
P0C186

# Drug_Target_61_SwissProt_Name:
PNTAA_RHORU

# Drug_Target_61_Synonyms:
EC 1.6.1.2
Nicotinamide nucleotide transhydrogenase subunit alpha 1
Proton-translocating transhydrogenase component 1
Pyridine nucleotide transhydrogenase subunit alpha 1
dI

# Drug_Target_61_Theoretical_pI:
7.05

# Drug_Target_61_Transmembrane_Regions:
None

# Drug_Target_62_Cellular_Location:
Cytoplasm (By similarity)

# Drug_Target_62_Chromosome_Location:
Not Available

# Drug_Target_62_Drug_References:
Not Available

# Drug_Target_62_Essentiality:
Non-Essential

# Drug_Target_62_GenAtlas_ID:
Not Available

# Drug_Target_62_GenBank_ID_Gene:
AE000512

# Drug_Target_62_GenBank_ID_Protein:
Not Available

# Drug_Target_62_GeneCard_ID:
Not Available

# Drug_Target_62_Gene_Name:
dapB

# Drug_Target_62_Gene_Sequence:
>651 bp
TCACTCACCTCCAAAGATCACTTCTTCGAAACTGTACATACCGGGATCTTTTCCCACAAG
AAACTCCGCCGCTTTCAGGGCTCCTATGGCGAAAACAGTCCTCGAAATCGCCCTGTGCTT
TATCTCGATCGTCTCACCTATGTTTCCAAAAACGACCACGTGATCTCCCGGAACACCACC
CACTCTCAGCGAGTGAATGGGAACACTCTTTCCCAGTGCGCTCTCCAGAAGAATCGCGGT
TCCGGAGGGTGCGTCCTTTTTGAAGCGGTGGTGCGTCTCCACGATCTCAACATCCCAATC
TTCGAGGACTTTGACGAGTTCCGAGAGGAACCTCTTCAGAACGTTTATGCCAATGGAGAA
GTTGTAAGCCTGAACAACGGGTACTTCTTTCGAAAGCTCCCTCAACATCTGGAGATGTTC
TTCTTTCAGGGCAGTTGTTCCCAGAACGAGGCCAGCCCTGTATTTTTTACACAGATCCAC
CGTTTTCGGAAGCGCTTCAGGTGAAGAAAAGTCGATCACAACATCCGGAGAATCCAGCTC
CTCGACACCGTTCACATCCACCTTCAAAACGAGTTCATGCCCTTTCTCCGAGAAGACCTT
CTGGATCTCCTGGCCCATCCTTCCGGAATAACCGACTATTCCGTACTTCAT

# Drug_Target_62_General_Function:
Involved in dihydrodipicolinate reductase activity

# Drug_Target_62_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.

# Drug_Target_62_HGNC_ID:
Not Available

# Drug_Target_62_HPRD_ID:
Not Available

# Drug_Target_62_ID:
4462

# Drug_Target_62_Locus:
Not Available

# Drug_Target_62_Molecular_Weight:
23732

# Drug_Target_62_Name:
Dihydrodipicolinate reductase

# Drug_Target_62_Number_of_Residues:
216

# Drug_Target_62_PDB_ID:
1VM6

# Drug_Target_62_Pathway:
Not Available

# Drug_Target_62_Pfam_Domain_Function:
PF01113	DapB_N
PF05173	DapB_C

# Drug_Target_62_Protein_Sequence:
>Dihydrodipicolinate reductase
MKYGIVGYSGRMGQEIQKVFSEKGHELVLKVDVNGVEELDSPDVVIDFSSPEALPKTVDL
CKKYRAGLVLGTTALKEEHLQMLRELSKEVPVVQAYNFSIGINVLKRFLSELVKVLEDWD
VEIVETHHRFKKDAPSGTAILLESALGKSVPIHSLRVGGVPGDHVVVFGNIGETIEIKHR
AISRTVFAIGALKAAEFLVGKDPGMYSFEEVIFGGE

# Drug_Target_62_Reaction:
Not Available

# Drug_Target_62_Signals:
None

# Drug_Target_62_Specific_Function:
2,3,4,5-tetrahydrodipicolinate + NAD(P)(+) = 2,3-dihydrodipicolinate + NAD(P)H

# Drug_Target_62_SwissProt_ID:
Q9X1K8

# Drug_Target_62_SwissProt_Name:
DAPB_THEMA

# Drug_Target_62_Synonyms:
DHPR
EC 1.3.1.26

# Drug_Target_62_Theoretical_pI:
5.90

# Drug_Target_62_Transmembrane_Regions:
None

# Drug_Target_63_Cellular_Location:
Not Available

# Drug_Target_63_Chromosome_Location:
Not Available

# Drug_Target_63_Drug_References:
Not Available

# Drug_Target_63_Essentiality:
Non-Essential

# Drug_Target_63_GenAtlas_ID:
Not Available

# Drug_Target_63_GenBank_ID_Gene:
D21201

# Drug_Target_63_GenBank_ID_Protein:
Not Available

# Drug_Target_63_GeneCard_ID:
Not Available

# Drug_Target_63_Gene_Name:
fdhA

# Drug_Target_63_Gene_Sequence:
>1200 bp
ATGTCTGGTAATCGTGGTGTCGTTTATCTCGGTTCGGGCAAGGTCGAAGTCCAGAAGATC
GACTACCCCAAAATGCAGGACCCTCGCGGCAAGAAGATCGAGCACGGGGTCATCCTGAAA
GTCGTCTCCACCAACATCTGCGGCTCGGACCAGCACATGGTGCGCGGTCGTACCACCGCC
CAGGTAGGCCTCGTGCTTGGCCACGAGATCACCGGTGAGGTGATCGAGAAGGGCCGTGAC
GTAGAGAACCTGCAGATCGGCGACCTGGTTTCCGTACCCTTCAACGTGGCCTGCGGCCGC
TGCCGTTCCTGCAAGGAAATGCACACCGGCGTTTGCCTGACCGTCAATCCGGCCCGCGCT
GGCGGCGCCTACGGCTATGTCGACATGGGCGACTGGACCGGTGGCCAGGCCGAGTACTTG
CTGGTGCCCTACGCCGACTTCAACCTGCTCAAGCTGCCGGATCGCGACAAGGCCATGGAG
AAGATCCGTGACCTGACCTGCCTTTCCGACATCCTGCCCACCGGCTACCACGGCGCCGTA
ACTGCCGGCGTTGGCCCGGGCAGCACCGTGTACGTGGCCGGTGCCGGCCCGGTCGGCCTG
GCCGCTGCCGCCTCCGCTCGCCTGCTGGGCGCCGCCGTGGTTATCGTCGGCGACCTCAAC
CCCGCCCGACTGGCCCACGCCAAGGCGCAGGGCTTCGAGATCGCCGACCTGTCGCTGGAC
ACCCCGCTGCACGAGCAGATCGCTGCGCTGCTGGGAGAGCCGGAAGTGGATTGCGCGGTG
GATGCGGTGGGCTTCGAAGCTCGCGGCCACGGCCACGAAGGTGCCAAGCACGAAGCCCCG
GCCACTGTGCTGAACTCGCTCATGCAAGTCACCCGCGTGGCCGGCAAGATCGGTATCCCC
GGCCTTTACGTCACCGAAGATCCGGGTGCCGTGGACGCCGCGGCGAAGATCGGCAGCCTG
AGTATTCGCTTCGGCCTCGGCTGGGCGAAATCCCACAGCTTCCACACTGGCCAGACCCCG
GTGATGAAGTACAACCGCGCACTCATGCAAGCGATCATGTGGGACCGCATCAATATCGCC
GAAGTGGTGGGCGTGCAGGTCATCAGCCTGGACGACGCACCGCGTGGCTATGGCGAGTTC
GATGCCGGCGTGCCGAAGAAGTTCGTCATCGACCCGCACAAGACCTTCAGCGCGGCCTGA

# Drug_Target_63_General_Function:
Involved in zinc ion binding

# Drug_Target_63_General_References:
8169197	Ito K, Takahashi M, Yoshimoto T, Tsuru D: Cloning and high-level expression of the glutathione-independent formaldehyde dehydrogenase gene from Pseudomonas putida. J Bacteriol. 1994 May;176(9):2483-91.

# Drug_Target_63_HGNC_ID:
Not Available

# Drug_Target_63_HPRD_ID:
Not Available

# Drug_Target_63_ID:
4466

# Drug_Target_63_Locus:
Not Available

# Drug_Target_63_Molecular_Weight:
42083

# Drug_Target_63_Name:
Glutathione-independent formaldehyde dehydrogenase

# Drug_Target_63_Number_of_Residues:
399

# Drug_Target_63_PDB_ID:
1KOL

# Drug_Target_63_Pathway:
Not Available

# Drug_Target_63_Pfam_Domain_Function:
PF00107	ADH_zinc_N
PF08240	ADH_N

# Drug_Target_63_Protein_Sequence:
>Glutathione-independent formaldehyde dehydrogenase
MSGNRGVVYLGSGKVEVQKIDYPKMQDPRGKKIEHGVILKVVSTNICGSDQHMVRGRTTA
QVGLVLGHEITGEVIEKGRDVENLQIGDLVSVPFNVACGRCRSCKEMHTGVCLTVNPARA
GGAYGYVDMGDWTGGQAEYLLVPYADFNLLKLPDRDKAMEKIRDLTCLSDILPTGYHGAV
TAGVGPGSTVYVAGAGPVGLAAAASARLLGAAVVIVGDLNPARLAHAKAQGFEIADLSLD
TPLHEQIAALLGEPEVDCAVDAVGFEARGHGHEGAKHEAPATVLNSLMQVTRVAGKIGIP
GLYVTEDPGAVDAAAKIGSLSIRFGLGWAKSHSFHTGQTPVMKYNRALMQAIMWDRINIA
EVVGVQVISLDDAPRGYGEFDAGVPKKFVIDPHKTFSAA

# Drug_Target_63_Reaction:
Not Available

# Drug_Target_63_Signals:
None

# Drug_Target_63_Specific_Function:
Catalyzes the oxidation of long-chain alcohols but is inactive against ethanol

# Drug_Target_63_SwissProt_ID:
P46154

# Drug_Target_63_SwissProt_Name:
FADH_PSEPU

# Drug_Target_63_Synonyms:
EC 1.2.1.46
FALDH
FDH

# Drug_Target_63_Theoretical_pI:
6.70

# Drug_Target_63_Transmembrane_Regions:
None

# Drug_Target_64_Cellular_Location:
Cytoplasmic

# Drug_Target_64_Chromosome_Location:
Not Available

# Drug_Target_64_Drug_References:
Not Available

# Drug_Target_64_Essentiality:
Non-Essential

# Drug_Target_64_GenAtlas_ID:
Not Available

# Drug_Target_64_GenBank_ID_Gene:
AE000512

# Drug_Target_64_GenBank_ID_Protein:
Not Available

# Drug_Target_64_GeneCard_ID:
Not Available

# Drug_Target_64_Gene_Name:
TM_0752

# Drug_Target_64_Gene_Sequence:
>1416 bp
TCAGAGTTTCTCTTTGTAGTATCTCCTCAACTCTTCGTTGAACGGCAGGTTGAAGATCTC
ATCGAGCACTTGCACGATCTGCTCGTAGGATTTTGTCCTTGGATCTCTGATGAGGATTTC
TTCGAGCACCTTTCTGTCCCTCGAGATGTATGCTTCTAAGTTCCACTCCATTCTCAGAAT
CCTGGGCCACAGATAGAAGATCTTTATCCGGTGGGTGAGATCGGGTTCCACTTTCTCTCT
GTGGATTCCACAGCAGTCCACCCAGACGGGAAGTTCCATCACGACATCATCGGGAAAGTC
TTTGAGTGTTCCCTGGTTCTCCACGTTCAGAAAGAGCCTCACACGTTTGTTGTTCGCTAT
CGCGTTGATGAAAGGAATGTGCTGTTCTCCGCTGAGTTTTCCTTTCGGGAAGATCTCGGG
ATGTTCCTCTGTGAGTTTCATACCTGGGTTTTGCTGAACCTCTTCTGCGAGTTTTATGAG
GCGCTCTCTTGCTCTTCTGAGTTGCTCGTGGAATTTCGGTCTTTCCACTTCGTTGTCTAT
ACCGCCGAACTTTCCAAACCACTTCTTCTTCGTCTCCAGGTTGTAGTGGTACTTCCAGCT
GCCGTTCCTCACGGTGTCACCTATCGGAAGCATACCGTAAAATTTGTACATATCCATCGC
GGCAGGAGACATCTGTGTGTCCCATGGGTTCTTCGGCTCCCACTCTGGTAGCTTCTTCTC
TATCCACTCGTCAAGAAGCGGGTATGCATCTTCTCCTCTGTATCTGAACCTGTTCAGCCA
GATACCGTGGTTCACCCCGGCGACCTGCCAGTCTACCTCTTCCGGATCGAGGTCGAGTTT
TTCGAAGACTTCATAAACCCCGGCAACACCGTGGCAGAACCCCACTATGTTCGCACCAGT
CCACCTTCTCACCGCCTGCGTGATCTCGAAGACGGGATTTGCCGTCTGCATCAAGTACGC
TTTGGGTGCCATCTTTTTCATCTTCTCCGCTATCTCGAGGGCGAGCTTCATGTCGGGATA
AGAAGAAAGAACGTAGGTGTAAGTGGAAACCATGTTCAGCTCTTGACTGTCTATTCCTCT
GTAGTAGCCGTGTTTTTCACCGACCTTTGTGACCTCGTCCCATCTTTGAGAGCCGCTGTC
GTGGTACCTCGGATCGTAAGGATAGGCGGTGTTTATGATGAAGTCTGCTCCATCTATGGC
TTCATCCAGACTGGATGTTTTTACGATCTTCACAGGAGAGTTCAGCTCTTCCACGTACTT
TCTTGCGAGGATGTAAGATGCGTTCAGTCTTCTTTCGTGAACGTCCATCATGTAGATGTG
TGTATCTTCCCTTGAAAGTTCCTCCGTCTGAGCGATGTCTCCCACAAGCTGAAGTGCGAA
CCTCACACTTCCTGCTCCGATGATGGAGATCTTCAT

# Drug_Target_64_General_Function:
Involved in hydrolase activity, hydrolyzing O-glycosyl compounds

# Drug_Target_64_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.

# Drug_Target_64_HGNC_ID:
Not Available

# Drug_Target_64_HPRD_ID:
Not Available

# Drug_Target_64_ID:
4467

# Drug_Target_64_Locus:
Not Available

# Drug_Target_64_Molecular_Weight:
55358

# Drug_Target_64_Name:
Alpha-glucosidase, putative

# Drug_Target_64_Number_of_Residues:
471

# Drug_Target_64_PDB_ID:
1VJT

# Drug_Target_64_Pathway:
Not Available

# Drug_Target_64_Pfam_Domain_Function:
PF02056	Glyco_hydro_4

# Drug_Target_64_Protein_Sequence:
>Alpha-glucosidase, putative
MKISIIGAGSVRFALQLVGDIAQTEELSREDTHIYMMDVHERRLNASYILARKYVEELNS
PVKIVKTSSLDEAIDGADFIINTAYPYDPRYHDSGSQRWDEVTKVGEKHGYYRGIDSQEL
NMVSTYTYVLSSYPDMKLALEIAEKMKKMAPKAYLMQTANPVFEITQAVRRWTGANIVGF
CHGVAGVYEVFEKLDLDPEEVDWQVAGVNHGIWLNRFRYRGEDAYPLLDEWIEKKLPEWE
PKNPWDTQMSPAAMDMYKFYGMLPIGDTVRNGSWKYHYNLETKKKWFGKFGGIDNEVERP
KFHEQLRRARERLIKLAEEVQQNPGMKLTEEHPEIFPKGKLSGEQHIPFINAIANNKRVR
LFLNVENQGTLKDFPDDVVMELPVWVDCCGIHREKVEPDLTHRIKIFYLWPRILRMEWNL
EAYISRDRKVLEEILIRDPRTKSYEQIVQVLDEIFNLPFNEELRRYYKEKL

# Drug_Target_64_Reaction:
Not Available

# Drug_Target_64_Signals:
None

# Drug_Target_64_Specific_Function:
Not Available

# Drug_Target_64_SwissProt_ID:
Q9WZL1

# Drug_Target_64_SwissProt_Name:
Q9WZL1_THEMA

# Drug_Target_64_Synonyms:
Not Available

# Drug_Target_64_Theoretical_pI:
6.13

# Drug_Target_64_Transmembrane_Regions:
None

# Drug_Target_65_Cellular_Location:
Cytoplasmic

# Drug_Target_65_Chromosome_Location:
Not Available

# Drug_Target_65_Drug_References:
Not Available

# Drug_Target_65_Essentiality:
Non-Essential

# Drug_Target_65_GenAtlas_ID:
Not Available

# Drug_Target_65_GenBank_ID_Gene:
AJ001089

# Drug_Target_65_GenBank_ID_Protein:
Not Available

# Drug_Target_65_GeneCard_ID:
Not Available

# Drug_Target_65_Gene_Name:
aglA

# Drug_Target_65_Gene_Sequence:
>1380 bp
ATGCCATCTGTGAAGATCGGTATCATCGGTGCGGGGAGCGCGGTGTTTTCTCTGAGGCTT
GTGAGTGATCTTTGCAAAACGCCGGGACTCTCTGGCAGCACGGTCACCCTCATGGATATC
GACGAAGAAAGACTCGACGCTATTCTGACCATCGCGAAAAAATACGTTGAAGAAGTGGGA
GCGGATCTGAAATTCGAAAAAACCATGAATTTAGATGACGTCATCATCGACGCGGATTTT
GTGATAAACACAGCGATGGTGGGTGGCCATACCTACTTGGAGAAGGTCAGACAGATCGGT
GAGAAATACGGCTACTACAGAGGAATAGACGCTCAGGAGTTTAACATGGTCTCCGACTAC
TACACCTTCTCCAACTACAACCAGCTCAAGTACTTCGTTGACATAGCAAGGAAGATAGAG
AAGCTCTCCCCAAAAGCCTGGTACTTGCAGGCAGCGAACCCCATTTTCGAGGGAACAACC
CTTGTGACAAGAACGGTTCCCATAAAGGCAGTGGGATTCTGCCATGGACACTACGGCGTG
ATGGAGATCGTAGAGAAACTGGGGCTGGAAGAAGAAAAAGTAGATTGGCAGGTCGCAGGA
GTGAACCACGGTATCTGGCTGAATAGGTTCAGATACAACGGGGGGAACGCGTATCCCCTC
CTTGACAAGTGGATCGAGGAAAAATCAAAAGATTGGAAACCAGAGAACCCCTTCAACGAC
CAGCTCTCTCCCGCCGCGATAGACATGTACAGATTCTACGGTGTGATGCCCATCGGTGAC
ACCGTGAGAAACTCTTCGTGGAGGTACCACAGGGATCTTGAAACCAAGAAGAAGTGGTAC
GGTGAACCCTGGGGAGGAGCAGATTCTGAAATAGGCTGGAAATGGTACCAAGACACGCTT
GGAAAGGTCACGGAGATCACAAAGAAGGTGGCAAAGTTCATCAAAGAAAATCCGTCCGTG
AGGCTCTCCGACCTTGGAAGTGTTCTGGGGAAAGACCTCTCAGAAAAGCAGTTTGTGCTC
GAAGTGGAGAAAATTCTCGATCCAGAAAGAAAGAGTGGAGAGCAGCACATCCCATTCATC
GATGCGCTGCTGAACGATAACAAGGCAAGATTCGTGGTGAACATACCAAATAAAGGTATC
ATTCACGGAATAGACGATGACGTGGTTGTTGAAGTCCCAGCCCTTGTGGACAAGAACGGA
ATCCATCCCGAGAAGATCGAACCACCGCTTCCAGATCGCGTGGTCAAGTACTACCTGAGA
CCCAGAATCATGAGGATGGAAATGGCTCTGGAGGCGTTTCTAACGGGTGACATAAGGATC
ATAAAAGAACTTCTCTACAGAGATCCAAGGACAAAGAGCGATGAACAGGTAGAAAGGTGA

# Drug_Target_65_General_Function:
Involved in hydrolase activity, hydrolyzing O-glycosyl compounds

# Drug_Target_65_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.
10972187	Raasch C, Streit W, Schanzer J, Bibel M, Gosslar U, Liebl W: Thermotoga maritima AglA, an extremely thermostable NAD+-, Mn2+-, and thiol-dependent alpha-glucosidase. Extremophiles. 2000 Aug;4(4):189-200.
12062450	Raasch C, Armbrecht M, Streit W, Hocker B, Strater N, Liebl W: Identification of residues important for NAD+ binding by the Thermotoga maritima alpha-glucosidase AglA, a member of glycoside hydrolase family 4. FEBS Lett. 2002 Apr 24;517(1-3):267-71.
12588867	Lodge JA, Maier T, Liebl W, Hoffmann V, Strater N: Crystal structure of Thermotoga maritima alpha-glucosidase AglA defines a new clan of NAD+-dependent glycosidases. J Biol Chem. 2003 May 23;278(21):19151-8. Epub 2003 Feb 14.
9453151	Bibel M, Brettl C, Gosslar U, Kriegshauser G, Liebl W: Isolation and analysis of genes for amylolytic enzymes of the hyperthermophilic bacterium Thermotoga maritima. FEMS Microbiol Lett. 1998 Jan 1;158(1):9-15.

# Drug_Target_65_HGNC_ID:
Not Available

# Drug_Target_65_HPRD_ID:
Not Available

# Drug_Target_65_ID:
4343

# Drug_Target_65_Locus:
Not Available

# Drug_Target_65_Molecular_Weight:
55048

# Drug_Target_65_Name:
Alpha-glucosidase

# Drug_Target_65_Number_of_Residues:
480

# Drug_Target_65_PDB_ID:
1OBB

# Drug_Target_65_Pathway:
Not Available

# Drug_Target_65_Pfam_Domain_Function:
PF02056	Glyco_hydro_4

# Drug_Target_65_Protein_Sequence:
>Alpha-glucosidase
MPSVKIGIIGAGSAVFSLRLVSDLCKTPGLSGSTVTLMDIDEERLDAILTIAKKYVEEVG
ADLKFEKTMNLDDVIIDADFVINTAMVGGHTYLEKVRQIGEKYGYYRGIDAQEFNMVSDY
YTFSNYNQLKYFVDIARKIEKLSPKAWYLQAANPIFEGTTLVTRTVPIKAVGFCHGHYGV
MEIVEKLGLEEEKVDWQVAGVNHGIWLNRFRYNGGNAYPLLDKWIEEKSKDWKPENPFND
QLSPAAIDMYRFYGVMPIGDTVRNSSWRYHRDLETKKKWYGEPWGGADSEIGWKWYQDTL
GKVTEITKKVAKFIKENPSVRLSDLGSVLGKDLSEKQFVLEVEKILDPERKSGEQHIPFI
DALLNDNKARFVVNIPNKGIIHGIDDDVVVEVPALVDKNGIHPEKIEPPLPDRVVKYYLR
PRIMRMEMALEAFLTGDIRIIKELLYRDPRTKSDEQVEKVIEEILALPENEEMRKHYLKR

# Drug_Target_65_Reaction:
Not Available

# Drug_Target_65_Signals:
None

# Drug_Target_65_Specific_Function:
Alpha-glycosidase with a very broad specificity. Hydrolyzes maltose and other small maltooligosaccharides but is inactive against the polymeric substrate starch. AglA is not specific with respect to the configuration at the C-4 position of its substrates because glycosidic derivatives of D-galactose are also hydrolyzed. Does not cleave beta-glycosidic bonds

# Drug_Target_65_SwissProt_ID:
O33830

# Drug_Target_65_SwissProt_Name:
AGLA_THEMA

# Drug_Target_65_Synonyms:
EC 3.2.1.20
Maltase

# Drug_Target_65_Theoretical_pI:
5.75

# Drug_Target_65_Transmembrane_Regions:
None

# Drug_Target_66_Cellular_Location:
Not Available

# Drug_Target_66_Chromosome_Location:
Not Available

# Drug_Target_66_Drug_References:
Not Available

# Drug_Target_66_Essentiality:
Non-Essential

# Drug_Target_66_GenAtlas_ID:
Not Available

# Drug_Target_66_GenBank_ID_Gene:
AE005674

# Drug_Target_66_GenBank_ID_Protein:
Not Available

# Drug_Target_66_GeneCard_ID:
Not Available

# Drug_Target_66_Gene_Name:
nadD

# Drug_Target_66_Gene_Sequence:
>642 bp
ATGAAATCTTTACAGGCTCTGTTTGGCGGCACCTTTGATCCGGTGCACTATGGTCATCTA
AAACCCGTGGAAACGCTGGCGAATTTGATTGGTCTGACGCGGGTCACAATCATCCCTAAT
AATGTTCCTCCGCATCGTCCCCAGCCGGAAGCGAACAGCGTGCAGCGTAAACACATGCTT
GAACTGGCGATTGCCGACAAGCCATTATTTACTCTTGATGAACGCGAGCTAAAGCGCAAT
GCCCCCTCTTACACTGCGCAAACACTGAAAGAGTGGCGGCAGGAACAAGGACCGGACGTG
CCGCTGGCGTTTATTATTGGTCAGGATTCATTGCTGACCTTTCCGACCTGGTACGAATAC
GAAACGATACTCGACAATGCACATTTGATCGTCTGTCGGCGTCCAGGTTACCCACTTGAA
ATGGCGCAACCGCAATACCAGCAATGGCTGGAAGATCATTTGACACATAACCCGGAAGAT
CTTCACCTTCAGCCTGCCGGTAAAATTTATCTGGCTGAAACGCCGTGGTTTAACATCTCG
GCGACCATCATCCGCGAACGTTTGCAAAACGGTGAATCGTGTGAGGATTTATTGCCGGAA
CCGGTATTGACTTACATTAACCAACAAGGCTTGTATCGCTGA

# Drug_Target_66_General_Function:
Involved in catalytic activity

# Drug_Target_66_General_References:
12384590	Jin Q, Yuan Z, Xu J, Wang Y, Shen Y, Lu W, Wang J, Liu H, Yang J, Yang F, Zhang X, Zhang J, Yang G, Wu H, Qu D, Dong J, Sun L, Xue Y, Zhao A, Gao Y, Zhu J, Kan B, Ding K, Chen S, Cheng H, Yao Z, He B, Chen R, Ma D, Qiang B, Wen Y, Hou Y, Yu J: Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids Res. 2002 Oct 15;30(20):4432-41.
12704152	Wei J, Goldberg MB, Burland V, Venkatesan MM, Deng W, Fournier G, Mayhew GF, Plunkett G 3rd, Rose DJ, Darling A, Mau B, Perna NT, Payne SM, Runyen-Janecky LJ, Zhou S, Schwartz DC, Blattner FR: Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T. Infect Immun. 2003 May;71(5):2775-86.

# Drug_Target_66_HGNC_ID:
Not Available

# Drug_Target_66_HPRD_ID:
Not Available

# Drug_Target_66_ID:
4469

# Drug_Target_66_Locus:
Not Available

# Drug_Target_66_Molecular_Weight:
24528

# Drug_Target_66_Name:
Nicotinate-nucleotide adenylyltransferase

# Drug_Target_66_Number_of_Residues:
213

# Drug_Target_66_PDB_ID:
1K4K

# Drug_Target_66_Pathway:
Not Available

# Drug_Target_66_Pfam_Domain_Function:
PF01467	CTP_transf_2

# Drug_Target_66_Protein_Sequence:
>Nicotinate-nucleotide adenylyltransferase
MKSLQALFGGTFDPVHYGHLKPVETLANLIGLTRVTIIPNNVPPHRPQPEANSVQRKHML
ELAIADKPLFTLDERELKRNAPSYTAQTLKEWRQEQGPDVPLAFIIGQDSLLTFPTWYEY
ETILDNAHLIVCRRPGYPLEMAQPQYQQWLEDHLTHNPEDLHLQPAGKIYLAETPWFNIS
ATIIRERLQNGESCEDLLPEPVLTYINQQGLYR

# Drug_Target_66_Reaction:
Not Available

# Drug_Target_66_Signals:
None

# Drug_Target_66_Specific_Function:
Catalyzes the reversible adenylation of nicotinate mononucleotide (NaMN) to nicotinic acid adenine dinucleotide (NaAD) (By similarity)

# Drug_Target_66_SwissProt_ID:
P0A753

# Drug_Target_66_SwissProt_Name:
NADD_SHIFL

# Drug_Target_66_Synonyms:
Deamido- NAD(+) pyrophosphorylase
Deamido-NAD(+) diphosphorylase
EC 2.7.7.18
NaMN adenylyltransferase
Nicotinate mononucleotide adenylyltransferase

# Drug_Target_66_Theoretical_pI:
5.54

# Drug_Target_66_Transmembrane_Regions:
None

# Drug_Target_67_Cellular_Location:
Not Available

# Drug_Target_67_Chromosome_Location:
Not Available

# Drug_Target_67_Drug_References:
Not Available

# Drug_Target_67_Essentiality:
Non-Essential

# Drug_Target_67_GenAtlas_ID:
Not Available

# Drug_Target_67_GenBank_ID_Gene:
L33181

# Drug_Target_67_GenBank_ID_Protein:
Not Available

# Drug_Target_67_GeneCard_ID:
Not Available

# Drug_Target_67_Gene_Name:
ascB

# Drug_Target_67_Gene_Sequence:
>1074 bp
ATGATTAATAATAGTTTCTGGCAAGGTAAACGGGTTTTTGTAACAGGCCATACTGGGTTT
AAAGGTGGCTGGTTGAGTTTATGGTTGCAAACCATGGGGGCAACGGTAAAAGGTTACTCT
CTGACCGCCCCCACTGTGCCTAGCCTATTTGAGACCGCACGAGTTGCCGACGGGATGCAA
TCGGAAATCGGTGATATTCGTGATCAAAACAAATTATTAGAATCAATCCGCGAATTCCAA
CCAGAGATTGTTTTCCACATGGCTGCTCAGCCACTGGTCCGTCTATCCTATTCCGAGCCT
GTTGAAACCTACTCGACGAATGTTATGGGTACCGTTTATTTACTGGAAGCTATTCGCCAT
GTTGGTGGCGTCAAAGCGGTGGTCAATATCACCAGTGATAAATGCTACGATAATAAAGAG
TGGATCTGGGGCTATCGCGAAAATGAAGCGATGGGGGGGTATGATCCTTACTCCAACAGT
AAAGGTTGTGCGGAATTAGTGACGTCATCCTACCGTAATTCGTTCTTCAATCCAGCGAAC
TATGGCCAGCATGGCACTGCCGTAGCGACAGTGCGTGCGGGTAATGTTATCGGTGGTGGC
GATTGGGCATTGGATCGCATCGTTCCAGATATTCTTCGGGCGTTTGAACAGTCCCAACCA
GTGATTATTCGCAACCCACATGCCATTCGCCCATGGCAGCATGTGTTGGAGCCTTTGTCG
GGTTATTTGCTGTTGGCACAGAAGTTATATACTGACGGTGCTGAATATGCCGAAGGTTGG
AACTTTGGTCCTAACGATGCTGATGCTACTCCAGTAAAAAACATTGTTGAACAAATGGTG
AAATATTGGGGAGAGGGTGCAAGCTGGCAATTAGATGGCAATGCTCACCCTCATGAAGCT
CATTATCTGAAACTGGATTGTTCAAAAGCTAAAATGCAACTTGGCTGGCATCCTCGCTGG
AACTTGAATACTACGCTCGAATATATTGTGGGCTGGCACAAGAACTGGTTATCAGGCACA
GATATGCATGAATACAGTATTACTGAAATTAATAATTACATGAACACTAAATGA

# Drug_Target_67_General_Function:
Involved in catalytic activity

# Drug_Target_67_General_References:
8071227	Thorson JS, Lo SF, Ploux O, He X, Liu HW: Studies of the biosynthesis of 3,6-dideoxyhexoses: molecular cloning and characterization of the asc (ascarylose) region from Yersinia pseudotuberculosis serogroup VA. J Bacteriol. 1994 Sep;176(17):5483-93.

# Drug_Target_67_HGNC_ID:
Not Available

# Drug_Target_67_HPRD_ID:
Not Available

# Drug_Target_67_ID:
4471

# Drug_Target_67_Locus:
Not Available

# Drug_Target_67_Molecular_Weight:
40274

# Drug_Target_67_Name:
CDP-D-glucose-4,6-dehydratase

# Drug_Target_67_Number_of_Residues:
357

# Drug_Target_67_PDB_ID:
1RKX

# Drug_Target_67_Pathway:
Not Available

# Drug_Target_67_Pfam_Domain_Function:
PF01370	Epimerase

# Drug_Target_67_Protein_Sequence:
>CDP-D-glucose-4,6-dehydratase
MINNSFWQGKRVFVTGHTGFKGGWLSLWLQTMGATVKGYSLTAPTVPSLFETARVADGMQ
SEIGDIRDQNKLLESIREFQPEIVFHMAAQPLVRLSYSEPVETYSTNVMGTVYLLEAIRH
VGGVKAVVNITSDKCYDNKEWIWGYRENEAMGGYDPYSNSKGCAELVTSSYRNSFFNPAN
YGQHGTAVATVRAGNVIGGGDWALDRIVPDILRAFEQSQPVIIRNPHAIRPWQHVLEPLS
GYLLLAQKLYTDGAEYAEGWNFGPNDADATPVKNIVEQMVKYWGEGASWQLDGNAHPHEA
HYLKLDCSKAKMQLGWHPRWNLNTTLEYIVGWHKNWLSGTDMHEYSITEINNYMNTK

# Drug_Target_67_Reaction:
Not Available

# Drug_Target_67_Signals:
None

# Drug_Target_67_Specific_Function:
Not Available

# Drug_Target_67_SwissProt_ID:
Q57329

# Drug_Target_67_SwissProt_Name:
Q57329_YERPS

# Drug_Target_67_Synonyms:
Not Available

# Drug_Target_67_Theoretical_pI:
6.37

# Drug_Target_67_Transmembrane_Regions:
None

# Drug_Target_68_Cellular_Location:
Not Available

# Drug_Target_68_Chromosome_Location:
Not Available

# Drug_Target_68_Drug_References:
Not Available

# Drug_Target_68_Essentiality:
Non-Essential

# Drug_Target_68_GenAtlas_ID:
Not Available

# Drug_Target_68_GenBank_ID_Gene:
J04805

# Drug_Target_68_GenBank_ID_Protein:
Not Available

# Drug_Target_68_GeneCard_ID:
Not Available

# Drug_Target_68_Gene_Name:
Not Available

# Drug_Target_68_Gene_Sequence:
>786 bp
ATGTATAAAGATTTAGAAGGAAAAGTAGTGGTCATAACAGGTTCATCTACAGGTTTGGGA
AAATCAATGGCGATTCGTTTTGCGACAGAAAAAGCCAAAGTAGTTGTGAACTATCGTTCT
AAGGAGGACGAAGCTAACAGCGTTTTAGAAGAAATTAAAAAAGTTGGCGGAGAAGCAATT
GCTGTCAAAGGTGATGTAACAGTTGAGTCTGACGTTATCAATTTAGTTCAATCTGCTATT
AAAGAGTTTGGAAAGCTAGACGTTATGATTAACAACGCAGGGTTAGAAAATCCGGTTTCA
TCTCATGAAATGTCTTTAAGCGATTGGAATAAAGTCATTGATACGAACTTAACGGGAGCT
TTTTTAGGCAGCCGTGAAGCGATTAAATATTTTGTGGAAAATGATATTAAGGGAACAGTT
ATTAACATGTCGAGTGTTCACGAGAAAATTCCTTGGCCATTATTTGTTCATTATGCAGCA
AGTAAAGGCGGTATGAAGCTTATGACTGAAACACTGGCATTAGAATACGCTCCAAAAGGT
ATTCGTGTAAATAACATTGGACCAGGAGCGATTAATACACCGATTAACGCTGAGAAATTT
GCTGATCCTGAGCAGCGTGCAGATGTAGAAAGCATGATTCCAATGGGATACATCGGAGAG
CCGGAAGAAATTGCAGCAGTTGCTGCATGGCTAGCTTCTTCAGAGGCGAGTTATGTAACA
GGAATTACGCTCTTTGCTGACGGCGGTATGACACAGTACCCATCATTCCAAGCAGGACGC
GGATAA

# Drug_Target_68_General_Function:
Involved in oxidoreductase activity

# Drug_Target_68_General_References:
2495285	Makino Y, Negoro S, Urabe I, Okada H: Stability-increasing mutants of glucose dehydrogenase from Bacillus megaterium IWG3. J Biol Chem. 1989 Apr 15;264(11):6381-5.

# Drug_Target_68_HGNC_ID:
Not Available

# Drug_Target_68_HPRD_ID:
Not Available

# Drug_Target_68_ID:
4472

# Drug_Target_68_Locus:
Not Available

# Drug_Target_68_Molecular_Weight:
28085

# Drug_Target_68_Name:
Glucose 1-dehydrogenase

# Drug_Target_68_Number_of_Residues:
261

# Drug_Target_68_PDB_ID:
1GCO

# Drug_Target_68_Pathway:
Not Available

# Drug_Target_68_Pfam_Domain_Function:
PF00106	adh_short

# Drug_Target_68_Protein_Sequence:
>Glucose 1-dehydrogenase
MYKDLEGKVVVITGSSTGLGKSMAIRFATEKAKVVVNYRSKEDEANSVLEEIKKVGGEAI
AVKGDVTVESDVINLVQSAIKEFGKLDVMINNAGLENPVSSHEMSLSDWNKVIDTNLTGA
FLGSREAIKYFVENDIKGTVINMSSVHEKIPWPLFVHYAASKGGMKLMTETLALEYAPKG
IRVNNIGPGAINTPINAEKFADPEQRADVESMIPMGYIGEPEEIAAVAAWLASSEASYVT
GITLFADGGMTQYPSFQAGRG

# Drug_Target_68_Reaction:
Not Available

# Drug_Target_68_Signals:
None

# Drug_Target_68_Specific_Function:
Beta-D-glucose + NAD(P)(+) = D-glucono-1,5- lactone + NAD(P)H

# Drug_Target_68_SwissProt_ID:
P40288

# Drug_Target_68_SwissProt_Name:
DHG_BACME

# Drug_Target_68_Synonyms:
EC 1.1.1.47

# Drug_Target_68_Theoretical_pI:
4.71

# Drug_Target_68_Transmembrane_Regions:
None

# Drug_Target_69_Cellular_Location:
Cytoplasm

# Drug_Target_69_Chromosome_Location:
Not Available

# Drug_Target_69_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_69_Essentiality:
Non-Essential

# Drug_Target_69_GenAtlas_ID:
ALDH9A1

# Drug_Target_69_GenBank_ID_Gene:
U34252

# Drug_Target_69_GenBank_ID_Protein:
1049219

# Drug_Target_69_GeneCard_ID:
ALDH9A1

# Drug_Target_69_Gene_Name:
ALDH9A1

# Drug_Target_69_Gene_Sequence:
>1482 bp
ATGAGCACTGGCACCTTCGTCGTGTCGCAGCCGCTCAATTACCGCGGCGGGGCCGCTGGA
GCCGGCGGACGCTCCGGTACCGAGAAAGCTTTCGAGCCAGCAACCGGCCGAGTGATAGCT
ACTTTCACATGTTCAGGAGAAAAGGAAGTAAATTTGGCTGTTCAAAATGCAAAGGCTGCT
TTTAAAATATGGAGTCAAAAATCTGGCATGGAGCGTTGCCGAATCCTTTTGGAGGCTGCC
AGGATAATAAGGGAACGGGAGGATGAAATTGCTACTATGGAGTGCATCAACAATGGCAAG
TCCATCTTTGAGGCCCGCTTGGACATTGACATTTCCTGGCAGTGCCTGGAGTATTATGCG
GGCTTGGCTGCATCCATGGCTGGTGAACACATCCAGCTCCCAGGTGGATCGTTTGGTTAT
ACCAGAAGAGAACCACTTGGGGTATGTGTGGGAATAGGAGCATGGAACTACCCCTTTCAG
ATTGCCTCTTGGAAGTCGGCTCCAGCATTAGCCTGTGGTAATGCCATGGTCTTTAAACCT
TCTCCCTTTACACCTGTTTCTGCATTGCTACTGGCTGAAATCTACAGTGAGGCTGGTGTA
CCTCCTGGGCTCTTCAATGTGGTGCAGGGAGGGGCTGCCACAGGCCAGTTTCTGTGTCAG
CATCCCGATGTGGCCAAAGTCTCCTTCACTGGAAGTGTGCCCACTGGCATGAAGATCATG
GAGATGTCAGCTAAAGGAATCAAACCTGTTACCTTGGAACTTGGAGGCAAATCTCCACTC
ATCATCTTCTCAGACTGTGATATGAACAATGCTGTAAAGGGGGCGCTGATGGCCAACTTC
CTCACACAAGGCCAGGTTTGCTGTAATGGCACAAGAGTATTTGTGCAGAAAGAAATTCTT
GATAAATTTACAGAGGAAGTGGTGAAACAGACCCAAAGGATTAAAATTGGAGATCCCCTT
CTGGAAGATACAAGGATGGGTCCACTCATCAACCGACCACACCTGGAGCGAGTCCTTGGG
TTTGTCAAAGTGGCAAAGGAGCAGGGTGCTAAAGTGTTATGTGGTGGAGATATATATGTA
CCTGAAGATCCCAAATTAAAGGATGGATATTACATGAGACCTTGTGTATTAACTAATTGC
AGAGACGACATGACCTGTGTGAAGGAAGAGATCTTTGGGCCTGTTATGTCCATTTTATCA
TTTGACACTGAAGCTGAGGTTCTAGAAAGAGCCAATGATACCACTTTTGGACTAGCAGCT
GGCGTCTTTACCAGGGACATCCAACGGGCTCATAGAGTGGTAGCTGAGCTTCAGGCTGGG
ACGTGCTTCATTAACAACTATAACGTCAGCCCAGTGGAGTTGCCCTTTGGTGGATATAAG
AAGTCAGGATTTGGCAGAGAGAACGGCCGTGTGACAATCGAATATTATTCACAGCTGAAG
ACTGTGTGTGTGGAGATGGGTGATGTGGAATCTGCTTTTTGA

# Drug_Target_69_General_Function:
Energy production and conversion

# Drug_Target_69_General_References:
10702312	Vaz FM, Fouchier SW, Ofman R, Sommer M, Wanders RJ: Molecular and biochemical characterization of rat gamma-trimethylaminobutyraldehyde dehydrogenase and evidence for the involvement of human aldehyde dehydrogenase 9 in carnitine biosynthesis. J Biol Chem. 2000 Mar 10;275(10):7390-4.
2925663	Kurys G, Ambroziak W, Pietruszko R: Human aldehyde dehydrogenase. Purification and characterization of a third isozyme with low Km for gamma-aminobutyraldehyde. J Biol Chem. 1989 Mar 15;264(8):4715-21.
8269919	Kurys G, Shah PC, Kikonygo A, Reed D, Ambroziak W, Pietruszko R: Human aldehyde dehydrogenase. cDNA cloning and primary structure of the enzyme that catalyzes dehydrogenation of 4-aminobutyraldehyde. Eur J Biochem. 1993 Dec 1;218(2):311-20.
8645224	Kikonyogo A, Pietruszko R: Aldehyde dehydrogenase from adult human brain that dehydrogenates gamma-aminobutyraldehyde: purification, characterization, cloning and distribution. Biochem J. 1996 May 15;316 ( Pt 1):317-24.
8786138	Lin SW, Chen JC, Hsu LC, Hsieh CL, Yoshida A: Human gamma-aminobutyraldehyde dehydrogenase (ALDH9): cDNA sequence, genomic organization, polymorphism, chromosomal localization, and tissue expression. Genomics. 1996 Jun 15;34(3):376-80.

# Drug_Target_69_HGNC_ID:
HGNC:412

# Drug_Target_69_HPRD_ID:
04109

# Drug_Target_69_ID:
316

# Drug_Target_69_Locus:
1q23.1

# Drug_Target_69_Molecular_Weight:
53802

# Drug_Target_69_Name:
4-trimethylaminobutyraldehyde dehydrogenase

# Drug_Target_69_Number_of_Residues:
494

# Drug_Target_69_PDB_ID:
Not Available

# Drug_Target_69_Pathway:
Not Available

# Drug_Target_69_Pfam_Domain_Function:
PF00171	Aldedh

# Drug_Target_69_Protein_Sequence:
>4-trimethylaminobutyraldehyde dehydrogenase
MSTGTFVVSQPLNYRGGARVEPADASGTEKAFEPATGRVIATFTCSGEKEVNLAVQNAKA
AFKIWSQKSGMERCRILLEAARIIREREDEIATMECINNGKSIFEARLDIDISWQCLEYY
AGLAASMAGEHIQLPGGSFGYTRREPLGVCVGIGAWNYPFQIASWKSAPALACGNAMVFK
PSPFTPVSALLLAEIYSEAGVPPGLFNVVQGGAATGQFLCQHPDVAKVSFTGSVPTGMKI
MEMSAKGIKPVTLELGGKSPLIIFSDCDMNNAVKGALMANFLTQGQVCCNGTRVFVQKEI
LDKFTEEVVKQTQRIKIGDPLLEDTRMGPLINRPHLERVLGFVKVAKEQGAKVLCGGDIY
VPEDPKLKDGYYMRPCVLTNCRDDMTCVKEEIFGPVMSILSFDTEAEVLERANDTTFGLA
AGVFTRDIQRAHRVVAELQAGTCFINNYNVSPVELPFGGYKKSGFGRENGRVTIEYYSQL
KTVCVEMGDVESAF

# Drug_Target_69_Reaction:
an aldehyde + NAD+ + H2O = an acid + NADH + H+

# Drug_Target_69_Signals:
None

# Drug_Target_69_Specific_Function:
Converts gamma-trimethylaminobutyraldehyde into gamma- butyrobetaine. Catalyzes the irreversible oxidation of a broad range of aldehydes to the corresponding acids in an NAD-dependent reaction

# Drug_Target_69_SwissProt_ID:
P49189

# Drug_Target_69_SwissProt_Name:
AL9A1_HUMAN

# Drug_Target_69_Synonyms:
Aldehyde dehydrogenase 9A1
Aldehyde dehydrogenase E3 isozyme
EC 1.2.1.19
EC 1.2.1.3
EC 1.2.1.47
Gamma-aminobutyraldehyde dehydrogenase
R- aminobutyraldehyde dehydrogenase
TMABADH

# Drug_Target_69_Theoretical_pI:
5.61

# Drug_Target_69_Transmembrane_Regions:
None

# Drug_Target_6_Cellular_Location:
Not Available

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
Not Available

# Drug_Target_6_GenBank_ID_Gene:
AF109682

# Drug_Target_6_GenBank_ID_Protein:
4235484

# Drug_Target_6_GeneCard_ID:
Not Available

# Drug_Target_6_Gene_Name:
mdh

# Drug_Target_6_Gene_Sequence:
>990 bp
ATGGCTAAAACCCCAATGCGTGTTGCTGTTACCGGCGCCGCCGGTCAGATTTGCTACTCA
CTGCTGTTTCGCATCGCCAACGGCGACATGCTCGGCAAGGATCAGCCAGTCATCTTGCAA
CTGCTTGAAATCCCGAACGAAAAAGCCCAGAAGGCCCTGCAAGGCGTGATGATGGAAATC
GACGATTGCGCCTTCCCTCTGCTGGCCGGCATGACCGCGCACGCTGATCCGATGACCGCA
TTCAAGGATGCCGACGTCGCCTTGCTGGTCGGCGCGCGTCCACGCGGCCCCGGCATGGAG
CGCAAGGATTTGCTGGAAGCCAATGCACAGATCTTCACGGTGCAAGGCAAGGCCATCGAT
GCCGTCGCGTCGCGCAACATCAAGGTGCTCGTGGTCGGCAATCCGGCCAACACCAACGCC
TATATCGCGATGAAATCGGCGCCTTCGCTGCCGGCCAAGAATTTCACCGCAATGCTGCGC
CTGGATCACAACCGCGCCTTGTCGCAAATTGCTGCCAAGACCGGCAAACCGGTATCGTCG
ATCGAAAAACTGTTCGTCTGGGGCAATCACTCGCCAACGATGTATGCCGACTACCGCTAC
GCGCAAATCGACGGCGCATCGGTCAAGGACATGATCAATGACGACGCATGGAACCGCGAC
ACGTTCTTGCCTACCGTGGGCAAGCGCGGCGCAGCCATCATCGATGCGCGCGGTGTATCG
TCGGCTGCCTCGGCTGCCAATGCGGCCATCGATCACATCCATGACTGGGTGCTGGGCACG
GCAGGCAAATGGACCACGATGGGCATCCCGTCCGATGGTTCGTATGGCATTCCGGAAGGG
GTGATCTTCGGCTTCCCGGTCACGACCGAAAACGGCGAATACAAGATCGTCCAAGGCTTG
AGCATTGACGCTTTCTCGCAAGAACGCATCAATGTCACACTGAACGAATTGCTGGAAGAG
CAGAACGGCGTCCAGCATCTGCTGGGCTAA

# Drug_Target_6_General_Function:
Energy production and conversion

# Drug_Target_6_General_References:
10206992	Kim SY, Hwang KY, Kim SH, Sung HC, Han YS, Cho Y: Structural basis for cold adaptation. Sequence, biochemical properties, and crystal structure of malate dehydrogenase from a psychrophile Aquaspirillium arcticum. J Biol Chem. 1999 Apr 23;274(17):11761-7.

# Drug_Target_6_HGNC_ID:
Not Available

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
3445

# Drug_Target_6_Locus:
Not Available

# Drug_Target_6_Molecular_Weight:
35252

# Drug_Target_6_Name:
Malate dehydrogenase

# Drug_Target_6_Number_of_Residues:
329

# Drug_Target_6_PDB_ID:
1B8V

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
PF00056	Ldh_1_N
PF02866	Ldh_1_C

# Drug_Target_6_Protein_Sequence:
>Malate dehydrogenase
MAKTPMRVAVTGAAGQICYSLLFRIANGDMLGKDQPVILQLLEIPNEKAQKALQGVMMEI
DDCAFPLLAGMTAHADPMTAFKDADVALLVGARPRGPGMERKDLLEANAQIFTVQGKAID
AVASRNIKVLVVGNPANTNAYIAMKSAPSLPAKNFTAMLRLDHNRALSQIAAKTGKPVSS
IEKLFVWGNHSPTMYADYRYAQIDGASVKDMINDDAWNRDTFLPTVGKRGAAIIDARGVS
SAASAANAAIDHIHDWVLGTAGKWTTMGIPSDGSYGIPEGVIFGFPVTTENGEYKIVQGL
SIDAFSQERINVTLNELLEEQNGVQHLLG

# Drug_Target_6_Reaction:
(S)-malate + NAD+ = oxaloacetate + NADH + H+

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
Catalyzes the reversible oxidation of malate to oxaloacetate

# Drug_Target_6_SwissProt_ID:
Q9ZF99

# Drug_Target_6_SwissProt_Name:
MDH_AQUAR

# Drug_Target_6_Synonyms:
EC 1.1.1.37

# Drug_Target_6_Theoretical_pI:
6.25

# Drug_Target_6_Transmembrane_Regions:
None

# Drug_Target_70_Cellular_Location:
Not Available

# Drug_Target_70_Chromosome_Location:
Not Available

# Drug_Target_70_Drug_References:
Not Available

# Drug_Target_70_Essentiality:
Non-Essential

# Drug_Target_70_GenAtlas_ID:
Not Available

# Drug_Target_70_GenBank_ID_Gene:
AE000516

# Drug_Target_70_GenBank_ID_Protein:
Not Available

# Drug_Target_70_GeneCard_ID:
Not Available

# Drug_Target_70_Gene_Name:
ino1

# Drug_Target_70_Gene_Sequence:
>1104 bp
CTAACCGATGATGAACTCTTCGAGTTGCGCGCGCGCGATGTCGTCGGGCAGCTGCTCGGG
CGGGCTCTTCATCAGGTAGGCCGACGCCGGGATCACCGGTCCGCCGATGCCGCGGTCCTT
GGCGATCTTGGCCGCCCGCACCGCGTCGATGATGACGCCGGCCGAGTTTGGCGAGTCCCA
CACCTCGAGCTTGTACTCCAGGTTCAACGGCACATCTCCGAAGGCGCGGCCCTCAAGACG
GACATAGGCCCATTTGCGATCGTCGAGCCATCCGACGTGGTCGGACGGGCCGATGTGCAC
GTCCTTGGTCTTGAACTCGCGCTTCAGATTCGAAGTGACGGCCTGGGTCTTGGAGATCTT
CTTGGACTCCAGCCGTTCACGTTCGAGCATGTTGAGGAAGTCCATGTTGCCGCCCACGTT
GAGCTGCATGGTGCGGTCGAGCTGCACGCCGCGGTCCTCGAACAGCTTGGCCAGCACCCG
GTGGGTGATCGTCGCGCCGACCTGGCTCTTGATGTCATCACCGACGATGGGTACCCCGGC
GTCGGTGAACTTCTTGGCCCACACCGGGTCGGAGGCGATGAACACCGGCAGCGCGTTGAC
GAACGCCACCCCGGCGTCGATAGCACACTGGGCGTAGAACTTGTCGGCTTCCTCCGAGCC
CACCGGCAAATAGGAGACCAGCACGTCGACCTTGGCCTCCTTGAGCGCCTGGACGACGTC
GACGGGCTCCGCGTCGGAGAGTTCGATGGTGTCGGCGTAGTACTTGCCGATGCCATCGAG
GGTAGGCCCGCGCTGCACGATCACGTTGGTCGGCGCCACATCGGCGATCTTGATGGTGTT
GTTCTCCGAGGCGAAGATGGCGTCGGACAGGTCGAAGCCGACCTTCTTGGCGTCCACGTC
GAACGCCGCCACGAACTTGACGTCGCGAACGTGGTACGGGCCGAACCGCACGTGCATGAG
GCCCGGTACGGTCGATGTGTCGTCGGCGTTGTAGTAGTACTCGACGCCCTGGACCAGCGA
GGACGCGCAGTTGCCGACGCCGACAATGGCGACTCGAACCTCCGTCGACGCCTCCGGCGC
CGGTAACGACTGGTGCTCACTCAT

# Drug_Target_70_General_Function:
Involved in inositol-3-phosphate synthase activity

# Drug_Target_70_General_References:
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_70_HGNC_ID:
Not Available

# Drug_Target_70_HPRD_ID:
Not Available

# Drug_Target_70_ID:
4475

# Drug_Target_70_Locus:
Not Available

# Drug_Target_70_Molecular_Weight:
40094

# Drug_Target_70_Name:
Hypothetical protein Rv0046c/MT0052

# Drug_Target_70_Number_of_Residues:
367

# Drug_Target_70_PDB_ID:
1GR0

# Drug_Target_70_Pathway:
Not Available

# Drug_Target_70_Pfam_Domain_Function:
PF01658	Inos-1-P_synth
PF07994	NAD_binding_5

# Drug_Target_70_Protein_Sequence:
>Hypothetical protein Rv0046c/MT0052
MSEHQSLPAPEASTEVRVAIVGVGNCASSLVQGVEYYYNADDTSTVPGLMHVRFGPYHVR
DVKFVAAFDVDAKKVGFDLSDAIFASENNTIKIADVAPTNVIVQRGPTLDGIGKYYADTI
ELSDAEPVDVVQALKEAKVDVLVSYLPVGSEEADKFYAQCAIDAGVAFVNALPVFIASDP
VWAKKFTDARVPIVGDDIKSQVGATITHRVLAKLFEDRGVQLDRTMQLNVGGNMDFLNML
ERERLESKKISKTQAVTSNLKREFKTKDVHIGPSDHVGWLDDRKWAYVRLEGRAFGDVPL
NLEYKLEVWDSPNSAGVIIDAVRAAKIAKDRGIGGPVIPASAYLMKSPPEQLPDDIARAQ
LEEFIIG

# Drug_Target_70_Reaction:
Not Available

# Drug_Target_70_Signals:
None

# Drug_Target_70_Specific_Function:
Not Available

# Drug_Target_70_SwissProt_ID:
P71703

# Drug_Target_70_SwissProt_Name:
INO1_MYCTU

# Drug_Target_70_Synonyms:
Not Available

# Drug_Target_70_Theoretical_pI:
4.80

# Drug_Target_70_Transmembrane_Regions:
None

# Drug_Target_71_Cellular_Location:
Not Available

# Drug_Target_71_Chromosome_Location:
Not Available

# Drug_Target_71_Drug_References:
Not Available

# Drug_Target_71_Essentiality:
Non-Essential

# Drug_Target_71_GenAtlas_ID:
Not Available

# Drug_Target_71_GenBank_ID_Gene:
AF007800

# Drug_Target_71_GenBank_ID_Protein:
Not Available

# Drug_Target_71_GeneCard_ID:
Not Available

# Drug_Target_71_Gene_Name:
mtlD

# Drug_Target_71_Gene_Sequence:
>1482 bp
ATGAAACTGAATAAGCAGAACCTCACCCAGCTGGCGCCCGAAGTGAAATTGCCAGCCTAT
ACGCTTGCCGACACACGCCAGGGCATCGCCCATATCGGCGTCGGCGGCTTCCATCGCGCG
CACCAGGCGTATTACACCGATGCGCTGATGAATACCGGCGAGGGCCTGGACTGGAGCATC
TGCGGCGTTGGCCTGCGCAGCGAGGACCGCAAGGCCCGCGATGACCTGGCCGGCCAGGAC
TACCTGTTCACCCTGTACGAACTGGGCGACACCGACGACACCGAAGTGCGCGTGATCGGC
TCGATCAGCGACATGCTGCTGGCCGAAGACAGCGCCCAGGCATTGATCGATAAACTGGCC
AGCCCCGAGATTCGCATCGTCTCGCTGACCATCACCGAAGGCGGCTACTGCATCGACGAC
AGCAACGGCGAATTCATGGCCCACTTGCCGCAGATCCAGCACGACCTGGCTCATCCGTCG
TCGCCAAAAACCGTGTTCGGCTTTATCTGCGCGGCATTGACCCAGCGCCGCGCGGCCGGC
ATCCCGGCGTTTACCGTGATGTCCTGCGATAACCTGCCCCACAATGGCGCTGTCACGCGC
AAGGCACTGCTGGCGTTCGCCGCCCTGCACAACGCCGAGCTGCATGACTGGATCAAGGCC
CATGTGAGCTTCCCGAACGCCATGGTCGACCGCATCACGCCGATGACCAGCACCGCCCAC
CGCCTGCAACTGCACGATGAACACGGCATCGACGATGCCTGGCCAGTTGTTTGCGAACCC
TTTGTGCAGTGGGTACTGGAAGACAAATTCGTCAACGGCCGCCCGGCGTGGGAAAAGGTT
GGCGTGCAGTTCACCGACGATGTGACACCCTATGAAGAGATGAAGATCGGCTTGCTCAAC
GGCAGCCACCTGGCCCTGACCTACCTGGGTTTTCTCAAGGGCTATCGGTTTGTGCACGAG
ACCATGAACGACCCGCTGTTCGTGGCCTACATGCGCGCCTACATGGACCTCGACGTCACG
CCAAACCTCGCGCCGGTACCGGGCATCGACCTGACCGACTACAAGCAGACCCTGGTGGAC
CGCTTCTCCAACCAGGCGATTGCCGACCAGTTGGAACGGGTGTGTTCGGATGGCTCGTCG
AAGTTTCCCAAGTTCACCGTGCCGACCATCAACCGCCTGATTGCCGACGGCCGTGAGACC
GAGCGTGCAGCACTGGTCGTCGCGGCCTGGGCCTTGTATTTGAAGGGTGTGGATGAGAAT
GGCGTGAGCTACACAATCCCCGATCCGCGCGCCGAGTTCTGCCAGGGGCTGGTGAGTGAC
GATGCACTGATCAGCCAGCGGTTGCTGGCAGTGGAAGAGATTTTCGGTACGGCTATTCCC
AACTCGCCTGAGTTTGTGGCAGCGTTCGAGCGGTGCTATGGGAGCCTGCGTGATAACGGC
GTCACCACTACCCTGAAGCACCTCCTGAAGAAACCGGTTTAA

# Drug_Target_71_General_Function:
Involved in oxidoreductase activity

# Drug_Target_71_General_References:
12196534	Kavanagh KL, Klimacek M, Nidetzky B, Wilson DK: Crystal structure of Pseudomonas fluorescens mannitol 2-dehydrogenase binary and ternary complexes. Specificity and catalytic mechanism. J Biol Chem. 2002 Nov 8;277(45):43433-42. Epub 2002 Aug 23.
9116029	Brunker P, Altenbuchner J, Kulbe KD, Mattes R: Cloning, nucleotide sequence and expression of a mannitol dehydrogenase gene from Pseudomonas fluorescens DSM 50106 in Escherichia coli. Biochim Biophys Acta. 1997 Mar 20;1351(1-2):157-67.
9461423	Brunker P, Altenbuchner J, Mattes R: Structure and function of the genes involved in mannitol, arabitol and glucitol utilization from Pseudomonas fluorescens DSM50106. Gene. 1998 Jan 5;206(1):117-26.

# Drug_Target_71_HGNC_ID:
Not Available

# Drug_Target_71_HPRD_ID:
Not Available

# Drug_Target_71_ID:
4476

# Drug_Target_71_Locus:
Not Available

# Drug_Target_71_Molecular_Weight:
54498

# Drug_Target_71_Name:
Mannitol dehydrogenase

# Drug_Target_71_Number_of_Residues:
493

# Drug_Target_71_PDB_ID:
1LJ8

# Drug_Target_71_Pathway:
Not Available

# Drug_Target_71_Pfam_Domain_Function:
PF01232	Mannitol_dh
PF08125	Mannitol_dh_C

# Drug_Target_71_Protein_Sequence:
>Mannitol dehydrogenase
MKLNKQNLTQLAPEVKLPAYTLADTRQGIAHIGVGGFHRAHQAYYTDALMNTGEGLDWSI
CGVGLRSEDRKARDDLAGQDYLFTLYELGDTDDTEVRVIGSISDMLLAEDSAQALIDKLA
SPEIRIVSLTITEGGYCIDDSNGEFMAHLPQIQHDLAHPSSPKTVFGFICAALTQRRAAG
IPAFTVMSCDNLPHNGAVTRKALLAFAALHNAELHDWIKAHVSFPNAMVDRITPMTSTAH
RLQLHDEHGIDDAWPVVCEPFVQWVLEDKFVNGRPAWEKVGVQFTDDVTPYEEMKIGLLN
GSHLALTYLGFLKGYRFVHETMNDPLFVAYMRAYMDLDVTPNLAPVPGIDLTDYKQTLVD
RFSNQAIADQLERVCSDGSSKFPKFTVPTINRLIADGRETERAALVVAAWALYLKGVDEN
GVSYTIPDPRAEFCQGLVSDDALISQRLLAVEEIFGTAIPNSPEFVAAFERCYGSLRDNG
VTTTLKHLLKKPV

# Drug_Target_71_Reaction:
Not Available

# Drug_Target_71_Signals:
None

# Drug_Target_71_Specific_Function:
Not Available

# Drug_Target_71_SwissProt_ID:
O08355

# Drug_Target_71_SwissProt_Name:
O08355_PSEFL

# Drug_Target_71_Synonyms:
EC 1.1.1.67

# Drug_Target_71_Theoretical_pI:
4.95

# Drug_Target_71_Transmembrane_Regions:
None

# Drug_Target_72_Cellular_Location:
Cytoplasm

# Drug_Target_72_Chromosome_Location:
Not Available

# Drug_Target_72_Drug_References:
Not Available

# Drug_Target_72_Essentiality:
Non-Essential

# Drug_Target_72_GenAtlas_ID:
Not Available

# Drug_Target_72_GenBank_ID_Gene:
M57613

# Drug_Target_72_GenBank_ID_Protein:
Not Available

# Drug_Target_72_GeneCard_ID:
Not Available

# Drug_Target_72_Gene_Name:
lpdV

# Drug_Target_72_Gene_Sequence:
>1380 bp
ATGCAACAGACTATCCAGACAACCCTGTTGATCATCGGCGGCGGCCCTGGCGGCTATGTG
GCGGCCATCCGCGCCGGGCAACTGGGCATCCCTACCGTGCTGGTGGAAGGCCAGGCGCTG
GGCGGTACCTGCCTGAACATCGGCTGCATTCCGTCCAAGGCGCTGATCCATGTGGCCGAG
CAGTTCCACCAGGCCTCGCGCTTTACCGAACCCTCGCCGCTGGGCATCAGCGTGGCTTCG
CCACGCCTGGACATCGGCCAGAGCGTGGCCTGGAAAGACGGCATCGTCGATCGCCTGACC
ACTGGTGTCGCCGCCCTGCTGAAAAAGCACGGGGTGAAGGTGGTGCACGGCTGGGCCAAG
GTGCTTGATGGCAAGCAGGTCGAGGTGGATGGCCAGCGCATCCAGTGCGAGCACCTGTTG
CTGGCCACGGGCTCCAGCAGTGTCGAACTGCCGATGCTGCCGTTGGGTGGGCCGGTGATT
TCCTCGACCGAGGCCCTGGCACCGAAAGCCCTGCCGCAACACCTGGTGGTGGTGGGCGGT
GGCTACATCGGCCTGGAGCTGGGTATCGCCTACCGCAAGCTCGGCGCGCAGGTCAGCGTG
GTGGAAGCGCGCGAGCGCATCCTGCCGACTTACGACAGCGAACTGACCGCCCCGGTGGCC
GAGTCGCTGAAAAAGCTGGGTATCGCCCTGCACCTTGGCCACAGCGTCGAAGGTTACGAA
AATGGCTGCCTGCTGGCCAACGATGGCAAGGGCGGACAACTGCGCCTGGAAGCCGACCGG
GTGCTGGTGGCCGTGGGCCGCCGCCCACGCACCAAGGGCTTCAACCTGGAATGCCTGGAC
CTGAAGATGAATGGTGCCGCGATTGCCATCGACGAGCGCTGCCAGACCAGCATGCACAAC
GTCTGGGCCATCGGCGACGTGGCCGGCGAACCGATGCTGGCGCACCGGGCCATGGCCCAG
GGCGAGATGGTGGCCGAGATCATCGCCGGCAAGGCACGCCGCTTCGAACCCGCTGCGATA
GCCGCCGTGTGCTTCACCGACCCGGAAGTGGTCGTGGTCGGCAAGACGCCGGAACAGGCC
AGTCAGCAAGGCCTGGACTGCATCGTCGCGCAGTTCCCGTTCGCCGCCAACGGCCGGGCC
ATGAGCCTGGAGTCGAAAAGCGGTTTCGTGCGCGTGGTCGCGCGGCGTGACAACCACCTG
ATCCTGGGCTGGCAAGCGGTTGGCGTGGCGGTTTCCGAGCTGTCCACGGCGTTTGCCCAG
TCGCTGGAGATGGGTGCCTGCCTGGAGGATGTGGCCGGTACCATCCATGCCCACCCGACC
CTGGGTGAAGCGGTACAGGAAGCGGCACTGCGTGCCCTGGGCCACGCCCTGCATATCTGA

# Drug_Target_72_General_Function:
Involved in oxidoreductase activity

# Drug_Target_72_General_References:
1325638	Mattevi A, Obmolova G, Sokatch JR, Betzel C, Hol WG: The refined crystal structure of Pseudomonas putida lipoamide dehydrogenase complexed with NAD+ at 2.45 A resolution. Proteins. 1992 Aug;13(4):336-51.
2917566	Burns G, Brown T, Hatter K, Sokatch JR: Sequence analysis of the lpdV gene for lipoamide dehydrogenase of branched-chain-oxoacid dehydrogenase of Pseudomonas putida. Eur J Biochem. 1989 Jan 15;179(1):61-9.
3046941	Burns G, Brown T, Hatter K, Sokatch JR: Comparison of the amino acid sequences of the transacylase components of branched chain oxoacid dehydrogenase of Pseudomonas putida, and the pyruvate and 2-oxoglutarate dehydrogenases of Escherichia coli. Eur J Biochem. 1988 Sep 1;176(1):165-9.

# Drug_Target_72_HGNC_ID:
Not Available

# Drug_Target_72_HPRD_ID:
Not Available

# Drug_Target_72_ID:
4477

# Drug_Target_72_Locus:
Not Available

# Drug_Target_72_Molecular_Weight:
48159

# Drug_Target_72_Name:
Dihydrolipoyl dehydrogenase

# Drug_Target_72_Number_of_Residues:
459

# Drug_Target_72_PDB_ID:
1LVL

# Drug_Target_72_Pathway:
Not Available

# Drug_Target_72_Pfam_Domain_Function:
PF00070	Pyr_redox
PF02852	Pyr_redox_dim
PF07992	Pyr_redox_2

# Drug_Target_72_Protein_Sequence:
>Dihydrolipoyl dehydrogenase
MQQTIQTTLLIIGGGPGGYVAAIRAGQLGIPTVLVEGQALGGTCLNIGCIPSKALIHVAE
QFHQASRFTEPSPLGISVASPRLDIGQSVAWKDGIVDRLTTGVAALLKKHGVKVVHGWAK
VLDGKQVEVDGQRIQCEHLLLATGSSSVELPMLPLGGPVISSTEALAPKALPQHLVVVGG
GYIGLELGIAYRKLGAQVSVVEARERILPTYDSELTAPVAESLKKLGIALHLGHSVEGYE
NGCLLANDGKGGQLRLEADRVLVAVGRRPRTKGFNLECLDLKMNGAAIAIDERCQTSMHN
VWAIGDVAGEPMLAHRAMAQGEMVAEIIAGKARRFEPAAIAAVCFTDPEVVVVGKTPEQA
SQQGLDCIVAQFPFAANGRAMSLESKSGFVRVVARRDNHLILGWQAVGVAVSELSTAFAQ
SLEMGACLEDVAGTIHAHPTLGEAVQEAALRALGHALHI

# Drug_Target_72_Reaction:
Not Available

# Drug_Target_72_Signals:
None

# Drug_Target_72_Specific_Function:
The branched-chain alpha-keto dehydrogenase complex catalyzes the overall conversion of alpha-keto acids to acyl-CoA and CO(2). It contains multiple copies of 3 enzymatic components:branched-chain alpha-keto acid decarboxylase (E1), lipoamide acyltransferase (E2) and lipoamide dehydrogenase (E3)

# Drug_Target_72_SwissProt_ID:
P09063

# Drug_Target_72_SwissProt_Name:
DLDH1_PSEPU

# Drug_Target_72_Synonyms:
Dihydrolipoamide dehydrogenase
E3 component of branched- chain alpha-keto acid dehydrogenase complex
EC 1.8.1.4
LPD-Val

# Drug_Target_72_Theoretical_pI:
6.79

# Drug_Target_72_Transmembrane_Regions:
None

# Drug_Target_73_Cellular_Location:
Cytoplasm

# Drug_Target_73_Chromosome_Location:
Not Available

# Drug_Target_73_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_73_Essentiality:
Non-Essential

# Drug_Target_73_GenAtlas_ID:
MDH1

# Drug_Target_73_GenBank_ID_Gene:
D55654

# Drug_Target_73_GenBank_ID_Protein:
1255604

# Drug_Target_73_GeneCard_ID:
MDH1

# Drug_Target_73_Gene_Name:
MDH1

# Drug_Target_73_Gene_Sequence:
>1005 bp
ATGTCTGAACCAATCAGAGTCCTTGTGACTGGAGCAGCTGGTCAAATTGCATATTCACTG
CTGTACAGTATTGGAAATGGATCTGTCTTTGGTAAAGATCAGCCTATAATTCTTGTGCTG
TTGGATATCACCCCCATGATGGGTGTCCTGGACGGTGTCCTAATGGAACTGCAAGACTGT
GCCCTTCCCCTCCTGAAAGATGTCATCGCAACAGATAAAGAAGACGTTGCCTTCAAAGAC
CTGGATGTGGCCATTCTTGTGGGCTCCATGCCAAGAAGGGAAGGCATGGAGAGAAAAGAT
TTACTGAAAGCAAATGTGAAAATCTTCAAATCCCAGGGTGCAGCCTTAGATAAATACGCC
AAGAAGTCAGTTAAGGTTATTGTTGTGGGTAATCCAGCCAATACCAACTGCCTGACTGCT
TCCAAGTCAGCTCCATCCATCCCCAAGGAGAACTTCAGTTGCTTGACTCGTTTGGATCAC
AACCGAGCTAAAGCTCAAATTGCTCTTAAACTTGGTGTGACTGCTAATGATGTAAAGAAT
GTCATTATCTGGGGAAACCATTCCTCGACTCAGTATCCAGATGTCAACCATGCCAAGGTG
AAATTGCAAGGAAAGGAAGTTGGTGTTTATGAAGCTCTGAAAGATGACAGCTGGCTCAAG
GGAGAATTTGTCACGACTGTGCAGCAGCGTGGCGCTGCTGTCATCAAGGCTCGAAAACTA
TCCAGTGCCATGTCTGCTGCAAAAGCCATCTGTGACCACGTCAGGGACATCTGGTTTGGA
ACCCCAGAGGGAGAGTTTGTGTCCATGGGTGTTATCTCTGATGGCAACTCCTATGGTGTT
CCTGATGATCTGCTCTACTCATTCCCTGTTGTAATCAAGAATAAGACCTGGAAGTTTGTT
GAAGGTCTCCCTATTAATGATTTCTCACGTGAGAAGATGGATCTTACTGCAAAGGAACTG
ACAGAAGAAAAAGAAAGTGCTTTTGAATTTCTTTCCTCTGCCTGA

# Drug_Target_73_General_Function:
Energy production and conversion

# Drug_Target_73_General_References:
7895732	Corbett JM, Wheeler CH, Baker CS, Yacoub MH, Dunn MJ: The human myocardial two-dimensional gel protein database: update 1994. Electrophoresis. 1994 Nov;15(11):1459-65.
8786100	Tanaka T, Inazawa J, Nakamura Y: Molecular cloning and mapping of a human cDNA for cytosolic malate dehydrogenase (MDH1). Genomics. 1996 Feb 15;32(1):128-30.

# Drug_Target_73_HGNC_ID:
HGNC:6970

# Drug_Target_73_HPRD_ID:
01100

# Drug_Target_73_ID:
646

# Drug_Target_73_Locus:
2p13.3

# Drug_Target_73_Molecular_Weight:
36295

# Drug_Target_73_Name:
Malate dehydrogenase, cytoplasmic

# Drug_Target_73_Number_of_Residues:
333

# Drug_Target_73_PDB_ID:
5MDH

# Drug_Target_73_Pathway:
Not Available

# Drug_Target_73_Pfam_Domain_Function:
PF00056	Ldh_1_N
PF02866	Ldh_1_C

# Drug_Target_73_Protein_Sequence:
>Malate dehydrogenase, cytoplasmic
SEPIRVLVTGAAGQIAYSLLYSIGNGSVFGKDQPIILVLLDITPMMGVLDGVLMELQDCA
LPLLKDVIATDKEDVAFKDLDVAILVGSMPRREGMERKDLLKANVKIFKSQGAALDKYAK
KSVKVIVVGNPANTNCLTASKSAPSIPKENFSCLTRLDHNRAKAQIALKLGVTANDVKNV
IIWGNHSSTQYPDVNHAKVKLQGKEVGVYEALKDDSWLKGEFVTTVQQRGAAVIKARKLS
SAMSAAKAICDHVRDIWFGTPEGEFVSMGVISDGNSYGVPDDLLYSFPVVIKNKTWKFVE
GLPINDFSREKMDLTAKELTEEKESAFEFLSSA

# Drug_Target_73_Reaction:
(S)-malate + NAD+ = oxaloacetate + NADH + H+

# Drug_Target_73_Signals:
None

# Drug_Target_73_Specific_Function:
Not Available

# Drug_Target_73_SwissProt_ID:
P40925

# Drug_Target_73_SwissProt_Name:
MDHC_HUMAN

# Drug_Target_73_Synonyms:
Cytosolic malate dehydrogenase
EC 1.1.1.37

# Drug_Target_73_Theoretical_pI:
7.45

# Drug_Target_73_Transmembrane_Regions:
None

# Drug_Target_74_Cellular_Location:
Cytoplasm

# Drug_Target_74_Chromosome_Location:
Not Available

# Drug_Target_74_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_74_Essentiality:
Non-Essential

# Drug_Target_74_GenAtlas_ID:
ALDH1A2

# Drug_Target_74_GenBank_ID_Gene:
AB015226

# Drug_Target_74_GenBank_ID_Protein:
3970842

# Drug_Target_74_GeneCard_ID:
ALDH1A2

# Drug_Target_74_Gene_Name:
ALDH1A2

# Drug_Target_74_Gene_Sequence:
>1557 bp
ATGACTTCCAGCAAGATAGAGATGCCCGGCGAGGTGAAGGCCGACCCCGCCGCCCTCATG
GCGTCGCTGCACCTCCTGCCGTCGCCCACGCCCAATCTCGAAATTAAGTACACCAAGATC
TTTATAAACAACGAGTGGCAGAACTCAGAGAGTGGGAGAGTGTTCCCTGTCTATAATCCA
GCCACAGGAGAACAGGTGTGTGAAGTTCAAGAAGCAGACAAGGCAGATATAGACAAAGCA
GTGCAGGCAGCCCGCCTGGCTTTCTCTCTTGGTTCAGTGTGGAGAAGGATGGATGCTTCA
GAAAGGGGACGTCTGTTGGATAAGCTTGCAGACTTGGTGGAACGGGACAGGGCAGTTCTT
GCAACCATGGAATCCCTAAATGGTGGCAAACCATTCCTGCAAGCTTTTTATGTGGATTTG
CAGGGCGTCATCAAAACCTTTCGATATTACGCAGGCTGGGCTGATAAAATTCATGGGATG
ACCATTCCTGTAGATGGAGACTATTTTACCTTTACAAGACATGAACCCATTGGAGTGTGT
GGACAGATCATCCCATGGAACTTCCCCCTGCTGATGTTTGCCTGGAAAATAGCTCCAGCT
TTGTGCTGTGGCAATACAGTAGTTATTAAGCCAGCAGAGCAAACACCACTCAGTGCACTC
TACATGGGAGCCCTCATCAAGGAGGCTGGCTTTCCTCCCGGGGTCATCAATATTTTGCCA
GGATATGGGCCAACGGCTGGGGCAGCAATAGCTTCTCACATTGGCATAGACAAGATTGCA
TTCACAGGGTCTACTGAGGTTGGAAAGCTTATCCAAGAAGCAGCTGGAAGAAGTAATTTG
AAGAGAGTAACTCTGGAACTTGGAGGCAAAAGTCCTAATATTATTTTTGCTGATGCTGAC
TTGGACTATGCTGTGGAGCAGGCCCACCAGGGTGTGTTCTTCAATCAAGGTCAGTGCTGC
ACTGCAGGCTCTCGCATCTTCGTGGAGGAGTCCATCTATGAGGAGTTTGTGAGAAGAAGC
GTGGAGCGGGCCAAGAGGCGCATAGTGGGGAGTCCCTTTGACCCCACCACTGAGCAGGGT
CCCCAGATTGATAAGAAACAGTACAACAAGATCTTGGAACTCATCCAGAGTGGTGTGGCT
GAGGGCGCCAAGCTGGAATGTGGAGGCAAAGGACTGGGCCGAAAGGGGTTTTTCATTGAG
CCCACAGTGTTTTCCAACGTCACTGATGATATGCGGATTGCCAAGGAGGAGATCTTTGGC
CCTGTTCAGGAAATTTTGAGATTTAAGACGATGGATGAAGTTATCGAAAGAGCCAATAAC
TCAGACTTTGGACTCGTAGCAGCTGTCTTTACTAATGACATCAACAAGGCCCTCACAGTG
TCTTCTGCAATGCAAGCTGGGACTGTTTGGATCAATTGTTACAATGCCTTAAATGCCCAG
AGCCCCTTTGGGGGATTCAAGATGTCTGGAAATGGGAGAGAAATGGGAGAATTTGGCTTG
CGGGAGTACTCAGAAGTTAAGACGGTGACAGTAAAGATCCCCCAGAAGAACTCCTAA

# Drug_Target_74_General_Function:
Energy production and conversion

# Drug_Target_74_General_References:
9819382	Ono Y, Fukuhara N, Yoshie O: TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3. Mol Cell Biol. 1998 Dec;18(12):6939-50.

# Drug_Target_74_HGNC_ID:
HGNC:15472

# Drug_Target_74_HPRD_ID:
04733

# Drug_Target_74_ID:
569

# Drug_Target_74_Locus:
15q22.1

# Drug_Target_74_Molecular_Weight:
56725

# Drug_Target_74_Name:
Retinal dehydrogenase 2

# Drug_Target_74_Number_of_Residues:
518

# Drug_Target_74_PDB_ID:
1BI9

# Drug_Target_74_Pathway:
Not Available

# Drug_Target_74_Pfam_Domain_Function:
PF00171	Aldedh

# Drug_Target_74_Protein_Sequence:
>Retinal dehydrogenase 2
MTSSKIEMPGEVKADPAALMASLHLLPSPTPNLEIKYTKIFINNEWQNSESGRVFPVYNP
ATGEQVCEVQEADKADIDKAVQAARLAFSLGSVWRRMDASERGRLLDKLADLVERDRAVL
ATMESLNGGKPFLQAFYVDLQGVIKTFRYYAGWADKIHGMTIPVDGDYFTFTRHEPIGVC
GQIIPWNFPLLMFAWKIAPALCCGNTVVIKPAEQTPLSALYMGALIKEAGFPPGVINILP
GYGPTAGAAIASHIGIDKIAFTGSTEVGKLIQEAAGRSNLKRVTLELGGKSPNIIFADAD
LDYAVEQAHQGVFFNQGQCCTAGSRIFVEESIYEEFVRRSVERAKRRVVGSPFDPTTEQG
PQIDKKQYNKILELIQSGVAEGAKLECGGKGLGRKGFFIEPTVFSNVTDDMRIAKEEIFG
PVQEILRFKTMDEVIERANNSDFGLVAAVFTNDINKALTVSSAMQAGTVWINCYNALNAQ
SPFGGFKMSGNGREMGEFGLREYSEVKTVTVKIPQKNS

# Drug_Target_74_Reaction:
retinal + NAD+ + H2O = retinoate + NADH + 2 H+

# Drug_Target_74_Signals:
None

# Drug_Target_74_Specific_Function:
Recognizes as substrates free retinal and cellular retinol-binding protein-bound retinal. Does metabolize octanal and decanal but does not metabolize citral, benzaldehyde, acetaldehyde and propanal efficiently

# Drug_Target_74_SwissProt_ID:
O94788

# Drug_Target_74_SwissProt_Name:
AL1A2_HUMAN

# Drug_Target_74_Synonyms:
Aldehyde dehydrogenase family 1 member A2
EC 1.2.1.36
RALDH 2
RALDH(II)
RalDH2
Retinaldehyde-specific dehydrogenase type 2

# Drug_Target_74_Theoretical_pI:
5.84

# Drug_Target_74_Transmembrane_Regions:
None

# Drug_Target_75_Cellular_Location:
Not Available

# Drug_Target_75_Chromosome_Location:
Not Available

# Drug_Target_75_Drug_References:
Not Available

# Drug_Target_75_Essentiality:
Non-Essential

# Drug_Target_75_GenAtlas_ID:
Not Available

# Drug_Target_75_GenBank_ID_Gene:
AJ430490

# Drug_Target_75_GenBank_ID_Protein:
Not Available

# Drug_Target_75_GeneCard_ID:
Not Available

# Drug_Target_75_Gene_Name:
galE

# Drug_Target_75_Gene_Sequence:
>1188 bp
ATGCGCGTTTTGGTTTGTGGAGGCGCAGGTTACATTGGAAGCCACTTCGTGCGGGCTCTT
TTGCGCGACACGAACCACAGTGTTGTCATCGTTGACTCGCTTGTGGGGACGCATGGGAAA
AGCGACCATGTGGAAACCAGGGAAAATGTAGCGCGAAAGTTGCAACAAAGTGATGGACCG
AAGCCGCCGTGGGCGGATCGATACGCCGCACTGGAGGTGGGAGACGTGCGTAACGAAGAC
TTCCTTAACGGCGTTTTCACTCGCCATGGTCCTATCGATGCTGTTGTCCACATGTGTGCT
TTCCTTGCCGTTGGTGAGAGTGTGAGAGATCCACTAAAGTATTATGACAACAATGTGGTT
GGTATTCTAAGGTTGCTTCAAGCGATGTTGTTACACAAGTGCGACAAAATCATCTTCTCC
AGTAGTGCCGCCATTTTTGGCAACCCAACAATGGGCTCCGTGTCCACAAACGCAGAACCC
ATCGATATTAACGCCAAAAAGAGCCCAGAAAGTCCATATGGCGAGTCAAAACTTATTGCG
GAGAGGATGATAAGGGATTGCGCGGAAGCATACGGGATTAAAGGCATTTGCCTCCGTTAC
TTCAATGCCTGTGGAGCGCACGAGGATGGAGATATCGGTGAGCATTACCAAGGCTCCACG
CATCTAATCCCTATAATCTTGGGTAGGGTAATGAGCGACATCGCACCGGATCAAAGATTA
ACAATTCACGAGGATGCGTCAACTGACAAGAGAATGCCCATATTTGGTACAGACTATCCT
ACACCCGACGGCACGTGTGTACGGGACTATGTTCACGTGTGTGATCTTGCGTCGGCTCAC
ATATTAGCTCTTGATTACGTGGAGAAACTGGGACCGAATGACAAGTCCAAGTACTTCTCT
GTGTTTAACCTTGGCACTTCGCGGGGGTACTCCGTGCGTGAGGTTATAGAAGTGGCGCGC
AAGACTACTGGGCACCCGATTCCGGTGCGTGAGTGTGGCCGTCGGGAGGGGGACCCGGCG
TATCTTGTGGCTGCCAGCGATAAGGCACGGGAGGTGCTGGGCTGGAAACCAAAATACGAC
ACTCTCGAGGCCATCATGGAAACATCCTGGAAGTTTCAGCGCACTCACCCTAATGGGTAC
GCATCACAGGAAAATGGAACGCCGGGGGGAAGGACCACTAAGTTGTAA

# Drug_Target_75_General_Function:
Involved in catalytic activity

# Drug_Target_75_General_References:
11983889	Roper JR, Guther ML, Milne KG, Ferguson MA: Galactose metabolism is essential for the African sleeping sickness parasite Trypanosoma brucei. Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):5884-9.
12615316	Shaw MP, Bond CS, Roper JR, Gourley DG, Ferguson MA, Hunter WN: High-resolution crystal structure of Trypanosoma brucei UDP-galactose 4'-epimerase: a potential target for structure-based development of novel trypanocides. Mol Biochem Parasitol. 2003 Feb;126(2):173-80.

# Drug_Target_75_HGNC_ID:
Not Available

# Drug_Target_75_HPRD_ID:
Not Available

# Drug_Target_75_ID:
4482

# Drug_Target_75_Locus:
Not Available

# Drug_Target_75_Molecular_Weight:
43521

# Drug_Target_75_Name:
UDP-galactose 4-epimerase

# Drug_Target_75_Number_of_Residues:
395

# Drug_Target_75_PDB_ID:
1GY8

# Drug_Target_75_Pathway:
Not Available

# Drug_Target_75_Pfam_Domain_Function:
PF01370	Epimerase

# Drug_Target_75_Protein_Sequence:
>UDP-galactose 4-epimerase
MRVLVCGGAGYIGSHFVRALLRDTNHSVVIVDSLVGTHGKSDHVETRENVARKLQQSDGP
KPPWADRYAALEVGDVRNEDFLNGVFTRHGPIDAVVHMCAFLAVGESVRDPLKYYDNNVV
GILRLLQAMLLHKCDKIIFSSSAAIFGNPTMGSVSTNAEPIDINAKKSPESPYGESKLIA
ERMIRDCAEAYGIKGICLRYFNACGAHEDGDIGEHYQGSTHLIPIILGRVMSDIAPDQRL
TIHEDASTDKRMPIFGTDYPTPDGTCVRDYVHVCDLASAHILALDYVEKLGPNDKSKYFS
VFNLGTSRGYSVREVIEVARKTTGHPIPVRECGRREGDPAYLVAASDKAREVLGWKPKYD
TLEAIMETSWKFQRTHPNGYASQENGTPGGRTTKL

# Drug_Target_75_Reaction:
Not Available

# Drug_Target_75_Signals:
None

# Drug_Target_75_Specific_Function:
Not Available

# Drug_Target_75_SwissProt_ID:
Q8T8E9

# Drug_Target_75_SwissProt_Name:
Q8T8E9_9TRYP

# Drug_Target_75_Synonyms:
EC 5.1.3.2

# Drug_Target_75_Theoretical_pI:
6.91

# Drug_Target_75_Transmembrane_Regions:
None

# Drug_Target_76_Cellular_Location:
Cytoplasm

# Drug_Target_76_Chromosome_Location:
Not Available

# Drug_Target_76_Drug_References:
Not Available

# Drug_Target_76_Essentiality:
Non-Essential

# Drug_Target_76_GenAtlas_ID:
Not Available

# Drug_Target_76_GenBank_ID_Gene:
M12799

# Drug_Target_76_GenBank_ID_Protein:
Not Available

# Drug_Target_76_GeneCard_ID:
Not Available

# Drug_Target_76_Gene_Name:
dkgA

# Drug_Target_76_Gene_Sequence:
>837 bp
ATGACAGTTCCCAGCATCGTGCTCAACGACGGCAATTCCATTCCCCAGCTCGGGTACGGC
GTCTTCAAGGTGCCGCCGGCGGACACCCAGCGCGCCGTCGAGGAAGCGCTCGAAGTCGGC
TACCGGCACATCGACACCGCGGCGATCTACGGAAACGAAGAAGGCGTCGGCGCCGCGATC
GCGGCGAGCGGCATCGCGCGCGACGACCTGTTCATCACGACGAAGCTCTGGAACGATCGC
CACGACGGCGATGAGCCCGCTGCAGCGATCGCCGAGAGCCTCGCGAAGCTGGCACTCGAT
CAGGTCGACCTGTACCTCGTGCACTGGCCGACGCCCGCCGCCGACAACTACGTGCACGCG
TGGGAGAAGATGATCGAGCTTCGCGCAGCCGGTCTCACCCGCAGCATCGGCGTCTCGAAC
CACCTCGTGCCGCACCTCGAGCGCATCGTCGCCGCCACCGGCGTCGTGCCGGCGGTGAAC
CAGATCGAGCTGCACCCCGCCTACCAGCAGCGCGAGATCACCGACTGGGCCGCCGCCCAC
GACGTGAAGATCGAATCGTGGGGGCCGCTCGGTCAGGGCAAGTACGACCTCTTCGGCGCC
GAGCCCGTCACTGCGGCTGCCGCCGCCCACGGCAAGACCCCGGCGCAGGCCGTGCTCCGT
TGGCACCTGCAGAAGGGTTTCGTGGTCTTCCCGAAGTCGGTCCGCCGCGAGCGCCTCGAA
GAGAACCTCGACGTGTTCGACTTCGACCTCACCGACACCGAGATCGCCGCGATCGACGCG
ATGGATCCGGGCGACGGTTCGGGTCGCGTGAGCGCACACCCCGATGAGGTCGACTGA

# Drug_Target_76_General_Function:
Involved in oxidoreductase activity

# Drug_Target_76_General_References:
10737928	Khurana S, Sanli G, Powers DB, Anderson S, Blaber M: Molecular modeling of substrate binding in wild-type and mutant Corynebacteria 2,5-diketo-D-gluconate reductases. Proteins. 2000 Apr 1;39(1):68-75.
11399090	Sanli G, Blaber M: Structural assembly of the active site in an aldo-keto reductase by NADPH cofactor. J Mol Biol. 2001 Jun 22;309(5):1209-18.
3597405	Miller JV, Estell DA, Lazarus RA: Purification and characterization of 2,5-diketo-D-gluconate reductase from Corynebacterium sp. J Biol Chem. 1987 Jul 5;262(19):9016-20.
9618487	Khurana S, Powers DB, Anderson S, Blaber M: Crystal structure of 2,5-diketo-D-gluconic acid reductase A complexed with NADPH at 2.1-A resolution. Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6768-73.

# Drug_Target_76_HGNC_ID:
Not Available

# Drug_Target_76_HPRD_ID:
Not Available

# Drug_Target_76_ID:
4484

# Drug_Target_76_Locus:
Not Available

# Drug_Target_76_Molecular_Weight:
30119

# Drug_Target_76_Name:
2,5-diketo-D-gluconic acid reductase A

# Drug_Target_76_Number_of_Residues:
278

# Drug_Target_76_PDB_ID:
1HW6

# Drug_Target_76_Pathway:
Not Available

# Drug_Target_76_Pfam_Domain_Function:
PF00248	Aldo_ket_red

# Drug_Target_76_Protein_Sequence:
>2,5-diketo-D-gluconic acid reductase A
MTVPSIVLNDGNSIPQLGYGVFKVPPADTQRAVEEALEVGYRHIDTAAIYGNEEGVGAAI
AASGIARDDLFITTKLWNDRHDGDEPAAAIAESLAKLALDQVDLYLVHWPTPAADNYVHA
WEKMIELRAAGLTRSIGVSNHLVPHLERIVAATGVVPAVNQIELHPAYQQREITDWAAAH
DVKIESWGPLGQGKYDLFGAEPVTAAAAAHGKTPAQAVLRWHLQKGFVVFPKSVRRERLE
ENLDVFDFDLTDTEIAAIDAMDPGDGSGRVSAHPDEVD

# Drug_Target_76_Reaction:
Not Available

# Drug_Target_76_Signals:
None

# Drug_Target_76_Specific_Function:
Catalyzes the reduction of 2,5-diketo-D-gluconic acid (25DKG) to 2-keto-L-gulonic acid (2KLG). 5-keto-D-fructose and dihydroxyacetone can also serve as substrates. 25DKGR-A exhibits a greater selectivity for the substrate and higher thermal stability than 25DKGR-B

# Drug_Target_76_SwissProt_ID:
P06632

# Drug_Target_76_SwissProt_Name:
DKGA_CORSC

# Drug_Target_76_Synonyms:
2,5-DKG reductase A
2,5-DKGR A
25DKGR-A
AKR5C
EC 1.1.1.274

# Drug_Target_76_Theoretical_pI:
4.56

# Drug_Target_76_Transmembrane_Regions:
None

# Drug_Target_77_Cellular_Location:
Not Available

# Drug_Target_77_Chromosome_Location:
Not Available

# Drug_Target_77_Drug_References:
Not Available

# Drug_Target_77_Essentiality:
Non-Essential

# Drug_Target_77_GenAtlas_ID:
Not Available

# Drug_Target_77_GenBank_ID_Gene:
AF140605

# Drug_Target_77_GenBank_ID_Protein:
Not Available

# Drug_Target_77_GeneCard_ID:
Not Available

# Drug_Target_77_Gene_Name:
pheA2

# Drug_Target_77_Gene_Sequence:
>486 bp
ATGGACGATCGCTTATTTCGCAATGCAATGGGGAAATTTGCTACAGGGGTTACGGTAATT
ACGACGGAGCTTAACGGGGCTGTCCATGGAATGACGGCAAACGCCTTTATGTCTGTTTCC
TTAAATCCGAAACTTGTGTTGGTTTCCATTGGAGAAAAAGCGAAAATGCTGGAAAAAATT
CAACAATCGAAAAAATATGCAGTTAACATTTTGTCACAGGATCAAAAAGTGCTTTCGATG
AATTTTGCCGGACAGCTGGAAAAACCAGTAGATGTGCAATTCGAAGAGCTGGGGGGACTG
CCGGTCATTAAAGATGCTCTTGCACAAATTTCCTGCCAAGTTGTTAACGAAGTTCAAGCA
GGCGATCATACCCTTTTCATTGGGGAAGTGACAGATATAAAAATTACAGAGCAAGATCCG
CTTCTGTTTTTTAGCGGAAAATATCATCAGCTTGCCCAAAACGAAAAAGTGGAGACGTCG
AGCTAA

# Drug_Target_77_General_Function:
Involved in oxidoreductase activity

# Drug_Target_77_General_References:
11054550	Duffner FM, Kirchner U, Bauer MP, Muller R: Phenol/cresol degradation by the thermophilic Bacillus thermoglucosidasius A7: cloning and sequence analysis of five genes involved in the pathway. Gene. 2000 Oct 3;256(1-2):215-21.

# Drug_Target_77_HGNC_ID:
Not Available

# Drug_Target_77_HPRD_ID:
Not Available

# Drug_Target_77_ID:
4486

# Drug_Target_77_Locus:
Not Available

# Drug_Target_77_Molecular_Weight:
17659

# Drug_Target_77_Name:
Phenol 2-hydroxylase component B

# Drug_Target_77_Number_of_Residues:
161

# Drug_Target_77_PDB_ID:
1RZ1

# Drug_Target_77_Pathway:
Not Available

# Drug_Target_77_Pfam_Domain_Function:
PF01613	Flavin_Reduct

# Drug_Target_77_Protein_Sequence:
>Phenol 2-hydroxylase component B
MDDRLFRNAMGKFATGVTVITTELNGAVHGMTANAFMSVSLNPKLVLVSIGEKAKMLEKI
QQSKKYAVNILSQDQKVLSMNFAGQLEKPVDVQFEELGGLPVIKDALAQISCQVVNEVQA
GDHTLFIGEVTDIKITEQDPLLFFSGKYHQLAQNEKVETSS

# Drug_Target_77_Reaction:
Not Available

# Drug_Target_77_Signals:
None

# Drug_Target_77_Specific_Function:
Not Available

# Drug_Target_77_SwissProt_ID:
Q9LAG2

# Drug_Target_77_SwissProt_Name:
Q9LAG2_BACTR

# Drug_Target_77_Synonyms:
Not Available

# Drug_Target_77_Theoretical_pI:
5.22

# Drug_Target_77_Transmembrane_Regions:
None

# Drug_Target_78_Cellular_Location:
Cytoplasmic

# Drug_Target_78_Chromosome_Location:
Not Available

# Drug_Target_78_Drug_References:
Not Available

# Drug_Target_78_Essentiality:
Non-Essential

# Drug_Target_78_GenAtlas_ID:
Not Available

# Drug_Target_78_GenBank_ID_Gene:
L42023

# Drug_Target_78_GenBank_ID_Protein:
Not Available

# Drug_Target_78_GeneCard_ID:
Not Available

# Drug_Target_78_Gene_Name:
nadR

# Drug_Target_78_Gene_Sequence:
>1266 bp
TCATTGAGATGTCCCTTTTATAGGAAAGGTTGTGTTTTGTAATTCACTGATTTCCTCTTC
ATTTAACACTTTCTCAATGACTGCTTTAACTTGGTTATAGCGATCAAGATAACTTGGTGA
TTCAATCTCTATATAAGGAACTTTATATTTATCTAACAGTTTTTTGAGTAGTTGTTGAAA
TTGTTGGCGTTGTTTTTGTGAGCCTAAGCTACGCAAGCCATCATCCACCCATTCAGTATT
GTTTTTAAGTAAAATAGTGACATCGAAGGGATATTCTTTAATCATTGAGTCTAAAAATGG
ATGGGCTTTTCCTTCATATTGAATGCAGAATGCTTGCGTGGTGATGAAATCCGTATCAAT
AAATGCAATTTTATGAGAATGGCGCACGGCATAATCAATGTATCGTTGATGACCAAGCGC
CATTTGCGGATAGTCAGAATATTGCATCGCTTGCTCGTCGCCACCGAGCTTTTCAAATAC
AAATTCACGCCCGTATTCCCACGCAGAAGTGGTATTAAATACGGCGGCTAACTTATTAAC
TAGCACGCTTTTACCACTGCTTTCTCCCCCTAAAATCGCCACCGTTTTGGCAAAGAAAGG
ACGAGCTTCTTTCGGAATAAACTTCCAATATTGGAATGGAGTGGTGCGAATTTTGGTGGC
GGACACATTAAAGAAAGTGCGGTCAGGATCGACTAACGAAACTTCTAAACCTAAGTATTT
CTCGTAAGGCGCTTTATCTTGAGGTTCGCTACTAAATACGATTGAAGGCTCAAAATGTTT
TTCATGAAATAGGGTTTTAACTGCTTCACTCCAAGATTGCCAGCCGTTTGGATAACTCGG
AATACCGTCTTCAACCAAATGATGAATAAAAATCTGATTTTTTTGATATTTGAAAATTTG
CTGCATCCAACGCAAACGATCTTGCACGGTTGGCATGCGTTTCATTTTACTATCGTAAAA
TAATTTCAAATCGCGCACAGTGTCACTACACACGATAACGTGTAGTTCATCGACTTTACT
GAACGCTTCATAAATCATATTTATATGACCTGTGTGTACAGGATAAAATTTCCCGAAAAT
GACACCGACTTTTTTCTCTTTTGTTTTTGACATAATCTGCTCTTGATAGCGTAAGAATTG
AGTGTGTTTATTGTAGGCTAAATGAAAATATTTTTCACGTTCTGATTTAGTGCCTAGGTA
TTTTGCGTTATACTTAGCTCGCATTCTCAGGGCAGGGTGAAATTCCCTACCGGTGGTAAA
GCCCAC

# Drug_Target_78_General_Function:
Involved in catalytic activity

# Drug_Target_78_General_References:
7542800	Fleischmann RD, Adams MD, White O, Clayton RA, Kirkness EF, Kerlavage AR, Bult CJ, Tomb JF, Dougherty BA, Merrick JM, et al.: Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science. 1995 Jul 28;269(5223):496-512.

# Drug_Target_78_HGNC_ID:
Not Available

# Drug_Target_78_HPRD_ID:
Not Available

# Drug_Target_78_ID:
4487

# Drug_Target_78_Locus:
Not Available

# Drug_Target_78_Molecular_Weight:
49432

# Drug_Target_78_Name:
Transcriptional regulator nadR

# Drug_Target_78_Number_of_Residues:
421

# Drug_Target_78_PDB_ID:
1LW7

# Drug_Target_78_Pathway:
Not Available

# Drug_Target_78_Pfam_Domain_Function:
PF01467	CTP_transf_2

# Drug_Target_78_Protein_Sequence:
>Transcriptional regulator nadR
MGFTTGREFHPALRMRAKYNAKYLGTKSEREKYFHLAYNKHTQFLRYQEQIMSKTKEKKV
GVIFGKFYPVHTGHINMIYEAFSKVDELHVIVCSDTVRDLKLFYDSKMKRMPTVQDRLRW
MQQIFKYQKNQIFIHHLVEDGIPSYPNGWQSWSEAVKTLFHEKHFEPSIVFSSEPQDKAP
YEKYLGLEVSLVDPDRTFFNVSATKIRTTPFQYWKFIPKEARPFFAKTVAILGGESSGKS
VLVNKLAAVFNTTSAWEYGREFVFEKLGGDEQAMQYSDYPQMALGHQRYIDYAVRHSHKI
AFIDTDFITTQAFCIQYEGKAHPFLDSMIKEYPFDVTILLKNNTEWVDDGLRSLGSQKQR
QQFQQLLKKLLDKYKVPYIEIESPSYLDRYNQVKAVIEKVLNEEEISELQNTTFPIKGTS
Q

# Drug_Target_78_Reaction:
Not Available

# Drug_Target_78_Signals:
None

# Drug_Target_78_Specific_Function:
NadR is bifunctional; it interacts with pnuC at low internal NAD levels, permitting transport of NMN intact into the cell. As NAD levels increase within the cell, the affinity of nadR for the operator regions of some genes increases, repressing the transcription of these genes (By similarity)

# Drug_Target_78_SwissProt_ID:
P44308

# Drug_Target_78_SwissProt_Name:
NADR_HAEIN

# Drug_Target_78_Synonyms:
Not Available

# Drug_Target_78_Theoretical_pI:
9.30

# Drug_Target_78_Transmembrane_Regions:
None

# Drug_Target_79_Cellular_Location:
Isoform 1:Endoplasmic reticulum
cytoplasmic side. Mit
endoplasmic reticulum membrane
lipid-anchor

# Drug_Target_79_Chromosome_Location:
Not Available

# Drug_Target_79_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_79_Essentiality:
Non-Essential

# Drug_Target_79_GenAtlas_ID:
CYB5R3

# Drug_Target_79_GenBank_ID_Gene:
M28713

# Drug_Target_79_GenBank_ID_Protein:
553600

# Drug_Target_79_GeneCard_ID:
CYB5R3

# Drug_Target_79_Gene_Name:
CYB5R3

# Drug_Target_79_Gene_Sequence:
>906 bp
ATGGGGGCCCAGCTCAGCACGTTGGGCCATATGGTCCTCTTCCCAGTCTGGTTCCTGTAC
AGTCTGCTCATGAAGCTGTTCCAGGGCTCCACGCCAGCCATCACCCTCGAGAGCCCGGAC
ATCAAGTACCCGCTGCGGCTCATCGACCGGGAGATCATCAGCCATGACACCCGGCGCTTC
CGCTTTGCCCTGCCGCCACCCCAGCACATCCTGGGCCTCCCTGTCGGCCAGCACATCTAC
CTCTCGGCTCGAATTGATGGAAACCTGGTCGTCCGGCCCTATACACCAATCTCCAGCGAT
GATGACAAGGGCTTCGTGGACCTGGTCATCAAGGTTTACTTCAAGGACACCCATCCCAAG
TTTCCCGCTGGAGGGAAGATGTCTCAGTACCTGGAGAGCATGCAGATTGGAGACACCATT
GAGTTCCGGGGCCCCAGTGGGCTGCTGGTCTACCAGGGCAAAGGGAAGTTCGCCATCCGA
CCTGACAAAAAGTCCAACCCTATCATCAGGACAGTGAAGTCTGTGGGCATGATCGCGGGA
GGGACAGGCATCACCCCGATGCTGCAGGTGATCCGCGCCATCATGAAGGACCCTGATGAC
CACACTGTGTGCCACCTGCTCTTTGCCAACCAGACCGAGAAGGACATCCTGCTGCGACCT
GAGCTGGAGGAACTCAGGAACAAACATTCTGCACGCTTCAAGCTCTGGTACACGCTGGAC
AGAGCCCCTGAAGCCTGGGACTACGGCCAGGGCTTCGTGAATGAGGAGATGATCCGGGAC
CACCTTCCACCCCCAGAGGAGGAGCCGCTGGTGCTGATGTGTGGCCCCCCACCCATGATC
CAGTACGCCTGCCTTCCCAACCTGGACCACGTGGGCCACCCCACGGAGCGCTGCTTCGTC
TTCTGA

# Drug_Target_79_General_Function:
Coenzyme transport and metabolism

# Drug_Target_79_General_References:
10591208	Dunham I, Shimizu N, Roe BA, Chissoe S, Hunt AR, Collins JE, Bruskiewich R, Beare DM, Clamp M, Smink LJ, Ainscough R, Almeida JP, Babbage A, Bagguley C, Bailey J, Barlow K, Bates KN, Beasley O, Bird CP, Blakey S, Bridgeman AM, Buck D, Burgess J, Burrill WD, O'Brien KP, et al.: The DNA sequence of human chromosome 22. Nature. 1999 Dec 2;402(6761):489-95.
10807796	Wang Y, Wu YS, Zheng PZ, Yang WX, Fang GA, Tang YC, Xie F, Lan FH, Zhu ZY: A novel mutation in the NADH-cytochrome b5 reductase gene of a Chinese patient with recessive congenital methemoglobinemia. Blood. 2000 May 15;95(10):3250-5.
1400360	Shirabe K, Yubisui T, Borgese N, Tang CY, Hultquist DE, Takeshita M: Enzymatic instability of NADH-cytochrome b5 reductase as a cause of hereditary methemoglobinemia type I (red cell type). J Biol Chem. 1992 Oct 5;267(28):20416-21.
1707593	Katsube T, Sakamoto N, Kobayashi Y, Seki R, Hirano M, Tanishima K, Tomoda A, Takazakura E, Yubisui T, Takeshita M, et al.: Exonic point mutations in NADH-cytochrome B5 reductase genes of homozygotes for hereditary methemoglobinemia, types I and III: putative mechanisms of tissue-dependent enzyme deficiency. Am J Hum Genet. 1991 Apr;48(4):799-808.
1898726	Yubisui T, Shirabe K, Takeshita M, Kobayashi Y, Fukumaki Y, Sakaki Y, Takano T: Structural role of serine 127 in the NADH-binding site of human NADH-cytochrome b5 reductase. J Biol Chem. 1991 Jan 5;266(1):66-70.
2019583	Shirabe K, Yubisui T, Nishino T, Takeshita M: Role of cysteine residues in human NADH-cytochrome b5 reductase studied by site-directed mutagenesis. Cys-273 and Cys-283 are located close to the NADH-binding site but are not catalytically essential. J Biol Chem. 1991 Apr 25;266(12):7531-6.
2479590	Tomatsu S, Kobayashi Y, Fukumaki Y, Yubisui T, Orii T, Sakaki Y: The organization and the complete nucleotide sequence of the human NADH-cytochrome b5 reductase gene. Gene. 1989 Aug 15;80(2):353-61.
3035541	Yubisui T, Naitoh Y, Zenno S, Tamura M, Takeshita M, Sakaki Y: Molecular cloning of cDNAs of human liver and placenta NADH-cytochrome b5 reductase. Proc Natl Acad Sci U S A. 1987 Jun;84(11):3609-13.
3700359	Yubisui T, Miyata T, Iwanaga S, Tamura M, Takeshita M: Complete amino acid sequence of NADH-cytochrome b5 reductase purified from human erythrocytes. J Biochem (Tokyo). 1986 Feb;99(2):407-22.
6389526	Yubisui T, Miyata T, Iwanaga S, Tamura M, Yoshida S, Takeshita M, Nakajima H: Amino acid sequence of NADH-cytochrome b5 reductase of human erythrocytes. J Biochem (Tokyo). 1984 Aug;96(2):579-82.
7718898	Vieira LM, Kaplan JC, Kahn A, Leroux A: Four new mutations in the NADH-cytochrome b5 reductase gene from patients with recessive congenital methemoglobinemia type II. Blood. 1995 Apr 15;85(8):2254-62.
8119939	Shirabe K, Fujimoto Y, Yubisui T, Takeshita M: An in-frame deletion of codon 298 of the NADH-cytochrome b5 reductase gene results in hereditary methemoglobinemia type II (generalized type). A functional implication for the role of the COOH-terminal region of the enzyme. J Biol Chem. 1994 Feb 25;269(8):5952-7.
9048929	Jenkins MM, Prchal JT: A high-frequency polymorphism of NADH-cytochrome b5 reductase in African-Americans. Hum Genet. 1997 Feb;99(2):248-50.
9639531	Bulbarelli A, Valentini A, DeSilvestris M, Cappellini MD, Borgese N: An erythroid-specific transcript generates the soluble form of NADH-cytochrome b5 reductase in humans. Blood. 1998 Jul 1;92(1):310-9.
9695975	Wu YS, Huang CH, Wan Y, Huang QJ, Zhu ZY: Identification of a novel point mutation (Leu72Pro) in the NADH-cytochrome b5 reductase gene of a patient with hereditary methaemoglobinaemia type I. Br J Haematol. 1998 Jul;102(2):575-7.
9886302	Higasa K, Manabe JI, Yubisui T, Sumimoto H, Pung-Amritt P, Tanphaichitr VS, Fukumaki Y: Molecular basis of hereditary methaemoglobinaemia, types I and II: two novel mutations in the NADH-cytochrome b5 reductase gene. Br J Haematol. 1998 Dec;103(4):922-30.

# Drug_Target_79_HGNC_ID:
HGNC:2873

# Drug_Target_79_HPRD_ID:
08942

# Drug_Target_79_ID:
178

# Drug_Target_79_Locus:
22q13.31-qter|22q13.2-q13.31

# Drug_Target_79_Molecular_Weight:
34104

# Drug_Target_79_Name:
NADH-cytochrome b5 reductase 3

# Drug_Target_79_Number_of_Residues:
300

# Drug_Target_79_PDB_ID:
1UMK

# Drug_Target_79_Pathway:
Not Available

# Drug_Target_79_Pfam_Domain_Function:
PF00175	NAD_binding_1
PF00970	FAD_binding_6

# Drug_Target_79_Protein_Sequence:
>NADH-cytochrome b5 reductase
GAQLSTLGHMVLFPVWFLYSLLMKLFQRSTPAITLESPDIKYPLRLIDREIISHDTRRFR
FALPSPQHILGLPVGQHIYLSARIDGNLVVRPYTPISSDDDKGFVDLVIKVYFKDTHPKF
PAGGKMSQYLESMQIGDTIEFRGPSGLLVYQGKGKFAIRPDKKSNPIIRTVKSVGMIAGG
TGITPMLQVIRAIMKDPDDHTVCHLLFANQTEKDILLRPELEELRNKHSARFKLWYTLDR
APEAWDYGQGFVNEEMIRDHLPPPEEEPLVLMCGPPPMIQYACLPNLDHVGHPTERCFVF

# Drug_Target_79_Reaction:
NADH + 2 ferricytochrome b5 = NAD+ + H+ + 2 ferrocytochrome b5

# Drug_Target_79_Signals:
None

# Drug_Target_79_Specific_Function:
Desaturation and elongation of fatty acids, cholesterol biosynthesis, drug metabolism, and, in erythrocyte, methemoglobin reduction

# Drug_Target_79_SwissProt_ID:
P00387

# Drug_Target_79_SwissProt_Name:
NB5R3_HUMAN

# Drug_Target_79_Synonyms:
B5R
Cytochrome b5 reductase
Diaphorase-1
EC 1.6.2.2

# Drug_Target_79_Theoretical_pI:
7.68

# Drug_Target_79_Transmembrane_Regions:
None

# Drug_Target_7_Cellular_Location:
Not Available

# Drug_Target_7_Chromosome_Location:
Not Available

# Drug_Target_7_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_7_Essentiality:
Non-Essential

# Drug_Target_7_GenAtlas_ID:
Not Available

# Drug_Target_7_GenBank_ID_Gene:
M26929

# Drug_Target_7_GenBank_ID_Protein:
149538

# Drug_Target_7_GeneCard_ID:
Not Available

# Drug_Target_7_Gene_Name:
Not Available

# Drug_Target_7_Gene_Sequence:
>1008 bp
ATGAAGATTATTGCTTACGGTGCTCGCGTTGACGAGATTCAATATTTCAAGCAATGGGCC
AAGGATACAGGCAACACACTTGAATACCATACAGAATTTCTCGATGAAAACACCGTTGAA
TGGGCTAAAGGGTTTGATGGCATCAATTCATTGCAGACAACGCCATATGCAGCCGGCGTT
TTTGAAAAAATGCACGCGTATGGTATCAAGTTCTTGACGATTCGGAATGTGGGTACGGAT
AACATTGATATGACTGCCATGAAGCAATACGGCATTCGTTTGAGCAATGTACCGGCTTAT
TCGCCAGCAGCGATTGCTGAATTTGCTTTGACCGATACTTTGTACTTGCTACGTAATATG
GGTAAAGTACAGGCGCAACTACAGGCGGGCGATTATGAAAAAGCGGGCACCTTCATCGGT
AAGGAACTCGGTCAGCAAACCGTTGGCGTGATGGGCACCGGTCATATTGGACAGGTTGCT
ATCAAACTGTTCAAAGGCTTTGGCGCCAAAGTGATTGCTTACGATCCTTATCCAATGAAG
GGCGATCACCCAGATTTTGACTATGTCAGCCTTGAAGACCTCTTTAAGCAAAGTGATGTC
ATTGATCTTCATGTTCCTGGGATTGAACAAAATACCCACATTATCAATGAAGCGGCATTT
AATTTGATGAAACCGGGTGCGATTGTGATCAACACGGCTCGGCCAAATCTGATTGACACG
CAAGCCATGCTCAGCAATCTTAAGTCTGGCAAGTTGGCCGGTGTCGGGATTGACACCTAT
GAATACGAAACCGAGGACTTGTTGAATCTCGCCAAGCACGGCAGCTTCAAGGATCCGTTG
TGGGACGAGCTGTTGGGGATGCCAAATGTTGTCCTCAGCCCGCACATTGCCTACTACACC
GAGACGGCTGTGCATAATATGGTTTACTTCTCACTACAACATCTCGTTGATTTCTTGACC
AAATTCAAACCAGCACGGAAGTTACTGGTCCAGCAAGTAGTCAACTGA

# Drug_Target_7_General_Function:
Energy production and conversion

# Drug_Target_7_General_References:
2504649	Lerch HP, Blocker H, Kallwass H, Hoppe J, Tsai H, Collins J: Cloning, sequencing and expression in Escherichia coli of the D-2-hydroxyisocaproate dehydrogenase gene of Lactobacillus casei. Gene. 1989 May 15;78(1):47-57.
9126843	Dengler U, Niefind K, Kiess M, Schomburg D: Crystal structure of a ternary complex of D-2-hydroxyisocaproate dehydrogenase from Lactobacillus casei, NAD+ and 2-oxoisocaproate at 1.9 A resolution. J Mol Biol. 1997 Apr 4;267(3):640-60.

# Drug_Target_7_HGNC_ID:
Not Available

# Drug_Target_7_HPRD_ID:
Not Available

# Drug_Target_7_ID:
3401

# Drug_Target_7_Locus:
Not Available

# Drug_Target_7_Molecular_Weight:
36893

# Drug_Target_7_Name:
D-2-hydroxyisocaproate dehydrogenase

# Drug_Target_7_Number_of_Residues:
333

# Drug_Target_7_PDB_ID:
1DXY

# Drug_Target_7_Pathway:
Not Available

# Drug_Target_7_Pfam_Domain_Function:
PF00389	2-Hacid_dh
PF02826	2-Hacid_dh_C

# Drug_Target_7_Protein_Sequence:
>D-2-hydroxyisocaproate dehydrogenase
MKIIAYGARVDEIQYFKQWAKDTGNTLEYHTEFLDENTVEWAKGFDGINSLQTTPYAAGV
FEKMHAYGIKFLTIRNVGTDNIDMTAMKQYGIRLSNVPAYSPAAIAEFALTDTLYLLRNM
GKVQAQLQAGDYEKAGTFIGKELGQQTVGVMGTGHIGQVAIKLFKGFGAKVIAYDPYPMK
GDHPDFDYVSLEDLFKQSDVIDLHVPGIEQNTHIINEAAFNLMKPGAIVINTARPNLIDT
QAMLSNLKSGKLAGVGIDTYEYETEDLLNLAKHGSFKDPLWDELLGMPNVVLSPHIAYYT
ETAVHNMVYFSLQHLVDFLTKGETSTEVTGPAK

# Drug_Target_7_Reaction:
Not Available

# Drug_Target_7_Signals:
None

# Drug_Target_7_Specific_Function:
Catalyzes the NAD dependent reversible, stereospecific interconversion between 2-ketocarboxylic acids and D-2-hydroxy- carboxylic acids

# Drug_Target_7_SwissProt_ID:
P17584

# Drug_Target_7_SwissProt_Name:
DHD2_LACPA

# Drug_Target_7_Synonyms:
D-HICDH
EC 1.1.1.-

# Drug_Target_7_Theoretical_pI:
5.05

# Drug_Target_7_Transmembrane_Regions:
None

# Drug_Target_80_Cellular_Location:
Cytoplasm

# Drug_Target_80_Chromosome_Location:
Not Available

# Drug_Target_80_Drug_References:
Not Available

# Drug_Target_80_Essentiality:
Non-Essential

# Drug_Target_80_GenAtlas_ID:
Not Available

# Drug_Target_80_GenBank_ID_Gene:
X16595

# Drug_Target_80_GenBank_ID_Protein:
Not Available

# Drug_Target_80_GeneCard_ID:
Not Available

# Drug_Target_80_Gene_Name:
gap

# Drug_Target_80_Gene_Sequence:
>996 bp
ATGAAGGTAGGCATCAACGGATTCGGCCGCATCGGGCGTCAGGTCTTCCGCATCCTGCAT
AGCCGGGGCGTGGAGGTGGCCCTTATCAACGACCTCACCGACAACAAGACCCTGGCCCAC
CTCCTCAAGTACGACTCCATCTACCACCGCTTCCCCGGCGAGGTGGCCTACGACGACCAG
TACCTCTACGTGGACGGGAAGGCCATCCGGGCCACGGCCGTCAAGGACCCCAAGGAGATT
CCCTGGGCCGAGGCGGGGGTGGGCGTGGTCATTGAGTCCACGGGGGTCTTCACCGACGCC
GACAAGGCCAAGGCCCACCTGGAAGGGGGGGCCAAGAAGGTCATTATCACCGCCCCCGCC
AAGGGCGAGGACATCACCATCGTCATGGGGGTGAACCACGAGGCCTACGACCCCTCCCGG
CACCACATCATCTCCAACGCCTCCTGCACCACCAACTCCCTGGCCCCGGTGATGAAGGTC
CTGGAGGAGGCCTTCGGCGTGGAGAAGGCCCTCATGACCACCGTCCACTCCTACACCAAC
GACCAGCGGCTCCTGGACCTGCCCCACAAGGACCTGCGCCGGGCCCGGGCCGCCGCCATC
AACATCATCCCCACCACCACCGGGGCGGCCAAGGCCACCGCTCTGGTCCTGCCCTCCCTC
AAGGGCCGCTTTGACGGCATGGCCCTCCGCGTGCCCACGGCCACGGGGAGCATCTCCGAC
ATCACCGCCCTCCTCAAGCGGGAGGTCACCGCCGAGGAGGTGAACGCCGCCCTCAAGGCC
GCCGCCGAAGGGCCCCTGAAGGGCATCCTGGCCTACACCGAGGACGAGATCGTCCTCCAG
GACATCGTCATGGACCCCCACTCCTCCATCGTGGACGCCAAGCTGACCAAGGCCCTGGGC
AACATGGTCAAGGTCTTCGCCTGGTACGACAACGAGTGGGGCTACGCCAACCGGGTGGCG
GACCTGGTGGAGCTGGTCCTCAGGAAGGGGGTTTAG

# Drug_Target_80_General_Function:
Involved in glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity

# Drug_Target_80_General_References:
2602126	Hecht RM, Garza A, Lee YH, Miller MD, Pisegna MA: Nucleotide sequence of the glyceraldehyde-3-phosphate dehydrogenase gene from Thermus aquaticus YT1. Nucleic Acids Res. 1989 Dec 11;17(23):10123.
6773768	Hocking JD, Harris JI: D-glyceraldehyde-3-phosphate dehydrogenase. Amino-acid sequence of the enzyme from the extreme thermophile Thermus aquaticus. Eur J Biochem. 1980 Jul;108(2):567-79.
8611563	Tanner JJ, Hecht RM, Krause KL: Determinants of enzyme thermostability observed in the molecular structure of Thermus aquaticus D-glyceraldehyde-3-phosphate dehydrogenase at 25 Angstroms Resolution. Biochemistry. 1996 Feb 27;35(8):2597-609.

# Drug_Target_80_HGNC_ID:
Not Available

# Drug_Target_80_HPRD_ID:
Not Available

# Drug_Target_80_ID:
4489

# Drug_Target_80_Locus:
Not Available

# Drug_Target_80_Molecular_Weight:
35893

# Drug_Target_80_Name:
Glyceraldehyde-3-phosphate dehydrogenase

# Drug_Target_80_Number_of_Residues:
331

# Drug_Target_80_PDB_ID:
1CER

# Drug_Target_80_Pathway:
Not Available

# Drug_Target_80_Pfam_Domain_Function:
PF00044	Gp_dh_N
PF02800	Gp_dh_C

# Drug_Target_80_Protein_Sequence:
>Glyceraldehyde-3-phosphate dehydrogenase
MKVGINGFGRIGRQVFRILHSRGVEVALINDLTDNKTLAHLLKYDSIYHRFPGEVAYDDQ
YLYVDGKAIRATAVKDPKEIPWAEAGVGVVIESTGVFTDADKAKAHLEGGAKKVIITAPA
KGEDITIVMGVNHEAYDPSRHHIISNASCTTNSLAPVMKVLEEAFGVEKALMTTVHSYTN
DQRLLDLPHKDLRRARAAAINIIPTTTGAAKATALVLPSLKGRFDGMALRVPTATGSISD
ITALLKREVTAEEVNAALKAAAEGPLKGILAYTEDEIVLQDIVMDPHSSIVDAKLTKALG
NMVKVFAWYDNEWGYANRVADLVELVLRKGV

# Drug_Target_80_Reaction:
Not Available

# Drug_Target_80_Signals:
None

# Drug_Target_80_Specific_Function:
D-glyceraldehyde 3-phosphate + phosphate + NAD(+) = 3-phospho-D-glyceroyl phosphate + NADH

# Drug_Target_80_SwissProt_ID:
P00361

# Drug_Target_80_SwissProt_Name:
G3P_THEAQ

# Drug_Target_80_Synonyms:
EC 1.2.1.12
GAPDH

# Drug_Target_80_Theoretical_pI:
7.09

# Drug_Target_80_Transmembrane_Regions:
None

# Drug_Target_81_Cellular_Location:
Cytoplasmic

# Drug_Target_81_Chromosome_Location:
Not Available

# Drug_Target_81_Drug_References:
Not Available

# Drug_Target_81_Essentiality:
Non-Essential

# Drug_Target_81_GenAtlas_ID:
Not Available

# Drug_Target_81_GenBank_ID_Gene:
AE016830

# Drug_Target_81_GenBank_ID_Protein:
Not Available

# Drug_Target_81_GeneCard_ID:
Not Available

# Drug_Target_81_Gene_Name:
ligA

# Drug_Target_81_Gene_Sequence:
>2031 bp
ATGGAACAACAACCATTAACATTAACGGCGGCGACAACTCGTGCGCAAGAATTAAGAAAA
CAACTCAATCAATATTCCCATGAATATTATGTCAAAGATCAACCATCCGTAGAAGATTAT
GTTTACGATCGTTTGTATAAAGAGTTAGTCGATATTGAAACGGAGTTTCCTGATTTAATC
ACGCCAGATTCGCCGACACAACGTGTAGGTGGCAAAGTTTTATCTGGTTTTGAAAAAGCT
CCGCATGACATTCCAATGTATAGTTTAAATGATGGGTTTAGCAAGGAAGACATTTTTGCT
TTTGATGAACGTGTTCGTAAGGCGATTGGTAAACCCGTTGCTTACTGTTGTGAGTTAAAA
ATTGATGGGTTAGCAATTTCATTACGTTATGAAAACGGGGTGTTTGTACGCGGAGCAACA
CGAGGCGATGGAACGGTTGGTGAAAACATTACAGAGAACTTACGAACGGTTCGCTCTGTA
CCGATGCGTTTAACGGAGCCCATTTCAGTGGAAGTTCGTGGCGAGTGCTACATGCCTAAA
CAATCCTTTGTCGCATTGAATGAAGAACGTGAAGAAAATGGCCAAGATATTTTTGCCAAT
CCTCGGAATGCAGCGGCGGGAAGCTTGCGCCAACTAGATACAAAAATTGTGGCTAAACGG
AACTTAAATACGTTTTTATACACAGTTGCTGACTTTGGACCAATGAAAGCGAAGACGCAG
TTTGAGGCATTAGAAGAGCTTTCTGCAATTGGTTTTAGAACCAATCCCGAACGGCAATTA
TGTCAGTCAATTGATGAAGTTTGGGCCTACATTGAAGAATACCATGAAAAGCGGAGCACT
TTGCCATACGAAATCGATGGAATTGTGATTAAAGTGAACGAATTTGCGTTGCAAGATGAA
TTAGGTTTCACTGTCAAAGCACCTCGCTGGGCGATTGCCTACAAATTTCCACCAGAAGAA
GCAGAAACAGTAGTGGAAGATATTGAATGGACAATTGGGCGCACGGGGGTGGTCACTCCT
ACTGCGGTCATGGCTCCTGTACGAGTCGCGGGAACCACGGTTAGTCGGGCAAGTTTGCAT
AATGCAGATTTTATTCAAATGAAAGATATCCGTTTAAATGATCATGTTATTATTTACAAA
GCCGGCGATATTATCCCAGAAGTAGCGCAAGTGCTAGTTGAAAAACGTGCAGCCGATAGT
CAGCCTTATGAAATGCCGACACATTGTCCAATTTGTCATAGTGAGTTGGTGCATTTAGAT
GAGGAAGTGGCGTTACGTTGTATTAATCCAAAATGCCCTGCGCAAATTAAAGAAGGGCTG
AATCACTTTGTCTCACGAAACGCAATGAACATTGATGGCTTGGGGCCACGAGTGTTAGCA
CAAATGTATGACAAAGGATTAGTGAAAGACGTAGCGGATCTGTATTTCTTAACAGAAGAA
CAATTAATGACTTTGGATAAAATCAAAGAAAAATCAGCAAACAACATTTATACTGCCATT
CAAGGGAGTAAAGAAAACTCTGTCGAACGTTTGATTTTTGGCTTAGGGATTCGCCATGTG
GGGGCGAAAGCGGCGAAAATTTTAGCGGAGCATTTTGGTGATTTACCAACCTTAAGTCGT
GCAACCGCGGAAGAAATTGTGGCTTTGGATTCAATTGGCGAAACAATCGCAGACAGCGTT
GTGACGTATTTTGAAAATGAGGAAGTTCATGAATTAATGGCTGAACTGGAAAAAGCCCAA
GTGAACTTGACATATAAAGGTCTCCGGACAGAACAATTAGCAGAAGTGGAGTCACCTTTC
AAAGACAAAACAGTTGTTTTAACAGGAAAATTAGCGCAGTACACTCGCGAAGAAGCCAAA
GAAAAAATTGAAAATCTTGGTGGAAAAGTTACAGGGAGTGTTTCGAAAAAAACTGACATT
GTGGTTGCTGGCGAAGATGCAGGCAGTAAATTAACCAAAGCTGAAAGCTTAGGCGTGACC
GTTTGGAATGAACAAGAAATGGTCGATGCGTTAGATGCAAGTCATTTTTAA

# Drug_Target_81_General_Function:
Involved in DNA ligase (NAD+) activity

# Drug_Target_81_General_References:
12663927	Paulsen IT, Banerjei L, Myers GS, Nelson KE, Seshadri R, Read TD, Fouts DE, Eisen JA, Gill SR, Heidelberg JF, Tettelin H, Dodson RJ, Umayam L, Brinkac L, Beanan M, Daugherty S, DeBoy RT, Durkin S, Kolonay J, Madupu R, Nelson W, Vamathevan J, Tran B, Upton J, Hansen T, Shetty J, Khouri H, Utterback T, Radune D, Ketchum KA, Dougherty BA, Fraser CM: Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus faecalis. Science. 2003 Mar 28;299(5615):2071-4.

# Drug_Target_81_HGNC_ID:
Not Available

# Drug_Target_81_HPRD_ID:
Not Available

# Drug_Target_81_ID:
4491

# Drug_Target_81_Locus:
Not Available

# Drug_Target_81_Molecular_Weight:
75585

# Drug_Target_81_Name:
DNA ligase, NAD-dependent

# Drug_Target_81_Number_of_Residues:
676

# Drug_Target_81_PDB_ID:
1TAE

# Drug_Target_81_Pathway:
Not Available

# Drug_Target_81_Pfam_Domain_Function:
PF00533	BRCT
PF03119	DNA_ligase_ZBD
PF03120	DNA_ligase_OB

# Drug_Target_81_Protein_Sequence:
>DNA ligase, NAD-dependent
MEQQPLTLTAATTRAQELRKQLNQYSHEYYVKDQPSVEDYVYDRLYKELVDIETEFPDLI
TPDSPTQRVGGKVLSGFEKAPHDIPMYSLNDGFSKEDIFAFDERVRKAIGKPVAYCCELK
IDGLAISLRYENGVFVRGATRGDGTVGENITENLRTVRSVPMRLTEPISVEVRGECYMPK
QSFVALNEEREENGQDIFANPRNAAAGSLRQLDTKIVAKRNLNTFLYTVADFGPMKAKTQ
FEALEELSAIGFRTNPERQLCQSIDEVWAYIEEYHEKRSTLPYEIDGIVIKVNEFALQDE
LGFTVKAPRWAIAYKFPPEEAETVVEDIEWTIGRTGVVTPTAVMAPVRVAGTTVSRASLH
NADFIQMKDIRLNDHVIIYKAGDIIPEVAQVLVEKRAADSQPYEMPTHCPICHSELVHLD
EEVALRCINPKCPAQIKEGLNHFVSRNAMNIDGLGPRVLAQMYDKGLVKDVADLYFLTEE
QLMTLDKIKEKSANNIYTAIQGSKENSVERLIFGLGIRHVGAKAAKILAEHFGDLPTLSR
ATAEEIVALDSIGETIADSVVTYFENEEVHELMAELEKAQVNLTYKGLRTEQLAEVESPF
KDKTVVLTGKLAQYTREEAKEKIENLGGKVTGSVSKKTDIVVAGEDAGSKLTKAESLGVT
VWNEQEMVDALDASHF

# Drug_Target_81_Reaction:
Not Available

# Drug_Target_81_Signals:
None

# Drug_Target_81_Specific_Function:
NAD(+) + (deoxyribonucleotide)(n) + (deoxyribonucleotide)(m) = AMP + nicotinamide nucleotide + (deoxyribonucleotide)(n+m)

# Drug_Target_81_SwissProt_ID:
Q837V6

# Drug_Target_81_SwissProt_Name:
DNLJ_ENTFA

# Drug_Target_81_Synonyms:
Not Available

# Drug_Target_81_Theoretical_pI:
4.73

# Drug_Target_81_Transmembrane_Regions:
None

# Drug_Target_82_Cellular_Location:
Not Available

# Drug_Target_82_Chromosome_Location:
Not Available

# Drug_Target_82_Drug_References:
Not Available

# Drug_Target_82_Essentiality:
Non-Essential

# Drug_Target_82_GenAtlas_ID:
Not Available

# Drug_Target_82_GenBank_ID_Gene:
AE000512

# Drug_Target_82_GenBank_ID_Protein:
Not Available

# Drug_Target_82_GeneCard_ID:
Not Available

# Drug_Target_82_Gene_Name:
TM_1169

# Drug_Target_82_Gene_Sequence:
>714 bp
TTAGAGCGGAAATTTGGAAAGCCCACCATCCACAACAATGGTTTGTCCAGTTAGATAAGA
GGCCTTTTCGGAACAGAGAAATGCCACAACACTGGCTATCTCTTCGGGTTTTGCCATCCT
TCTCATGGGGATCTGAGATTCCACCTGTTTTTTCTTTTCTTCACTGAGAAGCTCTTTCAC
CCTCTCTGTCTCCGTCCAGCCCGGTGCCACACAGTTCACTGTGATACCGTACGGTGCCAC
CTCAAAAGAGAGTGTCTTTAGAAATCCGGTGAGGGCCATCCTCGCAGAATTGGATGTGTA
GAGATTTTCTATCGGTGAGATCACGGAGAAAGAAGTGATGGCTACGATCCTTCCCCAGCC
CTTTTCTTTCATCGCTGGAAGATAGTTTCTCACAATTTTGATCATGTTCAAAAAGAGGCT
GTCGATCGCTTCTTTGAAATCTTCATTCGTAAGTTCATCGAAGAATCCCGCTTTTGGTCC
TCCTGCGTTCAGAACGAGGATGTCCACCTCTTTCACCTTTTCGAACAGTAGATCCAGATC
CTTCCTGAGATCGCAGACGACGTATCTGTGGCCGCTTCTCTTCAAAAGTTCTTCATTTCT
CGCACAGATGGTAACTTCCGCTCCTTCCTGGCTCAAAACATCCGCTACAGCTCTTCCAAT
ACCCCTGCTCGCCGCAAGAACGAGTACTCCCTTATCCCTGATGCCCAGTTCCAA

# Drug_Target_82_General_Function:
Involved in oxidoreductase activity

# Drug_Target_82_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.

# Drug_Target_82_HGNC_ID:
Not Available

# Drug_Target_82_HPRD_ID:
Not Available

# Drug_Target_82_ID:
4495

# Drug_Target_82_Locus:
Not Available

# Drug_Target_82_Molecular_Weight:
26193

# Drug_Target_82_Name:
3-oxoacyl-(Acyl carrier protein) reductase

# Drug_Target_82_Number_of_Residues:
237

# Drug_Target_82_PDB_ID:
1O5I

# Drug_Target_82_Pathway:
Not Available

# Drug_Target_82_Pfam_Domain_Function:
PF00106	adh_short

# Drug_Target_82_Protein_Sequence:
>3-oxoacyl-(Acyl carrier protein) reductase
MELGIRDKGVLVLAASRGIGRAVADVLSQEGAEVTICARNEELLKRSGHRYVVCDLRKDL
DLLFEKVKEVDILVLNAGGPKAGFFDELTNEDFKEAIDSLFLNMIKIVRNYLPAMKEKGW
GRIVAITSFSVISPIENLYTSNSARMALTGFLKTLSFEVAPYGITVNCVAPGWTETERVK
ELLSEEKKKQVESQIPMRRMAKPEEIASVVAFLCSEKASYLTGQTIVVDGGLSKFPL

# Drug_Target_82_Reaction:
Not Available

# Drug_Target_82_Signals:
None

# Drug_Target_82_Specific_Function:
Acyl-[acyl-carrier-protein] + NAD(+) = trans- 2,3-dehydroacyl-[acyl-carrier-protein] + NADH

# Drug_Target_82_SwissProt_ID:
Q9X0Q1

# Drug_Target_82_SwissProt_Name:
Q9X0Q1_THEMA

# Drug_Target_82_Synonyms:
Not Available

# Drug_Target_82_Theoretical_pI:
6.08

# Drug_Target_82_Transmembrane_Regions:
None

# Drug_Target_83_Cellular_Location:
Cytoplasm. Nucleus

# Drug_Target_83_Chromosome_Location:
Not Available

# Drug_Target_83_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_83_Essentiality:
Non-Essential

# Drug_Target_83_GenAtlas_ID:
CTBP1

# Drug_Target_83_GenBank_ID_Gene:
U37408

# Drug_Target_83_GenBank_ID_Protein:
Not Available

# Drug_Target_83_GeneCard_ID:
Not Available

# Drug_Target_83_Gene_Name:
CTBP1

# Drug_Target_83_Gene_Sequence:
>1323 bp
ATGGGCAGCTCGCACTTGCTCAACAAGGGCCTGCCGCTTGGCGTCCGACCTCCGATCATG
AACGGGCCCCTGCACCCGCGGCCCCTGGTGGCATTGCTGGATGGCCGGGACTGCACAGTG
GAGATGCCCATCCTGAAGGACGTGGCCACTGTGGCCTTCTGCGACGCGCAGTCCACGCAG
GAGATCCATGAGAAGGTCCTGAACGAGGCTGTGGGGGCCCTGATGTACCACACCATCACT
CTCACCAGGGAGGACCTGGAGAAGTTCAAAGCCCTCCGCATCATCGTCCGGATTGGCAGT
GGTTTTGACAACATCGACATCAAGTCGGCCGGGGATTTAGGCATTGCCGTCTGCAACGTG
CCCGCGGCGTCTGTGGAGGAGACGGCCGACTCGACGCTGTGCCACATCCTGAACCTGTAC
CGGCGGGCCACCTGGCTGCACCAGGCGCTGCGGGAGGGCACACGAGTCCAGAGCGTCGAG
CAGATCCGCGAGGTGGCGTCCGGCGCTGCCAGGATCCGCGGGGAGACCTTGGGCATCATC
GGACTTGGTCGCGTGGGGCAGGCAGTGGCGCTGCGGGCCAAGGCCTTCGGCTTCAACGTG
CTCTTCTACGACCCTTACTTGTCGGATGGCGTGGAGCGGGCGCTGGGGCTGCAGCGTGTC
AGCACCCTGCAGGACCTGCTCTTCCACAGCGACTGCGTGACCCTGCACTGCGGCCTCAAC
GAGCACAACCACCACCTCATCAACGACTTCACCGTCAAGCAGATGAGACAAGGGGCCTTC
CTGGTGAACACAGCCCGGGGTGGCCTGGTGGATGAGAAGGCGCTGGCCCAGGCCCTGAAG
GAGGGCCGGATCCGCGGCGCGGCCCTGGATGTGCACGAGTCGGAACCCTTCAGCTTTAGC
CAGGGCCCTCTGAAGGATGCACCCAACCTCATCTGCACCCCCCATGCTGCATGGTACAGC
GAGCAGGCATCCATCGAGATGCGAGAGGAGGCGGCACGGGAGATCCGCAGAGCCATCACA
GGCCGGATCCCAGACAGCCTGAAGAACTGTGTCAACAAGGACCATCTGACAGCCGCCACC
CACTGGGCCAGCATGGACCCCGCCGTCGTGCACCCTGAGCTCAATGGGGCTGCCTATAGG
TACCCTCCGGGCGTGGTGGGCGTGGCCCCCACTGGCATCCCAGCTGCTGTGGAAGGTATC
GTCCCCAGCGCCATGTCCCTGTCCCACGGCCTGCCCCCTGTGGCCCACCCGCCCCACGCC
CCTTCTCCTGGCCAAACCGTCAAGCCCGAGGCGGATAGAGACCACGCCAGTGACCAGTTG
TAG

# Drug_Target_83_General_Function:
Involved in oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor

# Drug_Target_83_General_References:
14567915	Zhang Q, Yoshimatsu Y, Hildebrand J, Frisch SM, Goodman RH: Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the transcriptional corepressor CtBP. Cell. 2003 Oct 17;115(2):177-86.
7479821	Schaeper U, Boyd JM, Verma S, Uhlmann E, Subramanian T, Chinnadurai G: Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation. Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10467-71.
8440238	Boyd JM, Subramanian T, Schaeper U, La Regina M, Bayley S, Chinnadurai G: A region in the C-terminus of adenovirus 2/5 E1a protein is required for association with a cellular phosphoprotein and important for the negative modulation of T24-ras mediated transformation, tumorigenesis and metastasis. EMBO J. 1993 Feb;12(2):469-78.
9858600	Sewalt RG, Gunster MJ, van der Vlag J, Satijn DP, Otte AP: C-Terminal binding protein is a transcriptional repressor that interacts with a specific class of vertebrate Polycomb proteins. Mol Cell Biol. 1999 Jan;19(1):777-87.

# Drug_Target_83_HGNC_ID:
HGNC:2494

# Drug_Target_83_HPRD_ID:
Not Available

# Drug_Target_83_ID:
4496

# Drug_Target_83_Locus:
4p16

# Drug_Target_83_Molecular_Weight:
47536

# Drug_Target_83_Name:
C-terminal-binding protein 1

# Drug_Target_83_Number_of_Residues:
440

# Drug_Target_83_PDB_ID:
1HL3

# Drug_Target_83_Pathway:
Not Available

# Drug_Target_83_Pfam_Domain_Function:
PF00389	2-Hacid_dh
PF02826	2-Hacid_dh_C

# Drug_Target_83_Protein_Sequence:
>C-terminal-binding protein 1
MGSSHLLNKGLPLGVRPPIMNGPLHPRPLVALLDGRDCTVEMPILKDVATVAFCDAQSTQ
EIHEKVLNEAVGALMYHTITLTREDLEKFKALRIIVRIGSGFDNIDIKSAGDLGIAVCNV
PAASVEETADSTLCHILNLYRRATWLHQALREGTRVQSVEQIREVASGAARIRGETLGII
GLGRVGQAVALRAKAFGFNVLFYDPYLSDGVERALGLQRVSTLQDLLFHSDCVTLHCGLN
EHNHHLINDFTVKQMRQGAFLVNTARGGLVDEKALAQALKEGRIRGAALDVHESEPFSFS
QGPLKDAPNLICTPHAAWYSEQASIEMREEAAREIRRAITGRIPDSLKNCVNKDHLTAAT
HWASMDPAVVHPELNGAAYRYPPGVVGVAPTGIPAAVEGIVPSAMSLSHGLPPVAHPPHA
PSPGQTVKPEADRDHASDQL

# Drug_Target_83_Reaction:
Not Available

# Drug_Target_83_Signals:
None

# Drug_Target_83_Specific_Function:
Involved in controlling the equilibrium between tubular and stacked structures in the Golgi complex (By similarity). Co- repressor targeting diverse transcription regulators such as GLIS2. Has dehydrogenase activity

# Drug_Target_83_SwissProt_ID:
Q13363

# Drug_Target_83_SwissProt_Name:
CTBP1_HUMAN

# Drug_Target_83_Synonyms:
CtBP1
EC 1.1.1.-

# Drug_Target_83_Theoretical_pI:
6.76

# Drug_Target_83_Transmembrane_Regions:
None

# Drug_Target_84_Cellular_Location:
Not Available

# Drug_Target_84_Chromosome_Location:
Not Available

# Drug_Target_84_Drug_References:
Not Available

# Drug_Target_84_Essentiality:
Non-Essential

# Drug_Target_84_GenAtlas_ID:
Not Available

# Drug_Target_84_GenBank_ID_Gene:
U61983

# Drug_Target_84_GenBank_ID_Protein:
Not Available

# Drug_Target_84_GeneCard_ID:
Not Available

# Drug_Target_84_Gene_Name:
xylB

# Drug_Target_84_Gene_Sequence:
>1116 bp
ATGAGTGAATTAAAAGATATTATTGCCGCAGTGACCCCATGTAAAGGTGCTGACTTTGAG
CTGCAAGCTTTAAAAATACGTCAGCCGCAAGGTGATGAAGTATTGGTAAAAGTGGTTGCT
ACAGGAATGTGCCACACCGATTTGATTGTACGTGATCAATATTATCCGGTACCGCTGCCT
GCCGTCCTTGGACATGAAGGGTCAGGAATTATTGAGGCGATTGGCCCTAACGTAACCGAG
CTTCAAGTCGGCGATCATGTGGTTTTAAGCTATGGTTATTGTGGGAAATGTACCCAATGT
AATACTGGTAATCCTGCCTATTGTTCAGAGTTTTTTGGACGAAATTTTAGTGGGGCAGAT
TCAGAAGGGAATCATGCGCTTTGTACCCATGATCAAGGCGTGGTAAATGATCATTTTTTT
GCCCAATCCTCCTTTGCAACCTATGCTTTAAGTCGTGAAAATAACACGGTTAAAGTGACC
AAAGACGTACCAATTGAACTATTAGGACCATTAGGTTGTGGTATTCAAACAGGTGCTGGC
GCATGTATAAATGCTTTAAAAGTGACACCTGCCAGTAGTTTGGTGACTTGGGGTGCCGGC
GCTGTTGGTCTGAGTGCTTTACTTGCGGCAAAAGTGTGTGGCGCTTCGATCATTATCGCT
GTTGATATTGTTGAATCACGTTTGGAATTGGCAAAACAATTGGGTGCAACTCATGTGATC
AATAGTAAAACTCAAGATCCTGTGGCTGCGATTAAAGAGATTACTGATGGTGGAGTCAAC
TTTGCATTGGAATCTACTGGGCGACCTGAGATATTAAAACAAGGTGTTGATGCGCTGGGT
ATTTTAGGTAAAATCGCCGTGGTAGGTGCACCTCAATTAGGCACAACTGCACAATTTGAT
GTAAATGATCTGTTATTGGGTGGGAAAACGATTTTAGGTGTCGTTGAGGGGAGTGGTTCG
CCCAAGAAATTTATCCCTGAGTTAGTCCGCTTATATCAACAAGGGAAATTTCCCTTTGAC
CAACTTGTAAAATTCTATGCATTTGATGAAATCAATCAAGCTGCGATAGATAGTCACAAG
GGTATTACACTCAAACCGATTATTAAAATTGCATAA

# Drug_Target_84_General_Function:
Involved in zinc ion binding

# Drug_Target_84_General_References:
9494109	Gillooly DJ, Robertson AG, Fewson CA: Molecular characterization of benzyl alcohol dehydrogenase and benzaldehyde dehydrogenase II of Acinetobacter calcoaceticus. Biochem J. 1998 Mar 15;330 ( Pt 3):1375-81.

# Drug_Target_84_HGNC_ID:
Not Available

# Drug_Target_84_HPRD_ID:
Not Available

# Drug_Target_84_ID:
4497

# Drug_Target_84_Locus:
Not Available

# Drug_Target_84_Molecular_Weight:
39015

# Drug_Target_84_Name:
Benzyl alcohol dehydrogenase

# Drug_Target_84_Number_of_Residues:
371

# Drug_Target_84_PDB_ID:
1F8F

# Drug_Target_84_Pathway:
Not Available

# Drug_Target_84_Pfam_Domain_Function:
PF00107	ADH_zinc_N
PF08240	ADH_N

# Drug_Target_84_Protein_Sequence:
>Benzyl alcohol dehydrogenase
MSELKDIIAAVTPCKGADFELQALKIRQPQGDEVLVKVVATGMCHTDLIVRDQYYPVPLP
AVLGHEGSGIIEAIGPNVTELQVGDHVVLSYGYCGKCTQCNTGNPAYCSEFFGRNFSGAD
SEGNHALCTHDQGVVNDHFFAQSSFATYALSRENNTVKVTKDVPIELLGPLGCGIQTGAG
ACINALKVTPASSLVTWGAGAVGLSALLAAKVCGASIIIAVDIVESRLELAKQLGATHVI
NSKTQDPVAAIKEITDGGVNFALESTGRPEILKQGVDALGILGKIAVVGAPQLGTTAQFD
VNDLLLGGKTILGVVEGSGSPKKFIPELVRLYQQGKFPFDQLVKFYAFDEINQAAIDSHK
GITLKPIIKIA

# Drug_Target_84_Reaction:
Not Available

# Drug_Target_84_Signals:
None

# Drug_Target_84_Specific_Function:
Not Available

# Drug_Target_84_SwissProt_ID:
Q59096

# Drug_Target_84_SwissProt_Name:
Q59096_ACICA

# Drug_Target_84_Synonyms:
Not Available

# Drug_Target_84_Theoretical_pI:
5.61

# Drug_Target_84_Transmembrane_Regions:
None

# Drug_Target_85_Cellular_Location:
Not Available

# Drug_Target_85_Chromosome_Location:
Not Available

# Drug_Target_85_Drug_References:
Not Available

# Drug_Target_85_Essentiality:
Non-Essential

# Drug_Target_85_GenAtlas_ID:
Not Available

# Drug_Target_85_GenBank_ID_Gene:
AE015451

# Drug_Target_85_GenBank_ID_Protein:
Not Available

# Drug_Target_85_GeneCard_ID:
Not Available

# Drug_Target_85_Gene_Name:
PP3533

# Drug_Target_85_Gene_Sequence:
>1053 bp
ATGACGTATTTCATTGATGTTCCAACCATGTCGGACTTGGTGCATGACATTGGCGTAGCG
CCGTTTATTGGCGAGCTTGCCGCTGCCCTGCGGGACGATTTCAAACGCTGGCAGGCGTTT
GACAAGTCCGCGCGCGTTGCCAGCCACTCGGAAGTGGGCGTGATCGAACTGATGCCGGTC
GCCGACAAAAGCCGCTATGCCTTCAAATACGTCAACGGCCACCCGGCCAATACTGCACGC
AACCTGCATACGGTGATGGCCTTCGGTGTACTGGCCGATGTCGACTCCGGTTACCCGGTG
CTGCTGTCCGAACTGACCATCGCCACCGCCCTGCGCACCGCAGCGACTTCGCTGATGGCA
GCCCAGGCACTGGCCCGCCCGAACGCGCGCAAGATGGCGCTGATCGGCAACGGCGCGCAA
AGCGAATTCCAGGCCCTGGCCTTCCACAAGCACCTGGGCATCGAAGAAATCGTCGCCTAC
GACACCGACCCGCTGGCCACCGCCAAGCTTATCGCCAACCTCAAGGAATACAGCGGCTTG
ACCATCCGCCGGGCCAGCTCGGTAGCCGAGGCAGTGAAAGGCGTGGACATCATCACCACG
GTAACGGCCGACAAGGCCTACGCCACCATCATTACCCCCGACATGCTGGAGCCCGGTATG
CACCTGAACGCCGTGGGTGGTGACTGCCCTGGCAAAACCGAGCTGCACGCCGATGTGCTG
CGCAACGCGCGGGTGTTCGTCGAGTACGAGCCACAAACCCGTATCGAAGGTGAGATCCAG
CAGCTGCCGGCGGACTTTCCGGTGGTCGACCTGTGGCGCGTGCTGCGCGGAGAAACCGAG
GGCCGCCAAAGCGACAGCCAGGTCACTGTATTCGATTCGGTGGGCTTCGCCCTCGAAGAT
TACACCGTACTACGGTACGTACTACAGCAAGCCGAAAAGCGCGGGATGGGCACCAAGATC
GACCTGGTGCCGTGGGTGGAGGACGACCCGAAAGACCTGTTCAGCCACACCCGAGGCCGC
GCTGGCAAAAGGCGTATCCGACGGGTTGCCTGA

# Drug_Target_85_General_Function:
Amino acid transport and metabolism

# Drug_Target_85_General_References:
12534463	Nelson KE, Weinel C, Paulsen IT, Dodson RJ, Hilbert H, Martins dos Santos VA, Fouts DE, Gill SR, Pop M, Holmes M, Brinkac L, Beanan M, DeBoy RT, Daugherty S, Kolonay J, Madupu R, Nelson W, White O, Peterson J, Khouri H, Hance I, Chris Lee P, Holtzapple E, Scanlan D, Tran K, Moazzez A, Utterback T, Rizzo M, Lee K, Kosack D, Moestl D, Wedler H, Lauber J, Stjepandic D, Hoheisel J, Straetz M, Heim S, Kiewitz C, Eisen JA, Timmis KN, Dusterhoft A, Tummler B, Fraser CM: Complete genome sequence and comparative analysis of the metabolically versatile Pseudomonas putida KT2440. Environ Microbiol. 2002 Dec;4(12):799-808.

# Drug_Target_85_HGNC_ID:
Not Available

# Drug_Target_85_HPRD_ID:
Not Available

# Drug_Target_85_ID:
4498

# Drug_Target_85_Locus:
Not Available

# Drug_Target_85_Molecular_Weight:
38425

# Drug_Target_85_Name:
Ornithine cyclodeaminase

# Drug_Target_85_Number_of_Residues:
350

# Drug_Target_85_PDB_ID:
1X7D

# Drug_Target_85_Pathway:
Not Available

# Drug_Target_85_Pfam_Domain_Function:
PF02423	OCD_Mu_crystall

# Drug_Target_85_Protein_Sequence:
>Ornithine cyclodeaminase
MTYFIDVPTMSDLVHDIGVAPFIGELAAALRDDFKRWQAFDKSARVASHSEVGVIELMPV
ADKSRYAFKYVNGHPANTARNLHTVMAFGVLADVDSGYPVLLSELTIATALRTAATSLMA
AQALARPNARKMALIGNGAQSEFQALAFHKHLGIEEIVAYDTDPLATAKLIANLKEYSGL
TIRRASSVAEAVKGVDIITTVTADKAYATIITPDMLEPGMHLNAVGGDCPGKTELHADVL
RNARVFVEYEPQTRIEGEIQQLPADFPVVDLWRVLRGETEGRQSDSQVTVFDSVGFALED
YTVLRYVLQQAEKRGMGTKIDLVPWVEDDPKDLFSHTRGRAGKRRIRRVA

# Drug_Target_85_Reaction:
Not Available

# Drug_Target_85_Signals:
None

# Drug_Target_85_Specific_Function:
Not Available

# Drug_Target_85_SwissProt_ID:
Q88H32

# Drug_Target_85_SwissProt_Name:
Q88H32_PSEPK

# Drug_Target_85_Synonyms:
Not Available

# Drug_Target_85_Theoretical_pI:
6.25

# Drug_Target_85_Transmembrane_Regions:
None

# Drug_Target_86_Cellular_Location:
Not Available

# Drug_Target_86_Chromosome_Location:
Not Available

# Drug_Target_86_Drug_References:
Not Available

# Drug_Target_86_Essentiality:
Non-Essential

# Drug_Target_86_GenAtlas_ID:
Not Available

# Drug_Target_86_GenBank_ID_Gene:
D78182

# Drug_Target_86_GenBank_ID_Protein:
Not Available

# Drug_Target_86_GeneCard_ID:
Not Available

# Drug_Target_86_Gene_Name:
rmlB

# Drug_Target_86_Gene_Sequence:
>1047 bp
ATGACAGAATATAAAAACATTATCGTTACCGGTGGCGCTGGATTCATCGGTTCAAACTTT
GTCCACTACGTTTACAATAATCACCCAGATGTCCATGTGACTGTTCTTGACAAACTCACT
TACGCTGGTAACCATGCTAACCTTGAAGAAATTCTTGGCGACCGTGTAGAGTTGGTTGTT
GGGGACATCGCAGACAGCGAATTGGTAGATAAATTGGCTGCCAAAGCGGATGCTATTGTC
CACTATGCGGCTGAAAGCCACAATGACAATTCACTAAAAGATCCATCACCATTTATTTAC
ACTAACTTTGTTGGAACTTATACCTTGTTGGAAGCTGCACGCAAATACGACATCCGTTTC
CACCACGTCTCAACTGATGAAGTTTACGGTGATCTTCCGCTACGTGAAGATTTGCCGGGC
CACGGTGAAGGTCCGGGTGAAAAATTCACAGCTGAAACGAAATACAATCCATCATCGCCT
TATTCATCAACCAAGGCAGCCTCTGACTTGATTGTCAAGGCTTGGGTGCGATCTTTTGGT
GTGAAAGCAACCATTTCCAACTGTTCAAACAACTATGGACCTTACCAACACATCGAAAAA
TTCATTCCGCGCCAAATTACTAACATCCTGTCAGGTATCAAACCAAAACTCTATGGTGAA
GGTAAGAACGTGCGTGACTGGATTCACACCAATGACCATTCAACAGGAGTTTGGGCAATT
CTCACTAAAGGCCGCATCGGCGAAACTTATCTCATCGGTGCTGATGGTGAAAAGAACAAC
AAAGAAGTGCTCGAACTTATCCTTGAAAAAATGAGTCAGCCAAAAGACGCATACGACCAT
GTAACAGACCGTGCAGGTCATGATCTTCGTTATGCCATTGATTCGACAAAGCTGCGTGAG
GAACTTGGCTGGAAACCACAATTCACTAATTTTGAAGAAGGCTTGGAAGATACCATTAAA
TGGTATACTGAGCATGAAGATTGGTGGAAAGCTGAAAAGGAAGCAGTCGAAGCCAACTAT
GCCAAAACACAAAAAATACTTAATTAA

# Drug_Target_86_General_Function:
Involved in dTDP-glucose 4,6-dehydratase activity

# Drug_Target_86_General_References:
11796113	Allard ST, Beis K, Giraud MF, Hegeman AD, Gross JW, Wilmouth RC, Whitfield C, Graninger M, Messner P, Allen AG, Maskell DJ, Naismith JH: Toward a structural understanding of the dehydratase mechanism. Structure. 2002 Jan;10(1):81-92.
12397186	Ajdic D, McShan WM, McLaughlin RE, Savic G, Chang J, Carson MB, Primeaux C, Tian R, Kenton S, Jia H, Lin S, Qian Y, Li S, Zhu H, Najar F, Lai H, White J, Roe BA, Ferretti JJ: Genome sequence of Streptococcus mutans UA159, a cariogenic dental pathogen. Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14434-9. Epub 2002 Oct 23.

# Drug_Target_86_HGNC_ID:
Not Available

# Drug_Target_86_HPRD_ID:
Not Available

# Drug_Target_86_ID:
4499

# Drug_Target_86_Locus:
Not Available

# Drug_Target_86_Molecular_Weight:
39281

# Drug_Target_86_Name:
dTDP-glucose 4,6-dehydratase

# Drug_Target_86_Number_of_Residues:
348

# Drug_Target_86_PDB_ID:
1OC2

# Drug_Target_86_Pathway:
Not Available

# Drug_Target_86_Pfam_Domain_Function:
PF01370	Epimerase

# Drug_Target_86_Protein_Sequence:
>dTDP-glucose 4,6-dehydratase
MTEYKNIIVTGGAGFIGSNFVHYVYNNHPDVHVTVLDKLTYAGNRANLEEILGDRVELVV
GDIADSELVDKLAAKADAIVHYAAESHNDNSLKDPSPFIYTNFVGTYILLEAARKYDIRF
HHVSTDEVYGDLPLREDLPGHGEGPGEKFTAETKYNPSSPYSSTKAASDLIVKAWVRSFG
VKATISNCSNNYGPYQHIEKFIPRQITNILSGIKPKLYGEGKNVRDWIHTNDHSTGVWAI
LTKGRIGETYLIGADGEKNNKEVLELILEKMSQPKNAYDHVTDRAGHDLRYAIDSTKLRE
ELGWKPQFTNFEEGLEDTIKWYTEHEDWWKAEKEAVEANYAKTQKILN

# Drug_Target_86_Reaction:
Not Available

# Drug_Target_86_Signals:
None

# Drug_Target_86_Specific_Function:
dTDP-glucose = dTDP-4-dehydro-6-deoxy-D- glucose + H(2)O

# Drug_Target_86_SwissProt_ID:
P95780

# Drug_Target_86_SwissProt_Name:
RMLB_STRMU

# Drug_Target_86_Synonyms:
EC 4.2.1.46

# Drug_Target_86_Theoretical_pI:
5.73

# Drug_Target_86_Transmembrane_Regions:
None

# Drug_Target_87_Cellular_Location:
Cytoplasm

# Drug_Target_87_Chromosome_Location:
Not Available

# Drug_Target_87_Drug_References:
Not Available

# Drug_Target_87_Essentiality:
Non-Essential

# Drug_Target_87_GenAtlas_ID:
Not Available

# Drug_Target_87_GenBank_ID_Gene:
M33585

# Drug_Target_87_GenBank_ID_Protein:
Not Available

# Drug_Target_87_GeneCard_ID:
Not Available

# Drug_Target_87_Gene_Name:
ldh2

# Drug_Target_87_Gene_Sequence:
>963 bp
ATGGCGGAAACTACCGTTAAGCCCACGAAGCTTGCTGTTATTGGTGCCGGTGCCGTTGGC
TCCACCCTCGCCTTCGCCGCTGCCCAGCGTGGCATCGCTCGCGAGATCGTGCTTGAAGAC
ATCGCCAAGGAGCGCGTGGAAGCCGAAGTGCTCGACATGCAGCATGGCTCCAGCTTCTAC
CCGACCGTGTCCATCGACGGTTCCGACGATCCTGAGATCTGCCGCGACGCCGACATGGTC
GTCATCACCGCTGGTCCGCGTCAGAAGCCGGGTCAGTCTCGTCTTGAGCTCGTTGGCGCT
ACCGTCAACATCCTCAAGGCCATCATGCCGAACCTGGTCAAGGTGGCTCCGAACGCCATC
TACATGCTCATCACCAACCCGGTCGACATCGCTACCCACGTGGCTCAGAAGCTCACCGGT
CTGCCCGAGAACCAGATCTTCGGTTCCGGCACCAACCTGGACTCCGCTCGTCTGCGCTTC
CTGATTGCCCAGCAGACCGGCGTCAACGTCAAGAACGTGCACGCCTACATCGCCGGCGAG
CACGGCGACTCCGAAGTCCCGCTGTGGGAGTCCGCCACCATCGGTGGCGTCCCCATGTGC
GACTGGACCCCGCTGCCCGGCCACGATCCGCTCGACGCCGACAAGCGCGAGGAGATCCAC
CAGGAAGTCAAGAACGCCGCTTACAAGATCATCAACGGTAAGGGTGCCACCAACTACGCC
ATCGGCATGTCCGGCGTCGACATCATCGAAGCCGTCCTGCACGACACCAACCGCATTCTG
CCCGTGAGCTCCATGCTCAAGGACTTCCACGGCATCTCCGACATCTGCATGTCCGTGCCG
ACCCTCCTCAACCGTCAGGGCGTCAACAACACCATCAACACCCCGGTCTCCGACAAGGAG
CTCGCCGCTCTGAAGCGCTCTGCCGAGACGCTGAAGGAAACCGCCGCCCAGTTCGGCTTC
TGA

# Drug_Target_87_General_Function:
Involved in oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor

# Drug_Target_87_General_References:
12381787	Schell MA, Karmirantzou M, Snel B, Vilanova D, Berger B, Pessi G, Zwahlen MC, Desiere F, Bork P, Delley M, Pridmore RD, Arigoni F: The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14422-7. Epub 2002 Oct 15.
2695396	Minowa T, Iwata S, Sakai H, Masaki H, Ohta T: Sequence and characteristics of the Bifidobacterium longum gene encoding L-lactate dehydrogenase and the primary structure of the enzyme: a new feature of the allosteric site. Gene. 1989 Dec 21;85(1):161-8.
7656036	Iwata S, Kamata K, Yoshida S, Minowa T, Ohta T: T and R states in the crystals of bacterial L-lactate dehydrogenase reveal the mechanism for allosteric control. Nat Struct Biol. 1994 Mar;1(3):176-85.
8450537	Iwata S, Ohta T: Molecular basis of allosteric activation of bacterial L-lactate dehydrogenase. J Mol Biol. 1993 Mar 5;230(1):21-7.

# Drug_Target_87_HGNC_ID:
Not Available

# Drug_Target_87_HPRD_ID:
Not Available

# Drug_Target_87_ID:
4500

# Drug_Target_87_Locus:
Not Available

# Drug_Target_87_Molecular_Weight:
34241

# Drug_Target_87_Name:
L-lactate dehydrogenase 2

# Drug_Target_87_Number_of_Residues:
320

# Drug_Target_87_PDB_ID:
1LTH

# Drug_Target_87_Pathway:
Not Available

# Drug_Target_87_Pfam_Domain_Function:
PF00056	Ldh_1_N
PF02866	Ldh_1_C

# Drug_Target_87_Protein_Sequence:
>L-lactate dehydrogenase 2
MAETTVKPTKLAVIGAGAVGSTLAFAAAQRGIAREIVLEDIAKERVEAEVLDMQHGSSFY
PTVSIDGSDDPEICRDADMVVITAGPRQKPGQSRLELVGATVNILKAIMPNLVKVAPNAI
YMLITNPVDIATHVAQKLTGLPENQIFGSGTNLDSARLRFLIAQQTGVNVKNVHAYIAGE
HGDSEVPLWESATIGGVPMCDWTPLPGHDPLDADKREEIHQEVKNAAYKIINGKGATNYA
IGMSGVDIIEAVLHDTNRILPVSSMLKDFHGISDICMSVPTLLNRQGVNNTINTPVSDKE
LAALKRSAETLKETAAQFGF

# Drug_Target_87_Reaction:
Not Available

# Drug_Target_87_Signals:
None

# Drug_Target_87_Specific_Function:
(S)-lactate + NAD(+) = pyruvate + NADH

# Drug_Target_87_SwissProt_ID:
P19869

# Drug_Target_87_SwissProt_Name:
LDH2_BIFLO

# Drug_Target_87_Synonyms:
EC 1.1.1.27
L-LDH 2

# Drug_Target_87_Theoretical_pI:
5.19

# Drug_Target_87_Transmembrane_Regions:
None

# Drug_Target_88_Cellular_Location:
Not Available

# Drug_Target_88_Chromosome_Location:
Not Available

# Drug_Target_88_Drug_References:
Not Available

# Drug_Target_88_Essentiality:
Non-Essential

# Drug_Target_88_GenAtlas_ID:
Not Available

# Drug_Target_88_GenBank_ID_Gene:
M64606

# Drug_Target_88_GenBank_ID_Protein:
Not Available

# Drug_Target_88_GeneCard_ID:
Not Available

# Drug_Target_88_Gene_Name:
cysG

# Drug_Target_88_Gene_Sequence:
>1374 bp
GTGGACCATTTGCCTATATTTTGTCAATTACGCGACCGCGACTGTCTGATCGTCGGCGGT
GGCGATGTCGCAGAACGCAAAGCACGGTTACTGCTGGAAGCAGGCGCACGTTTAACGGTC
AATGCGCTAACCTTTATTCCACAGTTCACCGTATGGGCAAATGAAGGCATGTTGACTCTG
GTTGAGGGACCGTTCGACGAAACGCTTCTCGACTCGTGTTGGCTGGCGATCGCGGCCACT
GACGACGATACCGTCAACCAGCGCGTCAGCGACGCGGCGGAGTCACGCCGTATCTTTTGC
AACGTGGTGGATGCGCCGAAAGCCGCCAGCTTTATCATGCCCTCCATTATTGACCGCTCG
CCGCTGATGGTCGCCGTCTCCTCGGGCGGCACCTCCCCGGTGCTGGCGCGTCTGCTGCGC
GAGAAACTGGAATCGCTGCTGCCGCAGCATCTGGGGCAGGTCGCGCGCTATGCCGGGCAA
CTCCGCGCCCGAGTGAAAAAGCAGTTTGCCACGATGGGCGAGCGTCGTCGCTTCTGGGAA
AAATTTTTCGTCAATGACCGGCTGGCGCAGTCGCTGGCGAATGCCGATGAGAAAGCGGTT
AACGCGACAACCGAACGCCTGTTTAGCGAACCGCTGGATCACCGTGGCGAAGTCGTGCTG
GTCGGCGCCGGGCCGGGCGATGCCGGACTGCTGACGCTGAAAGGGTTACAACAAATCCAA
CAGGCGGATATCGTGGTTTACGATCGCCTCGTCTCCGACGACATTATGAACCTGGTACGC
CGCGATGCCGATCGGGTCTTTGTGGGGAAACGCGCGGGTTACCACTGCGTCCCACAGGAG
GAAATCAACCAGATCCTGCTGCGTGAAGCGCAAAAAGGTAAACGCGTGGTACGCCTGAAA
GGCGGCGATCCCTTTATCTTTGGTCGCGGCGGCGAAGAGCTGGAAACGCTGTGTCATGCC
GGTATTCCTTTCTCGGTAGTGCCGGGGATTACCGCGGCTTCCGGCTGCTCCGCCTACTCC
GGTATTCCGCTAACTCATCGCGATTACGCCCAGAGCGTACGTCTGGTCACGGGTCACCTG
AAAACCGGCGGCGAGCTGGACTGGGAAAACCTGGCGGCAGAAAAACAGACGCTGGTGTTC
TACATGGGGCTGAATCAGGCAGCGACTATCCAGGAAAAACTGATCGCATTCGGTATGCAG
GCCGATATGCCGGTTGCGCTGGTAGAAAACGGTACCTCCGTGAAGCAACGCGTCGTCCAC
GGTGTGCTGACGCAGCTCGGTGAATTAGCGCAACAGGTTGAAAGCCCGGCGCTGATTATC
GTTGGTCGCGTGGTAGCCTTACGCGATAAATTAAATTGGTTCTCTAATCATTAA

# Drug_Target_88_General_Function:
Involved in methyltransferase activity

# Drug_Target_88_General_References:
11677609	McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, Porwollik S, Ali J, Dante M, Du F, Hou S, Layman D, Leonard S, Nguyen C, Scott K, Holmes A, Grewal N, Mulvaney E, Ryan E, Sun H, Florea L, Miller W, Stoneking T, Nhan M, Waterston R, Wilson RK: Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature. 2001 Oct 25;413(6858):852-6.
1987123	Wu JY, Siegel LM, Kredich NM: High-level expression of Escherichia coli NADPH-sulfite reductase: requirement for a cloned cysG plasmid to overcome limiting siroheme cofactor. J Bacteriol. 1991 Jan;173(1):325-33.

# Drug_Target_88_HGNC_ID:
Not Available

# Drug_Target_88_HPRD_ID:
Not Available

# Drug_Target_88_ID:
4318

# Drug_Target_88_Locus:
Not Available

# Drug_Target_88_Molecular_Weight:
50147

# Drug_Target_88_Name:
Siroheme synthase

# Drug_Target_88_Number_of_Residues:
457

# Drug_Target_88_PDB_ID:
1PJT

# Drug_Target_88_Pathway:
Not Available

# Drug_Target_88_Pfam_Domain_Function:
PF00590	TP_methylase

# Drug_Target_88_Protein_Sequence:
>Siroheme synthase
MDHLPIFCQLRDRDCLIVGGGDVAERKARLLLEAGARLTVNALTFIPQFTVWANEGMLTL
VEGPFDETLLDSCWLAIAATDDDTVNQRVSDAAESRRIFCNVVDAPKAASFIMPSIIDRS
PLMVAVSSGGTSPVLARLLREKLESLLPQHLGQVARYAGQLRARVKKQFATMGERRRFWE
KFFVNDRLAQSLANADEKAVNATTERLFSEPLDHRGEVVLVGAGPGDAGLLTLKGLQQIQ
QADIVVYDRLVSDDIMNLVRRDADRVFVGKRAGYHCVPQEEINQILLREAQKGKRVVRLK
GGDPFIFGRGGEELETLCHAGIPFSVVPGITAASGCSAYSGIPLTHRDYAQSVRLVTGHL
KTGGELDWENLAAEKQTLVFYMGLNQAATIQEKLIAFGMQADMPVALVENGTSVKQRVVH
GVLTQLGELAQQVESPALIIVGRVVALRDKLNWFSNH

# Drug_Target_88_Reaction:
Not Available

# Drug_Target_88_Signals:
None

# Drug_Target_88_Specific_Function:
Multifunctional enzyme that catalyze the SAM-dependent methylation of uroporphyrinogen III at position C-2 and C-7 to form precorrin-2 and then position C-12 or C-18 to form trimethylpyrrocorphin 2. It also catalyzes the conversion of precorrin-2 into siroheme. This reaction consist of the NAD- dependent oxidation of precorrin-2 into sirohydrochlorin and its subsequent ferrochelation into siroheme

# Drug_Target_88_SwissProt_ID:
P25924

# Drug_Target_88_SwissProt_Name:
CYSG_SALTY

# Drug_Target_88_Synonyms:
Not Available

# Drug_Target_88_Theoretical_pI:
6.79

# Drug_Target_88_Transmembrane_Regions:
None

# Drug_Target_89_Cellular_Location:
Not Available

# Drug_Target_89_Chromosome_Location:
Not Available

# Drug_Target_89_Drug_References:
Not Available

# Drug_Target_89_Essentiality:
Non-Essential

# Drug_Target_89_GenAtlas_ID:
Not Available

# Drug_Target_89_GenBank_ID_Gene:
Not Available

# Drug_Target_89_GenBank_ID_Protein:
Not Available

# Drug_Target_89_GeneCard_ID:
Not Available

# Drug_Target_89_Gene_Name:
Not Available

# Drug_Target_89_Gene_Sequence:
Not Available

# Drug_Target_89_General_Function:
Involved in oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor

# Drug_Target_89_General_References:
1597184	Lamzin VS, Aleshin AE, Strokopytov BV, Yukhnevich MG, Popov VO, Harutyunyan EH, Wilson KS: Crystal structure of NAD-dependent formate dehydrogenase. Eur J Biochem. 1992 Jun 1;206(2):441-52.
1954846	Tishkov VI, Galkin AG, Egorov AM: [NAD-dependent formate dehydrogenase of methylotrophic bacteria Pseudomonas sp. 101: cloning, expression, and study of the genetic structure] Dokl Akad Nauk SSSR. 1991;317(3):745-8.
2357236	Popov VO, Shumilin IA, Ustinnikova TB, Lamzin VS, Egorov TsA: [NAD-dependent formate dehydrogenase from methylotrophic bacteria Pseudomonas sp. 101. I. Amino acid sequence] Bioorg Khim. 1990 Mar;16(3):324-35.
8484798	Tishkov VI, Galkin AG, Marchenko GN, Egorova OA, Sheluho DV, Kulakova LB, Dementieva LA, Egorov AM: Catalytic properties and stability of a Pseudomonas sp.101 formate dehydrogenase mutants containing Cys-255-Ser and Cys-255-Met replacements. Biochem Biophys Res Commun. 1993 Apr 30;192(2):976-81.

# Drug_Target_89_HGNC_ID:
Not Available

# Drug_Target_89_HPRD_ID:
Not Available

# Drug_Target_89_ID:
4502

# Drug_Target_89_Locus:
Not Available

# Drug_Target_89_Molecular_Weight:
44137

# Drug_Target_89_Name:
Formate dehydrogenase

# Drug_Target_89_Number_of_Residues:
401

# Drug_Target_89_PDB_ID:
2NAD

# Drug_Target_89_Pathway:
Not Available

# Drug_Target_89_Pfam_Domain_Function:
PF00389	2-Hacid_dh
PF02826	2-Hacid_dh_C

# Drug_Target_89_Protein_Sequence:
>Formate dehydrogenase
MAKVLCVLYDDPVDGYPKTYARDDLPKIDHYPGGQTLPTPKAIDFTPGQLLGSVSGELGL
RKYLESNGHTLVVTSDKDGPDSVFERELVDADVVISQPFWPAYLTPERIAKAKNLKLALT
AGIGSDHVDLQSAIDRNVTVAEVTYCNSISVAEHVVMMILSLVRNYLPSHEWARKGGWNI
ADCVSHAYDLEAMHVGTVAAGRIGLAVLRRLAPFDVHLHYTDRHRLPESVEKELNLTWHA
TREDMYPVCDVVTLNCPLHPETEHMINDETLKLFKRGAYIVNTARGKLCDRDAVARALES
GRLAGYAGDVWFPQPAPKDHPWRTMPYNGMTPHISGTTLTAQARYAAGTREILECFFEGR
PIRDEYLIVQGGALAGTGAHSYSKGNATGGSEEAAKFKKAV

# Drug_Target_89_Reaction:
Not Available

# Drug_Target_89_Signals:
None

# Drug_Target_89_Specific_Function:
Formate + NAD(+) = CO(2) + NADH

# Drug_Target_89_SwissProt_ID:
P33160

# Drug_Target_89_SwissProt_Name:
FDH_PSESR

# Drug_Target_89_Synonyms:
EC 1.2.1.2
FDH
NAD-dependent formate dehydrogenase

# Drug_Target_89_Theoretical_pI:
6.51

# Drug_Target_89_Transmembrane_Regions:
None

# Drug_Target_8_Cellular_Location:
Not Available

# Drug_Target_8_Chromosome_Location:
Not Available

# Drug_Target_8_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_8_Essentiality:
Non-Essential

# Drug_Target_8_GenAtlas_ID:
Not Available

# Drug_Target_8_GenBank_ID_Gene:
X13462

# Drug_Target_8_GenBank_ID_Protein:
41709

# Drug_Target_8_GeneCard_ID:
Not Available

# Drug_Target_8_Gene_Name:
hisD

# Drug_Target_8_Gene_Sequence:
>1305 bp
ATGAGCTTTAACACAATCATTGACTGGAATAGCTGTACTGCGGTGCAACAACGCCAGCTG
TTAATGCGCCCGGCGATTTCCGCCTCTGAAAGCATTACCCGCACTGTTAACGATATTCTC
GATAACGTGAAAGCACGCGGCGATGAGGCCCTGCGGGAATACAGCGCGAAGTTTGATAAA
ACCACGGTTACCGCGCTGAAGGTGTCTGCAGAGGAGATCGCCGCCGCCAGCGAACGCCTG
AGCGACGAGCTAAAACAGGCGATGGCGGTGGCAGTAAAGAATATTGAAACCTTCCACACT
GCGCAAAAACTGCCGCCGGTAGATGTAGAAACGCAGCCAGGCGTGCGTTGCCAGCAGGTC
ACGCGTCCGGTAGCTTCAGTTGGGTTGTATATTCCTGGCGGCTCCGCCCCGCTCTTCTCA
ACGGTATTAATGCTGGCGACTCCGGCGCGTATTGCGGGCTGTAAAAAAGTGGTGCTGTGC
TCACCGCCGCCGATTGCCGATGAGATCCTTTATGCGGCGCAGCTGTGCGGTGTGCAGGAC
GTGTTCAACGTCGGCGGCGCACAGGCCATTGCCGCACTGGCGTTTGGTACGGAATCCGTG
CCAAAAGTGGACAAAATCTTCGGGCCGGGTAACGCCTTTGTCACCGAAGCGAAACGTCAG
GTGAGCCAGCGTCTGGACGGTGCGGCGATCGATATGCCCGCAGGCCCGTCGGAAGTGCTG
GTGATTGCTGACAGCGGCGCAACGCCGGATTTCGTGGCTTCTGATTTGCTCTCTCAGGCT
GAACACGGCCCGGACTCACAGGTGATTTTACTGACGCCCGCTGCTGATATGGCGCGTCGC
GTTGCCGAGGCCGTCGAACGCCAACTGGCGGAACTGCCGCGTGCCGAAACCGCCCGCCAG
GCACTGAACGCCAGCCGCCTGATCGTGACTAAAGATTCAGCGCAGTGCGTGGAGATCTCT
AATCAGTACGGCCCGGAGCACCTGATCATTCAGACCCGCAACGCCCGTGAACTGGTCGAT
AGCATCACCAGCGCCGGTTCGGTATTTCTTGGTGACTGGTCACCGGAATCGGCAGGTGAT
TACGCCTCCGGAACCAACCACGTTCTACCGACTTACGGTTACACCGCCACCTGTTCCAGC
CTCGGGCTGGCAGATTTCCAGAAGCGTATGACCGTACAGGAACTGTCGAAAGAGGGGTTC
TCCGCGGTGGCTTCAACCATAGAAACACTGGCCGCCGCCGAACGTCTGACCGCCCATAAA
AATGCCGTTACCTTGCGCGTTAACGCCCTCAAGGAGCAAGCATGA

# Drug_Target_8_General_Function:
Amino acid transport and metabolism

# Drug_Target_8_General_References:
11842181	Barbosa JA, Sivaraman J, Li Y, Larocque R, Matte A, Schrag JD, Cygler M: Mechanism of action and NAD+-binding mode revealed by the crystal structure of L-histidinol dehydrogenase. Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):1859-64. Epub 2002 Feb 12.
2194167	Jovanovic G, Kostic T, Savic DJ: Nucleotide and amino acid polymorphism in the gene for L-histidinol dehydrogenase of Escherichia coli K12. Nucleic Acids Res. 1990 Jun 25;18(12):3634.
3018428	Chiariotti L, Alifano P, Carlomagno MS, Bruni CB: Nucleotide sequence of the Escherichia coli hisD gene and of the Escherichia coli and Salmonella typhimurium hisIE region. Mol Gen Genet. 1986 Jun;203(3):382-8.
3062174	Carlomagno MS, Chiariotti L, Alifano P, Nappo AG, Bruni CB: Structure and function of the Salmonella typhimurium and Escherichia coli K-12 histidine operons. J Mol Biol. 1988 Oct 5;203(3):585-606.
6246067	Bruni CB, Musti AM, Frunzio R, Blasi F: Structural and physiological studies of the Escherichia coli histidine operon inserted into plasmid vectors. J Bacteriol. 1980 Apr;142(1):32-42.
9097040	Itoh T, Aiba H, Baba T, Hayashi K, Inada T, Isono K, Kasai H, Kimura S, Kitakawa M, Kitagawa M, Makino K, Miki T, Mizobuchi K, Mori H, Mori T, Motomura K, Nakade S, Nakamura Y, Nashimoto H, Nishio Y, Oshima T, Saito N, Sampei G, Seki Y, Horiuchi T, et al.: A 460-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 40.1-50.0 min region on the linkage map. DNA Res. 1996 Dec 31;3(6):379-92.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9298646	Link AJ, Robison K, Church GM: Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12. Electrophoresis. 1997 Aug;18(8):1259-313.

# Drug_Target_8_HGNC_ID:
Not Available

# Drug_Target_8_HPRD_ID:
Not Available

# Drug_Target_8_ID:
3191

# Drug_Target_8_Locus:
Not Available

# Drug_Target_8_Molecular_Weight:
46111

# Drug_Target_8_Name:
Histidinol dehydrogenase

# Drug_Target_8_Number_of_Residues:
434

# Drug_Target_8_PDB_ID:
1K75

# Drug_Target_8_Pathway:
Not Available

# Drug_Target_8_Pfam_Domain_Function:
PF00815	Histidinol_dh

# Drug_Target_8_Protein_Sequence:
>Histidinol dehydrogenase
MSFNTIIDWNSCTAEQQRQLLMRPAISASESITRTVNDILDNVKARGDEALREYSAKFDK
TTVTALKVSAEEIAAASERLSDELKQAMAVAVKNIETFHTAQKLPPVDVETQPGVRCQQV
TRPVASVGLYIPGGSAPLFSTVLMLATPASIAGCKKVVLCSPPPIADEILYAAQLCGVQD
VFNVGGAQAIAALAFGTESVPKVDKIFGPGNAFVTEAKRQVSQRLDGAAIDMPAGPSEVL
VIADSGATPDFVASDLLSQAEHGPDSQVILLTPAADMARRVAEAVERQLAELPRAETARQ
ALNASRLIVTKDLAQCVEISNQYGPEHLIIQTRNARELVDSITSAGSVFLGDWSPESAGD
YASGTNHVLPTYGYTATCSSLGLADFQKRMTVQELSKEGFSALASTIETLAAAERLTAHK
NAVTLRVNALKEQA

# Drug_Target_8_Reaction:
L-histidinol + 2 NAD+ = L-histidine + 2 NADH + 2 H+

# Drug_Target_8_Signals:
None

# Drug_Target_8_Specific_Function:
Catalyzes the sequential NAD-dependent oxidations of L- histidinol to L-histidinaldehyde and then to L-histidine

# Drug_Target_8_SwissProt_ID:
P06988

# Drug_Target_8_SwissProt_Name:
HISX_ECOLI

# Drug_Target_8_Synonyms:
EC 1.1.1.23
HDH

# Drug_Target_8_Theoretical_pI:
4.81

# Drug_Target_8_Transmembrane_Regions:
None

# Drug_Target_90_Cellular_Location:
Not Available

# Drug_Target_90_Chromosome_Location:
Not Available

# Drug_Target_90_Drug_References:
Not Available

# Drug_Target_90_Essentiality:
Non-Essential

# Drug_Target_90_GenAtlas_ID:
Not Available

# Drug_Target_90_GenBank_ID_Gene:
U08996

# Drug_Target_90_GenBank_ID_Protein:
Not Available

# Drug_Target_90_GeneCard_ID:
Not Available

# Drug_Target_90_Gene_Name:
frp

# Drug_Target_90_Gene_Sequence:
>723 bp
ATGAACAATACGATTGAAACCATTCTTGCTCATCGCTCTATCCGAAAATTCACCGCAGTT
CCTATTACTGATGAACAAAGACAAACCATCATTCAAGCAGGTTTAGCTGCGTCTTCTTCT
AGTATGCTTCAAGTCGTCTCAATCGTTCGAGTGACTGACTCTGAAAAGCGTAACGAATTG
GCTCAATTTGCTGGTAACCAAGCTTATGTTGAAAGTGCGGCTGAGTTCTTAGTGTTTTGT
ATTGATTATCAGCGCCATGCAACCATCAATCCTGATGTACAGGCAGACTTTACAGAACTA
ACTCTGATTGGAGCAGTAGATTCTGGAATCATGGCACAAAACTGCTTGCTTGCAGCCGAG
TCTATGGGATTAGGTGGCGTATATATTGGAGGACTAAGGAATAGCGCAGCTCAAGTTGAT
GAGCTATTGGGCTTACCGGAAAATAGCGCGGTGTTGTTTGGTATGTGCTTAGGGCATCCC
GATCAAAATCCCGAAGTAAAGCCACGCCTACCTGCACATGTGGTTGTTCATGAAAATCAA
TACCAAGAGCTAAATTTAGATGATATTCAGAGCTACGATCAAACTATGCAAGCGTATTAT
GCGAGCCGTACAAGCAATCAAAAACTGAGTACATGGTCGCAAGAAGTCACTGGGAAGCTT
GCTGGTGAGTCGCGACCTCATATTCTGCCGTACTTGAACAGTAAGGGGCTAGCAAAACGC
TAA

# Drug_Target_90_General_Function:
Involved in oxidoreductase activity

# Drug_Target_90_General_References:
8206832	Lei B, Liu M, Huang S, Tu SC: Vibrio harveyi NADPH-flavin oxidoreductase: cloning, sequencing and overexpression of the gene and purification and characterization of the cloned enzyme. J Bacteriol. 1994 Jun;176(12):3552-8.
8885832	Tanner JJ, Lei B, Tu SC, Krause KL: Flavin reductase P: structure of a dimeric enzyme that reduces flavin. Biochemistry. 1996 Oct 22;35(42):13531-9.

# Drug_Target_90_HGNC_ID:
Not Available

# Drug_Target_90_HPRD_ID:
Not Available

# Drug_Target_90_ID:
4503

# Drug_Target_90_Locus:
Not Available

# Drug_Target_90_Molecular_Weight:
26310

# Drug_Target_90_Name:
NADPH-flavin oxidoreductase

# Drug_Target_90_Number_of_Residues:
240

# Drug_Target_90_PDB_ID:
2BKJ

# Drug_Target_90_Pathway:
Not Available

# Drug_Target_90_Pfam_Domain_Function:
PF00881	Nitroreductase

# Drug_Target_90_Protein_Sequence:
>NADPH-flavin oxidoreductase
MNNTIETILAHRSIRKFTAVPITDEQRQTIIQAGLAASSSSMLQVVSIVRVTDSEKRNEL
AQFAGNQAYVESAAEFLVFCIDYQRHATINPDVQADFTELTLIGAVDSGIMAQNCLLAAE
SMGLGGVYIGGLRNSAAQVDELLGLPENSAVLFGMCLGHPDQNPEVKPRLPAHVVVHENQ
YQELNLDDIQSYDQTMQAYYASRTSNQKLSTWSQEVTGKLAGESRPHILPYLNSKGLAKR

# Drug_Target_90_Reaction:
Not Available

# Drug_Target_90_Signals:
None

# Drug_Target_90_Specific_Function:
Involved in bioluminescence. It is a good supplier of reduced flavin mononucleotide (FMNH2) to the bioluminescence reaction

# Drug_Target_90_SwissProt_ID:
Q56691

# Drug_Target_90_SwissProt_Name:
FRP_VIBHA

# Drug_Target_90_Synonyms:
EC 1.6.99.-
Flavin reductase P
NADPH- FMN oxidoreductase

# Drug_Target_90_Theoretical_pI:
5.06

# Drug_Target_90_Transmembrane_Regions:
None

# Drug_Target_91_Cellular_Location:
Not Available

# Drug_Target_91_Chromosome_Location:
Not Available

# Drug_Target_91_Drug_References:
Not Available

# Drug_Target_91_Essentiality:
Non-Essential

# Drug_Target_91_GenAtlas_ID:
Not Available

# Drug_Target_91_GenBank_ID_Gene:
AF498417

# Drug_Target_91_GenBank_ID_Protein:
Not Available

# Drug_Target_91_GeneCard_ID:
Not Available

# Drug_Target_91_Gene_Name:
Not Available

# Drug_Target_91_Gene_Sequence:
>1026 bp
ATGATGAGTCGTTATGAAGAGCTAAGAAAGGAATTGCCGGCGCAGCCGAAAGTCTGGCTG
ATTACAGGTGTGGCGGGCTTTATTGGCTCTAATCTTCTTGAGACTTTGCTAAAGCTTGAT
CAGAAGGTTGTCGGTCTGGATAATTTTGCTACTGGTCATCAGCGGAACCTGGACGAAGTG
CGGTCCTTGGTTAGCGAGAAGCAATGGTCAAATTTTAAATTTATTCAAGGTGATATTCGC
AATCTGGATGATTGCAATAACGCCTGTGCAGGTGTTGATTACGTTTTACATCAAGCTGCC
TTGGGTTCGGTACCGCGTTCTATTAACGATCCGATCACCTCCAATGCAACGAACATCGAT
GGTTTCTTGAATATGCTGATTGCAGCCAGAGATGCCAAGGTGCAGAGTTTCACTTATGCG
GCAAGTAGCTCTACCTATGGAGATCATCCTGGTTTACCGAAGGTGGAGGATACTATAGGT
AAGCCTCTTTCCCCTTATGCGGTTACCAAATATGTGAATGAGCTTTATGCCGATGTGTTT
TCACGCTGCTACGGCTTTTCGACCATTGGGCTTCGTTATTTCAATGTGTTCGGTCGTCGA
CAGGATCCCAATGGTGCCTATGCGGCAGTCATACCAAAATGGACCTCTTCGATGATCCAG
GGTGATGACGTCTATATTAACGGTGATGGCGAGACCAGTCGGGATTTTTGTTATATTGAA
AACACCGTTCAGGCCAATCTGCTTGCTGCAACCGCGGGGCTTGATGCTCGTAATCAAGTT
TACAATATTGCTGTTGGCGGGCGGACGAGTTTGAATCAGTTGTTCTTTGCGCTTCGCGAC
GGCCTTGCCGAAAACGGTGTGTCCTATCACCGGGAACCTGTTTATCGTGATTTTAGGGAG
GGGGATGTACGTCACTCTCTCGCTGATATCAGCAAGGCTGCCAAACTGCTGGGGTATGCG
CCGAAATATGATGTGTCTGCAGGTGTGGCGTTGGCCATGCCTTGGTACATCATGTTTTTG
AAATGA

# Drug_Target_91_General_Function:
Involved in catalytic activity

# Drug_Target_91_General_References:
12057956	Raymond CK, Sims EH, Kas A, Spencer DH, Kutyavin TV, Ivey RG, Zhou Y, Kaul R, Clendenning JB, Olson MV: Genetic variation at the O-antigen biosynthetic locus in Pseudomonas aeruginosa. J Bacteriol. 2002 Jul;184(13):3614-22.

# Drug_Target_91_HGNC_ID:
Not Available

# Drug_Target_91_HPRD_ID:
Not Available

# Drug_Target_91_ID:
4504

# Drug_Target_91_Locus:
Not Available

# Drug_Target_91_Molecular_Weight:
37749

# Drug_Target_91_Name:
WbpP

# Drug_Target_91_Number_of_Residues:
341

# Drug_Target_91_PDB_ID:
1SB9

# Drug_Target_91_Pathway:
Not Available

# Drug_Target_91_Pfam_Domain_Function:
PF01370	Epimerase

# Drug_Target_91_Protein_Sequence:
>WbpP
MMSRYEELRKELPAQPKVWLITGVAGFIGSNLLETLLKLDQKVVGLDNFATGHQRNLDEV
RSLVSEKQWSNFKFIQGDIRNLDDCNNACAGVDYVLHQAALGSVPRSINDPITSNATNID
GFLNMLIAARDAKVQSFTYAASSSTYGDHPGLPKVEDTIGKPLSPYAVTKYVNELYADVF
SRCYGFSTIGLRYFNVFGRRQDPNGAYAAVIPKWTSSMIQGDDVYINGDGETSRDFCYIE
NTVQANLLAATAGLDARNQVYNIAVGGRTSLNQLFFALRDGLAENGVSYHREPVYRDFRE
GDVRHSLADISKAAKLLGYAPKYDVSAGVALAMPWYIMFLK

# Drug_Target_91_Reaction:
Not Available

# Drug_Target_91_Signals:
None

# Drug_Target_91_Specific_Function:
Not Available

# Drug_Target_91_SwissProt_ID:
Q8KN66

# Drug_Target_91_SwissProt_Name:
Q8KN66_PSEAE

# Drug_Target_91_Synonyms:
Not Available

# Drug_Target_91_Theoretical_pI:
6.37

# Drug_Target_91_Transmembrane_Regions:
None

# Drug_Target_92_Cellular_Location:
Not Available

# Drug_Target_92_Chromosome_Location:
Not Available

# Drug_Target_92_Drug_References:
Not Available

# Drug_Target_92_Essentiality:
Non-Essential

# Drug_Target_92_GenAtlas_ID:
Not Available

# Drug_Target_92_GenBank_ID_Gene:
X66122

# Drug_Target_92_GenBank_ID_Protein:
Not Available

# Drug_Target_92_GeneCard_ID:
Not Available

# Drug_Target_92_Gene_Name:
bphB

# Drug_Target_92_Gene_Sequence:
>834 bp
ATGAAACTGAAAGGTGAAGCGGTACTGATCACGGGGGGCGCCTCCGGATTAGGGCGCGCG
CTCGTGGACCGATTCGTGGCCGAAGGCGCCAAAGTGGCGGTGCTCGACAAGTCGGCAGAG
CGCCTTGCAGAGCTGGAAACCGATCATGGCGACAACGTGCTCGGCATCGTCGGCGATGTG
CGTTCACTGGAAGACCAGAAACAGGCTGCCAGCCGCTGCGTGGCCAGGTTCGGGAAAATC
GACACCTTGATTCCCAATGCAGGCATCTGGGATTACTCGACGGCCTTGGTCGACCTGCCC
GAAGAGAGCCTCGATGCCGCGTTCGATGAGGTCTTTCACATCAATGTCAAGGGTTATATC
CATGCAGTGAAGGCCTGCCTGCCGGCCCTGGTCGCCAGCCGTGGCAACGTGATCTTCACG
ATCTCCAATGCGGGCTTCTATCCCAATGGCGGCGGCCCTCTTTACACCGCAGCCAAGCAC
GCCATCGTGGGCCTGGTGCGTGAACTGGCGTTCGAGCTGGCGCCATACGTGCGCGTCAAC
GGCGTGGGGTCGGGCGGCATCAATAGCGATCTGAGAGGTCCTTCCTCGCTGGGAATGGGC
AGCAAGGCGATTTCGACCGTACCGCTGGCCGACATGCTGAAGTCGGTGCTGCCGATTGGT
CGCATGCCCGAGGTCGAAGAGTACACCGGGGCCTATGTGTTTTTTGCCACCCGAGGCGAT
GCGGCGCCTGCGACCGGGGCCTTGCTGAACTACGACGGTGGCTTGGGCGTTCGTGGATTC
TTCTCGGGTGCCGGAGGTAATGACTTGCTCGAACAGCTGAATATCCATCCCTAA

# Drug_Target_92_General_Function:
Involved in oxidoreductase activity

# Drug_Target_92_General_References:
1569021	Erickson BD, Mondello FJ: Nucleotide sequencing and transcriptional mapping of the genes encoding biphenyl dioxygenase, a multicomponent polychlorinated-biphenyl-degrading enzyme in Pseudomonas strain LB400. J Bacteriol. 1992 May;174(9):2903-12.
8344527	Hofer B, Eltis LD, Dowling DN, Timmis KN: Genetic analysis of a Pseudomonas locus encoding a pathway for biphenyl/polychlorinated biphenyl degradation. Gene. 1993 Aug 16;130(1):47-55.
9655331	Hulsmeyer M, Hecht HJ, Niefind K, Hofer B, Eltis LD, Timmis KN, Schomburg D: Crystal structure of cis-biphenyl-2,3-dihydrodiol-2,3-dehydrogenase from a PCB degrader at 2.0 A resolution. Protein Sci. 1998 Jun;7(6):1286-93.

# Drug_Target_92_HGNC_ID:
Not Available

# Drug_Target_92_HPRD_ID:
Not Available

# Drug_Target_92_ID:
4505

# Drug_Target_92_Locus:
Not Available

# Drug_Target_92_Molecular_Weight:
28901

# Drug_Target_92_Name:
Cis-2,3-dihydrobiphenyl-2,3-diol dehydrogenase

# Drug_Target_92_Number_of_Residues:
277

# Drug_Target_92_PDB_ID:
1BDB

# Drug_Target_92_Pathway:
Not Available

# Drug_Target_92_Pfam_Domain_Function:
PF00106	adh_short

# Drug_Target_92_Protein_Sequence:
>Cis-2,3-dihydrobiphenyl-2,3-diol dehydrogenase
MKLKGEAVLITGGASGLGRALVDRFVAEGAKVAVLDKSAERLAELETDHGDNVLGIVGDV
RSLEDQKQAASRCVARFGKIDTLIPNAGIWDYSTALVDLPEESLDAAFDEVFHINVKGYI
HAVKACLPALVASRGNVIFTISNAGFYPNGGGPLYTAAKHAIVGLVRELAFELAPYVRVN
GVGSGGINSDLRGPSSLGMGSKAISTVPLADMLKSVLPIGRMPEVEEYTGAYVFFATRGD
AAPATGALLNYDGGLGVRGFFSGAGGNDLLEQLNIHP

# Drug_Target_92_Reaction:
Not Available

# Drug_Target_92_Signals:
None

# Drug_Target_92_Specific_Function:
Cis-3-phenylcyclohexa-3,5-diene-1,2-diol + NAD(+) = biphenyl-2,3-diol + NADH

# Drug_Target_92_SwissProt_ID:
P47227

# Drug_Target_92_SwissProt_Name:
BPHB_BURXL

# Drug_Target_92_Synonyms:
2,3-dihydro-2,3- dihydroxybiphenyl dehydrogenase
2,3-dihydroxy-4-phenylhexa-4,6-diene dehydrogenase
Biphenyl-2,3-dihydro-2,3-diol dehydrogenase
Biphenyl-cis-diol dehydrogenase
EC 1.3.1.56

# Drug_Target_92_Theoretical_pI:
5.13

# Drug_Target_92_Transmembrane_Regions:
None

# Drug_Target_93_Cellular_Location:
Not Available

# Drug_Target_93_Chromosome_Location:
Not Available

# Drug_Target_93_Drug_References:
Not Available

# Drug_Target_93_Essentiality:
Non-Essential

# Drug_Target_93_GenAtlas_ID:
Not Available

# Drug_Target_93_GenBank_ID_Gene:
AE000512

# Drug_Target_93_GenBank_ID_Protein:
Not Available

# Drug_Target_93_GeneCard_ID:
Not Available

# Drug_Target_93_Gene_Name:
TM_1419

# Drug_Target_93_Gene_Sequence:
>1149 bp
TCACAGCCACTTCGGTTTCAATCCCGCCCAGATTCTCATCTTCTCGTAAGCAATGATTCT
TGGGATGTTCTTTTCTTCCGCCGGTCCCGGGTTCTTCATGTAGAAGGCGTTCACTGGGTA
GACCGTTCCGAACTCCTTCCTGTCGAGTGCGATCTTTCCGAGTCTCACAAGGTCAACAAG
GAGACCTCCAAGAGCCGGGCTGTCGTTTATTCTTCCGTTTATCATGAGCTCATCTGTAGC
ACCGTTGAAACTCACGTACTCGATGTGAATGGCTATGAACTTTTTATCTCCAAGTGGTTC
AAGATACCCTGTAGGTTTTATGTAATGCGGTGCATCGTAACCGAGAATGTCCTTCACTAT
ACTGGATTTGGTGAATTCTTTACTCTTGTTCTTTCCATCGTCTGTGAGTGCCAGAAAGTC
CATGTTCCCTCCTATGTTGAACTGCGCAACATCTTTGACGTACCTGTTTCTCTGGGCAAG
ATGGCTGAGAACGTCCGCTGTGAACGGTGTGGCACCGGTAGCACCGTCGTCTCCGAAAAC
GACGAGGTTGTTCTCCTTCGCGAGTTCAACGAAAGCCGGGTCGTTCGCTATGAAGGTCGG
AATAACGTTCACAAAAGCCGCTCCTCCACGCTTGTTCGCGTACAGTGCCGCTGCGTAAGC
GTACACCTGAGTTGCAGTGAGTCTCTCTTTGTCGTTGTTTTCGATAGCTTTCAGAAGATC
TTCTTTGTTCCCGAAGGGCACGAAAGCTTCTGTAGTACAGGTGTTCACGATCACATCGGG
ATCGAGTTCTGTCCATTCCTTGACGAGAGTATCAACTGCTTCCTTCAGAGTCATGCTGTC
TTCGAGACCTTCAGCTTCGATGGGGAGGTTCCTCACGCTTCCAAGGTGTACTCCTTTGCG
AATCTCAGGATCACTCGTCAGCGAGTCAACATCGTTCCAGTACTGCTTCACCACTTCGCT
CAGTTTCTTTCCAATCTTCGCTCTGTCCACGTCGTAGCTTCCAACAATCTTGATGTCTTC
GAAGCCGATGGGAAGTTCCCTTGCAAGGGGCACTCCGTAAGGTTCTATTTCCCCTTTCCT
GAGCTTTTCAAGTCCGGCAACGAATGTACTGGCAACGTAGCCCTGACCGAGGATCAGGAC
CTTGACCAT

# Drug_Target_93_General_Function:
Involved in inositol-3-phosphate synthase activity

# Drug_Target_93_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.

# Drug_Target_93_HGNC_ID:
Not Available

# Drug_Target_93_HPRD_ID:
Not Available

# Drug_Target_93_ID:
4506

# Drug_Target_93_Locus:
Not Available

# Drug_Target_93_Molecular_Weight:
42195

# Drug_Target_93_Name:
Myo-inositol-1-phosphate synthase-related protein

# Drug_Target_93_Number_of_Residues:
382

# Drug_Target_93_PDB_ID:
1VJP

# Drug_Target_93_Pathway:
Not Available

# Drug_Target_93_Pfam_Domain_Function:
PF01658	Inos-1-P_synth
PF07994	NAD_binding_5

# Drug_Target_93_Protein_Sequence:
>Myo-inositol-1-phosphate synthase-related protein
MVKVLILGQGYVASTFVAGLEKLRKGEIEPYGVPLARELPIGFEDIKIVGSYDVDRAKIG
KKLSEVVKQYWNDVDSLTSDPEIRKGVHLGSVRNLPIEAEGLEDSMTLKEAVDTLVKEWT
ELDPDVIVNTCTTEAFVPFGNKEDLLKAIENNDKERLTATQVYAYAAALYANKRGGAAFV
NVIPTFIANDPAFVELAKENNLVVFGDDGATGATPFTADVLSHLAQRNRYVKDVAQFNIG
GNMDFLALTDDGKNKSKEFTKSSIVKDILGYDAPHYIKPTGYLEPLGDKKFIAIHIEYVS
FNGATDELMINGRINDSPALGGLLVDLVRLGKIALDRKEFGTVYPVNAFYMKNPGPAEEK
NIPRIIAYEKMRIWAGLKPKWL

# Drug_Target_93_Reaction:
Not Available

# Drug_Target_93_Signals:
None

# Drug_Target_93_Specific_Function:
Not Available

# Drug_Target_93_SwissProt_ID:
Q9X1D6

# Drug_Target_93_SwissProt_Name:
Q9X1D6_THEMA

# Drug_Target_93_Synonyms:
Not Available

# Drug_Target_93_Theoretical_pI:
5.09

# Drug_Target_93_Transmembrane_Regions:
None

# Drug_Target_94_Cellular_Location:
Not Available

# Drug_Target_94_Chromosome_Location:
Not Available

# Drug_Target_94_Drug_References:
Not Available

# Drug_Target_94_Essentiality:
Non-Essential

# Drug_Target_94_GenAtlas_ID:
Not Available

# Drug_Target_94_GenBank_ID_Gene:
D37807

# Drug_Target_94_GenBank_ID_Protein:
Not Available

# Drug_Target_94_GeneCard_ID:
Not Available

# Drug_Target_94_Gene_Name:
ald

# Drug_Target_94_Gene_Sequence:
>1086 bp
ATGGAAATCGGCGTTCCCAAAGAGATTAAGAATCAGGAATTTCGGGTGGGGCTGAGTCCC
AGCAGCGTCCGCACGCTGGTCGAAGCAGGACACACAGTATTTATCGAAACCCAGGCGGGC
ATCGGCGCAGGATTTGCCGATCAGGACTATGTTCAAGCTGGCGCTCAGGTCGTGCCTTCT
GCAAAGGATGCCTGGAGCCGAGAGATGGTGGTGAAGGTCAAGGAACCGCTGCCTGCGGAA
TATGACCTGATGCAAAAAGATCAATTGCTGTTTACCTACCTGCACCTGGCGGCGGCAAGA
GAACTGACGGAGCAACTGATGCGGGTGGGGCTGACGGCGATCGCCTATGAAACCGTCGAA
CTGCCCAACCGCAGCCTGCCCCTGCTGACTCCCATGAGCATCATCGCTGGGCGGCTCTCG
GTTCAGTTTGGGGCCCGCTTTTTGGAACGACAGCAGGGTGGGCGCGGCGTGCTGCTAGGC
GGCGTGCCGGGGGTAAAACCAGGCAAAGTCGTGATCTTGGGCGGCGGTGTGGTGGGCACC
GAAGCTGCCAAGATGGCCGTCGGGCTGGGCGCTCAGGTGCAAATTTTTGACATCAATGTG
GAGCGGCTGTCTTACCTGGAAACCCTGTTTGGCTCGCGGGTCGAGCTGCTCTACAGCAAT
TCCGCCGAGATCGAGACTGCGGTCGCCGAGGCTGATTTGCTCATCGGCGCAGTGCTGGTA
CCGGGCCGACGTGCGCCCATCCTAGTGCCTGCCAGCCTGGTGGAGCAAATGCGGACAGGC
TCGGTGATCGTAGACGTGGCGGTGGATCAGGGCGGCTGCGTAGAGACGCTGCACCCAACT
TCCCACACGCAGCCCACCTACGAGGTGTTTGGCGTGGTTCACTATGGCGTGCCGAATATG
CCCGGAGCCGTTCCCTGGACAGCGACGCAGGCACTCAACAACAGCACCCTGCCCTACGTG
GTGAAGCTGGCCAACCAGGGACTTAAGGCACTGGAAACCGATGACGCGCTAGCCAAGGGG
CTAAACGTGCAGGCCCATCGCTTGGTGCATCCCGCAGTGCAGCAGGTTTTCCCCGATCTG
GCGTAG

# Drug_Target_94_General_Function:
Involved in alanine dehydrogenase activity

# Drug_Target_94_General_References:
7896761	Sawa Y, Tani M, Murata K, Shibata H, Ochiai H: Purification and characterization of alanine dehydrogenase from a cyanobacterium, Phormidium lapideum. J Biochem. 1994 Nov;116(5):995-1000.
9437424	Schultz J, Hoffmuller U, Krause G, Ashurst J, Macias MJ, Schmieder P, Schneider-Mergener J, Oschkinat H: Specific interactions between the syntrophin PDZ domain and voltage-gated sodium channels. Nat Struct Biol. 1998 Jan;5(1):19-24.
9665169	Baker PJ, Sawa Y, Shibata H, Sedelnikova SE, Rice DW: Analysis of the structure and substrate binding of Phormidium lapideum alanine dehydrogenase. Nat Struct Biol. 1998 Jul;5(7):561-7.

# Drug_Target_94_HGNC_ID:
Not Available

# Drug_Target_94_HPRD_ID:
Not Available

# Drug_Target_94_ID:
4507

# Drug_Target_94_Locus:
Not Available

# Drug_Target_94_Molecular_Weight:
38558

# Drug_Target_94_Name:
Alanine dehydrogenase

# Drug_Target_94_Number_of_Residues:
361

# Drug_Target_94_PDB_ID:
1PJC

# Drug_Target_94_Pathway:
Not Available

# Drug_Target_94_Pfam_Domain_Function:
PF01262	AlaDh_PNT_C
PF05222	AlaDh_PNT_N

# Drug_Target_94_Protein_Sequence:
>Alanine dehydrogenase
MEIGVPKEIKNQEFRVGLSPSSVRTLVEAGHTVFIETQAGIGAGFADQDYVQAGAQVVPS
AKDAWSREMVVKVKEPLPAEYDLMQKDQLLFTYLHLAAARELTEQLMRVGLTAIAYETVE
LPNRSLPLLTPMSIIAGRLSVQFGARFLERQQGGRGVLLGGVPGVKPGKVVILGGGVVGT
EAAKMAVGLGAQVQIFDINVERLSYLETLFGSRVELLYSNSAEIETAVAEADLLIGAVLV
PGRRAPILVPASLVEQMRTGSVIVDVAVDQGGCVETLHPTSHTQPTYEVFGVVHYGVPNM
PGAVPWTATQALNNSTLPYVVKLANQGLKALETDDALAKGLNVQAHRLVHPAVQQVFPDL
A

# Drug_Target_94_Reaction:
Not Available

# Drug_Target_94_Signals:
None

# Drug_Target_94_Specific_Function:
Not Available

# Drug_Target_94_SwissProt_ID:
O52942

# Drug_Target_94_SwissProt_Name:
O52942_PHOLP

# Drug_Target_94_Synonyms:
EC 1.4.1.1

# Drug_Target_94_Theoretical_pI:
5.40

# Drug_Target_94_Transmembrane_Regions:
None

# Drug_Target_95_Cellular_Location:
Not Available

# Drug_Target_95_Chromosome_Location:
Not Available

# Drug_Target_95_Drug_References:
Not Available

# Drug_Target_95_Essentiality:
Non-Essential

# Drug_Target_95_GenAtlas_ID:
Not Available

# Drug_Target_95_GenBank_ID_Gene:
AE004091

# Drug_Target_95_GenBank_ID_Protein:
Not Available

# Drug_Target_95_GeneCard_ID:
Not Available

# Drug_Target_95_Gene_Name:
adhA

# Drug_Target_95_Gene_Sequence:
>1029 bp
ATGACCCTGCCACAGACCATGAAAGCCGCGGTCGTGCACGCCTACGGCGCGCCGCTGCGG
ATCGAGGAAGTCAAGGTTCCGCTGCCCGGCCCCGGGCAGGTACTGGTGAAGATCGAAGCC
TCCGGCGTCTGCCACACCGACCTGCATGCCGCCGAGGGCGACTGGCCGGTGAAGCCGCCG
TTGCCGTTCATTCCCGGTCACGAAGGCGTCGGCTACGTCGCCGCGGTGGGCAGCGGAGTG
ACCCGAGTGAAGGAAGGCGACCGGGTCGGCATCCCCTGGCTGTACACCGCCTGCGGCTGC
TGCGAGCACTGCCTGACCGGCTGGGAGACCCTCTGCGAGAGCCAGCAGAACACCGGCTAC
TCGGTGAACGGCGGCTATGCCGAATACGTATTGGCCGACCCGAACTACGTCGGAATTCTG
CCGAAAAACGTCGAATTCGCTGAAATCGCGCCGATCCTCTGCGCCGGCGTCACCGTCTAC
AAGGGGCTCAAGCAGACTAACGCGCGCCCCGGCCAGTGGGTGGCGATCTCCGGCATCGGC
GGCCTCGGCCACGTCGCCGTGCAGTACGCCAGGGCCATGGGCCTGCACGTCGCCGCCATC
GACATCGACGACGCCAAGCTGGAACTGGCGCGCAAGCTCGGTGCCAGCCTGACGGTCAAC
GCCCGGCAGGAAGACCCGGTGGAGGTGCTCCAGCGCGACATCGGCGGCGCCCACGGGGTG
CTGGTCACCGCGGTATCCAATAGCGCCTTCGGCCAGGCCATCGGCATGGCGCGCCGCGGC
GGCACCATCGCCCTGGTCGGCCTGCCGCCGGGTGACTTCCCGACGCCGATCTTCGACGTG
GTGCTCAAGGGCCTGCACATCGCCGGCTCAATCGTCGGCACCCGCGCGGACCTTCAGGAA
GCCCTCGACTTTGCCGGCGAAGGCCTGGTCAAGGCGACCATCCATCCGGGCAAGCTGGAC
GACATCAACCAGATCCTCGACCAGATGCGCGCCGGGCAGATCGAGGGGCGCATCGTCCTT
GAGATGTGA

# Drug_Target_95_General_Function:
Involved in zinc ion binding

# Drug_Target_95_General_References:
10984043	Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV: Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature. 2000 Aug 31;406(6799):959-64.

# Drug_Target_95_HGNC_ID:
Not Available

# Drug_Target_95_HPRD_ID:
Not Available

# Drug_Target_95_ID:
4508

# Drug_Target_95_Locus:
Not Available

# Drug_Target_95_Molecular_Weight:
35912

# Drug_Target_95_Name:
Alcohol dehydrogenase

# Drug_Target_95_Number_of_Residues:
342

# Drug_Target_95_PDB_ID:
1LLU

# Drug_Target_95_Pathway:
Not Available

# Drug_Target_95_Pfam_Domain_Function:
PF00107	ADH_zinc_N
PF08240	ADH_N

# Drug_Target_95_Protein_Sequence:
>Alcohol dehydrogenase
MTLPQTMKAAVVHAYGAPLRIEEVKVPLPGPGQVLVKIEASGVCHTDLHAAEGDWPVKPP
LPFIPGHEGVGYVAAVGSGVTRVKEGDRVGIPWLYTACGCCEHCLTGWETLCESQQNTGY
SVNGGYAEYVLADPNYVGILPKNVEFAEIAPILCAGVTVYKGLKQTNARPGQWVAISGIG
GLGHVAVQYARAMGLHVAAIDIDDAKLELARKLGASLTVNARQEDPVEVLQRDIGGAHGV
LVTAVSNSAFGQAIGMARRGGTIALVGLPPGDFPTPIFDVVLKGLHIAGSIVGTRADLQE
ALDFAGEGLVKATIHPGKLDDINQILDQMRAGQIEGRIVLEM

# Drug_Target_95_Reaction:
Not Available

# Drug_Target_95_Signals:
None

# Drug_Target_95_Specific_Function:
Not Available

# Drug_Target_95_SwissProt_ID:
Q9HTD9

# Drug_Target_95_SwissProt_Name:
Q9HTD9_PSEAE

# Drug_Target_95_Synonyms:
Not Available

# Drug_Target_95_Theoretical_pI:
5.78

# Drug_Target_95_Transmembrane_Regions:
None

# Drug_Target_96_Cellular_Location:
Not Available

# Drug_Target_96_Chromosome_Location:
Not Available

# Drug_Target_96_Drug_References:
Not Available

# Drug_Target_96_Essentiality:
Non-Essential

# Drug_Target_96_GenAtlas_ID:
Not Available

# Drug_Target_96_GenBank_ID_Gene:
D86412

# Drug_Target_96_GenBank_ID_Protein:
Not Available

# Drug_Target_96_GeneCard_ID:
Not Available

# Drug_Target_96_Gene_Name:
budC

# Drug_Target_96_Gene_Sequence:
>771 bp
ATGAAAAAAGTCGCACTTGTTACCGGCGCCGGCCAGGGGATTGGTAAAGCTATCGCCCTT
CGTCTGGTGAAGGATGGATTTGCCGTGGCCATTGCCGATTATAACGACGCCACCGCCAAA
GCGGTCGCCTCGGAAATCAACCAGGCCGGCGGACACGCCGTGGCGGTGAAAGTGGATGTC
TCCGACCGCGATCAGGTATTTGCCGCCGTTGAACAGGCGCGCAAAACGCTGGGCGGCTTC
GACGTCATCGTCAATAACGCCGGTGTGGCACCGTCTACGCCGATCGAGTCCATTACCCCG
GAGATTGTCGACAAAGTCTACAACATCAACGTCAAAGGGGTGATCTGGGGTATTCAGGCG
GCGGTCGAGGCCTTTAAGAAAGAGGGGCACGGCGGGAAAATCATCAACGCCTGTTCCCAG
GCCGGCCACGTCGGCAACCCGGAGCTGGCGGTGTATAGCTCCAGTAAATTCGCGGTACGC
GGCTTAACCCAGACCGCCGCTCGCGACCTCGCGCCGCTGGGCATCACGGTCAACGGCTAC
TGCCCGGGGATTGTCAAAACGCCAATGTGGGCCGAAATTGACCGCCAGGTGTCCGAAGCC
GCCGGTAAACCGCTGGGCTACGGTACCGCCGAGTTCGCCAAACGCATCACTCTCGGTCGT
CTGTCCGAGCCGGAAGATGTCGCCGCCTGCGTCTCCTATCTTGCCAGCCCGGATTCTGAT
TACATGACCGGTCAGTCGTTGCTGATCGACGGCGGGATGGTATTTAACTAA

# Drug_Target_96_General_Function:
Involved in oxidoreductase activity

# Drug_Target_96_General_References:
11173520	Otagiri M, Kurisu G, Ui S, Takusagawa Y, Ohkuma M, Kudo T, Kusunoki M: Crystal structure of meso-2,3-butanediol dehydrogenase in a complex with NAD+ and inhibitor mercaptoethanol at 1.7 A resolution for understanding of chiral substrate recognition mechanisms. J Biochem. 2001 Feb;129(2):205-8.

# Drug_Target_96_HGNC_ID:
Not Available

# Drug_Target_96_HPRD_ID:
Not Available

# Drug_Target_96_ID:
4509

# Drug_Target_96_Locus:
Not Available

# Drug_Target_96_Molecular_Weight:
26643

# Drug_Target_96_Name:
Acetoin(diacetyl) reductase

# Drug_Target_96_Number_of_Residues:
256

# Drug_Target_96_PDB_ID:
1GEG

# Drug_Target_96_Pathway:
Not Available

# Drug_Target_96_Pfam_Domain_Function:
PF00106	adh_short

# Drug_Target_96_Protein_Sequence:
>Acetoin(diacetyl) reductase
MKKVALVTGAGQGIGKAIALRLVKDGFAVAIADYNDATAKAVASEINQAGGRAMAVKVDV
SDRDQVFAAVEQARKTLGGFDVIVNNAGVAPSTPIESITPEIVDKVYNINVKGVIWGIQA
AVEAFKKEGHGGKIINACSQAGHVGNPELAVYSSSKFAVRGLTQTAARDLAPLGITVNGY
CPGIVKTPMWAEIDRQVSEAAGKPLGYGTAEFAKRITLGRLSEPEDVAACVSYLASPDSD
YMTGQSLLIDGGMVFN

# Drug_Target_96_Reaction:
Not Available

# Drug_Target_96_Signals:
None

# Drug_Target_96_Specific_Function:
Catalyzes the reversible reduction of acetoin to 2,3- butanediol in the presence of NADH

# Drug_Target_96_SwissProt_ID:
Q48436

# Drug_Target_96_SwissProt_Name:
BUDC_KLEPN

# Drug_Target_96_Synonyms:
AR
Acetoin dehydrogenase
EC 1.1.1.5
Meso-2,3-butanediol dehydrogenase

# Drug_Target_96_Theoretical_pI:
6.53

# Drug_Target_96_Transmembrane_Regions:
None

# Drug_Target_97_Cellular_Location:
Not Available

# Drug_Target_97_Chromosome_Location:
Not Available

# Drug_Target_97_Drug_References:
Not Available

# Drug_Target_97_Essentiality:
Non-Essential

# Drug_Target_97_GenAtlas_ID:
Not Available

# Drug_Target_97_GenBank_ID_Gene:
X60220

# Drug_Target_97_GenBank_ID_Protein:
Not Available

# Drug_Target_97_GeneCard_ID:
Not Available

# Drug_Target_97_Gene_Name:
ldhA

# Drug_Target_97_Gene_Sequence:
>1002 bp
ATGACTAAAATTTTTGCTTACGCAATTCGTGAAGATGAAAAGCCATTCTTGAAGGAATGG
GAAGACGCTCACAAGGACGTCGAAGTTGAATACACTGACAAGCTTTTGACCCCAGAAACT
GTTGCTTTGGCAAAGGGTGCTGACGGTGTTGTTGTTTACCAACAACTTGACTACACCGCT
GAAACTCTGCAAGCTTTGGCAGACAACGGCATCACTAAGATGAGCCTGCGTAACGTTGGT
GTTGACAACATCGACATGGCTAAGGCTAAGGAACTTGGCTTCCAAATCACCAACGTTCCA
GTTTACTCACCAAACGCCATCGCAGAACACGCTGCTATCCAAGCTGCCGCCATCCTGCGT
CAAGACAAGGCTATGGACGAAAAGGTTGCCCGTCACGACTTGCGTTGGGCACCAACTATC
GGCCGTGAAGTTCGCGACCAAGTTGTTGGTGTTATAGGTACTGGCCACATCGGTCAAGTC
TTCATGCAAATCATGGAAGGCTTCGGCGCTAAGGTTATCACTTACGACATCTTCCGCAAC
CCAGAATTGGAAAAGAAGGGCTACTACGTAGACTCACTTGACGACCTGTACAAGCAAGCT
GACGTTATTTCCCTGCACGTTCCTGACGTTCCAGCTAACGTTCACATGATCAACGACGAG
TCAATCGCTAAAATGAAGCAAGACGTAGTTATCGTTAACGTATCACGTGGTCCATTGGTT
GACACTGACGCGGTTATCCGTGGTTTGGACTCAGGCAAGATCTTCGGTTACGCAATGGAC
GTTTACGAAGGTGAAGTTGGCATCTTCAACGAAGACTGGGAAGGCAAGGAATTCCCAGAC
GCACGTTTAGCTGACTTAATCGCTCGTCCAAACGTTCTGGTAACTCCACACACTGCTTTC
TACACTACTCACGCTGTTCGCAACATGGTAGTTAAGGCCTTCGACAACAACCTTGAATTG
GTTGAAGGCAAGGAAGCTGAAACTCCAGTTAAGGTTGGCTAA

# Drug_Target_97_General_Function:
Involved in oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor

# Drug_Target_97_General_References:
1567457	Kochhar S, Hunziker PE, Leong-Morgenthaler P, Hottinger H: Evolutionary relationship of NAD(+)-dependent D-lactate dehydrogenase: comparison of primary structure of 2-hydroxy acid dehydrogenases. Biochem Biophys Res Commun. 1992 Apr 15;184(1):60-6.
1569100	Kochhar S, Hunziker PE, Leong-Morgenthaler P, Hottinger H: Primary structure, physicochemical properties, and chemical modification of NAD(+)-dependent D-lactate dehydrogenase. Evidence for the presence of Arg-235, His-303, Tyr-101, and Trp-19 at or near the active site. J Biol Chem. 1992 Apr 25;267(12):8499-513.
1610363	Kochhar S, Chuard N, Hottinger H: Cloning and overexpression of the Lactobacillus bulgaricus NAD(+)-dependent D-lactate dehydrogenase gene in Escherichia coli:purification and characterization of the recombinant enzyme. Biochem Biophys Res Commun. 1992 Jun 15;185(2):705-12.
1915894	Bernard N, Ferain T, Garmyn D, Hols P, Delcour J: Cloning of the D-lactate dehydrogenase gene from Lactobacillus delbrueckii subsp. bulgaricus by complementation in Escherichia coli. FEBS Lett. 1991 Sep 23;290(1-2):61-4.
8476420	Vinals C, Depiereux E, Feytmans E: Prediction of structurally conserved regions of D-specific hydroxy acid dehydrogenases by multiple alignment with formate dehydrogenase. Biochem Biophys Res Commun. 1993 Apr 15;192(1):182-8.
9063466	Bernard N, Johnsen K, Gelpi JL, Alvarez JA, Ferain T, Garmyn D, Hols P, Cortes A, Clarke AR, Holbrook JJ, Delcour J: D-2-hydroxy-4-methylvalerate dehydrogenase from Lactobacillus delbrueckii subsp. bulgaricus. II. Mutagenic analysis of catalytically important residues. Eur J Biochem. 1997 Feb 15;244(1):213-9.

# Drug_Target_97_HGNC_ID:
Not Available

# Drug_Target_97_HPRD_ID:
Not Available

# Drug_Target_97_ID:
4510

# Drug_Target_97_Locus:
Not Available

# Drug_Target_97_Molecular_Weight:
37050

# Drug_Target_97_Name:
D-lactate dehydrogenase

# Drug_Target_97_Number_of_Residues:
333

# Drug_Target_97_PDB_ID:
1J49

# Drug_Target_97_Pathway:
Not Available

# Drug_Target_97_Pfam_Domain_Function:
PF00389	2-Hacid_dh
PF02826	2-Hacid_dh_C

# Drug_Target_97_Protein_Sequence:
>D-lactate dehydrogenase
MTKIFAYAIREDEKPFLKEWEDAHKDVEVEYTDKLLTPETVALAKGADGVVVYQQLDYTA
ETLQALADNGITKMSLRNVGVDNIDMAKAKELGFQITNVPVYSPNAIAEHAAIQAARILR
QDKAMDEKVARHDLRWAPTIGREVRDQVVGVIGTGHIGQVFMQIMEGFGAKVIAYDIFRN
PELEKKGYYVDSLDDLYKQADVISLHVPDVPANVHMINDESIAKMKQDVVIVNVSRGPLV
DTDAVIRGLDSGKIFGYAMDVYEGEVGIFNEDWEGKEFPDARLADLIARPNVLVTPHTAF
YTTHAVRNMVVKAFDNNLELVEGKEAETPVKVG

# Drug_Target_97_Reaction:
Not Available

# Drug_Target_97_Signals:
None

# Drug_Target_97_Specific_Function:
(R)-lactate + NAD(+) = pyruvate + NADH

# Drug_Target_97_SwissProt_ID:
P26297

# Drug_Target_97_SwissProt_Name:
LDHD_LACDA

# Drug_Target_97_Synonyms:
D-LDH
D-specific D-2- hydroxyacid dehydrogenase
EC 1.1.1.28

# Drug_Target_97_Theoretical_pI:
4.64

# Drug_Target_97_Transmembrane_Regions:
None

# Drug_Target_98_Cellular_Location:
Not Available

# Drug_Target_98_Chromosome_Location:
Not Available

# Drug_Target_98_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_98_Essentiality:
Non-Essential

# Drug_Target_98_GenAtlas_ID:
Not Available

# Drug_Target_98_GenBank_ID_Gene:
L08444

# Drug_Target_98_GenBank_ID_Protein:
295189

# Drug_Target_98_GeneCard_ID:
Not Available

# Drug_Target_98_Gene_Name:
hasB

# Drug_Target_98_Gene_Sequence:
>1209 bp
ATGAAAATAGCAGTTGCTGGATCAGGATATGTTGGATTATCACTAGGAGTTCTTTTATCA
CTTCAAAACGAAGTCACTATTGTTGATATTCTTCCCTCTAAAGTTGATAAGATTAATAAT
GGCTTATCACCAATTCAAGATGAATATATTGAATATTACTTAAAAAGTAAGCAATTATCT
ATTAAAGCAACTTTAGATAGCAAAGCAGCTTATAAAGAAGCGGAACTGGTCATTATTGCC
ACACCTACAAATTACAACAGTAGAATTAATTATTTTGATACACAGCATGTTGAAACAGTT
ATCAAAGAGGTACTAAGCGTTAATAGCCATGCAACTCTTATCATCAAATCAACAATTCCA
ATAGGTTTCATTACTGAAATGAGACAGAAATTCCAAACTGATCGTATTATCTTCAGCCCT
GAATTTTTAAGAGAATCTAAAGCTTTATATGACAACTTATATCCAAGCCGAATTATTGTT
TCTTGTGAAGAAAACGATTCTCCAAAAGTAAAGGCAGACGCAGAAAAATTTGCACTTTTA
TTAAAGTCTGCAGCTAAAAAAAATAATGTACCAGTACTTATTATGGGAGCTTCAGAAGCT
GAAGCAGTAAAACTATTTGCCAATACTTATTTAGCGTTAAGGGTAGCTTATTTTAATGAG
TTAGACACTTACGCAGAATCGAGAAAATTAAATAGTCACATGATTATTCAAGGAATTTCT
TATGATGATCGAATAGGAATGCATTATAATAACCCATCATTTGGTTATGGAGGTTATTGT
CTACCTAAAGATACGAAGCAATTATTGGCAAATTACAATAATATTCCCCAAACACTAATT
GAAGCTATCGTTTCATCAAATAATGTGCGCAAGTCCTATATTGCTAAGCAAATTATCAAC
GTCTTAAAAGAGCAGGAGTCCCCAGTAAAAGTAGTCGGGGTTTACCGTTTAATTATGAAA
AGTAACTCAGATAACTTTAGAGAAAGTGCTATCAAAGATGTTATTGACATTCTTAAAAGT
AAAGACATTAAGATAATTATTTATGAGCCAATGTTAAACAAACTTGAATCTGAAGATCAA
TCTGTACTTGTAAATGATTTAGAGAATTTCAAGAAACAAGCAAATATTATCGTAACTAAT
CGCTATGATAATGAATTACAAGATGTTAAAAATAAAGTTTACAGTAGAGATATTTTTGGT
AGAGACTAG

# Drug_Target_98_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_98_General_References:
10841783	Campbell RE, Mosimann SC, van De Rijn I, Tanner ME, Strynadka NC: The first structure of UDP-glucose dehydrogenase reveals the catalytic residues necessary for the two-fold oxidation. Biochemistry. 2000 Jun 13;39(23):7012-23.
8463246	Dougherty BA, van de Rijn I: Molecular characterization of hasB from an operon required for hyaluronic acid synthesis in group A streptococci. Demonstration of UDP-glucose dehydrogenase activity. J Biol Chem. 1993 Apr 5;268(10):7118-24.

# Drug_Target_98_HGNC_ID:
Not Available

# Drug_Target_98_HPRD_ID:
Not Available

# Drug_Target_98_ID:
3672

# Drug_Target_98_Locus:
Not Available

# Drug_Target_98_Molecular_Weight:
45484

# Drug_Target_98_Name:
UDP-glucose 6-dehydrogenase

# Drug_Target_98_Number_of_Residues:
402

# Drug_Target_98_PDB_ID:
1DLI

# Drug_Target_98_Pathway:
Not Available

# Drug_Target_98_Pfam_Domain_Function:
PF00984	UDPG_MGDP_dh
PF03720	UDPG_MGDP_dh_C
PF03721	UDPG_MGDP_dh_N

# Drug_Target_98_Protein_Sequence:
>UDP-glucose 6-dehydrogenase
MKIAVAGSGYVGLSLGVLLSLQNEVTIVDILPSKVDKINNGLSPIQDEYIEYYLKSKQLS
IKATLDSKAAYKEAELVIIATPTNYNSRINYFDTQHVETVIKEVLSVNSHATLIIKSTIP
IGFITEMRQKFQTDRIIFSPEFLRESKALYDNLYPSRIIVSCEENDSPKVKADAEKFALL
LKSAAKKNNVPVLIMGASEAEAVKLFANTYLALRVAYFNELDTYAESRKLNSHMIIQGIS
YDDRIGMHYNNPSFGYGGYCLPKDTKQLLANYNNIPQTLIEAIVSSNNVRKSYIAKQIIN
VLKEQESPVKVVGVYRLIMKSNSDNFRESAIKDVIDILKSKDIKIIIYEPMLNKLESEDQ
SVLVNDLENFKKQANIIVTNRYDNELQDVKNKVYSRDIFGRD

# Drug_Target_98_Reaction:
UDP-glucose + 2 NAD+ + H2O = UDP-glucuronate + 2 NADH + 2 H+

# Drug_Target_98_Signals:
None

# Drug_Target_98_Specific_Function:
Catalyzes the formation of UDP-glucuronic acid which is required for capsular hyaluronic acid synthesis

# Drug_Target_98_SwissProt_ID:
P0C0F4

# Drug_Target_98_SwissProt_Name:
UDG_STRPY

# Drug_Target_98_Synonyms:
EC 1.1.1.22
UDP-Glc dehydrogenase
UDP-GlcDH
UDPGDH

# Drug_Target_98_Theoretical_pI:
8.10

# Drug_Target_98_Transmembrane_Regions:
None

# Drug_Target_99_Cellular_Location:
Cell inner membrane
peripheral membrane protein

# Drug_Target_99_Chromosome_Location:
Not Available

# Drug_Target_99_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_99_Essentiality:
Non-Essential

# Drug_Target_99_GenAtlas_ID:
Not Available

# Drug_Target_99_GenBank_ID_Gene:
X78733

# Drug_Target_99_GenBank_ID_Protein:
587106

# Drug_Target_99_GeneCard_ID:
Not Available

# Drug_Target_99_Gene_Name:
fabI

# Drug_Target_99_Gene_Sequence:
>789 bp
ATGGGTTTTCTTTCCGGTAAGCGCATTCTGGTAACCGGTGTTGCCAGCAAACTATCCATC
GCCTACGGTATCGCTCAGGCGATGCACCGCGAAGGAGCTGAACTGGCATTCACCTACCAG
AACGACAAACTGAAAGGCCGCGTAGAAGAATTTGCCGCTCAATTGGGTTCTGACATCGTT
CTGCAGTGCGATGTTGCAGAAGATGCCAGCATCGACACCATGTTCGCTGAACTGGGGAAA
GTTTGGCCGAAATTTGACGGTTTCGTACACTCTATTGGTTTTGCACCTGGCGATCAGCTG
GATGGTGACTATGTTAACGCCGTTACCCGTGAAGGCTTCAAAATTGCCCACGACATCAGC
TCCTACAGCTTCGTTGCAATGGCAAAAGCTTGCCGCTCCATGCTGAATCCGGGTTCTGCC
CTGCTGACCCTTTCCTACCTTGGCGCTGAGCGCGCTATCCCGAACTACAACGTTATGGGT
CTGGCAAAAGCGTCTCTGGAAGCGAACGTGCGCTATATGGCGAACGCGATGGGTCCGGAA
GGTGTGCGTGTTAACGCCATCTCTGCTGGTCCGATCCGTACTCTGGCGGCCTCCGGTATC
AAAGACTTCCGCAAAATGCTGGCTCATTGCGAAGCCGTTACCCCGATTCGCCGTACCGTT
ACTATTGAAGATGTGGGTAACTCTGCGGCATTCCTGTGCTCCGATCTCTCTGCCGGTATC
TCCGGTGAAGTGGTCCACGTTGACGGCGGTTTCAGCATTGCTGCAATGAACGAACTCGAA
CTGAAATAA

# Drug_Target_99_General_Function:
Lipid transport and metabolism

# Drug_Target_99_General_References:
10201369	Levy CW, Roujeinikova A, Sedelnikova S, Baker PJ, Stuitje AR, Slabas AR, Rice DW, Rafferty JB: Molecular basis of triclosan activity. Nature. 1999 Apr 1;398(6726):383-4.
10398587	Stewart MJ, Parikh S, Xiao G, Tonge PJ, Kisker C: Structural basis and mechanism of enoyl reductase inhibition by triclosan. J Mol Biol. 1999 Jul 23;290(4):859-65.
10493822	Ward WH, Holdgate GA, Rowsell S, McLean EG, Pauptit RA, Clayton E, Nichols WW, Colls JG, Minshull CA, Jude DA, Mistry A, Timms D, Camble R, Hales NJ, Britton CJ, Taylor IW: Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan. Biochemistry. 1999 Sep 21;38(38):12514-25.
1364817	Bergler H, Hogenauer G, Turnowsky F: Sequences of the envM gene and of two mutated alleles in Escherichia coli. J Gen Microbiol. 1992 Oct;138(10):2093-100.
8075395	Kater MM, Koningstein GM, Nijkamp HJ, Stuitje AR: The use of a hybrid genetic system to study the functional relationship between prokaryotic and plant multi-enzyme fatty acid synthetase complexes. Plant Mol Biol. 1994 Aug;25(5):771-90.
8119879	Bergler H, Wallner P, Ebeling A, Leitinger B, Fuchsbichler S, Aschauer H, Kollenz G, Hogenauer G, Turnowsky F: Protein EnvM is the NADH-dependent enoyl-ACP reductase (FabI) of Escherichia coli. J Biol Chem. 1994 Feb 25;269(8):5493-6.
8953047	Baldock C, Rafferty JB, Sedelnikova SE, Baker PJ, Stuitje AR, Slabas AR, Hawkes TR, Rice DW: A mechanism of drug action revealed by structural studies of enoyl reductase. Science. 1996 Dec 20;274(5295):2107-10.
9097039	Aiba H, Baba T, Hayashi K, Inada T, Isono K, Itoh T, Kasai H, Kashimoto K, Kimura S, Kitakawa M, Kitagawa M, Makino K, Miki T, Mizobuchi K, Mori H, Mori T, Motomura K, Nakade S, Nakamura Y, Nashimoto H, Nishio Y, Oshima T, Saito N, Sampei G, Horiuchi T, et al.: A 570-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 28.0-40.1 min region on the linkage map. DNA Res. 1996 Dec 31;3(6):363-77.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9298646	Link AJ, Robison K, Church GM: Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12. Electrophoresis. 1997 Aug;18(8):1259-313.

# Drug_Target_99_HGNC_ID:
Not Available

# Drug_Target_99_HPRD_ID:
Not Available

# Drug_Target_99_ID:
3678

# Drug_Target_99_Locus:
Not Available

# Drug_Target_99_Molecular_Weight:
27864

# Drug_Target_99_Name:
Enoyl-[acyl-carrier-protein] reductase [NADH]

# Drug_Target_99_Number_of_Residues:
262

# Drug_Target_99_PDB_ID:
1MFP

# Drug_Target_99_Pathway:
Not Available

# Drug_Target_99_Pfam_Domain_Function:
PF00106	adh_short

# Drug_Target_99_Protein_Sequence:
>Enoyl-[acyl-carrier-protein] reductase [NADH]
MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIV
LQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDIS
SYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPE
GVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGI
SGEVVHVDGGFSIAAMNELELK

# Drug_Target_99_Reaction:
acyl-[acyl-carrier protein] + NAD+ = trans-2,3-dehydroacyl-[acyl-carrier protein] + NADH + H+

# Drug_Target_99_Signals:
None

# Drug_Target_99_Specific_Function:
Acyl-[acyl-carrier-protein] + NAD(+) = trans- 2,3-dehydroacyl-[acyl-carrier-protein] + NADH

# Drug_Target_99_SwissProt_ID:
P0AEK4

# Drug_Target_99_SwissProt_Name:
FABI_ECOLI

# Drug_Target_99_Synonyms:
EC 1.3.1.9
NADH- dependent enoyl-ACP reductase

# Drug_Target_99_Theoretical_pI:
5.67

# Drug_Target_99_Transmembrane_Regions:
None

# Drug_Target_9_Cellular_Location:
Not Available

# Drug_Target_9_Chromosome_Location:
Not Available

# Drug_Target_9_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_9_Essentiality:
Non-Essential

# Drug_Target_9_GenAtlas_ID:
Not Available

# Drug_Target_9_GenBank_ID_Gene:
M29682

# Drug_Target_9_GenBank_ID_Protein:
154340

# Drug_Target_9_GeneCard_ID:
Not Available

# Drug_Target_9_Gene_Name:
rfbE

# Drug_Target_9_Gene_Sequence:
>1017 bp
ATGAAGCTTTTAATTACCGGTGGATGTGGCTTCCTTGGGAGTAATCTTGCCTCCTTTGCT
TTAAGTCAAGGGATTGATTTAATTGTATTCGATAATCTATCACGTAAAGGTGCAACAGAT
AATTTACATTGGTTATCCTCCTTAGGAAACTTTGAGTTTGTACATGGTGATATTCGCAAC
AAAAATGATGTTACAAGATTAATAACTAAGTATATGCCTGATAGCTGTTTTCATCTTGCA
GGTCAAGTGGCAATGACTACATCTATTGACAATCCTTGTATGGATTTTGAAATTAATGTA
GGTGGAACTTTAAATTTACTTGAGGCAGTACGGCAGTATAATTCAAATTGTAATATAATT
TATTCATCAACAAATAAAGTATACGGCGATCTTGAGCAATATAAATACAATGAAACAGAA
ACTAGATACACTTGTGTAGATAAGCCTAATGGATATGATGAGAGCACACAATTAGATTTC
CACTCACCATATGGTTGTTCAAAAGGTGCTGCAGACCAATACATGCTTGATTATGCAAGG
ATTTTTGGTTTGAATACAGTGGTGTTCAGGCATTCATCAATGTATGGTGGGAGACAGTTT
GCTACTTATGATCAAGGCTGGGTAGGTTGGTTTTGTCAAAAAGCGGTTGAAATTAAAAAT
GGTATTAATAAACCCTTCACTATTTCTGGTAATGGTAAGCAAGTTAGGGATGTTTTGCAT
GCTGAAGATATGATTTCGTTATATTTCACTGCCTTGGCAAATGTATCAAAAATTAGGGGG
AACGCTTTTAATATTGGTGGTACCATTGTCAACAGCCTATCATTACTTGAATTATTCAAA
TTGCTTGAAGATTATTGCAACATAGATATGAGGTTCACTAATTTACCTGTAAGGGAAAGT
GATCAGCGTGTTTTTGTTGCAGATATTAAAAAAATCACTAATGCAATTGACTGGAGCCCG
AAAGTCTCGGCAAAAGATGGTGTCCAGAAAATGTATGATTGGACTAGTTCTATATGA

# Drug_Target_9_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_9_General_References:
11677608	Parkhill J, Dougan G, James KD, Thomson NR, Pickard D, Wain J, Churcher C, Mungall KL, Bentley SD, Holden MT, Sebaihia M, Baker S, Basham D, Brooks K, Chillingworth T, Connerton P, Cronin A, Davis P, Davies RM, Dowd L, White N, Farrar J, Feltwell T, Hamlin N, Haque A, Hien TT, Holroyd S, Jagels K, Krogh A, Larsen TS, Leather S, Moule S, O'Gaora P, Parry C, Quail M, Rutherford K, Simmonds M, Skelton J, Stevens K, Whitehead S, Barrell BG: Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18. Nature. 2001 Oct 25;413(6858):848-52.
12642575	Koropatkin NM, Liu HW, Holden HM: High resolution x-ray structure of tyvelose epimerase from Salmonella typhi. J Biol Chem. 2003 Jun 6;278(23):20874-81. Epub 2003 Mar 17.
12644504	Deng W, Liou SR, Plunkett G 3rd, Mayhew GF, Rose DJ, Burland V, Kodoyianni V, Schwartz DC, Blattner FR: Comparative genomics of Salmonella enterica serovar Typhi strains Ty2 and CT18. J Bacteriol. 2003 Apr;185(7):2330-7.
2793833	Verma N, Reeves P: Identification and sequence of rfbS and rfbE, which determine antigenic specificity of group A and group D salmonellae. J Bacteriol. 1989 Oct;171(10):5694-701.

# Drug_Target_9_HGNC_ID:
Not Available

# Drug_Target_9_HPRD_ID:
Not Available

# Drug_Target_9_ID:
2967

# Drug_Target_9_Locus:
Not Available

# Drug_Target_9_Molecular_Weight:
37958

# Drug_Target_9_Name:
CDP-paratose 2-epimerase

# Drug_Target_9_Number_of_Residues:
338

# Drug_Target_9_PDB_ID:
1ORR

# Drug_Target_9_Pathway:
Not Available

# Drug_Target_9_Pfam_Domain_Function:
PF01370	Epimerase

# Drug_Target_9_Protein_Sequence:
>CDP-paratose 2-epimerase
MKLLITGGCGFLGSNLASFALSQGIDLIVFDNLSRKGATDNLHWLSSLGNFEFVHGDIRN
KNDVTRLITKYMPDSCFHLAGQVAMTTSIDNPCMDFEINVGGTLNLLEAVRQYNSNCNII
YSSTNKVYGDLEQYKYNETETRYTCVDKPNGYDESTQLDFHSPYGCSKGAADQYMLDYAR
IFGLNTVVFRHSSMYGGRQFATYDQGWVGWFCQKAVEIKNGINKPFTISGNGKQVRDVLH
AEDMISLYFTALANVSKIRGNAFNIGGTIVNSLSLLELFKLLEDYCNIDMRFTNLPVRES
DQRVFVADIKKITNAIDWSPKVSAKDGVQKMYDWTSSI

# Drug_Target_9_Reaction:
CDP-3,6-dideoxy-D-glucose = CDP-3,6-dideoxy-D-mannose

# Drug_Target_9_Signals:
None

# Drug_Target_9_Specific_Function:
Catalyzes the isomeration of CDP-paratose to CDP- tyvelose

# Drug_Target_9_SwissProt_ID:
P14169

# Drug_Target_9_SwissProt_Name:
RFBE_SALTI

# Drug_Target_9_Synonyms:
CDP-tyvelose 2-epimerase
EC 5.1.3.10

# Drug_Target_9_Theoretical_pI:
6.25

# Drug_Target_9_Transmembrane_Regions:
None

#END_DRUGCARD DB01907
